Psyllid ID: psy13250
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 224 | 2.2.26 [Sep-21-2011] | |||||||
| Q15131 | 360 | Cyclin-dependent kinase 1 | yes | N/A | 0.656 | 0.408 | 0.644 | 3e-51 | |
| Q2TBL8 | 361 | Cyclin-dependent kinase 1 | yes | N/A | 0.656 | 0.407 | 0.644 | 3e-51 | |
| Q3UMM4 | 360 | Cyclin-dependent kinase 1 | yes | N/A | 0.656 | 0.408 | 0.644 | 3e-51 | |
| Q4KM47 | 358 | Cyclin-dependent kinase 1 | yes | N/A | 0.656 | 0.410 | 0.637 | 1e-50 | |
| Q7XUF4 | 710 | Cyclin-dependent kinase G | yes | N/A | 0.647 | 0.204 | 0.523 | 1e-38 | |
| A2XUW1 | 710 | Cyclin-dependent kinase G | N/A | N/A | 0.647 | 0.204 | 0.523 | 1e-38 | |
| A2X6X1 | 693 | Cyclin-dependent kinase G | N/A | N/A | 0.647 | 0.209 | 0.503 | 6e-37 | |
| Q6K5F8 | 693 | Cyclin-dependent kinase G | no | N/A | 0.647 | 0.209 | 0.503 | 6e-37 | |
| P24788 | 784 | Cyclin-dependent kinase 1 | no | N/A | 0.785 | 0.224 | 0.415 | 4e-36 | |
| Q9UQ88 | 783 | Cyclin-dependent kinase 1 | no | N/A | 0.785 | 0.224 | 0.415 | 8e-36 |
| >sp|Q15131|CDK10_HUMAN Cyclin-dependent kinase 10 OS=Homo sapiens GN=CDK10 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 201 bits (512), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 96/149 (64%), Positives = 120/149 (80%), Gaps = 2/149 (1%)
Query: 66 FGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTG 123
G+CR+V EFEKLNRIGEG+YG+VYR RD+ D+I+ALKK+ + + + + LRE+T
Sbjct: 30 LGRCRSVKEFEKLNRIGEGTYGIVYRARDTQTDEIVALKKVRMDKEKDGIPISSLREITL 89
Query: 124 LTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLK 183
L + RH NIV+LKEVVVG L SIFLVM YCE DLASL +N+ +PF+E+QVKC++LQVL+
Sbjct: 90 LLRLRHPNIVELKEVVVGNHLESIFLVMGYCEQDLASLLENMPTPFSEAQVKCIVLQVLR 149
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVK 212
GL YLH NFIIHRDLK SNLL+ DKGCVK
Sbjct: 150 GLQYLHRNFIIHRDLKVSNLLMTDKGCVK 178
|
Homo sapiens (taxid: 9606) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 2 |
| >sp|Q2TBL8|CDK10_BOVIN Cyclin-dependent kinase 10 OS=Bos taurus GN=CDK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 201 bits (512), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 96/149 (64%), Positives = 120/149 (80%), Gaps = 2/149 (1%)
Query: 66 FGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTG 123
G+CR+V EFEKLNRIGEG+YG+VYR RD+ D+I+ALKK+ + + + + LRE+T
Sbjct: 28 LGRCRSVKEFEKLNRIGEGTYGIVYRARDTHTDEIVALKKVRMDKEKDGVPISSLREITL 87
Query: 124 LTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLK 183
L + RH NIV+LKEVVVG L SIFLVM YCE DLASL +N+ +PF+E+QVKC++LQVL+
Sbjct: 88 LLRLRHPNIVELKEVVVGNHLESIFLVMGYCEQDLASLLENMPTPFSEAQVKCIVLQVLR 147
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVK 212
GL YLH NFIIHRDLK SNLL+ DKGCVK
Sbjct: 148 GLQYLHRNFIIHRDLKVSNLLMTDKGCVK 176
|
Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q3UMM4|CDK10_MOUSE Cyclin-dependent kinase 10 OS=Mus musculus GN=Cdk10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 201 bits (511), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 96/149 (64%), Positives = 120/149 (80%), Gaps = 2/149 (1%)
Query: 66 FGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTG 123
G+CR+V EFEKLNRIGEG+YG+VYR RD+ D+I+ALKK+ + + + + LRE+T
Sbjct: 30 LGRCRSVKEFEKLNRIGEGTYGIVYRARDTQTDEIVALKKVRMDKEKDGIPISSLREITL 89
Query: 124 LTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLK 183
L + RH NIV+LKEVVVG L SIFLVM YCE DLASL +N+ +PF+E+QVKC++LQVL+
Sbjct: 90 LLRLRHPNIVELKEVVVGNHLESIFLVMGYCEQDLASLLENMPTPFSEAQVKCIMLQVLR 149
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVK 212
GL YLH NFIIHRDLK SNLL+ DKGCVK
Sbjct: 150 GLQYLHRNFIIHRDLKVSNLLMTDKGCVK 178
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q4KM47|CDK10_RAT Cyclin-dependent kinase 10 OS=Rattus norvegicus GN=Cdk10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 199 bits (506), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 95/149 (63%), Positives = 120/149 (80%), Gaps = 2/149 (1%)
Query: 66 FGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTG 123
G+CR+V EFEKLNRIGEG+YG+VYR RD+ D+I+ALKK+ + + + + LRE+T
Sbjct: 28 LGRCRSVKEFEKLNRIGEGTYGIVYRARDTQTDEIVALKKVRMDKEKDGIPISSLREITL 87
Query: 124 LTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLK 183
L + RH NIV+LKEVVVG L SIFLVM YCE DLASL +N+ +PF+E+QVKC++LQVL+
Sbjct: 88 LLRLRHPNIVELKEVVVGNHLESIFLVMGYCEQDLASLLENMPTPFSEAQVKCILLQVLR 147
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVK 212
GL YLH +FIIHRDLK SNLL+ DKGCVK
Sbjct: 148 GLQYLHRSFIIHRDLKVSNLLMTDKGCVK 176
|
Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q7XUF4|CDKG2_ORYSJ Cyclin-dependent kinase G-2 OS=Oryza sativa subsp. japonica GN=CDKG-2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 159 bits (402), Expect = 1e-38, Method: Composition-based stats.
Identities = 77/147 (52%), Positives = 109/147 (74%), Gaps = 2/147 (1%)
Query: 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTK 126
CR+V EFE+LN+I EG+YGVVYR RD +I+ALKK+ ++ LRE+ L
Sbjct: 359 CRSVDEFERLNKINEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLS 418
Query: 127 CRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLN 186
H +IV +KEVVVG SL SIF+VMEY EHDL + + ++ P+++S+VKC++LQ+L+G+
Sbjct: 419 FHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKGVMEAMKQPYSQSEVKCLMLQLLEGVK 478
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YLH N+++HRDLK SNLLLN++G +KI
Sbjct: 479 YLHDNWVLHRDLKTSNLLLNNRGELKI 505
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|A2XUW1|CDKG2_ORYSI Cyclin-dependent kinase G-2 OS=Oryza sativa subsp. indica GN=CDKG-2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 159 bits (402), Expect = 1e-38, Method: Composition-based stats.
Identities = 77/147 (52%), Positives = 109/147 (74%), Gaps = 2/147 (1%)
Query: 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTK 126
CR+V EFE+LN+I EG+YGVVYR RD +I+ALKK+ ++ LRE+ L
Sbjct: 359 CRSVDEFERLNKINEGTYGVVYRARDKKTGEIVALKKVKMEKEREGFPLTSLREINILLS 418
Query: 127 CRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLN 186
H +IV +KEVVVG SL SIF+VMEY EHDL + + ++ P+++S+VKC++LQ+L+G+
Sbjct: 419 FHHPSIVDVKEVVVGSSLDSIFMVMEYMEHDLKGVMEAMKQPYSQSEVKCLMLQLLEGVK 478
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YLH N+++HRDLK SNLLLN++G +KI
Sbjct: 479 YLHDNWVLHRDLKTSNLLLNNRGELKI 505
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|A2X6X1|CDKG1_ORYSI Cyclin-dependent kinase G-1 OS=Oryza sativa subsp. indica GN=CDKG-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 154 bits (388), Expect = 6e-37, Method: Compositional matrix adjust.
Identities = 74/147 (50%), Positives = 108/147 (73%), Gaps = 2/147 (1%)
Query: 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTK 126
CR+V EFE+LN I EG+YGVV+RVRD +I+ALKK+ ++ LRE+ L
Sbjct: 343 CRSVDEFERLNTINEGTYGVVFRVRDKRTGEIVALKKVKMEKEREGFPLTSLREMNILLS 402
Query: 127 CRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLN 186
H +IV++KEVVVG + IF+VMEY EHDL + + ++ P+++S+VKC++LQ+L+G+
Sbjct: 403 FHHPSIVEVKEVVVGSNDRDIFMVMEYMEHDLKGVMETMKQPYSQSEVKCLMLQLLEGVK 462
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YLH N+++HRDLK SNLLLN++G +KI
Sbjct: 463 YLHDNWVLHRDLKTSNLLLNNRGELKI 489
|
Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|Q6K5F8|CDKG1_ORYSJ Cyclin-dependent kinase G-1 OS=Oryza sativa subsp. japonica GN=CDKG-1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 154 bits (388), Expect = 6e-37, Method: Compositional matrix adjust.
Identities = 74/147 (50%), Positives = 108/147 (73%), Gaps = 2/147 (1%)
Query: 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTK 126
CR+V EFE+LN I EG+YGVV+RVRD +I+ALKK+ ++ LRE+ L
Sbjct: 343 CRSVDEFERLNTINEGTYGVVFRVRDKRTGEIVALKKVKMEKEREGFPLTSLREMNILLS 402
Query: 127 CRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLN 186
H +IV++KEVVVG + IF+VMEY EHDL + + ++ P+++S+VKC++LQ+L+G+
Sbjct: 403 FHHPSIVEVKEVVVGSNDRDIFMVMEYMEHDLKGVMETMKQPYSQSEVKCLMLQLLEGVK 462
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YLH N+++HRDLK SNLLLN++G +KI
Sbjct: 463 YLHDNWVLHRDLKTSNLLLNNRGELKI 489
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 3 |
| >sp|P24788|CD11B_MOUSE Cyclin-dependent kinase 11B OS=Mus musculus GN=Cdk11b PE=1 SV=2 | Back alignment and function description |
|---|
Score = 151 bits (381), Expect = 4e-36, Method: Compositional matrix adjust.
Identities = 76/183 (41%), Positives = 115/183 (62%), Gaps = 7/183 (3%)
Query: 38 PQSKFAKRRDVLMNFVTGEPIEILEQ-----DCFGKCRNVAEFEKLNRIGEGSYGVVYRV 92
PQS D + + PIE+ ++ CR+V EF+ LNRI EG+YGVVYR
Sbjct: 385 PQSSAPTEGDYVPDSPALSPIELKQELPKYLPALQGCRSVEEFQCLNRIEEGTYGVVYRA 444
Query: 93 RDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150
+D D+I+ALK+L ++ LRE+ + K +H NIV ++E+VVG ++ I++V
Sbjct: 445 KDKKTDEIVALKRLKMEKEKEGFPITSLREINTILKAQHPNIVTVREIVVGSNMDKIYIV 504
Query: 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC 210
M Y EHDL SL + ++ PF +VK +++Q+L G+ +LH N+I+HRDLK SNLLL+ G
Sbjct: 505 MNYVEHDLKSLMETMKQPFLPGEVKTLMIQLLSGVKHLHDNWILHRDLKTSNLLLSHAGI 564
Query: 211 VKI 213
+K+
Sbjct: 565 LKV 567
|
Acts as a negative regulator of the normal cell cycle progression. In vitro, this protein kinase has been shown to phosphorylate a number of substrates, including histone h1, casein, and galactosyltransferase. May function in regulating proliferation by the phosphorylation and subsequent plasma membrane targeting of galactosyltransferase. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9UQ88|CD11A_HUMAN Cyclin-dependent kinase 11A OS=Homo sapiens GN=CDK11A PE=1 SV=4 | Back alignment and function description |
|---|
Score = 150 bits (378), Expect = 8e-36, Method: Compositional matrix adjust.
Identities = 76/183 (41%), Positives = 116/183 (63%), Gaps = 7/183 (3%)
Query: 38 PQSKFAKRRDVLMNFVTGEPIEILEQ-----DCFGKCRNVAEFEKLNRIGEGSYGVVYRV 92
PQS D + + PIE+ ++ CR+V EF+ LNRI EG+YGVVYR
Sbjct: 384 PQSSALTEGDYVPDSPALLPIELKQELPKYLPALQGCRSVEEFQCLNRIEEGTYGVVYRA 443
Query: 93 RDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150
+D D+I+ALK+L ++ LRE+ + K +H NIV ++E+VVG ++ I++V
Sbjct: 444 KDKKTDEIVALKRLKMEKEKEGFPITSLREINTILKAQHPNIVTVREIVVGSNMDKIYIV 503
Query: 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC 210
M Y EHDL SL + ++ PF +VK +++Q+L+G+ +LH N+I+HRDLK SNLLL+ G
Sbjct: 504 MNYVEHDLKSLMETMKQPFLPGEVKTLMIQLLRGVKHLHDNWILHRDLKTSNLLLSHAGI 563
Query: 211 VKI 213
+K+
Sbjct: 564 LKV 566
|
Appears to play multiple roles in cell cycle progression, cytokinesis and apoptosis. The p110 isoforms have been suggested to be involved in pre-mRNA splicing, potentially by phosphorylating the splicing protein SFRS7. The p58 isoform may act as a negative regulator of normal cell cycle progression. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 224 | ||||||
| 383859126 | 410 | PREDICTED: cyclin-dependent kinase 10-li | 0.857 | 0.468 | 0.635 | 7e-67 | |
| 380023352 | 410 | PREDICTED: cyclin-dependent kinase 10-li | 0.857 | 0.468 | 0.625 | 1e-65 | |
| 328792585 | 411 | PREDICTED: cyclin-dependent kinase 10 [A | 0.857 | 0.467 | 0.625 | 1e-65 | |
| 350413270 | 410 | PREDICTED: cyclin-dependent kinase 10-li | 0.857 | 0.468 | 0.625 | 1e-65 | |
| 340708507 | 410 | PREDICTED: cyclin-dependent kinase 10-li | 0.857 | 0.468 | 0.625 | 1e-65 | |
| 238814355 | 405 | cyclin-dependent kinase 10 isoform 2 [Na | 0.897 | 0.496 | 0.593 | 4e-64 | |
| 238814353 | 408 | cyclin-dependent kinase 10 isoform 1 [Na | 0.866 | 0.475 | 0.611 | 4e-64 | |
| 307178092 | 401 | Cell division protein kinase 10 [Campono | 0.857 | 0.478 | 0.615 | 7e-64 | |
| 332029704 | 405 | Cell division protein kinase 10 [Acromyr | 0.857 | 0.474 | 0.615 | 9e-64 | |
| 357617680 | 403 | cdc2-related kinase [Danaus plexippus] | 0.852 | 0.473 | 0.618 | 2e-61 |
| >gi|383859126|ref|XP_003705048.1| PREDICTED: cyclin-dependent kinase 10-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 259 bits (661), Expect = 7e-67, Method: Compositional matrix adjust.
Identities = 124/195 (63%), Positives = 156/195 (80%), Gaps = 3/195 (1%)
Query: 22 ESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLNRI 81
E++D K +T++S PDP + RR VL +F+TG+P+EI EQD GKCR V+EFEKLNRI
Sbjct: 13 ENNDTDKKATSESGPDPSAPIT-RRGVLTSFLTGKPMEIPEQDILGKCRFVSEFEKLNRI 71
Query: 82 GEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVV 139
GEG+YG+VYR RD+ DK++ALKK+ ++N + L LRE++ L CRHENIV L+EVV
Sbjct: 72 GEGTYGIVYRARDTKNDKVVALKKVRMENEKDGLPVSGLREISVLLSCRHENIVHLREVV 131
Query: 140 VGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLK 199
VG+SL SIFL MEYCE DLASL DN+++PF+ESQVKC++LQVLKGL YLH NFI+HRDLK
Sbjct: 132 VGRSLESIFLAMEYCEQDLASLLDNMQAPFSESQVKCIVLQVLKGLRYLHHNFIVHRDLK 191
Query: 200 PSNLLLNDKGCVKIV 214
SNLL+ DKGCVKI
Sbjct: 192 VSNLLMTDKGCVKIA 206
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380023352|ref|XP_003695487.1| PREDICTED: cyclin-dependent kinase 10-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 255 bits (651), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 122/195 (62%), Positives = 155/195 (79%), Gaps = 3/195 (1%)
Query: 22 ESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLNRI 81
E++D K + ++S PDP + RR VL +F+TG+P+EI EQD GKCR V+EFEKLNRI
Sbjct: 13 ENNDTDKKTASESGPDPSAPIT-RRGVLTSFLTGKPMEIPEQDILGKCRFVSEFEKLNRI 71
Query: 82 GEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVV 139
GEG+YG+VYR RD+ DK++ALKK+ +++ + L LRE++ L CRHENIV L+EVV
Sbjct: 72 GEGTYGIVYRARDTKNDKVVALKKVRMEHEKDGLPVSGLREISVLLSCRHENIVHLREVV 131
Query: 140 VGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLK 199
VG+SL SIFL MEYCE DLASL DN+++PF+ESQVKC++LQVLKGL YLH NFI+HRDLK
Sbjct: 132 VGRSLESIFLAMEYCEQDLASLLDNMQAPFSESQVKCIVLQVLKGLRYLHHNFIVHRDLK 191
Query: 200 PSNLLLNDKGCVKIV 214
SNLL+ DKGCVKI
Sbjct: 192 VSNLLMTDKGCVKIA 206
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328792585|ref|XP_392973.4| PREDICTED: cyclin-dependent kinase 10 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 255 bits (651), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 122/195 (62%), Positives = 155/195 (79%), Gaps = 3/195 (1%)
Query: 22 ESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLNRI 81
E++D K + ++S PDP + RR VL +F+TG+P+EI EQD GKCR V+EFEKLNRI
Sbjct: 14 ENNDTDKKTASESGPDPSAPIT-RRGVLTSFLTGKPMEIPEQDILGKCRFVSEFEKLNRI 72
Query: 82 GEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVV 139
GEG+YG+VYR RD+ DK++ALKK+ +++ + L LRE++ L CRHENIV L+EVV
Sbjct: 73 GEGTYGIVYRARDTKNDKVVALKKVRMEHEKDGLPVSGLREISVLLSCRHENIVHLREVV 132
Query: 140 VGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLK 199
VG+SL SIFL MEYCE DLASL DN+++PF+ESQVKC++LQVLKGL YLH NFI+HRDLK
Sbjct: 133 VGRSLESIFLAMEYCEQDLASLLDNMQAPFSESQVKCIVLQVLKGLRYLHHNFIVHRDLK 192
Query: 200 PSNLLLNDKGCVKIV 214
SNLL+ DKGCVKI
Sbjct: 193 VSNLLMTDKGCVKIA 207
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350413270|ref|XP_003489943.1| PREDICTED: cyclin-dependent kinase 10-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 255 bits (651), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 122/195 (62%), Positives = 155/195 (79%), Gaps = 3/195 (1%)
Query: 22 ESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLNRI 81
E++D K + ++S PDP + RR VL +F+TG+P+EI EQD GKCR V+EFEKLNRI
Sbjct: 13 ENNDTDKKTASESGPDPSAPIT-RRGVLTSFLTGKPMEIPEQDILGKCRFVSEFEKLNRI 71
Query: 82 GEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVV 139
GEG+YG+VYR RD+ DK++ALKK+ +++ + L LRE++ L CRHENIV L+EVV
Sbjct: 72 GEGTYGIVYRARDTKNDKVVALKKVRMEHEKDGLPVSGLREISVLLSCRHENIVHLREVV 131
Query: 140 VGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLK 199
VG+SL SIFL MEYCE DLASL DN+++PF+ESQVKC++LQVLKGL YLH NFI+HRDLK
Sbjct: 132 VGRSLESIFLAMEYCEQDLASLLDNMQAPFSESQVKCIVLQVLKGLRYLHHNFIVHRDLK 191
Query: 200 PSNLLLNDKGCVKIV 214
SNLL+ DKGCVKI
Sbjct: 192 VSNLLMTDKGCVKIA 206
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340708507|ref|XP_003392867.1| PREDICTED: cyclin-dependent kinase 10-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 254 bits (650), Expect = 1e-65, Method: Compositional matrix adjust.
Identities = 122/195 (62%), Positives = 155/195 (79%), Gaps = 3/195 (1%)
Query: 22 ESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLNRI 81
E++D K + ++S PDP + RR VL +F+TG+P+EI EQD GKCR V+EFEKLNRI
Sbjct: 13 ENNDTDKKTASESGPDPSAPIT-RRGVLTSFLTGKPMEIPEQDILGKCRFVSEFEKLNRI 71
Query: 82 GEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVV 139
GEG+YG+VYR RD+ DK++ALKK+ +++ + L LRE++ L CRHENIV L+EVV
Sbjct: 72 GEGTYGIVYRARDTKNDKVVALKKVRMEHEKDGLPVSGLREISVLLSCRHENIVHLREVV 131
Query: 140 VGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLK 199
VG+SL SIFL MEYCE DLASL DN+++PF+ESQVKC++LQVLKGL YLH NFI+HRDLK
Sbjct: 132 VGRSLESIFLAMEYCEQDLASLLDNMQAPFSESQVKCIVLQVLKGLRYLHHNFIVHRDLK 191
Query: 200 PSNLLLNDKGCVKIV 214
SNLL+ DKGCVKI
Sbjct: 192 VSNLLMTDKGCVKIA 206
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|238814355|ref|NP_001154939.1| cyclin-dependent kinase 10 isoform 2 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 250 bits (638), Expect = 4e-64, Method: Compositional matrix adjust.
Identities = 121/204 (59%), Positives = 156/204 (76%), Gaps = 3/204 (1%)
Query: 13 MKVQDDGNPESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNV 72
M D +++D K S+ + PDP + R+ VL +F+TG+P++I EQD GKCR V
Sbjct: 1 MTKDDKKGNDANDTEKKSSLDAGPDPTAPIT-RKGVLTSFLTGKPMDIPEQDILGKCRFV 59
Query: 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHE 130
+EFEKLNRIGEG+YG+VYR RD+ DK++ALKK+ +++ + L LRE++ L CRHE
Sbjct: 60 SEFEKLNRIGEGTYGIVYRARDTKSDKVVALKKVRMEHEKDGLPVSGLREISVLLSCRHE 119
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
NIV LKEVVVG+SL SIFL MEYCE DLASL DN+++PF+ESQVKC++LQVLKGL YLH
Sbjct: 120 NIVHLKEVVVGRSLESIFLAMEYCEQDLASLLDNMQAPFSESQVKCIMLQVLKGLRYLHH 179
Query: 191 NFIIHRDLKPSNLLLNDKGCVKIV 214
NF++HRDLK SNLL+ DKGCVKI
Sbjct: 180 NFVVHRDLKVSNLLMTDKGCVKIA 203
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|238814353|ref|NP_001154938.1| cyclin-dependent kinase 10 isoform 1 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 249 bits (637), Expect = 4e-64, Method: Compositional matrix adjust.
Identities = 121/198 (61%), Positives = 156/198 (78%), Gaps = 4/198 (2%)
Query: 19 GNPESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKL 78
GN +++D K S+ + PDP + R+ VL +F+TG+P++I EQD GKCR V+EFEKL
Sbjct: 11 GN-DANDTEKKSSLDAGPDPTAPIT-RKGVLTSFLTGKPMDIPEQDILGKCRFVSEFEKL 68
Query: 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLK 136
NRIGEG+YG+VYR RD+ DK++ALKK+ +++ + L LRE++ L CRHENIV LK
Sbjct: 69 NRIGEGTYGIVYRARDTKSDKVVALKKVRMEHEKDGLPVSGLREISVLLSCRHENIVHLK 128
Query: 137 EVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHR 196
EVVVG+SL SIFL MEYCE DLASL DN+++PF+ESQVKC++LQVLKGL YLH NF++HR
Sbjct: 129 EVVVGRSLESIFLAMEYCEQDLASLLDNMQAPFSESQVKCIMLQVLKGLRYLHHNFVVHR 188
Query: 197 DLKPSNLLLNDKGCVKIV 214
DLK SNLL+ DKGCVKI
Sbjct: 189 DLKVSNLLMTDKGCVKIA 206
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307178092|gb|EFN66919.1| Cell division protein kinase 10 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 249 bits (635), Expect = 7e-64, Method: Compositional matrix adjust.
Identities = 120/195 (61%), Positives = 153/195 (78%), Gaps = 3/195 (1%)
Query: 22 ESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLNRI 81
E +D+ K + + S PDP + R+ VL +F+T +P+EI EQD GKCR V+EFEKLNRI
Sbjct: 13 ERNDSDKKAASDSGPDPSAPIT-RKGVLTSFLTCKPMEIPEQDILGKCRFVSEFEKLNRI 71
Query: 82 GEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVV 139
GEG+YG+VYR RD+ DK++ALKK+ +++ + L LRE++ L CRHENIV L+EVV
Sbjct: 72 GEGTYGIVYRARDTKNDKVVALKKVRMEHEKDGLPVSGLREISVLLSCRHENIVHLREVV 131
Query: 140 VGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLK 199
VG+SL SIFL MEYCE DLASL DN+++PF+ESQVKC++LQVLKGL YLH NFI+HRDLK
Sbjct: 132 VGRSLESIFLAMEYCEQDLASLLDNMQAPFSESQVKCIVLQVLKGLRYLHHNFIVHRDLK 191
Query: 200 PSNLLLNDKGCVKIV 214
SNLL+ DKGCVKI
Sbjct: 192 VSNLLMTDKGCVKIA 206
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332029704|gb|EGI69583.1| Cell division protein kinase 10 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 248 bits (634), Expect = 9e-64, Method: Compositional matrix adjust.
Identities = 120/195 (61%), Positives = 153/195 (78%), Gaps = 3/195 (1%)
Query: 22 ESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLNRI 81
E +D+ K + + S PDP + R+ VL +F+TG+ +EI EQD GKCR V+EFEKLNRI
Sbjct: 13 ERNDSDKKAVSDSGPDPSAPIT-RKGVLTSFLTGKAMEIPEQDILGKCRFVSEFEKLNRI 71
Query: 82 GEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVV 139
GEG+YG+VYR RD+ DK++ALKK+ +++ + L LRE++ L CRHENIV L+EVV
Sbjct: 72 GEGTYGIVYRARDTKNDKVVALKKVRMEHEKDGLPVSGLREISVLLSCRHENIVHLREVV 131
Query: 140 VGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLK 199
VG+SL SIFL MEYCE DLASL DN+++PF+ESQVKC++LQVLKGL YLH NFI+HRDLK
Sbjct: 132 VGRSLESIFLAMEYCEQDLASLLDNMQAPFSESQVKCIVLQVLKGLRYLHHNFIVHRDLK 191
Query: 200 PSNLLLNDKGCVKIV 214
SNLL+ DKGCVKI
Sbjct: 192 VSNLLMTDKGCVKIA 206
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|357617680|gb|EHJ70924.1| cdc2-related kinase [Danaus plexippus] | Back alignment and taxonomy information |
|---|
Score = 241 bits (615), Expect = 2e-61, Method: Compositional matrix adjust.
Identities = 120/194 (61%), Positives = 147/194 (75%), Gaps = 3/194 (1%)
Query: 23 SHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLNRIG 82
S + KP ++Q + DP R+ VL++F TG+ +EI E+D G+CR V EFEKLNRIG
Sbjct: 2 SQGSEKPLSSQDVVDPTGP-TTRKGVLISFRTGKTMEIPEKDILGRCRFVGEFEKLNRIG 60
Query: 83 EGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTGLTKCRHENIVQLKEVVV 140
EG+YG+VYR +D + I+ALKK+ + + + L LRE+ L CRHENIVQLKEV+V
Sbjct: 61 EGTYGIVYRAKDKLNGNIVALKKVRMDVEKDGLPLSGLREIQVLMACRHENIVQLKEVLV 120
Query: 141 GKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKP 200
G+SL SIFL MEYCE DLASL DN+ SPFTESQVKC++LQVLKGL YLHSNFI+HRDLK
Sbjct: 121 GRSLESIFLSMEYCEQDLASLLDNMTSPFTESQVKCLMLQVLKGLKYLHSNFIVHRDLKV 180
Query: 201 SNLLLNDKGCVKIV 214
SNLLL DKGCVKI
Sbjct: 181 SNLLLTDKGCVKIA 194
|
Source: Danaus plexippus Species: Danaus plexippus Genus: Danaus Family: Nymphalidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 224 | ||||||
| FB|FBgn0013435 | 387 | cdc2rk "cdc2-related-kinase" [ | 0.808 | 0.467 | 0.597 | 6.1e-55 | |
| UNIPROTKB|F1NCQ0 | 362 | CDK10 "Uncharacterized protein | 0.691 | 0.428 | 0.630 | 8.5e-49 | |
| UNIPROTKB|I3LKS0 | 361 | CDK10 "Uncharacterized protein | 0.767 | 0.476 | 0.572 | 3.7e-48 | |
| UNIPROTKB|E2R4K3 | 360 | CDK10 "Uncharacterized protein | 0.651 | 0.405 | 0.648 | 4.7e-48 | |
| UNIPROTKB|Q15131 | 360 | CDK10 "Cyclin-dependent kinase | 0.651 | 0.405 | 0.648 | 7.7e-48 | |
| ZFIN|ZDB-GENE-050417-94 | 360 | cdk10 "cyclin-dependent kinase | 0.736 | 0.458 | 0.580 | 9.8e-48 | |
| UNIPROTKB|Q2TBL8 | 361 | CDK10 "Cyclin-dependent kinase | 0.651 | 0.404 | 0.648 | 1.2e-47 | |
| MGI|MGI:2448549 | 360 | Cdk10 "cyclin-dependent kinase | 0.651 | 0.405 | 0.648 | 1.2e-47 | |
| RGD|1304851 | 358 | Cdk10 "cyclin-dependent kinase | 0.651 | 0.407 | 0.641 | 3.3e-47 | |
| UNIPROTKB|F1LSV8 | 370 | Cdk10 "Cyclin-dependent kinase | 0.651 | 0.394 | 0.641 | 3.3e-47 |
| FB|FBgn0013435 cdc2rk "cdc2-related-kinase" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 567 (204.7 bits), Expect = 6.1e-55, P = 6.1e-55
Identities = 110/184 (59%), Positives = 141/184 (76%)
Query: 32 TQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLNRIGEGSYGVVYR 91
T PDPQ+ R+ LM+ TG P+ I EQ+ FG+CR V+EFEKLNR+GEGSYG+VYR
Sbjct: 11 TNPAPDPQAPIT-RKGFLMSLNTGTPMPIPEQNLFGRCRPVSEFEKLNRVGEGSYGIVYR 69
Query: 92 VRDSVQDKILALKKLFL--QNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149
RD+ ++I+ALKK+ + + + L LRE+ L +C HENIV+L+EVVVGKSL SIFL
Sbjct: 70 ARDTRSNEIVALKKVRMDQEKDGLPISGLREIMILKQCHHENIVRLREVVVGKSLDSIFL 129
Query: 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG 209
VM++CE DLAS+ DN+ PFTES+VKC+ LQVLK L YLHS F+IHRDLK SNLL+ DKG
Sbjct: 130 VMDFCEQDLASVLDNMSQPFTESEVKCITLQVLKALKYLHSRFMIHRDLKVSNLLMTDKG 189
Query: 210 CVKI 213
C+K+
Sbjct: 190 CIKV 193
|
|
| UNIPROTKB|F1NCQ0 CDK10 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 509 (184.2 bits), Expect = 8.5e-49, P = 8.5e-49
Identities = 99/157 (63%), Positives = 123/157 (78%)
Query: 59 EILEQDCFGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRG 116
E+ + GKCR+V EFEKLNRIGEG+YG+VYR RD+V D+ +ALKK+ + N +
Sbjct: 23 EVPASERLGKCRSVKEFEKLNRIGEGTYGIVYRARDTVTDETVALKKVRMDNEKEGMPVS 82
Query: 117 ELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKC 176
LRE+T L + +H NIV+LKEVVVG L SIFLVM YCE DLASL +N+++PF+E+QVKC
Sbjct: 83 SLREITLLLELQHPNIVELKEVVVGNHLESIFLVMGYCEQDLASLLENMQTPFSEAQVKC 142
Query: 177 VILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ILQVLKGL YLH +IIHRDLK SNLL+ DKGCVKI
Sbjct: 143 IILQVLKGLQYLHERYIIHRDLKVSNLLMTDKGCVKI 179
|
|
| UNIPROTKB|I3LKS0 CDK10 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 503 (182.1 bits), Expect = 3.7e-48, P = 3.7e-48
Identities = 103/180 (57%), Positives = 133/180 (73%)
Query: 36 PDPQSKFAKRRDVLMN-FVTGEPIEILEQDCFGKCRNVAEFEKLNRIGEGSYGVVYRVRD 94
P+P+S+ + + + F T P L G+CR+V EFEKLNRIGEG+YG+VYR RD
Sbjct: 4 PEPESEQIRLKCIRKEGFFTVPPEHRL-----GRCRSVKEFEKLNRIGEGTYGIVYRARD 58
Query: 95 SVQDKILALKKLFL--QNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152
+ D+I+ALKK+ + + + + LRE+T L + RH NIV+LKEVVVG L SIFLVM
Sbjct: 59 TQTDEIVALKKVRMDKEKDGVPISSLREITLLLRLRHPNIVELKEVVVGNHLESIFLVMG 118
Query: 153 YCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVK 212
YCE DLASL +N+ +PF+E+QVKC++LQVL+GL YLH NFIIHRDLK SNLL+ DKGCVK
Sbjct: 119 YCEQDLASLLENMPTPFSEAQVKCIVLQVLRGLQYLHQNFIIHRDLKVSNLLMTDKGCVK 178
|
|
| UNIPROTKB|E2R4K3 CDK10 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 502 (181.8 bits), Expect = 4.7e-48, P = 4.7e-48
Identities = 96/148 (64%), Positives = 121/148 (81%)
Query: 67 GKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTGL 124
G+CR+V EFEKLNRIGEG+YG+VYR RD++ D+I+ALKK+ + + + + LRE+T L
Sbjct: 31 GRCRSVKEFEKLNRIGEGTYGIVYRARDTLTDEIVALKKVRMDKEKDGVPISSLREITLL 90
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKG 184
+ RH NIV+LKEVVVG L SIFLVM YCE DLASL +N+ +PF+E+QVKC++LQVL+G
Sbjct: 91 LRLRHPNIVELKEVVVGTHLESIFLVMGYCEQDLASLLENMPTPFSEAQVKCIVLQVLRG 150
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVK 212
L YLH NFIIHRDLK SNLL+ DKGCVK
Sbjct: 151 LQYLHQNFIIHRDLKVSNLLMTDKGCVK 178
|
|
| UNIPROTKB|Q15131 CDK10 "Cyclin-dependent kinase 10" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 500 (181.1 bits), Expect = 7.7e-48, P = 7.7e-48
Identities = 96/148 (64%), Positives = 120/148 (81%)
Query: 67 GKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTGL 124
G+CR+V EFEKLNRIGEG+YG+VYR RD+ D+I+ALKK+ + + + + LRE+T L
Sbjct: 31 GRCRSVKEFEKLNRIGEGTYGIVYRARDTQTDEIVALKKVRMDKEKDGIPISSLREITLL 90
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKG 184
+ RH NIV+LKEVVVG L SIFLVM YCE DLASL +N+ +PF+E+QVKC++LQVL+G
Sbjct: 91 LRLRHPNIVELKEVVVGNHLESIFLVMGYCEQDLASLLENMPTPFSEAQVKCIVLQVLRG 150
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVK 212
L YLH NFIIHRDLK SNLL+ DKGCVK
Sbjct: 151 LQYLHRNFIIHRDLKVSNLLMTDKGCVK 178
|
|
| ZFIN|ZDB-GENE-050417-94 cdk10 "cyclin-dependent kinase 10" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 499 (180.7 bits), Expect = 9.8e-48, P = 9.8e-48
Identities = 97/167 (58%), Positives = 126/167 (75%)
Query: 49 LMNFVTGEPIEILEQDCFGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL 108
L + T I + GKCR+V EFEK+NRIGEG+YG+VYR RD+ ++I+ALKK+ +
Sbjct: 14 LKSLKTDRTFVIPHSERLGKCRSVKEFEKINRIGEGTYGIVYRARDTRTNEIVALKKVRM 73
Query: 109 --QNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVE 166
+ + + LRE+ L + RH NIV+LKEVVVG L S+FLVM YCE DLASL +N++
Sbjct: 74 DKEKDGIPISSLREINLLIRLRHPNIVELKEVVVGSHLESLFLVMSYCEQDLASLLENMQ 133
Query: 167 SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
SPF+E+QVKC++LQ+LKGL YLH NFI+HRDLK SNLL+ DKGCVKI
Sbjct: 134 SPFSEAQVKCIVLQLLKGLAYLHHNFILHRDLKVSNLLMTDKGCVKI 180
|
|
| UNIPROTKB|Q2TBL8 CDK10 "Cyclin-dependent kinase 10" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 1.2e-47, P = 1.2e-47
Identities = 96/148 (64%), Positives = 120/148 (81%)
Query: 67 GKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTGL 124
G+CR+V EFEKLNRIGEG+YG+VYR RD+ D+I+ALKK+ + + + + LRE+T L
Sbjct: 29 GRCRSVKEFEKLNRIGEGTYGIVYRARDTHTDEIVALKKVRMDKEKDGVPISSLREITLL 88
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKG 184
+ RH NIV+LKEVVVG L SIFLVM YCE DLASL +N+ +PF+E+QVKC++LQVL+G
Sbjct: 89 LRLRHPNIVELKEVVVGNHLESIFLVMGYCEQDLASLLENMPTPFSEAQVKCIVLQVLRG 148
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVK 212
L YLH NFIIHRDLK SNLL+ DKGCVK
Sbjct: 149 LQYLHRNFIIHRDLKVSNLLMTDKGCVK 176
|
|
| MGI|MGI:2448549 Cdk10 "cyclin-dependent kinase 10" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 498 (180.4 bits), Expect = 1.2e-47, P = 1.2e-47
Identities = 96/148 (64%), Positives = 120/148 (81%)
Query: 67 GKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTGL 124
G+CR+V EFEKLNRIGEG+YG+VYR RD+ D+I+ALKK+ + + + + LRE+T L
Sbjct: 31 GRCRSVKEFEKLNRIGEGTYGIVYRARDTQTDEIVALKKVRMDKEKDGIPISSLREITLL 90
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKG 184
+ RH NIV+LKEVVVG L SIFLVM YCE DLASL +N+ +PF+E+QVKC++LQVL+G
Sbjct: 91 LRLRHPNIVELKEVVVGNHLESIFLVMGYCEQDLASLLENMPTPFSEAQVKCIMLQVLRG 150
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVK 212
L YLH NFIIHRDLK SNLL+ DKGCVK
Sbjct: 151 LQYLHRNFIIHRDLKVSNLLMTDKGCVK 178
|
|
| RGD|1304851 Cdk10 "cyclin-dependent kinase 10" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 3.3e-47, P = 3.3e-47
Identities = 95/148 (64%), Positives = 120/148 (81%)
Query: 67 GKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTGL 124
G+CR+V EFEKLNRIGEG+YG+VYR RD+ D+I+ALKK+ + + + + LRE+T L
Sbjct: 29 GRCRSVKEFEKLNRIGEGTYGIVYRARDTQTDEIVALKKVRMDKEKDGIPISSLREITLL 88
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKG 184
+ RH NIV+LKEVVVG L SIFLVM YCE DLASL +N+ +PF+E+QVKC++LQVL+G
Sbjct: 89 LRLRHPNIVELKEVVVGNHLESIFLVMGYCEQDLASLLENMPTPFSEAQVKCILLQVLRG 148
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVK 212
L YLH +FIIHRDLK SNLL+ DKGCVK
Sbjct: 149 LQYLHRSFIIHRDLKVSNLLMTDKGCVK 176
|
|
| UNIPROTKB|F1LSV8 Cdk10 "Cyclin-dependent kinase 10" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 494 (179.0 bits), Expect = 3.3e-47, P = 3.3e-47
Identities = 95/148 (64%), Positives = 120/148 (81%)
Query: 67 GKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTGL 124
G+CR+V EFEKLNRIGEG+YG+VYR RD+ D+I+ALKK+ + + + + LRE+T L
Sbjct: 41 GRCRSVKEFEKLNRIGEGTYGIVYRARDTQTDEIVALKKVRMDKEKDGIPISSLREITLL 100
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKG 184
+ RH NIV+LKEVVVG L SIFLVM YCE DLASL +N+ +PF+E+QVKC++LQVL+G
Sbjct: 101 LRLRHPNIVELKEVVVGNHLESIFLVMGYCEQDLASLLENMPTPFSEAQVKCILLQVLRG 160
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVK 212
L YLH +FIIHRDLK SNLL+ DKGCVK
Sbjct: 161 LQYLHRSFIIHRDLKVSNLLMTDKGCVK 188
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q7XUF4 | CDKG2_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5238 | 0.6473 | 0.2042 | yes | N/A |
| Q3UMM4 | CDK10_MOUSE | 2, ., 7, ., 1, 1, ., 2, 2 | 0.6442 | 0.6562 | 0.4083 | yes | N/A |
| Q15131 | CDK10_HUMAN | 2, ., 7, ., 1, 1, ., 2, 2 | 0.6442 | 0.6562 | 0.4083 | yes | N/A |
| Q4KM47 | CDK10_RAT | 2, ., 7, ., 1, 1, ., 2, 2 | 0.6375 | 0.6562 | 0.4106 | yes | N/A |
| Q2TBL8 | CDK10_BOVIN | 2, ., 7, ., 1, 1, ., 2, 2 | 0.6442 | 0.6562 | 0.4072 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 224 | |||
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-84 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-65 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-57 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-56 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-44 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-43 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-42 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-41 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-40 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-40 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-40 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-38 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-38 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-34 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-33 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-32 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-32 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-32 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-31 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-31 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-31 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-30 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-30 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-30 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-30 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-29 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-29 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-29 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-28 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-28 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-28 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-27 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-26 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-26 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-26 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-26 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-25 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-25 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-24 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-24 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-23 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-23 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-23 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-22 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-22 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-22 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-21 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-21 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-21 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-21 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-21 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-21 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-20 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-19 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-19 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-18 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-18 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-17 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-16 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-14 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 9e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-12 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-11 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-09 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-09 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-08 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-08 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-07 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-06 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.001 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.001 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 0.001 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.001 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 0.001 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 0.002 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.002 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 0.003 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 0.004 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.004 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.004 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 5e-84
Identities = 100/149 (67%), Positives = 121/149 (81%), Gaps = 2/149 (1%)
Query: 67 GKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGL 124
G+CR+V EFEKLNRIGEG+YG+VYR RD+ +I+ALKK+ + N + + LRE+T L
Sbjct: 1 GRCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLL 60
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKG 184
RH NIV+LKEVVVGK L SIFLVMEYCE DLASL DN+ +PF+ESQVKC++LQ+L+G
Sbjct: 61 LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
L YLH NFIIHRDLK SNLLL DKGC+KI
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKI 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 2e-65
Identities = 82/149 (55%), Positives = 111/149 (74%), Gaps = 6/149 (4%)
Query: 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT----LTRGELREVTGL 124
CR+V E+EKLNRI EG+YGVVYR RD +I+ALKKL ++ +T LRE+ L
Sbjct: 1 CRSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPIT--SLREINIL 58
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKG 184
K +H NIV +KEVVVG +L I++VMEY EHDL SL + ++ PF +S+VKC++LQ+L G
Sbjct: 59 LKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSG 118
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ +LH N+I+HRDLK SNLLLN++G +KI
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGILKI 147
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 4e-57
Identities = 68/141 (48%), Positives = 99/141 (70%), Gaps = 2/141 (1%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENI 132
+EK+ +IGEG+YG VY+ R+ +++ALKK+ ++N +RE+ L K RH NI
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
V+LKE+V K SI++V EY +HDL L D+ E FTESQ+KC + Q+L+GL YLHSN
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 193 IIHRDLKPSNLLLNDKGCVKI 213
I+HRD+K SN+L+N+ G +K+
Sbjct: 121 ILHRDIKGSNILINNDGVLKL 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (458), Expect = 3e-56
Identities = 58/141 (41%), Positives = 92/141 (65%), Gaps = 4/141 (2%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTGLTKCRHENI 132
+EKL ++GEG+YGVVY+ RD +I+ALKK+ L + + LRE++ L + +H NI
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
V+L +V+ + ++LV EYC+ DL D P + + +K ++ Q+L+GL Y HS+
Sbjct: 61 VKLLDVIHTER--KLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR 118
Query: 193 IIHRDLKPSNLLLNDKGCVKI 213
I+HRDLKP N+L+N G +K+
Sbjct: 119 ILHRDLKPQNILINRDGVLKL 139
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-44
Identities = 57/142 (40%), Positives = 84/142 (59%), Gaps = 7/142 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENIV 133
+E L ++GEGS+G VY RD K++A+K + + R LRE+ L K +H NIV
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 134 QLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
+L +V + ++LVMEYCE DL L+ +E + + + Q+L L YLHS
Sbjct: 61 RLYDVFEDED--KLYLVMEYCEGGDLFDLLKKRG--RLSEDEARFYLRQILSALEYLHSK 116
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
I+HRDLKP N+LL++ G VK+
Sbjct: 117 GIVHRDLKPENILLDEDGHVKL 138
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 8e-43
Identities = 62/160 (38%), Positives = 96/160 (60%), Gaps = 8/160 (5%)
Query: 62 EQDCFGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELR 119
+Q F C V+++EKL +IG+G++G V++ R +I+ALKK+ ++N LR
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR 60
Query: 120 EVTGLTKCRHENIVQLKEVVVGKSL------SSIFLVMEYCEHDLASLQDNVESPFTESQ 173
E+ L +HEN+V L E+ K+ S +LV E+CEHDLA L N FT S+
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE 120
Query: 174 VKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+K V+ +L GL Y+H N I+HRD+K +N+L+ G +K+
Sbjct: 121 IKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKL 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 1e-42
Identities = 57/144 (39%), Positives = 87/144 (60%), Gaps = 7/144 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ-----NNTLTRGELREVTGLTKCRH 129
+EK ++GEG+Y VVY+ RD +I+A+KK+ L + + LRE+ L + +H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
NI+ L +V KS +I LV E+ E DL + + T + +K +L L+GL YLH
Sbjct: 62 PNIIGLLDVFGHKS--NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH 119
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
SN+I+HRDLKP+NLL+ G +K+
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKL 143
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-41
Identities = 56/141 (39%), Positives = 91/141 (64%), Gaps = 4/141 (2%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKK--LFLQNNTLTRGELREVTGLTKCRHENI 132
++KL +IGEG+YGVVY+ RD + +I+A+KK L ++ + + LRE+ L + H NI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
++L +V K ++LV E+ + DL L + + ES +K + Q+L+GL + HS+
Sbjct: 61 IKLLDVFRHKG--DLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG 118
Query: 193 IIHRDLKPSNLLLNDKGCVKI 213
I+HRDLKP NLL+N +G +K+
Sbjct: 119 ILHRDLKPENLLINTEGVLKL 139
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 4e-41
Identities = 56/142 (39%), Positives = 88/142 (61%), Gaps = 4/142 (2%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHEN 131
++ L RIGEG++G+V++ +D + +ALKK+ L+ + LRE+ L C+H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
+V+L +V S LVMEY DL+ + + E P E+QVK + +LKG+ Y+H+N
Sbjct: 61 VVKLLDVF--PHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
I+HRDLKP+NLL++ G +KI
Sbjct: 119 GIMHRDLKPANLLISADGVLKI 140
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-40
Identities = 57/144 (39%), Positives = 86/144 (59%), Gaps = 7/144 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
FE L +IG+G +G VY+ R K +A+K + L++ + E+ L KC+H NIV
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 134 QLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES---PFTESQVKCVILQVLKGLNYLHS 190
+ + K +++VME+C SL+D ++S TESQ+ V ++LKGL YLHS
Sbjct: 61 KYYGSYLKKD--ELWIVMEFC--SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 191 NFIIHRDLKPSNLLLNDKGCVKIV 214
N IIHRD+K +N+LL G VK++
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLI 140
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-40
Identities = 59/136 (43%), Positives = 84/136 (61%), Gaps = 5/136 (3%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRHENIVQLKEVV 139
+GEG +G VY RD K +A+K + ++++ EL RE+ L K H NIV+L V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 140 VGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDL 198
+ + ++LVMEYCE L L E +E ++ ++LQ+L+GL YLHSN IIHRDL
Sbjct: 61 --EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 199 KPSNLLL-NDKGCVKI 213
KP N+LL +D G VK+
Sbjct: 119 KPENILLDSDNGKVKL 134
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 7e-40
Identities = 59/142 (41%), Positives = 85/142 (59%), Gaps = 6/142 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENI 132
+E L ++G GS+G VY+ + KI+A+K L ++ + RE+ L + H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
V+L + K ++LVMEYCE DL + P +E + K + LQ+L+GL YLHSN
Sbjct: 61 VRLIDAFEDKD--HLYLVMEYCEGGDLFDY-LSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
IIHRDLKP N+LL++ G VKI
Sbjct: 118 GIIHRDLKPENILLDENGVVKI 139
|
Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-38
Identities = 60/158 (37%), Positives = 100/158 (63%), Gaps = 12/158 (7%)
Query: 66 FGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT----LTRGELREV 121
F C + ++E L ++GEG++G VY+ R +++ALKK+ + N +T LRE+
Sbjct: 1 FYGCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPIT--ALREI 58
Query: 122 TGLTKCRHENIVQLKEVVV------GKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVK 175
L K +H N+V L ++ V + S+++V Y +HDL+ L +N TESQ+K
Sbjct: 59 KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK 118
Query: 176 CVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
C +LQ+L+G+NYLH N I+HRD+K +N+L++++G +KI
Sbjct: 119 CYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKI 156
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-38
Identities = 54/148 (36%), Positives = 84/148 (56%), Gaps = 9/148 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTK---CRH 129
+E+L IGEG+YG VY+ RD + +ALKK+ + + + LRE+ L + H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 130 ENIVQLKEVVVGKSLS---SIFLVMEYCEHDLASLQDNVESP-FTESQVKCVILQVLKGL 185
NIV+L +V G + LV E+ + DLA+ P +K ++ Q+L+G+
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
++LHS+ I+HRDLKP N+L+ G VKI
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDGQVKI 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 1e-34
Identities = 53/142 (37%), Positives = 91/142 (64%), Gaps = 5/142 (3%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENI 132
++K+ +IGEG+YGVVY+ RD + +I+ALKK+ L+ + +RE++ L + H NI
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSN 191
V+L +VV S + ++LV E+ + DL D+ + +K + Q+L+G+ Y HS+
Sbjct: 61 VRLLDVV--HSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH 118
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
++HRDLKP NLL++ +G +K+
Sbjct: 119 RVLHRDLKPQNLLIDREGALKL 140
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-33
Identities = 54/153 (35%), Positives = 86/153 (56%), Gaps = 15/153 (9%)
Query: 75 FEKLNRIGEGSYGVVYRVR--DSVQDKILALKKLFLQNNTLTRG----ELREVTGLTKCR 128
+E IG G+YG VY+ + + K A+KK F + G RE+ L + +
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-FKGDKEQYTGISQSACREIALLRELK 60
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEHDLASL----QDNVESPFTESQVKCVILQVLKG 184
HEN+V L EV + + S++L+ +Y EHDL + + S VK ++ Q+L G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 185 LNYLHSNFIIHRDLKPSNLLL----NDKGCVKI 213
++YLHSN+++HRDLKP+N+L+ ++G VKI
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKI 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-33
Identities = 56/144 (38%), Positives = 85/144 (59%), Gaps = 10/144 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ---NNTLTRGELREVTGLTKCRHEN 131
+E L +GEG+YGVV + R+ +I+A+KK F + + + + LREV L + RHEN
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKK-FKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESP--FTESQVKCVILQVLKGLNYLH 189
IV LKE + ++LV EY E L L+ SP V+ I Q+L+ + Y H
Sbjct: 62 IVNLKEAF--RRKGRLYLVFEYVERTL--LELLEASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
S+ IIHRD+KP N+L+++ G +K+
Sbjct: 118 SHNIIHRDIKPENILVSESGVLKL 141
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-32
Identities = 57/145 (39%), Positives = 83/145 (57%), Gaps = 8/145 (5%)
Query: 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRHEN 131
++ E++ +G+GS GVVY+VR KI ALKK+ + + R +L RE+ L C
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLH 189
+V+ + I +V+EY D SL D ++ E + + Q+LKGL+YLH
Sbjct: 61 VVKCYGAFYKEG--EISIVLEYM--DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 190 SNF-IIHRDLKPSNLLLNDKGCVKI 213
+ IIHRD+KPSNLL+N KG VKI
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKI 141
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-32
Identities = 54/147 (36%), Positives = 77/147 (52%), Gaps = 12/147 (8%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTKCRHE 130
+E + +IG+GS+G VY VR K+ LK++ L N ++ E L EV L K H
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN--MSEKEREDALNEVKILKKLNHP 59
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEH-DLASL---QDNVESPFTESQVKCVILQVLKGLN 186
NI++ E K + +VMEY + DL+ Q PF E Q+ +Q+ L
Sbjct: 60 NIIKYYESFEEKG--KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALK 117
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YLHS I+HRD+KP N+ L G VK+
Sbjct: 118 YLHSRKILHRDIKPQNIFLTSNGLVKL 144
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-32
Identities = 61/154 (39%), Positives = 92/154 (59%), Gaps = 10/154 (6%)
Query: 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKC 127
R V +F+ + +IGEG+YG VY+ RD +++ALKK+ L N +RE+ L +
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL 63
Query: 128 RHENIVQLKEVVVGKSLS--------SIFLVMEYCEHDLASLQDNVESPFTESQVKCVIL 179
H NIV LKE+V K + + +LV EY +HDL L ++ F+E +K +
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 180 QVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
Q+L+GLNY H +HRD+K SN+LLN+KG +K+
Sbjct: 124 QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-32
Identities = 55/145 (37%), Positives = 81/145 (55%), Gaps = 11/145 (7%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
++E + RIG G+YG VY+ RD +++A+K + L+ +E++ L +CRH NIV
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIV 63
Query: 134 QLKEVVVG--KSLSSIFLVMEYCEHDLASLQD--NV-ESPFTESQVKCVILQVLKGLNYL 188
G +++VMEYC SLQD V P +E Q+ V + LKGL YL
Sbjct: 64 AY----FGSYLRRDKLWIVMEYCGG--GSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
H IHRD+K +N+LL + G VK+
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKL 142
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 4e-31
Identities = 55/151 (36%), Positives = 83/151 (54%), Gaps = 21/151 (13%)
Query: 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----------------LREVT 122
+GEG+YG V + D++ KI+A+KK+ + ++ LRE+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKV--KIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 123 GLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVL 182
+ + +HENI+ L +V V I LVM+ DL + D + TESQVKC++LQ+L
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDF--INLVMDIMASDLKKVVDR-KIRLTESQVKCILLQIL 129
Query: 183 KGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
GLN LH + +HRDL P+N+ +N KG KI
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFINSKGICKI 160
|
Length = 335 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 5e-31
Identities = 55/144 (38%), Positives = 91/144 (63%), Gaps = 9/144 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRG----ELREVTGLTKCRHE 130
F+K+ +IGEG+YGVVY+ R+ + +++ALKK+ L +T T G +RE++ L + H
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL--DTETEGVPSTAIREISLLKELNHP 59
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLH 189
NIV+L +V+ + + ++LV E+ DL D S +K + Q+L+GL + H
Sbjct: 60 NIVKLLDVI--HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
S+ ++HRDLKP NLL+N +G +K+
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKL 141
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 9e-31
Identities = 53/145 (36%), Positives = 83/145 (57%), Gaps = 11/145 (7%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTKC-RH 129
++ + ++G+G++G VY R+ +++A+KK+ E LREV L K H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM---KKKFYSWEECMNLREVKSLRKLNEH 57
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEHDLASL-QDNVESPFTESQVKCVILQVLKGLNYL 188
NIV+LKEV ++ V EY E +L L +D PF+ES ++ +I Q+L+GL ++
Sbjct: 58 PNIVKLKEVFREND--ELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
H + HRDLKP NLL++ VKI
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKI 140
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 1e-30
Identities = 53/146 (36%), Positives = 82/146 (56%), Gaps = 10/146 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTGLTKCRHENI 132
+E L IG G+YGVV D + +A+KK+ + + LRE+ L RHENI
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 133 VQLKEVVVGKSLSS---IFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNY 187
+ L +++ S +++V E E DL + ++S P T+ ++ + Q+L+GL Y
Sbjct: 62 IGLLDILRPPSPEDFNDVYIVTELMETDLHKV---IKSPQPLTDDHIQYFLYQILRGLKY 118
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
LHS +IHRDLKPSN+L+N +KI
Sbjct: 119 LHSANVIHRDLKPSNILVNSNCDLKI 144
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-30
Identities = 43/145 (29%), Positives = 77/145 (53%), Gaps = 6/145 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE--LREVTGLTKCRHEN 131
E+ + +G GS+G VY D +++A+K + L ++ E RE+ L+ +H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLH 189
IV+ + +++ + +EY SL ++ E ++ Q+L+GL YLH
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSG--GSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH 118
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKIV 214
SN I+HRD+K +N+L++ G VK+
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLA 143
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-30
Identities = 55/141 (39%), Positives = 88/141 (62%), Gaps = 4/141 (2%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENI 132
+EKL +IGEG+YG V++ ++ +I+ALK++ L ++ + LRE+ L + +H+NI
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
V+L +V+ S + LV EYC+ DL D+ VK + Q+LKGL + HS+
Sbjct: 62 VRLYDVL--HSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 193 IIHRDLKPSNLLLNDKGCVKI 213
++HRDLKP NLL+N G +K+
Sbjct: 120 VLHRDLKPQNLLINKNGELKL 140
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 4e-30
Identities = 48/147 (32%), Positives = 80/147 (54%), Gaps = 19/147 (12%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
F+ L ++GEGSYG VY+ +++A+K + + ++E++ L +C IV+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIK--VVPVEEDLQEIIKEISILKQCDSPYIVK 62
Query: 135 -----LKEVVVGKSLSSIFLVMEYCEHDLASLQDNVE---SPFTESQVKCVILQVLKGLN 186
K + +++VMEYC S+ D ++ TE ++ ++ Q LKGL
Sbjct: 63 YYGSYFKN-------TDLWIVMEYC--GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YLHSN IHRD+K N+LLN++G K+
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKL 140
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 7e-30
Identities = 50/141 (35%), Positives = 76/141 (53%), Gaps = 6/141 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
++ L +IGEG+ G VY+ D K +A+KK+ L+ + E+ + C+H NIV
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPNIVD 79
Query: 135 -LKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
+VG L ++VMEY + L + E Q+ V +VL+GL YLHS
Sbjct: 80 YYDSYLVGDEL---WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 193 IIHRDLKPSNLLLNDKGCVKI 213
+IHRD+K N+LL+ G VK+
Sbjct: 137 VIHRDIKSDNILLSKDGSVKL 157
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-29
Identities = 52/150 (34%), Positives = 90/150 (60%), Gaps = 8/150 (5%)
Query: 66 FGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTR-GELREVTGL 124
FGK + ++KL+++GEGSY VY+ R + +++ALK++ L++ +RE + L
Sbjct: 1 FGK---LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLL 57
Query: 125 TKCRHENIVQLKEVV-VGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLK 183
+H NIV L +++ K+L+ LV EY + DL D+ + V+ + Q+L+
Sbjct: 58 KDLKHANIVTLHDIIHTKKTLT---LVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR 114
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
GL Y H ++HRDLKP NLL++++G +K+
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKL 144
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-29
Identities = 56/138 (40%), Positives = 93/138 (67%), Gaps = 9/138 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTGLTKCRHEN 131
++EK+ +IGEG+YGVVY+ RD V ++ +ALKK+ L ++ + +RE++ L + +H N
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESP-FTESQ--VKCVILQVLKGLNYL 188
IV+L++VV S ++LV EY + DL D+ SP F ++ +K + Q+L+G+ Y
Sbjct: 63 IVRLQDVV--HSEKRLYLVFEYLDLDLKKHMDS--SPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 189 HSNFIIHRDLKPSNLLLN 206
HS+ ++HRDLKP NLL++
Sbjct: 119 HSHRVLHRDLKPQNLLID 136
|
Length = 294 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-29
Identities = 50/155 (32%), Positives = 82/155 (52%), Gaps = 19/155 (12%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTKCRH 129
++E L IG+GS+G V +VR KIL K++ +T E + EV L + +H
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEI--DYGNMTEKEKQQLVSEVNILRELKH 58
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASL-----QDNVESPFTESQVKCVILQVLK 183
NIV+ + ++ +S ++++VMEYCE DLA L ++ E + ++ Q+L
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER--KYIEEEFIWRILTQLLL 116
Query: 184 GLNYLH-----SNFIIHRDLKPSNLLLNDKGCVKI 213
L H N ++HRDLKP+N+ L+ VK+
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 55/143 (38%), Positives = 88/143 (61%), Gaps = 7/143 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCR-HEN 131
+E L ++G+G+YG+V++ D +++ALKK+F +N T + RE+ L + H N
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPN 68
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDL-ASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
IV+L V+ ++ I+LV EY E DL A ++ N+ + + ++ Q+LK L Y+HS
Sbjct: 69 IVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI---LEDVHKRYIMYQLLKALKYIHS 125
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
+IHRDLKPSN+LLN VK+
Sbjct: 126 GNVIHRDLKPSNILLNSDCRVKL 148
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-28
Identities = 50/144 (34%), Positives = 92/144 (63%), Gaps = 6/144 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHEN 131
++ K+ +IGEG+YGVVY+ R+ +I+A+KK+ L++ + +RE++ L + +H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESP--FTESQVKCVILQVLKGLNYLH 189
IV L++V++ +S ++L+ E+ DL D++ VK + Q+L+G+ + H
Sbjct: 61 IVCLQDVLMQES--RLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
S ++HRDLKP NLL+++KG +K+
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKL 142
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-28
Identities = 52/142 (36%), Positives = 87/142 (61%), Gaps = 6/142 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHEN 131
+EKL++IGEGSYGVV++ R+ +I+A+KK F+++ + + LRE+ L + +H N
Sbjct: 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKK-FVESEDDPVIKKIALREIRMLKQLKHPN 61
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
+V L EV K + LV EYC+H + + + E +K +I Q L+ +N+ H +
Sbjct: 62 LVNLIEVFRRKR--KLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH 119
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
IHRD+KP N+L+ +G +K+
Sbjct: 120 NCIHRDVKPENILITKQGQIKL 141
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-27
Identities = 57/145 (39%), Positives = 79/145 (54%), Gaps = 5/145 (3%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENI 132
+ +L+R+GEG+ G V + R I ALK + N L + LRE+ C+ I
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 133 VQLKEVVVGKSLSSIFLVMEYCE-HDLASLQDNVESP---FTESQVKCVILQVLKGLNYL 188
V+ + +S SSI + MEYCE L S+ V+ E + + VLKGL+YL
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
HS IIHRD+KPSN+LL KG VK+
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKL 146
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-27
Identities = 52/142 (36%), Positives = 86/142 (60%), Gaps = 5/142 (3%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLT-RGELREVTGLTKCRHENIV 133
F++L ++GEG+Y VY+ R+ +I+ALK++ L T +RE++ + + +HENIV
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61
Query: 134 QLKEVVVGKSLSSIFLVMEYCEHDLASLQD--NVESPFTESQVKCVILQVLKGLNYLHSN 191
+L +V+ + + + LV EY + DL D V + VK Q+LKG+ + H N
Sbjct: 62 RLHDVI--HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
++HRDLKP NLL+N +G +K+
Sbjct: 120 RVLHRDLKPQNLLINKRGELKL 141
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-26
Identities = 52/145 (35%), Positives = 73/145 (50%), Gaps = 9/145 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL-QNNTLTRGELREVTGLTKCRHENI 132
+ E L +G G+ GVV +V KI+A+K + L N + + LRE+ L KC I
Sbjct: 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYI 61
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQD---NVESPFTESQVKCVILQVLKGLNYLH 189
V I + MEY D SL V+ E + + + VLKGL YLH
Sbjct: 62 VGFYGAFYNNG--DISICMEYM--DGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 190 SNF-IIHRDLKPSNLLLNDKGCVKI 213
IIHRD+KPSN+L+N +G +K+
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKL 142
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-26
Identities = 58/149 (38%), Positives = 86/149 (57%), Gaps = 6/149 (4%)
Query: 66 FGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTR-GELREVTGL 124
FGK + +EKL ++GEGSY VY+ + V K++ALK + LQ T +RE + L
Sbjct: 1 FGKADS---YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLL 57
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKG 184
+H NIV L +++ K ++ LV EY DL D VK + Q+L+G
Sbjct: 58 KGLKHANIVLLHDIIHTKE--TLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRG 115
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
L+Y+H +I+HRDLKP NLL++D G +K+
Sbjct: 116 LSYIHQRYILHRDLKPQNLLISDTGELKL 144
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-26
Identities = 50/145 (34%), Positives = 87/145 (60%), Gaps = 5/145 (3%)
Query: 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL--FLQNNTLTRGELREVTGLTKCRHE 130
+ ++ + IG G+YGVV D+ K +A+KK+ TL + LRE+ L +H+
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 131 NIVQLKEVVV--GKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
NI+ +++++ G +++VM+ E DL + + + P TE ++ + Q+L+GL Y+
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYI 123
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
HS +IHRDLKPSNLL+N+ ++I
Sbjct: 124 HSANVIHRDLKPSNLLVNEDCELRI 148
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-26
Identities = 51/142 (35%), Positives = 87/142 (61%), Gaps = 6/142 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ---NNTLTRGELREVTGLTKCRHEN 131
+E L +GEGSYG+V + + +I+A+KK FL+ + + + +RE+ L + RHEN
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKK-FLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
+V L EV K ++LV E+ +H + + + ES+V+ + Q+L+G+ + HS+
Sbjct: 62 LVNLIEVFRRKK--RLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH 119
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
IIHRD+KP N+L++ G VK+
Sbjct: 120 NIIHRDIKPENILVSQSGVVKL 141
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-25
Identities = 54/149 (36%), Positives = 90/149 (60%), Gaps = 6/149 (4%)
Query: 66 FGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTR-GELREVTGL 124
FGK + + KL+++GEG+Y V++ R + + ++ALK++ L++ +REV+ L
Sbjct: 1 FGK---LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLL 57
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKG 184
+H NIV L +++ + + LV EY + DL DN + + VK + Q+L+G
Sbjct: 58 KNLKHANIVTLHDII--HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRG 115
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
L+Y H I+HRDLKP NLL+N+KG +K+
Sbjct: 116 LSYCHKRKILHRDLKPQNLLINEKGELKL 144
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-25
Identities = 55/149 (36%), Positives = 90/149 (60%), Gaps = 6/149 (4%)
Query: 66 FGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTR-GELREVTGL 124
FGK + + KL+++GEG+Y VY+ R + D ++ALK++ L++ +REV+ L
Sbjct: 2 FGK---LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLL 58
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKG 184
+H NIV L +++ + S+ LV EY + DL D+ + VK + Q+L+G
Sbjct: 59 KDLKHANIVTLHDII--HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRG 116
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
LNY H ++HRDLKP NLL+N++G +K+
Sbjct: 117 LNYCHRRKVLHRDLKPQNLLINERGELKL 145
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 4e-25
Identities = 44/141 (31%), Positives = 79/141 (56%), Gaps = 6/141 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRHENI 132
F L IG+GS+G VY+ D ++++A+K + L+ ++ +E+ L++CR I
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES-PFTESQVKCVILQVLKGLNYLHSN 191
+ + S ++++MEYC S D ++ E+ + ++ +VL GL YLH
Sbjct: 62 TKYYGSFLKGS--KLWIIMEYC--GGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 192 FIIHRDLKPSNLLLNDKGCVK 212
IHRD+K +N+LL+++G VK
Sbjct: 118 GKIHRDIKAANILLSEEGDVK 138
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 9e-25
Identities = 55/150 (36%), Positives = 90/150 (60%), Gaps = 8/150 (5%)
Query: 66 FGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTR-GELREVTGL 124
FGK + + KL ++GEG+Y V++ R + + ++ALK++ L++ +REV+ L
Sbjct: 2 FGK---METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLL 58
Query: 125 TKCRHENIVQLKEVV-VGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLK 183
+H NIV L ++V KSL+ LV EY + DL D+ + + VK + Q+L+
Sbjct: 59 KDLKHANIVTLHDIVHTDKSLT---LVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILR 115
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
GL Y H ++HRDLKP NLL+N++G +K+
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKL 145
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 1e-24
Identities = 45/139 (32%), Positives = 77/139 (55%), Gaps = 12/139 (8%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTG----LTKCRHENIVQLK 136
IG G++GVVY+ + +A+K++ L + L+ + L +H NIV+
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISL--EKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 137 EVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLHSNFII 194
+ ++ S+++++EY E+ SL+ ++ PF ES V + QVL+GL YLH +I
Sbjct: 66 GSI--ETSDSLYIILEYAEN--GSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVI 121
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HRD+K +N+L G VK+
Sbjct: 122 HRDIKAANILTTKDGVVKL 140
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-24
Identities = 49/142 (34%), Positives = 80/142 (56%), Gaps = 5/142 (3%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL---QNNTLTRGELREVTGLTKCRHEN 131
F L IG GS+G VY RD ++++A+KK+ Q+N + ++EV L + RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
++ K + + + +LVMEYC + + + + P E ++ + L+GL YLHS+
Sbjct: 77 TIEYKGCYLREH--TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
IHRD+K N+LL + G VK+
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKL 156
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-24
Identities = 44/134 (32%), Positives = 79/134 (58%), Gaps = 3/134 (2%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVV 140
+G+G++G VY+ + A K + +++ + E+ L++C+H NIV L E
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 141 GKSLSSIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLK 199
++ +++++E+C+ L S+ +E TE Q++ V Q+L+ LN+LHS+ +IHRDLK
Sbjct: 73 YEN--KLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130
Query: 200 PSNLLLNDKGCVKI 213
N+LL G VK+
Sbjct: 131 AGNILLTLDGDVKL 144
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 4e-24
Identities = 45/140 (32%), Positives = 68/140 (48%), Gaps = 9/140 (6%)
Query: 81 IGEGSYGVVYR----VRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENIVQL 135
+GEG++G VY+ + ++ +A+K L + E LRE + K H NIV+L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 136 KEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSNFI 193
V + + +VMEY DL L+ N + S + LQ+ +G+ YL S
Sbjct: 67 LGVCTEEE--PLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNF 124
Query: 194 IHRDLKPSNLLLNDKGCVKI 213
IHRDL N L+ + VKI
Sbjct: 125 IHRDLAARNCLVGENLVVKI 144
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (239), Expect = 5e-24
Identities = 44/146 (30%), Positives = 68/146 (46%), Gaps = 10/146 (6%)
Query: 75 FEKLNRIGEGSYGVVYR----VRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRH 129
E ++GEG++G VY+ + +A+K L + R E L E + + K H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNY 187
NIV+L V +++V EY DL L+ + T + + LQ+ KG+ Y
Sbjct: 61 PNIVRLLGVCTQGE--PLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKGMEY 117
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
L S +HRDL N L+ + VKI
Sbjct: 118 LESKNFVHRDLAARNCLVTENLVVKI 143
|
Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-23
Identities = 55/146 (37%), Positives = 78/146 (53%), Gaps = 10/146 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN-NTLTRGE-LREVTGLTKCRHEN 131
+FE LN+IG+GS+GVV++V ++ A+K++ L N R E + E L K
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCE----HDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
I++ E + K +I VMEY E H L +Q P E QV +Q+L GL +
Sbjct: 61 IIRYYESFLDKGKLNI--VMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAH 116
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
LHS I+HRD+K NL L+ VKI
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKI 142
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-23
Identities = 57/153 (37%), Positives = 85/153 (55%), Gaps = 15/153 (9%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHEN 131
+EKL +IGEG+YG VY+ RD K++ALKK L+ + + LRE++ L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 132 -IVQLKEVV-----VGKSLSSIFLVMEYCEHDLASLQDN----VESPFTESQVKCVILQV 181
IV+L +V GK S++LV EY + DL D+ P +K + Q+
Sbjct: 62 YIVRLLDVEHVEEKNGKP--SLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLLN-DKGCVKI 213
LKG+ + H + ++HRDLKP NLL++ KG +KI
Sbjct: 120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKI 152
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 6e-23
Identities = 54/167 (32%), Positives = 91/167 (54%), Gaps = 23/167 (13%)
Query: 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENI 132
+ + L +G GS G+V+ DS DK +A+KK+ L + + LRE+ + + H+NI
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNI 64
Query: 133 VQLKEVVVGKS------------LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQ 180
V++ EV+ L+S+++V EY E DLA++ + + P +E + + Q
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQ 122
Query: 181 VLKGLNYLHSNFIIHRDLKPSNLLLN---------DKGCVKIVYSTY 218
+L+GL Y+HS ++HRDLKP+N+ +N D G +IV Y
Sbjct: 123 LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 94.8 bits (234), Expect = 8e-23
Identities = 52/146 (35%), Positives = 76/146 (52%), Gaps = 7/146 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHE-NI 132
+ L ++GEGS+G VY RD + L K + LRE+ L H NI
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 133 VQLKEVVVGKSLSSIFLVMEYCE-HDLASLQDN--VESPFTESQVKCVILQVLKGLNYLH 189
V+L + + S++LVMEY + L L + P +ES+ ++ Q+L L YLH
Sbjct: 61 VKLYDF--FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 190 SNFIIHRDLKPSNLLLNDKGC-VKIV 214
S IIHRD+KP N+LL+ G VK++
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLI 144
|
Length = 384 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 8e-23
Identities = 49/138 (35%), Positives = 73/138 (52%), Gaps = 7/138 (5%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
I +G+YG V+ + I A+K K + L E L++ + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 138 VVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHR 196
GK +++LVMEY DLASL +NV S E + I +++ L YLHSN IIHR
Sbjct: 61 SFQGKK--NLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLHSNGIIHR 117
Query: 197 DLKPSNLLLNDKGCVKIV 214
DLKP N+L++ G +K+
Sbjct: 118 DLKPDNILIDSNGHLKLT 135
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 9e-23
Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 9/140 (6%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTLTRGELREVTGLTKCRHENIVQLK 136
+G+GS+G V VR K+ A+K L ++ + L E L++ H IV+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEH-TLTERNILSRINHPFIVKLH 59
Query: 137 EVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIH 195
++ ++LV+EY +L S E F+E + + +++ L YLHS II+
Sbjct: 60 YAF--QTEEKLYLVLEYAPGGELFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIY 116
Query: 196 RDLKPSNLLLNDKGCVKIVY 215
RDLKP N+LL+ G +K+
Sbjct: 117 RDLKPENILLDADGHIKLTD 136
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 1e-22
Identities = 47/145 (32%), Positives = 72/145 (49%), Gaps = 10/145 (6%)
Query: 76 EKLNRIGEGSYGVVYR--VRDSVQDKIL--ALKKLFLQNNTLTRGE-LREVTGLTKCRHE 130
++GEG++G VY+ ++ K + A+K L + E LRE + K H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYL 188
N+V+L V + +++VMEY E DL S L+ N + S + LQ+ +G+ YL
Sbjct: 62 NVVKLLGVCTEEE--PLYIVMEYMEGGDLLSYLRKN-RPKLSLSDLLSFALQIARGMEYL 118
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
S IHRDL N L+ + VKI
Sbjct: 119 ESKNFIHRDLAARNCLVGENLVVKI 143
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-22
Identities = 44/145 (30%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGELREVTGLTKC-RH 129
+F K+ IGEGS+ V ++ +K A+K K L + E LT+ H
Sbjct: 4 KFGKI--IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
I++L + +++ V+EY + +L S E + ++L L YL
Sbjct: 62 PGIIKLYYTF--QDEENLYFVLEYAPNGELLQYIRKYGS-LDEKCTRFYAAEILLALEYL 118
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
HS IIHRDLKP N+LL+ +KI
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKI 143
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 2e-22
Identities = 50/146 (34%), Positives = 85/146 (58%), Gaps = 10/146 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL--FLQNNTLTRGELREVTGLTKCRHEN 131
++ L+ IGEG+YG+V +A+KK+ F ++ T + LRE+ L + +HEN
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHEN 64
Query: 132 IVQLKEVVVGKSLSS---IFLVMEYCEHDLASLQDNVES-PFTESQVKCVILQVLKGLNY 187
I+ + +++ S S +++V E E DL L +++ + ++ + Q+L+GL Y
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKL---IKTQHLSNDHIQYFLYQILRGLKY 121
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
+HS ++HRDLKPSNLLLN +KI
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKI 147
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-22
Identities = 57/164 (34%), Positives = 87/164 (53%), Gaps = 16/164 (9%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCR--- 128
++E + IG G+YG VY+ RD +ALK + +Q N L +REV L +
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 129 HENIVQLKEVVVGKSL---SSIFLVMEYCEHDLASLQDNVESP-FTESQVKCVILQVLKG 184
H NIV+L +V + + LV E+ + DL + D V P +K ++ Q L+G
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI-------VYSTYLEL 221
L++LH+N I+HRDLKP N+L+ G VK+ +YS + L
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMAL 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-21
Identities = 50/157 (31%), Positives = 90/157 (57%), Gaps = 16/157 (10%)
Query: 80 RIGEGSYGVVYRVR--DSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
++G G+YG VY+ + D +K ALK++ + ++ RE+ L + +H N++ L++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQK 65
Query: 138 VVVGKSLSSIFLVMEYCEHDL--------ASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
V + S ++L+ +Y EHDL AS + S VK ++ Q+L G++YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 190 SNFIIHRDLKPSNLLL----NDKGCVKIVYSTYLELY 222
+N+++HRDLKP+N+L+ ++G VKI + L+
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 1e-21
Identities = 48/146 (32%), Positives = 82/146 (56%), Gaps = 8/146 (5%)
Query: 75 FEKLNRIGEGSYGVVYRVRD--SVQDKILALKKL--FLQNNTLTRGELREVTGLTKCR-H 129
+E + +G+G+YG+V R+ + +++ +A+KK+ L + LRE+ L R H
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 130 ENIVQL--KEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
+NI L ++V + + ++L E E DL + + P T++ + I Q+L GL Y
Sbjct: 62 KNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKY 120
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
+HS ++HRDLKP NLL+N +KI
Sbjct: 121 IHSANVLHRDLKPGNLLVNADCELKI 146
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-21
Identities = 49/148 (33%), Positives = 78/148 (52%), Gaps = 14/148 (9%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTKCRHE 130
F+ L ++G+GSYG VY+V+ ++ ALK++ L + +++ E + E+ L H
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS--MSQKEREDAVNEIRILASVNHP 59
Query: 131 NIVQLKEV-VVGKSLSSIFLVMEYCE-HDLASLQDN---VESPFTESQVKCVILQVLKGL 185
NI+ KE + G L +VMEY DL+ E ++ + +Q+L+GL
Sbjct: 60 NIISYKEAFLDGNKL---CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
LH I+HRDLK +N+LL VKI
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKI 144
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 2e-21
Identities = 46/142 (32%), Positives = 80/142 (56%), Gaps = 14/142 (9%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKL--FLQNNTLTRGELREVTGLTKCRHENIVQLKEV 138
IG G+YG+V ++S ++ +A+KK+ N + LRE+ L HEN++ +K++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 139 VVG---KSLSSIFLVMEYCEHDL----ASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
+ ++ + +++V E + DL S Q ++ + + Q+L+GL Y+HS
Sbjct: 73 MPPPHREAFNDVYIVYELMDTDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHSA 127
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
++HRDLKPSNLLLN +KI
Sbjct: 128 NVLHRDLKPSNLLLNANCDLKI 149
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 3e-21
Identities = 48/152 (31%), Positives = 70/152 (46%), Gaps = 16/152 (10%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE--LREVTGLTK-CRHEN 131
FE + IGEG+YG VY+ R +++A+K + + E E L K H N
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIK---IMDIIEDEEEEIKEEYNILRKYSNHPN 64
Query: 132 IVQ-----LKEVVVGKSLSSIFLVMEYCEH----DLASLQDNVESPFTESQVKCVILQVL 182
I +K+ G ++LVME C DL E + ++ + L
Sbjct: 65 IATFYGAFIKKNPPGND-DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL 123
Query: 183 KGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
+GL YLH N +IHRD+K N+LL VK+V
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLTKNAEVKLV 155
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-21
Identities = 49/142 (34%), Positives = 82/142 (57%), Gaps = 4/142 (2%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL--FLQNNTLTRGELREVTGLTKCRHEN 131
+FE L +GEG+YGVV + R +I+A+KK +N + LRE+ L + EN
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
IV+LKE + ++LV EY E ++ L + + + +V+ I Q++K +++ H N
Sbjct: 62 IVELKEAF--RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
I+HRD+KP NLL++ +K+
Sbjct: 120 DIVHRDIKPENLLISHNDVLKL 141
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 6e-21
Identities = 51/149 (34%), Positives = 78/149 (52%), Gaps = 14/149 (9%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL--FLQNNTLTRGELREVTGLTKCRHEN 131
+ E IG G++GVV+ V D K +ALKK+ QN + RE+ L +H+N
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 132 IVQLKEVVVGKSLS---SIFLVMEYCEHDL----ASLQDNVESPFTESQVKCVILQVLKG 184
++ +++ + I++V E + DL S Q P + VK + Q+L+G
Sbjct: 61 VLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQ-----PLSSDHVKVFLYQILRG 115
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
L YLHS I+HRD+KP NLL+N +KI
Sbjct: 116 LKYLHSAGILHRDIKPGNLLVNSNCVLKI 144
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 6e-21
Identities = 45/145 (31%), Positives = 83/145 (57%), Gaps = 8/145 (5%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL--REVTGLTKCRHEN 131
+++ N+IG G++G VY + +++A+K++ +Q+N + E+ L +H N
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQ--VKCVILQVLKGLNYLH 189
+V+ V V + IF MEYC +L++ +E + ++ LQ+L+GL YLH
Sbjct: 61 LVKYYGVEVHREKVYIF--MEYCSG--GTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH 116
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKIV 214
S+ I+HRD+KP+N+ L+ G +K+
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLG 141
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 7e-21
Identities = 48/157 (30%), Positives = 89/157 (56%), Gaps = 16/157 (10%)
Query: 80 RIGEGSYGVVYRVR--DSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
++G G+YG VY+ + D D+ ALK++ + ++ RE+ L + +H N++ L++
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVISLQK 65
Query: 138 VVVGKSLSSIFLVMEYCEHDL--------ASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
V + + ++L+ +Y EHDL AS + VK ++ Q+L G++YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 190 SNFIIHRDLKPSNLLL----NDKGCVKIVYSTYLELY 222
+N+++HRDLKP+N+L+ ++G VKI + L+
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 8e-21
Identities = 45/138 (32%), Positives = 75/138 (54%), Gaps = 3/138 (2%)
Query: 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTR-GELREVTGLTKCR-HENIVQL 135
L +IGEG++ V + + K A+K + +L + LRE+ L + H NI++L
Sbjct: 4 LGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 136 KEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIH 195
EV+ + + LV E + +L L + P E +VK + Q+LK L+++H N I H
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFH 123
Query: 196 RDLKPSNLLLNDKGCVKI 213
RD+KP N+L+ D +K+
Sbjct: 124 RDIKPENILIKDD-ILKL 140
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 9e-21
Identities = 52/142 (36%), Positives = 81/142 (57%), Gaps = 5/142 (3%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL---QNNTLTRGELREVTGLTKCRHEN 131
F L IG GS+G VY RD +++A+KK+ Q+N + ++EV L K RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
+Q + + + + +LVMEYC + L + + P E ++ V L+GL YLHS+
Sbjct: 77 TIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
+IHRD+K N+LL++ G VK+
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKL 156
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-20
Identities = 52/152 (34%), Positives = 84/152 (55%), Gaps = 8/152 (5%)
Query: 66 FGKCRNVAE-FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVT 122
FG + + L +G G++G+V RD + + +A+KK+ +T L + RE+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 123 GLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQ-VKCVILQV 181
L RHENI+ L ++ + L I+ V E DL L + S E Q ++ + Q+
Sbjct: 62 LLKHLRHENIISLSDIFI-SPLEDIYFVTELLGTDLHRL---LTSRPLEKQFIQYFLYQI 117
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
L+GL Y+HS ++HRDLKPSN+L+N+ +KI
Sbjct: 118 LRGLKYVHSAGVVHRDLKPSNILINENCDLKI 149
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-20
Identities = 56/149 (37%), Positives = 83/149 (55%), Gaps = 11/149 (7%)
Query: 70 RNVAE-FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR 128
RN E FE + RIG G+YG VY+ R+ ++ A+K + L+ +E+ + C+
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64
Query: 129 HENIVQLKEVVVGKSL--SSIFLVMEYCEHDLASLQD--NVESPFTESQVKCVILQVLKG 184
H NIV G L +++ ME+C SLQD +V P +ESQ+ V + L+G
Sbjct: 65 HSNIV----AYFGSYLRRDKLWICMEFCGG--GSLQDIYHVTGPLSESQIAYVSRETLQG 118
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
L YLHS +HRD+K +N+LL D G VK+
Sbjct: 119 LYYLHSKGKMHRDIKGANILLTDNGHVKL 147
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-20
Identities = 52/146 (35%), Positives = 81/146 (55%), Gaps = 9/146 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCRHENI 132
+ L ++G G+YG V D + +A+KKL Q+ + RE+T L +HEN+
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 133 VQLKEV----VVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
+ L +V V G +LVM Y + DL + + P +E +V+ ++ Q+L GL Y+
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH---PLSEDKVQYLVYQMLCGLKYI 133
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKIV 214
HS IIHRDLKP NL +N+ +KI+
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKIL 159
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 4e-20
Identities = 56/147 (38%), Positives = 87/147 (59%), Gaps = 21/147 (14%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFL-----QNNTLTRGEL----REVTGLTKCRHEN 131
IG GS+G VY ++ +++A+K++ L + R L RE+ L + +HEN
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 132 IVQLKEVVVGKSLSS----IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLN 186
IVQ +G SL + IFL EY +A+L +N + F E+ V+ + Q+LKGLN
Sbjct: 68 IVQY----LGSSLDADHLNIFL--EYVPGGSVAALLNNYGA-FEETLVRNFVRQILKGLN 120
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YLH+ IIHRD+K +N+L+++KG +KI
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKI 147
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-19
Identities = 52/144 (36%), Positives = 82/144 (56%), Gaps = 10/144 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
++E + R+G G+YG VY+ R+ ++ A+K + L+ +E+ + +C+H NIV
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 134 QLKEVVVGKSLS--SIFLVMEYCEHDLASLQD--NVESPFTESQVKCVILQVLKGLNYLH 189
G LS +++ MEYC SLQD +V P +E Q+ V + L+GL YLH
Sbjct: 70 ----AYFGSYLSREKLWICMEYCGG--GSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
S +HRD+K +N+LL D G VK+
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKL 147
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-19
Identities = 49/142 (34%), Positives = 81/142 (57%), Gaps = 5/142 (3%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL---QNNTLTRGELREVTGLTKCRHEN 131
F L IG GS+G VY RD ++++A+KK+ Q+N + ++EV L + +H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
++ K + + + +LVMEYC + L + + P E ++ + L+GL YLHS+
Sbjct: 87 SIEYKGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
+IHRD+K N+LL + G VK+
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKL 166
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-19
Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCRHE 130
++ L+ +G G+YG V D+ + +A+KKL Q+ + RE+ L HE
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 131 NIVQLKEVVV-GKSLSS---IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLN 186
N++ L +V SL ++LV DL ++ ++ ++ ++ Q+L+GL
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLK 132
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
Y+HS IIHRDLKPSN+ +N+ +KI
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDCELKI 159
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-19
Identities = 51/145 (35%), Positives = 79/145 (54%), Gaps = 11/145 (7%)
Query: 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL--REVTGLTKCRHE 130
+ + +IGEGS G+V D + +A+KK+ L+ R EL EV + +H
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHP 76
Query: 131 NIVQL-KEVVVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYL 188
NIV++ +VG L ++VME+ E +L D V + E Q+ V L VLK L++L
Sbjct: 77 NIVEMYSSYLVGDEL---WVVMEFLEG--GALTDIVTHTRMNEEQIATVCLAVLKALSFL 131
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
H+ +IHRD+K ++LL G VK+
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKL 156
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-19
Identities = 50/145 (34%), Positives = 75/145 (51%), Gaps = 10/145 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL-QNNTLTRGELREVTGLTKCRHENIV 133
+E + IG G+ VVY ++ +A+K++ L + T +EV +++C H N+V
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 134 QL-KEVVVGKSLSSIFLVMEYCE----HDLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
+ VVG L +LVM Y D+ E+ + V+ +VLKGL YL
Sbjct: 63 KYYTSFVVGDEL---WLVMPYLSGGSLLDIMK-SSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
HSN IHRD+K N+LL + G VKI
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKI 143
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 3e-19
Identities = 41/151 (27%), Positives = 67/151 (44%), Gaps = 21/151 (13%)
Query: 79 NRIGEGSYGVVYR--VRDSVQDKIL-ALKKLFLQNNTLTRGE----LREVTGLTKCRHEN 131
++GEG++G VY+ ++ A+K L + E L+E + K H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL---KEDASEEERKDFLKEARVMKKLGHPN 57
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEH-DL--------ASLQDNVESPFTESQVKCVILQVL 182
+V+L V + ++LV+EY E DL +S + + +Q+
Sbjct: 58 VVRLLGVCTEEE--PLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 183 KGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
KG+ YL S +HRDL N L+ + VKI
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVGEDLVVKI 146
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-19
Identities = 39/139 (28%), Positives = 67/139 (48%), Gaps = 9/139 (6%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKK-LFLQNNTLTRGEL----REVTGLTKCRHENIVQL 135
+G GS+G VY + A+K+ + + + +E+ L+K +H NIVQ
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 136 KEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
+ ++++ +E LA L S F E ++ Q+L GL YLH +
Sbjct: 68 LGTE--REEDNLYIFLELVPGGSLAKLLKKYGS-FPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HRD+K +N+L++ G VK+
Sbjct: 125 HRDIKGANILVDTNGVVKL 143
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 6e-19
Identities = 48/142 (33%), Positives = 81/142 (57%), Gaps = 5/142 (3%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL---QNNTLTRGELREVTGLTKCRHEN 131
F L+ IG GS+G VY +S ++++A+KK+ Q N + ++EV L + +H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
++ K + + + +LVMEYC + L + + P E ++ + L+GL YLHS+
Sbjct: 83 TIEYKGCYLKEH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
+IHRD+K N+LL + G VK+
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKL 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-18
Identities = 50/150 (33%), Positives = 89/150 (59%), Gaps = 10/150 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQD-KILALKKLFLQNNT--LTRGELREVTGLTKCR-- 128
++E + IGEG+YG V++ RD + +ALK++ +Q + +REV L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 129 -HENIVQLKEV-VVGKS--LSSIFLVMEYCEHDLASLQDNVESPFTESQ-VKCVILQVLK 183
H N+V+L +V V ++ + + LV E+ + DL + D V P ++ +K ++ Q+L+
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
GL++LHS+ ++HRDLKP N+L+ G +K+
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQIKL 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-18
Identities = 48/144 (33%), Positives = 78/144 (54%), Gaps = 7/144 (4%)
Query: 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRH 129
+++E E++NRIG G+ G VY+V ++ ALK ++ + R ++ RE+ L H
Sbjct: 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH 131
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
N+V+ ++ I +++E+ D SL+ E + V Q+L G+ YLH
Sbjct: 132 PNVVKCHDMF--DHNGEIQVLLEFM--DGGSLEGT--HIADEQFLADVARQILSGIAYLH 185
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
I+HRD+KPSNLL+N VKI
Sbjct: 186 RRHIVHRDIKPSNLLINSAKNVKI 209
|
Length = 353 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-18
Identities = 47/148 (31%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCRHE 130
+ L ++G G+YG V D +A+KKL+ Q+ + RE+ L +HE
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 131 NIVQLKEVVVGKS----LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLN 186
N++ L +V +LVM + DL L + +E +++ ++ Q+LKGL
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLK 132
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
Y+H+ IIHRDLKP NL +N+ +KI+
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKIL 160
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-18
Identities = 45/144 (31%), Positives = 75/144 (52%), Gaps = 3/144 (2%)
Query: 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGELREVTGLTKCRH 129
+ L ++GEGSY VY+ + +++ALK + ++ + +RE + L +H
Sbjct: 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
NIV L +++ K ++ V EY DLA V+ + Q+L+GL Y+H
Sbjct: 63 ANIVLLHDIIHTKE--TLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH 120
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
I+HRDLKP NLL++ G +K+
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKL 144
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-17
Identities = 50/149 (33%), Positives = 85/149 (57%), Gaps = 12/149 (8%)
Query: 71 NVAEF-EKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELR----EVTGLT 125
N EF E + +G+G++G VY+ ++ + +LA K+ +T + EL E+ L
Sbjct: 2 NPEEFWEIIGELGDGAFGKVYKAQNK-ETGVLAAAKVI---DTKSEEELEDYMVEIDILA 57
Query: 126 KCRHENIVQLKEVVVGKSLSSIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKG 184
C H NIV+L + ++ ++++++E+C + ++ +E P TE Q++ V Q L+
Sbjct: 58 SCDHPNIVKLLDAFYYEN--NLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA 115
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
LNYLH N IIHRDLK N+L G +K+
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGDIKL 144
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-17
Identities = 47/140 (33%), Positives = 78/140 (55%), Gaps = 11/140 (7%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKL-FLQNNTLTRGELR----EVTGLTKCRHENIVQL 135
+G+G++G VY D + LA+K++ F ++ T+ E+ E+ L +HE IVQ
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 136 KEVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLHSNFI 193
+ SIF MEY S++D +++ TE+ + Q+L+G+ YLHSN I
Sbjct: 70 YGCLRDDETLSIF--MEYMPG--GSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 194 IHRDLKPSNLLLNDKGCVKI 213
+HRD+K +N+L + G VK+
Sbjct: 126 VHRDIKGANILRDSAGNVKL 145
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-17
Identities = 45/145 (31%), Positives = 78/145 (53%), Gaps = 11/145 (7%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRH---E 130
+++L IG G+YG VYR + +++ALK + L ++ REV L++ R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 131 NIVQL-KEVVVGKSLSSIFLVMEYCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYL 188
NI + + G L +++MEY E S++ ++ P E + +I +VL L Y+
Sbjct: 63 NITKYYGSYLKGPRL---WIIMEYAEG--GSVRTLMKAGPIAEKYISVIIREVLVALKYI 117
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
H +IHRD+K +N+L+ + G VK+
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKL 142
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-16
Identities = 48/139 (34%), Positives = 74/139 (53%), Gaps = 8/139 (5%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKL---FLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
IG+GSYGVV D+ + +A+KK+ F + TR LRE+ L RH +IV++K
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDIVEIKH 66
Query: 138 VVVGKS---LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
+++ S I++V E E DL + T + + Q+L+ L Y+H+ +
Sbjct: 67 IMLPPSRREFKDIYVVFELMESDLHQVI-KANDDLTPEHHQFFLYQLLRALKYIHTANVF 125
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HRDLKP N+L N +KI
Sbjct: 126 HRDLKPKNILANADCKLKI 144
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-16
Identities = 47/142 (33%), Positives = 86/142 (60%), Gaps = 8/142 (5%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELR-EVTGLTKCRHENIV 133
F KL RIG+GS+G V++ D+ +++A+K + L+ +++ E+T L++C +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 134 QLKEVVVGKSL--SSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
+ G L + ++++MEY ++L PF E Q+ ++ ++LKGL+YLHS
Sbjct: 66 KY----YGSYLKGTKLWIIMEYLGGG-SALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
IHRD+K +N+LL+++G VK+
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKL 142
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-16
Identities = 49/142 (34%), Positives = 77/142 (54%), Gaps = 7/142 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
++ + +IG+G+ G VY D + +A+K++ LQ + E+ + + +H NIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 134 Q-LKEVVVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSN 191
L +VG L ++VMEY SL D V E+ E Q+ V + L+ L +LHSN
Sbjct: 80 NYLDSYLVGDEL---WVVMEYLAG--GSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 134
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
+IHRD+K N+LL G VK+
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKL 156
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-16
Identities = 48/145 (33%), Positives = 79/145 (54%), Gaps = 9/145 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCRHENI 132
++ L IG G+ G+V D+V + +A+KKL QN T + RE+ + H+NI
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 133 VQLKEVVV-GKSLSS---IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
+ L V KSL ++LVME + +L + ++ ++ ++ Q+L G+ +L
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELMDANLCQV---IQMDLDHERMSYLLYQMLCGIKHL 134
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
HS IIHRDLKPSN+++ +KI
Sbjct: 135 HSAGIIHRDLKPSNIVVKSDCTLKI 159
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 6e-16
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 13/148 (8%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNN--TLTRGELREVTGLTKC 127
+FE + IG G++G V+ VRD ++ A+K L ++ N R E R++ L
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAE-RDI--LADA 58
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLN 186
IV+L + ++LVMEY DL +L + F E + I +++ L+
Sbjct: 59 DSPWIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAELVLALD 115
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
+H IHRD+KP N+L++ G +K+
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLA 143
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-15
Identities = 50/144 (34%), Positives = 68/144 (47%), Gaps = 14/144 (9%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELR----------EVTGLTKCRHE 130
IG+G+YG VY + +++A+K++ L R + R E+ L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
NIVQ + SIFL EY + S F E V+ QVL+GL YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFL--EYVPGGSIGSCLRT-YGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
S I+HRDLK NLL++ G KI
Sbjct: 126 SKGILHRDLKADNLLVDADGICKI 149
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-15
Identities = 48/147 (32%), Positives = 79/147 (53%), Gaps = 8/147 (5%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCRHEN 131
++ L+ +G G+YG V D+ +A+KKL Q+ + RE+ L +HEN
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 132 IVQLKEVVVG----KSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
++ L +V + + ++LV DL ++ T+ V+ +I Q+L+GL Y
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKY 135
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKIV 214
+HS IIHRDLKPSNL +N+ +KI+
Sbjct: 136 IHSADIIHRDLKPSNLAVNEDCELKIL 162
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-15
Identities = 47/142 (33%), Positives = 85/142 (59%), Gaps = 8/142 (5%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELR-EVTGLTKCRHENIV 133
F KL RIG+GS+G VY+ D+ +++A+K + L+ +++ E+T L++C I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 134 QLKEVVVGKSL--SSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
+ G L + ++++MEY ++L P E+ + ++ ++LKGL+YLHS
Sbjct: 66 RY----YGSYLKGTKLWIIMEYLGGG-SALDLLKPGPLEETYIATILREILKGLDYLHSE 120
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
IHRD+K +N+LL+++G VK+
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKL 142
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-15
Identities = 46/146 (31%), Positives = 79/146 (54%), Gaps = 9/146 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCRHENI 132
++ L IG G+ G+V D+V D+ +A+KKL QN T + RE+ + H+NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 133 VQLKEVVVGK----SLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
+ L V + ++LVME + +L + ++ ++ ++ Q+L G+ +L
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQV---IQMELDHERMSYLLYQMLCGIKHL 135
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKIV 214
HS IIHRDLKPSN+++ +KI+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKIL 161
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 2e-15
Identities = 44/144 (30%), Positives = 75/144 (52%), Gaps = 6/144 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN-NTLTRGELR-EVTGLTKCRHEN 131
++ K+ +IGEGS+G V+ K +K++ + + R E R EV L+ +H N
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVE-SPFTESQVKCVILQVLKGLNYLH 189
IVQ +E + ++++VM+YCE DL + F E Q+ +Q+ L ++H
Sbjct: 61 IVQYQESF--EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
I+HRD+K N+ L G +K+
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKL 142
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-15
Identities = 48/143 (33%), Positives = 86/143 (60%), Gaps = 10/143 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELR-EVTGLTKCRHENIV 133
F KL +IG+GS+G V++ D+ K++A+K + L+ +++ E+T L++C +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 134 QLKEVVVGKSL--SSIFLVMEYCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHS 190
+ G L + ++++MEY S D +E P E+Q+ ++ ++LKGL+YLHS
Sbjct: 66 KY----YGSYLKDTKLWIIMEYLGG--GSALDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
IHRD+K +N+LL++ G VK+
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKL 142
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-15
Identities = 39/143 (27%), Positives = 72/143 (50%), Gaps = 5/143 (3%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL-QNNTLTRGELREVTGLTKCRHENI 132
++ L +GEGS+G V+ D+ A+K++ L ++++ +E L K +H NI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHD--LASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
V KE +++VMEYC+ + ++ F E + +Q+ G+ ++H
Sbjct: 61 VAFKESFEADG--HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
++HRD+K N+ L G VK+
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKL 141
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-15
Identities = 46/146 (31%), Positives = 80/146 (54%), Gaps = 8/146 (5%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCRHENI 132
++ L +G G+YG V D+ + +A+KKL Q+ R RE+ L +HEN+
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76
Query: 133 VQLKEVVV----GKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
+ L +V ++ + ++LV DL ++ ++ V+ +I Q+L+GL Y+
Sbjct: 77 IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYI 134
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKIV 214
HS IIHRDLKPSN+ +N+ ++I+
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRIL 160
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 3e-15
Identities = 47/139 (33%), Positives = 68/139 (48%), Gaps = 9/139 (6%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
+G G +G V V+ +++ ALK K + E L +C H IV+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 138 VVVGKSLSSIFLVMEYCE-HDLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIH 195
K I+++MEYC +L + L+D F E + I V+ YLH+ II+
Sbjct: 61 TFKDKK--YIYMLMEYCLGGELWTILRDRGL--FDEYTARFYIACVVLAFEYLHNRGIIY 116
Query: 196 RDLKPSNLLLNDKGCVKIV 214
RDLKP NLLL+ G VK+V
Sbjct: 117 RDLKPENLLLDSNGYVKLV 135
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 6e-15
Identities = 49/145 (33%), Positives = 76/145 (52%), Gaps = 11/145 (7%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALK----KLFLQNNTLTRGELREVTGLTKCRHE 130
FE L IG+G++G V V+ K+ A+K + ++ + R L E L + H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGS-VRNVLNERRILQELNHP 60
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEH-DLA-SLQDNVESPFTESQVKCVILQVLKGLNYL 188
+V L + +++LV++ DL L V F+E QVK I +++ L YL
Sbjct: 61 FLVNLWYSF--QDEENMYLVVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYL 116
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
HS IIHRD+KP N+LL+++G V I
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHI 141
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-14
Identities = 43/143 (30%), Positives = 70/143 (48%), Gaps = 10/143 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL--REVTGLTKCRHENI 132
+E + +IGEGS+G +Y + + +K++ L + E +EV L K +H NI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESP----FTESQVKCVILQVLKGLNYL 188
V + +F+VMEYC D L + F+E Q+ +Q+ GL ++
Sbjct: 62 VTFFASF--QENGRLFIVMEYC--DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHI 117
Query: 189 HSNFIIHRDLKPSNLLLNDKGCV 211
H I+HRD+K N+ L+ G V
Sbjct: 118 HDRKILHRDIKSQNIFLSKNGMV 140
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-14
Identities = 48/142 (33%), Positives = 78/142 (54%), Gaps = 7/142 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
++ + +IG+G+ G VY D + +A+K++ LQ + E+ + + ++ NIV
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 134 Q-LKEVVVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSN 191
L +VG L ++VMEY SL D V E+ E Q+ V + L+ L++LHSN
Sbjct: 80 NYLDSYLVGDEL---WVVMEYLAG--GSLTDVVTETCMDEGQIAAVCRECLQALDFLHSN 134
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
+IHRD+K N+LL G VK+
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKL 156
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-14
Identities = 49/146 (33%), Positives = 79/146 (54%), Gaps = 9/146 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCRHENI 132
+++L IG G+ G+V D+V +A+KKL QN T + RE+ L H+NI
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 133 VQLKEVVV-GKSLSS---IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
+ L V KSL ++LVME + +L + + ++ ++ Q+L G+ +L
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQV---IHMELDHERMSYLLYQMLCGIKHL 139
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKIV 214
HS IIHRDLKPSN+++ +KI+
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKIL 165
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-14
Identities = 47/142 (33%), Positives = 78/142 (54%), Gaps = 7/142 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
++ + +IG+G+ G V+ D + +A+K++ LQ + E+ + + ++ NIV
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIV 79
Query: 134 Q-LKEVVVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSN 191
L +VG L F+VMEY SL D V E+ E+Q+ V + L+ L +LH+N
Sbjct: 80 NFLDSFLVGDEL---FVVMEYLAG--GSLTDVVTETCMDEAQIAAVCRECLQALEFLHAN 134
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
+IHRD+K N+LL G VK+
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKL 156
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 2e-14
Identities = 39/143 (27%), Positives = 74/143 (51%), Gaps = 10/143 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE------LREVTGLTKC 127
E+ K ++G G++ Y+ RD ++A+K++ NT + E +E+ + +
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLN 186
H +I+++ S ++F+ E+ ++ L F E+ + Q+L+GL+
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFV--EWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLS 117
Query: 187 YLHSNFIIHRDLKPSNLLLNDKG 209
YLH N IIHRD+K +NLL++ G
Sbjct: 118 YLHENQIIHRDVKGANLLIDSTG 140
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-14
Identities = 49/147 (33%), Positives = 83/147 (56%), Gaps = 11/147 (7%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKC-RHEN 131
++ L IG G+ G+V D++ ++ +A+KKL QN T + RE+ L KC H+N
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELV-LMKCVNHKN 84
Query: 132 IVQLKEVVV-GKSLSS---IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
I+ L V KSL +++VME + +L + ++ ++ ++ Q+L G+ +
Sbjct: 85 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV---IQMELDHERMSYLLYQMLCGIKH 141
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKIV 214
LHS IIHRDLKPSN+++ +KI+
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKIL 168
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-14
Identities = 44/147 (29%), Positives = 65/147 (44%), Gaps = 14/147 (9%)
Query: 77 KLNRIGEGSYGVVYRVR-DSVQDK---ILALKKL-FLQNNTLTRGELREVTGLTKCRHEN 131
+ ++GEG +G V R D + D +A+K L RE+ L HEN
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 132 IVQLKEVVVGKSLSSIFLVMEYC-----EHDLASLQDNVESPFTESQVKCVILQVLKGLN 186
IV+ K V S+ L+MEY L +D + ++ Q+ KG++
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK----RLLLFSSQICKGMD 123
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YL S IHRDL N+L+ + VKI
Sbjct: 124 YLGSQRYIHRDLAARNILVESEDLVKI 150
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-14
Identities = 42/145 (28%), Positives = 73/145 (50%), Gaps = 7/145 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ-NNTLTRGELREVTGLTKCRHENI 132
E E L+ +G+G+YG VY+V +A+K++ L+ + + + E+ L K I
Sbjct: 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYI 61
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESP--FTESQVKCVILQVLKGLNYLH 189
V + ++++ MEY + L L + E ++ + V+KGL +L
Sbjct: 62 VDFYGAFFIE--GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 190 SNF-IIHRDLKPSNLLLNDKGCVKI 213
IIHRD+KP+N+L+N G VK+
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKL 144
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 4e-14
Identities = 47/142 (33%), Positives = 77/142 (54%), Gaps = 7/142 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
++ + +IG+G+ G VY D + +A++++ LQ + E+ + + ++ NIV
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 134 Q-LKEVVVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSN 191
L +VG L ++VMEY SL D V E+ E Q+ V + L+ L +LHSN
Sbjct: 81 NYLDSYLVGDEL---WVVMEYLAG--GSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
+IHRD+K N+LL G VK+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKL 157
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 4e-14
Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 15/144 (10%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALK----KLFLQNNTLTRGEL-REVTGLTKCRH 129
F+K+ +G+G G V+ VR K+ ALK K ++ N + R +E+ L H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDH 60
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCE----HDLASLQDNVESPFTESQVKCVILQVLKGL 185
+ L ++ + + LVM+YC L LQ +E + +VL L
Sbjct: 61 PFLPTLYASF--QTETYLCLVMDYCPGGELFRL--LQRQPGKCLSEEVARFYAAEVLLAL 116
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKG 209
YLH I++RDLKP N+LL++ G
Sbjct: 117 EYLHLLGIVYRDLKPENILLHESG 140
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 7e-14
Identities = 47/136 (34%), Positives = 73/136 (53%), Gaps = 7/136 (5%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQL-KEV 138
+IGEGS G+V + K +A+KK+ L+ EV + HEN+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 139 VVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRD 197
+VG L ++VME+ E +L D V + E Q+ V L VL+ L+YLH+ +IHRD
Sbjct: 89 LVGDEL---WVVMEFLEG--GALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRD 143
Query: 198 LKPSNLLLNDKGCVKI 213
+K ++LL G +K+
Sbjct: 144 IKSDSILLTSDGRIKL 159
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-14
Identities = 48/136 (35%), Positives = 74/136 (54%), Gaps = 7/136 (5%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQL-KEV 138
+IGEGS G+V K++A+KK+ L+ EV + +HEN+V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 139 VVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRD 197
+VG L ++VME+ E +L D V + E Q+ V L VLK L+ LH+ +IHRD
Sbjct: 87 LVGDEL---WVVMEFLEG--GALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRD 141
Query: 198 LKPSNLLLNDKGCVKI 213
+K ++LL G VK+
Sbjct: 142 IKSDSILLTHDGRVKL 157
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 8e-14
Identities = 38/146 (26%), Positives = 76/146 (52%), Gaps = 9/146 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKK--LFLQNNTLTRGE-LREVTGLTKCRHEN 131
F+ +IG+G + VVY+ + +++ALKK +F + R + L+E+ L + H N
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVES---PFTESQVKCVILQVLKGLNY 187
+++ + + +I V+E + DL+ + + + E + +Q+ L +
Sbjct: 64 VIKYLASFIENNELNI--VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
+HS I+HRD+KP+N+ + G VK+
Sbjct: 122 MHSKRIMHRDIKPANVFITATGVVKL 147
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-14
Identities = 46/137 (33%), Positives = 71/137 (51%), Gaps = 5/137 (3%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLT--RGELREVTGLTKCRHENIVQLKEV 138
+G+GSYG V VR K +KKL L+N + + +E L++ +H NIV +E
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 139 VVGKSLSSIFLVMEYCEH-DL-ASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHR 196
G+ +++VM +CE DL L++ E+QV +Q+ L YLH I+HR
Sbjct: 68 WEGED-GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHR 126
Query: 197 DLKPSNLLLNDKGCVKI 213
DLK N+ L +K+
Sbjct: 127 DLKTQNVFLTRTNIIKV 143
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-13
Identities = 46/141 (32%), Positives = 77/141 (54%), Gaps = 7/141 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
E +IGEGS G+V R+ + +A+K + L+ EV + +H+N+V+
Sbjct: 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVE 82
Query: 135 L-KEVVVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNF 192
+ K +VG+ L +++ME+ + +L D V ++ E Q+ V VL+ L YLHS
Sbjct: 83 MYKSYLVGEEL---WVLMEFLQG--GALTDIVSQTRLNEEQIATVCESVLQALCYLHSQG 137
Query: 193 IIHRDLKPSNLLLNDKGCVKI 213
+IHRD+K ++LL G VK+
Sbjct: 138 VIHRDIKSDSILLTLDGRVKL 158
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-13
Identities = 44/138 (31%), Positives = 72/138 (52%), Gaps = 5/138 (3%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKL-FLQNNTLTRGELR----EVTGLTKCRHENIVQL 135
+G+G++G VY D + LA K++ F + T E+ E+ L +HE IVQ
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 136 KEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIH 195
+ ++ ++ + MEY Q TES + Q+L+G++YLHSN I+H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 196 RDLKPSNLLLNDKGCVKI 213
RD+K +N+L + G VK+
Sbjct: 130 RDIKGANILRDSAGNVKL 147
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-13
Identities = 44/142 (30%), Positives = 67/142 (47%), Gaps = 13/142 (9%)
Query: 80 RIGEGSYGVVYR-VRDSVQDKIL--ALKKLFLQNNTLTRGE-LREVTGLTKCRHENIVQL 135
++G+GS+GVV R + K++ A+K L + + L+E + HEN+++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 136 KEVVVGKSLSSIFLVMEYCEHDLASLQDNVE----SPFTESQVKCVILQVLKGLNYLHSN 191
VV+ L +V E L SL D + F S + +Q+ G+ YL S
Sbjct: 62 YGVVLTHPL---MMVTELAP--LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
IHRDL N+LL VKI
Sbjct: 117 RFIHRDLAARNILLASDDKVKI 138
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-13
Identities = 37/139 (26%), Positives = 65/139 (46%), Gaps = 8/139 (5%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
+ + + GS G V+ Q + LK + + TL L L H ++++
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLK-IGQKGTTLIEAML-----LQNVNHPSVIR 121
Query: 135 LKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
+K+ +V +++ + V+ + DL + P Q + Q+L+GL YLH+ II
Sbjct: 122 MKDTLVSGAITCM--VLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRII 179
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HRD+K N+ +ND V I
Sbjct: 180 HRDVKTENIFINDVDQVCI 198
|
Length = 357 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-13
Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 9/147 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-----LREVTGLTKC- 127
E+ K +G+G+YG VY + Q +++A+K++ L + + E L+E L K
Sbjct: 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
+H NIVQ + + SIF ME+ S N P E Q+L G+ Y
Sbjct: 60 KHVNIVQYLGTCLDDNTISIF--MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAY 117
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKIV 214
LH+N ++HRD+K +N++L G +K++
Sbjct: 118 LHNNCVVHRDIKGNNVMLMPNGIIKLI 144
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-13
Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 23/159 (14%)
Query: 74 EFEKLNRIGEGSYGVVYRVR-DSVQDKILALKKLFLQNNTLTRGE----------LREVT 122
E+ L +G G++G VY+VR + +LALK++ + N + + + EVT
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 123 GLTK-CRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES------PFTESQVK 175
+ + RH NIV+ + + +++VM+ E A L ++ S FTE ++
Sbjct: 61 IIKEQLRHPNIVRYYKTFLEND--RLYIVMDLIEG--APLGEHFNSLKEKKQRFTEERIW 116
Query: 176 CVILQVLKGLNYLH-SNFIIHRDLKPSNLLLNDKGCVKI 213
+ +Q++ L YLH I+HRDL P+N++L + V I
Sbjct: 117 NIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-13
Identities = 39/140 (27%), Positives = 74/140 (52%), Gaps = 3/140 (2%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
+E + +G+G++G VY+ ++ + A K + ++ + E+ L C H IV+
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73
Query: 135 LKEVVVGKSLSSIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFI 193
L +++++E+C + ++ ++ TE Q++ + Q+L+ L YLHS I
Sbjct: 74 LLGAFYWDG--KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKI 131
Query: 194 IHRDLKPSNLLLNDKGCVKI 213
IHRDLK N+LL G +K+
Sbjct: 132 IHRDLKAGNVLLTLDGDIKL 151
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-13
Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 11/147 (7%)
Query: 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHE 130
N E + IG+G +G V + + +A+K L ++T + L E + +T RH
Sbjct: 4 NSKELKLGATIGKGEFGDVML--GDYRGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHP 60
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES----PFTESQVKCVILQVLKGLN 186
N+VQL VV+ + +++V EY SL D + S T +Q L V +G+
Sbjct: 61 NLVQLLGVVLQGN--PLYIVTEYMAK--GSLVDYLRSRGRAVITLAQQLGFALDVCEGME 116
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YL +HRDL N+L+++ K+
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVAKV 143
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 4e-13
Identities = 52/147 (35%), Positives = 69/147 (46%), Gaps = 11/147 (7%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE---LREVTGLTKCRHE 130
+FE + +G GS+G V VR K ALK L + L E L RH
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP 61
Query: 131 NIVQLKEVVVG--KSLSSIFLVMEYCE-HDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
+V L G + S+++LVMEY +L S F E + QV+ L Y
Sbjct: 62 FLVNL----YGSFQDDSNLYLVMEYVPGGELFSHLRKSGR-FPEPVARFYAAQVVLALEY 116
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKIV 214
LHS I++RDLKP NLLL+ G +KI
Sbjct: 117 LHSLDIVYRDLKPENLLLDSDGYIKIT 143
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-13
Identities = 50/165 (30%), Positives = 70/165 (42%), Gaps = 30/165 (18%)
Query: 81 IGEGSYGVVYRVR----DSVQDKIL-ALKKLF-LQNNTLTRGELREVTGLTKCRHENIVQ 134
+GEG++G V+ + DK L A+K L +N + RE LT +HENIV+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 135 LKEVVVGKSLSSIFLVMEYCEH-DLASL-------------QDNVESPFTESQVKCVILQ 180
V +V EY EH DL D+ T SQ+ + +Q
Sbjct: 73 FYGVCTEGD--PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 181 VLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI--------VYST 217
+ G+ YL S +HRDL N L+ VKI VY+T
Sbjct: 131 IASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT 175
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 5e-13
Identities = 41/144 (28%), Positives = 74/144 (51%), Gaps = 7/144 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL---FLQNNTLTRGELREVTGLTKCRHE 130
+F+ L ++G+G YG V+ + +I+ALK++ L R L E LT + E
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 131 NIVQLKEVVVGKSLSSIFLVMEY-CEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
+V+L + + ++L MEY D +L +N+ +E + + ++ + ++ LH
Sbjct: 62 WLVKL--LYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYMAEMFEAVDALH 118
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
IHRDLKP N L++ G +K+
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKL 142
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-13
Identities = 46/147 (31%), Positives = 71/147 (48%), Gaps = 26/147 (17%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ------ 134
+G+G+YG+VY RD +A+K++ +++ + E+ + +H NIVQ
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 135 -------LKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
E V G SLS++ L+DN E + Q+L+GL Y
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL------RSKWGPLKDN------EQTIIFYTKQILEGLKY 123
Query: 188 LHSNFIIHRDLKPSNLLLND-KGCVKI 213
LH N I+HRD+K N+L+N G VKI
Sbjct: 124 LHDNQIVHRDIKGDNVLVNTYSGVVKI 150
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-13
Identities = 45/143 (31%), Positives = 66/143 (46%), Gaps = 12/143 (8%)
Query: 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
L I +G++G VY + A+K L + +VT + R ++Q +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMI----AKNQVTNVKAERAIMMIQGES 56
Query: 138 VVVGK---SLSS---IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
V K S S ++LVMEY D ASL E K I +V+ G+ LH
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQYIAEVVLGVEDLHQ 115
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
IIHRD+KP NLL++ G +K+
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKL 138
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-12
Identities = 45/161 (27%), Positives = 67/161 (41%), Gaps = 30/161 (18%)
Query: 78 LNRIGEGSYGVVYR-------VRDSVQDKILALKKLFLQNNTLTRGELR-EVTGLTKCRH 129
L +GEG++G VY+ R S +A+K L + E R E ++ +H
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSAT--SVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67
Query: 130 ENIVQLKEVVVGKS-LSSIFLVMEYCEH-DL---------------ASLQDNVESPFTES 172
NIV L V + +F EY H DL S + V+S S
Sbjct: 68 PNIVCLLGVCTKEQPTCMLF---EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS 124
Query: 173 QVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ +Q+ G+ YL S+ +HRDL N L+ + VKI
Sbjct: 125 DFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKI 165
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-12
Identities = 36/148 (24%), Positives = 68/148 (45%), Gaps = 9/148 (6%)
Query: 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELR-EVTGLTKCRH-E 130
+ + L IG G++G V ++ I+A+K++ + + L ++ + +
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEHDLASL----QDNVESPFTESQVKCVILQVLKGLN 186
IV+ + + I ME + L + ++S E + + + +K LN
Sbjct: 64 YIVKFYGALFREGDCWI--CMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALN 121
Query: 187 YLHSNF-IIHRDLKPSNLLLNDKGCVKI 213
YL IIHRD+KPSN+LL+ G +K+
Sbjct: 122 YLKEELKIIHRDVKPSNILLDRNGNIKL 149
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-12
Identities = 43/145 (29%), Positives = 73/145 (50%), Gaps = 9/145 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHE- 130
+ E L IG G+ G VY++R ++A+K++ N R L ++ + K H+
Sbjct: 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKR-ILMDLDVVLKS-HDC 73
Query: 131 -NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
IV+ + S +F+ ME L L ++ P E + + + ++K L+YL
Sbjct: 74 PYIVKCYGYFITDS--DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 190 SNF-IIHRDLKPSNLLLNDKGCVKI 213
+IHRD+KPSN+LL+ G VK+
Sbjct: 132 EKHGVIHRDVKPSNILLDASGNVKL 156
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-12
Identities = 42/146 (28%), Positives = 67/146 (45%), Gaps = 21/146 (14%)
Query: 79 NRIGEGSYGVV----YRVRDSVQDKILALKKLFLQNNTLTRGE---LREVTGLTKCRHEN 131
+G G++G V Y ++ + ++ A+K L+ + G+ LRE + + + H
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEV-AVK--TLKQEHIAAGKKEFLREASVMAQLDHPC 57
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCE----HDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
IV+L V G+ L LVME L+ E S +K + QV G+ Y
Sbjct: 58 IVRLIGVCKGEPL---MLVMELAPLGPLLKY--LKKRRE--IPVSDLKELAHQVAMGMAY 110
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
L S +HRDL N+LL ++ KI
Sbjct: 111 LESKHFVHRDLAARNVLLVNRHQAKI 136
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-12
Identities = 37/142 (26%), Positives = 75/142 (52%), Gaps = 4/142 (2%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENI 132
+ E ++ +G G+ G V +V+ ++A K + + + R + LRE+ + +CR I
Sbjct: 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYI 65
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS-N 191
V + ++ +I + ME+ + P + + + V++GL YL++ +
Sbjct: 66 VSFYGAFLNEN--NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
I+HRD+KPSN+L+N +G +K+
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKL 145
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-12
Identities = 45/149 (30%), Positives = 77/149 (51%), Gaps = 12/149 (8%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTK-CRHENIV 133
FE + +G G+YG VY+ R ++ A+K + + + +L E+ L K H NI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL-EINMLKKYSHHRNIA 76
Query: 134 QLKEVVVGKSLS----SIFLVMEYCEHDLASLQDNVESP----FTESQVKCVILQVLKGL 185
+ KS ++LVME+C S+ D V++ E + + ++L+GL
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFC--GAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
+LH++ +IHRD+K N+LL + VK+V
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLTENAEVKLV 163
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-12
Identities = 44/140 (31%), Positives = 77/140 (55%), Gaps = 9/140 (6%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKL-FLQNNTLTRGELR----EVTGLTKCRHENIVQL 135
+G+G++G VY D+ + LA+K++ F + T E+ E+ L HE IVQ
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 136 KEVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLHSNFI 193
+ ++ + ME+ S++D ++S TE+ + Q+L+G++YLHSN I
Sbjct: 70 YGCLRDPMERTLSIFMEHMPG--GSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMI 127
Query: 194 IHRDLKPSNLLLNDKGCVKI 213
+HRD+K +N+L + G VK+
Sbjct: 128 VHRDIKGANILRDSVGNVKL 147
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-12
Identities = 41/147 (27%), Positives = 76/147 (51%), Gaps = 11/147 (7%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTKCRH 129
++EK+ +G G++G+V+ R K++ +K++ ++ +T+ E E L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQ--MTKDERLAAQNECQVLKLLSH 58
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEHDLAS--LQDNVESPFTESQVKCVILQVLKGLNY 187
NI++ E + ++ +VMEY + +Q S E + +Q+L L++
Sbjct: 59 PNIIEYYENFLEDK--ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHH 116
Query: 188 LHSNFIIHRDLKPSNLLLND-KGCVKI 213
+H+ I+HRDLK N+LL+ K VKI
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKI 143
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-11
Identities = 47/146 (32%), Positives = 75/146 (51%), Gaps = 7/146 (4%)
Query: 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGELREVTGLTKCR 128
+ EF + I G++G VY R K+ A+K K + N + E L +
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEY-CEHDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
IV L + +S ++++LVMEY D+ SL ++ F E I +V L+Y
Sbjct: 63 SPFIVHLYYSL--QSANNVYLVMEYLIGGDVKSLL-HIYGYFDEEMAVKYISEVALALDY 119
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
LH + IIHRDLKP N+L++++G +K+
Sbjct: 120 LHRHGIIHRDLKPDNMLISNEGHIKL 145
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-11
Identities = 43/140 (30%), Positives = 77/140 (55%), Gaps = 9/140 (6%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKL-FLQNNTLTRGELR----EVTGLTKCRHENIVQL 135
+G G++G VY D+ + LA+K++ F ++ T E+ E+ L RH+ IVQ
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 136 KEVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLHSNFI 193
+ + + +EY S++D +++ TE+ + Q+L+G++YLHSN I
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPG--GSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMI 127
Query: 194 IHRDLKPSNLLLNDKGCVKI 213
+HRD+K +N+L + G VK+
Sbjct: 128 VHRDIKGANILRDSAGNVKL 147
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-11
Identities = 37/147 (25%), Positives = 68/147 (46%), Gaps = 15/147 (10%)
Query: 74 EFEKLNRIGEGSYGVVYRV--RDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRHE 130
EF ++G G +G V+ ++ V+ I LK ++ L + + +EV L + RH+
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILK----SDDLLKQQDFQKEVQALKRLRHK 62
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVIL----QVLKGLN 186
+++ L V ++++ E E SL + SP + ++ QV +G+
Sbjct: 63 HLISLFAVCSVGE--PVYIITELMEK--GSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YL IHRDL N+L+ + K+
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKV 145
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-11
Identities = 48/148 (32%), Positives = 72/148 (48%), Gaps = 15/148 (10%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
+FE + I G+YG VY VR + A+KK+ QN L R ++++V +I+
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLIL-RNQIQQVFV-----ERDIL 55
Query: 134 QLKE--VVVGKSLS-----SIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGL 185
E VV S + +VMEY E D A+L N+ + + + L
Sbjct: 56 TFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLAL 114
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YLH+ I+HRDLKP NLL+ G +K+
Sbjct: 115 EYLHNYGIVHRDLKPDNLLITSMGHIKL 142
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-11
Identities = 47/144 (32%), Positives = 74/144 (51%), Gaps = 8/144 (5%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENI 132
+FEKL +G G+ GVV +V I+A K + L+ R + +RE+ L +C I
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESP--FTESQVKCVILQVLKGLNYLHS 190
V S I + ME+ D SL ++ E+ + + + VL+GL YL
Sbjct: 62 VGFYGAFY--SDGEISICMEHM--DGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 191 NF-IIHRDLKPSNLLLNDKGCVKI 213
I+HRD+KPSN+L+N +G +K+
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKL 141
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-11
Identities = 41/147 (27%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKK-----LFLQNNTLTRGELREVTGLTKCR 128
+F+ + +G G +G V VR+ I A+K L Q E R++ L+
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDI--LSISN 59
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNY 187
I QL+ K +++LVMEY DL SL + E F E + + +++ ++
Sbjct: 60 SPWIPQLQYAFQDKD--NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKIV 214
+H +HRD+KP N+L++ G +K+
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLA 144
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-11
Identities = 39/148 (26%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHE--- 130
+ E + +G G+YGVV ++R I+A+K++ N+ + + R + L
Sbjct: 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDC 59
Query: 131 -NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESP---FTESQVKCVILQVLKGLN 186
V + + +++ ME + L V E + + + ++K L
Sbjct: 60 PYTVTFYGALFREG--DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 187 YLHSNF-IIHRDLKPSNLLLNDKGCVKI 213
YLHS +IHRD+KPSN+L+N G VK+
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKL 145
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-11
Identities = 41/145 (28%), Positives = 72/145 (49%), Gaps = 7/145 (4%)
Query: 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELR---EVTGLTKCRH 129
+ E++ +G G++G V+ VRD + + ALK + + + E E L + H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEY-CEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
I++L ++++MEY +L S N F+ S +++ L YL
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGR-FSNSTGLFYASEIVCALEYL 117
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
HS I++RDLKP N+LL+ +G +K+
Sbjct: 118 HSKEIVYRDLKPENILLDKEGHIKL 142
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-11
Identities = 47/145 (32%), Positives = 73/145 (50%), Gaps = 8/145 (5%)
Query: 75 FEKLNRIGEGSYGVVYRVR-DSVQD---KILALKKLFLQNN-TLTRGELREVTGLTKCRH 129
+K+ +GEG +G V D D +++A+K L + T G +E+ L H
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYH 65
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYL 188
ENIV+ K + + L+MEY L SL+D + + +Q+ Q+ +G+ YL
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVP--LGSLRDYLPKHKLNLAQLLLFAQQICEGMAYL 123
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
HS IHRDL N+LL++ VKI
Sbjct: 124 HSQHYIHRDLAARNVLLDNDRLVKI 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-10
Identities = 46/143 (32%), Positives = 76/143 (53%), Gaps = 9/143 (6%)
Query: 78 LNRIGEGSYGVVYRVR-DSVQD---KILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
+ ++G+G++G V R D +QD +++A+KKL R RE+ L +H+NIV
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68
Query: 134 QLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVIL---QVLKGLNYLHS 190
+ K V ++ LVMEY + SL+D ++ + ++L Q+ KG+ YL S
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPY--GSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
+HRDL N+L+ + VKI
Sbjct: 127 KRYVHRDLATRNILVESENRVKI 149
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-10
Identities = 38/143 (26%), Positives = 66/143 (46%), Gaps = 9/143 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENI 132
E L +G G +GVV+ + + + A+K ++ ++ + + E + K H N+
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDV-AIK--MIREGAMSEDDFIEEAKVMMKLSHPNL 61
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHD--LASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
VQL V + IF+V EY + L L++ + + + V + + YL S
Sbjct: 62 VQLYGVCTKQR--PIFIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCEAMEYLES 118
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
N IHRDL N L+ + VK+
Sbjct: 119 NGFIHRDLAARNCLVGEDNVVKV 141
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-10
Identities = 47/144 (32%), Positives = 75/144 (52%), Gaps = 8/144 (5%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRHENI 132
+FEK++ +G G+ GVV++V I+A K + L+ R ++ RE+ L +C I
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESP--FTESQVKCVILQVLKGLNYLHS 190
V S I + ME+ D SL ++ E + V + V+KGL YL
Sbjct: 66 VGFYGAFY--SDGEISICMEHM--DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 191 NF-IIHRDLKPSNLLLNDKGCVKI 213
I+HRD+KPSN+L+N +G +K+
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKL 145
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 2e-10
Identities = 41/148 (27%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTK--CRHENI 132
FE + +G G+YG VY+ R ++ A+K + + + E+++ + K H NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNI 65
Query: 133 VQLKEVVVGKSL----SSIFLVMEYC-EHDLASLQDNVE-SPFTESQVKCVILQVLKGLN 186
+ K+ ++LVME+C + L N + + E + + ++L+GL+
Sbjct: 66 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
+LH + +IHRD+K N+LL + VK+V
Sbjct: 126 HLHQHKVIHRDIKGQNVLLTENAEVKLV 153
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 4e-10
Identities = 46/147 (31%), Positives = 71/147 (48%), Gaps = 20/147 (13%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELR---------EVTGLTKCRHE 130
R+G+GS+G VY V+D LK L + GEL E L+K H
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVL----KEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCE-HDL-ASLQD--NVESPFTESQVKCVILQVLKGLN 186
IV+ + + + ++ EYCE DL L++ + +E+QV +Q+L G++
Sbjct: 63 AIVKFHASFLERD--AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
Y+H I+HRDLK N+ L +KI
Sbjct: 121 YMHQRRILHRDLKAKNIFLK-NNLLKI 146
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-10
Identities = 35/152 (23%), Positives = 70/152 (46%), Gaps = 24/152 (15%)
Query: 75 FEKLNRIGEGSYG--VVYRVRDSVQDKILALKKLFLQ--NNTLTRGELREVTGLTKCRHE 130
+ + +G+G++G +YR + D ++ K++ L + R L E+ L+ +H
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTED--DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 131 NIVQ-----LKEVVVGKSLSSIFLVMEYCE----HDLASLQDNVESPFTESQVKCVILQV 181
NI+ + + +++ + MEY +D Q F E V + Q+
Sbjct: 60 NIIAYYNHFMDD-------NTLLIEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQI 110
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ ++Y+H I+HRD+K N+ L G +K+
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIFLTKAGLIKL 142
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 6e-10
Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 8/144 (5%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRHENI 132
+FE+++ +G G+ GVV +V+ I+A K + L+ R ++ RE+ L +C I
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESP--FTESQVKCVILQVLKGLNYLHS 190
V S I + ME+ D SL ++ E + V + VL+GL YL
Sbjct: 66 VGFYGAFY--SDGEISICMEHM--DGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 191 NF-IIHRDLKPSNLLLNDKGCVKI 213
I+HRD+KPSN+L+N +G +K+
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKL 145
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 8e-10
Identities = 42/140 (30%), Positives = 63/140 (45%), Gaps = 16/140 (11%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEV-- 138
IG+GS+G V + K A+K L + L + E + + E V LK V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVL-QKKAILKKKEQKHIMA------ERNVLLKNVKH 55
Query: 139 --VVGKSLS-----SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
+VG S ++ V++Y E F E + + ++ L YLHS
Sbjct: 56 PFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL 115
Query: 192 FIIHRDLKPSNLLLNDKGCV 211
II+RDLKP N+LL+ +G V
Sbjct: 116 NIIYRDLKPENILLDSQGHV 135
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-09
Identities = 48/139 (34%), Positives = 69/139 (49%), Gaps = 17/139 (12%)
Query: 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEV 138
N IG GS+GVVY + +A+KK+ LQ+ RE+ + H NI+ LK+
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKV-LQDPQYKN---RELLIMKNLNHINIIFLKDY 127
Query: 139 ----VVGKSLSSIFL--VMEYCEHDLASL-----QDNVESPFTESQVKCVILQVLKGLNY 187
K+ +IFL VME+ + ++N P VK Q+ + L Y
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLF--LVKLYSYQLCRALAY 185
Query: 188 LHSNFIIHRDLKPSNLLLN 206
+HS FI HRDLKP NLL++
Sbjct: 186 IHSKFICHRDLKPQNLLID 204
|
Length = 440 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-09
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRG------ELREVTGL 124
+F+ + IG G++G V VR ++ A+K L + + R E R++ +
Sbjct: 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-KFEMIKRSDSAFFWEERDI--M 97
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLK 183
E IVQL + +++VMEY DL +L N + P E + +V+
Sbjct: 98 AHANSEWIVQLHYAF--QDDKYLYMVMEYMPGGDLVNLMSNYDIP--EKWARFYTAEVVL 153
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
L+ +HS IHRD+KP N+LL+ G +K+
Sbjct: 154 ALDAIHSMGFIHRDVKPDNMLLDKSGHLKL 183
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-09
Identities = 41/140 (29%), Positives = 72/140 (51%), Gaps = 10/140 (7%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVV 140
IG+G++G VY+VR +I A+K L + + + E+ G ++ +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS-KKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 141 G-----KSLSSIFLVMEY-CEHDLA-SLQDNVESPFTESQVKCVILQVLKGLNYLHSNFI 193
G ++ S ++LV +Y +L LQ E F+E + K I +++ L +LH I
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDI 117
Query: 194 IHRDLKPSNLLLNDKGCVKI 213
++RDLKP N+LL+ G + +
Sbjct: 118 VYRDLKPENILLDATGHIAL 137
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-09
Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 10/139 (7%)
Query: 81 IGEGSYGVVYR--VRDSVQDKILALKKLFLQNNTLTRGE--LREVTGLTKCRHENIVQLK 136
IGEG +G VY+ +KI K + + E L+E + + H +IV+L
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 137 EVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
V+ + + +++VME +L S LQ N S S + Q+ L YL S +
Sbjct: 74 GVI---TENPVWIVMELAPLGELRSYLQVNKYSLDLASLIL-YSYQLSTALAYLESKRFV 129
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HRD+ N+L++ CVK+
Sbjct: 130 HRDIAARNVLVSSPDCVKL 148
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 29/71 (40%), Positives = 39/71 (54%), Gaps = 5/71 (7%)
Query: 145 SSIFLVMEYCEH-DLA-SLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSN 202
+ VMEY DL + +V F+E + V+ GL YLH N I++RDLK N
Sbjct: 75 DHVCFVMEYAAGGDLMMHIHTDV---FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDN 131
Query: 203 LLLNDKGCVKI 213
LLL+ +G VKI
Sbjct: 132 LLLDTEGFVKI 142
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-09
Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 17/143 (11%)
Query: 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENIVQLKE 137
+++G G YG VY +A+K L + +T+ E L+E + + +H N+VQL
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 138 VVVGKSLSSIFLVMEYCEHD--LASLQDNVESPFTESQVKCVIL-----QVLKGLNYLHS 190
V + +++ E+ + L L++ +V V+L Q+ + YL
Sbjct: 70 VCTREP--PFYIITEFMTYGNLLDYLREC-----NRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
IHRDL N L+ + VK+
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKV 145
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-09
Identities = 48/215 (22%), Positives = 89/215 (41%), Gaps = 29/215 (13%)
Query: 7 GNPERAMKVQDDGNPESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCF 66
P A D + D P +P Q+K + L +F I+ L F
Sbjct: 107 DGPSGAEDS--DASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHF---RVIDDLPAGAF 161
Query: 67 GKC-----RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL--FLQNNTLTRGELR 119
GK R E + R + + + ++ A + L+N
Sbjct: 162 GKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLEN--------- 212
Query: 120 EVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQ-----DNVESPFTESQV 174
E+ L + HENI++++E++ +S ++ +++ + + DL S D + P + Q
Sbjct: 213 EILALGRLNHENILKIEEIL--RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK-QT 269
Query: 175 KCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG 209
+ ++ Q+L + Y+H +IHRD+K N+ LN G
Sbjct: 270 RAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304
|
Length = 501 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-09
Identities = 46/138 (33%), Positives = 65/138 (47%), Gaps = 7/138 (5%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE---LREVTGLTKCRHENIVQLKE 137
+G+G +G V + K+ A KKL + +GE L E L K IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 138 VVVGKS-LSSIFLVMEYCEHDLASLQDNVESP-FTESQVKCVILQVLKGLNYLHSNFIIH 195
K L + +M DL NV P F E++ Q++ GL +LH I++
Sbjct: 61 AFETKDDLCLVMTLMN--GGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 196 RDLKPSNLLLNDKGCVKI 213
RDLKP N+LL+D G V+I
Sbjct: 119 RDLKPENVLLDDHGNVRI 136
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-09
Identities = 40/142 (28%), Positives = 67/142 (47%), Gaps = 14/142 (9%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKL----FLQNN----TLTRGELREVTGLTKCRHENI 132
+G+GS+G V D++ A+K L LQ++ T+T + + G +H +
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG----KHPFL 58
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
QL ++ +F VMEY F E + + +++ GL +LH
Sbjct: 59 TQLHSCF--QTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG 116
Query: 193 IIHRDLKPSNLLLNDKGCVKIV 214
II+RDLK N+LL+ +G +KI
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIA 138
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-09
Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 28/170 (16%)
Query: 70 RNVAEFEKLNRIGEGSYGVVYRVR-----DSVQDKILALKKLFLQNNTLTRGEL-REVTG 123
RN E+ + IG+G++G V++ R ++A+K L + + + + RE
Sbjct: 4 RNNIEYVR--DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 124 LTKCRHENIVQLKEV-VVGKSLSSIFLVMEY----------CEHDLASLQDNVES----- 167
+ + H NIV+L V VGK + +F M Y SL + S
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 168 ----PFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
P + ++ C+ QV G+ YL +HRDL N L+ + VKI
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 171
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-09
Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 21/152 (13%)
Query: 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHE 130
N+ E + L IG+G +G V + + +A+K ++N+ + L E + +T+ RH
Sbjct: 4 NMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVK--CIKNDATAQAFLAEASVMTQLRHS 59
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVI---------LQV 181
N+VQL V+V + +++V EY SL D + S+ + V+ L V
Sbjct: 60 NLVQLLGVIVEEK-GGLYIVTEYMAK--GSLVD-----YLRSRGRSVLGGDCLLKFSLDV 111
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ + YL +N +HRDL N+L+++ K+
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDNVAKV 143
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 6e-09
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 118 LREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCV 177
L+E + K RH+ +VQL V + I++V EY SL D ++S +++
Sbjct: 49 LQEAQIMKKLRHDKLVQLYAVCSEEE--PIYIVTEYMSK--GSLLDFLKSG-EGKKLRLP 103
Query: 178 IL-----QVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
L Q+ +G+ YL S IHRDL N+L+ + KI
Sbjct: 104 QLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKI 144
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-09
Identities = 41/137 (29%), Positives = 66/137 (48%), Gaps = 7/137 (5%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTKCRHENIVQLK 136
+G+G++G V VR+ K A+K + + + + E L E L RH + LK
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMK-ILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 137 EVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHR 196
K + VMEY + E F+E + + +++ L+YLHS I++R
Sbjct: 62 YSFQTKD--RLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119
Query: 197 DLKPSNLLLNDKGCVKI 213
DLK NL+L+ G +KI
Sbjct: 120 DLKLENLMLDKDGHIKI 136
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-09
Identities = 41/146 (28%), Positives = 74/146 (50%), Gaps = 12/146 (8%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALK-----KLFLQNNTLTRGELREVTGLTKCR 128
+++ + IG G++G V VR K+ A+K ++ ++++ E R++
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNY 187
+VQL + +++VMEY DL +L N + P E K +V+ L+
Sbjct: 104 W--VVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVP--EKWAKFYTAEVVLALDA 157
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
+HS +IHRD+KP N+LL+ G +K+
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKL 183
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 8e-09
Identities = 44/144 (30%), Positives = 80/144 (55%), Gaps = 13/144 (9%)
Query: 78 LNRIGEGSYGVVYRVR-----DSVQ---DKILALKKLFLQNNTLTRGELREVTGLTKCRH 129
L +G+GS+G V+ VR D+ Q K+L L +++ T+ E R++ L + H
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKME-RDI--LAEVNH 57
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
IV+L ++ ++L++++ + + E FTE VK + ++ L++LH
Sbjct: 58 PFIVKLHYAF--QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
S II+RDLKP N+LL+++G +K+
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKL 139
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-09
Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 17/152 (11%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL--FLQNNTLTRGELREVTGLTKCRHENI 132
+E + IG+G+YG V++V + A+K L + E + L+ H N+
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSD--HPNV 77
Query: 133 VQL------KEVVVGKSLSSIFLVMEYCE----HDLASLQDNVESPFTESQVKCVILQVL 182
V+ K+V G L +LV+E C DL E + ++ + L
Sbjct: 78 VKFYGMYYKKDVKNGDQL---WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 183 KGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
GL +LH N IHRD+K +N+LL +G VK+V
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-08
Identities = 51/163 (31%), Positives = 75/163 (46%), Gaps = 28/163 (17%)
Query: 81 IGEGSYGVVYRVRD----SVQDKIL-ALKKLFLQNNTLTRGELREVTGLTKCRHENIVQL 135
+GEG++G V+ QDKIL A+K L ++ + RE LT +HE+IV+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 136 KEVVVGKSLSSIFLVMEYCEH-DLASL------------QDNVESPFTESQVKCVILQVL 182
V V + +V EY +H DL + N + T+SQ+ + Q+
Sbjct: 73 YGVCVEGD--PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 183 KGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI--------VYST 217
G+ YL S +HRDL N L+ + VKI VYST
Sbjct: 131 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST 173
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-08
Identities = 42/140 (30%), Positives = 68/140 (48%), Gaps = 9/140 (6%)
Query: 81 IGEGSYGVVYRVR---DSVQDKILALKKL----FLQNNTLTRGELREVTGLTKCRHENIV 133
+G+G YG V++VR + KI A+K L ++N T E L +H IV
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 134 QLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFI 193
L + ++ ++L++EY + E F E + ++ L +LH I
Sbjct: 64 DL--IYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 194 IHRDLKPSNLLLNDKGCVKI 213
I+RDLKP N+LL+ +G VK+
Sbjct: 122 IYRDLKPENILLDAQGHVKL 141
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-08
Identities = 40/145 (27%), Positives = 71/145 (48%), Gaps = 7/145 (4%)
Query: 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRH 129
+ +E + IG G +G+V+ + K+ A+K + + ++ + + E + K H
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKV-AIKTI--REGAMSEEDFIEEAQVMMKLSH 58
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYL 188
+VQL V +S I LV E+ EH L+ F++ + + L V +G+ YL
Sbjct: 59 PKLVQLYGVCTERS--PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYL 116
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
S+ +IHRDL N L+ + VK+
Sbjct: 117 ESSNVIHRDLAARNCLVGENQVVKV 141
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 36/149 (24%), Positives = 64/149 (42%), Gaps = 18/149 (12%)
Query: 81 IGEGSYGVVY-----RVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENIVQ 134
+G+GS+G+VY V + +A+K + + R E L E + + + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 135 LKEVVVGKSLSSIFLVMEYCEH-DLASL---------QDNVESPFTESQVKCVILQVLKG 184
L VV + +VME DL S + P T + + ++ G
Sbjct: 74 LLGVV--STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ YL + +HRDL N ++ + VKI
Sbjct: 132 MAYLAAKKFVHRDLAARNCMVAEDLTVKI 160
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-08
Identities = 42/133 (31%), Positives = 66/133 (49%), Gaps = 7/133 (5%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTKCRHENIVQLK 136
IG+GS+G V +VR +I ALK + + + ++R E L E T L + IV LK
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTI-RKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 137 EVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHR 196
+S ++LV+ + E F S+ + ++L L LH +I+R
Sbjct: 60 --FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYR 117
Query: 197 DLKPSNLLLNDKG 209
DLKP N+LL+ +G
Sbjct: 118 DLKPENILLDYQG 130
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 17/153 (11%)
Query: 75 FEK--LNRI---GEGSYGVV----YRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGL 124
FEK L RI GEG +G V Y + +A+K L ++ +L +E+ L
Sbjct: 1 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEIL 60
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQD----NVESPFTESQVKCVILQ 180
HENIV+ K + + I L+ME+ SL++ N + Q+K + Q
Sbjct: 61 RNLYHENIVKYKGICTEDGGNGIKLIMEFLPS--GSLKEYLPRNKNKINLKQQLKYAV-Q 117
Query: 181 VLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ KG++YL S +HRDL N+L+ + VKI
Sbjct: 118 ICKGMDYLGSRQYVHRDLAARNVLVESEHQVKI 150
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-08
Identities = 45/152 (29%), Positives = 76/152 (50%), Gaps = 17/152 (11%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
+E + IG+G+YG VY+V + + A+K L ++ E + H N+V+
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVK 83
Query: 135 L------KEVVVGKSLSSIFLVMEYCEHDLASLQDNVE------SPFTESQVKCVILQVL 182
+ +VG L +LV+E C S+ + V+ E+ + ++ L
Sbjct: 84 FYGMFYKADKLVGGQL---WLVLELCNG--GSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 183 KGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
GL +LH+N IIHRD+K +N+LL +G VK+V
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-08
Identities = 42/145 (28%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTG----LTKCRH 129
+FE + IG G++G V V+ I A+KKL ++ L + ++ V L + +
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRAERDILAEADN 60
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
+V+L ++ ++L+MEY D+ +L ++ FTE + + I + + ++ +
Sbjct: 61 PWVVKLYYSFQDEN--YLYLIMEYLPGGDMMTLLMKKDT-FTEEETRFYIAETILAIDSI 117
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
H IHRD+KP NLLL+ KG +K+
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKL 142
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-08
Identities = 31/139 (22%), Positives = 65/139 (46%), Gaps = 8/139 (5%)
Query: 81 IGEGSYG--VVYRVRDSVQDKILALKKLFLQNNTLTRGEL--REVTGLTKCRHENIVQLK 136
IG+ +V+ + + ++A+KK+ L + + +L +E+ + +H NI+
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV 65
Query: 137 EVVVGKSLSSIFLVMEYCEHDLAS--LQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
+ S +++V + L+ + E + ++ VL L+Y+HS I
Sbjct: 66 TSFIVDS--ELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFI 123
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HR +K S++LL+ G V +
Sbjct: 124 HRSVKASHILLSGDGKVVL 142
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-08
Identities = 45/163 (27%), Positives = 69/163 (42%), Gaps = 26/163 (15%)
Query: 81 IGEGSYGVVYRVRDS----VQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRHENIVQL 135
+GEG++G V+ QDK+L K + + R + RE LT +H++IV+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 136 KEVVV-GKSLSSIFLVMEYCE------------HDLASLQDNVESPFTESQVKCVILQVL 182
V G+ L +F M + + LA +D T Q+ + Q+
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 183 KGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI--------VYST 217
G+ YL S +HRDL N L+ VKI +YST
Sbjct: 133 SGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 175
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-08
Identities = 42/147 (28%), Positives = 73/147 (49%), Gaps = 24/147 (16%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVV 140
IG G +G VY R + K+ A+K L + + +GE T +E I+ L V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-------TLALNERIM-LSLVST 53
Query: 141 GKSLSSIFLVMEYCEH---------DLASLQD-----NVESPFTESQVKCVILQVLKGLN 186
G + M Y H DL + D + F+E++++ +++ GL
Sbjct: 54 GDC--PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLE 111
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
++H+ F+++RDLKP+N+LL++ G V+I
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRI 138
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-08
Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ-NNTLTRGELREVTGLTKCRHENIVQLK 136
+G G+ G VY+ + +ILA+K + L L + + E+ L KC I+
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 137 EVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHR 196
++ SI E+ D SL +V E + + + V+KGL YL S I+HR
Sbjct: 66 GAFFVENRISI--CTEFM--DGGSL--DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHR 119
Query: 197 DLKPSNLLLNDKGCVKI 213
D+KPSN+L+N +G VK+
Sbjct: 120 DVKPSNMLVNTRGQVKL 136
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-08
Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 7/138 (5%)
Query: 81 IGEGSYGVVYRVR---DSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENIVQLK 136
IG G +G V R R ++ +A+K L ++ R + L E + + + H NI++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRL- 70
Query: 137 EVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIH 195
E VV KS + ++ EY E+ L + FT Q+ ++ + G+ YL +H
Sbjct: 71 EGVVTKS-RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVH 129
Query: 196 RDLKPSNLLLNDKGCVKI 213
RDL N+L+N K+
Sbjct: 130 RDLAARNILVNSNLVCKV 147
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-08
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 24/147 (16%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVV 140
IG G +G VY R + K+ A+K L + + +GE T +E I+ L V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGE-------TLALNERIM-LSLVST 53
Query: 141 GKSLSSIFLVMEYCEH---------DLASLQD-----NVESPFTESQVKCVILQVLKGLN 186
G + M Y H DL + D + F+E +++ +++ GL
Sbjct: 54 GDC--PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLE 111
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
++H+ F+++RDLKP+N+LL++ G V+I
Sbjct: 112 HMHNRFVVYRDLKPANILLDEHGHVRI 138
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-08
Identities = 37/137 (27%), Positives = 66/137 (48%), Gaps = 7/137 (5%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTKCRHENIVQLK 136
+G+G++G V VR+ + A+K + + + + E + E L RH + LK
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 137 EVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHR 196
++ + VMEY + E FTE + + +++ L YLHS +++R
Sbjct: 62 YAF--QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119
Query: 197 DLKPSNLLLNDKGCVKI 213
D+K NL+L+ G +KI
Sbjct: 120 DIKLENLMLDKDGHIKI 136
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 8e-08
Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 7/137 (5%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTKCRHENIVQLK 136
+G+G++G V VR+ K A+K L + + + E L E L RH + LK
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKIL-KKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 137 EVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHR 196
++ + VMEY + E F+E + + +++ L YLHS +++R
Sbjct: 62 YSF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 197 DLKPSNLLLNDKGCVKI 213
DLK NL+L+ G +KI
Sbjct: 120 DLKLENLMLDKDGHIKI 136
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 8e-08
Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 16/161 (9%)
Query: 63 QDCFGKCRNV----AEFEKLNRIGEGSYGVVYRVRDSVQDKILALK-----KLFLQNNTL 113
+D K R++ ++E + IG G++G V VR K+ A+K ++ ++++
Sbjct: 29 KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 88
Query: 114 TRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTES 172
E R++ +VQL + +++VMEY DL +L N + P E
Sbjct: 89 FFWEERDIMAFANSPW--VVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP--EK 142
Query: 173 QVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ +V+ L+ +HS IHRD+KP N+LL+ G +K+
Sbjct: 143 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKL 183
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-08
Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 6/87 (6%)
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFT--ESQVKCVILQVLKGLNYL 188
N+V L + +V S S+FLV+++ E L ++ E VK +++ L+ L
Sbjct: 46 NMVCLHKYIV--SEDSVFLVLQHAEG--GKLWSHISKFLNIPEECVKRWAAEMVVALDAL 101
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKIVY 215
H I+ RDL P+N+LL+D+G +++ Y
Sbjct: 102 HREGIVCRDLNPNNILLDDRGHIQLTY 128
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-08
Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 23/145 (15%)
Query: 80 RIGEGSYGVVYR----------VRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRH 129
+IG+G++G VY+ V+ LK+ FLQ E L + H
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQ----------EAEILKQYDH 51
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
NIV+L V V K I++VME L + ++ T ++ + L G+ YL
Sbjct: 52 PNIVKLIGVCVQKQ--PIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL 109
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
S IHRDL N L+ + +KI
Sbjct: 110 ESKNCIHRDLAARNCLVGENNVLKI 134
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-07
Identities = 39/136 (28%), Positives = 72/136 (52%), Gaps = 9/136 (6%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVV 139
IGEG +G V + + Q +A+K + + + + L E +TK H+N+V+L V+
Sbjct: 13 IIGEGEFGAVLQGEYTGQK--VAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 140 VGKSLSSIFLVMEY-CEHDLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRD 197
+ L ++VME + +L + L+ + + Q+ L V +G+ YL S ++HRD
Sbjct: 69 LHNGL---YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRD 125
Query: 198 LKPSNLLLNDKGCVKI 213
L N+L+++ G K+
Sbjct: 126 LAARNILVSEDGVAKV 141
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 1e-07
Identities = 37/148 (25%), Positives = 72/148 (48%), Gaps = 17/148 (11%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN-NTLTRGELR-EVTGLTKCRHEN 131
E+E + +IG G +G V+ V+ + K + + + +L EV + + +H+N
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKN 73
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFT------ESQVKCVILQVLKGL 185
IV+ + + K+ ++++ME+C D L N++ + E + + Q+L L
Sbjct: 74 IVRYIDRFLNKANQKLYILMEFC--DAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 186 NYLHS-------NFIIHRDLKPSNLLLN 206
Y H+ ++HRDLKP N+ L+
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLS 159
|
Length = 1021 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-07
Identities = 41/149 (27%), Positives = 74/149 (49%), Gaps = 17/149 (11%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL--REVTGLTKCRHEN 131
+FE L IG G++G V V+ + A+K L + ++ +E G + +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMK-------ILRKADMLEKEQVGHIRAERDI 54
Query: 132 IVQLKEVVVGKSLSS------IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKG 184
+V+ + V K S ++L+ME+ D+ +L ++ TE + + I + +
Sbjct: 55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT-LTEEETQFYIAETVLA 113
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
++ +H IHRD+KP NLLL+ KG VK+
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLDSKGHVKL 142
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-07
Identities = 44/163 (26%), Positives = 75/163 (46%), Gaps = 20/163 (12%)
Query: 71 NVAEFEKLNRIGEGSYGVVYR-----VRDSVQDKILALKKLFLQNNTLTRGELR-EVTGL 124
N++ + +GE +G VY+ Q + +A+K L + R E + E
Sbjct: 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 125 TKCRHENIVQLKEVVVGKSLSSI------------FLVMEYCEHDLASLQDN--VESPFT 170
++ +H NIV L VV + S+ FLVM D+ S D+ V+S
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 171 ESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ ++ Q+ G+ +L S+ ++H+DL N+L+ DK VKI
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKI 165
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-07
Identities = 37/147 (25%), Positives = 68/147 (46%), Gaps = 11/147 (7%)
Query: 71 NVAEFEKLNRIGEGSYGVVY--RVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR 128
N +E + +G G +GVV+ + R ++ I A+ + + + E + K
Sbjct: 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDF----IEEAKVMMKLS 57
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEHD--LASLQDNVESPFTESQVKCVILQVLKGLN 186
H +VQL V + +++V E+ E+ L L+ + ++ + + V +G+
Sbjct: 58 HPKLVQLYGVCTQQK--PLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGME 114
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YL N IHRDL N L++ G VK+
Sbjct: 115 YLERNSFIHRDLAARNCLVSSTGVVKV 141
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-07
Identities = 37/139 (26%), Positives = 63/139 (45%), Gaps = 8/139 (5%)
Query: 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENIVQLK 136
L ++G G +G V+ + + A+K L + T+ + L E + K RH ++QL
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTPV-AVKTL--KPGTMDPKDFLAEAQIMKKLRHPKLIQLY 67
Query: 137 EVVVGKSLSSIFLVMEYCEHD--LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
V + I++V E ++ L LQ Q+ + QV G+ YL + I
Sbjct: 68 AVCTLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI 125
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HRDL N+L+ + K+
Sbjct: 126 HRDLAARNVLVGENNICKV 144
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-07
Identities = 29/101 (28%), Positives = 44/101 (43%), Gaps = 8/101 (7%)
Query: 119 REVTGLTKCRHENIVQL-KEVVVGKSLSSIFLVMEYCE-HDLASLQDNVESPFTESQVKC 176
RE + H NIV L L +F V EY L + + +
Sbjct: 27 RETALCARLYHPNIVALLDSGEAPPGL--LFAVFEYVPGRTLREVLAA-DGALPAGETGR 83
Query: 177 VILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG---CVKIV 214
++LQVL L H+ I+HRDLKP N++++ G K++
Sbjct: 84 LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVL 124
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 2e-07
Identities = 24/67 (35%), Positives = 39/67 (58%), Gaps = 2/67 (2%)
Query: 143 SLSSIFLVMEYC-EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPS 201
+L L+M+Y + DL L E +E++VK +I Q+++ LN LH + IIH D+K
Sbjct: 80 TLKGHVLIMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLE 138
Query: 202 NLLLNDK 208
N+L +
Sbjct: 139 NVLYDRA 145
|
Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-07
Identities = 47/140 (33%), Positives = 66/140 (47%), Gaps = 9/140 (6%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKL---FLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
+G+G +G V + K+ A KKL L+ G + E L K IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 138 VVVGKSLSSIFLVMEYCEH-DLASLQDNV--ESP-FTESQVKCVILQVLKGLNYLHSNFI 193
K+ + LVM DL NV E+P F E + Q++ GL +LH I
Sbjct: 61 AFQTKT--DLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118
Query: 194 IHRDLKPSNLLLNDKGCVKI 213
I+RDLKP N+LL++ G V+I
Sbjct: 119 IYRDLKPENVLLDNDGNVRI 138
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-07
Identities = 37/136 (27%), Positives = 63/136 (46%), Gaps = 8/136 (5%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTG-----LTKCRHENIVQL 135
IG+GS+G V + + K A+K L + L R E + + L +H +V L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVL-QKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 136 KEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIH 195
++ ++ V+++ E F E + + ++ L YLHS I++
Sbjct: 62 HYSF--QTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVY 119
Query: 196 RDLKPSNLLLNDKGCV 211
RDLKP N+LL+ +G V
Sbjct: 120 RDLKPENILLDSQGHV 135
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 38/149 (25%), Positives = 71/149 (47%), Gaps = 20/149 (13%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELR----EVTGLTKCRHENIVQLK 136
+G G+ G V + + A+K + ++ ++ + EV L C +IV+
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEG--MSEADKNRAQAEVCCLLNCDFFSIVKCH 97
Query: 137 EVVVGK------SLSSIFLVMEYCEHDLASLQDNVES------PFTESQVKCVILQVLKG 184
E K ++ I LV++Y + L+ ++S F E + + +QVL
Sbjct: 98 EDFAKKDPRNPENVLMIALVLDYA--NAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
++++HS +IHRD+K +N+LL G VK+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKL 184
|
Length = 496 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-07
Identities = 43/138 (31%), Positives = 69/138 (50%), Gaps = 7/138 (5%)
Query: 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENIVQLK 136
L +G G +GVV + Q + A+K ++ +++ E + E + K HE +VQL
Sbjct: 9 LKELGTGQFGVVKYGKWRGQYDV-AIK--MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLY 65
Query: 137 EVVVGKSLSSIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIH 195
V + I++V EY + L + F SQ+ + V +G+ YL S IH
Sbjct: 66 GVCTKQR--PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123
Query: 196 RDLKPSNLLLNDKGCVKI 213
RDL N L++D+GCVK+
Sbjct: 124 RDLAARNCLVDDQGCVKV 141
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-07
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 26/154 (16%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENI 132
+FE L IG G++G V V+ ++ A+K L + L R E T C R E
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILN-KWEMLKRAE-------TACFREERD 53
Query: 133 VQLKEVVVGKSL------------SSIFLVMEY-CEHDLASLQDNVESPFTESQVKCVIL 179
V +V G ++++LVM+Y DL +L E E + +
Sbjct: 54 V----LVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA 109
Query: 180 QVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+++ ++ +H +HRD+KP N+LL+ G +++
Sbjct: 110 EMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRL 143
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-07
Identities = 37/149 (24%), Positives = 73/149 (48%), Gaps = 9/149 (6%)
Query: 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKK--LFLQNNTLTRGE-LREVTGLTKCR 128
+A F +IG G + VYR + +ALKK +F + R + ++E+ L +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESP---FTESQVKCVILQVLKG 184
H N+++ + + + +V+E + DL+ + + + E V +Q+
Sbjct: 61 HPNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
L ++HS ++HRD+KP+N+ + G VK+
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKL 147
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-07
Identities = 37/134 (27%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTG-----LTKCRHENIVQL 135
IG+GS+G V R ++K A+K L + L + E + + L +H +V L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVL-QKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 136 KEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIH 195
++ ++ V++Y E F E + + ++ L YLHS I++
Sbjct: 62 HFSF--QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY 119
Query: 196 RDLKPSNLLLNDKG 209
RDLKP N+LL+ +G
Sbjct: 120 RDLKPENILLDSQG 133
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 4e-07
Identities = 43/144 (29%), Positives = 65/144 (45%), Gaps = 7/144 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE---LREVTGLTKCRHEN 131
F +G+G +G V + K+ A KKL + +GE L E L K
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 132 IVQLKEVVVGK-SLSSIFLVMEYCEHDLASLQDNVESP-FTESQVKCVILQVLKGLNYLH 189
+V L K +L + +M DL N+ +P F E + ++ GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMN--GGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH 119
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
I++RDLKP N+LL+D G ++I
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRI 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-07
Identities = 48/147 (32%), Positives = 71/147 (48%), Gaps = 24/147 (16%)
Query: 81 IGEGSYGVVYR--VRDSVQDKI-LALKKLFLQNNTLTRGE-----LREVTGLTKCRHENI 132
IG+G +G VY + DS KI A+K L N +T E L+E + H N+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSL----NRITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 133 VQLKEVVVGKSL---SSIFLVMEYCEHDLASLQDNVESPFTESQVKCVI---LQVLKGLN 186
+ L +G L S +V+ Y +H L++ + S VK +I LQV KG+
Sbjct: 59 LSL----LGICLPSEGSPLVVLPYMKH--GDLRNFIRSETHNPTVKDLIGFGLQVAKGME 112
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YL S +HRDL N +L++ VK+
Sbjct: 113 YLASKKFVHRDLAARNCMLDESFTVKV 139
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 7e-07
Identities = 42/149 (28%), Positives = 71/149 (47%), Gaps = 17/149 (11%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHEN-- 131
+FE L IG G++G V V+ I A+K L + ++ E + R E
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMK-------ILRKADMLEKEQVAHIRAERDI 54
Query: 132 IVQLKEVVVGKSLSS------IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKG 184
+V+ V K S ++L+ME+ D+ +L ++ +E + I + +
Sbjct: 55 LVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT-LSEEATQFYIAETVLA 113
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
++ +H IHRD+KP NLLL+ KG VK+
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKL 142
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-07
Identities = 38/146 (26%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALK-----KLFLQNNTLTRGELREVTGLTKCR 128
+FE L IG G++G V V+ DK+ A+K ++ + T E R+V L
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV--LVNGD 59
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEY-CEHDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
++ I L + ++++LVM+Y DL +L E E + + +++ ++
Sbjct: 60 NQWITTLHYAF--QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
+H +HRD+KP N+L++ G +++
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRL 143
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-07
Identities = 40/144 (27%), Positives = 70/144 (48%), Gaps = 9/144 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTG----LTKCRHE 130
F K+ IG G++G V VR + + A+K L + + L R + V L + +E
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTL-RKADVLMRNQAAHVKAERDILAEADNE 61
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
+V+L K +++ VM+Y D+ SL + F E + I ++ + +H
Sbjct: 62 WVVKLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAELTCAIESVH 118
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
IHRD+KP N+L++ G +K+
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKL 142
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 8e-07
Identities = 39/137 (28%), Positives = 61/137 (44%), Gaps = 10/137 (7%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGELREVTG-----LTKCRHENIVQ 134
IG+GS+G V + A+K LQ T L + E + L +H +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVK--VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 135 LKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
L ++ ++ V++Y E F E + + +V + YLHS II
Sbjct: 61 LHYSF--QTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 195 HRDLKPSNLLLNDKGCV 211
+RDLKP N+LL+ +G V
Sbjct: 119 YRDLKPENILLDSQGHV 135
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 8e-07
Identities = 37/149 (24%), Positives = 75/149 (50%), Gaps = 9/149 (6%)
Query: 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKK--LFLQNNTLTRGE-LREVTGLTKCR 128
+A F+ +IG G + VYR + K +ALKK +F + R + ++E+ L +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESP---FTESQVKCVILQVLKG 184
H N+++ + + + + +V+E + DL+ + + E V +Q+
Sbjct: 61 HPNVIKYLDSFIEDN--ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ ++HS ++HRD+KP+N+ + G VK+
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKL 147
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-06
Identities = 22/41 (53%), Positives = 28/41 (68%)
Query: 174 VKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
+K V+ QVL GL LH I+HRD+KP NLL+ G VKI+
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKII 351
|
Length = 507 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-06
Identities = 39/149 (26%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 73 AEFEKLNRIGEGSYGVVYR---VRDSVQDKI-LALKKLFLQNNTLTRGE-LREVTGLTKC 127
E EK+ +G G++G VY+ + + + KI +A+K L + + E L E +
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVI---LQVLKG 184
H ++V+L + + + I +M L L D V + + ++ +Q+ KG
Sbjct: 67 DHPHVVRLLGICLSSQVQLITQLMP-----LGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
++YL ++HRDL N+L+ VKI
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQHVKI 150
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 44/162 (27%), Positives = 68/162 (41%), Gaps = 39/162 (24%)
Query: 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHEN 131
+++FE +G GS+G V + + A+K L + RE+ + + +H
Sbjct: 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCL----------KKREILKMKQVQH-- 64
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDN--------------------VESPFTE 171
+ Q K ++ LS F+V C S QD F
Sbjct: 65 VAQEKSIL--MELSHPFIVNMMC-----SFQDENRVYFLLEFVVGGELFTHLRKAGRFPN 117
Query: 172 SQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
K +++ YLHS II+RDLKP NLLL++KG VK+
Sbjct: 118 DVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKV 159
|
Length = 329 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-06
Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL---FLQNNTLTRGELREVTGLTKCRHEN 131
++ + IG+G G VY D V + +ALKK+ +N L + LRE H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCE-HDLASL------QDNVESPFTE-SQVKCVI---LQ 180
IV + + ++ M Y E + L SL ++++ E + V + +
Sbjct: 64 IVPVYSICSDGD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 181 VLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
+ + Y+HS ++HRDLKP N+LL G V I+
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVIL 155
|
Length = 932 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-06
Identities = 41/146 (28%), Positives = 68/146 (46%), Gaps = 10/146 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTL--TRGELREVTGLTKC 127
+F L +G+GS+G V D++ A+K L +Q++ + T E R V L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKR-VLALPG- 58
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
+ + QL +++ ++ VMEY F E ++ GL +
Sbjct: 59 KPPFLTQLHSCF--QTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFF 116
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
LHS II+RDLK N++L+ +G +KI
Sbjct: 117 LHSKGIIYRDLKLDNVMLDAEGHIKI 142
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-06
Identities = 42/144 (29%), Positives = 67/144 (46%), Gaps = 7/144 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE---LREVTGLTKCRHEN 131
F + +G+G +G V + K+ A K+L + +GE L E L K +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 132 IVQLKEVVVGK-SLSSIFLVMEYCEHDLASLQDNVESP-FTESQVKCVILQVLKGLNYLH 189
+V L K +L + +M DL N+ +P F E + ++L GL LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMN--GGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
++RDLKP N+LL+D G ++I
Sbjct: 120 RENTVYRDLKPENILLDDYGHIRI 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-06
Identities = 34/89 (38%), Positives = 44/89 (49%), Gaps = 8/89 (8%)
Query: 129 HENIVQLKEVVVGKSLSS--IFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKG 184
HENIV L +G I ++ EYC + DL + L+ ES T + QV KG
Sbjct: 98 HENIVNL----LGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ +L S IHRDL N+LL VKI
Sbjct: 154 MAFLASKNCIHRDLAARNVLLTHGKIVKI 182
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-06
Identities = 37/155 (23%), Positives = 69/155 (44%), Gaps = 28/155 (18%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--------------QNNTLTRGELR 119
+FE + IG G++G V V+ ++I A+K L + N L G+ +
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 120 EVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEY-CEHDLASLQDNVESPFTESQVKCVI 178
+T L + + ++LVM+Y DL +L E E + I
Sbjct: 62 WITTLHYAFQDE-------------NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYI 108
Query: 179 LQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+++ ++ +H +HRD+KP N+LL+ G +++
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRL 143
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 46/168 (27%), Positives = 65/168 (38%), Gaps = 35/168 (20%)
Query: 81 IGEGSYGVVYRVR----DSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRHENIVQL 135
+GEG++G V+ +DK+L K R + RE LT +HE+IV+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 136 KEVVVGKSLSSIFLVMEYCEH------------------DLASLQDNVESPFTESQVKCV 177
V + +V EY +H D Q E SQ+ +
Sbjct: 73 YGVCGDGD--PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE--LGLSQMLHI 128
Query: 178 ILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI--------VYST 217
Q+ G+ YL S +HRDL N L+ VKI VYST
Sbjct: 129 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-06
Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 20/156 (12%)
Query: 78 LNRIGEGSYGVVYR----VRDSVQDKILALKKLFLQNNTLTRGELR-EVTGLTKCRHENI 132
+ +GE ++G +Y+ + +++A+K L NN GE + E + + + H NI
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69
Query: 133 VQLKEVVVGKSLSSI------------FLVMEYCEHDLASLQD---NVESPFTESQVKCV 177
V L VV + + FL+M D+ D V+S +
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 178 ILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+Q+ G+ YL S+F +H+DL N+L+ ++ VKI
Sbjct: 130 AIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKI 165
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-06
Identities = 28/91 (30%), Positives = 42/91 (46%), Gaps = 3/91 (3%)
Query: 119 REVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVI 178
RE+ L H I+ L KS + +VM + DL + D P Q +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKST--VCMVMPKYKCDLFTYVDRS-GPLPLEQAITIQ 191
Query: 179 LQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG 209
++L+ L YLH IIHRD+K N+ L++
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTENIFLDEPE 222
|
Length = 392 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-06
Identities = 26/71 (36%), Positives = 40/71 (56%), Gaps = 4/71 (5%)
Query: 145 SSIFLVMEYCEH-DLA-SLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSN 202
+F VMEY DL +Q + F E++ + +++ GL +LH II+RDLK N
Sbjct: 69 EHLFFVMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDN 126
Query: 203 LLLNDKGCVKI 213
+LL+ G +KI
Sbjct: 127 VLLDKDGHIKI 137
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-06
Identities = 38/139 (27%), Positives = 70/139 (50%), Gaps = 13/139 (9%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLT-RGELREVTGLTKCRHENIVQLKEV 138
++G+G +G V+ + ++ A+K L + T++ L+E + K RHE +VQL V
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRV-AIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 139 VVGKSLSSIFLVMEYCEHDLASLQDNVESPFTE----SQVKCVILQVLKGLNYLHSNFII 194
V S I++V EY SL D ++ + Q+ + Q+ G+ Y+ +
Sbjct: 70 V---SEEPIYIVTEYM--SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HRDL+ +N+L+ + K+
Sbjct: 125 HRDLRAANILVGENLVCKV 143
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-06
Identities = 26/76 (34%), Positives = 36/76 (47%), Gaps = 3/76 (3%)
Query: 141 GKSLSSIFLV-MEYC--EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRD 197
S SS F+ E + A +D + T + C QV KG+ +L S IHRD
Sbjct: 145 QSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRD 204
Query: 198 LKPSNLLLNDKGCVKI 213
L N+LL++ VKI
Sbjct: 205 LAARNILLSENNVVKI 220
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-06
Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 39/194 (20%)
Query: 36 PDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLNRIGEGSYGVVYRVRDS 95
DP+ + + R L + L + FG+ AE L+ E S V ++D
Sbjct: 3 LDPEWELPRDRLTL--------GKPLGEGAFGQVV-KAEAVGLDNPNETSTVAVKMLKDD 53
Query: 96 VQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE 155
+K L+ + ++ E+ ++ G +H+NI+ L V + +++V+EY
Sbjct: 54 ATEKDLS--------DLVSEMEMMKMIG----KHKNIINLLGVCTQEG--PLYVVVEYAA 99
Query: 156 H--------------DLASLQDNVESPFTESQVKCV--ILQVLKGLNYLHSNFIIHRDLK 199
H + AS D T +Q V QV +G+ +L S IHRDL
Sbjct: 100 HGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLA 159
Query: 200 PSNLLLNDKGCVKI 213
N+L+ + +KI
Sbjct: 160 ARNVLVTEDHVMKI 173
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-06
Identities = 41/147 (27%), Positives = 76/147 (51%), Gaps = 11/147 (7%)
Query: 74 EFEKLNRIGEGSYGVVYR---VRDSVQDKI-LALKKLFLQNNTLTRGE-LREVTGLTKCR 128
EF+K+ +G G++G VY+ + + + KI +A+K+L + E L E +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEY-CEHD-LASLQDNVESPFTESQVKCVILQVLKGLN 186
+ ++ +L + + ++ I +M + C D + +DN+ S + + CV Q+ KG+N
Sbjct: 68 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW--CV--QIAKGMN 123
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YL ++HRDL N+L+ VKI
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKI 150
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-06
Identities = 40/139 (28%), Positives = 61/139 (43%), Gaps = 10/139 (7%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTL----TRGELREVTGLTKCRHENIVQL 135
RIG G++G V+ R + +A+K TL L+E L + H NIV+L
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSC---RETLPPDLKAKFLQEARILKQYSHPNIVRL 58
Query: 136 KEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
V K I++VME + D + ++ ++ G+ YL S I
Sbjct: 59 IGVCTQKQ--PIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HRDL N L+ +K +KI
Sbjct: 117 HRDLAARNCLVTEKNVLKI 135
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-06
Identities = 37/137 (27%), Positives = 60/137 (43%), Gaps = 6/137 (4%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK----KLFLQNNTLTRGELREVTGLTKCRHENIVQLK 136
IG GSY V VR ++I A+K +L + + + + H +V L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 137 EVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHR 196
++ S +F V+EY + E + ++ LNYLH II+R
Sbjct: 63 SCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 197 DLKPSNLLLNDKGCVKI 213
DLK N+LL+ +G +K+
Sbjct: 121 DLKLDNVLLDSEGHIKL 137
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 6e-06
Identities = 44/156 (28%), Positives = 66/156 (42%), Gaps = 23/156 (14%)
Query: 76 EKLNRIGEGSYGVVY------RVRDSV--QDKILALKKLFLQNNTLTRGELREVTGLTKC 127
L +G G++G VY R D+V Q + L + + + L E ++K
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDF--LMEALIMSKF 66
Query: 128 RHENIVQLKEVVVGKSLSSI--FLVMEYCEH-DLASL----QDNVESPF--TESQVKCVI 178
H+NIV+L +G S + F+++E DL S + E P T +
Sbjct: 67 NHQNIVRL----IGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 179 LQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
V KG YL N IHRD+ N LL KG ++
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVA 158
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-06
Identities = 38/141 (26%), Positives = 65/141 (46%), Gaps = 14/141 (9%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKL----FLQNN----TLTRGELREVTGLTKCRHENI 132
+G+GS+G V D++ A+K L LQ++ T+T + + L +H +
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTE---KRILALAA-KHPFL 58
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
L ++ +F VMEY Q F E + + +V L +LH +
Sbjct: 59 TALHCCF--QTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116
Query: 193 IIHRDLKPSNLLLNDKGCVKI 213
+I+RDLK N+LL+ +G K+
Sbjct: 117 VIYRDLKLDNILLDAEGHCKL 137
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-06
Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 9/139 (6%)
Query: 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLT-RGELREVTGLTKCRHENIVQLK 136
+ ++G G +G V+ + K+ A+K L + T++ L E + K RH+ +VQL
Sbjct: 11 IKKLGNGQFGEVWMGTWNGNTKV-AVKTL--KPGTMSPESFLEEAQIMKKLRHDKLVQLY 67
Query: 137 EVVVGKSLSSIFLVMEYCEHD--LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
VV S I++V EY L L+D + + QV G+ Y+ I
Sbjct: 68 AVV---SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HRDL+ +N+L+ D KI
Sbjct: 125 HRDLRSANILVGDGLVCKI 143
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-06
Identities = 37/139 (26%), Positives = 64/139 (46%), Gaps = 10/139 (7%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTL--TRGELREVTGLTKCRHENIVQ 134
+G+GS+G V R ++ A+K L LQ++ + T E R ++ H + Q
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILS--LARNHPFLTQ 60
Query: 135 LKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
L ++ +F VME+ F E++ + ++ L +LH II
Sbjct: 61 L--YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGII 118
Query: 195 HRDLKPSNLLLNDKGCVKI 213
+RDLK N+LL+ +G K+
Sbjct: 119 YRDLKLDNVLLDHEGHCKL 137
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-06
Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 29/161 (18%)
Query: 80 RIGEGSYGVVYRVRD--------------SVQDKILALKKLFLQNNTLTRGE-LREVTGL 124
++GEG +G V+ Q ++A+K L R + L+E+ +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASL--QDNVESPFTESQ-VKCV--- 177
++ ++ NI++L V V S + ++ EY E+ DL Q +ES FT + + V
Sbjct: 72 SRLKNPNIIRLLGVCV--SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 178 -----ILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+Q+ G+ YL S +HRDL N L+ + +KI
Sbjct: 130 NLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKI 170
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-06
Identities = 38/144 (26%), Positives = 69/144 (47%), Gaps = 9/144 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTG----LTKCRHE 130
F K+ +G G++G V R + A+K L + + L R ++ V L + +E
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTL-RKKDVLLRNQVAHVKAERDILAEADNE 61
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
+V+L K +++ VM+Y D+ SL + F E + I ++ + +H
Sbjct: 62 WVVRLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVH 118
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
IHRD+KP N+L++ G +K+
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKL 142
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-05
Identities = 39/146 (26%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSV---QDKILALKKLFLQNNTLTRGELREVTGLTKCRHEN 131
FE L +G G+YG V+ VR K+ A+K L + + + + E T + E
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVL-KKATIVQKAKTAEHTRTERQVLEA 60
Query: 132 IVQLKEVV----VGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
+ + +V ++ + + L+++Y FTES+V+ I +++ L++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
LH II+RD+K N+LL+ +G V +
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVL 146
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 10/100 (10%)
Query: 120 EVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DL-----ASLQDNVESPFTESQ 173
E+ L C H IV K KS + L+MEY DL L++++ PF E +
Sbjct: 115 ELHCLAACDHFGIV--KHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHL--PFQEYE 170
Query: 174 VKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
V + Q++ L+ +HS ++HRDLK +N+ L G +K+
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKL 210
|
Length = 478 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-05
Identities = 28/100 (28%), Positives = 56/100 (56%), Gaps = 9/100 (9%)
Query: 118 LREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESP----FTESQ 173
L E + + +H +V+L VV + I+++ EY E+ SL D +++P T ++
Sbjct: 49 LAEANLMKQLQHPRLVRLYAVVTQEP---IYIITEYMEN--GSLVDFLKTPEGIKLTINK 103
Query: 174 VKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ + Q+ +G+ ++ IHRDL+ +N+L+++ C KI
Sbjct: 104 LIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKI 143
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 50/182 (27%), Positives = 77/182 (42%), Gaps = 36/182 (19%)
Query: 76 EKLN---RIGEGSYGVVYRVR-DSVQDKIL---------------ALKKLFLQNNTLTRG 116
+ LN ++GEG +G V+ D +QD A+K L + R
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 117 E-LREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNV-ESPFTES 172
+ L+EV L++ NI +L V + ++MEY E+ DL LQ +V E+
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDP--PLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 173 QVKCV--------ILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCVKIV-YSTYLELY 222
K + Q+ G+ YL S NF+ HRDL N L+ +KI + LY
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFV-HRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 223 LN 224
+
Sbjct: 182 SS 183
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-05
Identities = 27/83 (32%), Positives = 42/83 (50%), Gaps = 2/83 (2%)
Query: 124 LTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLK 183
L + H ++ L +V V L+ LV+ DL + P +QV V Q+L
Sbjct: 214 LRRLSHPAVLALLDVRVVGGLTC--LVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLS 271
Query: 184 GLNYLHSNFIIHRDLKPSNLLLN 206
++Y+H IIHRD+K N+L+N
Sbjct: 272 AIDYIHGEGIIHRDIKTENVLVN 294
|
Length = 461 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-05
Identities = 36/145 (24%), Positives = 71/145 (48%), Gaps = 9/145 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTG----LTKCRH 129
+F + IG+G++G V V+ KI A+K L L++ + +L V L +
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
+V L + ++L+ME+ DL ++ ++ F+E + + + + + +
Sbjct: 61 PWVVSLYYSF--QDAQYLYLIMEFLPGGDLMTMLIKYDT-FSEDVTRFYMAECVLAIEAV 117
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
H IHRD+KP N+L++ G +K+
Sbjct: 118 HKLGFIHRDIKPDNILIDRGGHIKL 142
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 52/188 (27%), Positives = 78/188 (41%), Gaps = 39/188 (20%)
Query: 57 PIEILEQDCFGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRG 116
P+E L + F K +F ++GEG++GVVY+ V + K L+ T
Sbjct: 120 PLEGLFRPSFKK----DDFVLGKKLGEGAFGVVYKA-SLVNKQSKKEGKYVLKKAT---- 170
Query: 117 ELREVTGLTKCR---------HENIVQLKEVVVGKSLSSIFLVMEY-CEHDLASL-QD-- 163
E V R + + E V K +LV Y E LA L Q
Sbjct: 171 EYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKE 230
Query: 164 ---NVES------------PFTESQVKCVIL-QVLKGLNYLHSNFIIHRDLKPSNLLLND 207
NVE E+++ I+ Q+L L+ LHS I+HRD+KP N++ ++
Sbjct: 231 FPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE 290
Query: 208 -KGCVKIV 214
G KI+
Sbjct: 291 GSGSFKII 298
|
Length = 566 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-05
Identities = 31/101 (30%), Positives = 42/101 (41%), Gaps = 13/101 (12%)
Query: 116 GELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDL-ASLQDNVESPFTESQV 174
G E L H +I+QLK + L++ + DL L
Sbjct: 129 GTATEAHILRAINHPSIIQLKGTFTYNKFTC--LILPRYKTDLYCYLAAKRNIAI----- 181
Query: 175 KCVIL----QVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCV 211
C IL VL+ + YLH N IIHRD+K N+ +N G V
Sbjct: 182 -CDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDV 221
|
Length = 391 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-05
Identities = 18/48 (37%), Positives = 26/48 (54%)
Query: 166 ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ P T + QV +G+ +L S IHRDL N+LL++ VKI
Sbjct: 167 KEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKI 214
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-05
Identities = 39/142 (27%), Positives = 61/142 (42%), Gaps = 3/142 (2%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE---LREVTGLTKCRHEN 131
F + +G+G +G V + K+ A KKL + +GE L E L K
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
+V L K + L + + E+ F E + ++ GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
I++RDLKP N+LL+D G ++I
Sbjct: 122 RIVYRDLKPENILLDDHGHIRI 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 38/137 (27%), Positives = 64/137 (46%), Gaps = 6/137 (4%)
Query: 81 IGEGSYGVVYRVRDSVQDKILA---LKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
+G+G++G V V++ + A LKK + L E L RH + LK
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 138 VVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF-IIHR 196
++ + VMEY + E F+E + + +++ L+YLHS +++R
Sbjct: 63 SF--QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 197 DLKPSNLLLNDKGCVKI 213
DLK NL+L+ G +KI
Sbjct: 121 DLKLENLMLDKDGHIKI 137
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-05
Identities = 28/87 (32%), Positives = 45/87 (51%), Gaps = 2/87 (2%)
Query: 128 RHENIVQLKEV-VVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLN 186
RH NI+ V G L I M Y + + L+ +E+ + ++ L+GLN
Sbjct: 57 RHPNIMTSWTVFTTGSWLWVISPFMAYGSAN-SLLKTYFPEGMSEALIGNILFGALRGLN 115
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YLH N IHR++K S++L++ G V +
Sbjct: 116 YLHQNGYIHRNIKASHILISGDGLVSL 142
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-05
Identities = 41/138 (29%), Positives = 64/138 (46%), Gaps = 7/138 (5%)
Query: 81 IGEGSYGVVYRVRDSVQDK---ILALKKLFLQNNTLTRGE-LREVTGLTKCRHENIVQLK 136
IG G +G V R + K +A+K L R + L E + + + H NI+ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL- 70
Query: 137 EVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIH 195
E VV KS + +V EY E+ L + + FT Q+ ++ + G+ YL +H
Sbjct: 71 EGVVTKS-KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVH 129
Query: 196 RDLKPSNLLLNDKGCVKI 213
RDL N+L+N K+
Sbjct: 130 RDLAARNILVNSNLVCKV 147
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-05
Identities = 47/166 (28%), Positives = 75/166 (45%), Gaps = 28/166 (16%)
Query: 77 KLNRI-GEGSYGVVYRVR----DSVQDKILALKKLFLQNNTLTRGE--LREVTGLTKCRH 129
KL +I GEG +G V + D Q K+ A+K + L +T + E L E + H
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKV-AVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 130 ENIVQLKEVVV-GKSLSSI---FLVMEYCEH-DLAS------LQDNVESPFTESQVKCVI 178
N+++L V SL I +++ + +H DL S L E ++ +K +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK-FM 119
Query: 179 LQVLKGLNYLHSNFIIHRDLKPSNLLLND--KGCV------KIVYS 216
+ + G+ YL + IHRDL N +L + CV K +YS
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYS 165
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-05
Identities = 39/139 (28%), Positives = 64/139 (46%), Gaps = 10/139 (7%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK----KLFLQNNTLTRGELREVTGLTKCRHENIVQLK 136
IG GSY V V +I A+K +L + + + + T H +V L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 137 EVVVGKSLSSIFLVMEYCEH-DLA-SLQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
++ S +F V+E+ DL +Q + P E + ++ LN+LH II
Sbjct: 63 SCF--QTESRLFFVIEFVSGGDLMFHMQRQRKLP--EEHARFYSAEISLALNFLHERGII 118
Query: 195 HRDLKPSNLLLNDKGCVKI 213
+RDLK N+LL+ +G +K+
Sbjct: 119 YRDLKLDNVLLDAEGHIKL 137
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-05
Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 10/146 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTK------C 127
+F L +G+GS+G V D++ A+K L+ + + + + E T + K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK--ILKKDVVIQDDDVECTMVEKRVLALSG 58
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
+ + QL +++ ++ VMEY Q F E ++ GL +
Sbjct: 59 KPPFLTQLHSCF--QTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFF 116
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
LHS II+RDLK N++L+ +G +KI
Sbjct: 117 LHSKGIIYRDLKLDNVMLDSEGHIKI 142
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-05
Identities = 20/48 (41%), Positives = 28/48 (58%)
Query: 166 ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+SP T + C QV +G+ +L S IHRDL N+LL++ VKI
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKI 215
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 7e-05
Identities = 38/144 (26%), Positives = 69/144 (47%), Gaps = 9/144 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTG----LTKCRHE 130
F K+ +G G++G V + A+K L + + L R ++ V L + +E
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTL-RKKDVLNRNQVAHVKAERDILAEADNE 61
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
+V+L K +++ VM+Y D+ SL +E F E + I ++ + +H
Sbjct: 62 WVVKLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAELTLAIESVH 118
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
IHRD+KP N+L++ G +K+
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKL 142
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-05
Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 18/152 (11%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE--------LREVTGLTKCRHENI 132
IG G +G V R R + K +++F+ TL G L E + + + H NI
Sbjct: 12 IGAGEFGEVCRGRLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
+ L E VV KS + ++ E+ E+ L S + FT Q+ ++ + G+ YL
Sbjct: 68 IHL-EGVVTKS-RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 192 FIIHRDLKPSNLLLNDKGCVKIV---YSTYLE 220
+HRDL N+L+N K+ S +LE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 9e-05
Identities = 37/137 (27%), Positives = 60/137 (43%), Gaps = 6/137 (4%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK----KLFLQNNTLTRGELREVTGLTKCRHENIVQLK 136
IG GSY V VR D+I A+K +L + + + + + +V L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 137 EVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHR 196
++ S +FLV+EY + E + ++ LN+LH II+R
Sbjct: 63 SCF--QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 197 DLKPSNLLLNDKGCVKI 213
DLK N+LL+ G +K+
Sbjct: 121 DLKLDNVLLDADGHIKL 137
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 42/144 (29%), Positives = 65/144 (45%), Gaps = 7/144 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE---LREVTGLTKCRHEN 131
F +G+G +G V + K+ A KKL + +GE L E L K
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 132 IVQLKEVVVGK-SLSSIFLVMEYCEHDLASLQDNVESP-FTESQVKCVILQVLKGLNYLH 189
+V L K +L + +M DL N+ +P F E + ++ GL L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMN--GGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
I++RDLKP N+LL+D+G ++I
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRI 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 40/144 (27%), Positives = 70/144 (48%), Gaps = 8/144 (5%)
Query: 75 FEKLNRIGEGSYGVVYRVRD-SVQD--KILALKKLFLQNNTLTRGELREVTGLTKCRHEN 131
FE L +G G+YG V+ VR S D K+ A+K L + + + + E T + E+
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVL-KKATIVQKAKTTEHTRTERQVLEH 60
Query: 132 IVQLKEVVV----GKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
I Q +V ++ + + L+++Y + F E +V+ +++ L +
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCV 211
LH II+RD+K N+LL+ G V
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHV 144
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 1e-04
Identities = 25/108 (23%), Positives = 48/108 (44%), Gaps = 15/108 (13%)
Query: 119 REVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQD-----------NVES 167
RE+ K H+N+V+L + + ++++EY DL L+
Sbjct: 57 RELDMFRKLSHKNVVRLLGLC--REAEPHYMILEYT--DLGDLKQFLRATKSKDEKLKPP 112
Query: 168 PFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVY 215
P + Q + Q+ G+++L + +HRDL N L++ + VK+
Sbjct: 113 PLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 2e-04
Identities = 40/142 (28%), Positives = 65/142 (45%), Gaps = 16/142 (11%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTKCRHENIVQLK 136
+GEG +G V + + D IL + ++ TR E L E + + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 137 EV----VVGKSLSSIFLVMEYCEH-DLAS------LQDNVESPFTESQVKCVILQVLKGL 185
V V + S +++ + +H DL S L D + T+ VK + + G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK-FMTDIASGM 125
Query: 186 NYLHSNFIIHRDLKPSNLLLND 207
YL S IHRDL N +LN+
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNE 147
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 2e-04
Identities = 36/139 (25%), Positives = 65/139 (46%), Gaps = 9/139 (6%)
Query: 81 IGEGSYGVVYRVRDSVQDK---ILALKKLFLQNNTLTRGE-LREVTGLTKCRHENIVQLK 136
IG G +G V+R + + +A+K L R + L E + + + H NI++L+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 137 EVVVGKSLSSIFLVMEYCEHDLAS--LQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
VV ++ EY E+ L+D+ + F+ Q+ ++ + G+ YL +
Sbjct: 73 GVV--TKFKPAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYV 129
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HRDL N+L+N K+
Sbjct: 130 HRDLAARNILVNSNLECKV 148
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 2e-04
Identities = 38/146 (26%), Positives = 67/146 (45%), Gaps = 10/146 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC------ 127
+F L +G+GS+G V D++ A+K L+ + + + + E T + K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIK--ILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
+ + QL +++ ++ VMEY F E Q ++ GL +
Sbjct: 59 KPPFLTQLHSCF--QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFF 116
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
LH II+RDLK N++L+ +G +KI
Sbjct: 117 LHRRGIIYRDLKLDNVMLDSEGHIKI 142
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 3e-04
Identities = 26/74 (35%), Positives = 39/74 (52%), Gaps = 14/74 (18%)
Query: 147 IFLVMEYCEH-DLA-SLQDN-----VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLK 199
+F VME+ DL +QD + F +++ C GL +LHS II+RDLK
Sbjct: 71 LFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVC-------GLQFLHSKGIIYRDLK 123
Query: 200 PSNLLLNDKGCVKI 213
N++L+ G +KI
Sbjct: 124 LDNVMLDRDGHIKI 137
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 5e-04
Identities = 24/70 (34%), Positives = 39/70 (55%), Gaps = 4/70 (5%)
Query: 146 SIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNL 203
++F VMEY L +++S F + +++ GL +LHS I++RDLK N+
Sbjct: 70 NLFFVMEYLNG--GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNI 127
Query: 204 LLNDKGCVKI 213
LL+ G +KI
Sbjct: 128 LLDTDGHIKI 137
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 5e-04
Identities = 44/152 (28%), Positives = 66/152 (43%), Gaps = 30/152 (19%)
Query: 79 NRIGEGSYGVVYR------VRDSVQDKILALKKLFLQNNTLTRGE--------LREVTGL 124
N +G G++G VY + +A+K TL +G L+E +
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVK-------TLRKGATDQEKKEFLKEAHLM 53
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPF-----TESQVKCV 177
+ H NIV+L V + +++ME E DL S L+D F T ++ +
Sbjct: 54 SNFNHPNIVKLLGVCLLNE--PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDI 111
Query: 178 ILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG 209
L V KG YL IHRDL N L+++KG
Sbjct: 112 CLDVAKGCVYLEQMHFIHRDLAARNCLVSEKG 143
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 6e-04
Identities = 45/163 (27%), Positives = 74/163 (45%), Gaps = 31/163 (19%)
Query: 81 IGEGSYGVVYRVRDSVQD---KILALKKLFLQNNTLTRGE--LREVTGLTKCRHENIVQL 135
+G+G +G V + +D + +A+K L + + E LRE + + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 136 KEVVVGKSLSS--------IFLVMEYCEH-DLAS--LQDNV-ESPFTESQVKCV--ILQV 181
+G SL S +++ + +H DL + L + E PFT V ++ +
Sbjct: 67 ----IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLLN--------DKGCVKIVYS 216
G+ YL S IHRDL N +LN D G K +YS
Sbjct: 123 ASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYS 165
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 8e-04
Identities = 38/136 (27%), Positives = 60/136 (44%), Gaps = 7/136 (5%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEV 138
+G+G++G V++ +++DK K ++ L L E L + H NIV+L V
Sbjct: 3 LGKGNFGEVFK--GTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 139 VVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRD 197
+ I++VME D S + Q+ L G+ YL S IHRD
Sbjct: 61 CTQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRD 118
Query: 198 LKPSNLLLNDKGCVKI 213
L N L+ + +KI
Sbjct: 119 LAARNCLVGENNVLKI 134
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 8e-04
Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 39/194 (20%)
Query: 37 DPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKC-RNVAEFEKLNRIGEGSYGVVYRVRDS 95
DP+ +F + R VL G+P L + CFG+ R A +R + V ++D+
Sbjct: 4 DPKWEFPRDRLVL-----GKP---LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN 55
Query: 96 VQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE 155
DK LA + ++ EL ++ G +H+NI+ L V + +++++EY
Sbjct: 56 ATDKDLA--------DLISEMELMKLIG----KHKNIINLLGVCTQEG--PLYVIVEYAA 101
Query: 156 H----------------DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLK 199
+ E + + QV +G+ YL S IHRDL
Sbjct: 102 KGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA 161
Query: 200 PSNLLLNDKGCVKI 213
N+L+ + +KI
Sbjct: 162 ARNVLVTEDNVMKI 175
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 37/160 (23%), Positives = 64/160 (40%), Gaps = 26/160 (16%)
Query: 80 RIGEGSYGVV---------------YRVRDSVQDKIL-ALKKLFLQNNTLTRGE-LREVT 122
++GEG +G V + + S +L A+K L N R + L+E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 123 GLTKCRHENIVQLKEVVV-GKSLSSIFLVME-------YCEHDLASLQDNVESPFTE-SQ 173
+++ + NI++L V + L I ME H+ + + S
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 174 VKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ + Q+ G+ YL S +HRDL N L+ +KI
Sbjct: 132 LIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKI 171
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 38/146 (26%), Positives = 69/146 (47%), Gaps = 10/146 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSV---QDKILALKKLFLQNNTLT-RGELREVTGLTKCRH 129
FE L +G G+YG V+ VR K+ A+K LQ L + + E T +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMK--VLQKAALVQKAKTVEHTRTERNVL 58
Query: 130 ENIVQLKEVVV----GKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGL 185
E++ Q +V ++ + + L+++Y F+E +V+ +++ L
Sbjct: 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCV 211
+LH I++RD+K N+LL+ +G V
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHV 144
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.001
Identities = 37/136 (27%), Positives = 64/136 (47%), Gaps = 7/136 (5%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVV 139
++G+G +G V+ + K+ A+K L + L+E + K RH+ +V L VV
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKV-AIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 140 VGKSLSSIFLVMEYCEHD--LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRD 197
S I++V E+ L L++ Q+ + Q+ G+ Y+ IHRD
Sbjct: 71 ---SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 198 LKPSNLLLNDKGCVKI 213
L+ +N+L+ D KI
Sbjct: 128 LRAANILVGDNLVCKI 143
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.001
Identities = 42/143 (29%), Positives = 68/143 (47%), Gaps = 19/143 (13%)
Query: 81 IGEGSYGVV----YRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRHENIVQL 135
+G G++G V Y++R D +A+K L +N R E+ RE + + + IV++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQID--VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 136 KEVVVGKSLSSIFLVMEYCEHD-----LASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
V ++L LVME L+ +D + T S V ++ QV G+ YL
Sbjct: 61 IGVCEAEAL---MLVMEMASGGPLNKFLSGKKDEI----TVSNVVELMHQVSMGMKYLEG 113
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
+HRDL N+LL ++ KI
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKI 136
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.001
Identities = 43/141 (30%), Positives = 66/141 (46%), Gaps = 15/141 (10%)
Query: 81 IGEGSYGVV----YRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQ 134
+G G++G V Y+++ S K +A+K L NN L LRE + + + IV+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSE--KTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 135 LKEVVVGKSLSSIFLVMEYCEHDLAS--LQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
+ + +S LVME E + LQ N TE + ++ QV G+ YL
Sbjct: 61 MIGICEAESW---MLVMELAELGPLNKFLQKNKH--VTEKNITELVHQVSMGMKYLEETN 115
Query: 193 IIHRDLKPSNLLLNDKGCVKI 213
+HRDL N+LL + KI
Sbjct: 116 FVHRDLAARNVLLVTQHYAKI 136
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 27/98 (27%), Positives = 45/98 (45%), Gaps = 4/98 (4%)
Query: 115 RGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHD-LASLQDNVESPFTESQ 173
RG L E L + H NIV+L+ V+ +++ +V EY + L S E Q
Sbjct: 51 RGFLAEALTLGQFDHSNIVRLEGVIT--RGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQ 108
Query: 174 VKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLN-DKGC 210
+ ++ + G+ YL +H+ L +L+N D C
Sbjct: 109 LMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVC 146
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.002
Identities = 31/136 (22%), Positives = 55/136 (40%), Gaps = 10/136 (7%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVV 139
+ G VY + +D +L K + R REV L + + K +
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYVL--KINPSREKGADR--EREVAILQLLARKGLPVPKVLA 60
Query: 140 VGKSLSSIFLVMEYCE-HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDL 198
G+S +L+ME+ E L S + + + ++L L+ L + H DL
Sbjct: 61 SGESDGWSYLLMEWIEGETLDE-----VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDL 115
Query: 199 KPSNLLLNDKGCVKIV 214
P N+L++D + I+
Sbjct: 116 HPGNILVDDGKILGII 131
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.003
Identities = 31/139 (22%), Positives = 67/139 (48%), Gaps = 13/139 (9%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEV 138
++G G +G V+ + K+ A+K + + +++ + K +H+ +V+L V
Sbjct: 13 KLGAGQFGEVWMATYNKHTKV-AVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 139 VVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVIL----QVLKGLNYLHSNFII 194
V + I+++ E+ SL D ++S Q ++ Q+ +G+ ++ I
Sbjct: 70 V---TKEPIYIITEFMAK--GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HRDL+ +N+L++ KI
Sbjct: 125 HRDLRAANILVSASLVCKI 143
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 37.2 bits (86), Expect = 0.004
Identities = 31/108 (28%), Positives = 47/108 (43%), Gaps = 21/108 (19%)
Query: 118 LREVTGLTKCRHENIVQLKEVVVGKSLSSI--FLVMEYCEHDLASLQDNVES-------- 167
L+EV + H N++Q +G+ + SI LV+E+C L L++ + S
Sbjct: 43 LQEVQPYRELNHPNVLQC----LGQCIESIPYLLVLEFC--PLGDLKNYLRSNRGMVAQM 96
Query: 168 --PFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
++ C +V GL +LH IH DL N L VKI
Sbjct: 97 AQKDVLQRMAC---EVASGLLWLHQADFIHSDLALRNCQLTADLSVKI 141
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 37.2 bits (86), Expect = 0.004
Identities = 15/30 (50%), Positives = 24/30 (80%)
Query: 180 QVLKGLNYLHSNFIIHRDLKPSNLLLNDKG 209
Q+ G+ +LHS I++RD+KP N+LL+D+G
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQG 132
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.004
Identities = 22/59 (37%), Positives = 29/59 (49%), Gaps = 4/59 (6%)
Query: 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND 207
+VMEY E L+D + S E + L G LHS IIH DL SN++L+
Sbjct: 76 IVMEYIEG--EPLKDLINSNGMEELELSREIGRLVGK--LHSAGIIHGDLTTSNMILSG 130
|
Length = 211 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 224 | |||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0611|consensus | 668 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.98 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.98 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0610|consensus | 459 | 99.98 | ||
| KOG0193|consensus | 678 | 99.98 | ||
| KOG0197|consensus | 468 | 99.98 | ||
| KOG0580|consensus | 281 | 99.98 | ||
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.98 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.97 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.97 | |
| KOG0588|consensus | 786 | 99.97 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0574|consensus | 502 | 99.97 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.97 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.97 | |
| KOG0578|consensus | 550 | 99.97 | ||
| KOG0586|consensus | 596 | 99.97 | ||
| KOG0194|consensus | 474 | 99.97 | ||
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0032|consensus | 382 | 99.97 | ||
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.97 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0577|consensus | 948 | 99.97 | ||
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0667|consensus | 586 | 99.97 | ||
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG1989|consensus | 738 | 99.97 | ||
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG4236|consensus | 888 | 99.97 | ||
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG1035|consensus | 1351 | 99.97 | ||
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0589|consensus | 426 | 99.97 | ||
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.96 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0666|consensus | 438 | 99.96 | ||
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.96 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.96 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.96 | |
| KOG4250|consensus | 732 | 99.96 | ||
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0690|consensus | 516 | 99.96 | ||
| KOG4717|consensus | 864 | 99.96 | ||
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.96 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.96 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.96 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| KOG1094|consensus | 807 | 99.96 | ||
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.96 | |
| KOG0983|consensus | 391 | 99.96 | ||
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.96 | |
| KOG0612|consensus | 1317 | 99.96 | ||
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0669|consensus | 376 | 99.96 | ||
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0033|consensus | 355 | 99.96 | ||
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.96 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.96 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.96 | |
| KOG0608|consensus | 1034 | 99.96 | ||
| KOG0599|consensus | 411 | 99.96 | ||
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.96 | |
| KOG0604|consensus | 400 | 99.96 | ||
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.96 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| KOG0579|consensus | 1187 | 99.96 | ||
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.96 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.95 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| KOG1006|consensus | 361 | 99.95 | ||
| PHA02988 | 283 | hypothetical protein; Provisional | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.95 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0984|consensus | 282 | 99.95 | ||
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.95 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG0201|consensus | 467 | 99.95 | ||
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.95 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.95 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0607|consensus | 463 | 99.95 | ||
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.95 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.95 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.95 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.95 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.95 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.95 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.95 | |
| KOG1026|consensus | 774 | 99.95 | ||
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.95 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.95 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.95 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.95 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.95 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.95 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.95 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.95 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| KOG0668|consensus | 338 | 99.95 | ||
| KOG2345|consensus | 302 | 99.95 | ||
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.95 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.95 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.95 | |
| KOG1095|consensus | 1025 | 99.95 | ||
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.95 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.95 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.95 | |
| KOG0986|consensus | 591 | 99.95 | ||
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.95 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.95 | |
| KOG4721|consensus | 904 | 99.95 | ||
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.95 | |
| KOG0584|consensus | 632 | 99.95 | ||
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| KOG0664|consensus | 449 | 99.95 | ||
| KOG0196|consensus | 996 | 99.95 | ||
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.94 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.94 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.94 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.94 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.94 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.94 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.94 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.94 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.94 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.94 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.94 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.94 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.94 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.94 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.94 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.94 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.94 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.94 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.94 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.94 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.94 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.94 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.94 | |
| KOG4279|consensus | 1226 | 99.94 | ||
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.94 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.94 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.94 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.94 | |
| KOG1152|consensus | 772 | 99.94 | ||
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.94 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.94 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.94 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.94 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.94 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.94 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.94 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0696|consensus | 683 | 99.94 | ||
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.94 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.94 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.94 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.94 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.94 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.94 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.94 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.94 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.94 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG4645|consensus | 1509 | 99.94 | ||
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.94 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.93 | |
| KOG0614|consensus | 732 | 99.93 | ||
| KOG0576|consensus | 829 | 99.93 | ||
| KOG0587|consensus | 953 | 99.93 | ||
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.93 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.93 | |
| KOG0695|consensus | 593 | 99.93 | ||
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0596|consensus | 677 | 99.93 | ||
| KOG3653|consensus | 534 | 99.93 | ||
| KOG4257|consensus | 974 | 99.93 | ||
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.93 | |
| KOG0199|consensus | 1039 | 99.93 | ||
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG1151|consensus | 775 | 99.92 | ||
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.92 | |
| KOG4278|consensus | 1157 | 99.92 | ||
| KOG1163|consensus | 341 | 99.92 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.92 | |
| KOG2052|consensus | 513 | 99.92 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.92 | |
| KOG1290|consensus | 590 | 99.92 | ||
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.92 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.92 | |
| KOG1165|consensus | 449 | 99.92 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.92 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.91 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.91 | |
| KOG0603|consensus | 612 | 99.91 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.91 | |
| KOG0671|consensus | 415 | 99.9 | ||
| KOG1025|consensus | 1177 | 99.9 | ||
| KOG1164|consensus | 322 | 99.9 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG0665|consensus | 369 | 99.89 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| KOG1345|consensus | 378 | 99.89 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1167|consensus | 418 | 99.88 | ||
| KOG0200|consensus | 609 | 99.88 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.87 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.87 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.86 | |
| KOG1027|consensus | 903 | 99.86 | ||
| KOG0670|consensus | 752 | 99.86 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.85 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.85 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.81 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.8 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.79 | |
| KOG1166|consensus | 974 | 99.73 | ||
| KOG1024|consensus | 563 | 99.72 | ||
| KOG0590|consensus | 601 | 99.65 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.65 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.65 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.62 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.61 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.6 | |
| KOG0603|consensus | 612 | 99.56 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.56 | |
| KOG3087|consensus | 229 | 99.48 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.45 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.4 | |
| KOG0601|consensus | 524 | 99.39 | ||
| KOG4158|consensus | 598 | 99.39 | ||
| KOG0606|consensus | 1205 | 99.31 | ||
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.3 | |
| KOG0590|consensus | 601 | 99.26 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.24 | |
| KOG1240|consensus | 1431 | 99.24 | ||
| KOG0601|consensus | 524 | 99.15 | ||
| KOG1243|consensus | 690 | 99.1 | ||
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.07 | |
| KOG1023|consensus | 484 | 99.03 | ||
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.03 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.99 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.94 | |
| KOG3741|consensus | 655 | 98.92 | ||
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.84 | |
| KOG0195|consensus | 448 | 98.83 | ||
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.83 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.8 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.75 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.72 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.66 | |
| KOG1033|consensus | 516 | 98.66 | ||
| KOG1235|consensus | 538 | 98.61 | ||
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.5 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.49 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.42 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.29 | |
| KOG1266|consensus | 458 | 98.28 | ||
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.19 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.12 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.07 | |
| KOG0606|consensus | 1205 | 98.05 | ||
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.05 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.96 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.81 | |
| KOG2270|consensus | 520 | 97.77 | ||
| PRK05231 | 319 | homoserine kinase; Provisional | 97.76 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.71 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.67 | |
| KOG2268|consensus | 465 | 97.64 | ||
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.62 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.51 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.39 | |
| PLN02236 | 344 | choline kinase | 97.38 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.33 | |
| KOG0576|consensus | 829 | 97.31 | ||
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.28 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.17 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.14 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.95 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.69 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.52 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.29 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.25 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 96.07 | |
| KOG2137|consensus | 700 | 95.93 | ||
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 95.85 | |
| KOG1033|consensus | 516 | 95.76 | ||
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.73 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.62 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.47 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 95.44 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.44 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.37 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.7 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 93.95 |
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=264.56 Aligned_cols=150 Identities=32% Similarity=0.477 Sum_probs=132.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
..++|.+.+.||.|+||+||+|+++.++..||||.+.... ....+....|+++|+.++|||||.+++++ ...+.+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~--~~~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI--EDDDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE--ecCCeEE
Confidence 4578999999999999999999999999999999997653 33445567899999999999999999999 4456999
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC------CcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK------GCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~------~~~kl~DfGla~~~ 222 (224)
||||||+|+-+..+....+.+++..++.++.|++.||++||+++||||||||+||||+.. -.+||+|||+||.+
T Consensus 86 lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 999999976555555557789999999999999999999999999999999999999875 35899999999975
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=271.23 Aligned_cols=154 Identities=42% Similarity=0.713 Sum_probs=141.5
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
...+.|+.+++||+|+||.||+|++..+++.||+|++..+.. .......|||.+|+++.||||+++.+.......+.+
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 345679999999999999999999999999999999987763 455667899999999999999999999987766799
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
|||+|||+.+|.-+.....-.|++.++..|+.|++.||+|||.+||+|||||.+|||||.+|.+||+|||||++|.
T Consensus 194 YlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 194 YLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999999999988888766789999999999999999999999999999999999999999999999999999763
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=255.91 Aligned_cols=158 Identities=52% Similarity=0.842 Sum_probs=148.0
Q ss_pred ccccccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q psy13250 66 FGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKS 143 (224)
Q Consensus 66 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (224)
.+.|+.+++|+.++.|++|+||.||+|+++.+++.||+|+++.... ...-..+|||.+|.+++|||||.+-.+.++.+
T Consensus 69 l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 69 LGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred ccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 6788999999999999999999999999999999999999976543 34455689999999999999999999999988
Q ss_pred cceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 144 LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 144 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
.+.+|||||||+.++.+++.....+|...++..++.|+++|++|||.+.|+|||||++|+|+++.|.+||+||||||.|.
T Consensus 149 ~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 149 MDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred cceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 89999999999999999999988899999999999999999999999999999999999999999999999999999874
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=254.32 Aligned_cols=149 Identities=34% Similarity=0.602 Sum_probs=136.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
+.|+.+.++|+|+||+||+|+++.||+.||||++...++ ...+-.+||++.|++++|+|+|.+.++| .....+++|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF--rrkrklhLV 79 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF--RRKRKLHLV 79 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH--HhcceeEEE
Confidence 468899999999999999999999999999999865443 2344558999999999999999999999 556689999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
+|||+.+.+..+......++.+.+..++.|++.|+.|+|++++|||||||+|||++.+|.+||||||+||.+.
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~ 152 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLS 152 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhc
Confidence 9999999888888888889999999999999999999999999999999999999999999999999999765
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=246.06 Aligned_cols=153 Identities=35% Similarity=0.496 Sum_probs=134.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
..++++.++.||+|+.|+||+|.++.+++.+|+|.+....+ ...+++.+|+.+++.++||+||.+|+.|..+.. .++|
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-~isI 155 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-EISI 155 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc-eEEe
Confidence 45678889999999999999999999999999999965443 456778899999999999999999999976543 6999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCcEEEEeccccccccC
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYLN 224 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 224 (224)
+||||+++.+..+....+.+++.....++.+|++||.|||. ++||||||||+|||++..|.+||||||.++.+.|
T Consensus 156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 99999976555544445789999999999999999999995 9999999999999999999999999999987654
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=239.70 Aligned_cols=149 Identities=38% Similarity=0.644 Sum_probs=137.9
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.+|..++.||+|.||+||+|++..+++.||||+++..+. ......+||+..|+.++|+||+.+.++| ...+++.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F--~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF--PHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc--cCCCceEEE
Confidence 468889999999999999999999999999999987643 3356678999999999999999999999 556689999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
+|||+.+|...++.....++..++..++.++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.|.
T Consensus 80 fEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~ 152 (318)
T KOG0659|consen 80 FEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFG 152 (318)
T ss_pred EEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccC
Confidence 9999999999998888899999999999999999999999999999999999999999999999999999875
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=246.27 Aligned_cols=150 Identities=31% Similarity=0.454 Sum_probs=133.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|++++.||+|+||+||.++.+.+++.+|+|+++... ....+....|..+|..++||+||.++..| .+...+
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF--Qt~~kL 100 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF--QTEEKL 100 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec--ccCCeE
Confidence 4578999999999999999999999999999999986532 22345567899999999999999999999 556699
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+||+.|+-+.......+.+++..++.|+.+|+.||.|||++|||||||||+|||++.+|+++|+||||++.-
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 999999998655555566788999999999999999999999999999999999999999999999999999854
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=247.32 Aligned_cols=148 Identities=29% Similarity=0.383 Sum_probs=127.3
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-------cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-------LTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
+.|.+.+.||+|+||.|-+|..+.+++.||||++...... ......+|+.+|++++|||||+++++| +..+
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f--~~~d 249 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF--EVPD 249 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee--ecCC
Confidence 4588889999999999999999999999999999754321 223346899999999999999999999 4555
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC---CcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK---GCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~---~~~kl~DfGla~~~ 222 (224)
..||||||++|+-+......++.+.+...+.++.|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|++.
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 889999999875444333446789999999999999999999999999999999999999876 67999999999875
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=253.53 Aligned_cols=148 Identities=28% Similarity=0.411 Sum_probs=134.1
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeec---cCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL---QNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.+|+..+.||+|+|+.||.+++..+|+.||+|++.. ......+...+|+++.+.++|||||+++++| ++..++||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F--EDs~nVYi 95 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF--EDSNNVYI 95 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe--ecCCceEE
Confidence 569999999999999999999999999999999975 2345567778999999999999999999999 55569999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+|+|..+.+..+.+.+.+++|.+++.|++||+.||.|||+++|||||||..|++++++.++||+|||||..+
T Consensus 96 vLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~l 168 (592)
T KOG0575|consen 96 VLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQL 168 (592)
T ss_pred EEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeee
Confidence 9999997655555557889999999999999999999999999999999999999999999999999999754
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=247.91 Aligned_cols=151 Identities=33% Similarity=0.472 Sum_probs=132.2
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc---CCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcc
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ---NNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (224)
....+|...+.||+|+|++|++|+++.+++.||||++... .....+...+|-.+|.+| .||.|++||..|.++ .
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~--~ 147 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE--E 147 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--c
Confidence 4567899999999999999999999999999999988532 223345566788888888 899999999999554 4
Q ss_pred eEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 146 SIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
.+|+|+||+.+ +++.++.+ .+.|++..+++|+.+|+.||+|||++|||||||||+|||++.+|++||+|||.|+.+.
T Consensus 148 sLYFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ceEEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 89999999985 57666655 5789999999999999999999999999999999999999999999999999999764
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=254.77 Aligned_cols=152 Identities=28% Similarity=0.519 Sum_probs=136.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccch-hHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTR-GELREVTGLTKCR-HENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~-~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 148 (224)
..++|.++++||.|+||.||+|....++..||||+++..-....+ --+||+..|+++. |||||++.+++.+... .+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence 356899999999999999999999999999999988643333222 2379999999999 9999999999965443 899
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
+|||||+.+|.+++..++..|++..++.|+.||+.||+|+|.+|+.|||+||+|||+.....+||+||||||...
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 999999999999999988899999999999999999999999999999999999999999999999999999753
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=231.96 Aligned_cols=151 Identities=30% Similarity=0.405 Sum_probs=133.5
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
...++|+.++.||.|+||+|.+++++.++..+|+|++....- ...+...+|..+|+.+.||+++++++.+ .+.+.
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~--~d~~~ 118 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF--KDNSN 118 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee--ccCCe
Confidence 356789999999999999999999999999999999865432 2334557899999999999999999999 55669
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||||++|+-...+.+..+++++..+++|+.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+..
T Consensus 119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v 194 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV 194 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence 9999999998755555555678999999999999999999999999999999999999999999999999999865
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=235.78 Aligned_cols=151 Identities=34% Similarity=0.647 Sum_probs=135.2
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCC-eeeeeEEEEcCC----c
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHEN-IVQLKEVVVGKS----L 144 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~----~ 144 (224)
...|+.+++||+|+||+||+|+.+.+|..||+|++..... ......++|+.+++.++|+| |+.+++++...+ .
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4568888999999999999999999999999999987654 35566789999999999999 999999996543 2
Q ss_pred ceEEEEEecccCChhHhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 145 SSIFLVMEYCEHDLASLQDNVE---SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 145 ~~~~lv~e~~~~~l~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
..+++|+||++.++..++.... ..++...++.+++|++.||+|||+++|+||||||+|||+++.|.+||+|||+|+.
T Consensus 90 ~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 90 GKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred ceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 4799999999999998888765 3688899999999999999999999999999999999999999999999999986
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
+
T Consensus 170 ~ 170 (323)
T KOG0594|consen 170 F 170 (323)
T ss_pred h
Confidence 5
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=239.89 Aligned_cols=157 Identities=34% Similarity=0.483 Sum_probs=136.1
Q ss_pred ccccccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--------------ccchhHHHHHHHhhcCCCCC
Q psy13250 66 FGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--------------TLTRGELREVTGLTKCRHEN 131 (224)
Q Consensus 66 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~n 131 (224)
.....-++.|++.+.||+|.||+|-+|++..+++.||||++..... ...+...+|+.+|++|.|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 3445667899999999999999999999999999999999864211 11246679999999999999
Q ss_pred eeeeeEEEEcCCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcE
Q psy13250 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCV 211 (224)
Q Consensus 132 iv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 211 (224)
||+|+++.-+...+.+|||+|||..+-..+......-+++.+++.|+++++.||+|||.+|||||||||+|+|++.+|++
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 99999999888888999999999976555554433339999999999999999999999999999999999999999999
Q ss_pred EEEeccccccc
Q psy13250 212 KIVYSTYLELY 222 (224)
Q Consensus 212 kl~DfGla~~~ 222 (224)
||+|||.+..+
T Consensus 250 KIsDFGVs~~~ 260 (576)
T KOG0585|consen 250 KISDFGVSNEF 260 (576)
T ss_pred Eeeccceeeec
Confidence 99999998765
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=242.76 Aligned_cols=151 Identities=25% Similarity=0.287 Sum_probs=131.4
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
...++|++++.||+|+||.||+|+.+.||..+|+|+++...- ........|-.+|....+++||++|..| .+..+
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF--QD~~~ 215 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF--QDKEY 215 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe--cCCCe
Confidence 356899999999999999999999999999999999975432 3344556677888889999999999999 55569
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||||++||-...+....+.|++..+++|+.+++.|++.+|+.|+|||||||+|+|||..|++||+||||+.-+
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999987544444445788999999999999999999999999999999999999999999999999999543
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=236.82 Aligned_cols=149 Identities=25% Similarity=0.368 Sum_probs=132.8
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc---cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT---LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.+|++.+.||+|.||+|-+|++...|+.||||.++.+.-. ..-.+.+|+++|+.++||||+.+|.+| ++.+.+.|
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF--ENkdKIvi 130 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF--ENKDKIVI 130 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh--cCCceEEE
Confidence 4799999999999999999999999999999988765433 334567999999999999999999999 66779999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
||||..++-+..+....+.+++.+++.|++||..|+.|||.++++|||||.+|||+|.++++||+||||+.+|-
T Consensus 131 vMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999876444455557789999999999999999999999999999999999999999999999999998763
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=235.39 Aligned_cols=149 Identities=30% Similarity=0.492 Sum_probs=131.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc----CC-ccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ----NN-TLTRGELREVTGLTKCR-HENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 144 (224)
..+.|.+.+.||+|+||+|+.|.+..++..||+|.+... .. ...+.+.+|+.+++.++ ||||+++++++. ..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~--t~ 92 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA--TP 92 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe--cC
Confidence 456799999999999999999999999999999966543 11 23445568999999999 999999999995 44
Q ss_pred ceEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC-CcEEEEeccccccc
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK-GCVKIVYSTYLELY 222 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfGla~~~ 222 (224)
..+|+|||||.| ++++.+.. .+++.+..++.+++|++.|++|||++||+||||||+|||++.+ +++||+|||++...
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 469999999986 67777766 7889999999999999999999999999999999999999999 99999999999864
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=228.38 Aligned_cols=149 Identities=34% Similarity=0.574 Sum_probs=133.7
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEee--ccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEc---CCcceE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCRHENIVQLKEVVVG---KSLSSI 147 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~~ 147 (224)
..|..++.||+|+||.|+.+.++.+++.||||++. .......++.+||+.+|+.++|+||+.+++++.. +....+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 34666899999999999999999999999999986 4555667888999999999999999999999864 335679
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+|+|+|+.+|.+.+.. +..+++..+..++.|+++||.|+|+.+|+||||||.|+|++.+..+||+||||||..
T Consensus 102 YiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 102 YLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred EEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeec
Confidence 99999999888887765 445999999999999999999999999999999999999999999999999999965
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=229.64 Aligned_cols=153 Identities=29% Similarity=0.440 Sum_probs=130.8
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
...+|+++++||+|+||.||++.+..++..+|.|.+....- ...+....|+.+|++++|||||++|+..+.++...++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 34579999999999999999999999999999999874432 2345568999999999999999999955445555699
Q ss_pred EEEecccC-ChhHhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 149 LVMEYCEH-DLASLQD---NVESPFTESQVKCVILQVLKGLNYLHS--NF--IIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~--~~--iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
||||||++ ++.+.+. .....+++..++.++.|+++||..||. .+ |+||||||.||+++.+|.+||.||||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999985 5555443 335679999999999999999999998 45 9999999999999999999999999999
Q ss_pred ccc
Q psy13250 221 LYL 223 (224)
Q Consensus 221 ~~~ 223 (224)
++.
T Consensus 177 ~l~ 179 (375)
T KOG0591|consen 177 FLS 179 (375)
T ss_pred Hhc
Confidence 874
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=234.96 Aligned_cols=152 Identities=28% Similarity=0.347 Sum_probs=129.9
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCc
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSL 144 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~ 144 (224)
...+++|.+++.||+|+||+|+++..+.+++.+|||++++.. ....+....|.+++... +||.++.++..| ...
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT~ 441 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QTK 441 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--ccC
Confidence 346789999999999999999999999999999999997643 23344556676666554 599999999999 566
Q ss_pred ceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 145 SSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 145 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
.++|+||||+.|+. .......+.|++..+++|+..|+.||+|||++||||||||.+|||+|.+|.+||+|||+++.-.
T Consensus 442 ~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred CeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 69999999998766 2333335789999999999999999999999999999999999999999999999999998643
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=226.65 Aligned_cols=146 Identities=32% Similarity=0.489 Sum_probs=125.6
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc---eEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS---SIFLV 150 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---~~~lv 150 (224)
.|...+.+|.|+||.||+|....+++.+|||++-.+. +.--+|+.+|+.+.|||||++..+|...... +..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 5888999999999999999999999999999885332 2234689999999999999998887643333 56689
Q ss_pred EecccCChhHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC-CcEEEEecccccccc
Q psy13250 151 MEYCEHDLASLQDN---VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK-GCVKIVYSTYLELYL 223 (224)
Q Consensus 151 ~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfGla~~~~ 223 (224)
||||+.++...+.. .+..++...++.+..||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|+.+.
T Consensus 101 leymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 101 LEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99999988877664 35678999999999999999999999999999999999999986 899999999998753
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=206.79 Aligned_cols=147 Identities=35% Similarity=0.683 Sum_probs=135.2
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.|...++||+|.||+||++++..+.+.||+|.+..+.+ ......++|+.+++.++|.|||+++++.. ....+-+|+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh--sdkkltlvf 80 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH--SDKKLTLVF 80 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc--cCceeEEeH
Confidence 46778899999999999999999999999999987654 34567899999999999999999999984 445789999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||..++..+....++.+..+.++.++.|+++||.|+|++++.||||||.|+||+.+|.+|++|||+|+.|
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglaraf 151 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAF 151 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999865
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=229.14 Aligned_cols=149 Identities=28% Similarity=0.359 Sum_probs=124.8
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeE-EEEEEeeccCCcc--chhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKI-LALKKLFLQNNTL--TRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~-~avK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
...++.+.+.||.|+||+||++.+. |.. +|+|++....... .+.+.+|+.+|.+++|||||+|+|++..+. ..+
T Consensus 39 ~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~-~~~ 115 (362)
T KOG0192|consen 39 DPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP-GSL 115 (362)
T ss_pred ChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-Cce
Confidence 3455667777999999999999986 444 9999886543222 457889999999999999999999995432 268
Q ss_pred EEEEecccCCh-hHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEEccCC-cEEEEeccccccc
Q psy13250 148 FLVMEYCEHDL-ASLQDN-VESPFTESQVKCVILQVLKGLNYLHSNF-IIHRDLKPSNLLLNDKG-CVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l-~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~-iiHrDlkp~Nill~~~~-~~kl~DfGla~~~ 222 (224)
+|||||+.++. ..++.. ....++...+..++.+|++||.|||+++ ||||||||+|||++.++ ++||+|||+++..
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence 99999998754 444444 2678999999999999999999999999 99999999999999998 9999999999754
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=235.97 Aligned_cols=147 Identities=30% Similarity=0.497 Sum_probs=133.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
++|-+.+.||+|+||+||+|+.+.+.+.||+|.+.+... ...+...+|+++++.++|||||.++++| +....+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf--Et~~~~~vV 79 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF--ETSAHLWVV 79 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh--cccceEEEE
Confidence 468889999999999999999999999999999865433 2345578999999999999999999999 666799999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.|||.|++..++.. .+.++++.++.++.+++.||.|||+++|+|||+||.|||++..|++|+||||+||..
T Consensus 80 te~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m 150 (808)
T KOG0597|consen 80 TEYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAM 150 (808)
T ss_pred ehhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhc
Confidence 99999987776655 678999999999999999999999999999999999999999999999999999864
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=221.55 Aligned_cols=150 Identities=29% Similarity=0.444 Sum_probs=128.1
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
.+|...+.||+|+||.||++.+..++..+|||.+........+.+.+|+.+|.+++|||||+++|.........++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45888899999999999999999889999999887654333555789999999999999999999743222236899999
Q ss_pred cccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc-CCcEEEEeccccccc
Q psy13250 153 YCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND-KGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~-~~~~kl~DfGla~~~ 222 (224)
|+.++ +.+++....+.+++..++.+.+||+.||.|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~ 168 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKL 168 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence 99865 55555554447999999999999999999999999999999999999999 799999999998754
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-32 Score=217.77 Aligned_cols=148 Identities=34% Similarity=0.610 Sum_probs=131.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|++.+.||.|+||.||+|.+..++..||+|++..... .......+|+.+++.++||||+++++++. .....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH--TERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc--CCCeEEEE
Confidence 5679999999999999999999999999999998865432 23345678999999999999999999984 44589999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|||+++++...+......+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~ 152 (288)
T cd07871 82 FEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARA 152 (288)
T ss_pred EeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceee
Confidence 99999888777766556689999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=225.90 Aligned_cols=146 Identities=25% Similarity=0.338 Sum_probs=126.4
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.||+|+||+||+|.+..+++.+|+|++.... ......+.+|+.++..++|+||+++++.+. ....+|+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~--~~~~~~l 78 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ--DKLNLYL 78 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCeEEE
Confidence 36999999999999999999999999999999986432 122345567899999999999999999984 4458999
Q ss_pred EEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 150 VMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||||++++ +...+. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 79 v~E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~ 150 (363)
T cd05628 79 IMEFLPGGDMMTLLM-KKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG 150 (363)
T ss_pred EEcCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence 99999875 444443 356799999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=218.92 Aligned_cols=148 Identities=36% Similarity=0.612 Sum_probs=131.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|++.+.||+|+||.||+|.+..+++.+|+|++..... .......+|+.+++.++||||+++++++.. ....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec--CCeEEEE
Confidence 4679999999999999999999999999999999865432 223456789999999999999999999854 4589999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|||+.+++...+......+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 152 (303)
T cd07869 82 FEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA 152 (303)
T ss_pred EECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCccee
Confidence 99999988887776667799999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=224.97 Aligned_cols=150 Identities=31% Similarity=0.412 Sum_probs=127.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|...+.||+|+||.||+|..... ..+|||++........+++.+|+.++.+++|||+|+++|+|.+... ..+||
T Consensus 73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~-~~~LV 150 (361)
T KOG1187|consen 73 ATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE-HRLLV 150 (361)
T ss_pred HHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc-eEEEE
Confidence 457899999999999999999997644 8899997765433214569999999999999999999999965432 58999
Q ss_pred EecccC-ChhHhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVES-PFTESQVKCVILQVLKGLNYLHSNF---IIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||.+ +|.+.+..... +++|.....|+.+++.||+|||... |||||||++|||+|++.++||+|||+|+..
T Consensus 151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~ 227 (361)
T KOG1187|consen 151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLG 227 (361)
T ss_pred EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccC
Confidence 999985 56566555444 8999999999999999999999754 999999999999999999999999999754
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=225.66 Aligned_cols=147 Identities=22% Similarity=0.337 Sum_probs=126.6
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|.+++.||+|+||.||++.+..+++.+|+|++.... ......+.+|+.+++.+.||||+++++++. ....+|+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~--~~~~~~l 78 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ--DAQYLYL 78 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE--cCCeeEE
Confidence 36999999999999999999999999999999886432 122345567999999999999999999995 4458999
Q ss_pred EEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+.++ +...+. ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 79 v~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 79 IMEFLPGGDLMTMLI-KYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred EEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999764 555444 3567899999999999999999999999999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=216.57 Aligned_cols=151 Identities=28% Similarity=0.411 Sum_probs=132.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCcc-chhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTL-TRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
+.++|++.+.||.|.-++||+|+...+++.||||++..+.... ...+.+|+..|+.++||||+.++..|+.+. .+|+
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~--~LWv 101 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS--ELWV 101 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc--eeEE
Confidence 5678999999999999999999999999999999998765543 477789999999999999999999996544 8999
Q ss_pred EEecccCC-hhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 150 VMEYCEHD-LASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
||.||.++ +.+++... ...+.|..+..++++++.||.|||++|-||||||+.||||+.+|.|||+|||.+-.++
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999864 55554433 4469999999999999999999999999999999999999999999999999875443
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=224.55 Aligned_cols=148 Identities=26% Similarity=0.333 Sum_probs=127.4
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.||+|+||+||+|++..+++.||+|++.... ......+.+|+.++..++|+||+++++.+. ..+.+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~l 78 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ--DENYLYL 78 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCeEEE
Confidence 36999999999999999999999999999999987532 223344567999999999999999999995 4458999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+.++.+.........+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 79 v~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 79 IMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred EECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 9999987544333334567999999999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-32 Score=225.15 Aligned_cols=145 Identities=23% Similarity=0.300 Sum_probs=126.2
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.|++++.||+|+||+||+|.+..++..+|+|++.... ......+.+|+.+++.++|+||+++++.+. ..+.+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~--~~~~~~lv 79 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ--DKDNLYFV 79 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe--cCCEEEEE
Confidence 5899999999999999999999999999999986532 223345678999999999999999999995 44589999
Q ss_pred EecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 151 MEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|||+.++ +..++. ....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~E~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 80 MDYIPGGDMMSLLI-RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred EecCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 9999865 544443 356789999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=223.72 Aligned_cols=145 Identities=25% Similarity=0.334 Sum_probs=125.7
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
+|++++.||+|+||.||+|++..+++.+|+|++.... ......+.+|+.+++.+.|+||+++++.+. ..+.+|+|
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~--~~~~~~lv 79 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ--DKDNLYFV 79 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE--cCCEEEEE
Confidence 6999999999999999999999999999999886432 122345668999999999999999999985 44589999
Q ss_pred EecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 151 MEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||||.++ +..++. ..+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|..
T Consensus 80 ~E~~~~g~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 80 MDYIPGGDMMSLLI-RLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred EeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 9999865 555444 356789999999999999999999999999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=219.04 Aligned_cols=149 Identities=26% Similarity=0.351 Sum_probs=129.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... ......+.+|+.+++.++||||+++++.+.. .+.+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 93 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD--ENRV 93 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc--CCEE
Confidence 4678999999999999999999999999999999986432 1233456789999999999999999999854 4589
Q ss_pred EEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||+.++ +...+. ....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 94 ~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLR-KAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEEEcCCCCChHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 9999999864 544444 3567899999999999999999999999999999999999999999999999999754
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=224.29 Aligned_cols=145 Identities=23% Similarity=0.321 Sum_probs=125.8
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.|++++.||+|+||.||+|++..+++.+|+|++..... .....+.+|+.+++.+.|+||+++++.+.+ .+.+|+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~--~~~~~lv 79 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD--KDNLYFV 79 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe--CCEEEEE
Confidence 58999999999999999999999999999998864321 223456789999999999999999999954 4589999
Q ss_pred EecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 151 MEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||||.++ +...+.. .+.+++..++.++.|++.||+|||+++|+||||||+|||++.+|.+||+|||+|+.
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 80 MDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 9999864 5555443 46789999999999999999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=214.60 Aligned_cols=151 Identities=28% Similarity=0.348 Sum_probs=130.1
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
....+.|++++.||+|.-|+||+|+...++..+|+|++....- ....+...|-.+|+.+.||.++.+|..| +...
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f--et~~ 150 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF--ETDK 150 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee--eccc
Confidence 3456789999999999999999999999999999999975432 2234455688899999999999999999 5666
Q ss_pred eEEEEEecccCC-hhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 146 SIFLVMEYCEHD-LASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 146 ~~~lv~e~~~~~-l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
..|++||||.|+ |..+..+. ...+++..+++|+.+++.||+|||..|||+|||||+||||.++|++-|+||-|+..
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence 899999999875 44444433 45799999999999999999999999999999999999999999999999998853
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=226.00 Aligned_cols=150 Identities=30% Similarity=0.369 Sum_probs=129.4
Q ss_pred ccccccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q psy13250 66 FGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKS 143 (224)
Q Consensus 66 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (224)
..+....+++.+...||+|.||+||+|++.. .||||++..... +..+.+.+|+..+++-+|.||+-|.|++..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 3445566778899999999999999999763 589999986543 45677889999999999999999999995443
Q ss_pred cceEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 144 LSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 144 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+.||+.+|+| +|...+......|.....+.|++||+.|+.|||.++|||||||..||++.+++.|||.|||||..
T Consensus 462 ---~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 462 ---LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred ---eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceee
Confidence 4899999998 46666665566799999999999999999999999999999999999999999999999999864
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=224.86 Aligned_cols=147 Identities=27% Similarity=0.346 Sum_probs=126.8
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
+...+++++.||+|.||.||.|.+..+ ..+|+|.++.. ......+++|+.+|++++|+|||++++++.. ...+|||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~--~~piyIV 279 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTK--QEPIYIV 279 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEec--CCceEEE
Confidence 345577889999999999999998743 36899988654 2344677899999999999999999999954 3479999
Q ss_pred Eeccc-CChhHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 151 MEYCE-HDLASLQDN-VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||||. |+|..++.. ....+.....+.++.||+.|++||.++++|||||..+|||++++..+||+||||||.
T Consensus 280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc
Confidence 99998 457777665 456689999999999999999999999999999999999999999999999999994
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-33 Score=208.59 Aligned_cols=150 Identities=31% Similarity=0.440 Sum_probs=131.3
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
...+++|++.+.||+|.||.||.|+.+.++-.+|+|++.... ......+.+|+++-+.++||||+++|++|.+. .
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--~ 95 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--K 95 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc--c
Confidence 345788999999999999999999999999999999987543 23456677899999999999999999999654 4
Q ss_pred eEEEEEecccC-ChhHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 146 SIFLVMEYCEH-DLASLQDN-VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.+|+++||... .+...+.. ....+++..+..|+.|++.||.|+|.++||||||||+|+|++.+|.+||+|||.+.
T Consensus 96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence 89999999974 56665543 34569999999999999999999999999999999999999999999999999875
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=220.17 Aligned_cols=146 Identities=32% Similarity=0.486 Sum_probs=125.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
..++|+.++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++|+||+++++++ ...+.+|+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF--DHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe--ccCCeEEE
Confidence 45679999999999999999999999999999998864432 2345677899999999999999999998 44568999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+.++.+.. .....+..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 150 v~e~~~~~~L~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 150 LLEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred EEecCCCCcccc----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 999998754321 223567888899999999999999999999999999999999999999999998753
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=217.64 Aligned_cols=148 Identities=26% Similarity=0.350 Sum_probs=127.5
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++..++||||+++++.+. ..+.+|+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~--~~~~~~l 78 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ--DDEYLYL 78 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE--cCCEEEE
Confidence 369999999999999999999999999999999874321 23345678999999999999999999984 4458999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+.++.+..+......+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 79 v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~ 151 (333)
T cd05600 79 AMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI 151 (333)
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccc
Confidence 9999987544444344567899999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=215.62 Aligned_cols=147 Identities=27% Similarity=0.406 Sum_probs=126.7
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.||+|+||.||+|.+..+++.+|+|++..... .....+.+|+.+++.+.||||+++++++. +...+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~l 78 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH--DQRFLYM 78 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc--cCCeEEE
Confidence 368999999999999999999999999999999864321 22345678999999999999999998884 4458999
Q ss_pred EEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+.++ +..++. ..+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.+
T Consensus 79 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~ 151 (291)
T cd05612 79 LMEYVPGGELFSYLR-NSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL 151 (291)
T ss_pred EEeCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhc
Confidence 99999865 444443 4567999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=227.37 Aligned_cols=149 Identities=27% Similarity=0.384 Sum_probs=132.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
.++-|++.+.||.|+-|.|.+|++..||+..|||++.... ......+-+|+.+|+.+.|||++.+|++| ++...+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw--e~~~~l 87 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW--ENKQHL 87 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee--ccCceE
Confidence 3567999999999999999999999999999999986542 23345667999999999999999999999 566699
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|+|+||+++|-+..+...++++++.++.++++||+.|+.|||..+|+||||||+|+|++.++++||+|||.|.+
T Consensus 88 ylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsL 161 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASL 161 (786)
T ss_pred EEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeec
Confidence 99999998765555555578999999999999999999999999999999999999999999999999999964
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=216.71 Aligned_cols=141 Identities=28% Similarity=0.364 Sum_probs=121.2
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEeccc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE 155 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 155 (224)
+.||+|+||.||+|.+..+++.+|+|++.... ........+|+.+++.++||||+.+++.+. ..+.+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~ 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ--THDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE--cCCEEEEEEeCCC
Confidence 36999999999999999999999999987432 122345678999999999999999999884 4458999999998
Q ss_pred CChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 156 HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 156 ~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++.+.........+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~ 144 (323)
T cd05571 79 GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcc
Confidence 754443334456799999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=217.90 Aligned_cols=147 Identities=25% Similarity=0.337 Sum_probs=126.6
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++++.||+|+||.||+|.+..++..+|+|++.... ......+.+|+.++..++|+||+++++.+. ..+.+|+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~--~~~~~~l 78 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ--DKRNLYL 78 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEE
Confidence 36999999999999999999999999999999986432 223345567889999999999999999984 4458999
Q ss_pred EEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+.++ +...+. ....+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 79 v~E~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 79 IMEFLPGGDMMTLLM-KKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred EEeCCCCccHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 99999875 444443 3567999999999999999999999999999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=216.50 Aligned_cols=149 Identities=23% Similarity=0.312 Sum_probs=126.4
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCC-eEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQD-KILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~-~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++.+.||+|+||.||+|.+..++ ..+|+|++.... ......+.+|+.+++.++||||+++++++.. .+.
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~--~~~ 105 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD--ESY 105 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe--CCE
Confidence 4568999999999999999999876554 789999886432 2233456789999999999999999999954 458
Q ss_pred EEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+||||+.++ +..++ .....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 106 ~~lv~Ey~~~g~L~~~i-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFL-RRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEeCCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999765 44444 34567999999999999999999999999999999999999999999999999999753
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-31 Score=215.04 Aligned_cols=148 Identities=30% Similarity=0.456 Sum_probs=127.8
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC---cceEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKS---LSSIF 148 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~~ 148 (224)
+|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.... ...+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4899999999999999999999999999999886422 123345678999999999999999999875432 23589
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||||++++...+.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 81 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999999887776654 456999999999999999999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=218.03 Aligned_cols=148 Identities=26% Similarity=0.323 Sum_probs=127.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|++.+.||+|+||.||++++..+++.+|+|++.... ......+.+|+.+++.++||||+++++.+. ....+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~--~~~~~ 118 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ--DDKYL 118 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEE
Confidence 4578999999999999999999999999999999886422 122334568899999999999999999984 44589
Q ss_pred EEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||+.++ +..++.. ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999864 5554432 35899999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=211.76 Aligned_cols=148 Identities=34% Similarity=0.593 Sum_probs=131.2
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|.+.+.||+|+||.||+|.+..++..+|+|++..... .......+|+.+++.++|+||+++++++.. .+..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT--DKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee--CCeEEEE
Confidence 4679999999999999999999999999999999875432 233456789999999999999999999854 4589999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|||+++++...+......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 153 (309)
T cd07872 83 FEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA 153 (309)
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcccccee
Confidence 99999888877766566689999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=210.15 Aligned_cols=148 Identities=32% Similarity=0.563 Sum_probs=130.7
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
++|++.+.||+|+||.||+|++..++..+|+|++..... .....+.+|+.+++.++|+||+++++++. ..+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR--RRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe--cCCEEEEE
Confidence 369999999999999999999999999999998865432 23455678999999999999999999984 44589999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+++...+......+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+|+.+
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 79 FEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL 150 (287)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence 999998877766655667999999999999999999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-33 Score=216.36 Aligned_cols=147 Identities=29% Similarity=0.537 Sum_probs=132.3
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEec
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEY 153 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 153 (224)
-|.++++||+|+||.||+|.++.+|.++|||.+..+ ...+++++|+.+|++|..+++|++||.++.. ..+||||||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~--sDLWIVMEY 109 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKH--SDLWIVMEY 109 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccC--CceEeehhh
Confidence 488899999999999999999999999999988755 3567889999999999999999999998643 479999999
Q ss_pred ccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccccC
Q psy13250 154 CEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYLN 224 (224)
Q Consensus 154 ~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 224 (224)
|+. +..++++.++.++++.++..+++..+.||+|||...-||||||..|||++.+|..||+|||.|-.+.|
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 985 45556666678899999999999999999999999999999999999999999999999999976653
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=219.06 Aligned_cols=142 Identities=24% Similarity=0.291 Sum_probs=126.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
...+|++++.||+|+||.||+|.+..+++.+|+|... .....+|+.+++.++||||+++++++.. ....+++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv 161 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY--NKFTCLI 161 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE--CCeeEEE
Confidence 3467999999999999999999999999999999653 2346789999999999999999999854 4478999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||++.+++...+.. ...+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 162 ~e~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 162 LPRYKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred EecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 99998887766654 45689999999999999999999999999999999999999999999999999974
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=213.88 Aligned_cols=148 Identities=24% Similarity=0.339 Sum_probs=127.2
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.||+|+||.||++.+..+++.+|+|++.... ......+.+|..++..++|+||+.+++++. ..+.+|+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ--DENNLYL 78 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe--cCCeEEE
Confidence 36999999999999999999999999999999986422 122334567888899999999999999984 4458999
Q ss_pred EEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+.+ ++..++......+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 152 (331)
T cd05597 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL 152 (331)
T ss_pred EEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeec
Confidence 9999976 566666554567999999999999999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=214.98 Aligned_cols=141 Identities=26% Similarity=0.365 Sum_probs=121.1
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEeccc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE 155 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 155 (224)
+.||+|+||.||++.+..++..||+|++.... ......+.+|+.+++.++||||+++++.+. ..+.+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~--~~~~~~lv~E~~~ 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRLCFVMEYAN 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe--cCCEEEEEEeCCC
Confidence 36899999999999999999999999986432 122345567999999999999999999984 3458999999998
Q ss_pred CChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 156 HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 156 ~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++.+.........+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 144 (323)
T cd05595 79 GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 144 (323)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhcc
Confidence 764444444456799999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=214.19 Aligned_cols=141 Identities=28% Similarity=0.378 Sum_probs=121.3
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEeccc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE 155 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 155 (224)
+.||+|+||.||++.+..++..+|+|++.... ......+.+|+.+++.++||||+++++.+. ..+.+|+||||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv~Ey~~ 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ--TKDRLCFVMEYVN 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE--cCCEEEEEEeCCC
Confidence 36899999999999999999999999986432 223345678999999999999999999884 4458999999998
Q ss_pred CChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 156 HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 156 ~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++.+.........+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~ 144 (328)
T cd05593 79 GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKE 144 (328)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCcc
Confidence 754444444456799999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=220.80 Aligned_cols=152 Identities=27% Similarity=0.426 Sum_probs=135.9
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
......|....+||+|+.|.||.|+...++..||||++........+-+++|+.+|+..+|+|||.+++.|... +.+|
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--deLW 346 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG--DELW 346 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc--ceeE
Confidence 44566799999999999999999999999999999999988877778889999999999999999999988644 5899
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
+|||||+|+.+..+.. ...+++..+..++++++.||+|||.+||+|||||.+|||++.+|.+||+||||+..+.
T Consensus 347 VVMEym~ggsLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVT-KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred EEEeecCCCchhhhhh-cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 9999999865544443 3459999999999999999999999999999999999999999999999999997654
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=216.91 Aligned_cols=154 Identities=25% Similarity=0.344 Sum_probs=134.6
Q ss_pred ccccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc--cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 68 KCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 68 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
.......|.+.+.||+|.|++|.++++..++..||||.+...... ....+.+|+++|+.+.|||||+++.+. ....
T Consensus 51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~--~t~~ 128 (596)
T KOG0586|consen 51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI--ETEA 128 (596)
T ss_pred ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee--eecc
Confidence 344677899999999999999999999999999999988765432 234578999999999999999999999 4556
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
.+|+||||+.++-...+...++...+..++.++.|+.+|++|||+++|+|||||.+||||+.+.++||+||||+.+|-
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec
Confidence 899999999876555555556778889999999999999999999999999999999999999999999999998763
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=219.82 Aligned_cols=148 Identities=25% Similarity=0.380 Sum_probs=126.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCC----eEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQD----KILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
.++..+.++||+|+||.||+|+....+ ..||+|...... .....++++|+++|++++|||||++||+...+.
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~- 234 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE- 234 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-
Confidence 355666799999999999999977542 238999887532 345567789999999999999999999997655
Q ss_pred ceEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.+|+|||+|.| +|.+.+......++..+...++.+.+.||+|||++++|||||..+|+|++.++.+||+||||++.
T Consensus 235 -Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 -PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred -ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 79999999987 56666666555799999999999999999999999999999999999999999999999999974
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=212.37 Aligned_cols=148 Identities=25% Similarity=0.345 Sum_probs=126.6
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.||+|+||.||++++..+++.+|+|.+.... ......+.+|..++..+.|+||+.+++.+. ..+.+|+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~--~~~~~~l 78 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ--DENYLYL 78 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--cCCEEEE
Confidence 36999999999999999999999999999999886422 112233567788888999999999999984 4458999
Q ss_pred EEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+.+ +|..++......+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 79 v~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~ 152 (331)
T cd05624 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKM 152 (331)
T ss_pred EEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeec
Confidence 9999976 466566554567999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=215.24 Aligned_cols=147 Identities=28% Similarity=0.401 Sum_probs=127.6
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.||+|+||+||+|.+..+++.+|+|++.... ......+.+|+.++..++|+||+++++.+. ..+.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ--DEEHLYL 78 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee--cCCeEEE
Confidence 36999999999999999999999999999999987432 123345678999999999999999999884 4458999
Q ss_pred EEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+.+ ++..++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 79 v~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 151 (350)
T cd05573 79 VMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKM 151 (350)
T ss_pred EEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccC
Confidence 9999976 45555544 467999999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=212.12 Aligned_cols=148 Identities=25% Similarity=0.334 Sum_probs=127.9
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.||+|+||.||+|.+..++..+|+|++..... .....+.+|+.+++.++|+||+.+++.+. ..+.+|+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~--~~~~~~l 78 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ--DKDNLYL 78 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe--cCCeEEE
Confidence 369999999999999999999999999999999875322 23344567888999999999999999884 3458999
Q ss_pred EEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+++ ++..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 79 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 152 (330)
T cd05601 79 VMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL 152 (330)
T ss_pred EECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeEC
Confidence 9999976 566565554567999999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=211.28 Aligned_cols=141 Identities=26% Similarity=0.370 Sum_probs=120.4
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEeccc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE 155 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 155 (224)
+.||+|+||.||++.+..++..+|+|++.... ........+|+.++..++||||+.+++.+. ..+.+|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~--~~~~~~lv~E~~~ 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ--THDRLCFVMEYAN 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE--cCCEEEEEEeCCC
Confidence 36899999999999999999999999987432 122345567889999999999999999884 4458999999998
Q ss_pred CChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 156 HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 156 ~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++.+.........+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.
T Consensus 79 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~ 145 (325)
T cd05594 79 GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE 145 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCee
Confidence 76444444445679999999999999999999997 7999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=215.07 Aligned_cols=149 Identities=26% Similarity=0.337 Sum_probs=127.2
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
...++|++.+.||+|+||.||++.+..++..+|+|++.... ......+.+|+.+++.++||||+.+++++. ....
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~--~~~~ 117 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ--DDKY 117 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCE
Confidence 35678999999999999999999999999999999986422 122334568999999999999999999884 4458
Q ss_pred EEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+||||+.++ +..++. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMS--NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEEcCCCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999865 554443 245889999999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=205.90 Aligned_cols=146 Identities=25% Similarity=0.288 Sum_probs=124.3
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
|+..+.||+|+||.||+|.+..+++.+|+|.+..... .....+.+|+.++..+.|+||+.+++.+. ..+..|++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~--~~~~~~lv~ 79 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE--TKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc--cCCeEEEEE
Confidence 7889999999999999999999999999998864321 22334678999999999999999999884 445899999
Q ss_pred ecccCC-hhHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHD-LASLQDN-VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~-l~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+.++ +...+.. ....+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~ 152 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI 152 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence 999865 4434332 2346899999999999999999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=213.81 Aligned_cols=147 Identities=35% Similarity=0.505 Sum_probs=127.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCcc---chhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTL---TRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~ 147 (224)
...|++.+.||+|.||.||+|..+.+|..+|+|.+....... .....+|+.+|+++. |||||.+++.| +....+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~--e~~~~~ 111 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF--EDPDSV 111 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE--EcCCeE
Confidence 356999999999999999999999999999999997654332 346789999999998 99999999999 455589
Q ss_pred EEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC----CcEEEEeccccccc
Q psy13250 148 FLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK----GCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~----~~~kl~DfGla~~~ 222 (224)
|+|||+|.|+ +.+.+... .+++..+..++.|++.|+.|||+.||+||||||+|+|+... +.+|++|||+|..+
T Consensus 112 ~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 9999999865 55544443 39999999999999999999999999999999999999754 47999999999865
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=214.78 Aligned_cols=148 Identities=26% Similarity=0.316 Sum_probs=126.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... ......+.+|+.+++.++||||+++++.+. ....+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~--~~~~~ 118 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ--DDRYL 118 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--cCCEE
Confidence 4578999999999999999999999999999999986422 122334567889999999999999999985 44589
Q ss_pred EEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||++++ +..++.. ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 119 ~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 9999999865 5444432 45899999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=213.40 Aligned_cols=151 Identities=24% Similarity=0.358 Sum_probs=122.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEc-----cCCeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS-----VQDKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (224)
..++|++.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.++..+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 4568999999999999999999752 3456899998864322 2234577899999999 899999999988533
Q ss_pred cceEEEEEecccCC-hhHhhhhc---------------------------------------------------------
Q psy13250 144 LSSIFLVMEYCEHD-LASLQDNV--------------------------------------------------------- 165 (224)
Q Consensus 144 ~~~~~lv~e~~~~~-l~~~~~~~--------------------------------------------------------- 165 (224)
.+.+|++|||++++ +..++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 34689999999864 54444321
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 166 ----ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 166 ----~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~ 224 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeeccccccc
Confidence 124778889999999999999999999999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=210.45 Aligned_cols=139 Identities=29% Similarity=0.366 Sum_probs=119.4
Q ss_pred eeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccCC
Q psy13250 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHD 157 (224)
Q Consensus 81 lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 157 (224)
||+|+||.||+|.+..+++.+|+|++.... ......+.+|+.++.+++||||+++++.+. ..+.+|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~g 78 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ--SPEKLYLVLAFINGG 78 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe--cCCeEEEEEcCCCCC
Confidence 699999999999999999999999986432 223345678999999999999999999884 445899999999875
Q ss_pred hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 158 LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 158 l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.+.......+.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~ 142 (312)
T cd05585 79 ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL 142 (312)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECccccc
Confidence 4433333356799999999999999999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-30 Score=210.27 Aligned_cols=146 Identities=25% Similarity=0.317 Sum_probs=122.3
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCC-CeeeeeEEEEcCCcceEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHE-NIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~l 149 (224)
+|++++.||+|+||.||+|.+..+++.+|+|++.... ......+..|..++..+.|+ +|+.+++++. ..+.+|+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE--cCCEEEE
Confidence 4889999999999999999999999999999986432 22334567788888888765 5778888884 3458999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||||+.++.+.........+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE 150 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence 999998654443333456789999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=225.90 Aligned_cols=152 Identities=33% Similarity=0.520 Sum_probs=136.3
Q ss_pred ccccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 68 KCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 68 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
...+-..|..+..||.|+||.||-|++..+.+.||||++..... +.+..+++|+..|.+++|||+|.+-++|..+.
T Consensus 21 k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~- 99 (948)
T KOG0577|consen 21 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH- 99 (948)
T ss_pred cCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-
Confidence 33344568889999999999999999999999999999975443 45677899999999999999999999997554
Q ss_pred ceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 145 SSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 145 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+.|+|||||-|+-.+++.....++.+.++..|..+.+.||.|||+.+.||||||..|||+.+.|.|||+|||.|.+
T Consensus 100 -TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi 175 (948)
T KOG0577|consen 100 -TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASI 175 (948)
T ss_pred -hHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhh
Confidence 7899999999987777777788999999999999999999999999999999999999999999999999999864
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=215.15 Aligned_cols=143 Identities=23% Similarity=0.254 Sum_probs=127.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
...|.+.+.||+|+||.||+|.+..++..||+|... .....+|+.++++++|+||+++++++.. .+..|++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~--~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVV--GGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEEEEE
Confidence 457999999999999999999999999999999542 2345689999999999999999998854 45789999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|++.+++...+......+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 240 e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~ 310 (461)
T PHA03211 240 PKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA 310 (461)
T ss_pred EccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceec
Confidence 99988888777665567999999999999999999999999999999999999999999999999999754
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=217.97 Aligned_cols=146 Identities=28% Similarity=0.358 Sum_probs=127.4
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-C-----CCeeeeeEEEEcCCcceE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-H-----ENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~~ 147 (224)
+|.+++.||+|+||+|.+|.+..+++.||||+++.. .....+...|+.+|..++ | -|+|+++++|... +++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr--~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR--NHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc--cce
Confidence 689999999999999999999999999999998633 234455667899998886 4 3999999999654 489
Q ss_pred EEEEecccCChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC--cEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG--CVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~--~~kl~DfGla~~~ 222 (224)
|||+|+++.+|..++... ..+++...++.|+.||+.||.+||+.+|||+|||||||||...+ .+||||||+|+..
T Consensus 264 ciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 264 CIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 999999999999988765 34699999999999999999999999999999999999998744 6999999999864
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-30 Score=209.53 Aligned_cols=146 Identities=24% Similarity=0.338 Sum_probs=122.3
Q ss_pred ceeEeeeeeccCceEEEEEEEc---cCCeEEEEEEeeccC----CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcc
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDS---VQDKILALKKLFLQN----NTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~---~~~~~~avK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (224)
+|++.+.||+|+||.||+++.. .++..+|+|++.... ........+|+.++..+ .|+||+.+++++. ..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ--TEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe--cCC
Confidence 4899999999999999998864 468899999886422 12234456788899988 5999999999884 445
Q ss_pred eEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+|+||||+.++ +...+. ....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 79 ~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 899999999864 444443 3567999999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=224.72 Aligned_cols=149 Identities=26% Similarity=0.405 Sum_probs=129.5
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-CCCeeeeeEE-EEcC---C-cce
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-HENIVQLKEV-VVGK---S-LSS 146 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~-~~~~---~-~~~ 146 (224)
.++++.+.|.+|||+.||+|.+...+..+|+|++...+....+...+|+.+|+.|. |+|||.|++. .... . .-.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 45888999999999999999999888999999998776667778889999999997 9999999993 2211 1 235
Q ss_pred EEEEEeccc-CChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 147 IFLVMEYCE-HDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNF--IIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++|+||||. |++.+++..+ ...|++.+++.|+.++++|+.+||... |||||||-|||||+.+|+.||||||.|.-
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 789999999 5788877643 456999999999999999999999887 99999999999999999999999999863
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-30 Score=211.85 Aligned_cols=147 Identities=30% Similarity=0.457 Sum_probs=127.2
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC----cc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKS----LS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 145 (224)
.++|++.+.||+|+||.||++.+..++..+|+|++.... ......+.+|+.+++.++||||+++++++.... ..
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 568999999999999999999999999999999886432 233456678999999999999999999885332 23
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.+|+||||+++++...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 100 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 100 DVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred eeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 579999999987766553 3488999999999999999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=211.47 Aligned_cols=141 Identities=26% Similarity=0.329 Sum_probs=126.3
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
.+|++++.||+|+||.||+|.+..++..+|+|.... .....|+.++++++|+||+++++++.. ....|+|||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 137 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVS--GAITCMVLP 137 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEe--CCeeEEEEE
Confidence 469999999999999999999998999999996432 233568999999999999999999854 347899999
Q ss_pred cccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 153 YCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 153 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++.+++..++......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 138 ~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred ccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence 999888887776667899999999999999999999999999999999999999999999999999974
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=215.93 Aligned_cols=147 Identities=28% Similarity=0.368 Sum_probs=123.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcC------Ccc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGK------SLS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------~~~ 145 (224)
..+|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+|+.++|+||+++++++... ...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45799999999999999999999999999999987532 22345799999999999999998876432 123
Q ss_pred eEEEEEecccCChhHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC-cEEEEecccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDN---VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG-CVKIVYSTYLEL 221 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfGla~~ 221 (224)
.+++||||+++++...+.. ....+++..++.++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+|+.
T Consensus 141 ~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~ 220 (440)
T PTZ00036 141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220 (440)
T ss_pred EEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchh
Confidence 5779999999887665432 345799999999999999999999999999999999999999765 699999999975
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
+
T Consensus 221 ~ 221 (440)
T PTZ00036 221 L 221 (440)
T ss_pred c
Confidence 4
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=208.23 Aligned_cols=148 Identities=25% Similarity=0.362 Sum_probs=126.5
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.||+|+||.||++.+..+++.+|+|++.... ......+.+|+.++..++|+||+.+++.+. ....+|+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ--DENNLYL 78 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe--cCCEEEE
Confidence 36999999999999999999999999999999885321 122233567888889999999999999984 4458999
Q ss_pred EEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+.+ ++..++......+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 79 v~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~ 152 (332)
T cd05623 79 VMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 152 (332)
T ss_pred EEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheec
Confidence 9999975 566666554567999999999999999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-30 Score=208.07 Aligned_cols=142 Identities=25% Similarity=0.320 Sum_probs=117.2
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhc-CCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTK-CRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||.||+|.+..+++.||+|++.... .........|..++.. ..||||+++++++. ..+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~--~~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ--TKEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 36999999999999999999999999987432 1223344556666654 58999999999984 445899999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.++.+.........+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 87544433344567999999999999999999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=204.62 Aligned_cols=155 Identities=65% Similarity=1.042 Sum_probs=136.3
Q ss_pred ccccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc--cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 68 KCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 68 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
.+...++|++.+.||+|+||.||+|.+..++..||+|.+...... ......+|+.++++++|+||+++++++.+...+
T Consensus 2 ~~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (309)
T cd07845 2 RCRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLD 81 (309)
T ss_pred CcccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCC
Confidence 345778999999999999999999999999999999988754322 233456899999999999999999998766556
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+|+||||+.+++..++......+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||+++.+
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred eEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 79999999998887777765677999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=204.67 Aligned_cols=149 Identities=35% Similarity=0.624 Sum_probs=131.8
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
..++|++.+.||+|+||.||+|.+..++..+|+|.+..... .......+|+..++.++|+||+++++++. ..+..|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~--~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH--TEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe--cCCeEEE
Confidence 35679999999999999999999999999999998865433 23345678999999999999999999995 4458999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||||+.+++...+......+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++..
T Consensus 82 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 153 (301)
T cd07873 82 VFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA 153 (301)
T ss_pred EEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhc
Confidence 999999888877766566789999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=207.44 Aligned_cols=146 Identities=26% Similarity=0.324 Sum_probs=121.4
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~l 149 (224)
+|.+.+.||+|+||.||+|.+..++..+|+|++..... ........|..++..+ .|++|+.+++++. ..+.+|+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ--TMDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe--cCCEEEE
Confidence 48899999999999999999999999999999874321 2223445677777666 5889999998884 4458999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||||+.++.+.........+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~ 150 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence 999998654333333456799999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-30 Score=213.29 Aligned_cols=147 Identities=32% Similarity=0.500 Sum_probs=126.7
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC---cceEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKS---LSSIF 148 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~~ 148 (224)
+|++.+.||+|+||.||++.+..+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++.... ...+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999998899999999885322 123356778999999999999999999985332 12689
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+||||+.+++...+.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 81 lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999999877766544 45799999999999999999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=207.71 Aligned_cols=144 Identities=28% Similarity=0.335 Sum_probs=119.9
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHH---hhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTG---LTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~---l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
|++++.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+ +..++||||+++++++. ..+.+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~--~~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ--TEDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE--cCCEEE
Confidence 678899999999999999999999999999986432 1222344455544 45678999999999984 445899
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+||||+.++.+..... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 lv~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05589 79 FVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE 150 (324)
T ss_pred EEEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCcc
Confidence 9999998754443333 35699999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=208.07 Aligned_cols=141 Identities=25% Similarity=0.359 Sum_probs=117.4
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHH-HhhcCCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVT-GLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||+||+|.+..++..+|+|++..... .....+.+|.. +++.++||||+++++.+. ..+..|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~--~~~~~~lv~e~~ 78 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ--TTEKLYFVLDFV 78 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe--cCCEEEEEEcCC
Confidence 368999999999999999999999999864321 22233445544 467799999999999884 445899999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 8764444444466799999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=207.91 Aligned_cols=141 Identities=25% Similarity=0.306 Sum_probs=118.1
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||.||+|.+..++..+|+|++.... .........|..++..+ +||||+.+++++. ..+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~--~~~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ--TKDRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCeEEEEEeCC
Confidence 36899999999999999999999999986432 22234456778877755 7999999999995 445899999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.++.+.........+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKE 145 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeeccccee
Confidence 8754433333456799999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=207.67 Aligned_cols=149 Identities=28% Similarity=0.397 Sum_probs=128.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|++.+.||+|+||.||++.+..++..+|+|.+..... .....+.+|+.+++.++||||+++++++.. .+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCEEEEE
Confidence 4679999999999999999999999999999998875432 234567889999999999999999999854 3489999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN-FIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||++++.+..+......+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 99998754443334455689999999999999999999986 6999999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=202.10 Aligned_cols=149 Identities=34% Similarity=0.599 Sum_probs=122.8
Q ss_pred ceeEeeeeeccCceEEEEEEEcc-CCeEEEEEEeeccCC--ccchhHHHHHHHhhcC---CCCCeeeeeEEEEc---CCc
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSV-QDKILALKKLFLQNN--TLTRGELREVTGLTKC---RHENIVQLKEVVVG---KSL 144 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~-~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~---~~~ 144 (224)
+|++.+.||+|+||.||+|.+.. .+..+|+|.+..... .......+|+.+++.+ .||||+++++++.. ...
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 68999999999999999999854 468899998865432 2233455677666554 79999999998752 233
Q ss_pred ceEEEEEecccCChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 145 SSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 145 ~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..+++||||+.+++..++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 82 TKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 468999999998887776543 345899999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=208.32 Aligned_cols=141 Identities=24% Similarity=0.288 Sum_probs=119.3
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||.||+|.+..++..||+|++.... ......+.+|..++..+ +||||+++++++. ....+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~--~~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ--TESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE--cCCEEEEEEeCC
Confidence 36899999999999999999999999987532 12234456788888887 7999999999984 445899999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+++.+.......+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccc
Confidence 8754433333456799999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=207.81 Aligned_cols=141 Identities=26% Similarity=0.316 Sum_probs=118.9
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||.||+|.+..++..+|+|++.... ......+.+|+.++.++ +||||+++++++.. .+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 36999999999999999999999999987532 12233456777777665 79999999999854 45899999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.++.+.........+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 8754444444456799999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=207.57 Aligned_cols=141 Identities=26% Similarity=0.375 Sum_probs=117.1
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHH-HhhcCCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVT-GLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||+||+|.+..+++.+|+|++..... .....+.+|.. .++.++||||+++++.+. ..+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~--~~~~~~lv~e~~ 78 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ--TADKLYFVLDYV 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE--eCCEEEEEEcCC
Confidence 369999999999999999999999999864321 12233445544 457799999999999884 445899999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.++.+.........+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 79 NGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 8754443334456799999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=210.47 Aligned_cols=143 Identities=27% Similarity=0.370 Sum_probs=125.4
Q ss_pred eeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEeccc
Q psy13250 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE 155 (224)
Q Consensus 78 ~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 155 (224)
.+.||.|.||+||-|.++.+|+.||||++..-.- .......+|+.+|+++.||.||.+.-.| +..+.+++|||-+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~--ET~ervFVVMEKl~ 646 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF--ETPERVFVVMEKLH 646 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee--cCCceEEEEehhhc
Confidence 3789999999999999999999999999975432 2335567899999999999999998888 66779999999999
Q ss_pred CChhH-hhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC---CcEEEEeccccccc
Q psy13250 156 HDLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK---GCVKIVYSTYLELY 222 (224)
Q Consensus 156 ~~l~~-~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~---~~~kl~DfGla~~~ 222 (224)
|+.+. ++....+.+++....+++.||+.||.|||.++|+|+||||+|||+... -++||||||+||++
T Consensus 647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI 717 (888)
T KOG4236|consen 647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII 717 (888)
T ss_pred chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeec
Confidence 98555 455567889999999999999999999999999999999999999764 47999999999975
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=207.19 Aligned_cols=141 Identities=26% Similarity=0.350 Sum_probs=117.0
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHH-HhhcCCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVT-GLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||.||+|++..++..+|+|++.... ......+.+|.. +++.++||||+++++.+. ..+.+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~--~~~~~~lv~e~~ 78 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ--TAEKLYFVLDYV 78 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 36999999999999999999999999986432 122233445544 577899999999999884 445899999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+++.+.........+++..+..++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++.
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 79 NGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 8754443334456789999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=206.85 Aligned_cols=141 Identities=29% Similarity=0.356 Sum_probs=118.4
Q ss_pred eeeeccCceEEEEEEEc---cCCeEEEEEEeeccC----CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 79 NRIGEGSYGVVYRVRDS---VQDKILALKKLFLQN----NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~---~~~~~~avK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+.||+|+||.||+++.. .+++.+|+|++.... ......+.+|+.+++.++||||+++++.+.. .+.+|+||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~--~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT--GGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec--CCeEEEEE
Confidence 67999999999999863 468899999986432 1223345679999999999999999999854 45899999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||+.++.+.......+.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (323)
T cd05584 80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKE 149 (323)
T ss_pred eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCee
Confidence 9998754443334456789999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=204.52 Aligned_cols=149 Identities=26% Similarity=0.355 Sum_probs=122.2
Q ss_pred ccceeEeeeeeccCceEEEEEEEcc----------------CCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeee
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSV----------------QDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQ 134 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~----------------~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~ 134 (224)
.++|++.+.||+|+||.||+|.+.. ++..+|+|.+..... .....+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4579999999999999999997532 345799998865432 23345778999999999999999
Q ss_pred eeEEEEcCCcceEEEEEecccC-ChhHhhhhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy13250 135 LKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVE------------------SPFTESQVKCVILQVLKGLNYLHSNFIIH 195 (224)
Q Consensus 135 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~------------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiH 195 (224)
+++++... +..|++|||+.+ ++..++.... ..+++..+..++.|++.||.|||+++|+|
T Consensus 84 ~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 84 LLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred EEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 99999543 478999999976 4554443211 23677889999999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 196 RDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 196 rDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||||+|||++.++.+||+|||+++.+
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~ 188 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNL 188 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceec
Confidence 999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=230.91 Aligned_cols=153 Identities=31% Similarity=0.480 Sum_probs=132.2
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC-CccchhHHHHHHHhhcCCCCCeeeeeEEEEcC-----
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN-NTLTRGELREVTGLTKCRHENIVQLKEVVVGK----- 142 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----- 142 (224)
.+...+|+.++.||+|+||.||+++++-+|+.||||++.... ......+.+|+..+++++|||||++|..|+..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456788999999999999999999999999999999997653 23456678999999999999999999887632
Q ss_pred --------------------------------------------------------------------------------
Q psy13250 143 -------------------------------------------------------------------------------- 142 (224)
Q Consensus 143 -------------------------------------------------------------------------------- 142 (224)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------Cc-------ceEEEEEecccCChhHhhhhcCCCC-CHHHHHHHHHHHHHHHHHHH
Q psy13250 143 -------------------------SL-------SSIFLVMEYCEHDLASLQDNVESPF-TESQVKCVILQVLKGLNYLH 189 (224)
Q Consensus 143 -------------------------~~-------~~~~lv~e~~~~~l~~~~~~~~~~l-~~~~~~~~~~~i~~~l~~lH 189 (224)
+. ..+||-||||+..+++.+...+... .....++++++|+.||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 00 1368999999988888777655544 57788999999999999999
Q ss_pred hCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 190 SNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 190 ~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++|||||||||.||+++.++.|||+|||+|+.
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchh
Confidence 99999999999999999999999999999986
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=209.53 Aligned_cols=149 Identities=30% Similarity=0.463 Sum_probs=127.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC----c
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKS----L 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~ 144 (224)
..++|++.+.||+|+||.||++.+..+++.+|+|++.... ........+|+.+++.++||||+++++++.... .
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3568999999999999999999999899999999886432 223456678999999999999999999885322 2
Q ss_pred ceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 145 SSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 145 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
...|+||||+++++...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 95 ~~~~lv~e~~~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ceeEEEhhhhcccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 3579999999987766553 34889999999999999999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=206.81 Aligned_cols=141 Identities=24% Similarity=0.307 Sum_probs=118.5
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||+||+|.+..+++.+|+|++.... .........|..++..+ .||||+++++++. ..+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~--~~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ--TPDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE--cCCEEEEEEcCC
Confidence 36899999999999999999999999986432 22334556777777765 6999999999984 445899999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.++.+.........+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 8754443334456799999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=206.41 Aligned_cols=146 Identities=25% Similarity=0.312 Sum_probs=121.3
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~l 149 (224)
+|+..+.||+|+||.||+|.+..+++.||+|++.... ....+....|..++..+. |++|+.+++++. ..+.+|+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ--TVDRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe--cCCEEEE
Confidence 4788899999999999999999999999999886432 122344567888887775 567778888874 3458999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||||++++.+.........+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence 999998654443334456799999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-29 Score=223.01 Aligned_cols=148 Identities=30% Similarity=0.416 Sum_probs=127.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
+++|.+++.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++..++|+||+.+++.+. ....+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~~ 80 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ--SANNVY 80 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE--ECCEEE
Confidence 4679999999999999999999999999999999864322 22345677888999999999999998884 345899
Q ss_pred EEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||||+.+ +|..++.. .+.+++..++.++.||+.||+|||.++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 lVmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 81 LVMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 99999976 45555443 456899999999999999999999999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-29 Score=208.89 Aligned_cols=142 Identities=24% Similarity=0.287 Sum_probs=123.2
Q ss_pred cceeEeeeeeccCceEEEEEEEc--cCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDS--VQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.+|++++.||+|+||.||+|... ..+..+|+|.+... ....+|+.+++.++||||+++++.+.. ...+|++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~--~~~~~lv 164 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW--KSTVCMV 164 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee--CCEEEEE
Confidence 46999999999999999999754 35678999977432 234679999999999999999998843 4589999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||++.+++..++ .....+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+|+.+
T Consensus 165 ~e~~~~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 165 MPKYKCDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred ehhcCCCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999998887776 33567999999999999999999999999999999999999999999999999998654
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=206.95 Aligned_cols=142 Identities=25% Similarity=0.358 Sum_probs=116.8
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHH-HhhcCCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVT-GLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||+||+|.+..++..+|+|++..... .....+.+|.. .++.+.|+||+++++.+. ..+.+|+||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~--~~~~~~lv~e~~ 78 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ--TADKLYFVLDYI 78 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE--cCCeEEEEEeCC
Confidence 369999999999999999999999999864321 12233344443 467789999999999984 445899999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.++.+.........+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 79 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 79 NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 87544444444567889999999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=213.17 Aligned_cols=151 Identities=33% Similarity=0.513 Sum_probs=131.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc--cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.++|..++++|+|+||.++.++++..+..+++|.+...... ..+..++|+.+++++.|||||.+.+.|+.++ ..++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~-~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG-QLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC-ceEEE
Confidence 46799999999999999999999999999999999865532 2345688999999999999999999996543 34999
Q ss_pred EEecccCC-hhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 150 VMEYCEHD-LASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
||+||+|+ +.+.+...+ ..++++.+..++.|++.|+.|||+++|+|||||+.||+++.++.|||.|||+|+.+.
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999975 555555544 569999999999999999999999999999999999999999999999999999764
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-29 Score=215.07 Aligned_cols=148 Identities=22% Similarity=0.336 Sum_probs=125.9
Q ss_pred cceeEeeeeeccCceEEEEEEEccC-CeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQ-DKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~-~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
..|.+.+.||+|+||.||+|....+ +..+|+|.+..........+.+|+.+++.++||||+++++.+.. .+.+||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~--~~~~~lv~ 144 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS--DDKLLLIM 144 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE--CCEEEEEE
Confidence 3499999999999999999998777 78889997755444444556789999999999999999999954 45899999
Q ss_pred ecccC-ChhHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDN---VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+.+ +|...+.. ...++++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 99986 45544332 2456899999999999999999999999999999999999999999999999999864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=206.86 Aligned_cols=148 Identities=29% Similarity=0.444 Sum_probs=127.5
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|++.+.||+|+||.||++.+..++..+|+|.+..... .....+.+|+.+++.++|+||+++++++.. .+.+|+|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE--CCEEEEE
Confidence 4679999999999999999999999999999998865432 233557799999999999999999999954 4589999
Q ss_pred EecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSN-FIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.++ |..++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+
T Consensus 82 ~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 82 MEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred EecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 9999864 544444 356689999999999999999999975 7999999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=200.07 Aligned_cols=148 Identities=32% Similarity=0.601 Sum_probs=130.5
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+..... .....+.+|+.+++.++|+||+++++++. .....|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH--TKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe--cCCeEEEE
Confidence 4679999999999999999999988899999998865432 22345678999999999999999999984 44589999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|||+.+++...+......+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 152 (291)
T cd07844 82 FEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA 152 (291)
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccc
Confidence 99999888777766556789999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=200.26 Aligned_cols=150 Identities=27% Similarity=0.364 Sum_probs=128.6
Q ss_pred cceeEeeeeeccCceEEEEEEE----ccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRD----SVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
.+|++.+.||+|+||.||++.. ..++..+|+|.+........+.+.+|+.+++.++||||+++++++...+...+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4699999999999999999874 456889999988655444455677899999999999999999987655555789
Q ss_pred EEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+.+ ++..++......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999975 566666554556899999999999999999999999999999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=205.59 Aligned_cols=141 Identities=23% Similarity=0.271 Sum_probs=117.5
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhc-CCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTK-CRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||.||+|.+..++..+|+|++.... .........|..++.. ..||||+++++.+. ..+.+|+||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~--~~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ--TKEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE--eCCEEEEEECCC
Confidence 46999999999999999999999999987532 1223445667777765 58999999999984 445899999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.++.+.........+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 8754333333356789999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=199.24 Aligned_cols=148 Identities=30% Similarity=0.519 Sum_probs=129.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|.+.+.||+|+||.||+|.+..++..+|+|.+...... ......+|+..++.++|+||+++++++.. ....|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~--~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT--KETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec--CCeEEEE
Confidence 46799999999999999999999989999999988654322 23356789999999999999999999853 4589999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|||+.+++...+......+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~ 152 (291)
T cd07870 82 FEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA 152 (291)
T ss_pred EecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccc
Confidence 99999888777665556688889999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=204.92 Aligned_cols=141 Identities=28% Similarity=0.368 Sum_probs=118.8
Q ss_pred eeeeccCceEEEEEEE---ccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEec
Q psy13250 79 NRIGEGSYGVVYRVRD---SVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEY 153 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~---~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 153 (224)
+.||+|+||.||++++ ..++..+|+|++..... .......+|+.++++++||||+++++.+. ..+.+|+||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ--TEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE--cCCEEEEEEcC
Confidence 5799999999999876 35789999999875332 12334567999999999999999999985 44589999999
Q ss_pred ccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 154 CEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 154 ~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+.++ +...+ .....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~~~L~~~l-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 148 (318)
T cd05582 80 LRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 148 (318)
T ss_pred CCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCccc
Confidence 9864 54444 33557999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=199.57 Aligned_cols=147 Identities=26% Similarity=0.301 Sum_probs=124.8
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.|++.+.||+|+||.||++.+..++..+|+|++..... .....+.+|+.+++.++|+||+.+++.+. ..+.+|+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv 78 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE--TKDALCLV 78 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec--CCCeEEEE
Confidence 38899999999999999999998999999998864321 12234568999999999999999999884 44589999
Q ss_pred EecccCC-hhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHD-LASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~-l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.++ +...+... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.+
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 152 (285)
T cd05605 79 LTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEI 152 (285)
T ss_pred EeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence 9999865 44444332 346899999999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-29 Score=207.01 Aligned_cols=147 Identities=28% Similarity=0.469 Sum_probs=126.9
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcC----Ccc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGK----SLS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~ 145 (224)
.++|++.+.||+|+||.||++.+..+++.+|+|++.... ........+|+.+++.++||||+.+++++... ...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 468999999999999999999999999999999886432 23345667899999999999999999887532 223
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.+|+||||+++++...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 103 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 103 DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred eEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 689999999988776653 3488899999999999999999999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=202.25 Aligned_cols=152 Identities=34% Similarity=0.597 Sum_probs=130.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCC----eEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQD----KILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
...|+....||+|.||.||+|....+. +.+|+|+++.+.. .......||+.+++.++|+|++.+..+|... ..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-DK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-Cc
Confidence 346999999999999999999654443 3789998875433 4566778999999999999999999998754 46
Q ss_pred eEEEEEecccCChhHhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC----CcEEEEecc
Q psy13250 146 SIFLVMEYCEHDLASLQDNV----ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK----GCVKIVYST 217 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~----~~~kl~DfG 217 (224)
.+|+++||.+.+|+.++... ...++...+..++.||+.|+.|||++-|+||||||.|||+..+ |.+||+|||
T Consensus 102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 89999999999999877643 2358999999999999999999999999999999999999887 899999999
Q ss_pred ccccccC
Q psy13250 218 YLELYLN 224 (224)
Q Consensus 218 la~~~~~ 224 (224)
|||+|-|
T Consensus 182 laR~~~~ 188 (438)
T KOG0666|consen 182 LARLFNN 188 (438)
T ss_pred HHHHhhc
Confidence 9998754
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-29 Score=198.85 Aligned_cols=149 Identities=36% Similarity=0.608 Sum_probs=124.2
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcC---CCCCeeeeeEEEEcC---Ccc
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKC---RHENIVQLKEVVVGK---SLS 145 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~---~~~ 145 (224)
+|++.+.||+|+||+||+|.+..++..+|+|.+..... .......+|+.+++.+ .||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 48899999999999999999999999999998865432 2233445666666554 799999999987532 234
Q ss_pred eEEEEEecccCChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.++++|||+.+++..++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 689999999988777665433 35899999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-29 Score=200.75 Aligned_cols=152 Identities=53% Similarity=0.845 Sum_probs=133.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc--cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
..++|++.+.||.|+||.||+|.+..++..+|+|.+...... ....+.+|+..+.+++||||+++++++........|
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 456899999999999999999999989999999998754322 233456899999999999999999998766557899
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
++|||+.+++..++......+++..++.++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++.+
T Consensus 83 lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 83 MVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred EEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99999998777776665557999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=202.79 Aligned_cols=143 Identities=31% Similarity=0.615 Sum_probs=120.3
Q ss_pred eeeeeccCceEEEEEEEc--cCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEeccc
Q psy13250 78 LNRIGEGSYGVVYRVRDS--VQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE 155 (224)
Q Consensus 78 ~~~lG~G~fg~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 155 (224)
.++||+|+||+||+|.+. .++..+|+|.+... .......+|+.+++.++||||+++++.+.......+|++|||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999965 46788999987533 23445678999999999999999999987666668999999999
Q ss_pred CChhHhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----ccCCcEEEEeccccccc
Q psy13250 156 HDLASLQDNV--------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL----NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 156 ~~l~~~~~~~--------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill----~~~~~~kl~DfGla~~~ 222 (224)
+++..++... ...+++..++.++.|++.||.|||+++|+||||||+|||+ +..+.+||+|||+|+.+
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07868 84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence 8877665421 1258999999999999999999999999999999999999 45678999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=197.56 Aligned_cols=150 Identities=30% Similarity=0.462 Sum_probs=129.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||.||+|.+..++..+|+|++..........+.+|+..++.++||||+++++.+.. ....|+|
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~--~~~~~iv 84 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS--REKLWIC 84 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe--CCEEEEE
Confidence 34579999999999999999999998999999999875544444556789999999999999999999854 3589999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||++++.+.........+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++..+
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 156 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKI 156 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceee
Confidence 999987544433334567899999999999999999999999999999999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=204.51 Aligned_cols=141 Identities=26% Similarity=0.305 Sum_probs=119.0
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||.||+|.+..++..+|+|++..... .....+.+|+.++.++ .|+||+.+++++. ....+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ--TTSRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE--eCCEEEEEEeCC
Confidence 369999999999999999999999999875321 2234456788888777 6999999999984 445899999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.++.+.........+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEecccccee
Confidence 8754443333456799999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=203.46 Aligned_cols=140 Identities=25% Similarity=0.326 Sum_probs=117.4
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhc-CCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTK-CRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||+||+|.+..+++.+|+|++.... .........|..++.. ..||||+++++++.. .+.+|+||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT--KENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe--CCEEEEEEeCC
Confidence 36999999999999999999999999987532 1223445567777765 589999999999854 45899999999
Q ss_pred cCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 155 EHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 155 ~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.++ +...+. ....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~g~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 79 NGGDLMFHIQ-SCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKE 145 (316)
T ss_pred CCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceE
Confidence 864 544443 345789999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-30 Score=216.64 Aligned_cols=151 Identities=29% Similarity=0.395 Sum_probs=125.4
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC----cceEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKS----LSSIF 148 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~~ 148 (224)
.|...+.||+|+||.||+++++.+|+.+|||.+..... ...+.+.+|+.+|++++|+|||+++++-.... .....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 46677889999999999999999999999998865432 34566789999999999999999998864333 34567
Q ss_pred EEEecccC-ChhHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc--CCc--EEEEecccccc
Q psy13250 149 LVMEYCEH-DLASLQDNV--ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND--KGC--VKIVYSTYLEL 221 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~--~~~--~kl~DfGla~~ 221 (224)
+|||||.| ++...+... ...+++.+++.++..+..||.|||++||+||||||.||++-. +|+ .||+|||.||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 99999986 566565543 335999999999999999999999999999999999999954 343 69999999997
Q ss_pred ccC
Q psy13250 222 YLN 224 (224)
Q Consensus 222 ~~~ 224 (224)
+-|
T Consensus 174 l~d 176 (732)
T KOG4250|consen 174 LDD 176 (732)
T ss_pred CCC
Confidence 643
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-29 Score=198.88 Aligned_cols=140 Identities=29% Similarity=0.316 Sum_probs=117.9
Q ss_pred eeccCceEEEEEEEccCCeEEEEEEeeccCCc---cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccCC
Q psy13250 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNT---LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHD 157 (224)
Q Consensus 81 lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 157 (224)
||+|+||+||++.+..+++.+|+|++...... ....+..|+.+++.++|+||+.+.+++. ....+|+||||++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~g 78 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ--TKTDLCLVMTIMNGG 78 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc--CCCeEEEEEeCCCCC
Confidence 69999999999999999999999988643221 2244567999999999999999998884 445799999999865
Q ss_pred hh-Hhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 158 LA-SLQDN---VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 158 l~-~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+ ..+.. ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.+
T Consensus 79 ~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 147 (280)
T cd05608 79 DLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL 147 (280)
T ss_pred CHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceec
Confidence 43 33322 2356899999999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=202.36 Aligned_cols=148 Identities=22% Similarity=0.327 Sum_probs=124.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCe----EEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDK----ILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~----~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..+|++.+.||+|+||.||+|.+..++. .+|+|.+..... ...+.+.+|+.+++.+.||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---C
Confidence 3579999999999999999998765554 489998764322 3345677899999999999999999998532 5
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.++++||+.+ ++.+.+......+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccc
Confidence 6799999975 466666554556889999999999999999999999999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=204.16 Aligned_cols=150 Identities=29% Similarity=0.415 Sum_probs=130.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
-.++|..++.||+|.||+|-+|+.+.+++.+|||+++..- .......+.|-++|+.++||.+..+-..| ...+.+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF--Qt~drl 243 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF--QTQDRL 243 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh--ccCceE
Confidence 4578999999999999999999999999999999886432 12233446788999999999999987777 566799
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||..|+-+.+...+...+++..+++|..+|+.||.|||+++|++||||.+|+|+|.+|++||.||||++.=
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 999999998755555555678999999999999999999999999999999999999999999999999999763
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=209.29 Aligned_cols=148 Identities=25% Similarity=0.398 Sum_probs=133.2
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc--cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
+-|.+.+.||+|.|++|-+|++..+|+.||||++....-. ....+++|++.|+.++|||||++|+++ +....+|||
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi--DTQTKlyLi 95 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI--DTQTKLYLI 95 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh--cccceEEEE
Confidence 4588999999999999999999999999999999765433 234567999999999999999999998 666789999
Q ss_pred EecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc-CCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND-KGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~-~~~~kl~DfGla~~~ 222 (224)
+|+-++ ++.+++.+....+.++.+..|+.||+.|+.|||+..++||||||+|+++.+ -|.+||.||||+..|
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 999985 788888888888999999999999999999999999999999999998876 689999999999765
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-29 Score=203.01 Aligned_cols=141 Identities=26% Similarity=0.360 Sum_probs=119.3
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||+||+|.+..++..+|+|++.... ........+|+.++..+ .||||+++++++. ..+.+|+||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~--~~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ--TKDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE--cCCEEEEEEcCC
Confidence 36999999999999999999999999987432 22334456788888776 6999999999984 445899999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.++.+.........+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCee
Confidence 8754444444456799999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=199.41 Aligned_cols=146 Identities=38% Similarity=0.668 Sum_probs=129.5
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|++.+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+..++.++|+||+++++++. .....|+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH--SDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc--cCCceEEEE
Confidence 48899999999999999999999999999998865432 23345678999999999999999999985 445899999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||+++++...+......+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++.
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 148 (284)
T cd07839 79 EYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA 148 (284)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhc
Confidence 9999888877766567799999999999999999999999999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=207.91 Aligned_cols=150 Identities=25% Similarity=0.294 Sum_probs=123.2
Q ss_pred cccceeEeeeeeccCceEEEEEEE-----ccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRD-----SVQDKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (224)
..++|++.+.||+|+||.||+|.+ ..++..||+|++..... .....+.+|+.++..+ +||||+++++++. .
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~--~ 110 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT--V 110 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec--c
Confidence 345799999999999999999974 34567899998864332 2334567899999999 8999999999984 4
Q ss_pred cceEEEEEecccC-ChhHhhhhc---------------------------------------------------------
Q psy13250 144 LSSIFLVMEYCEH-DLASLQDNV--------------------------------------------------------- 165 (224)
Q Consensus 144 ~~~~~lv~e~~~~-~l~~~~~~~--------------------------------------------------------- 165 (224)
.+..|+|||||++ ++..++...
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 4578999999985 454444321
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 166 -----------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 166 -----------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~ 264 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 264 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceec
Confidence 124778889999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=203.84 Aligned_cols=139 Identities=29% Similarity=0.378 Sum_probs=114.3
Q ss_pred eeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcC---CCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKC---RHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 81 lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
||+|+||+||+|.+..++..+|+|++..... ........|..++... .||||+.+++.+. ....+|+||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~--~~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ--TDSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe--cCCeEEEEEcCC
Confidence 6999999999999999999999999864321 1122334566666554 6999999999984 445899999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.++.+.........+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 8654333333456799999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=196.73 Aligned_cols=146 Identities=34% Similarity=0.633 Sum_probs=127.3
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|++.+.||+|+||.||+|.+..++..+|+|.+..... .......+|+.+++.+.||||+++++++.. ....|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ--ESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee--CCeEEEEE
Confidence 48899999999999999999998999999998865432 233556789999999999999999999854 45899999
Q ss_pred ecccCChhHhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 152 EYCEHDLASLQDNVE--SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 152 e~~~~~l~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||+.+++........ ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++..
T Consensus 79 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 79 EFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARA 150 (285)
T ss_pred ecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceee
Confidence 999987766654432 5689999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=206.74 Aligned_cols=147 Identities=23% Similarity=0.328 Sum_probs=119.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC------CCCeeeeeEEEEcCCcc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR------HENIVQLKEVVVGKSLS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~~~~ 145 (224)
.++|++++.||+|+||+||+|.+..++..||||++.... ........|+.++..++ |.+++.+++++... ..
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-~~ 205 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-TG 205 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-Cc
Confidence 468999999999999999999999999999999985322 12233345666665554 45688888888543 35
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCC---------------
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKG--------------- 209 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~--------------- 209 (224)
.+|+|||++++++...+.. .+.+++..+..++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 206 ~~~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 206 HMCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred eEEEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 7899999998888776654 4679999999999999999999998 5999999999999998766
Q ss_pred -cEEEEecccccc
Q psy13250 210 -CVKIVYSTYLEL 221 (224)
Q Consensus 210 -~~kl~DfGla~~ 221 (224)
.+||+|||++..
T Consensus 285 ~~vkl~DfG~~~~ 297 (467)
T PTZ00284 285 CRVRICDLGGCCD 297 (467)
T ss_pred ceEEECCCCcccc
Confidence 499999998753
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=207.33 Aligned_cols=150 Identities=23% Similarity=0.290 Sum_probs=122.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEccC-----CeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQ-----DKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (224)
..++|++.+.||+|+||.||+|.+... +..||+|++..... .....+.+|+.+++.+ +|+||+++++.+. .
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~--~ 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT--H 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec--C
Confidence 456799999999999999999986443 35799998865432 2234567899999998 8999999999984 4
Q ss_pred cceEEEEEecccC-ChhHhhhhc---------------------------------------------------------
Q psy13250 144 LSSIFLVMEYCEH-DLASLQDNV--------------------------------------------------------- 165 (224)
Q Consensus 144 ~~~~~lv~e~~~~-~l~~~~~~~--------------------------------------------------------- 165 (224)
.+.+|+|||||.+ ++...+...
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 4589999999985 454443221
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 166 ------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 166 ------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..++++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~ 262 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI 262 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeec
Confidence 124788889999999999999999999999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=195.97 Aligned_cols=148 Identities=23% Similarity=0.302 Sum_probs=124.9
Q ss_pred ccceeEeeeeeccCceEEEEEEEc---cCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDS---VQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..+|++.+.||+|+||.||+|.+. ..+..+|+|.+..... .....+.+|+..+.+++||||+++++++. ..+..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT--RGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe--cCCCc
Confidence 457999999999999999999764 4567899998865432 22345678999999999999999999984 44589
Q ss_pred EEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 148 FLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|+||||++++ +..++......+++..++.++.|++.||+|||+++++||||||+|||++.++.++++|||++..
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 9999999875 4444444455789999999999999999999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=205.88 Aligned_cols=149 Identities=30% Similarity=0.487 Sum_probs=126.9
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC----cc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKS----LS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 145 (224)
.++|++++.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++|+||+++++++.... ..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 4579999999999999999999999999999998864322 22345678999999999999999998874321 24
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..|+++|++++++..... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 94 ~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 94 EVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 579999999877766553 346999999999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=194.79 Aligned_cols=148 Identities=34% Similarity=0.615 Sum_probs=129.4
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
++|++.+.||+|+||.||+|.+..++..+|+|++..... ...+.+.+|+.+++.+.|+|++++++.+.. ....|++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR--KRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee--CCEEEEE
Confidence 369999999999999999999998999999998864432 223456789999999999999999999853 4589999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||++++++.........+++..++.++.|++.||.|||+++++|+||||+||+++.++.++|+|||++..+
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07847 79 FEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL 150 (286)
T ss_pred EeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceec
Confidence 999998877766555567999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=202.67 Aligned_cols=139 Identities=20% Similarity=0.192 Sum_probs=110.5
Q ss_pred ccceeEeeeeeccCceEEEEEEEcc-CCeEEEEEEeecc-----CCccchhHHHHHHHhhcCCCCCeee-eeEEEEcCCc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSV-QDKILALKKLFLQ-----NNTLTRGELREVTGLTKCRHENIVQ-LKEVVVGKSL 144 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~~~~avK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~ 144 (224)
.++|.+.+.||+|+||+||+|.+.. ++..+|||++... .......+.+|+.+|+.++|+|++. ++..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~------ 90 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT------ 90 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc------
Confidence 3569999999999999999998875 6778899986522 1112345679999999999999985 4432
Q ss_pred ceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEccCCcEEEEecccccccc
Q psy13250 145 SSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDL-KPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 145 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDl-kp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
+..|+||||+.|+.+.... ... ...++.+++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 2579999999876544221 111 1467889999999999999999999 9999999999999999999998653
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=197.07 Aligned_cols=150 Identities=31% Similarity=0.490 Sum_probs=129.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||.||+|.+..++..+|+|.+..........+.+|+..++.++||||+++++.+.. .+..|++
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~--~~~~~lv 84 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR--RDKLWIC 84 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe--CCEEEEE
Confidence 34579999999999999999999999999999999876544444456789999999999999999999854 4589999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||++++.+..+....+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 999987544433344567999999999999999999999999999999999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=198.98 Aligned_cols=148 Identities=28% Similarity=0.404 Sum_probs=126.5
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
++|++.+.||+|+||.||++.+..++..+|+|.+..... .....+.+|+.+++.++||||+++++.+.. .+.+|++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS--DGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCEEEEEe
Confidence 369999999999999999999999999999998864422 233456789999999999999999999954 45899999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||++++.+..+......+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++...
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 150 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccc
Confidence 999875444333345678999999999999999999997 69999999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=210.08 Aligned_cols=152 Identities=26% Similarity=0.373 Sum_probs=126.7
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc----
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL---- 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---- 144 (224)
..++|.+.+.||+|+||+||+|.+..+++.||+|++..... .....+.+|+..+..+.|+||++++..+.....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 34689999999999999999999999999999999865432 223456789999999999999998877643221
Q ss_pred --ceEEEEEecccC-ChhHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccc
Q psy13250 145 --SSIFLVMEYCEH-DLASLQDN---VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTY 218 (224)
Q Consensus 145 --~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGl 218 (224)
..+++||||+.+ +|...+.. ....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 247899999986 45554433 234689999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q psy13250 219 LELY 222 (224)
Q Consensus 219 a~~~ 222 (224)
++.+
T Consensus 190 s~~~ 193 (496)
T PTZ00283 190 SKMY 193 (496)
T ss_pred Ceec
Confidence 9754
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=218.67 Aligned_cols=148 Identities=28% Similarity=0.363 Sum_probs=125.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+++.+|+.+++.++||||+++++++. ..+..|+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~--d~~~lyL 79 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS--DGDPVYY 79 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe--eCCEEEE
Confidence 579999999999999999999999999999999864322 22456788999999999999999999984 4458999
Q ss_pred EEecccCC-hhHhhhhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccc
Q psy13250 150 VMEYCEHD-LASLQDNV----------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTY 218 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~----------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGl 218 (224)
+|||++|+ +..++... ...++...+..++.|++.||+|||++||+||||||+|||++.+|.++|+|||+
T Consensus 80 VMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred EEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCc
Confidence 99999864 54444321 12355677889999999999999999999999999999999999999999999
Q ss_pred cccc
Q psy13250 219 LELY 222 (224)
Q Consensus 219 a~~~ 222 (224)
|+..
T Consensus 160 Ak~i 163 (932)
T PRK13184 160 AIFK 163 (932)
T ss_pred ceec
Confidence 9754
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=205.20 Aligned_cols=150 Identities=26% Similarity=0.328 Sum_probs=128.7
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccc-hhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLT-RGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~-~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
+.+...+.++||+|.||.|.+|... .+..||+|.++...+... ..+.+|+++|.+|+||||+.++++|..++ .+++
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De--Picm 612 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD--PLCM 612 (807)
T ss_pred chhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC--chHH
Confidence 3456788999999999999999865 368999999987665544 78899999999999999999999997554 7899
Q ss_pred EEeccc-CChhHhhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 150 VMEYCE-HDLASLQDNVESP-FTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 150 v~e~~~-~~l~~~~~~~~~~-l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
++|||+ |++.+++.....+ +......+|+.||+.|++||.+.+++||||.+.|+|++.++++||+|||.+|-++
T Consensus 613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence 999997 5677777665333 3566677899999999999999999999999999999999999999999999654
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=197.55 Aligned_cols=142 Identities=33% Similarity=0.631 Sum_probs=119.6
Q ss_pred eeeeccCceEEEEEEEcc--CCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccC
Q psy13250 79 NRIGEGSYGVVYRVRDSV--QDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH 156 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 156 (224)
.+||+|+||.||+|.... ++..+|+|.+... .......+|+.+++.++||||+++++++.......+|++|||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 579999999999999653 5688999987533 233456789999999999999999999876666689999999998
Q ss_pred ChhHhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----ccCCcEEEEeccccccc
Q psy13250 157 DLASLQDNV--------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL----NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 157 ~l~~~~~~~--------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill----~~~~~~kl~DfGla~~~ 222 (224)
++...+... ...+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 877665321 2248899999999999999999999999999999999999 45678999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=196.15 Aligned_cols=154 Identities=39% Similarity=0.697 Sum_probs=132.0
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC---
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKS--- 143 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 143 (224)
....++|++.+.||+|+||.||+|.+..++..+|+|.+..... .......+|+.++++++||||+++++++....
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 3456789999999999999999999999999999998864432 22334567999999999999999999875432
Q ss_pred ---cceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 144 ---LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 144 ---~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
....|+||||+.+++...+......+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||++.
T Consensus 88 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 88 NRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred cCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 23579999999988877776655578999999999999999999999999999999999999999999999999997
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
.+
T Consensus 168 ~~ 169 (310)
T cd07865 168 AF 169 (310)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-28 Score=197.92 Aligned_cols=149 Identities=36% Similarity=0.606 Sum_probs=129.4
Q ss_pred ceeEeeeeeccCceEEEEEEEcc--CCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSV--QDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~--~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
.|++.+.||+|+||.||+|.+.. ++..+|+|.+.... ........+|+.+++.++||||+++++++.......+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 38889999999999999999988 78999999987633 34456677899999999999999999999766446899
Q ss_pred EEEecccCChhHhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc----CCcEEEEeccccc
Q psy13250 149 LVMEYCEHDLASLQDNV----ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND----KGCVKIVYSTYLE 220 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~----~~~~kl~DfGla~ 220 (224)
+||||+++++..++... ...+++..+..++.|++.||.|||+++|+||||||+||+++. ++.+||+|||+++
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 99999998777655432 236899999999999999999999999999999999999999 9999999999987
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
.+
T Consensus 161 ~~ 162 (316)
T cd07842 161 LF 162 (316)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-28 Score=195.15 Aligned_cols=148 Identities=25% Similarity=0.411 Sum_probs=124.3
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHH-hhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTG-LTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
++|++.+.||+|+||.||++.+..+++.||+|++..... ........|+.. ++...||||+++++++.. .+.+|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~--~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR--EGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec--CCcEEEE
Confidence 369999999999999999999999999999998865432 223344556554 566789999999999853 4579999
Q ss_pred EecccCChhHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDN---VESPFTESQVKCVILQVLKGLNYLHSN-FIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+++++..++.. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.+
T Consensus 79 ~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 79 MEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999877665543 234689999999999999999999997 9999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=191.67 Aligned_cols=148 Identities=34% Similarity=0.552 Sum_probs=129.9
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
++|++.+.||.|+||.||+|.+..++..+++|.+..........+.+|+.+++.++||||+++++.+.. ...+|++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR--RDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe--CCEEEEEEe
Confidence 579999999999999999999988899999999876655555677889999999999999999999854 458999999
Q ss_pred cccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|++++ +..++......+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.++|+|||++..+
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 151 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQL 151 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhh
Confidence 99875 44444443467999999999999999999999999999999999999999999999999998653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=192.10 Aligned_cols=153 Identities=25% Similarity=0.430 Sum_probs=133.2
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~ 147 (224)
..+++.+.+..||.|+.|+|++++.+.++..+|||.+....+ +..+++++.+.++.+.+ .|.||+.+|+|..+. .+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~--dV 166 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT--DV 166 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc--hH
Confidence 345678888999999999999999999999999999976544 45677788888877765 899999999997544 68
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCcEEEEeccccccccC
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYLN 224 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 224 (224)
++.||.|..-...++.+..+++++..+-.+...++.||.||-. ++|||||+||+|||+|..|++||||||++-.+.|
T Consensus 167 ~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 167 FICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 8999999877777777778889999999999999999999985 5899999999999999999999999999977654
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=195.26 Aligned_cols=143 Identities=27% Similarity=0.406 Sum_probs=124.3
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
+|++.+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+.+++++.||||+++++.+... ...++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE--NRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC--CEEEEEEe
Confidence 58889999999999999999999999999998865422 2335577899999999999999999998543 47899999
Q ss_pred cccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|++++.+... ..+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++..+
T Consensus 80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~ 145 (279)
T cd06619 80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145 (279)
T ss_pred cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence 9998655433 34788999999999999999999999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-30 Score=226.99 Aligned_cols=147 Identities=29% Similarity=0.380 Sum_probs=128.4
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|.+++.||+|+||.|..++++.++++||+|++.... ......|..|-.+|.....+.|+.+...| .+..++
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF--QD~~~L 150 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF--QDERYL 150 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh--cCccce
Confidence 4578999999999999999999999999999999886522 22334456677788888999999999888 445599
Q ss_pred EEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 148 FLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
|+||||++| ++..++.+.. ++++..+++|+..|+.||+-||+.|+|||||||+|||||..|++||+|||.+-
T Consensus 151 YlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred EEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence 999999976 5777777655 89999999999999999999999999999999999999999999999999874
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=194.96 Aligned_cols=144 Identities=31% Similarity=0.560 Sum_probs=126.1
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccch--hHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTR--GELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
|++.+.||+|+||+||++.+..++..+|+|++......... ...+|+..++.++|+||+++++++.. ....+++||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD--DNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE--SSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc--ccccccccc
Confidence 78899999999999999999999999999999766543222 23568999999999999999999965 458899999
Q ss_pred cccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 153 YCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 153 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++.+ ++..++. ....+++..+..++.|++.||.+||+++|+|+||||+||+++.++.++|+|||++..
T Consensus 79 ~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~ 147 (260)
T PF00069_consen 79 YCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVK 147 (260)
T ss_dssp EETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEE
T ss_pred cccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9998 5655555 456789999999999999999999999999999999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-28 Score=195.55 Aligned_cols=147 Identities=35% Similarity=0.434 Sum_probs=127.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.||+|+||.||++.+..+++.+|+|++.... ......+.+|+.+++++.||||+++++.+. ....+|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~ 78 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ--DDSNLYL 78 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE--cCCeEEE
Confidence 36999999999999999999999899999999886432 123455678999999999999999999985 4458999
Q ss_pred EEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||+.+ ++...+.. ...+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.+||+|||+++..
T Consensus 79 v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~ 151 (290)
T cd05580 79 VMEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV 151 (290)
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCcccc
Confidence 9999965 45555443 467999999999999999999999999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-31 Score=201.93 Aligned_cols=155 Identities=35% Similarity=0.665 Sum_probs=135.7
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEc-----
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVG----- 141 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----- 141 (224)
+...+.|+.+.+||+|.||.||+|+.+.+++.||+|++...+ .......++|+.+|..+.|+|++.+.+.+..
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 445677999999999999999999999999999999775433 3456677999999999999999998777642
Q ss_pred -CCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 142 -KSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 142 -~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.....+|+||.+|+.++.-++......++..++..++.++..||.|+|++.|+|||+|++|+||+.+|.+||+|||+|+
T Consensus 93 ~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 1234599999999999998888877789999999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q psy13250 221 LYL 223 (224)
Q Consensus 221 ~~~ 223 (224)
.|.
T Consensus 173 ~fs 175 (376)
T KOG0669|consen 173 AFS 175 (376)
T ss_pred cee
Confidence 764
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-28 Score=191.97 Aligned_cols=148 Identities=26% Similarity=0.336 Sum_probs=126.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-----cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-----LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
.+|++.+.||+|+||.||++.+..++..+|+|.+...... ....+.+|+..++++.|+||+++++++.+.....+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4699999999999999999999999999999988643221 12355679999999999999999998865445678
Q ss_pred EEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 148 FLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|++|||++++ +...+. ....+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK-SYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 9999999864 544443 345689999999999999999999999999999999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-31 Score=199.35 Aligned_cols=149 Identities=28% Similarity=0.339 Sum_probs=125.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.+.|++.+.||+|.|+.|++|.+..+|+.+|+|.+.... ....+.+.+|+++-+.++||||+++.+.+ .+.+..||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti--~~~~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI--QEESFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh--cccceeEE
Confidence 356999999999999999999999999999999886432 22445677899999999999999999988 55568999
Q ss_pred EEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC---cEEEEecccccccc
Q psy13250 150 VMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG---CVKIVYSTYLELYL 223 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~---~~kl~DfGla~~~~ 223 (224)
|+|+|.|+ +...+.. +..+++..+..+++||+.||.|+|.++|+|||+||+|+|+..+. -+||+|||+|..+.
T Consensus 88 vFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 99999975 4333333 35688999999999999999999999999999999999997643 48999999998653
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-28 Score=195.55 Aligned_cols=147 Identities=38% Similarity=0.633 Sum_probs=127.3
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-----cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-----LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
+|++.+.||+|+||.||+|.+..++..+|+|.+...... ....+..|+..++.++|+||+++++++.. ...+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~ 78 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH--KSNIN 78 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec--CCEEE
Confidence 488889999999999999999988999999998654322 23445678999999999999999999954 45899
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+.+++..++......+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||+++.+
T Consensus 79 lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 79 LVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred EEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 99999966677666554347999999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=195.88 Aligned_cols=148 Identities=30% Similarity=0.498 Sum_probs=129.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++.+.||.|+||.||++.+..++..+|+|.+..........+.+|+.++++++|+||+++++.+.. ....|+||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY--ENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec--CCeEEEEe
Confidence 4579999999999999999999988899999999876544445667789999999999999999999853 45899999
Q ss_pred ecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 152 EYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 152 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||++++ +..++......+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++..
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~ 152 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAK 152 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchh
Confidence 999874 5555555456799999999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-28 Score=193.67 Aligned_cols=145 Identities=26% Similarity=0.313 Sum_probs=123.1
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
|+..+.||+|+||+||++.+..+++.+|+|.+..... .....+.+|+.+++.++|+||+.+++.+. ..+.+|++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~--~~~~~~lv~ 79 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE--TKDALCLVL 79 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe--cCCEEEEEE
Confidence 7788999999999999999999999999998864322 22234578999999999999999998884 345899999
Q ss_pred ecccCC-hhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 152 EYCEHD-LASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 152 e~~~~~-l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||+.++ +...+... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVK 151 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCccee
Confidence 999865 44343332 34699999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-28 Score=203.87 Aligned_cols=150 Identities=24% Similarity=0.275 Sum_probs=122.8
Q ss_pred cccceeEeeeeeccCceEEEEEEEccC-----CeEEEEEEeeccCCc-cchhHHHHHHHhhcCC-CCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQ-----DKILALKKLFLQNNT-LTRGELREVTGLTKCR-HENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 143 (224)
+.++|++.+.||+|+||.||+|.+... ...||+|++...... ..+.+.+|+.+++.+. ||||+++++++. .
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~--~ 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT--K 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc--c
Confidence 456799999999999999999986432 357999988644332 2356788999999996 999999999994 4
Q ss_pred cceEEEEEecccC-ChhHhhhhc---------------------------------------------------------
Q psy13250 144 LSSIFLVMEYCEH-DLASLQDNV--------------------------------------------------------- 165 (224)
Q Consensus 144 ~~~~~lv~e~~~~-~l~~~~~~~--------------------------------------------------------- 165 (224)
.+.+|||||||.+ +|..++...
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 5589999999986 444433221
Q ss_pred --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc
Q psy13250 166 --------------------------------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND 207 (224)
Q Consensus 166 --------------------------------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~ 207 (224)
...+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 124778888999999999999999999999999999999999
Q ss_pred CCcEEEEeccccccc
Q psy13250 208 KGCVKIVYSTYLELY 222 (224)
Q Consensus 208 ~~~~kl~DfGla~~~ 222 (224)
++.+||+|||+++.+
T Consensus 273 ~~~~kL~DfGla~~~ 287 (400)
T cd05105 273 GKIVKICDFGLARDI 287 (400)
T ss_pred CCEEEEEeCCcceec
Confidence 999999999999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-28 Score=190.40 Aligned_cols=147 Identities=23% Similarity=0.336 Sum_probs=124.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++.+.||+|+||.||++.... +..+|+|.+.... .....+.+|+..++.++||||+++++++. .....|++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~iv~ 78 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT--QQKPLYIVT 78 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEc--cCCCEEEEE
Confidence 4579999999999999999998764 4578999875332 23456778999999999999999999984 445799999
Q ss_pred ecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+.+ ++...+......+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~ 150 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCcccc
Confidence 99985 465555544456899999999999999999999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-29 Score=208.45 Aligned_cols=148 Identities=25% Similarity=0.350 Sum_probs=125.6
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.-|..++.||-|+||.|.+++...|...||+|.+....- ........|-.+|....++.||+||..| .+.+++|+
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF--QDkdnLYF 706 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF--QDKDNLYF 706 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe--ccCCceEE
Confidence 358889999999999999999999999999998754321 1222334567788888999999999999 45569999
Q ss_pred EEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 150 VMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
||+|+.| ++..++.+ -+.|.+..+++|+.++..|+++.|..|+|||||||+|||||.+|++||.||||+.=|-
T Consensus 707 VMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence 9999986 56666655 5679999999999999999999999999999999999999999999999999986543
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=193.05 Aligned_cols=148 Identities=27% Similarity=0.398 Sum_probs=126.5
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc--------cchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--------LTRGELREVTGLTKC-RHENIVQLKEVVVGKS 143 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (224)
..|.-.+.||+|..++|.+|.++.++..+|+|++...... ..+...+|+.+|+++ .||+|+.+.+++ +.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--es 94 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--ES 94 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--cC
Confidence 4577788999999999999999999999999998753321 123346788899885 799999999999 55
Q ss_pred cceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 144 LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 144 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
...+++|+|.|..+-+..+......+++...+.+++|++.|++|||.++|+||||||+|||++++.++||+|||+|+.+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 6689999999986544444455678999999999999999999999999999999999999999999999999999864
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=194.94 Aligned_cols=148 Identities=26% Similarity=0.440 Sum_probs=129.1
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.+.|++++.||.|+||.||++.+..++..+++|.+..........+.+|+..++.+.|+||+++++.+.. .+..|+||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 88 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW--DGKLWIMI 88 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe--CCeEEEEE
Confidence 3569999999999999999999999999999999876554455667789999999999999999999854 34899999
Q ss_pred ecccCChhH-hhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 152 EYCEHDLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 152 e~~~~~l~~-~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||++++.+. .+......+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++..
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 999876443 4444456789999999999999999999999999999999999999999999999998864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=191.49 Aligned_cols=146 Identities=27% Similarity=0.337 Sum_probs=119.1
Q ss_pred cccceeEe-eeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEc--CCcce
Q psy13250 71 NVAEFEKL-NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVG--KSLSS 146 (224)
Q Consensus 71 ~~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~--~~~~~ 146 (224)
-.++|++. +.||-|-.|.|..|.++.+++.+|+|++. ......+|+++.-.. .|||||.++++|.+ ....+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34567664 56999999999999999999999999873 234456777765444 69999999998843 23457
Q ss_pred EEEEEecccCC-hhHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc---CCcEEEEecccccc
Q psy13250 147 IFLVMEYCEHD-LASLQDN-VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND---KGCVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~~~-l~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~---~~~~kl~DfGla~~ 221 (224)
+.+|||+|+|+ |++.+.. ....|++.++..|+.||+.|+.|||+.+|.||||||+|+|... +..+||+|||||+.
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 88999999975 5444433 3446999999999999999999999999999999999999975 44689999999985
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-28 Score=194.59 Aligned_cols=149 Identities=27% Similarity=0.420 Sum_probs=128.7
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
....+|++.+.||+|+||.||++.+..++..+|+|.+..........+.+|+.+++.++|+||+++++.+.. ....|+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~l 93 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 93 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEE
Confidence 345789999999999999999999988999999999876554445566789999999999999999999853 458999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||||++++.+..+.. ...+++..+..++.|++.||.|||+.+++||||||+|||++.++.++|+|||++..
T Consensus 94 v~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 94 VMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred eecccCCCCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceE
Confidence 999998754443333 34588999999999999999999999999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-28 Score=215.83 Aligned_cols=153 Identities=24% Similarity=0.425 Sum_probs=128.7
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
...++|++++.||+|+||+||+|.+..++..+|+|.+..... .....+..|+.+++.+.||||++++++|.......+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 356789999999999999999999999999999998865422 234556789999999999999999999876666789
Q ss_pred EEEEecccC-ChhHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceecCCCCCcEEEcc---------
Q psy13250 148 FLVMEYCEH-DLASLQDNV---ESPFTESQVKCVILQVLKGLNYLHSN-------FIIHRDLKPSNLLLND--------- 207 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~-------~iiHrDlkp~Nill~~--------- 207 (224)
||||||+.+ +|..++... ...+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999986 565555432 35699999999999999999999984 4999999999999964
Q ss_pred --------CCcEEEEeccccccc
Q psy13250 208 --------KGCVKIVYSTYLELY 222 (224)
Q Consensus 208 --------~~~~kl~DfGla~~~ 222 (224)
.+.+||+|||+++.+
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l 192 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNI 192 (1021)
T ss_pred ccccccCCCCceEEccCCccccc
Confidence 345899999998754
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.4e-28 Score=192.26 Aligned_cols=140 Identities=29% Similarity=0.270 Sum_probs=117.1
Q ss_pred eeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccCC
Q psy13250 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHD 157 (224)
Q Consensus 81 lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 157 (224)
||+|+||.||++....+++.+|+|++..... ........|+.++++++||||+++++.+. .....|+||||+.++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~--~~~~~~lv~e~~~g~ 78 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE--SKTHLCLVMSLMNGG 78 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe--cCCeEEEEEecCCCC
Confidence 6999999999999999999999998864221 12334456899999999999999999884 445899999999864
Q ss_pred -hhHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 158 -LASLQDN-VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 158 -l~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+...+.. ....+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|||++..+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~ 145 (277)
T cd05607 79 DLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL 145 (277)
T ss_pred CHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeec
Confidence 4444433 2335889999999999999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-28 Score=192.55 Aligned_cols=149 Identities=25% Similarity=0.338 Sum_probs=125.5
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCC---eEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQD---KILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~---~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..+|++.+.||+|+||.||+|.+..++ ..+|+|.+..... .....+.+|+..++.++||||+++++++. ..+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCcc
Confidence 357999999999999999999876443 4799998764322 23456678999999999999999999984 34579
Q ss_pred EEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|++|||+++ ++...+......+++..+..++.|++.||.|||+++++||||||+|||++.++.++|+|||+++.+
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999986 465565554567899999999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=189.92 Aligned_cols=146 Identities=27% Similarity=0.385 Sum_probs=125.2
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-----cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-----LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
++|++.+.||+|+||.||+|.+..++..+|+|.+...... ....+.+|+.++++++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 79 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD--DETL 79 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc--CCeE
Confidence 4689999999999999999999889999999988643221 12346679999999999999999999954 4589
Q ss_pred EEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 148 FLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|+++||+.++ +...+. ....+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.++|+|||+++.
T Consensus 80 ~~v~e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 80 SIFMEYMPGGSVKDQLK-AYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEEEECCCCcHHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 9999999865 444443 355689999999999999999999999999999999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=193.81 Aligned_cols=149 Identities=26% Similarity=0.318 Sum_probs=125.8
Q ss_pred ceeEeeeeeccCceEEEEEEE----ccCCeEEEEEEeeccC-CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRD----SVQDKILALKKLFLQN-NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~----~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
.|++++.||+|+||.||+|.. ..++..+|+|.+.... ......+.+|+.+++.+.|+||+++++++........|
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478999999999999999974 4567899999886443 23345677899999999999999999988655456789
Q ss_pred EEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+++ ++..++......+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.+
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999976 455555444446899999999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=192.15 Aligned_cols=147 Identities=39% Similarity=0.662 Sum_probs=129.8
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|++.+.||+|+||.||+|.+..++..+|+|++.... ......+.+|+.+++.++|+||+++++++.. ....|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH--GSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec--CCeeEEEe
Confidence 4889999999999999999998899999999987543 2234567789999999999999999999854 45899999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+.+++...+......+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++..+
T Consensus 79 e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~ 149 (286)
T cd07832 79 EYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLF 149 (286)
T ss_pred cccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence 99966777776665677999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-28 Score=193.04 Aligned_cols=146 Identities=29% Similarity=0.506 Sum_probs=126.6
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
|++.+.||+|+||.||++.+..++..+++|.+..........+.+|+.+++.+.|+||+++++.+.. ....|+||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee--CCEEEEEEEec
Confidence 6888999999999999999999999999998865444445567789999999999999999999854 45889999999
Q ss_pred cCChhH-hhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 155 EHDLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 155 ~~~l~~-~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.++.+. .+.....++++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++...
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccc
Confidence 875444 44444567999999999999999999999999999999999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-27 Score=191.59 Aligned_cols=146 Identities=34% Similarity=0.627 Sum_probs=128.2
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
+|++.+.||.|++|.||+|.+..++..+|+|++...... ....+.+|+.+++.++|+||+++++.+.. .+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT--ENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee--CCcEEEEEe
Confidence 489999999999999999999999999999998765432 34456789999999999999999999954 357899999
Q ss_pred cccCChhHhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 153 YCEHDLASLQDNVE--SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 153 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|+++++..++.... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~ 149 (284)
T cd07836 79 YMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARA 149 (284)
T ss_pred cCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence 99988777665433 4689999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=215.75 Aligned_cols=149 Identities=28% Similarity=0.450 Sum_probs=132.9
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.+.+.|.++..||.|+||+||+|..+.++...|.|++..........++-||.+|..|.||+||++++.|+.++ .+||
T Consensus 29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en--kLwi 106 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN--KLWI 106 (1187)
T ss_pred CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC--ceEE
Confidence 34456899999999999999999999999889999987776667778888999999999999999999886544 8999
Q ss_pred EEecccCCh-hHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 150 VMEYCEHDL-ASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 150 v~e~~~~~l-~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
+.|||+|+- ..++......+++..+..+++|++.||.|||+++|||||||..|||+.-+|.++|+|||.+-
T Consensus 107 liEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred EEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccc
Confidence 999999864 44555667889999999999999999999999999999999999999999999999999873
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-28 Score=189.80 Aligned_cols=141 Identities=27% Similarity=0.364 Sum_probs=120.5
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccC-
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH- 156 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 156 (224)
+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+.+++.+.|+||+++++++.. ....|+||||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ--KQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCeEEEEeeccCC
Confidence 368999999999999998999999998753322 234567889999999999999999999854 4579999999976
Q ss_pred ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 157 DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 157 ~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++...+......+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 143 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSRE 143 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcc
Confidence 45555544445689999999999999999999999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-27 Score=191.79 Aligned_cols=145 Identities=26% Similarity=0.314 Sum_probs=123.0
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc---cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT---LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
|+..+.||+|+||.||++.+..+++.+|+|.+...... ....+.+|+.+++.++|+||+.+++.+.. .+.+|+||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~--~~~~~lv~ 79 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET--KDALCLVL 79 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec--CCEEEEEE
Confidence 77889999999999999999999999999988643221 12345679999999999999999998843 45899999
Q ss_pred ecccCC-hhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 152 EYCEHD-LASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 152 e~~~~~-l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||+.++ +...+... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++..
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVH 151 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceee
Confidence 999864 54444332 33589999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-28 Score=194.15 Aligned_cols=152 Identities=41% Similarity=0.677 Sum_probs=131.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC-----
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKS----- 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 143 (224)
..++|++.+.||+|+||.||+|.+..++..+|+|.+..... .......+|+..++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 45689999999999999999999998899999999875432 23345568999999999999999999885432
Q ss_pred ---cceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 144 ---LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 144 ---~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.+.+|+++||+++++...+......+++..+..++.|++.||.|||+.+|+|+||||+||+++.++.+||+|||++.
T Consensus 85 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~ 164 (302)
T cd07864 85 KKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR 164 (302)
T ss_pred cccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence 23789999999988777766555578999999999999999999999999999999999999999999999999987
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
.+
T Consensus 165 ~~ 166 (302)
T cd07864 165 LY 166 (302)
T ss_pred cc
Confidence 54
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-27 Score=190.57 Aligned_cols=149 Identities=24% Similarity=0.328 Sum_probs=126.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccC---CeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQ---DKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
.++|++.+.||+|+||.||+|.+... ...+|+|.+..... .....+.+|+.+++.++|+||+++++.+. ..+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT--KSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe--cCCce
Confidence 35799999999999999999987643 46799998764432 23345678999999999999999999884 34578
Q ss_pred EEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|++|||+.+ ++..++....+.+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||+++.+
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999986 455555554557899999999999999999999999999999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-27 Score=193.68 Aligned_cols=146 Identities=29% Similarity=0.401 Sum_probs=125.6
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.||+|+||.||++.+..+++.+++|.+..... .....+.+|+.+++.++||||+++++.+. ..+.+|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~l 78 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE--TKRHLCM 78 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe--cCCEEEE
Confidence 368999999999999999999999999999998865432 22345568899999999999999999884 4458999
Q ss_pred EEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 150 VMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||||+.++ +..++ ...+.+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.
T Consensus 79 v~e~~~g~~L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 79 VMEYVEGGDCATLL-KNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred EEecCCCCcHHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999875 44444 3356789999999999999999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=199.41 Aligned_cols=151 Identities=24% Similarity=0.358 Sum_probs=122.4
Q ss_pred cccceeEeeeeeccCceEEEEEEE-----ccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRD-----SVQDKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (224)
..++|++.+.||+|+||.||+|.+ ..+++.||||.+..... .....+.+|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 456899999999999999999984 34578899999865332 2234567899999999 689999999987543
Q ss_pred cceEEEEEecccCC-hhHhhhhc---------------------------------------------------------
Q psy13250 144 LSSIFLVMEYCEHD-LASLQDNV--------------------------------------------------------- 165 (224)
Q Consensus 144 ~~~~~lv~e~~~~~-l~~~~~~~--------------------------------------------------------- 165 (224)
...++++|||++++ +..++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 34789999999864 44443321
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 166 ---------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 166 ---------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~ 229 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEeccccccc
Confidence 123677888899999999999999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=189.62 Aligned_cols=148 Identities=24% Similarity=0.398 Sum_probs=125.8
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+..++.++||||+++++.+.. .+..|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE--DNELNI 79 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE--CCeEEE
Confidence 579999999999999999999999999999998764322 223456789999999999999999999854 358899
Q ss_pred EEecccC-ChhHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDN---VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||+++ ++..++.. ....+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++..+
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 80 VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 9999986 45444432 2345889999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=192.27 Aligned_cols=150 Identities=24% Similarity=0.350 Sum_probs=123.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEc----cCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS----VQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
..++|++.+.||+|+||+||+|... ..+..+|+|.+..... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ--EQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec--CC
Confidence 3467999999999999999999853 3557899998864332 223456789999999999999999999843 45
Q ss_pred eEEEEEecccC-ChhHhhhhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC
Q psy13250 146 SIFLVMEYCEH-DLASLQDNV----------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK 208 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~----------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~ 208 (224)
..|++|||+.+ ++..++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 78999999986 454444211 1247888899999999999999999999999999999999999
Q ss_pred CcEEEEeccccccc
Q psy13250 209 GCVKIVYSTYLELY 222 (224)
Q Consensus 209 ~~~kl~DfGla~~~ 222 (224)
+.+||+|||+++..
T Consensus 161 ~~~kl~dfg~~~~~ 174 (283)
T cd05090 161 LHVKISDLGLSREI 174 (283)
T ss_pred CcEEeccccccccc
Confidence 99999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=193.13 Aligned_cols=148 Identities=32% Similarity=0.608 Sum_probs=128.2
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc--cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
++|++.+.||+|+||.||+|.+..+++.+|+|++...... ..+.+.+|+.+++.++||||+++++++. .....|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR--RKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc--cCCeEEEE
Confidence 3689999999999999999999888999999987543222 2345678999999999999999999984 45689999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.++...........+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 79 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07846 79 FEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 150 (286)
T ss_pred EecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence 999998766655554556899999999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=208.88 Aligned_cols=149 Identities=19% Similarity=0.324 Sum_probs=115.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCe-EEEEEEee-----------------ccCCccchhHHHHHHHhhcCCCCCee
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDK-ILALKKLF-----------------LQNNTLTRGELREVTGLTKCRHENIV 133 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~-~~avK~~~-----------------~~~~~~~~~~~~e~~~l~~l~h~niv 133 (224)
.++|++++.||+|+||+||+|..+.... ..+.|.+. .........+.+|+.+|+.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987643321 11211110 00111233456899999999999999
Q ss_pred eeeEEEEcCCcceEEEEEecccCChhHhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC
Q psy13250 134 QLKEVVVGKSLSSIFLVMEYCEHDLASLQDNV----ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG 209 (224)
Q Consensus 134 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~ 209 (224)
++++++.. .+..|+++|++.+++...+... ........++.++.|++.||.|||+++|+||||||+|||++.++
T Consensus 227 ~l~~~~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRS--EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEE--CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999854 4578999999988776655432 12234667888999999999999999999999999999999999
Q ss_pred cEEEEeccccccc
Q psy13250 210 CVKIVYSTYLELY 222 (224)
Q Consensus 210 ~~kl~DfGla~~~ 222 (224)
.+||+|||+|+.+
T Consensus 305 ~vkL~DFGla~~~ 317 (501)
T PHA03210 305 KIVLGDFGTAMPF 317 (501)
T ss_pred CEEEEeCCCceec
Confidence 9999999999754
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=191.62 Aligned_cols=148 Identities=22% Similarity=0.290 Sum_probs=124.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCe----EEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDK----ILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~----~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..+|++.+.||+|+||+||+|.+..++. .||+|.+..... .....+.+|+..++.+.|+||+.+++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---ST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC---CC
Confidence 4579999999999999999999776665 489998764332 234556788999999999999999998853 25
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.++++||+++ ++..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 7899999975 566665554567999999999999999999999999999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=191.53 Aligned_cols=146 Identities=29% Similarity=0.377 Sum_probs=122.4
Q ss_pred eeEeeeeeccCceEEEEEE----EccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVR----DSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~----~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
|++.+.||+|+||+||++. ...++..+|+|.+..... .....+.+|+..++.++||||+++++++.......+|+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 3899999999999998765 334678899998865432 23456678999999999999999999886555557899
Q ss_pred EEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||+.++ +..++.. ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||+++.+
T Consensus 86 v~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999865 4444433 35899999999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-29 Score=193.50 Aligned_cols=149 Identities=26% Similarity=0.391 Sum_probs=124.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHH-hhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTG-LTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.++.+.+..||.|+||+|++-.++.+|+.+|||++...+. ...+++++|... ++.-..||||+|||.... .+..||
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~--EGdcWi 140 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS--EGDCWI 140 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc--CCceee
Confidence 3567778899999999999999999999999999987665 334556677765 455578999999999854 447899
Q ss_pred EEecccCChhHhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHDLASLQDN----VESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~l~~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.||+|+-++..++.. ....+++..+..+....+.||.||-. ..|||||+||+|||++..|.+||||||.+-.+
T Consensus 141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL 218 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQL 218 (361)
T ss_pred eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhH
Confidence 999999877666543 35579999999999999999999985 57999999999999999999999999998654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=191.79 Aligned_cols=141 Identities=16% Similarity=0.207 Sum_probs=119.1
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccCCcc---chhHHHHHHHhhcCCCCCeeeeeEEEEc--CCcceEEEEEec
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTL---TRGELREVTGLTKCRHENIVQLKEVVVG--KSLSSIFLVMEY 153 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~~~lv~e~ 153 (224)
..||+|++|.||+|.. +++.||+|.+....... .+.+.+|+.+|.+++||||+++++++.+ +....+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999986 68899999886543322 3455699999999999999999999865 444578999999
Q ss_pred ccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 154 CEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 154 ~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+.++.+..+......+++.....++.+++.||.|||+ .+++||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~ 172 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKI 172 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhh
Confidence 9976444333445678999999999999999999998 4999999999999999999999999999875
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=193.53 Aligned_cols=152 Identities=38% Similarity=0.730 Sum_probs=131.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc--cchhHHHHHHHhhcCCCCCeeeeeEEEEcCC-----
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENIVQLKEVVVGKS----- 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----- 143 (224)
..++|++.+.||+|+||.||+|.+..++..+|+|++...... ......+|+..++.++|+||+++++.+....
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 467899999999999999999999999999999988654322 2345678999999999999999998875432
Q ss_pred -cceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 144 -LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 144 -~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
...+|++|||+.+++...+......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||+++.+
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 2358999999998877776665567999999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=187.83 Aligned_cols=147 Identities=28% Similarity=0.373 Sum_probs=124.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++.+.||+|+||.||++.+.. +..+|+|.+.... .....+.+|+..+++++||||+++++++. .....|++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 78 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT--KQRPIYIVT 78 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEc--cCCCcEEEE
Confidence 4579999999999999999998753 4469999876332 22356788999999999999999999984 445789999
Q ss_pred ecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+.++ +...+......+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||+++..
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~ 150 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV 150 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceec
Confidence 999764 55555444456899999999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=194.24 Aligned_cols=148 Identities=25% Similarity=0.357 Sum_probs=121.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeE--EEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKI--LALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~--~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (224)
.+++|++.+.||+|+||.||+|.+..++.. +|+|.+..... .....+.+|+.++.++ +|+||+++++++. ..+.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~--~~~~ 82 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGY 82 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC--CCCC
Confidence 356899999999999999999998776654 57776543221 2334567899999998 8999999999984 4457
Q ss_pred EEEEEecccC-ChhHhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc
Q psy13250 147 IFLVMEYCEH-DLASLQDNV---------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC 210 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 210 (224)
+|++|||+.+ ++..++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 9999999975 555555432 125789999999999999999999999999999999999999999
Q ss_pred EEEEeccccc
Q psy13250 211 VKIVYSTYLE 220 (224)
Q Consensus 211 ~kl~DfGla~ 220 (224)
+||+|||+++
T Consensus 163 ~kl~dfg~~~ 172 (303)
T cd05088 163 AKIADFGLSR 172 (303)
T ss_pred EEeCccccCc
Confidence 9999999985
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=191.94 Aligned_cols=148 Identities=27% Similarity=0.456 Sum_probs=128.5
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
....+|++.+.||+|+||.||++.+..++..+|+|.+..........+.+|+.+++.+.|+||+++++.+.. ....|+
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~--~~~~~l 94 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 94 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe--CCEEEE
Confidence 345689999999999999999999988999999998876554445667789999999999999999999854 448999
Q ss_pred EEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 150 VMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||||+.++ +..++. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.
T Consensus 95 v~e~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~ 165 (296)
T cd06654 95 VMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (296)
T ss_pred eecccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchh
Confidence 99999865 444443 34689999999999999999999999999999999999999999999999998864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=190.01 Aligned_cols=149 Identities=26% Similarity=0.370 Sum_probs=126.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCe---EEEEEEeeccC-CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDK---ILALKKLFLQN-NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~---~~avK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..+|++.+.||+|+||.||+|.+..++. .+|+|.+.... ......+..|+..++.+.||||+++++.+. .....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~--~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT--KSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC--CCCce
Confidence 4569999999999999999999876554 69999886432 223456778999999999999999999984 44578
Q ss_pred EEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
++||||+.++ +..++....+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++.+
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 9999999864 55555554567899999999999999999999999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=178.50 Aligned_cols=151 Identities=24% Similarity=0.401 Sum_probs=126.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhc-CCCCCeeeeeEEEEcCCcceEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTK-CRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.++..-+..||+|+||.|-+.++..+|..+|+|.+...-+ ...++.++|+.+..+ ...|.+|.|||... ..+.+||
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~--regdvwI 122 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF--REGDVWI 122 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh--ccccEEE
Confidence 3456667889999999999999999999999999976544 334556778876555 46899999999884 3458999
Q ss_pred EEecccCChhHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEccCCcEEEEeccccccccC
Q psy13250 150 VMEYCEHDLASLQDN---VESPFTESQVKCVILQVLKGLNYLHSN-FIIHRDLKPSNLLLNDKGCVKIVYSTYLELYLN 224 (224)
Q Consensus 150 v~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~~ 224 (224)
.||.|+.++..++.. ..+.+++..+-+|+..+..||.|||++ .+||||+||+|||++.+|++|+||||.+-.+.|
T Consensus 123 cME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 123 CMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred eHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 999999877666543 466799999999999999999999975 799999999999999999999999999876543
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=189.25 Aligned_cols=147 Identities=27% Similarity=0.386 Sum_probs=125.7
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-----ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-----TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
+|+..+.||+|+||.||++.+..++..+|+|++..... .....+.+|+.+++.++|+||+++++.+.......++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 68899999999999999999999999999998864321 1223456799999999999999999988655556889
Q ss_pred EEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 149 LVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 149 lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++|||+.++ +...+.. ...+++.....++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.
T Consensus 83 l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 83 IFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 999999864 5544443 45689999999999999999999999999999999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=188.95 Aligned_cols=147 Identities=25% Similarity=0.293 Sum_probs=124.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
..+|++.+.||+|+||.||++.+. ++..+|+|.+.... .....+.+|+..++.++|+||+++++++. ..+..|++|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~ 78 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT--KQRPIFIVT 78 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEc--CCCceEEEE
Confidence 346889999999999999999876 46678999875322 23345678999999999999999999884 445799999
Q ss_pred ecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+++ ++.+++......+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~ 150 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV 150 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceec
Confidence 99976 466565554557899999999999999999999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=198.68 Aligned_cols=151 Identities=23% Similarity=0.336 Sum_probs=122.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEcc-----CCeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSV-----QDKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (224)
+.++|++.+.||+|+||.||+|.... +++.||+|++..... .....+.+|+.++.++ +|+||+++++.+...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 45689999999999999999997433 457899998864332 2234567899999998 899999999987533
Q ss_pred cceEEEEEecccCC-hhHhhhhc---------------------------------------------------------
Q psy13250 144 LSSIFLVMEYCEHD-LASLQDNV--------------------------------------------------------- 165 (224)
Q Consensus 144 ~~~~~lv~e~~~~~-l~~~~~~~--------------------------------------------------------- 165 (224)
...++++|||+.++ +...+...
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 35789999999864 44443221
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 166 ---ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 166 ---~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
...+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||+|+.+
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~ 223 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 223 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhc
Confidence 125789999999999999999999999999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=188.51 Aligned_cols=148 Identities=26% Similarity=0.365 Sum_probs=126.5
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC-----CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN-----NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
.+|.+.+.||+|+||.||++.+..++..+|+|.+.... ......+.+|+..+++++|+||+++++.+.......+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 36999999999999999999999999999999875321 1223456789999999999999999999866555678
Q ss_pred EEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 148 FLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+++|||+.++ +...+. ....+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK-AYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccc
Confidence 9999999865 444443 345689999999999999999999999999999999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=193.05 Aligned_cols=149 Identities=32% Similarity=0.520 Sum_probs=130.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
....|++.+.||+|+||.||++.+..++..+|+|++..... .....+.+|+.+++.++||||+++.+++.. .+..
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~--~~~~ 90 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR--EHTA 90 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe--CCeE
Confidence 34569999999999999999999988899999998864332 223456789999999999999999999854 3478
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|+||||+.+++..++......+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.++|+|||++..
T Consensus 91 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 91 WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred EEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCccee
Confidence 99999999888777665566799999999999999999999999999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=191.15 Aligned_cols=149 Identities=26% Similarity=0.422 Sum_probs=129.3
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
....+|++.+.||.|+||.||++.+..++..+++|.+..........+.+|+..++.++|+||+.+++.+.. ...+|+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 93 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV--GDELFV 93 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec--CceEEE
Confidence 345679999999999999999999999999999998876554445667789999999999999999999853 458999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|+||+.++.+..... ...+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++..
T Consensus 94 v~e~~~~~~L~~~~~-~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~ 164 (296)
T cd06655 94 VMEYLAGGSLTDVVT-ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ 164 (296)
T ss_pred EEEecCCCcHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchh
Confidence 999998754443333 34689999999999999999999999999999999999999999999999998864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=191.85 Aligned_cols=149 Identities=28% Similarity=0.356 Sum_probs=124.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEc-----cCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDS-----VQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..+|.+.+.||+|+||.||++... .++..+|+|.+..........+.+|+.+++++.|+||+++++++. ..+.
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 81 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV--EGDP 81 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe--cCCc
Confidence 467999999999999999999752 345678999886544444556788999999999999999999985 3458
Q ss_pred EEEEEecccC-ChhHhhhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEE
Q psy13250 147 IFLVMEYCEH-DLASLQDNVE------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl 213 (224)
.|++|||+.+ ++..++.... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 9999999985 4554443221 24899999999999999999999999999999999999999999999
Q ss_pred Eeccccccc
Q psy13250 214 VYSTYLELY 222 (224)
Q Consensus 214 ~DfGla~~~ 222 (224)
+|||+++..
T Consensus 162 ~dfg~~~~~ 170 (288)
T cd05093 162 GDFGMSRDV 170 (288)
T ss_pred ccCCccccc
Confidence 999998743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-29 Score=203.17 Aligned_cols=149 Identities=30% Similarity=0.472 Sum_probs=130.8
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCcc-chhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTL-TRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
..|..++.||+|+||.||+|.+..+++.||+|++.+..... ...+.+|+.++..++++||.++|+.++... .+|++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~--~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT--KLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc--cHHHHH
Confidence 35888899999999999999999999999999998765543 456678999999999999999999997554 899999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
|||.|+....+......+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.|-.+.
T Consensus 91 ey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred HHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee
Confidence 999987555555556667899999999999999999999999999999999999999999999999986543
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=189.43 Aligned_cols=147 Identities=30% Similarity=0.464 Sum_probs=126.7
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
|++.+.||+|+||.||++.+..++..+|+|++..... .......+|+..+.++. |+|++++++++.+...+.+|+|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 6788999999999999999998999999998864322 22234457888888885 999999999997654468999999
Q ss_pred cccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+.+++...+......+++..+..++.|++.||.|||+++++||||+|+||+++. +.+||+|||+++.+
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~ 149 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGI 149 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccc
Confidence 9998888777665567899999999999999999999999999999999999999 99999999999754
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=196.83 Aligned_cols=148 Identities=29% Similarity=0.453 Sum_probs=126.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC----cc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKS----LS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 145 (224)
.++|++.+.||+|+||.||+|.+..++..+|+|.+.... ........+|+.+++.++|+||+++++++.... ..
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 467999999999999999999999999999999875322 223345678999999999999999999875322 23
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..|+||||+.+++...+.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 95 ~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 95 DVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred cEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 5799999999877766543 2889999999999999999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=188.23 Aligned_cols=149 Identities=21% Similarity=0.307 Sum_probs=126.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
...+|.+.+.||+|+||.||+|.+..++..+|+|.+... ......+.+|+..++.+.|+||+++++++. ..+.++++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 80 (263)
T cd05052 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYII 80 (263)
T ss_pred chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEc--CCCCcEEE
Confidence 345799999999999999999999989999999987533 223456778999999999999999999984 34578999
Q ss_pred EecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+++ ++...+... ...+++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||+++..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~ 154 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 154 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccc
Confidence 999975 455554432 345899999999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=189.14 Aligned_cols=148 Identities=47% Similarity=0.778 Sum_probs=130.4
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
|++.+.||.|+||.||+|.+..++..+|+|.+.... ......+.+|+.+++.+.|+|++++++++.....+..|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999999889999999997653 233456778999999999999999999986543368999999
Q ss_pred cccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+++++..++......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPY 150 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeec
Confidence 9998877777665467999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=190.78 Aligned_cols=147 Identities=36% Similarity=0.610 Sum_probs=130.0
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|++.+.||+|+||.||+|.+..++..+|+|++.... ......+.+|+..++.+.|+||+++++.+.. .+..|++|
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~ 79 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR--KGRLYLVF 79 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE--CCEEEEEE
Confidence 6999999999999999999999899999999876432 2334567889999999999999999999954 45899999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+++++...+......+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++..+
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~ 150 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARAL 150 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence 99998877766655667999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=185.78 Aligned_cols=147 Identities=29% Similarity=0.454 Sum_probs=126.1
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
+|++.+.||+|+||.||++.+..++..+|+|.+..... ...+...+|+.+++.++|+||+++++.+. ..+.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE--ADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE--ECCEEEEEEe
Confidence 48899999999999999999999999999998864332 23455678899999999999999999985 4458999999
Q ss_pred cccC-ChhHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEH-DLASLQDN-VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~-~l~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+++ ++...+.. ....+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||+++.+
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 150 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceee
Confidence 9986 45555443 2345899999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-29 Score=193.26 Aligned_cols=143 Identities=29% Similarity=0.395 Sum_probs=124.3
Q ss_pred eeEe-eeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 75 FEKL-NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 75 ~~~~-~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
|++. +.||+|+|+.|--|....++..||||++..+......+.++|+.++..|+ |+||+.++++|. +...+|||||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE--dd~~FYLVfE 156 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE--DDTRFYLVFE 156 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc--ccceEEEEEe
Confidence 4443 56999999999999999999999999998887677788899999999985 999999999994 4558999999
Q ss_pred cccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc---EEEEeccccc
Q psy13250 153 YCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC---VKIVYSTYLE 220 (224)
Q Consensus 153 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~---~kl~DfGla~ 220 (224)
-|.|+ +++.+.. +..|++.++.+++.+|+.||+|||.+||.||||||+|||-..... +|||||-|+.
T Consensus 157 Km~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgS 227 (463)
T KOG0607|consen 157 KMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGS 227 (463)
T ss_pred cccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccc
Confidence 99875 5544443 567999999999999999999999999999999999999977554 7999998763
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=196.17 Aligned_cols=149 Identities=32% Similarity=0.546 Sum_probs=127.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC-CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC---cceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN-NTLTRGELREVTGLTKCRHENIVQLKEVVVGKS---LSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~ 147 (224)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++|+||+++++++.... ...+
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 357999999999999999999999999999999886432 223455678999999999999999998765322 2458
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+++||+.+++..... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 9999999987766553 346899999999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=190.32 Aligned_cols=148 Identities=22% Similarity=0.299 Sum_probs=121.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCe----EEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDK----ILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~----~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
.++|++.+.||+|+||+||+|.+..++. .+++|.+..... .....+..|+..+..+.||||+++++++.+ ..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~---~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG---AS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC---Cc
Confidence 3579999999999999999999876665 467776643221 122445667778889999999999998732 35
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.++++||+.+ ++.+.+......+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||+++.+
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 7889999974 676666655667999999999999999999999999999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=193.62 Aligned_cols=147 Identities=28% Similarity=0.423 Sum_probs=125.1
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
+|++++.||+|+||.||++.+..++..+|+|.+..... .....+.+|+.++++++|+||+++++.+.. .+.+|+|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI--EGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec--CCeEEEEEe
Confidence 68899999999999999999998999999998865322 223567789999999999999999998853 458999999
Q ss_pred cccCChhH-hhhhc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHDLAS-LQDNV--ESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~l~~-~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+.++.+. ++... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||++..+
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 153 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL 153 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99875444 43332 2368999999999999999999996 59999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-27 Score=189.28 Aligned_cols=147 Identities=37% Similarity=0.639 Sum_probs=125.3
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
++|++.+.||+|++|.||++.+..+++.+|+|.+..... .....+.+|+..++.++|+||+++++++. .....|+|
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 79 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH--SEKRLYLV 79 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe--cCCeEEEE
Confidence 579999999999999999999998999999998865432 22345678999999999999999999995 44589999
Q ss_pred EecccCChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc-CCcEEEEecccccc
Q psy13250 151 MEYCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND-KGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~-~~~~kl~DfGla~~ 221 (224)
|||+++++........ ..+++..+..++.|++.||+|||+++++||||+|+||+++. ++.+||+|||++..
T Consensus 80 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~ 152 (294)
T PLN00009 80 FEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA 152 (294)
T ss_pred EecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence 9999887776664432 23678888999999999999999999999999999999986 45799999999864
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=190.31 Aligned_cols=150 Identities=37% Similarity=0.577 Sum_probs=126.1
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCc---ce
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCR-HENIVQLKEVVVGKSL---SS 146 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~---~~ 146 (224)
++|++.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.+. |+||+++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 369999999999999999999999999999998765432 23355678999999985 6999999988854321 23
Q ss_pred EEEEEecccCChhHhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc-CCcEEEEecccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNV----ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND-KGCVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~-~~~~kl~DfGla~~ 221 (224)
.|++|||+++++...+... ...+++..++.++.||+.||.|||+++|+||||||+||+++. ++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999998877765543 235899999999999999999999999999999999999999 88999999999875
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
+
T Consensus 161 ~ 161 (295)
T cd07837 161 F 161 (295)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=188.93 Aligned_cols=150 Identities=21% Similarity=0.284 Sum_probs=122.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEc-----cCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS-----VQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
..++|++.+.||+|+||.||+|.+. .++..+|+|.+..... .....+.+|+.+++.++|+||+++++++ ...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~--~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV--SQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE--cCC
Confidence 3467999999999999999998764 2357799998753322 2234567899999999999999999998 444
Q ss_pred ceEEEEEecccC-ChhHhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEE
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNVE---------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~~---------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~ 214 (224)
...++||||+.+ ++..++.... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 579999999986 4554443321 235778889999999999999999999999999999999999999999
Q ss_pred eccccccc
Q psy13250 215 YSTYLELY 222 (224)
Q Consensus 215 DfGla~~~ 222 (224)
|||+|+..
T Consensus 162 dfg~~~~~ 169 (277)
T cd05062 162 DFGMTRDI 169 (277)
T ss_pred CCCCcccc
Confidence 99998743
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=188.49 Aligned_cols=146 Identities=32% Similarity=0.444 Sum_probs=123.4
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCcc---------chhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTL---------TRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
|.+.+.||+|+||.||+|.+..++..+|+|.+....... .+.+.+|+.++++++||||+++++++.. ..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~ 79 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD--AD 79 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe--CC
Confidence 677889999999999999998889999999886443221 1345678999999999999999999854 45
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..+++|||+.++.+..+......+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||+++.+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 88999999987543333333567899999999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=191.28 Aligned_cols=150 Identities=24% Similarity=0.321 Sum_probs=124.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCC----------------eEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCee
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQD----------------KILALKKLFLQNN-TLTRGELREVTGLTKCRHENIV 133 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~----------------~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv 133 (224)
+..+|++.+.||+|+||.||+|.+...+ ..+|+|.+..... .....+.+|+.++++++|+||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3467999999999999999998875433 5689998865433 2345667899999999999999
Q ss_pred eeeEEEEcCCcceEEEEEecccC-ChhHhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q psy13250 134 QLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVE----------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSN 202 (224)
Q Consensus 134 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~N 202 (224)
++++++... +..+++|||+.+ ++..++.... ..+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 83 RLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 999998543 578999999986 4555544322 268999999999999999999999999999999999
Q ss_pred EEEccCCcEEEEeccccccc
Q psy13250 203 LLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 203 ill~~~~~~kl~DfGla~~~ 222 (224)
|+++.++.++|+|||+++..
T Consensus 161 ili~~~~~~~l~dfg~~~~~ 180 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNL 180 (296)
T ss_pred eeecCCCceEEccccceeec
Confidence 99999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=190.14 Aligned_cols=150 Identities=23% Similarity=0.301 Sum_probs=121.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEcc-----CCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSV-----QDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
..++|++.+.||+|+||.||+|.... .+..+|+|.+..... .....+.+|+..++.++|+||+++++.+. ..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS--KG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc--CC
Confidence 45689999999999999999987542 345799998753332 22334678899999999999999999984 44
Q ss_pred ceEEEEEecccC-ChhHhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEE
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNVE---------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~~---------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~ 214 (224)
...|++|||+.+ ++...+.... ..++...+..++.|++.||.|||+++|+||||||+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 578999999975 5555554321 234677888999999999999999999999999999999999999999
Q ss_pred eccccccc
Q psy13250 215 YSTYLELY 222 (224)
Q Consensus 215 DfGla~~~ 222 (224)
|||+++..
T Consensus 162 Dfg~~~~~ 169 (288)
T cd05061 162 DFGMTRDI 169 (288)
T ss_pred cCCccccc
Confidence 99998743
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=186.51 Aligned_cols=148 Identities=23% Similarity=0.312 Sum_probs=125.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+..+++++|+||+++++++. ..+..|++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 79 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT--LEEPIYIV 79 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe--cCCCeeee
Confidence 3457999999999999999999875 45679999886433 23456778999999999999999999884 44578999
Q ss_pred Eeccc-CChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCE-HDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+. +++...+.... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.+
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 99996 45666654433 46899999999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=186.00 Aligned_cols=147 Identities=27% Similarity=0.328 Sum_probs=126.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||.|+||.||+|... +..+|+|.+..... ..+.+.+|+.+++.++|+||+++++++.. ....|+|
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 78 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ--GNPLYIV 78 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC--CCCeEEE
Confidence 3567999999999999999999864 78899998865433 45667889999999999999999999854 4589999
Q ss_pred EecccC-ChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ ++..++.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~ 152 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEA 152 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccc
Confidence 999985 5666554432 26899999999999999999999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=210.87 Aligned_cols=151 Identities=26% Similarity=0.366 Sum_probs=130.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEc-----cCCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS-----VQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
...+.+..+.||+|+||+||+|+.. .....||||.++..... ..++|.||+.++..++|||||+|+|++. ..
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~--~~ 561 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR--EG 561 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc--cC
Confidence 3456788899999999999998743 34578999998766554 6778899999999999999999999994 45
Q ss_pred ceEEEEEeccc-CChhHhhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc
Q psy13250 145 SSIFLVMEYCE-HDLASLQDNVE-------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC 210 (224)
Q Consensus 145 ~~~~lv~e~~~-~~l~~~~~~~~-------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 210 (224)
+.+|||+|||. |||..++.... .+++..+.+.|+.||+.|++||-++.++||||..+|+|++++..
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE
Confidence 58999999998 57777665431 23788999999999999999999999999999999999999999
Q ss_pred EEEEecccccccc
Q psy13250 211 VKIVYSTYLELYL 223 (224)
Q Consensus 211 ~kl~DfGla~~~~ 223 (224)
|||+||||+|..|
T Consensus 642 VKIsDfGLsRdiY 654 (774)
T KOG1026|consen 642 VKISDFGLSRDIY 654 (774)
T ss_pred EEecccccchhhh
Confidence 9999999999876
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=189.95 Aligned_cols=149 Identities=26% Similarity=0.349 Sum_probs=123.9
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCC-----eEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQD-----KILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~-----~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
.++|++.+.||+|+||.||+|.....+ ..+|+|.+..... .....+.+|+..+..++||||+++++++. ...
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~--~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT--KEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc--CCC
Confidence 457999999999999999999876544 7899998764332 22345678999999999999999999984 345
Q ss_pred eEEEEEecccC-ChhHhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC
Q psy13250 146 SIFLVMEYCEH-DLASLQDNVE---------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG 209 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~ 209 (224)
..|++|||+.+ ++..++.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 78999999985 4555543321 4578899999999999999999999999999999999999999
Q ss_pred cEEEEeccccccc
Q psy13250 210 CVKIVYSTYLELY 222 (224)
Q Consensus 210 ~~kl~DfGla~~~ 222 (224)
.++|+|||+++..
T Consensus 162 ~~~L~dfg~~~~~ 174 (283)
T cd05048 162 TVKISDFGLSRDI 174 (283)
T ss_pred cEEECCCcceeec
Confidence 9999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=188.22 Aligned_cols=147 Identities=31% Similarity=0.412 Sum_probs=126.7
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
+|++.+.||.|+||.||+|.+..++..+|+|.+..... ...+.+.+|+..+++++||||+++++.+ ......|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~lv 78 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF--QDEENMYLV 78 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh--cCCCeEEEE
Confidence 48999999999999999999998999999998864332 2345677899999999999999999888 445689999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||+.++.+.........+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~ 150 (258)
T cd05578 79 VDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150 (258)
T ss_pred EeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence 999987544433333467999999999999999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=189.44 Aligned_cols=146 Identities=36% Similarity=0.651 Sum_probs=127.1
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|+..+.||.|+||.||+|.+..++..+|+|.+..... .....+.+|+..+++++||||+++++++. ..+..|++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH--TENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc--cCCcEEEEe
Confidence 48899999999999999999998999999998865432 23346778999999999999999999984 445899999
Q ss_pred ecccCChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 152 EYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 152 e~~~~~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||+.+++...+... ...+++..+..++.|++.||+|||+++++|+||+|+||+++.++.+||+|||+++.
T Consensus 79 e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~ 149 (284)
T cd07860 79 EFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA 149 (284)
T ss_pred eccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhh
Confidence 99987776665443 35689999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=181.18 Aligned_cols=138 Identities=22% Similarity=0.236 Sum_probs=105.2
Q ss_pred eeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccc---------h-----------------hHHHHHHHhhcCCCCC
Q psy13250 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLT---------R-----------------GELREVTGLTKCRHEN 131 (224)
Q Consensus 78 ~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~---------~-----------------~~~~e~~~l~~l~h~n 131 (224)
...||+|+||.||+|.+. +|+.||+|+++....... . ...+|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999987 899999999875421110 1 1124888888887776
Q ss_pred eeeeeEEEEcCCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEEccCCc
Q psy13250 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL-HSNFIIHRDLKPSNLLLNDKGC 210 (224)
Q Consensus 132 iv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l-H~~~iiHrDlkp~Nill~~~~~ 210 (224)
+........ . ..+|||||++++...........++...+..++.|++.+|.|+ |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~-~---~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILL-K---SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEe-c---CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 644332221 1 2389999999754332222345789999999999999999999 799999999999999998 588
Q ss_pred EEEEecccccc
Q psy13250 211 VKIVYSTYLEL 221 (224)
Q Consensus 211 ~kl~DfGla~~ 221 (224)
++|+|||+|..
T Consensus 156 v~LiDFG~a~~ 166 (190)
T cd05147 156 LYIIDVSQSVE 166 (190)
T ss_pred EEEEEcccccc
Confidence 99999999973
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=189.28 Aligned_cols=150 Identities=23% Similarity=0.342 Sum_probs=123.8
Q ss_pred cccceeEeeeeeccCceEEEEEEEccC-----CeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQ-----DKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (224)
..++|++.+.||+|+||.||++..... ...+|+|.+..... .....+.+|+..+.++ +|+||+++++++. .
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~ 87 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT--Q 87 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc--C
Confidence 446799999999999999999987643 37899998764322 2234567899999999 7999999999984 4
Q ss_pred cceEEEEEecccC-ChhHhhhh---------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc
Q psy13250 144 LSSIFLVMEYCEH-DLASLQDN---------------VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND 207 (224)
Q Consensus 144 ~~~~~lv~e~~~~-~l~~~~~~---------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~ 207 (224)
.+.+|++|||+.+ ++..++.. ....+++..+..++.|++.||.|||+++|+||||||+||+++.
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 4579999999976 45544432 2346889999999999999999999999999999999999999
Q ss_pred CCcEEEEeccccccc
Q psy13250 208 KGCVKIVYSTYLELY 222 (224)
Q Consensus 208 ~~~~kl~DfGla~~~ 222 (224)
++.+||+|||+++.+
T Consensus 168 ~~~~kL~Dfg~~~~~ 182 (293)
T cd05053 168 DHVMKIADFGLARDI 182 (293)
T ss_pred CCeEEeCcccccccc
Confidence 999999999999753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=188.10 Aligned_cols=148 Identities=21% Similarity=0.391 Sum_probs=123.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEcc-----CCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSV-----QDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
.++|++...||+|+||.||+|+... ....+++|.+...... ....+.+|+.++++++|+||+++++++ ....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC--REAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE--CCCC
Confidence 3579999999999999999999653 3467899977544332 345678899999999999999999988 4445
Q ss_pred eEEEEEecccC-ChhHhhhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEec
Q psy13250 146 SIFLVMEYCEH-DLASLQDNVE--------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYS 216 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~~--------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~Df 216 (224)
..|+||||+++ ++..++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++++||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 78999999985 5555554322 15899999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q psy13250 217 TYLEL 221 (224)
Q Consensus 217 Gla~~ 221 (224)
|+++.
T Consensus 162 ~~~~~ 166 (275)
T cd05046 162 SLSKD 166 (275)
T ss_pred ccccc
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=186.76 Aligned_cols=149 Identities=23% Similarity=0.352 Sum_probs=125.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCC---eEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQD---KILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~---~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
.++|+..+.||+|+||.||+|....++ ..+|+|.+..... .....+.+|+..+..+.|+||+++.+++. ..+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT--KFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc--cCCCc
Confidence 347889999999999999999986544 3799998864422 23455678999999999999999999984 44578
Q ss_pred EEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|++|||++++ +..++....+.+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++...
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999864 55555444567899999999999999999999999999999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=198.09 Aligned_cols=150 Identities=22% Similarity=0.293 Sum_probs=122.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEc-----cCCeEEEEEEeeccCCc-cchhHHHHHHHhhcCC-CCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS-----VQDKILALKKLFLQNNT-LTRGELREVTGLTKCR-HENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~ 143 (224)
..++|.+.+.||+|+||.||+|.+. ..+..||+|++...... ....+.+|+.+|.++. ||||+++++.+..
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~-- 112 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK-- 112 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence 4567899999999999999999864 34578999998654322 2345778999999997 9999999999854
Q ss_pred cceEEEEEecccC-ChhHhhhhcC--------------------------------------------------------
Q psy13250 144 LSSIFLVMEYCEH-DLASLQDNVE-------------------------------------------------------- 166 (224)
Q Consensus 144 ~~~~~lv~e~~~~-~l~~~~~~~~-------------------------------------------------------- 166 (224)
.+.+|+||||+.+ +|..++....
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 4579999999986 4554443211
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy13250 167 -----------------------------------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL 205 (224)
Q Consensus 167 -----------------------------------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill 205 (224)
..+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl 272 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEE
Confidence 235677788999999999999999999999999999999
Q ss_pred ccCCcEEEEeccccccc
Q psy13250 206 NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 206 ~~~~~~kl~DfGla~~~ 222 (224)
+.++.+||+|||+++.+
T Consensus 273 ~~~~~~kL~DfGla~~~ 289 (401)
T cd05107 273 CEGKLVKICDFGLARDI 289 (401)
T ss_pred eCCCEEEEEecCcceec
Confidence 99999999999999754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=188.29 Aligned_cols=148 Identities=24% Similarity=0.340 Sum_probs=125.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCe----EEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDK----ILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~----~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..+|++.+.||+|+||.||+|.+..++. .+|+|....... .....+.+|+..++.+.|+||+++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS---SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec---Cc
Confidence 4579999999999999999999766554 588997754432 233566789999999999999999999854 47
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+++|||+.+ ++...+......+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++.+
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 8999999975 566666555567999999999999999999999999999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=187.34 Aligned_cols=150 Identities=22% Similarity=0.270 Sum_probs=123.8
Q ss_pred cccceeEeeeeeccCceEEEEEEEccC-----CeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQ-----DKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
..++|.+.+.||+|+||.||++.+... +..+|+|.+..... .....+.+|+..++.+.|+||+++++++. ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--TG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc--CC
Confidence 356899999999999999999987643 47899998754332 22345678999999999999999999984 44
Q ss_pred ceEEEEEecccC-ChhHhhhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEE
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNV---------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~---------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~ 214 (224)
...|+||||+.+ ++...+... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 589999999975 555554332 1246788999999999999999999999999999999999999999999
Q ss_pred eccccccc
Q psy13250 215 YSTYLELY 222 (224)
Q Consensus 215 DfGla~~~ 222 (224)
|||+++..
T Consensus 162 dfg~~~~~ 169 (277)
T cd05032 162 DFGMTRDI 169 (277)
T ss_pred Ccccchhh
Confidence 99998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-27 Score=187.02 Aligned_cols=148 Identities=21% Similarity=0.271 Sum_probs=120.3
Q ss_pred eeEeeeeeccCceEEEEEEEcc---CCeEEEEEEeeccCCc--cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc----c
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSV---QDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENIVQLKEVVVGKSL----S 145 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~---~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----~ 145 (224)
|++.+.||+|+||.||+|.... ++..+|+|.+...... ....+.+|+..++.+.|+||+++++.+..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998754 3478999988754322 23456789999999999999999998754321 2
Q ss_pred eEEEEEecccCC-hhHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccc
Q psy13250 146 SIFLVMEYCEHD-LASLQDNV-----ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYL 219 (224)
Q Consensus 146 ~~~lv~e~~~~~-l~~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla 219 (224)
..+++|||+.++ +...+... ...+++..+..++.|++.||.|||+++++||||||+||++++++.+||+|||+|
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 479999999864 44443221 235899999999999999999999999999999999999999999999999999
Q ss_pred ccc
Q psy13250 220 ELY 222 (224)
Q Consensus 220 ~~~ 222 (224)
+.+
T Consensus 161 ~~~ 163 (273)
T cd05035 161 KKI 163 (273)
T ss_pred eec
Confidence 754
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-27 Score=184.09 Aligned_cols=147 Identities=35% Similarity=0.507 Sum_probs=126.4
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|.+.+.||+|+||.||++.+..++..+++|.+.... ......+.+|+..++.++||||+++++.+.. .+..|++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD--KGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc--CCEEEEEE
Confidence 4888999999999999999999999999999886432 2334566789999999999999999999854 45899999
Q ss_pred ecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+.+ ++..++... ...+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++.+
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~ 151 (256)
T cd08529 79 EYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL 151 (256)
T ss_pred EeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceec
Confidence 99976 555555443 456899999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=195.17 Aligned_cols=149 Identities=36% Similarity=0.590 Sum_probs=128.1
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc--CCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ--NNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (224)
.++|++.+.||+|+||.||+|.+..++..+|+|++... .........+|+..++++ +|+||+++++++........|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 45799999999999999999999888999999988532 122334566899999999 999999999988655555789
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+.+++...+.. ..+++.....++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+
T Consensus 86 lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYMETDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999999877666544 26889999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=187.98 Aligned_cols=147 Identities=27% Similarity=0.398 Sum_probs=124.2
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc------cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT------LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
+|+..+.||+|+||.||++.+..++..+|+|++...... ....+.+|+..+++++|+||+++++.+. ..+..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC--EDSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec--cCCeE
Confidence 377889999999999999999999999999988643321 2345678999999999999999999984 44589
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC-cEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG-CVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfGla~~~ 222 (224)
++||||+.++.+........++++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++..+
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999998754443333456789999999999999999999999999999999999998876 5999999998654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=191.49 Aligned_cols=149 Identities=24% Similarity=0.349 Sum_probs=121.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccC--------------CeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeee
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQ--------------DKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLK 136 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~--------------~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~ 136 (224)
..+|++.+.||+|+||.||+|.+..+ ...+|+|.+..... .....+.+|+.++++++|+|+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 35799999999999999999886532 23589998864322 2234567899999999999999999
Q ss_pred EEEEcCCcceEEEEEecccC-ChhHhhhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q psy13250 137 EVVVGKSLSSIFLVMEYCEH-DLASLQDNVE-----------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLL 204 (224)
Q Consensus 137 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-----------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nil 204 (224)
+++. .....|+||||+.+ ++..++.... ..+++..+..++.|++.||.|||+++++||||||+||+
T Consensus 84 ~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 84 GVCV--SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEc--CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9985 44578999999986 4554443211 13678889999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccc
Q psy13250 205 LNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 205 l~~~~~~kl~DfGla~~~ 222 (224)
++.++.+||+|||+++.+
T Consensus 162 l~~~~~~kl~dfg~~~~~ 179 (295)
T cd05097 162 VGNHYTIKIADFGMSRNL 179 (295)
T ss_pred EcCCCcEEeccccccccc
Confidence 999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=194.95 Aligned_cols=149 Identities=33% Similarity=0.596 Sum_probs=128.6
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcC--CcceEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGK--SLSSIF 148 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~~~ 148 (224)
.+|++.+.||+|+||.||+|.+..++..+|+|++..... .....+.+|+.+++.++|+||+++++++... ....+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 579999999999999999999999999999998865322 3345667899999999999999998877432 335789
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+.+++..++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++..
T Consensus 85 lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999998877666544 456999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-27 Score=184.13 Aligned_cols=147 Identities=22% Similarity=0.379 Sum_probs=127.4
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|+.++.||+|+||.||.+++..++..+++|.+.... ......+.+|+.++++++|+||+++++++.. .+.++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD--DNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec--CCeEEEEE
Confidence 4899999999999999999999999999999886543 2334556789999999999999999999954 45899999
Q ss_pred ecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+.+ ++...+... ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||+++.+
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~ 151 (256)
T cd08221 79 EYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151 (256)
T ss_pred EecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence 99986 565555443 346899999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=186.65 Aligned_cols=149 Identities=38% Similarity=0.497 Sum_probs=128.2
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
++|+..+.||.|++|.||++.+..++..+|+|.+..... .....+.+|+..++.++||||+++++++.....+.+|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 368999999999999999999998999999998865433 2345678899999999999999999998766666899999
Q ss_pred ecccC-ChhHhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 152 EYCEH-DLASLQD---NVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 152 e~~~~-~l~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||+++ ++..++. .....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~ 154 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGE 154 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccc
Confidence 99986 4544332 2245689999999999999999999999999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=188.12 Aligned_cols=147 Identities=22% Similarity=0.299 Sum_probs=118.5
Q ss_pred eEeeeeeccCceEEEEEEEccCCe--EEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC----cceE
Q psy13250 76 EKLNRIGEGSYGVVYRVRDSVQDK--ILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKS----LSSI 147 (224)
Q Consensus 76 ~~~~~lG~G~fg~V~~~~~~~~~~--~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~ 147 (224)
.+.+.||+|+||.||+|.+..++. .+|+|.+.... ......+.+|+..++.++|+||+++++.+.... ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999876664 68999876432 223455678999999999999999998764322 2357
Q ss_pred EEEEecccC-ChhHhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 148 FLVMEYCEH-DLASLQDN-----VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+++|||+.+ ++...+.. ....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 899999985 44444321 123488999999999999999999999999999999999999999999999999875
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
+
T Consensus 162 ~ 162 (272)
T cd05075 162 I 162 (272)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=187.95 Aligned_cols=150 Identities=27% Similarity=0.339 Sum_probs=127.9
Q ss_pred cceeEeeeeeccCceEEEEEEEc----cCCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDS----VQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
.+|++.+.||+|+||.||++... .++..+|+|.+...... ....+.+|+..++.+.|+||+++++++........
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46888899999999999999864 34789999988654432 34567889999999999999999998865555679
Q ss_pred EEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|++|||+.+ ++..++......+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++..+
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 999999975 565565554446999999999999999999999999999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-27 Score=186.59 Aligned_cols=140 Identities=19% Similarity=0.261 Sum_probs=117.1
Q ss_pred eeeeccCceEEEEEEEccCC----------eEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 79 NRIGEGSYGVVYRVRDSVQD----------KILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~----------~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
+.||+|+||.||++.+..++ ..+++|.+...... ...+.+|+..++.+.|+||+++++++.. ...|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR---DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec---CCcE
Confidence 36899999999999987666 45778876544333 5677889999999999999999998854 4679
Q ss_pred EEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC-------cEEEEeccccc
Q psy13250 149 LVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG-------CVKIVYSTYLE 220 (224)
Q Consensus 149 lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~-------~~kl~DfGla~ 220 (224)
+||||+.++ +..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+|+
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 999999865 4444444344789999999999999999999999999999999999999888 79999999987
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
..
T Consensus 157 ~~ 158 (259)
T cd05037 157 TV 158 (259)
T ss_pred cc
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=188.48 Aligned_cols=149 Identities=22% Similarity=0.297 Sum_probs=128.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.-.+|++.+.||.|+||.||+|.+.. +..+|+|.+..........+.+|+..++.++|+||+++++++. .....|++
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv 80 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS--VGEPVYII 80 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe--cCCCeEEE
Confidence 34579999999999999999999887 8889999987655444566778999999999999999999884 44578999
Q ss_pred EecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+++ ++...+... ...+++..+..++.|++.||.|||+++|+|+||||+||+++.++.+||+|||++..+
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhc
Confidence 999986 565555442 346899999999999999999999999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-27 Score=190.16 Aligned_cols=147 Identities=29% Similarity=0.376 Sum_probs=126.4
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc---cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT---LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
+|++.+.||+|+||.||+|.+..++..+|+|.+...... ..+.+..|+..+..+.|+||+++++.+. .....|++
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv 79 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ--TETYLCLV 79 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee--cCCEEEEE
Confidence 699999999999999999999989999999988654322 3345678999999999999999999984 44589999
Q ss_pred EecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ ++..++... ...+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 153 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQS 153 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcc
Confidence 999976 555555432 356899999999999999999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=188.96 Aligned_cols=149 Identities=26% Similarity=0.313 Sum_probs=123.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEc-----cCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDS-----VQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..+|.+.+.||+|+||.||+|.+. .+...+++|.+........+.+.+|+..+++++|+||+++++++. ....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 81 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG--DGDP 81 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc--cCCc
Confidence 457999999999999999999853 345678889876444344456778999999999999999999984 4457
Q ss_pred EEEEEecccC-ChhHhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc
Q psy13250 147 IFLVMEYCEH-DLASLQDNV---------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC 210 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 210 (224)
.++||||+.+ ++..++... ...+++..++.++.|++.||.|||+++|+||||||+||+++.++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 9999999975 455554331 134789999999999999999999999999999999999999999
Q ss_pred EEEEeccccccc
Q psy13250 211 VKIVYSTYLELY 222 (224)
Q Consensus 211 ~kl~DfGla~~~ 222 (224)
++|+|||+|+..
T Consensus 162 ~~l~dfg~a~~~ 173 (291)
T cd05094 162 VKIGDFGMSRDV 173 (291)
T ss_pred EEECCCCccccc
Confidence 999999998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=193.92 Aligned_cols=149 Identities=30% Similarity=0.541 Sum_probs=128.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc--CCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC---cceE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ--NNTLTRGELREVTGLTKCRHENIVQLKEVVVGKS---LSSI 147 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~ 147 (224)
.+|++.+.||+|+||+||++.+..++..||+|.+... .........+|+.+++.++|+||+++++++.... ...+
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4699999999999999999999999999999988643 2223445678999999999999999998875322 2358
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+++||+++++...+.. .+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++..
T Consensus 85 ~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 85 YIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 99999999877766654 467999999999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-27 Score=186.00 Aligned_cols=146 Identities=31% Similarity=0.423 Sum_probs=123.3
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc----------cchhHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT----------LTRGELREVTGLTKCRHENIVQLKEVVVGKS 143 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (224)
+|.+.+.||.|+||.||+|....++..+|+|.+...... ..+.+.+|+..++.++|+|++++++++. .
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~ 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET--T 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec--c
Confidence 478889999999999999999888999999987542111 1124567889999999999999999884 4
Q ss_pred cceEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 144 LSSIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 144 ~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
...+++||||+.++ +...+.. ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++..
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRT-YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 45899999999865 5444433 467899999999999999999999999999999999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-29 Score=185.11 Aligned_cols=145 Identities=26% Similarity=0.448 Sum_probs=128.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~l 149 (224)
+.++|++.+++|+|.|+.||.|....+.+.++||.++.. ..+.+.+|+.+|..+. ||||++++++..++......+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 578999999999999999999999889999999988643 3567889999999986 999999999998877778899
Q ss_pred EEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC-CcEEEEeccccccc
Q psy13250 150 VMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK-GCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfGla~~~ 222 (224)
++||+++. ...++ ..++..+++.++.+++.||.|||++||+|||+||.|++|+.. ..++|+|.|||.+|
T Consensus 113 iFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999863 43333 348889999999999999999999999999999999999975 56999999999875
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=181.72 Aligned_cols=152 Identities=24% Similarity=0.378 Sum_probs=133.2
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcC---Ccce
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGK---SLSS 146 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---~~~~ 146 (224)
.+.++|.+.+.||+|+|+-||++++..++..+|+|++.....+..+..++|+...++++|||++++++..+.+ ....
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3557899999999999999999999999999999999888777778889999999999999999998776532 3356
Q ss_pred EEEEEeccc-CChhHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 147 IFLVMEYCE-HDLASLQDNV---ESPFTESQVKCVILQVLKGLNYLHSNF--IIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 147 ~~lv~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.||+++|.. |++++.+... ...+++.+++.++.++++||++||+.. .+||||||.|||+...+.++|.|||.++
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999986 5566654432 346999999999999999999999998 9999999999999999999999999986
Q ss_pred c
Q psy13250 221 L 221 (224)
Q Consensus 221 ~ 221 (224)
.
T Consensus 178 ~ 178 (302)
T KOG2345|consen 178 Q 178 (302)
T ss_pred c
Confidence 4
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=183.90 Aligned_cols=148 Identities=24% Similarity=0.422 Sum_probs=126.8
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+.+++++.|+||+++++.+.. .+..++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~--~~~~~l 79 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE--NNELNI 79 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEEE
Confidence 579999999999999999999998999999998864322 224567789999999999999999999854 357899
Q ss_pred EEecccC-ChhHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDN---VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||+++ ++..++.. ....+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||+++.+
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 80 VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 9999986 55555432 2345899999999999999999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=189.82 Aligned_cols=140 Identities=19% Similarity=0.243 Sum_probs=113.5
Q ss_pred eeeccCceEEEEEEEcc------------------------CCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeee
Q psy13250 80 RIGEGSYGVVYRVRDSV------------------------QDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQL 135 (224)
Q Consensus 80 ~lG~G~fg~V~~~~~~~------------------------~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~ 135 (224)
.||+|+||.||++.... ....+++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 68999999999987432 124688888764443344566788889999999999999
Q ss_pred eEEEEcCCcceEEEEEecccCChhH-hhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC-----
Q psy13250 136 KEVVVGKSLSSIFLVMEYCEHDLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG----- 209 (224)
Q Consensus 136 ~~~~~~~~~~~~~lv~e~~~~~l~~-~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~----- 209 (224)
++++... ...|+||||++++.+. ++....+.+++..+..++.|++.||+|||+++|+||||||+|||++..+
T Consensus 82 ~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 82 HGVCVRG--SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred EEEEEeC--CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 9998543 4789999999976444 4444456789999999999999999999999999999999999998654
Q ss_pred --cEEEEecccccc
Q psy13250 210 --CVKIVYSTYLEL 221 (224)
Q Consensus 210 --~~kl~DfGla~~ 221 (224)
.+|++|||++..
T Consensus 160 ~~~~kl~d~g~~~~ 173 (274)
T cd05076 160 SPFIKLSDPGVSFT 173 (274)
T ss_pred cceeeecCCccccc
Confidence 389999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.6e-27 Score=184.76 Aligned_cols=147 Identities=29% Similarity=0.482 Sum_probs=127.0
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc--cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|++.+.||+|+||.||++.+..++..+++|.+...... ....+.+|+..++.++|+||+++++.+. ..+..++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV--HREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe--cCCEEEEEE
Confidence 488899999999999999999888999999998765442 4556778999999999999999999874 445899999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+.++.+.........+++..+..++.+++.||.|||+.+|+|+||+|+||+++.++.+||+|||++..+
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~ 149 (264)
T cd06626 79 EYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL 149 (264)
T ss_pred ecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccccccccc
Confidence 99986544443333456889999999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-27 Score=184.84 Aligned_cols=148 Identities=20% Similarity=0.317 Sum_probs=124.8
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.++||+|+||.||+|... .+..+|+|.+.... ...+.+.+|+.+++.++|+||+++++.+. ..+..|++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 79 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT--KEEPIYII 79 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCCcEEE
Confidence 4568999999999999999999865 45678999875432 23456778999999999999999999884 45578999
Q ss_pred EecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ ++..++... ...+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 153 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVI 153 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceec
Confidence 999975 566555432 346888999999999999999999999999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-27 Score=189.81 Aligned_cols=147 Identities=32% Similarity=0.540 Sum_probs=128.3
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
..|+..+.||+|+||.||++.+..++..+|+|++..... .....+.+|+..++.++|+|++++++++.. ....|+
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~l 102 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR--EHTAWL 102 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--CCeEEE
Confidence 348889999999999999999988999999998864322 223456789999999999999999999854 347899
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||||+.+++..........+++..+..++.|++.||.|||+++|+||||+|+||+++.++.++|+|||++..
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~ 174 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASI 174 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccc
Confidence 999999887777666566799999999999999999999999999999999999999999999999998864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-27 Score=189.72 Aligned_cols=149 Identities=24% Similarity=0.340 Sum_probs=121.9
Q ss_pred ccceeEeeeeeccCceEEEEEEEcc----------------CCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeee
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSV----------------QDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQ 134 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~----------------~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~ 134 (224)
.++|++.+.||+|+||.||++.+.. +...+|+|.+..... .....+.+|+..++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3579999999999999999986432 345789998864432 23356778999999999999999
Q ss_pred eeEEEEcCCcceEEEEEecccC-ChhHhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q psy13250 135 LKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVE----------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNL 203 (224)
Q Consensus 135 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Ni 203 (224)
+++++.. .+..|++|||+.+ ++..++.... ..+++..+..++.|++.||+|||+++++||||||+||
T Consensus 84 ~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 84 LLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred EEEEEec--CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999854 3478999999975 5555544321 2367788999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccccccc
Q psy13250 204 LLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 204 ll~~~~~~kl~DfGla~~~ 222 (224)
|++.++.++|+|||+++.+
T Consensus 162 li~~~~~~~l~dfg~~~~~ 180 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNL 180 (296)
T ss_pred EEcCCCCEEeccCcccccc
Confidence 9999999999999999754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-27 Score=186.32 Aligned_cols=149 Identities=28% Similarity=0.460 Sum_probs=126.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC----cce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKS----LSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~----~~~ 146 (224)
.+.|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+..+.++ +|+||+++++.+.... ...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 356889999999999999999999999999999886543 2334567888888888 6999999999986432 246
Q ss_pred EEEEEecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+|++|||+.+ ++..++... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 8999999986 455555442 34689999999999999999999999999999999999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=189.43 Aligned_cols=150 Identities=25% Similarity=0.372 Sum_probs=122.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccC-----CeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQ-----DKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
...+|++.+.||+|+||.||+|.+..+ +..+|+|++...... ....+.+|+.++..++||||+++++++. ..
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~--~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT--KE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CC
Confidence 345688999999999999999987543 578999988644322 2345668889999999999999999984 44
Q ss_pred ceEEEEEecccCC-hhHhhhh---------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC
Q psy13250 145 SSIFLVMEYCEHD-LASLQDN---------------VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK 208 (224)
Q Consensus 145 ~~~~lv~e~~~~~-l~~~~~~---------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~ 208 (224)
...++++||+.++ +..++.. ....+++..+..++.|++.||.|||+++|+||||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 5789999999754 4444321 12347888899999999999999999999999999999999999
Q ss_pred CcEEEEeccccccc
Q psy13250 209 GCVKIVYSTYLELY 222 (224)
Q Consensus 209 ~~~kl~DfGla~~~ 222 (224)
+.+||+|||+++..
T Consensus 161 ~~~kl~Dfg~~~~~ 174 (283)
T cd05091 161 LNVKISDLGLFREV 174 (283)
T ss_pred CceEeccccccccc
Confidence 99999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-27 Score=189.96 Aligned_cols=149 Identities=21% Similarity=0.288 Sum_probs=122.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEcc-------CCeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcC
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSV-------QDKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVGK 142 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~-------~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 142 (224)
.++|.+.+.||+|+||.||++.+.. +...+|+|.+..... .....+.+|+.+++.+ +|+||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~- 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence 4679999999999999999998643 235699998864322 2334567899999988 79999999999843
Q ss_pred CcceEEEEEecccC-ChhHhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc
Q psy13250 143 SLSSIFLVMEYCEH-DLASLQDNVE---------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLN 206 (224)
Q Consensus 143 ~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~ 206 (224)
.+..|+||||+.+ ++..++.... ..+++..++.++.|++.||+|||++|++||||||+||+++
T Consensus 96 -~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 96 -DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred -CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 4579999999985 5655554321 2478899999999999999999999999999999999999
Q ss_pred cCCcEEEEeccccccc
Q psy13250 207 DKGCVKIVYSTYLELY 222 (224)
Q Consensus 207 ~~~~~kl~DfGla~~~ 222 (224)
.++.+||+|||+|+.+
T Consensus 175 ~~~~~kL~dfg~a~~~ 190 (307)
T cd05098 175 EDNVMKIADFGLARDI 190 (307)
T ss_pred CCCcEEECCCcccccc
Confidence 9999999999998743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=210.93 Aligned_cols=152 Identities=29% Similarity=0.373 Sum_probs=131.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccC-----CeEEEEEEeeccC-CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQ-----DKILALKKLFLQN-NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
+.....+...||+|+||.||.|..... ...||+|.+.... ......+++|..+|+++.|||||+++|++.. .
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~--~ 767 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD--S 767 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC--C
Confidence 345678889999999999999986543 2358999886543 3456778999999999999999999999975 4
Q ss_pred ceEEEEEecccC-ChhHhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecc
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNV------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYST 217 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG 217 (224)
...+|++|||.+ +|..+++.. ...++..+.+.++.+|+.|+.||+++++|||||..+|+|++....+||+|||
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccc
Confidence 578999999985 688888776 5568999999999999999999999999999999999999999999999999
Q ss_pred ccccccC
Q psy13250 218 YLELYLN 224 (224)
Q Consensus 218 la~~~~~ 224 (224)
+||.+++
T Consensus 848 lArDiy~ 854 (1025)
T KOG1095|consen 848 LARDIYD 854 (1025)
T ss_pred hhHhhhh
Confidence 9997654
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=189.39 Aligned_cols=149 Identities=24% Similarity=0.420 Sum_probs=128.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|++.+.||+|+||+||++.+..++..+|+|++..... .....+.+|+.+++.++||||+++++.+... ...|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE--NNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC--CEEEEE
Confidence 4679999999999999999999998999999998765432 3345677899999999999999999999544 589999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||++++.+..+....+.+++..+..++.+++.||.|||+ .+++||||||+||+++.++.++|+|||++..+
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 9999876554444445678999999999999999999997 68999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=188.94 Aligned_cols=149 Identities=28% Similarity=0.315 Sum_probs=124.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEcc-----CCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSV-----QDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
..+|.+.+.||+|+||.||+|.+.. ++..+|+|.+...... ....+.+|+.+++.+.|+||+++++++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE--GD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec--CC
Confidence 4568999999999999999998743 3578999988654333 34567889999999999999999999854 45
Q ss_pred eEEEEEecccCC-hhHhhhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcE
Q psy13250 146 SIFLVMEYCEHD-LASLQDNV-------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCV 211 (224)
Q Consensus 146 ~~~lv~e~~~~~-l~~~~~~~-------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 211 (224)
..|++|||+.++ +...+... ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 899999999864 44444322 2347889999999999999999999999999999999999999999
Q ss_pred EEEeccccccc
Q psy13250 212 KIVYSTYLELY 222 (224)
Q Consensus 212 kl~DfGla~~~ 222 (224)
||+|||+++.+
T Consensus 162 kl~d~g~~~~~ 172 (280)
T cd05049 162 KIGDFGMSRDV 172 (280)
T ss_pred EECCcccceec
Confidence 99999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-27 Score=187.98 Aligned_cols=149 Identities=26% Similarity=0.314 Sum_probs=124.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEc-----cCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDS-----VQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..+|+..++||+|+||.||++... .++..+|+|.+..........+.+|+..++.+.|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 81 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE--GRP 81 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec--CCc
Confidence 457899999999999999998743 3467899998765444445667889999999999999999998854 457
Q ss_pred EEEEEecccC-ChhHhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcE
Q psy13250 147 IFLVMEYCEH-DLASLQDNVE--------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCV 211 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~--------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 211 (224)
.|++|||+.+ ++..++.... ..+++..+..++.|++.||.|||+++++||||||+|||++.++.+
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCE
Confidence 8999999986 4544443321 247899999999999999999999999999999999999999999
Q ss_pred EEEeccccccc
Q psy13250 212 KIVYSTYLELY 222 (224)
Q Consensus 212 kl~DfGla~~~ 222 (224)
||+|||+++..
T Consensus 162 kL~dfg~~~~~ 172 (280)
T cd05092 162 KIGDFGMSRDI 172 (280)
T ss_pred EECCCCceeEc
Confidence 99999998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=186.39 Aligned_cols=140 Identities=24% Similarity=0.241 Sum_probs=113.0
Q ss_pred eeeccCceEEEEEEEcc--CCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccC
Q psy13250 80 RIGEGSYGVVYRVRDSV--QDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH 156 (224)
Q Consensus 80 ~lG~G~fg~V~~~~~~~--~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 156 (224)
.||+|+||.||+|.... ....+|+|.+..... .....+.+|+..++.++|+||+++++.+. .....|+||||+.+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~--~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI--ESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC--CCCceEEEEEeCCC
Confidence 58999999999996432 345788887654332 22345678999999999999999999984 44579999999986
Q ss_pred -ChhHhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 157 -DLASLQDNVE----SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 157 -~l~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++..++.... ...++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 149 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALE 149 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccc
Confidence 4555554422 2346788899999999999999999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.1e-27 Score=183.92 Aligned_cols=146 Identities=27% Similarity=0.424 Sum_probs=124.5
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-----ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-----TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
+|+..+.||+|+||.||+|....++..+++|.+..... ...+.+.+|+..++.++|+||+++++++. .....|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~ 78 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER--EEDNLY 78 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe--cCCeEE
Confidence 36778899999999999999988899999998865432 23345678999999999999999999884 445899
Q ss_pred EEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+++||++++ +...+. ....+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.+||+|||++...
T Consensus 79 lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 79 IFLELVPGGSLAKLLK-KYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEEEecCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 999999864 444443 3456899999999999999999999999999999999999999999999999998753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=183.09 Aligned_cols=147 Identities=26% Similarity=0.361 Sum_probs=123.7
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
+..+|++.+.||+|+||.||++... +..+|+|.+... ...+.+.+|+..+++++|+|++++++++.. .....|++
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv 78 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE-EKGGLYIV 78 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEc-CCCceEEE
Confidence 4568999999999999999999764 678899987533 234567789999999999999999987653 33478999
Q ss_pred EecccC-ChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+++ ++...+.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 152 (256)
T cd05082 79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 152 (256)
T ss_pred EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceec
Confidence 999986 5666555433 34889999999999999999999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=189.49 Aligned_cols=146 Identities=25% Similarity=0.309 Sum_probs=120.5
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCe--EEEEEEeeccC-CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDK--ILALKKLFLQN-NTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~--~~avK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (224)
++|++.+.||+|+||.||+|....++. .+++|.++... ....+.+.+|+..+.++ +||||+++++++. ..+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE--NRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc--cCCcce
Confidence 579999999999999999998876654 46888775322 22345577899999888 7999999999984 445799
Q ss_pred EEEecccC-ChhHhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEE
Q psy13250 149 LVMEYCEH-DLASLQDNVE---------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVK 212 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~k 212 (224)
++|||+.+ ++..++.... ..+++..+..++.|++.||+|||+++|+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 99999975 5555553321 2488999999999999999999999999999999999999999999
Q ss_pred EEeccccc
Q psy13250 213 IVYSTYLE 220 (224)
Q Consensus 213 l~DfGla~ 220 (224)
|+|||++.
T Consensus 160 l~dfg~~~ 167 (297)
T cd05089 160 IADFGLSR 167 (297)
T ss_pred ECCcCCCc
Confidence 99999985
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=191.60 Aligned_cols=148 Identities=31% Similarity=0.529 Sum_probs=125.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc----c
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL----S 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----~ 145 (224)
.++|++.+.||+|+||.||++.+..++..||+|++..... .....+.+|+.+++.++|+||+++++++..... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 3569999999999999999999999999999998854321 223456789999999999999999998853321 2
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
..|+||||+++++..+.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 94 ~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 94 DFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred eEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 468999999766665554 34689999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=185.71 Aligned_cols=150 Identities=27% Similarity=0.392 Sum_probs=124.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEc---CCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVG---KSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~---~~~~~ 146 (224)
..++|++.+.||+|+||.||++.+..++..+|+|++.... .....+.+|+.+++.+ +|+||+++++++.. .....
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 4578999999999999999999999999999999875422 2234556788888888 69999999998753 23357
Q ss_pred EEEEEecccCC-hhHhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 147 IFLVMEYCEHD-LASLQD---NVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~~~-l~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+|++|||++++ +..++. .....+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceee
Confidence 89999999865 444432 2235688999999999999999999999999999999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=195.43 Aligned_cols=150 Identities=26% Similarity=0.305 Sum_probs=127.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
.+.|..-+.||+|+||.||-|..+.||+.+|+|++.... ..-..-.++|-.+|.+++.+.||.+-..| +..+.+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf--eTkd~LC 261 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF--ETKDALC 261 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee--cCCCceE
Confidence 356889999999999999999999999999999875322 12223446888999999999999998788 6677999
Q ss_pred EEEecccCChhHh-hhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 149 LVMEYCEHDLASL-QDN-VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 149 lv~e~~~~~l~~~-~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
+||..|+|+-+.+ +.. .+..+++..+++|+.+|+.||++||..+|++|||||+|||+|+.|++.|+|+|||..+.
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999998754443 322 23479999999999999999999999999999999999999999999999999998764
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=183.41 Aligned_cols=140 Identities=25% Similarity=0.323 Sum_probs=116.9
Q ss_pred eeeccCceEEEEEEEc--cCCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccC
Q psy13250 80 RIGEGSYGVVYRVRDS--VQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH 156 (224)
Q Consensus 80 ~lG~G~fg~V~~~~~~--~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 156 (224)
.||+|+||.||+|.+. ..+..+|+|.+...... ..+.+.+|+.++++++|+||+++++++. ....|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~---~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE---AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc---CCCeEEEEEeCCC
Confidence 4899999999998765 44567999988654322 2345678999999999999999999873 2368999999986
Q ss_pred -ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 157 -DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 157 -~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
++...+......+++..++.++.|++.||.|||+++++||||||+|||++.++.+||+|||+++.+
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~ 145 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccc
Confidence 455555444567999999999999999999999999999999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=183.97 Aligned_cols=147 Identities=29% Similarity=0.388 Sum_probs=123.5
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEec
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEY 153 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 153 (224)
.+.....||+|+||.||++.+..++..+|+|.+........+.+.+|+..++.++|+||+++++++. ..+..|+++||
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~ 86 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS--ENGFFKIFMEQ 86 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec--cCCEEEEEEec
Confidence 3444568999999999999998889999999886555445567788999999999999999999984 34589999999
Q ss_pred ccC-ChhHhhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc-CCcEEEEeccccccc
Q psy13250 154 CEH-DLASLQDNVESPF--TESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND-KGCVKIVYSTYLELY 222 (224)
Q Consensus 154 ~~~-~l~~~~~~~~~~l--~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~-~~~~kl~DfGla~~~ 222 (224)
+.+ ++...+......+ ++..+..++.|++.||.|||+++|+||||||+||+++. .+.++|+|||++..+
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 87 VPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred CCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 986 4555554433445 78889999999999999999999999999999999986 679999999998643
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-26 Score=181.44 Aligned_cols=148 Identities=30% Similarity=0.445 Sum_probs=125.1
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|++.+.||+|+||.||++.+..+++.+|+|++..... .....+.+|+..++.++|+|++++++.+.. ....+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG-EDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC-CCCEEEEEe
Confidence 48999999999999999999998899999999865432 233456788999999999999999888742 234689999
Q ss_pred ecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+.+ ++...+... ...+++..+..++.+++.||.|||++|++|+||||+||+++.++.++|+|||+++.+
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~ 152 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEe
Confidence 99986 455554432 345899999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-27 Score=191.61 Aligned_cols=142 Identities=20% Similarity=0.256 Sum_probs=119.4
Q ss_pred Eeeeeecc--CceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 77 KLNRIGEG--SYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 77 ~~~~lG~G--~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
+++.||+| +|++||++....+++.||+|++..... .....+.+|+.+++.++||||+++++++..+ +..|+|||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~--~~~~lv~e 79 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD--NELWVVTS 79 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC--CEEEEEEe
Confidence 45789999 789999999999999999999865432 2334456788999999999999999999644 47999999
Q ss_pred cccCC-hhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 153 YCEHD-LASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 153 ~~~~~-l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
|++++ +..++... ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.++++|||.+.
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhh
Confidence 99864 55554432 3458999999999999999999999999999999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=191.47 Aligned_cols=147 Identities=28% Similarity=0.415 Sum_probs=125.3
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
+.|.....||+|+||.||++.+..++..+|+|.+..........+.+|+..++.++|+||+++++.+.. .+..|+|||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~--~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV--GDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec--CCeEEEEEe
Confidence 346667789999999999999988999999998865544445567789999999999999999998854 458999999
Q ss_pred cccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|++++.+..... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++..+
T Consensus 100 ~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 100 FLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred CCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 998764443333 346899999999999999999999999999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-27 Score=187.39 Aligned_cols=148 Identities=24% Similarity=0.389 Sum_probs=125.7
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.||+|+||.||++.+..++..+|+|.+..... .....+.+|+..++.+.|+||+++++.+.. .+..++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~~ 79 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE--DNELNI 79 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe--CCeEEE
Confidence 468899999999999999999988999999998764322 223456789999999999999999999854 348999
Q ss_pred EEecccC-ChhHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDN---VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||+.+ ++..++.. ....+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++..+
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 80 VLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 9999986 45554432 2346899999999999999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=184.12 Aligned_cols=145 Identities=36% Similarity=0.530 Sum_probs=120.5
Q ss_pred eEeeeeeccCceEEEEEEEc----cCCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 76 EKLNRIGEGSYGVVYRVRDS----VQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 76 ~~~~~lG~G~fg~V~~~~~~----~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
++.+.||.|+||.||+|... ..+..|+||.+...... ....+.+|+..+++++||||+++++++.. .+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~--~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE--NEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES--SSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc--ccccccc
Confidence 46788999999999999987 44678999998543332 35677899999999999999999999973 3468999
Q ss_pred EecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ ++...+... ...+++.....++.|++.||.|||+++++|+||+++||+++.++.+||+|||+++..
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999985 566666554 467999999999999999999999999999999999999999999999999998764
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-28 Score=200.73 Aligned_cols=145 Identities=28% Similarity=0.354 Sum_probs=122.4
Q ss_pred ccccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 68 KCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 68 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
+....+....++.||.|+-|.||+++. .++.||||+++..+ ..+|+.|++|+|+||+.|.|+|. ..-.+
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt--qsPcy 187 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT--QSPCY 187 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec--CCcee
Confidence 344556677789999999999999985 47889999774211 23678899999999999999994 44489
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
|||||||..+-+..+.+...+++......+..+|+.|+.|||.+.|||||||.-||||..+..+||+|||-++...
T Consensus 188 CIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred EEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 9999999876555555557789999999999999999999999999999999999999999999999999987653
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=185.21 Aligned_cols=150 Identities=28% Similarity=0.305 Sum_probs=124.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEcc-----CCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSV-----QDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
..++|++.+.||+|+||.||+|.+.. ++..+|+|.+..... .....+.+|+.+++.++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE--R 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc--C
Confidence 34679999999999999999999876 678899998754332 233457889999999999999999998854 4
Q ss_pred ceEEEEEecccC-ChhHhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC---cEEEE
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNVE------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG---CVKIV 214 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~---~~kl~ 214 (224)
...|++|||+.+ ++..++.... ..+++..+..++.||+.||.|||+++++||||||+||+++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 478999999975 5555554332 2588999999999999999999999999999999999998765 59999
Q ss_pred eccccccc
Q psy13250 215 YSTYLELY 222 (224)
Q Consensus 215 DfGla~~~ 222 (224)
|||+++.+
T Consensus 162 dfg~~~~~ 169 (277)
T cd05036 162 DFGMARDI 169 (277)
T ss_pred cCcccccc
Confidence 99999753
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=202.13 Aligned_cols=147 Identities=27% Similarity=0.312 Sum_probs=128.9
Q ss_pred eEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC----CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 76 EKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN----NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 76 ~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+....||+|+|-+||+|.+..+|..||.-.++..+ ....+++..|+.+|+.|+|+||+++|++|.+....++-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 55678999999999999999999999887665322 23346788999999999999999999999987777899999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcc-CCcEEEEeccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF--IIHRDLKPSNLLLND-KGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--iiHrDlkp~Nill~~-~~~~kl~DfGla~~~ 222 (224)
|++..|.+..+.+..+.+....++.|++||+.||.|||++. |||||||.+||+|+. .|.|||.|+|||.+.
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 99987777777777888999999999999999999999885 999999999999986 689999999999764
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=188.11 Aligned_cols=150 Identities=27% Similarity=0.295 Sum_probs=124.1
Q ss_pred cccceeEeeeeeccCceEEEEEEE-----ccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRD-----SVQDKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (224)
..++|.+.+.||+|+||.||++.+ ..++..+|+|.+..... .....+.+|+.+++++ +|+||+++++.+..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI-- 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec--
Confidence 456799999999999999999975 23456899998764322 2234567899999999 79999999999854
Q ss_pred cceEEEEEecccC-ChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 144 LSSIFLVMEYCEH-DLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 144 ~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.+..|++|||+.+ ++..++.... ..+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||+++.
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence 4579999999985 5655554432 3489999999999999999999999999999999999999999999999999975
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
+
T Consensus 191 ~ 191 (302)
T cd05055 191 I 191 (302)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-29 Score=191.05 Aligned_cols=146 Identities=32% Similarity=0.517 Sum_probs=123.6
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeec--cCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc---ceEEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSL---SSIFL 149 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~~~l 149 (224)
.+-.+.||-|+||+||.+.+..+++++|+|++.. .+-...+++.+|+..|...+|.|++..++...-... ..+|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 4445789999999999999999999999998752 222345678899999999999999998887632221 24788
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++|+|..++-.++.. ...++...+..+++||++||.|||+.+|+||||||.|+|++.+..+|||||||||.
T Consensus 135 ~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 135 LTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccc
Confidence 999998887776654 56799999999999999999999999999999999999999999999999999985
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=204.42 Aligned_cols=155 Identities=25% Similarity=0.328 Sum_probs=136.2
Q ss_pred ccccccceeEeeeeeccCceEEEEEEEccCC---eEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q psy13250 68 KCRNVAEFEKLNRIGEGSYGVVYRVRDSVQD---KILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKS 143 (224)
Q Consensus 68 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~---~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (224)
+........+.+.||.|.||.|++++.+..+ ..||||.++.... .....|+.|+.+|-+..||||++|.|+. ..
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV--Tk 701 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV--TK 701 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEE--ec
Confidence 3345567889999999999999999987655 5799999986543 4567789999999999999999999999 44
Q ss_pred cceEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 144 LSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 144 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
...++||.|||++ .|..+++...+.|+..++..++++|+.|+.||-+++.+||||..+|||++.+-.||++||||+|++
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 5589999999985 577788888889999999999999999999999999999999999999999999999999999977
Q ss_pred cC
Q psy13250 223 LN 224 (224)
Q Consensus 223 ~~ 224 (224)
-|
T Consensus 782 ed 783 (996)
T KOG0196|consen 782 ED 783 (996)
T ss_pred cc
Confidence 43
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=183.33 Aligned_cols=145 Identities=29% Similarity=0.397 Sum_probs=121.8
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc------cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT------LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
+|++.+.||+|+||.||+|... ++..+|+|.+...... ....+.+|+..++.++|+||+++++++.. .+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD--DNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec--CCeE
Confidence 4788899999999999999864 7788999988643221 12346689999999999999999999854 4689
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|++|||+.++.+.........+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||+++.
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 151 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARR 151 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHh
Confidence 99999998754443333446789999999999999999999999999999999999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-26 Score=182.93 Aligned_cols=149 Identities=33% Similarity=0.520 Sum_probs=127.6
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|++.+.||.|+||.||++.+..++..+|+|.+..... .....+..|+..++.++|+||+++++.+........|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 48899999999999999999999999999998864322 2234567899999999999999999988765666789999
Q ss_pred ecccC-ChhHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNV---ESPFTESQVKCVILQVLKGLNYLH-----SNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH-----~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+.+ ++...+... ...+++..+..++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++..+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99986 455554432 457899999999999999999999 899999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-26 Score=186.94 Aligned_cols=147 Identities=22% Similarity=0.306 Sum_probs=119.5
Q ss_pred ceeEeeeeeccCceEEEEEEEcc-----CCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSV-----QDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~-----~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
+|++.+.||+|+||.||+|.... ....+++|.+..... .....+.+|+..++.+.||||+++++.+. ..+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS--QDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe--cCCCc
Confidence 47888999999999999998643 235688887754332 22345678999999999999999999884 34578
Q ss_pred EEEEecccCC-hhHhhhhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q psy13250 148 FLVMEYCEHD-LASLQDNV-----------------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNL 203 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~-----------------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Ni 203 (224)
|++|||+.++ +..++... ...+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999864 44443221 13478899999999999999999999999999999999
Q ss_pred EEccCCcEEEEeccccccc
Q psy13250 204 LLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 204 ll~~~~~~kl~DfGla~~~ 222 (224)
|++.++.+||+|||+++..
T Consensus 159 ll~~~~~~kl~dfg~~~~~ 177 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDV 177 (290)
T ss_pred EEcCCCcEEeccccccccc
Confidence 9999999999999999753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=183.20 Aligned_cols=147 Identities=24% Similarity=0.326 Sum_probs=122.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.++||+|+||.||+|.+..+ ..+|+|++.... .....+.+|+.+++.++|+||+++++.+. . ...|+|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~-~~~~lv 78 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS--E-EPIYIV 78 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC--C-CCcEEE
Confidence 346799999999999999999988655 458999886422 22345778999999999999999998873 2 357999
Q ss_pred EecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ ++..++... ...+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||+++.+
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~ 152 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 152 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeec
Confidence 999986 555555432 335789999999999999999999999999999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=187.97 Aligned_cols=150 Identities=23% Similarity=0.321 Sum_probs=122.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEcc-------CCeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSV-------QDKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVG 141 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~-------~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 141 (224)
..++|.+.+.||+|+||.||++.+.. ....+|+|.+..... .....+.+|+.+++.+ .||||+++++++.
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~- 88 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT- 88 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc-
Confidence 34679999999999999999998632 345789998764322 2234567899999988 6999999999984
Q ss_pred CCcceEEEEEecccC-ChhHhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy13250 142 KSLSSIFLVMEYCEH-DLASLQDNV---------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL 205 (224)
Q Consensus 142 ~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill 205 (224)
..+.+|++|||+.+ ++..++... ...+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 89 -~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 89 -QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred -cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 34578999999986 455554332 1348899999999999999999999999999999999999
Q ss_pred ccCCcEEEEeccccccc
Q psy13250 206 NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 206 ~~~~~~kl~DfGla~~~ 222 (224)
+.++.+||+|||+++..
T Consensus 168 ~~~~~~kL~Dfg~~~~~ 184 (314)
T cd05099 168 TEDNVMKIADFGLARGV 184 (314)
T ss_pred cCCCcEEEccccccccc
Confidence 99999999999999743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-27 Score=189.84 Aligned_cols=147 Identities=27% Similarity=0.383 Sum_probs=125.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
..|.....||+|+||.||++.+..++..+|+|++..........+.+|+..+..+.||||+++++.+.. .+..|++||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~iv~e 98 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV--GEELWVLME 98 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee--CCeEEEEEe
Confidence 345566789999999999999988899999999876544445567789999999999999999998854 458999999
Q ss_pred cccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|++++.+..+.. ...+++..+..++.|++.||.|||+++++||||||+||+++.++.++|+|||++..+
T Consensus 99 ~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 99 FLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred cCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 998754443333 346899999999999999999999999999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=184.81 Aligned_cols=142 Identities=20% Similarity=0.223 Sum_probs=115.1
Q ss_pred eeeeccCceEEEEEEEcc------------CCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 79 NRIGEGSYGVVYRVRDSV------------QDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~------------~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
+.||+|+||.||+|.... ....+++|.+..........+.+|+..+..++||||+++++++... ..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~--~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD--VE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CC
Confidence 368999999999997532 2345888877554444445667888899999999999999998543 46
Q ss_pred EEEEEecccCChhHhhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc-------EEEEeccc
Q psy13250 147 IFLVMEYCEHDLASLQD-NVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC-------VKIVYSTY 218 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~-------~kl~DfGl 218 (224)
.+++|||++++.+..+. .....+++..+..++.|++.||+|||+++|+||||||+|||++.++. ++++|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 78999999876544443 33456899999999999999999999999999999999999987664 89999999
Q ss_pred cccc
Q psy13250 219 LELY 222 (224)
Q Consensus 219 a~~~ 222 (224)
+..+
T Consensus 159 ~~~~ 162 (262)
T cd05077 159 PITV 162 (262)
T ss_pred Cccc
Confidence 8643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=187.48 Aligned_cols=150 Identities=21% Similarity=0.304 Sum_probs=122.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEc-------cCCeEEEEEEeeccC-CccchhHHHHHHHhhcC-CCCCeeeeeEEEEc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS-------VQDKILALKKLFLQN-NTLTRGELREVTGLTKC-RHENIVQLKEVVVG 141 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~-------~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 141 (224)
...+|.+.+.||+|+||.||+|++. ..+..+|+|.+.... ......+.+|+..++.+ .||||+++++.+..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 4567999999999999999999753 234578999875332 22335677899999998 89999999999853
Q ss_pred CCcceEEEEEecccC-ChhHhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy13250 142 KSLSSIFLVMEYCEH-DLASLQDNV---------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL 205 (224)
Q Consensus 142 ~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill 205 (224)
...+|++|||+.+ ++..++... ...+++..+..++.|++.||.|||++||+||||||+||++
T Consensus 93 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili 170 (304)
T cd05101 93 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV 170 (304)
T ss_pred --CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEE
Confidence 4588999999986 555554432 1247788899999999999999999999999999999999
Q ss_pred ccCCcEEEEeccccccc
Q psy13250 206 NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 206 ~~~~~~kl~DfGla~~~ 222 (224)
+.++.+||+|||+|+.+
T Consensus 171 ~~~~~~kl~D~g~~~~~ 187 (304)
T cd05101 171 TENNVMKIADFGLARDV 187 (304)
T ss_pred cCCCcEEECCCccceec
Confidence 99999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=186.58 Aligned_cols=148 Identities=28% Similarity=0.466 Sum_probs=127.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||.||++.+..++..+|+|.+..........+.+|+..++.++||||+++++.+.. ....|+|
T Consensus 17 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~--~~~~~lv 94 (293)
T cd06647 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV--GDELWVV 94 (293)
T ss_pred chhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee--CCcEEEE
Confidence 45689999999999999999999888899999998865544445567889999999999999999999854 3478999
Q ss_pred EecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||+.++ +...+. ...+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++..+
T Consensus 95 ~e~~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~ 165 (293)
T cd06647 95 MEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165 (293)
T ss_pred EecCCCCcHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecc
Confidence 9999864 444443 245889999999999999999999999999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=182.15 Aligned_cols=142 Identities=28% Similarity=0.405 Sum_probs=122.6
Q ss_pred eeeeccCceEEEEEEEccC---CeEEEEEEeeccCCcc-chhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQ---DKILALKKLFLQNNTL-TRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~---~~~~avK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||.||+|.+... +..+++|.+....... ...+.+|+..+..++|+||+++++++.. ...++++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE--EEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC--CCceEEEEEec
Confidence 4689999999999998865 8899999887554332 4567789999999999999999999854 56899999999
Q ss_pred cC-ChhHhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 155 EH-DLASLQDNV--------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 155 ~~-~l~~~~~~~--------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+ ++...+... ...+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccc
Confidence 64 566665554 367999999999999999999999999999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=184.13 Aligned_cols=146 Identities=30% Similarity=0.485 Sum_probs=123.8
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
-|++.+.||.|+||.||++.+..++..+|+|.+..... .....+.+|+..+..++|+||+++++.+.. ....|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--DTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe--CCeEEEEEE
Confidence 37888999999999999999988899999998754332 223456789999999999999999999854 458999999
Q ss_pred cccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|++++.+..+.. ...+++..+..++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||++..+
T Consensus 83 ~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 83 YLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred eCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceec
Confidence 998754433332 346899999999999999999999999999999999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=185.22 Aligned_cols=146 Identities=26% Similarity=0.334 Sum_probs=121.9
Q ss_pred ceeEeeeeeccCceEEEEEEEc---cCCeEEEEEEeeccCC----ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcc
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDS---VQDKILALKKLFLQNN----TLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~---~~~~~~avK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (224)
+|++.+.||+|+||.||++.+. .++..+|+|++..... ...+.+.+|+.++..+ +|+||+.+++.+. ...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~--~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ--TDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee--cCC
Confidence 4888999999999999999874 4788999998864321 2234566789999998 5899999998884 345
Q ss_pred eEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..|+||||+.++ +...+. ....+++..+..++.|++.||.|||+.+++||||+|+|||++.++.+||+|||+++.+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~-~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 79 KLHLILDYINGGELFTHLS-QRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred eEEEEEecCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 889999999864 444443 3567899999999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=188.13 Aligned_cols=148 Identities=23% Similarity=0.314 Sum_probs=122.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCe----EEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDK----ILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~----~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..+|+..+.||+|+||.||++.+..++. .+|+|.+...... ....+.+|+.+++.+.||||+++++.+... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---C
Confidence 3578999999999999999999876665 5688877543322 223567899999999999999999988532 4
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.++++||+.+ ++...+......+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.+
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccc
Confidence 6789999985 566665554556899999999999999999999999999999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=180.76 Aligned_cols=148 Identities=26% Similarity=0.339 Sum_probs=125.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|.+.+.||+|+||.||++.+. .+..+|+|.+.... .....+.+|+..++.+.|+||+++++++. .....|++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~v 79 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS--EEEPIYIV 79 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee--cCCceEEE
Confidence 4568999999999999999999876 45778999876433 23456788999999999999999999884 44578999
Q ss_pred EecccC-ChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ ++...+.... ..+++..+..++.+++.||.|||+++++|+||||+||+++.++.++|+|||+++.+
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~ 153 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI 153 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceec
Confidence 999986 4555554432 46899999999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=181.62 Aligned_cols=146 Identities=31% Similarity=0.565 Sum_probs=128.3
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
++|++.+.||.|+||.||++.+..++..+++|.+..... ...+.+|+..++.++|+||+++++.+.. ....|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK--NTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec--CCcEEEEEe
Confidence 579999999999999999999998889999998865432 5667889999999999999999999854 358999999
Q ss_pred cccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+.+ ++...+......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~ 149 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL 149 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhc
Confidence 9986 455555544567899999999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=181.19 Aligned_cols=146 Identities=38% Similarity=0.605 Sum_probs=127.9
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
+|++.+.||+|++|.||+|.+..++..+++|++..... .....+.+|+..+..++|+||+++++.+.. ....|++||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK--EGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc--CCeEEEEEE
Confidence 68999999999999999999999999999998875543 335667889999999999999999999854 468999999
Q ss_pred cccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|++++ +...+.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..+
T Consensus 80 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~ 150 (264)
T cd06623 80 YMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL 150 (264)
T ss_pred ecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceec
Confidence 99964 5544443 4679999999999999999999999 99999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=183.24 Aligned_cols=141 Identities=24% Similarity=0.263 Sum_probs=114.9
Q ss_pred eeeeccCceEEEEEEEc--cCCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEeccc
Q psy13250 79 NRIGEGSYGVVYRVRDS--VQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE 155 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~--~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 155 (224)
+.||+|+||.||+|... .++..+|+|.+...... ....+.+|+..++.++||||+++++.+. .....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT--EVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--CCCCcEEEEECCC
Confidence 35899999999999754 35577999987654432 2345678999999999999999999884 4457899999998
Q ss_pred C-ChhHhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 156 H-DLASLQDNV----ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 156 ~-~l~~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+ ++..++... ....++..+..++.|++.||.|||+++++||||||+||+++.++++||+|||+++.
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~ 149 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHN 149 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCcccccc
Confidence 5 455554332 12456778889999999999999999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=182.56 Aligned_cols=139 Identities=28% Similarity=0.368 Sum_probs=116.5
Q ss_pred eeeccCceEEEEEEE--ccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEeccc
Q psy13250 80 RIGEGSYGVVYRVRD--SVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE 155 (224)
Q Consensus 80 ~lG~G~fg~V~~~~~--~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 155 (224)
+||+|+||.||+|.+ ..++..+|+|++..... .....+.+|+.+++.+.|+||+++++++.. ...++||||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA---ESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CCcEEEEecCC
Confidence 589999999999964 45678999998864432 234556789999999999999999998732 35789999998
Q ss_pred CC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 156 HD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 156 ~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
++ +..++. ....+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||+++.+
T Consensus 79 ~~~L~~~l~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~ 145 (257)
T cd05116 79 LGPLNKFLQ-KNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145 (257)
T ss_pred CCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCcccccc
Confidence 65 555543 3457899999999999999999999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=181.83 Aligned_cols=147 Identities=25% Similarity=0.355 Sum_probs=123.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+..... ....+.+|+.++++++|+|++++++++. . ...|++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~-~~~~lv 78 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS--E-EPIYIV 78 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC--C-CCcEEE
Confidence 4567999999999999999999876 456689998764332 3456788999999999999999998873 2 357999
Q ss_pred EecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ ++...+... ...+++..+..++.+++.||.|||+++|+||||||+||+++.++.++|+|||++..+
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~ 152 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI 152 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeec
Confidence 999986 555555432 345899999999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=186.45 Aligned_cols=147 Identities=31% Similarity=0.512 Sum_probs=128.1
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc---cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT---LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
+.|...+.||+|+||.||+|.+..++..+++|++...... ....+.+|+..++.++|+|++++++++.+ ....|+
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 98 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK--EHTAWL 98 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEE
Confidence 3477788899999999999999989999999988654322 22456789999999999999999999854 357899
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+|||+.+++...+......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++..
T Consensus 99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~ 170 (313)
T cd06633 99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASK 170 (313)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcc
Confidence 999999888777766666799999999999999999999999999999999999999999999999998763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=183.50 Aligned_cols=147 Identities=23% Similarity=0.299 Sum_probs=123.5
Q ss_pred cceeEeeeeeccCceEEEEEEEccC---CeEEEEEEeeccC-CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQ---DKILALKKLFLQN-NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~---~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
.+|.+.+.||+|+||.||+|.+... ...+|+|...... ....+.+.+|+..++.+.|+||+++++++.+ ...|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~---~~~~ 82 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE---NPVW 82 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC---CCcE
Confidence 4689999999999999999987543 4568999776443 2334567789999999999999999998843 3578
Q ss_pred EEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
++|||+.+ ++..++......+++..+..++.+++.||.|||+++++|+||||+||+++.++.++|+|||+++..
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 99999975 566666554456899999999999999999999999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-26 Score=182.56 Aligned_cols=151 Identities=28% Similarity=0.426 Sum_probs=125.8
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC---cce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKS---LSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~---~~~ 146 (224)
..++|.+.+.||+|+||.||++....+++.+|+|++.... .....+.+|+.++.++ .|||++++++++...+ .+.
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~ 98 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ 98 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence 4578999999999999999999999899999999885432 2234456788888888 7999999999886432 246
Q ss_pred EEEEEecccCC-hhHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHD-LASLQDN---VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~-l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.|+||||+.++ +..++.. ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.+
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 89999999864 4444332 2456899999999999999999999999999999999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=181.19 Aligned_cols=149 Identities=32% Similarity=0.467 Sum_probs=126.8
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
++|++.+.||.|+||+||+|....++..+|+|++..... .....+.+|+..++.++|+||+++++.+.. ....|++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV--GDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee--CCEEEEEE
Confidence 369999999999999999999888899999998864332 234566789999999999999999998854 45899999
Q ss_pred ecccCC-hhHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 152 EYCEHD-LASLQDNV--ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 152 e~~~~~-l~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
|++.++ +...+... ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..+.
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 999864 54444432 2468999999999999999999999999999999999999999999999999987553
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=188.45 Aligned_cols=148 Identities=31% Similarity=0.529 Sum_probs=124.8
Q ss_pred ceeEeeeeeccCceEEEEEEEccC--CeEEEEEEeeccC--CccchhHHHHHHHhhcC-CCCCeeeeeEEEEc--CCcce
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQ--DKILALKKLFLQN--NTLTRGELREVTGLTKC-RHENIVQLKEVVVG--KSLSS 146 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~--~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~--~~~~~ 146 (224)
+|++.+.||+|+||.||++.+..+ +..+|+|++.... ....+...+|+.+++++ .|+||+++++.+.. .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488899999999999999999877 8899999886422 12345567899999988 59999999886532 23346
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+++||+++++...+.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+|+.+
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 899999999887776644 457899999999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=183.77 Aligned_cols=141 Identities=23% Similarity=0.362 Sum_probs=114.1
Q ss_pred eeeccCceEEEEEEEccCCeEEEEEEeeccCCcc---chhHHHH---HHHhhcCCCCCeeeeeEEEEcCCcceEEEEEec
Q psy13250 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTL---TRGELRE---VTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEY 153 (224)
Q Consensus 80 ~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~---~~~~~~e---~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 153 (224)
.||+|+||.||++.+..+++.+|+|.+....... ......| ...++...||||+.+++.+. ..+..|+||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~--~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH--TPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee--cCCEEEEEEec
Confidence 3899999999999999899999999886432211 1112233 33445568999999999884 44589999999
Q ss_pred ccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 154 CEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 154 ~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+.++.+.........+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||+++.+
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~ 147 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence 987644444444567999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=183.29 Aligned_cols=141 Identities=23% Similarity=0.334 Sum_probs=113.3
Q ss_pred eeeccCceEEEEEEEccCCeEEEEEEeeccCCc--c-chhHHHHHH---HhhcCCCCCeeeeeEEEEcCCcceEEEEEec
Q psy13250 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--L-TRGELREVT---GLTKCRHENIVQLKEVVVGKSLSSIFLVMEY 153 (224)
Q Consensus 80 ~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--~-~~~~~~e~~---~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 153 (224)
.||+|+||.||++.+..++..+|+|.+...... . .....+|.. .+....|+||+.+++.+.. .+..|+||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT--PDKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec--CCeEEEEEec
Confidence 489999999999999989999999988643221 1 122233333 3334579999999998843 4578999999
Q ss_pred ccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 154 CEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 154 ~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+.++.+.........+++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|||++..+
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~ 147 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 147 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence 987544444444567999999999999999999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=188.68 Aligned_cols=149 Identities=22% Similarity=0.300 Sum_probs=121.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEcc-------CCeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcC
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSV-------QDKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVGK 142 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~-------~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 142 (224)
..+|++.+.||+|+||.||+|.+.. ....+|+|.+..... .....+.+|+.+++++ .|+||+++++.+.
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-- 88 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT-- 88 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc--
Confidence 3469999999999999999998643 234689997764322 2345677899999999 7999999999984
Q ss_pred CcceEEEEEecccC-ChhHhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc
Q psy13250 143 SLSSIFLVMEYCEH-DLASLQDNV---------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLN 206 (224)
Q Consensus 143 ~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~ 206 (224)
..+.+|++|||+.+ ++..++... ...+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~ 168 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT 168 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc
Confidence 44579999999976 455554432 12477888999999999999999999999999999999999
Q ss_pred cCCcEEEEeccccccc
Q psy13250 207 DKGCVKIVYSTYLELY 222 (224)
Q Consensus 207 ~~~~~kl~DfGla~~~ 222 (224)
.++.+||+|||+++.+
T Consensus 169 ~~~~~kL~Dfg~~~~~ 184 (334)
T cd05100 169 EDNVMKIADFGLARDV 184 (334)
T ss_pred CCCcEEECCcccceec
Confidence 9999999999998753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=189.36 Aligned_cols=147 Identities=38% Similarity=0.582 Sum_probs=125.3
Q ss_pred cceeE-eeeeeccCceEEEEEEEccCCeEEEEEEeeccCCcc--------------chhHHHHHHHhhcCCCCCeeeeeE
Q psy13250 73 AEFEK-LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTL--------------TRGELREVTGLTKCRHENIVQLKE 137 (224)
Q Consensus 73 ~~~~~-~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~ 137 (224)
++|.. .+.||.|+||+||+|.+..++..+|+|++....... ...+.+|+.+++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 35654 567999999999999999899999999886432211 124678999999999999999999
Q ss_pred EEEcCCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecc
Q psy13250 138 VVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYST 217 (224)
Q Consensus 138 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG 217 (224)
++.. ....|++|||+.+++...+.. ...+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.++|+|||
T Consensus 88 ~~~~--~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVE--GDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEec--CCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9854 458999999999887776654 4568999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q psy13250 218 YLELY 222 (224)
Q Consensus 218 la~~~ 222 (224)
+++.+
T Consensus 165 ~~~~~ 169 (335)
T PTZ00024 165 LARRY 169 (335)
T ss_pred ceeec
Confidence 98754
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=186.73 Aligned_cols=146 Identities=31% Similarity=0.486 Sum_probs=124.5
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC-CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN-NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
.|+..+.||+|+||.||+|.+..++..+|+|.+.... ......+.+|+..++.+.|+||+++++.+.. ....|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK--GTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc--CCceEEEEE
Confidence 4778889999999999999998889999999886433 2233456789999999999999999999853 457999999
Q ss_pred cccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|++++.+..... ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++.+
T Consensus 83 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06642 83 YLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred ccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccc
Confidence 998754433332 356899999999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=184.14 Aligned_cols=146 Identities=36% Similarity=0.667 Sum_probs=126.5
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
|++.+.||.|++|.||+|.+..++..+|+|++..... .....+.+|+..++.++|+|++++++++. ..+..|++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~--~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH--SENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec--cCCeEEEEEe
Confidence 5678899999999999999998999999998875432 23345678999999999999999999984 4468999999
Q ss_pred cccCChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+++++..++.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++.+
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~ 149 (283)
T cd07835 79 FLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF 149 (283)
T ss_pred ccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 99877776665433 36899999999999999999999999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=183.89 Aligned_cols=145 Identities=30% Similarity=0.497 Sum_probs=125.8
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC-CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN-NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
+|++.+.||.|+||.||++.+..++..+|+|.+.... ......+.+|+..++.++|+||+++++.+.+. ..+|+|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG--SKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC--CeEEEEEE
Confidence 6888999999999999999999999999999886543 22334567899999999999999999998644 58999999
Q ss_pred cccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+.++ +...+.. ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++.+
T Consensus 80 ~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 148 (274)
T cd06609 80 YCGGGSCLDLLKP--GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQL 148 (274)
T ss_pred eeCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceee
Confidence 99864 5544443 37899999999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=184.33 Aligned_cols=150 Identities=19% Similarity=0.237 Sum_probs=114.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccC---CeEEEEEEeeccCCccch-----------hHHHHHHHhhcCCCCCeeeeeE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQ---DKILALKKLFLQNNTLTR-----------GELREVTGLTKCRHENIVQLKE 137 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~~avK~~~~~~~~~~~-----------~~~~e~~~l~~l~h~niv~~~~ 137 (224)
.++|++.+.||+|+||+||+|.+..+ +..+|+|........... ....+...+..+.|+|++.+++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 35799999999999999999998777 667777765433321111 1122334456678999999998
Q ss_pred EEEcCCc--ceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEe
Q psy13250 138 VVVGKSL--SSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVY 215 (224)
Q Consensus 138 ~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~D 215 (224)
....... ...++++|++...+...... ....++..+..++.|++.||.|||+++|+||||||+|||++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 7643321 23478888877665555443 33467888999999999999999999999999999999999999999999
Q ss_pred ccccccc
Q psy13250 216 STYLELY 222 (224)
Q Consensus 216 fGla~~~ 222 (224)
||+|+.+
T Consensus 170 FGla~~~ 176 (294)
T PHA02882 170 YGIASHF 176 (294)
T ss_pred cCCceee
Confidence 9999765
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=181.57 Aligned_cols=146 Identities=29% Similarity=0.366 Sum_probs=123.8
Q ss_pred eeEeeeeeccCceEEEEEEEccCC----eEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQD----KILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~----~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
+++.+.||.|+||.||++.+...+ ..+|+|.+...... ....+..|+..+..+.|+||+++++.+.. .+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE--EEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC--CCeeEE
Confidence 356788999999999999988766 88999988654332 45567789999999999999999999854 358999
Q ss_pred EEecccC-ChhHhhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDNVESP-FTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~-l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||+.+ ++...+...... +++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||+++..
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceec
Confidence 9999986 455555443333 899999999999999999999999999999999999999999999999999754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=174.54 Aligned_cols=139 Identities=19% Similarity=0.210 Sum_probs=107.6
Q ss_pred eeeeeccCceEEEEEEEccCCeEEEEEEeeccCCcc--------------------------chhHHHHHHHhhcCCCCC
Q psy13250 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTL--------------------------TRGELREVTGLTKCRHEN 131 (224)
Q Consensus 78 ~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~n 131 (224)
...||+|+||.||+|.+. +|+.||||++....... .....+|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 467999999999999987 89999999987542110 001236788888888888
Q ss_pred eeeeeEEEEcCCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCc
Q psy13250 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGC 210 (224)
Q Consensus 132 iv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~ 210 (224)
+.....+... ..||||||++|+...........++...+..++.|++.++.++|. +||+||||||+|||++ ++.
T Consensus 81 i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~ 155 (190)
T cd05145 81 VPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCC
Confidence 7554443321 238999999875222111123567888999999999999999999 9999999999999999 899
Q ss_pred EEEEeccccccc
Q psy13250 211 VKIVYSTYLELY 222 (224)
Q Consensus 211 ~kl~DfGla~~~ 222 (224)
++|+|||+|+.+
T Consensus 156 ~~liDFG~a~~~ 167 (190)
T cd05145 156 PYIIDVSQAVEL 167 (190)
T ss_pred EEEEEcccceec
Confidence 999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=183.68 Aligned_cols=145 Identities=31% Similarity=0.514 Sum_probs=125.0
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
.|+..+.||.|+||.||+|.+..++..+|+|.+..... .....+.+|+..++.+.|+||+++++.+.+ ....|+|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK--GTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE--CCEEEEEEe
Confidence 58888999999999999999998999999998864432 234566789999999999999999999854 458999999
Q ss_pred cccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|++++ +...+. ...+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++..+
T Consensus 83 ~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~ 151 (277)
T cd06640 83 YLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151 (277)
T ss_pred cCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceec
Confidence 99875 444443 356899999999999999999999999999999999999999999999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=185.71 Aligned_cols=150 Identities=27% Similarity=0.437 Sum_probs=127.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 148 (224)
..++|++.+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+..+.+.. |+||+++++++.. ....|
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~ 90 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVF 90 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeEE
Confidence 45789999999999999999999998899999999865432 23344566776666664 9999999999854 45899
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
++|||+.+.+..+.......+++..+..++.|++.||.|||+ .+|+||||+|+||+++.++.+||+|||++..+
T Consensus 91 ~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 91 ICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred EEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999887777766656689999999999999999999997 69999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=188.51 Aligned_cols=148 Identities=32% Similarity=0.496 Sum_probs=125.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcC----Ccc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGK----SLS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~ 145 (224)
.++|.+.+.||+|+||.||++.+..++..||+|++..... ...+.+.+|+.++.+++|+||+++++++... ...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 4679999999999999999999988999999998864322 2234567899999999999999999887532 123
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
..|++++++.+++...... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 96 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred cEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 5789999997777665543 4589999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=179.24 Aligned_cols=147 Identities=28% Similarity=0.467 Sum_probs=126.2
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|++.+.||+|+||.||++.+..++..+|+|.+.... ......+.+|+..+++++|+||+++++.+ ...+..|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF--EENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee--cCCCeEEEEE
Confidence 4889999999999999999999899999999886532 22334677899999999999999999998 4455899999
Q ss_pred ecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+.+ ++...+... ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..+
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~ 151 (256)
T cd08218 79 DYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151 (256)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence 99976 565555443 235889999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-26 Score=179.95 Aligned_cols=146 Identities=24% Similarity=0.330 Sum_probs=122.2
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++...||+|+||.||++.+..+. .+|+|.+.... .....+.+|+.+++.+.|+|++++++++. . +..|++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~-~~~~~v~ 79 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS--E-EPIYIVT 79 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc--C-CCcEEEE
Confidence 457999999999999999999876554 58999775432 23456778999999999999999998873 2 3579999
Q ss_pred ecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+.+ ++.+.+... ...+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||+++..
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~ 152 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI 152 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEc
Confidence 99986 566666543 234789999999999999999999999999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=185.15 Aligned_cols=149 Identities=26% Similarity=0.375 Sum_probs=123.7
Q ss_pred cccceeEeeeeeccCceEEEEEEEcc-----CCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSV-----QDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
..++|++.+.||+|+||.||+|.+.. ++..+|+|.+..... .....+.+|+..++.+.||||+++++++. ..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~--~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA--VG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc--CC
Confidence 34679999999999999999998743 578899998864432 22355778999999999999999999884 44
Q ss_pred ceEEEEEecccC-ChhHhhhhc---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNV---------------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSN 202 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~---------------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~N 202 (224)
...|++|||+.+ ++...+... ...+++..+..++.|++.||.|||+++++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 578999999986 455554321 1247788899999999999999999999999999999
Q ss_pred EEEccCCcEEEEecccccc
Q psy13250 203 LLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 203 ill~~~~~~kl~DfGla~~ 221 (224)
|+++.++.++|+|||+++.
T Consensus 161 il~~~~~~~~l~dfg~~~~ 179 (288)
T cd05050 161 CLVGENMVVKIADFGLSRN 179 (288)
T ss_pred eEecCCCceEECcccccee
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=190.32 Aligned_cols=148 Identities=34% Similarity=0.583 Sum_probs=126.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC--------
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKS-------- 143 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-------- 143 (224)
..+|.+.+.||.|+||.||+|.+..++..+|+|++........+...+|+.+++.++||||+++++.+....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 357999999999999999999999999999999987665555566788999999999999999987764322
Q ss_pred ----cceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc-CCcEEEEeccc
Q psy13250 144 ----LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND-KGCVKIVYSTY 218 (224)
Q Consensus 144 ----~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~-~~~~kl~DfGl 218 (224)
....|++|||+++++...+. ...+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||+
T Consensus 84 ~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 84 SLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred cccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence 13579999999987665554 346899999999999999999999999999999999999985 55789999999
Q ss_pred ccc
Q psy13250 219 LEL 221 (224)
Q Consensus 219 a~~ 221 (224)
++.
T Consensus 162 ~~~ 164 (342)
T cd07854 162 ARI 164 (342)
T ss_pred cee
Confidence 864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=183.17 Aligned_cols=140 Identities=30% Similarity=0.341 Sum_probs=118.2
Q ss_pred eeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccCC
Q psy13250 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHD 157 (224)
Q Consensus 81 lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 157 (224)
||+|+||+||+|.+..+++.+|+|.+.... ......+.+|+.+++.++||||+++++.+. ..+..|+||||++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~ 78 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE--TKDDLCLVMTLMNGG 78 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe--cCCeEEEEEecCCCC
Confidence 689999999999999999999999886432 122334567999999999999999999884 445899999999864
Q ss_pred -hhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 158 -LASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 158 -l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+...+.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..+
T Consensus 79 ~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~ 145 (277)
T cd05577 79 DLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL 145 (277)
T ss_pred cHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhh
Confidence 544444322 36899999999999999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=178.43 Aligned_cols=146 Identities=30% Similarity=0.508 Sum_probs=126.2
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|++.+.||+|++|.||++.+..++..+++|.+..... .....+.+|+..+.+++|+|++++++++.. ....|++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET--SDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe--CCEEEEEE
Confidence 48889999999999999999998899999998865443 234566789999999999999999998854 45899999
Q ss_pred ecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+.+. +...+. ....+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++...
T Consensus 79 e~~~~~~L~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 149 (254)
T cd06627 79 EYAENGSLRQIIK-KFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKL 149 (254)
T ss_pred ecCCCCcHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceec
Confidence 999874 444443 3467999999999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=185.85 Aligned_cols=148 Identities=24% Similarity=0.387 Sum_probs=124.2
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv 150 (224)
++|+..+.||+|+||.||++.+..++..+|+|.+..... .....+.+|+..+.++. |+||+++++++.. ....|++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~--~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR--EGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec--CCcEEEE
Confidence 467788899999999999999999999999998865432 23345678888888886 9999999998854 4478999
Q ss_pred EecccCChhHhhh----hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQD----NVESPFTESQVKCVILQVLKGLNYLHSN-FIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~----~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+..++..+.. .....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+|+.+
T Consensus 82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 9999876554332 2245699999999999999999999974 9999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=181.09 Aligned_cols=151 Identities=30% Similarity=0.470 Sum_probs=127.7
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC----cc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKS----LS 145 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~----~~ 145 (224)
..++|++.+.||+|+||.||+|.+..++..+++|.+..... ....+.+|+.+++++ .|+||+++++++.... ..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 45789999999999999999999988899999998865433 234567899999988 6999999999986533 34
Q ss_pred eEEEEEecccCC-hhHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 146 SIFLVMEYCEHD-LASLQDNV---ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 146 ~~~lv~e~~~~~-l~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.+|++|||++++ +..+.... ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 689999999874 44443332 35789999999999999999999999999999999999999999999999999865
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
.
T Consensus 163 ~ 163 (275)
T cd06608 163 L 163 (275)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=179.87 Aligned_cols=140 Identities=29% Similarity=0.365 Sum_probs=120.2
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccC-
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH- 156 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 156 (224)
+.||+|+||.||++.+.. +..+|+|.+...... ....+.+|+.+++++.|+||+++++++.. ....|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ--KQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec--CCCeEEEEEcCCCC
Confidence 368999999999999877 899999988654332 34567789999999999999999999854 4578999999976
Q ss_pred ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 157 DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 157 ~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++...+......+++..+..++.+++.||.|||+++++||||||+||+++.++.++|+|||+++.
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~ 142 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRE 142 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeecccccc
Confidence 45555555455688999999999999999999999999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=182.74 Aligned_cols=146 Identities=29% Similarity=0.465 Sum_probs=123.3
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCC---CCCeeeeeEEEEcCCcceEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCR---HENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~l 149 (224)
.|+..+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+.+++.+. |||++++++++.. ....|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence 47888999999999999999998999999998865432 23345667888888886 9999999998854 458999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||+.++.+..+.. ...+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.++|+|||++..+
T Consensus 80 v~e~~~~~~L~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 80 IMEYAEGGSVRTLMK-AGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEecCCCCcHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999998754333333 247899999999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=198.59 Aligned_cols=141 Identities=31% Similarity=0.425 Sum_probs=127.3
Q ss_pred eeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccCC-h
Q psy13250 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHD-L 158 (224)
Q Consensus 80 ~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~-l 158 (224)
.||+|.||+||-|++..+..+.|||.+........+....|+.+.+.++|.|||+++|.+ ...+.+-|.||-++|+ +
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~--senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV--SENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc--CCCCeEEEEeecCCCCcH
Confidence 599999999999999999999999999877777778888999999999999999999998 5556888999999865 6
Q ss_pred hHhhhhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc-CCcEEEEeccccccc
Q psy13250 159 ASLQDNVESPF--TESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND-KGCVKIVYSTYLELY 222 (224)
Q Consensus 159 ~~~~~~~~~~l--~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~-~~~~kl~DfGla~~~ 222 (224)
.+++....+++ .+.++.+|..||++||.|||++.|+|||||-+|+|++. .|.+||+|||-++.+
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRL 726 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRL 726 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhh
Confidence 66777777888 89999999999999999999999999999999999986 789999999988754
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-26 Score=178.40 Aligned_cols=147 Identities=27% Similarity=0.383 Sum_probs=123.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
..+|++.+.||+|+||.||++.+. .+..+|+|.+.... .....+.+|+..++++.|||++++++++. .....|++|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~ 78 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT--ERSPICLVF 78 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEc--cCCceEEEE
Confidence 457999999999999999999875 46689999875322 22346778999999999999999999984 445789999
Q ss_pred ecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+.++ +...+......+++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||+++..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 150 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFV 150 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeec
Confidence 999865 44444444456899999999999999999999999999999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=185.80 Aligned_cols=147 Identities=32% Similarity=0.577 Sum_probs=126.5
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.++|++.+.||+|+||.||++.+..++..+|+|++.... ....+.+.+|+.+++.++||||+++++++... ....|+
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~~l 87 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-LEDIYF 87 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC-CCcEEE
Confidence 467999999999999999999999999999999875432 22345667899999999999999999988543 347899
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+|||+++++..++. ...+++..+..++.|++.||.|||+++|+||||+|+||+++.++.++|+|||++..
T Consensus 88 v~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 88 VTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 99999877665554 34688899999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=184.03 Aligned_cols=146 Identities=38% Similarity=0.670 Sum_probs=128.2
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc--cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
|++.+.||+|++|.||+|.+..++..+++|.+...... ....+.+|+..++.++|+||+++++.+. ....+|+++|
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR--HKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc--cCCCEEEEEe
Confidence 56778999999999999999889999999988644322 3456678999999999999999999984 3468999999
Q ss_pred cccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+++++...+......+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||.+..+
T Consensus 79 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~ 148 (283)
T cd05118 79 FMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSF 148 (283)
T ss_pred ccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEec
Confidence 9998888777765668999999999999999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=180.82 Aligned_cols=143 Identities=27% Similarity=0.290 Sum_probs=116.3
Q ss_pred eeeeccCceEEEEEEEcc---CCeEEEEEEeeccC-CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSV---QDKILALKKLFLQN-NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~---~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||.||+|.+.. ....+|+|.+.... ......+.+|+..++.++||||+++++.+... .+..|++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS-EGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC-CCCcEEEEecC
Confidence 368999999999998643 34679999875322 22345667899999999999999999977533 34678999999
Q ss_pred cC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 155 EH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 155 ~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+ ++..++......+++..+..++.|++.||.|||+.+++||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccc
Confidence 75 566665554455778888999999999999999999999999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=180.82 Aligned_cols=141 Identities=28% Similarity=0.353 Sum_probs=119.8
Q ss_pred eeeeccCceEEEEEEEcc-CC--eEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSV-QD--KILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~-~~--~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||.||+|.+.. .+ ..+|+|.+..... ...+.+.+|+..+++++|+||+++++.+.. ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT---HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC---CeEEEEEEec
Confidence 368999999999998754 23 3689998875544 445677889999999999999999999854 5899999999
Q ss_pred cC-ChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 155 EH-DLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 155 ~~-~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+ ++...+.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||+++.+
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccc
Confidence 75 5666555433 46899999999999999999999999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-27 Score=194.26 Aligned_cols=148 Identities=24% Similarity=0.399 Sum_probs=126.2
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--------CccchhHHHHHHHhhcCC---CCCeeeeeEE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--------NTLTRGELREVTGLTKCR---HENIVQLKEV 138 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~niv~~~~~ 138 (224)
....+|..++.+|.|+||.|++|.++.....|++|.+.+.. ....-..-.|+++|..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 34567999999999999999999999999999999886432 112223456999999987 9999999999
Q ss_pred EEcCCcceEEEEEecccC--ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEec
Q psy13250 139 VVGKSLSSIFLVMEYCEH--DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYS 216 (224)
Q Consensus 139 ~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~Df 216 (224)
| ++.++.||+||-... +|..++.. +..+++.++..|+.||+.|+++||+.||+|||||-+|+.++.+|-+||+||
T Consensus 638 F--Eddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 638 F--EDDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred e--ecCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 9 556699999998864 45555543 567999999999999999999999999999999999999999999999999
Q ss_pred cccc
Q psy13250 217 TYLE 220 (224)
Q Consensus 217 Gla~ 220 (224)
|.|-
T Consensus 715 gsaa 718 (772)
T KOG1152|consen 715 GSAA 718 (772)
T ss_pred cchh
Confidence 9985
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=189.24 Aligned_cols=148 Identities=35% Similarity=0.539 Sum_probs=128.2
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC---cceEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKS---LSSIF 148 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~~ 148 (224)
+|++.+.||.|+||.||+|.+..++..+|+|++.... ....+.+.+|+..++.++|+||+++++++.... ...+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4889999999999999999998889999999886433 234456788999999999999999999885432 24689
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
++|||+.+++...+.. ...+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999999877666654 447999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=179.82 Aligned_cols=140 Identities=27% Similarity=0.347 Sum_probs=117.7
Q ss_pred eeeeccCceEEEEEEEccCC---eEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQD---KILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~---~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||.||+|....++ ..+|+|.+..... .....+.+|+..++.+.|+||+++++++.. ...+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~---~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG---EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC---CceEEEEEeC
Confidence 46999999999999876554 7899998864443 234567789999999999999999998742 3579999999
Q ss_pred cC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 155 EH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 155 ~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+ ++..++.. ...+++..+..++.|++.||.|||.++++|+||||+|||++.++.+||+|||+++.+
T Consensus 78 ~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 78 PLGPLLKYLKK-RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred CCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEecccccccee
Confidence 75 45555544 347899999999999999999999999999999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=179.54 Aligned_cols=140 Identities=26% Similarity=0.334 Sum_probs=117.6
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccC-
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH- 156 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 156 (224)
+.||+|+||.||++... .+..+|+|.+..... .....+.+|+..++.+.||||+++++++.. .+..|+||||+.+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ--RQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec--CCccEEEEECCCCC
Confidence 36899999999999865 678899998754332 223456789999999999999999999854 4578999999976
Q ss_pred ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 157 DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 157 ~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++...+......+++..+..++.+++.||.|+|+++++||||||+||+++.++.+||+|||++..
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 142 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQ 142 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCcccee
Confidence 45555544455689999999999999999999999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=182.82 Aligned_cols=147 Identities=34% Similarity=0.525 Sum_probs=127.9
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
+|+..+.||.|+||.||++.+..++..+|+|.+..... .....+.+|+..++.+.||||+++++.+... +..|+++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN--GDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC--CEEEEEEE
Confidence 58888999999999999999999999999998865432 3345667899999999999999999998543 58999999
Q ss_pred cccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+.+ ++..++......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..+
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~ 151 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhh
Confidence 9995 5666655544779999999999999999999999 99999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=185.35 Aligned_cols=142 Identities=16% Similarity=0.183 Sum_probs=115.8
Q ss_pred eeeeccCceEEEEEEEccCC-------eEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 79 NRIGEGSYGVVYRVRDSVQD-------KILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~-------~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+.||.|+||.||+|.+...+ ..+|+|.+..........+..|+.+++.+.||||+++++++... ...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~--~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG--DESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC--CCcEEEE
Confidence 36899999999999875443 34888877544333445667888999999999999999998643 4789999
Q ss_pred ecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc--------EEEEeccccccc
Q psy13250 152 EYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC--------VKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~--------~kl~DfGla~~~ 222 (224)
||+.++ +..++......+++..+..++.|++.||.|||+++|+||||||+||+++.++. ++++|||++...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 999865 55555544456899999999999999999999999999999999999988765 699999998643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=185.44 Aligned_cols=149 Identities=34% Similarity=0.526 Sum_probs=128.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
....|+..+.||+|+||.||++.+..++..+|+|.+..... .....+.+|+..++.++|+|++++++++.. ....
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 90 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR--EHTA 90 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc--CCee
Confidence 34458888999999999999999998899999998864322 223456789999999999999999999854 3578
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|+||||+.+++...+......+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++..
T Consensus 91 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred EEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCccccee
Confidence 99999999877776665566789999999999999999999999999999999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-26 Score=181.77 Aligned_cols=144 Identities=30% Similarity=0.463 Sum_probs=124.1
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEec
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEY 153 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 153 (224)
.|...+.||+|++|.||++.+..++..+++|++..........+.+|+.+++.+.|+||+++++++.. .+..|+++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~--~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV--GDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc--CCeEEEEEec
Confidence 46667899999999999999988899999998865544445567789999999999999999998854 4578999999
Q ss_pred ccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 154 CEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 154 ~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+.++ +...+.. ..+++..+..++.|++.||.|||+++|+||||+|+||+++.++.++|+|||++..
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 9864 4444433 5689999999999999999999999999999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.6e-26 Score=180.87 Aligned_cols=151 Identities=18% Similarity=0.255 Sum_probs=124.8
Q ss_pred cccceeEeeeeeccCceEEEEEEEcc----CCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSV----QDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~----~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
..++|++.+.||+|+||.||+|.+.. .+..+++|.+..... .....+.+|+..++++.|+||+++++++... ..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~ 82 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED-GE 82 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CC
Confidence 35679999999999999999999875 357889998753322 2344567899999999999999999987643 35
Q ss_pred eEEEEEecccC-ChhHhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecc
Q psy13250 146 SIFLVMEYCEH-DLASLQDNVE-------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYST 217 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG 217 (224)
..++++||+.+ ++..++.... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 78899999975 4555543321 458899999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q psy13250 218 YLELY 222 (224)
Q Consensus 218 la~~~ 222 (224)
+++.+
T Consensus 163 ~~~~~ 167 (280)
T cd05043 163 LSRDL 167 (280)
T ss_pred Ccccc
Confidence 99854
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=181.32 Aligned_cols=138 Identities=32% Similarity=0.481 Sum_probs=118.8
Q ss_pred eeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccC-
Q psy13250 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH- 156 (224)
Q Consensus 81 lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 156 (224)
||.|+||.||++.+..++..+++|.+..... .....+.+|+..+++++|+||+++++.+. .....|++|||+.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~~~ 78 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ--GKKNLYLVMEYLPGG 78 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee--cCcEEEEEEecCCCC
Confidence 6899999999999998899999998864432 23456678899999999999999998884 45589999999986
Q ss_pred ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 157 DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 157 ~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++..++.. ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..
T Consensus 79 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~ 142 (265)
T cd05579 79 DLASLLEN-VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKV 142 (265)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchh
Confidence 45555444 34789999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-26 Score=180.61 Aligned_cols=140 Identities=26% Similarity=0.376 Sum_probs=114.8
Q ss_pred eeeeccCceEEEEEEEccCCe--EEEEEEeeccC-CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDK--ILALKKLFLQN-NTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~--~~avK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||.||+|....++. .+++|.+.... ......+.+|+..+.++ .||||+++++.+.. .+..|++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeC
Confidence 358999999999999877765 46788775322 22334667899999999 79999999999843 45789999999
Q ss_pred cC-ChhHhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccc
Q psy13250 155 EH-DLASLQDNVE---------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTY 218 (224)
Q Consensus 155 ~~-~l~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGl 218 (224)
.+ ++..++.... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 75 5655544321 2478999999999999999999999999999999999999999999999999
Q ss_pred cc
Q psy13250 219 LE 220 (224)
Q Consensus 219 a~ 220 (224)
++
T Consensus 159 ~~ 160 (270)
T cd05047 159 SR 160 (270)
T ss_pred cc
Confidence 85
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-26 Score=178.85 Aligned_cols=144 Identities=26% Similarity=0.418 Sum_probs=121.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||.||++. .++..+|+|.+.... ....+.+|+..++.++|+|++++++++... ..|++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---~~~~v 76 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN---GLYIV 76 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC---CcEEE
Confidence 34679999999999999999986 467789999875432 335677899999999999999999988532 47999
Q ss_pred EecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 151 MEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|||+.+ ++..++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcccee
Confidence 999985 566665443 23588999999999999999999999999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-27 Score=189.28 Aligned_cols=149 Identities=26% Similarity=0.324 Sum_probs=125.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 147 (224)
..+|..+..||+|+||+|.+++.+.+.+.+|||+++.+- ....+-.+.|-++|... +-|.++++...| ...+.+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF--QTmDRL 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF--QTMDRL 425 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh--hhhhhe
Confidence 457999999999999999999999999999999886432 22333345566666554 467889998888 666799
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||+.|+-+.+..+.-+.+-+..+.+|+.+|+-||-|||++|||+||||.+|||++.+|++||+|||+++.-
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999987655555555678999999999999999999999999999999999999999999999999999764
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=178.07 Aligned_cols=147 Identities=22% Similarity=0.372 Sum_probs=123.4
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.++||+|+||.||+|... .+..+|+|.+.... .....+.+|+.++++++|+||+++++++. .+..|++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~---~~~~~~v 78 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT---QEPIYII 78 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc---cCCcEEE
Confidence 3457999999999999999999865 56789999886433 23456788999999999999999998873 2368999
Q ss_pred EecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ ++...+... ...+++..+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||+++.+
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeec
Confidence 999975 565554432 346889999999999999999999999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=182.41 Aligned_cols=147 Identities=28% Similarity=0.379 Sum_probs=126.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 148 (224)
++|.+.+.||+|+||.||++....++..+|+|++.... ........+|..+++++. |+||+++++++. ..+..|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ--DEENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc--CCceEE
Confidence 36999999999999999999999899999999886422 122345677889999998 999999999884 455899
Q ss_pred EEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
++||++.+ ++...+.. ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..+
T Consensus 79 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 79 FVLEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 99999965 56555544 457999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=185.29 Aligned_cols=146 Identities=34% Similarity=0.554 Sum_probs=124.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC----cce
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKS----LSS 146 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~ 146 (224)
++|.+.+.||+|+||.||+|.+..++..+|+|++.... ......+.+|+.+++.+.|+||+++++++.... ...
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 57999999999999999999998899999999886432 223345678999999999999999999885322 235
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.|+|+||+..++.... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.
T Consensus 95 ~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 95 FYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred EEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 7999999986554433 34689999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=180.41 Aligned_cols=150 Identities=28% Similarity=0.452 Sum_probs=125.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcC----Ccc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGK----SLS 145 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~----~~~ 145 (224)
..+.|++.+.||.|+||.||+|.+..++..+|+|.+..... ....+..|+.+++++ .|+||+++++++... ...
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 34579999999999999999999999999999998765432 234566788888887 699999999988532 235
Q ss_pred eEEEEEecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 146 SIFLVMEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.+|++|||+.+ ++..++... ...+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++..
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 78999999986 455555432 34588899999999999999999999999999999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-25 Score=175.18 Aligned_cols=148 Identities=29% Similarity=0.437 Sum_probs=127.2
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|...+.||+|++|.||+|.+..++..+++|++..... .....+.+|+..++++.|+||+++++.+........++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47888999999999999999998999999998865442 3345667899999999999999999998654336899999
Q ss_pred ecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+.++ +...+.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...
T Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 151 (260)
T cd06606 81 EYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRL 151 (260)
T ss_pred EecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEec
Confidence 999654 5444443 447999999999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-26 Score=179.95 Aligned_cols=140 Identities=22% Similarity=0.222 Sum_probs=112.1
Q ss_pred eeeccCceEEEEEEEccC--CeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccC
Q psy13250 80 RIGEGSYGVVYRVRDSVQ--DKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH 156 (224)
Q Consensus 80 ~lG~G~fg~V~~~~~~~~--~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 156 (224)
.||+|+||.||++..... ...+++|.+..... .....+.+|+..++.++||||+++++.+.. ....|+||||+.+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE--AIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC--CCccEEEEecCCC
Confidence 589999999999875432 34566776654332 234567889999999999999999999853 4578999999986
Q ss_pred -ChhHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 157 -DLASLQDNV---ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 157 -~l~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++..++... ...+++..+..++.|++.||+|||+++++||||||+|||++.++.++|+|||++..
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccc
Confidence 555555432 23466777889999999999999999999999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=181.60 Aligned_cols=146 Identities=40% Similarity=0.742 Sum_probs=128.3
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
|+..+.||+|.||.||+|....++..+|+|.+.... .........|+..++.+.|+|++++++++.. ....|+|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT--ERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc--CCceEEEec
Confidence 567788999999999999999999999999887543 2334566789999999999999999999853 468999999
Q ss_pred cccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+++++..++......+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.++|+|||+++.+
T Consensus 79 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~ 148 (282)
T cd07829 79 YCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAF 148 (282)
T ss_pred CcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCccccc
Confidence 9998887777665457999999999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=178.38 Aligned_cols=139 Identities=31% Similarity=0.454 Sum_probs=119.4
Q ss_pred eeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccCC
Q psy13250 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHD 157 (224)
Q Consensus 81 lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 157 (224)
||.|+||.||+|.+..++..+|+|++..... ...+.+.+|+.+++.++|+||+++++.+.. ....|++|||+.++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~ 78 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD--KKYIYMLMEYCLGG 78 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc--CCccEEEEecCCCC
Confidence 6999999999999998899999998864322 234567789999999999999999998853 45799999999864
Q ss_pred -hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 158 -LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 158 -l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+...+.. ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||+++..
T Consensus 79 ~L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~ 143 (262)
T cd05572 79 ELWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143 (262)
T ss_pred cHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCccccc
Confidence 5444443 456899999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-26 Score=181.53 Aligned_cols=146 Identities=35% Similarity=0.571 Sum_probs=125.1
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-cchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
|++.+.||+|+||.||+|....+++.+++|++...... ......+|+..+.++. |+||+.+++.+.. .+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence 67788999999999999999888999999987543221 2223457888999999 9999999999854 568999999
Q ss_pred cccCChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+.+++...+.... ..+++..+..++.|++.+|.|||+++++|+||+|+||+++.++.++|+|||+++..
T Consensus 79 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 79 YMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI 149 (283)
T ss_pred cCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceec
Confidence 99877777665543 46899999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-25 Score=174.47 Aligned_cols=147 Identities=37% Similarity=0.609 Sum_probs=128.4
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEec
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEY 153 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 153 (224)
+|...+.||+|++|.||++.+..++..+++|++..........+.+|+..++.+.|+|++.+++.+... ...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK--DELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEEec
Confidence 478889999999999999999888999999998765444556778899999999999999999998543 588999999
Q ss_pred ccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 154 CEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 154 ~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+++ ++...+......+++..+..++.|++.||.|||.++++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 985 555555544467999999999999999999999999999999999999999999999999998754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-25 Score=176.07 Aligned_cols=147 Identities=35% Similarity=0.539 Sum_probs=127.9
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|++.+.||.|+||.||++.+..++..+++|++..... .......+|+..++.++|+|++++.+.+... ...++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK--GKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC--CEEEEEE
Confidence 48899999999999999999998899999999875433 3445667899999999999999999998544 6899999
Q ss_pred ecccC-ChhHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNV---ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+++ ++...+... ...+++..+..++.+++.||.|||+++++|+||+|+||+++.++.++|+|||++..+
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 153 (258)
T cd08215 79 EYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL 153 (258)
T ss_pred EecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeec
Confidence 99986 455555443 367999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=183.45 Aligned_cols=145 Identities=29% Similarity=0.416 Sum_probs=123.3
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
|.....||+|+||.||++....++..+|+|++..........+.+|+..++.++|+||+++++.+.. .+..|++|||+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~ 99 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV--GDELWVVMEFL 99 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe--CCEEEEEEecC
Confidence 4455789999999999999999999999998865443344556789999999999999999999854 45899999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.++.+..+.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 100 ~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~ 166 (292)
T cd06657 100 EGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166 (292)
T ss_pred CCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceec
Confidence 8754444333 346899999999999999999999999999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-25 Score=178.99 Aligned_cols=148 Identities=36% Similarity=0.603 Sum_probs=122.2
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcC---CCCCeeeeeEEEEcCCc---ce
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKC---RHENIVQLKEVVVGKSL---SS 146 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~---~~ 146 (224)
|++.+.||+|+||.||++.+..++..+|+|++..... .....+.+|+..+.++ .|+|++++++.+..... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6788999999999999999988899999999864332 2223445676665544 69999999999864331 23
Q ss_pred EEEEEecccCChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|++|||+.+++..++.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++..+
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 89999999987776655432 35899999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-25 Score=175.99 Aligned_cols=147 Identities=27% Similarity=0.431 Sum_probs=124.2
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|+..+.||+|+||.||++.+..++..+|+|.+..... .....+.+|+..++.++|+|++++++.+. ..+..++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~--~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL--EDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe--cCCEEEEEE
Confidence 48899999999999999999999999999998865432 23455678999999999999999999884 345899999
Q ss_pred ecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC-cEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG-CVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfGla~~~ 222 (224)
||+++ ++..++... ...+++..+..++.+++.||.|||+++++|+||+|+||+++.++ .++|+|||++...
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (256)
T cd08220 79 EYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152 (256)
T ss_pred ecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence 99986 455555443 34589999999999999999999999999999999999998654 5799999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-27 Score=210.93 Aligned_cols=147 Identities=29% Similarity=0.405 Sum_probs=128.7
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|+-...||.|.||.||.|.+..+|+..|+|.+..+.. .....+.+|..++..++|||+|++||+-++.+ .++|.|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe--kv~IFM 1313 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE--KVYIFM 1313 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH--HHHHHH
Confidence 57778899999999999999999999999998875443 33455678999999999999999999987655 789999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||.++.+..+....+..++.....|..|++.|+.|||++|||||||||+||+++.+|.+|+.|||.|..+
T Consensus 1314 EyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEe
Confidence 99997765555555666888888999999999999999999999999999999999999999999999764
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=177.80 Aligned_cols=142 Identities=25% Similarity=0.298 Sum_probs=114.7
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHH-hhcCCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTG-LTKCRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+.||+|+||.||+|.+..+++.+|+|.+..... ........|... .....|+|++++++.+. ..+.+|++|||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ--SKDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE--cCCeEEEEEecc
Confidence 568999999999999988999999998864321 112223344443 34558999999999984 445899999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.++.+..+......+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||+++..
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 87544433334567899999999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=178.99 Aligned_cols=148 Identities=20% Similarity=0.263 Sum_probs=118.5
Q ss_pred eeEeeeeeccCceEEEEEEEc---cCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc----c
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDS---VQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL----S 145 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~---~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----~ 145 (224)
|.+.+.||+|+||.||+|... .++..+|+|++..... ...+.+.+|+..++.+.||||+++++++..... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999854 3578999998864322 234456789999999999999999998754322 1
Q ss_pred eEEEEEecccCC-hhHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccc
Q psy13250 146 SIFLVMEYCEHD-LASLQDNV-----ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYL 219 (224)
Q Consensus 146 ~~~lv~e~~~~~-l~~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla 219 (224)
..++++||+.++ +..++... ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 347889999754 43333211 124788999999999999999999999999999999999999999999999998
Q ss_pred ccc
Q psy13250 220 ELY 222 (224)
Q Consensus 220 ~~~ 222 (224)
+.+
T Consensus 161 ~~~ 163 (273)
T cd05074 161 KKI 163 (273)
T ss_pred ccc
Confidence 754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-25 Score=176.16 Aligned_cols=147 Identities=19% Similarity=0.315 Sum_probs=122.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||.||++... .+..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.. ...|++
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~v 78 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---EPIYII 78 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC---CCeEEE
Confidence 3467999999999999999999865 45568999775332 234567789999999999999999998843 468999
Q ss_pred EecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ ++..++... ...+++..+..++.|++.||.|||+.+++|+||||+||+++.++.+||+|||++..+
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 152 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 152 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeec
Confidence 999975 566665442 345788899999999999999999999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=179.70 Aligned_cols=146 Identities=28% Similarity=0.367 Sum_probs=121.0
Q ss_pred ceeEeeeeeccCceEEEEEEEc---cCCeEEEEEEeeccCC----ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcc
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDS---VQDKILALKKLFLQNN----TLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~---~~~~~~avK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (224)
+|++.+.||+|+||.||++.+. .++..+|+|.+..... .....+.+|+.++.++ +|+||+.+++.+. ...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~--~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ--TDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee--cCC
Confidence 4888999999999999998854 4568899998864321 2234456889999999 5999999998884 445
Q ss_pred eEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..|+||||+.++ +...+. ....+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||+++.+
T Consensus 79 ~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 79 KLHLILDYVNGGELFTHLY-QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEEEecCCCCcHHHHHh-hcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 899999999864 444443 3456899999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=178.56 Aligned_cols=149 Identities=32% Similarity=0.524 Sum_probs=129.3
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
...+.|+..+.||+|+||.||++.+..++..+++|++..... ....+.+|+..++.++|+|++++++.+... ...|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~l 92 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG--DELWV 92 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC--CEEEE
Confidence 345679999999999999999999988899999999875543 345677899999999999999999998654 58999
Q ss_pred EEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 150 VMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++||+++ ++.+++......+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 165 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQ 165 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhh
Confidence 9999985 56666555333799999999999999999999999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=185.64 Aligned_cols=149 Identities=30% Similarity=0.486 Sum_probs=126.9
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC----cc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKS----LS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 145 (224)
.++|++...||+|+||.||+|.+..++..+|+|++.... ........+|+.+++.+.|+||+++.+++.... ..
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 457999999999999999999999999999999876432 123345678999999999999999988774322 13
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..|+|+||+++++..++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+
T Consensus 94 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 94 DVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 4899999998777666653 46899999999999999999999999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-28 Score=197.16 Aligned_cols=151 Identities=26% Similarity=0.463 Sum_probs=128.4
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc---CCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ---NNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
...+.+++.+..||-|+||.|-++........+|+|+++.. .....+....|-.+|..++.|.||++|..| .+..
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf--rd~k 493 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF--RDSK 493 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh--ccch
Confidence 34567888899999999999999887765556888877542 334455567888999999999999999999 5556
Q ss_pred eEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
++|++||-|-| .++..+.. ++.|.+.++++++..+++|++|||++|||+|||||+|++++.+|.+||.|||+|+.+
T Consensus 494 yvYmLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 494 YVYMLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hhhhhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence 89999999865 46655544 678999999999999999999999999999999999999999999999999999865
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-27 Score=199.30 Aligned_cols=151 Identities=34% Similarity=0.526 Sum_probs=137.8
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
...++|+++..+|.|+||.||++++..+++..|+|.++........-+..|+..++.++||||+.+++.+... +.+|+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~--dklwi 89 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRR--DKLWI 89 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhh--cCcEE
Confidence 3557899999999999999999999999999999999988777777788899999999999999999999644 47999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+++.++.+....+++++.++....++.+.||.|||++|-+|||||-.|||++..|.+|+.|||.+-.+
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhh
Confidence 9999998777777677889999999999999999999999999999999999999999999999999988554
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-25 Score=190.36 Aligned_cols=150 Identities=29% Similarity=0.439 Sum_probs=124.1
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhc-CCCCCeeeeeEEEEcC---CcceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTK-CRHENIVQLKEVVVGK---SLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~---~~~~~ 147 (224)
.+.|++.+.||.|.+|.||+++++.++...|+|+........ .++..|..+++. ..|||++.+|+++... ..+.+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 456999999999999999999999999999999886655433 333345566655 5799999999998742 34689
Q ss_pred EEEEecccCChhH-hhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLAS-LQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~-~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||||||+++... +.... ...+.|..+..|++.++.|+.+||.+.++|||+|-.|||++.++.+||+|||++..+
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 9999999875433 33322 456899999999999999999999999999999999999999999999999998653
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=175.00 Aligned_cols=147 Identities=31% Similarity=0.502 Sum_probs=125.0
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|++.+.||+|+||.||++.+..++..+++|.+..... .....+.+|+..++.++|+||+++++.+.. ....|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD--GNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc--CCEEEEEe
Confidence 48899999999999999999998999999998865432 223455789999999999999999998854 36899999
Q ss_pred ecccC-ChhHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNV---ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+++ ++...+... ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~ 153 (256)
T cd08530 79 EYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL 153 (256)
T ss_pred hhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhh
Confidence 99976 454444331 346899999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-25 Score=175.18 Aligned_cols=141 Identities=25% Similarity=0.348 Sum_probs=113.9
Q ss_pred cceeEeeee--eccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhh-cCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRI--GEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLT-KCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~l--G~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.+ |+|+||.||++....++..+|+|.+........ |+.... ...|+||+++++.+.. .+..|+
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~--~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT--LKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec--CCeeEE
Confidence 456666665 999999999999999999999998764321111 222221 1279999999999954 348999
Q ss_pred EEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC-cEEEEecccccc
Q psy13250 150 VMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG-CVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfGla~~ 221 (224)
||||+++ ++..++.. ...+++..+..++.|++.||.|||+.+++||||||+||+++.++ .++|+|||+++.
T Consensus 87 v~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 87 IMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 9999975 55555544 45899999999999999999999999999999999999999998 999999999864
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=177.06 Aligned_cols=152 Identities=25% Similarity=0.319 Sum_probs=125.5
Q ss_pred ccccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhc-CCCCCeeeeeEEEEcCC
Q psy13250 68 KCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTK-CRHENIVQLKEVVVGKS 143 (224)
Q Consensus 68 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~ 143 (224)
+...+.+|.++..||+|+|++|..++++.+.+.+|+|+++... .+...-...|-.+..+ -+||.+|-+..+| ..
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf--qt 322 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF--QT 322 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh--cc
Confidence 3446789999999999999999999999999999999886432 1111111234344333 4799999999998 45
Q ss_pred cceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 144 LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 144 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
...+++|.||++|+-+.+.....+.++++.+++|..+|+.||.|||++|||+||||.+|+|++.+|.+||.|+|..+.
T Consensus 323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc
Confidence 568999999999765555555577899999999999999999999999999999999999999999999999999875
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-25 Score=173.60 Aligned_cols=147 Identities=29% Similarity=0.471 Sum_probs=124.0
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+|.+.+.||+|+||.||++.+..++..+|+|.+..... .....+.+|+..++.++|+||+++++.+. .....|+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ--ENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec--cCCeEEEEE
Confidence 48899999999999999999999999999998865422 23345678999999999999999999884 455899999
Q ss_pred ecccC-ChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc-EEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC-VKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~-~kl~DfGla~~~ 222 (224)
||+.+ ++...+.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++. ++|+|||++..+
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~ 152 (257)
T cd08225 79 EYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152 (257)
T ss_pred ecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence 99976 5555554432 35789999999999999999999999999999999999998864 699999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=185.76 Aligned_cols=148 Identities=32% Similarity=0.434 Sum_probs=126.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc--CCccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ--NNTLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~ 147 (224)
....|+++++||+|+.+.||++.... ...+|+|++... .......+..|+..|.+++ |.+||+++++-+.+ +.+
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d--~~l 435 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD--GYL 435 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC--ceE
Confidence 45679999999999999999998654 456777766432 2344567789999999985 89999999998654 489
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||||-+.+|..++.....-.+...+++|..|++.|+.++|++||||.||||.|+|+- .|.+||||||.|...
T Consensus 436 YmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred EEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 99999999999999988777677678999999999999999999999999999999986 789999999999754
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=185.04 Aligned_cols=148 Identities=22% Similarity=0.268 Sum_probs=117.9
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHH--HHHhhcCCCCCeeeeeEEEEcCC--c
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELRE--VTGLTKCRHENIVQLKEVVVGKS--L 144 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e--~~~l~~l~h~niv~~~~~~~~~~--~ 144 (224)
..+....++++.||+|.||.||+|... ++.||||++..... +.+..| +..+-.+.|+||++|++.-.... .
T Consensus 206 l~~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 206 LLELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred cccCCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 345677889999999999999999864 68999999865432 334444 44455689999999988763111 2
Q ss_pred ceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---------CCceecCCCCCcEEEccCCcEEEEe
Q psy13250 145 SSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS---------NFIIHRDLKPSNLLLNDKGCVKIVY 215 (224)
Q Consensus 145 ~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---------~~iiHrDlkp~Nill~~~~~~kl~D 215 (224)
...|||+||.+.+.+..+.. ...++|....+++..+++||+|||+ ..|+|||||..|||+.+++++.|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~-~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLK-ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHH-hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 36899999998654444433 3569999999999999999999995 3599999999999999999999999
Q ss_pred ccccccc
Q psy13250 216 STYLELY 222 (224)
Q Consensus 216 fGla~~~ 222 (224)
||||..+
T Consensus 360 FGLAl~~ 366 (534)
T KOG3653|consen 360 FGLALRL 366 (534)
T ss_pred cceeEEe
Confidence 9999865
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=188.34 Aligned_cols=146 Identities=23% Similarity=0.326 Sum_probs=124.4
Q ss_pred eeEeeeeeccCceEEEEEEEccC----CeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQ----DKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~----~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
..+.+.||.|-||.||+|..... .-.||||.-+.+.. ...+.++.|..+|+++.|||||+++|++.+. .+||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~---P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ---PMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc---ceeE
Confidence 44567899999999999975432 34588886655333 4467789999999999999999999999543 6999
Q ss_pred EEeccc-CChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 150 VMEYCE-HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 150 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
|||++. |.|..++......++......|+.||+.||.|||+.+++||||..+|||+.....+||+||||+|.+-
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 999998 55777777777789999999999999999999999999999999999999999999999999998653
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=181.19 Aligned_cols=139 Identities=26% Similarity=0.360 Sum_probs=115.8
Q ss_pred eeeecc--CceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEG--SYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G--~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
..||+| +||+||++.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.. .+..|++|||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT--GSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec--CCceEEEEecc
Confidence 456666 999999999999999999998865432 223456678888888999999999999954 45789999999
Q ss_pred cC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccc
Q psy13250 155 EH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYL 219 (224)
Q Consensus 155 ~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla 219 (224)
.+ ++..++... ...+++..+..++.|++.||+|||+++|+||||||+|||++.++.++++|||.+
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~ 148 (328)
T cd08226 82 AYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHL 148 (328)
T ss_pred cCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHH
Confidence 86 455554432 235899999999999999999999999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=193.01 Aligned_cols=148 Identities=26% Similarity=0.336 Sum_probs=127.1
Q ss_pred ccceeEeeeeeccCceEEEEEEEccC---CeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQ---DKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
.++..+.++||+|.||+|++|.|... -..||||++..+... ....+++|+.+|.+|+|+|++++||+..+. .+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q---p~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ---PA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc---hh
Confidence 34577889999999999999998643 356999999765443 567889999999999999999999999752 68
Q ss_pred EEEEecccC-ChhHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEH-DLASLQDN-VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.||||++.. +|+..+.+ ....|.......|+.||+.|+.||.++++|||||...|+|+....++||+||||.|-+
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 899999985 56655554 4567889999999999999999999999999999999999999999999999999754
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=173.29 Aligned_cols=147 Identities=30% Similarity=0.507 Sum_probs=119.9
Q ss_pred ceeEeeeeeccCceEEEEEEEcc-CCeEEEEEEeeccCC----------ccchhHHHHHHHhhc-CCCCCeeeeeEEEEc
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSV-QDKILALKKLFLQNN----------TLTRGELREVTGLTK-CRHENIVQLKEVVVG 141 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~-~~~~~avK~~~~~~~----------~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~ 141 (224)
+|++.+.||+|+||.||++.+.. ++..+|+|.+..... .......+|+..+.+ ++|+||+.+++.+.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~- 79 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL- 79 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence 37888999999999999999887 678999998764321 112335667777764 79999999999984
Q ss_pred CCcceEEEEEecccC-ChhHhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCcEEEEec
Q psy13250 142 KSLSSIFLVMEYCEH-DLASLQD---NVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCVKIVYS 216 (224)
Q Consensus 142 ~~~~~~~lv~e~~~~-~l~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~kl~Df 216 (224)
..+..|++|||+.+ ++...+. .....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+||
T Consensus 80 -~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 80 -ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred -cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 44589999999986 4544432 234568999999999999999999996 78999999999999999999999999
Q ss_pred cccccc
Q psy13250 217 TYLELY 222 (224)
Q Consensus 217 Gla~~~ 222 (224)
|++...
T Consensus 159 g~~~~~ 164 (269)
T cd08528 159 GLAKQK 164 (269)
T ss_pred cceeec
Confidence 998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-26 Score=184.75 Aligned_cols=149 Identities=28% Similarity=0.414 Sum_probs=126.9
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-------ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-------TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
++|-++..||+|+|+.||+|.+....+.||+|+-.+..+ ...+...+|..+.+.+.||.||++|++|.-+ .+
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD-td 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD-TD 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec-cc
Confidence 568889999999999999999998889999997644321 1123446888999999999999999999744 35
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceecCCCCCcEEEcc---CCcEEEEeccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN--FIIHRDLKPSNLLLND---KGCVKIVYSTYLE 220 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~--~iiHrDlkp~Nill~~---~~~~kl~DfGla~ 220 (224)
.+|-|+|||+|+-++++.+.+..+++.+++.|+.||+.||.||.+. .|||-||||.|||+.. -|.+||.||||++
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 7899999999877777777778899999999999999999999975 5999999999999965 5789999999998
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
+.
T Consensus 622 IM 623 (775)
T KOG1151|consen 622 IM 623 (775)
T ss_pred hc
Confidence 75
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=174.26 Aligned_cols=141 Identities=29% Similarity=0.338 Sum_probs=115.5
Q ss_pred eeeccCceEEEEEEEccCC------eEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 80 RIGEGSYGVVYRVRDSVQD------KILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 80 ~lG~G~fg~V~~~~~~~~~------~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
.||+|+||.||+|...... ..+|+|.+..... .....+.+|+..++.++||||+++++++.. ....|++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL--NEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC--CCCeEEEEe
Confidence 5899999999999876443 6899997754321 234567789999999999999999999853 447899999
Q ss_pred cccC-ChhHhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC-----cEEEEeccccc
Q psy13250 153 YCEH-DLASLQDNV------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG-----CVKIVYSTYLE 220 (224)
Q Consensus 153 ~~~~-~l~~~~~~~------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~-----~~kl~DfGla~ 220 (224)
|+.+ ++...+... ...+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++|+|||+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 9985 555554331 23478899999999999999999999999999999999999887 89999999986
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
..
T Consensus 160 ~~ 161 (269)
T cd05044 160 DI 161 (269)
T ss_pred cc
Confidence 43
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-26 Score=189.59 Aligned_cols=147 Identities=22% Similarity=0.315 Sum_probs=128.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
.+.....+||-|.||.||.+.|+.....||||.++.+. ....++++|..+|+.++|||+|+++++|..+. .+|||+|
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep--PFYIiTE 343 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP--PFYIITE 343 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC--CeEEEEe
Confidence 45566788999999999999999999999999886443 45678899999999999999999999996544 7999999
Q ss_pred ccc-CChhHhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCE-HDLASLQDNVES-PFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~-~~l~~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||. |+|++++...++ -++.-..+.++.||..|++||..+++|||||...|.|+.++..+|++||||+|+.
T Consensus 344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 997 567777665543 4677777889999999999999999999999999999999999999999999975
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=164.33 Aligned_cols=150 Identities=21% Similarity=0.248 Sum_probs=122.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCC-CCeeeeeEEEEcCCcceEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRH-ENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~l 149 (224)
..+.|+++++||.|+||.+|.+.....|+.||||.-.... .......|..+...+++ ..|..+..+. .+...-.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYG--TEKDYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhc--ccccccee
Confidence 3567999999999999999999999999999999764322 22334567777776664 3454554444 44456789
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC---CcEEEEeccccccccC
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK---GCVKIVYSTYLELYLN 224 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~---~~~kl~DfGla~~~~~ 224 (224)
||++++.+|.++..-....++..+++.++-|++.-++|+|.++.|||||||+|+|..-. ..+.+||||||+.|.|
T Consensus 89 VMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 89 VMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred eeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 99999988888877777789999999999999999999999999999999999999754 4578999999998865
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=165.33 Aligned_cols=137 Identities=17% Similarity=0.229 Sum_probs=103.4
Q ss_pred EeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-----CCCCeeeeeEEEEcCCc-ceEE-E
Q psy13250 77 KLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-----RHENIVQLKEVVVGKSL-SSIF-L 149 (224)
Q Consensus 77 ~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~-~~~~-l 149 (224)
-.+.||+|+||.||. +..+... +||++........+...+|+..++.+ .||||+++++++..+.. +.++ +
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 347899999999995 6555554 69988765444556788999999998 57999999999965431 3434 7
Q ss_pred EEeccc---CChhHhhhhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCceecCCCCCcEEEccC----CcEEEEe-ccccc
Q psy13250 150 VMEYCE---HDLASLQDNVESPFTESQVKCVILQVLKGL-NYLHSNFIIHRDLKPSNLLLNDK----GCVKIVY-STYLE 220 (224)
Q Consensus 150 v~e~~~---~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l-~~lH~~~iiHrDlkp~Nill~~~----~~~kl~D-fGla~ 220 (224)
||||++ ++|..++.. ..+++. ..++.+++.++ +|||+++|+||||||+|||++.. +.++|+| ||.+.
T Consensus 83 I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~ 158 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGEST 158 (210)
T ss_pred EecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence 899954 356666644 346655 35678888877 89999999999999999999753 3799999 55443
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=177.50 Aligned_cols=143 Identities=27% Similarity=0.339 Sum_probs=118.2
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhc--CCCCCeeeeeEEEEcCC--cceEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTK--CRHENIVQLKEVVVGKS--LSSIF 148 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~--~~~~~ 148 (224)
.+..+.+.||+|.||.||+|.++ |+.||||++... .+..+.+|.++.+. ++|+||+.|++.-.... -..+|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 46889999999999999999875 888999998643 34566777777664 79999999987654322 24689
Q ss_pred EEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCcEEEccCCcEEEEecccc
Q psy13250 149 LVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHS--------NFIIHRDLKPSNLLLNDKGCVKIVYSTYL 219 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--------~~iiHrDlkp~Nill~~~~~~kl~DfGla 219 (224)
||++|.+. +|.+++.. ..++.+..+.++..++.||+|||. -.|.|||||..|||+.++|+|-|+|+|||
T Consensus 286 LvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 99999985 45555543 679999999999999999999994 24999999999999999999999999999
Q ss_pred ccc
Q psy13250 220 ELY 222 (224)
Q Consensus 220 ~~~ 222 (224)
-.+
T Consensus 364 v~h 366 (513)
T KOG2052|consen 364 VRH 366 (513)
T ss_pred EEe
Confidence 654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=184.13 Aligned_cols=154 Identities=23% Similarity=0.321 Sum_probs=113.1
Q ss_pred cccccceeEeeeeeccCceEEEEEEEc----------------cCCeEEEEEEeeccCCccch--------------hHH
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDS----------------VQDKILALKKLFLQNNTLTR--------------GEL 118 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~----------------~~~~~~avK~~~~~~~~~~~--------------~~~ 118 (224)
....++|++.++||+|+||+||+|... ..++.||||++........+ ...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 345678999999999999999998642 23467999998654322222 223
Q ss_pred HHHHHhhcCCCCCe-----eeeeEEEEcC------CcceEEEEEecccC-ChhHhhhhcC--------------------
Q psy13250 119 REVTGLTKCRHENI-----VQLKEVVVGK------SLSSIFLVMEYCEH-DLASLQDNVE-------------------- 166 (224)
Q Consensus 119 ~e~~~l~~l~h~ni-----v~~~~~~~~~------~~~~~~lv~e~~~~-~l~~~~~~~~-------------------- 166 (224)
.|+..+.+++|.++ +.+++++... ..+..|+||||+.+ ++..++....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 46666666666554 5566665321 12468999999986 4444433211
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 167 ---SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 167 ---~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~ 359 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDM 359 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCcccc
Confidence 12456778899999999999999999999999999999999999999999999653
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-24 Score=173.19 Aligned_cols=139 Identities=30% Similarity=0.395 Sum_probs=118.2
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC--------CCCeeeeeEEEE
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR--------HENIVQLKEVVV 140 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~ 140 (224)
..+.++|.+.++||.|.|++||+|.+....+.||+|+.+.. ....+..+.||.+|++++ -..||+|++.|.
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 34457899999999999999999999999999999988643 345566788999998863 247999999986
Q ss_pred --cCCcceEEEEEecccCChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccC
Q psy13250 141 --GKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDK 208 (224)
Q Consensus 141 --~~~~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~ 208 (224)
+.+..++|||+|+++..|+.++... ...++...++.|++||+.||.|||. +||||-||||+|||+...
T Consensus 153 hsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred ecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 3456689999999998898887765 4569999999999999999999995 699999999999999754
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=176.55 Aligned_cols=136 Identities=21% Similarity=0.283 Sum_probs=111.9
Q ss_pred CceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccCC-hhHh
Q psy13250 85 SYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHD-LASL 161 (224)
Q Consensus 85 ~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~-l~~~ 161 (224)
++|.||.++...++..+|+|++.... ......+.+|+..++.++|+||+++++++.. ....|++|||+.++ +..+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~--~~~~~~~~e~~~~~~l~~~ 89 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV--DSELYVVSPLMAYGSCEDL 89 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec--CCeEEEEEeccCCCCHHHH
Confidence 44556666666789999999987542 2334567889999999999999999999854 44789999999865 4444
Q ss_pred hhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 162 QDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 162 ~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||.+..+
T Consensus 90 l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~ 151 (314)
T cd08216 90 LKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSM 151 (314)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceee
Confidence 4432 346899999999999999999999999999999999999999999999999988643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=169.78 Aligned_cols=139 Identities=32% Similarity=0.451 Sum_probs=118.8
Q ss_pred eeccCceEEEEEEEccCCeEEEEEEeeccCCc---cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccC-
Q psy13250 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNT---LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH- 156 (224)
Q Consensus 81 lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~- 156 (224)
||+|+||.||++.+..++..+|+|.+...... ....+..|+.++++++|+||+++++.+ .....+|++|||+.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~~~~v~e~~~~~ 78 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF--QTEEKLYLVLEYAPGG 78 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe--ecCCeeEEEEecCCCC
Confidence 69999999999999888999999988654321 234567889999999999999999888 445589999999964
Q ss_pred ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 157 DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 157 ~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
++...+.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 143 (250)
T cd05123 79 ELFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKEL 143 (250)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceec
Confidence 55555543 446899999999999999999999999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=170.43 Aligned_cols=148 Identities=22% Similarity=0.299 Sum_probs=124.5
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
-.|++.++||+|+||+.+.+.+..+++.||||.-.... ..-....|.+..+.| ..++|...|.+. .+..+-.|||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLVi 103 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILVI 103 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhhh
Confidence 36999999999999999999999999999999654322 233445566666665 457887776544 5555667999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC-----cEEEEeccccccccC
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG-----CVKIVYSTYLELYLN 224 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~-----~~kl~DfGla~~~~~ 224 (224)
|+++.+|.+++....+.|+..++..++.|++.-++|+|++.+|+|||||+|+||...+ .+.|+|||+|+.|+|
T Consensus 104 dLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 104 DLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred hhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 9999999998888888999999999999999999999999999999999999998654 589999999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=168.99 Aligned_cols=130 Identities=28% Similarity=0.340 Sum_probs=108.9
Q ss_pred cCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccCC-hhHhh
Q psy13250 84 GSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHD-LASLQ 162 (224)
Q Consensus 84 G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~ 162 (224)
|.||.||++.+..+++.+|+|.+..... ..+|...+....||||+++++.+.. ....|++|||+.++ +...+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheec--CCeEEEEEecCCCCCHHHHH
Confidence 8999999999999999999999865421 2234444555679999999999854 45899999999864 55554
Q ss_pred hhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 163 DNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 163 ~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++++|||++..
T Consensus 77 ~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~ 134 (237)
T cd05576 77 SK-FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSE 134 (237)
T ss_pred HH-hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhc
Confidence 43 45689999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=170.75 Aligned_cols=146 Identities=29% Similarity=0.411 Sum_probs=117.1
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC-----CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN-----NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
+|.+.+.||+|+||.||++.+..++..+++|.++... ........+|+..++.++||||+++++.+.+ ....|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE--RDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc--CCceE
Confidence 4888999999999999999988776666666554211 1122345578889999999999999998843 44789
Q ss_pred EEEecccCC-hhHhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHD-LASLQD---NVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~-l~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
++|||+.++ +...+. .....+++..+..++.|++.||.|||+++++|+||+|+||+++. +.++|+|||+++.+
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 79 IITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeec
Confidence 999999864 444333 22456899999999999999999999999999999999999975 67999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=186.37 Aligned_cols=150 Identities=25% Similarity=0.339 Sum_probs=103.3
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccC----CeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEE----
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQ----DKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVV---- 140 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~----~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~---- 140 (224)
....++|++.+.||+|+||.||+|.+..+ +..+|+|++..... .+....+ .+....+.++..+...+.
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 34567899999999999999999999888 89999998743211 1111111 111222222222221111
Q ss_pred cCCcceEEEEEecccCC-hhHhhhhcCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy13250 141 GKSLSSIFLVMEYCEHD-LASLQDNVESP-------------------FTESQVKCVILQVLKGLNYLHSNFIIHRDLKP 200 (224)
Q Consensus 141 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~-------------------l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp 200 (224)
.......|+||||++++ +..++...... .....+..++.|++.||.|||+++|+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 13345789999999864 44444322111 12344667999999999999999999999999
Q ss_pred CcEEEcc-CCcEEEEeccccccc
Q psy13250 201 SNLLLND-KGCVKIVYSTYLELY 222 (224)
Q Consensus 201 ~Nill~~-~~~~kl~DfGla~~~ 222 (224)
+|||++. ++.+||+|||+|+.+
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l 306 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADL 306 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccc
Confidence 9999996 579999999999743
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=181.12 Aligned_cols=145 Identities=26% Similarity=0.367 Sum_probs=117.7
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhc-CCCCCeeeeeEEEEcCCcceEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTK-CRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~l 149 (224)
....|.+...+|.|+|+.|..|.+..++...++|++.... ....+|+.++.. -.||||+++.+.+ .....+|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~--~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVY--EDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeeccee--cCCceeee
Confidence 3567889999999999999999999999999999986542 222345544433 4799999999999 55568999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE-ccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL-NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill-~~~~~~kl~DfGla~~~ 222 (224)
|||++.|+...........+. ..+..|+.+|+.|+.|||++|++||||||+|||+ +..|+++|+|||+|+..
T Consensus 394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 999999864433333233333 7788899999999999999999999999999999 69999999999999865
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=164.24 Aligned_cols=142 Identities=18% Similarity=0.078 Sum_probs=108.2
Q ss_pred ceeEeeeeeccCceEEEEEE-EccCCeEEEEEEeeccCCcc------------------------chhHHHHHHHhhcCC
Q psy13250 74 EFEKLNRIGEGSYGVVYRVR-DSVQDKILALKKLFLQNNTL------------------------TRGELREVTGLTKCR 128 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~-~~~~~~~~avK~~~~~~~~~------------------------~~~~~~e~~~l~~l~ 128 (224)
.|.+.+.||+|+||.||+|. +..++..||+|++....... .....+|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58889999999999999998 66789999999887532110 012346888888886
Q ss_pred CCC--eeeeeEEEEcCCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceecCCCCCcEEE
Q psy13250 129 HEN--IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF-IIHRDLKPSNLLL 205 (224)
Q Consensus 129 h~n--iv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-iiHrDlkp~Nill 205 (224)
+.+ +..++.. . ..|+||||+++............+....+..++.|++.++.+||.+| |+||||||+||++
T Consensus 109 ~~~i~~p~~~~~---~---~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW---R---RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe---c---CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 533 2333332 1 34899999998544332222345666777899999999999999999 9999999999999
Q ss_pred ccCCcEEEEeccccccc
Q psy13250 206 NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 206 ~~~~~~kl~DfGla~~~ 222 (224)
+ ++.++|+|||+|...
T Consensus 183 ~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred E-CCCEEEEEChhhhcc
Confidence 9 889999999999743
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=166.44 Aligned_cols=147 Identities=22% Similarity=0.345 Sum_probs=121.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCC------CeeeeeEEEEcCCcc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHE------NIVQLKEVVVGKSLS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~~ 145 (224)
.++|.++..+|+|.||.|..|.+..++..||+|+++... ...+..+-|+..|.++.+. -+|.+.++| +-.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF--dyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF--DYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh--hccC
Confidence 578999999999999999999999999999999886433 2344556688888888432 356666777 5567
Q ss_pred eEEEEEecccCChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc-----------------
Q psy13250 146 SIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND----------------- 207 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~----------------- 207 (224)
.+|||+|.++-++.+++... ..+++...++.++.|++.++.|||+.+++|-||||+|||+..
T Consensus 165 hiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 165 HICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred ceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 89999999997777777653 447999999999999999999999999999999999999952
Q ss_pred ---CCcEEEEecccccc
Q psy13250 208 ---KGCVKIVYSTYLEL 221 (224)
Q Consensus 208 ---~~~~kl~DfGla~~ 221 (224)
...++|+|||.|..
T Consensus 245 ~~ks~~I~vIDFGsAtf 261 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATF 261 (415)
T ss_pred cCCCcceEEEecCCcce
Confidence 23589999999974
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=185.13 Aligned_cols=146 Identities=23% Similarity=0.298 Sum_probs=125.9
Q ss_pred ceeEeeeeeccCceEEEEEEEccCC----eEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQD----KILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~----~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
..+..++||+|+||+||+|.+...+ .+||+|++..... ....+++.|+..|.++.|||++++++++... .+.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s---~~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS---TLQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc---hHH
Confidence 3556789999999999999886655 4688887754332 3456778999999999999999999999543 478
Q ss_pred EEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||++||+. .|+++....+..+..+..+.+..||+.|+.|||.++++||||..+|+|+.....+||.|||+|+.+
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 99999985 577777777888999999999999999999999999999999999999999999999999999865
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.2e-23 Score=166.84 Aligned_cols=146 Identities=25% Similarity=0.301 Sum_probs=120.4
Q ss_pred ceeEeeeeeccCceEEEEEEEccCC-eEEEEEEeeccCCccchhHHHHHHHhhcCCC----CCeeeeeEEEEcCCcceEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQD-KILALKKLFLQNNTLTRGELREVTGLTKCRH----ENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~~~~~~~~~~ 148 (224)
+|++.+.||+|+||.||.|.+...+ ..+|+|............+..|..++..+.. +++..+++... .....-|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence 7999999999999999999987664 6789997765433332356677777777652 57777777663 2345789
Q ss_pred EEEecccCChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC-----CcEEEEeccccc
Q psy13250 149 LVMEYCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK-----GCVKIVYSTYLE 220 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~-----~~~kl~DfGla~ 220 (224)
+||+.++.+|..+..... +.++..++..++.|++.+|++||+.|++||||||+|+++... ..+.|+|||+|+
T Consensus 98 iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 98 IVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 999999988888876554 679999999999999999999999999999999999999875 468999999998
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-22 Score=156.68 Aligned_cols=146 Identities=36% Similarity=0.553 Sum_probs=125.5
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEec
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEY 153 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 153 (224)
|.+.+.||.|++|.||++....++..+|+|.+...... ....+.+|+..+..++|+|++++++.+.. ....++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~--~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED--PEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec--CCceEEEEec
Confidence 56778999999999999999888899999998765443 45667789999999999999999998854 3578999999
Q ss_pred ccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 154 CEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 154 ~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+.+ ++...+......+++..+..++.+++.++.|||+++++|+||+|.||+++.++.++|+|||++..+
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 987 566555543322889999999999999999999999999999999999999999999999998765
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-24 Score=167.26 Aligned_cols=145 Identities=31% Similarity=0.463 Sum_probs=123.7
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeec--cCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcC----Ccce
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTGLTKCRHENIVQLKEVVVGK----SLSS 146 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~~ 146 (224)
.+|.-++.+|.|+- .|..+.+.-.+++||+|+... .+....++..+|..++..+.|+||++++.+|.-. ....
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46888999999998 777888888899999997743 3345567788999999999999999999998522 1235
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+|+|||+|..++-.... -.+.-+++..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+-
T Consensus 96 ~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence 89999999987766654 2367788999999999999999999999999999999999999999999999963
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9e-23 Score=157.06 Aligned_cols=140 Identities=13% Similarity=0.115 Sum_probs=108.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchh---------HHHHHHHhhcCCCCCeeeeeEEEEcC
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRG---------ELREVTGLTKCRHENIVQLKEVVVGK 142 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~---------~~~e~~~l~~l~h~niv~~~~~~~~~ 142 (224)
.++|+..+.||.|+||.||++.. ++..+|+|++.......... +.+|+..+.++.|++|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 46799999999999999999765 36679999886443322222 45788889999999999998886533
Q ss_pred C------cceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEec
Q psy13250 143 S------LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYS 216 (224)
Q Consensus 143 ~------~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~Df 216 (224)
. .+..+++|||++|..+.... .+++ ....+++.+|..+|+.|++|||+||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 2 23578999999985332221 1333 2456899999999999999999999999999988 999999
Q ss_pred cccccc
Q psy13250 217 TYLELY 222 (224)
Q Consensus 217 Gla~~~ 222 (224)
|..+.+
T Consensus 179 g~~~~~ 184 (232)
T PRK10359 179 SGKRCT 184 (232)
T ss_pred CCcccc
Confidence 988654
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-23 Score=161.06 Aligned_cols=146 Identities=24% Similarity=0.313 Sum_probs=117.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.+.|.+.+.||+|.||.+.+|+++.+...+++|.+.... ...+.+.+|...--.+ .|.||+.-|++-. ...+..+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF-qt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAF-QTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHh-hcCceEEEe
Confidence 457999999999999999999999999999999775332 3456777887653333 5899998776654 344578899
Q ss_pred Eeccc-CChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc--CCcEEEEecccccc
Q psy13250 151 MEYCE-HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND--KGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~--~~~~kl~DfGla~~ 221 (224)
+||++ |+|.+-+.. ..+-+.....++.|+++|+.|+|+++++|||||.+||||-. .-.+||||||+.+.
T Consensus 101 qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccc
Confidence 99998 455544432 45888899999999999999999999999999999999964 34799999999863
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.3e-22 Score=149.61 Aligned_cols=140 Identities=42% Similarity=0.659 Sum_probs=120.3
Q ss_pred eeccCceEEEEEEEccCCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccC-Ch
Q psy13250 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DL 158 (224)
Q Consensus 81 lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l 158 (224)
||+|.+|.||++....++..+++|+....... ....+.+|+..++.+.|++++++++.+.. ....++++|++.+ ++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED--ENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec--CCeEEEEEecCCCCcH
Confidence 68999999999999888999999988654322 23567889999999999999999999854 3589999999994 56
Q ss_pred hHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc-CCcEEEEeccccccc
Q psy13250 159 ASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND-KGCVKIVYSTYLELY 222 (224)
Q Consensus 159 ~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~-~~~~kl~DfGla~~~ 222 (224)
..++......+++..+..++.+++.++.+||+.+++|+||+|.||+++. ++.++|+|||.+..+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~ 143 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEc
Confidence 6665543356899999999999999999999999999999999999999 899999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=184.21 Aligned_cols=137 Identities=20% Similarity=0.335 Sum_probs=113.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
..|...+.||+|+||.||+|.+..++..||+|++..... ....|+..+++++||||+++++++... ...|+|||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~--~~~~lv~E 763 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSE--KGAYLIHE 763 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcC--CCCEEEEe
Confidence 456677889999999999999988999999998753221 223468889999999999999999543 47899999
Q ss_pred cccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 153 YCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLH---SNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 153 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
|++++ +...+. .+++.....++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+.
T Consensus 764 y~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 764 YIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred CCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 99865 544443 3889999999999999999999 6799999999999999998888775 66543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.8e-22 Score=148.85 Aligned_cols=131 Identities=15% Similarity=0.089 Sum_probs=98.9
Q ss_pred eEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc----cchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEEEE
Q psy13250 76 EKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT----LTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 76 ~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv 150 (224)
.+...|++|+||+|+.+.. .+..++.+.+.....- ....+.+|+.+|+++. |++++.++++. ..|++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLD 76 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEE
Confidence 3457899999999997764 5666776655432210 1124578999999995 47788887752 46899
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC-CCCcEEEccCCcEEEEecccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDL-KPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDl-kp~Nill~~~~~~kl~DfGla~~ 221 (224)
|||+.|..+.... +.. ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|..
T Consensus 77 meyI~G~~L~~~~------~~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~ 141 (218)
T PRK12274 77 RSYLAGAAMYQRP------PRG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVR 141 (218)
T ss_pred EeeecCccHHhhh------hhh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCcee
Confidence 9999886443211 111 2357789999999999999999999 79999999999999999999974
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.4e-23 Score=164.88 Aligned_cols=142 Identities=28% Similarity=0.447 Sum_probs=120.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEcc---CCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSV---QDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~ 147 (224)
.+.|..+++||+|.|++||++.+.. .++.||+|.+.... ...++..|+..|..+ .+.||+.+.+.+ ...+.+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~--rnnd~v 110 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCF--RNNDQV 110 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhh--ccCCee
Confidence 3568999999999999999998776 78899999886553 345678899999887 589999999998 566789
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC-CcEEEEeccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK-GCVKIVYSTYLE 220 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfGla~ 220 (224)
.+||||++..-...+.. .++...++.|++.++.||.++|.+|||||||||+|+|++.. +.-.|+|||||.
T Consensus 111 ~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 99999999754433332 36788999999999999999999999999999999999874 567899999996
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=174.03 Aligned_cols=151 Identities=23% Similarity=0.308 Sum_probs=124.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEc---c----CCeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS---V----QDKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVG 141 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~---~----~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 141 (224)
..++..+.+.||+|+||.|++|... . ....||||.++.... ...+.+..|+..|+.+ .|+||+.+.+++..
T Consensus 294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~ 373 (609)
T KOG0200|consen 294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ 373 (609)
T ss_pred chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence 4455667779999999999998743 1 256799998864433 3345667899999887 59999999999954
Q ss_pred CCcceEEEEEeccc-CChhHhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy13250 142 KSLSSIFLVMEYCE-HDLASLQDNVE---------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL 205 (224)
Q Consensus 142 ~~~~~~~lv~e~~~-~~l~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill 205 (224)
.+.+++|+||+. |++..++...+ ..++..+...++.||+.|++||++..++||||..+|||+
T Consensus 374 --~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 374 --DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLI 451 (609)
T ss_pred --CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEe
Confidence 568999999997 56777666555 348899999999999999999999999999999999999
Q ss_pred ccCCcEEEEecccccccc
Q psy13250 206 NDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 206 ~~~~~~kl~DfGla~~~~ 223 (224)
..+..+||+|||||+...
T Consensus 452 ~~~~~~kIaDFGlar~~~ 469 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHY 469 (609)
T ss_pred cCCCEEEEccccceeccC
Confidence 999999999999998643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=149.96 Aligned_cols=133 Identities=21% Similarity=0.218 Sum_probs=102.8
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccCCc--------cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--------LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
+.||+|++|.||+|.. .+..+++|+....... ......+|+..+..+.|+++.....++.+. ...+++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~~~lv 77 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP--ENFIIV 77 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC--CCCEEE
Confidence 5789999999999987 5667888875432211 112456788899999998887666555433 367899
Q ss_pred EecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 151 MEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|||++|. +...... . .. ....++.+++.+|.++|+.+++|+|++|+|||++ ++.++|+|||+++.
T Consensus 78 ~e~~~G~~L~~~~~~-~---~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINS-N---GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHh-c---cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999874 4444332 1 12 7788899999999999999999999999999999 88999999999874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=149.73 Aligned_cols=135 Identities=21% Similarity=0.164 Sum_probs=101.9
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCcc----------------------chhHHHHHHHhhcCCCCC-
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTL----------------------TRGELREVTGLTKCRHEN- 131 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~----------------------~~~~~~e~~~l~~l~h~n- 131 (224)
|.+.+.||+|+||.||++... +++.+|||++....... .....+|...+..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 777899999999999999875 78999999876432110 012356777888887764
Q ss_pred -eeeeeEEEEcCCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc
Q psy13250 132 -IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC 210 (224)
Q Consensus 132 -iv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 210 (224)
+...++. ...+++|||++|..+..... ......++.+++.++.++|+.||+||||||+||+++.++.
T Consensus 96 ~v~~~~~~------~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~ 163 (198)
T cd05144 96 PVPKPIDW------NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEK 163 (198)
T ss_pred CCCceeec------CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCc
Confidence 3333321 24589999999854332211 1345678899999999999999999999999999999999
Q ss_pred EEEEeccccccc
Q psy13250 211 VKIVYSTYLELY 222 (224)
Q Consensus 211 ~kl~DfGla~~~ 222 (224)
++|+|||.|..+
T Consensus 164 ~~liDfg~~~~~ 175 (198)
T cd05144 164 IYIIDWPQMVST 175 (198)
T ss_pred EEEEECCccccC
Confidence 999999999643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=150.13 Aligned_cols=135 Identities=39% Similarity=0.588 Sum_probs=116.3
Q ss_pred CceEEEEEEEccCCeEEEEEEeeccCCcc-chhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccC-ChhHhh
Q psy13250 85 SYGVVYRVRDSVQDKILALKKLFLQNNTL-TRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQ 162 (224)
Q Consensus 85 ~fg~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~ 162 (224)
+||.||+|.+..++..+++|++....... ...+.+|+..+++++|+||+++++.+.. ....++++||+.+ ++...+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED--EDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee--CCEEEEEEeCCCCCCHHHHH
Confidence 58999999999889999999986554433 5677889999999999999999999854 3588999999987 565555
Q ss_pred hhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 163 DNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 163 ~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.. ...+++..+..++.+++.++.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus 79 ~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~ 137 (244)
T smart00220 79 KK-RGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQL 137 (244)
T ss_pred Hh-ccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeee
Confidence 44 333899999999999999999999999999999999999999999999999998754
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-22 Score=171.09 Aligned_cols=141 Identities=27% Similarity=0.399 Sum_probs=111.2
Q ss_pred eeEeeeeeccCceE-EEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 75 FEKLNRIGEGSYGV-VYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 75 ~~~~~~lG~G~fg~-V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
|.-.+.+|.|+-|+ ||+|.. .++.||||++-. +......+|+..|+.. .|||||++|+.- .+....||+.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEEeh
Confidence 44456789999876 577764 578999998742 2234557899998877 599999998776 55668999999
Q ss_pred cccCChhHhhhhc--CCCCC-HHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc---CC--cEEEEeccccccc
Q psy13250 153 YCEHDLASLQDNV--ESPFT-ESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND---KG--CVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~l~~~~~~~--~~~l~-~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~---~~--~~kl~DfGla~~~ 222 (224)
+|..+|.+++... ..... ....+..+.|++.||++||+.+||||||||.||||.. ++ .++|+|||+++.+
T Consensus 584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9999888887763 11111 1455778899999999999999999999999999987 34 6899999999864
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=161.92 Aligned_cols=147 Identities=20% Similarity=0.285 Sum_probs=123.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC------CCCeeeeeEEEEcCCcce
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR------HENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~~~~~~~~~~~ 146 (224)
++|.+....|+|-|++|.+|.+...+..||||+|...+ ...+.=++|+.+|++|. --+.+.|+..|. -.++
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~--hknH 508 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK--HKNH 508 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh--hcce
Confidence 46889999999999999999999999999999986332 23345578999999985 236778887774 4458
Q ss_pred EEEEEecccCChhHhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC-cEEEEeccccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVE--SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG-CVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfGla~~~ 222 (224)
+|||+|-+..+|..++.... ..|....++.|+.|++.||..|-.+||+|.||||+|||+++.. .+||||||.|.+.
T Consensus 509 LClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 509 LCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred eEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccc
Confidence 99999999888887776653 3588899999999999999999999999999999999999854 5799999999653
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.4e-21 Score=165.01 Aligned_cols=135 Identities=17% Similarity=0.085 Sum_probs=101.4
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc--CC------ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ--NN------TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~--~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
.|...+.||+|+||+||++.+.... +++|+.... .. .....+.+|+.++..++|++++....+.... .
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~ 409 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP--E 409 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC--C
Confidence 3566789999999999998865433 344432211 11 1123467899999999999998876665433 3
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
..++||||+++..+..... ....++.+++.+|.|||+.+++||||||+|||+ .++.++|+|||+|+.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 5689999998754332221 346788999999999999999999999999999 678999999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.5e-21 Score=144.57 Aligned_cols=131 Identities=16% Similarity=0.122 Sum_probs=96.2
Q ss_pred eeeccCceEEEEEEEccCCeEEEEEEeeccCCc--------cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--------LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 80 ~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.||+|+||.||++.. .+..+++|........ ......+|+.++..+.|+++.....++.... ..+++|
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--~~~lv~ 76 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD--NKTIVM 76 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC--CCEEEE
Confidence 379999999999984 5677888975432111 1134457889999888876554433333232 568999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||++|..+......... .++.+++.+|.+||+.+++|+|++|+||+++ ++.++++|||+|+..
T Consensus 77 e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 77 EYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred EEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99987533322221110 7889999999999999999999999999999 899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=141.44 Aligned_cols=134 Identities=20% Similarity=0.191 Sum_probs=93.0
Q ss_pred eeeeeccCceEEEEEEEccCCeEEEEEEeeccCCcc--chhH----------------------HHHHHHhhcCCCCC--
Q psy13250 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTL--TRGE----------------------LREVTGLTKCRHEN-- 131 (224)
Q Consensus 78 ~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~--~~~~----------------------~~e~~~l~~l~h~n-- 131 (224)
.+.||+|+||+||+|.+. ++..||||++....... .... ..|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999976 78899999876432211 1110 13444444443332
Q ss_pred eeeeeEEEEcCCcceEEEEEecccCChhH--hhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccC
Q psy13250 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLAS--LQDNVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDK 208 (224)
Q Consensus 132 iv~~~~~~~~~~~~~~~lv~e~~~~~l~~--~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~ 208 (224)
+...++. ...+++|||++++... .+... .....+..++.+++.++.++|. ++|+|+||||+||+++ +
T Consensus 81 ~~~~~~~------~~~~lv~e~~~g~~~~~~~l~~~---~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 81 VPKPIDL------NRHVLVMEFIGGDGIPAPRLKDV---RLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D 150 (187)
T ss_pred CCceEec------CCCEEEEEEeCCCCccChhhhhh---hhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C
Confidence 2333322 1358999999873211 11111 1116678899999999999999 9999999999999999 9
Q ss_pred CcEEEEeccccccc
Q psy13250 209 GCVKIVYSTYLELY 222 (224)
Q Consensus 209 ~~~kl~DfGla~~~ 222 (224)
+.++|+|||.|...
T Consensus 151 ~~~~liDfg~a~~~ 164 (187)
T cd05119 151 GKVYIIDVPQAVEI 164 (187)
T ss_pred CcEEEEECcccccc
Confidence 99999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.3e-18 Score=140.41 Aligned_cols=143 Identities=38% Similarity=0.569 Sum_probs=119.1
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc---cchhHHHHHHHhhcCCCC-CeeeeeEEEEcCCcceEEEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT---LTRGELREVTGLTKCRHE-NIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~lv 150 (224)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+..+..+.|+ +++.+++.+. .....+++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~--~~~~~~~~ 76 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ--DEGSLYLV 76 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe--cCCEEEEE
Confidence 678889999999999999987 67888988654332 356678899999999988 7999999983 33458999
Q ss_pred EecccCChhHhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC-cEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVES---PFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG-CVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfGla~~~ 222 (224)
++++.+........... .++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||+++.+
T Consensus 77 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~ 152 (384)
T COG0515 77 MEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLL 152 (384)
T ss_pred EecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceec
Confidence 99998754443333332 689999999999999999999999999999999999999998 7999999998743
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-18 Score=136.16 Aligned_cols=136 Identities=18% Similarity=0.187 Sum_probs=98.5
Q ss_pred eeee-ccCceEEEEEEEccCCeEEEEEEeeccC-------C------ccchhHHHHHHHhhcCCCCCe--eeeeEEEEcC
Q psy13250 79 NRIG-EGSYGVVYRVRDSVQDKILALKKLFLQN-------N------TLTRGELREVTGLTKCRHENI--VQLKEVVVGK 142 (224)
Q Consensus 79 ~~lG-~G~fg~V~~~~~~~~~~~~avK~~~~~~-------~------~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~ 142 (224)
..|| .|+.|+||.+... +..+++|...... . .......+|+..+..+.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 7888888888764 6778898774211 0 122456789999999988775 5555554322
Q ss_pred Cc--ceEEEEEecccC--ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccc
Q psy13250 143 SL--SSIFLVMEYCEH--DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTY 218 (224)
Q Consensus 143 ~~--~~~~lv~e~~~~--~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGl 218 (224)
.. ...++|||+++| ++...+.. ..+++.. +.+++.+|.+||++||+||||||+|||++.++.++|+|||.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 21 123599999986 45444432 3455543 56889999999999999999999999999999999999999
Q ss_pred cccc
Q psy13250 219 LELY 222 (224)
Q Consensus 219 a~~~ 222 (224)
++..
T Consensus 189 ~~~~ 192 (239)
T PRK01723 189 GELR 192 (239)
T ss_pred cccC
Confidence 9764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.79 E-value=1e-18 Score=126.72 Aligned_cols=132 Identities=21% Similarity=0.205 Sum_probs=104.8
Q ss_pred EeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCC--CCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 77 KLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRH--ENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 77 ~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+++.||+|.++.||++.... ..+++|....... ...+.+|+..+..+.| .++.+++... ...+..|++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~--~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASG--ESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCCccEEEEEec
Confidence 45789999999999999753 6789998754332 3456788888888876 4888887776 3335789999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN---FIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.+.....+ +......++.+++.++.++|.. +++|+|++|+||+++..+.++++|||+++.
T Consensus 76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 87433221 5566677889999999999984 699999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.4e-17 Score=149.11 Aligned_cols=142 Identities=27% Similarity=0.293 Sum_probs=103.2
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC---CCCeeeeeEEEEcCCcceEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR---HENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~ 148 (224)
...|.+-+.||+|+||.||+|.... ++.+|+|+-+..+ .+.-.+- .+++.+|+ -+.|..+....+..+ .-+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~-~WEfYI~--~q~~~RLk~~~~~~~~~~~~a~~~~~--~S~ 770 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN-PWEFYIC--LQVMERLKPQMLPSIMHISSAHVFQN--ASV 770 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC-ceeeeeh--HHHHHhhchhhhcchHHHHHHHccCC--cce
Confidence 4568999999999999999999887 9999999765332 1211111 12223333 122333333332222 457
Q ss_pred EEEeccc-CChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC-------CcEEEEeccccc
Q psy13250 149 LVMEYCE-HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK-------GCVKIVYSTYLE 220 (224)
Q Consensus 149 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~-------~~~kl~DfGla~ 220 (224)
+|+||.+ |+++.+.. ..+..++..+.+++.|++.-++.||..+|||+||||+|+||... -.++|||||-|-
T Consensus 771 lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 9999998 45666655 56678999999999999999999999999999999999999642 358999999874
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.2e-17 Score=134.22 Aligned_cols=152 Identities=19% Similarity=0.224 Sum_probs=115.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCC-----eEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQD-----KILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~-----~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
...++++...+-+|.||.||.|.+...+ +.+-+|.++.... -....++.|...+..+.|||+..+.++... +.
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie-~~ 360 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE-DY 360 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee-cc
Confidence 3456888889999999999999665322 2233443322211 122345677778888899999999998874 44
Q ss_pred ceEEEEEeccc-CChhHhhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEec
Q psy13250 145 SSIFLVMEYCE-HDLASLQDNV-------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYS 216 (224)
Q Consensus 145 ~~~~lv~e~~~-~~l~~~~~~~-------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~Df 216 (224)
...+.++.+++ |++..++... ...++..+...++.|++.|++|||.++|||.||..+|.+|++.-++||+|-
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 57788888887 4455454411 224778888899999999999999999999999999999999999999999
Q ss_pred ccccccc
Q psy13250 217 TYLELYL 223 (224)
Q Consensus 217 Gla~~~~ 223 (224)
.|+|.++
T Consensus 441 aLSRDLF 447 (563)
T KOG1024|consen 441 ALSRDLF 447 (563)
T ss_pred hhccccC
Confidence 9999764
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.65 E-value=8e-17 Score=140.65 Aligned_cols=144 Identities=28% Similarity=0.427 Sum_probs=106.0
Q ss_pred eEeeeeeccCceEEEEEEEccCCeEEEEEEeecc--CCc----cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 76 EKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ--NNT----LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 76 ~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~--~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.....+|.|++|.|+.+......+..+.|..... ... ....+..|..+-..+.|+|++.....+.+ ....+-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~--~~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQE--IDGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhh--cccchh
Confidence 4567799999998887776655555555543211 111 11113345555567899998876555532 223344
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||++++..++.. ...+...++..++.|++.|++|+|+.||.|||+|++|+++...|.+||+|||.+..+
T Consensus 399 ~mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf 470 (601)
T KOG0590|consen 399 SMEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVF 470 (601)
T ss_pred hhhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceee
Confidence 599999866666654 356888999999999999999999999999999999999999999999999999765
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.7e-17 Score=146.01 Aligned_cols=91 Identities=20% Similarity=0.203 Sum_probs=69.8
Q ss_pred CC-CCeeeeeEEEEc-----CCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy13250 128 RH-ENIVQLKEVVVG-----KSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPS 201 (224)
Q Consensus 128 ~h-~niv~~~~~~~~-----~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~ 201 (224)
.| .||..+++++.. .....++++||+++++|..++......+++..++.++.||+.||.|||++||+||||||+
T Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~ 109 (793)
T PLN00181 30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPS 109 (793)
T ss_pred hHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCch
Confidence 44 466666666511 112367888999998888888665567999999999999999999999999999999999
Q ss_pred cEEEccCCcEEEEeccc
Q psy13250 202 NLLLNDKGCVKIVYSTY 218 (224)
Q Consensus 202 Nill~~~~~~kl~DfGl 218 (224)
||||+..|.+|++|||+
T Consensus 110 NiLl~~~~~~k~~d~~~ 126 (793)
T PLN00181 110 CFVMSSFNHVSFIESAS 126 (793)
T ss_pred hEEEcccCcEEEeeccc
Confidence 99996544444444433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-15 Score=129.27 Aligned_cols=139 Identities=20% Similarity=0.166 Sum_probs=89.1
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccCCccc----------------------------------------hhHH
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLT----------------------------------------RGEL 118 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~----------------------------------------~~~~ 118 (224)
+.||.|++|+||+|+.. +|+.||||+.+..-.... -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999875 688999998753211000 0122
Q ss_pred HHHHHhhcC----CCCCeeeeeEEEEcCCcceEEEEEecccCChhH-hhhhcCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q psy13250 119 REVTGLTKC----RHENIVQLKEVVVGKSLSSIFLVMEYCEHDLAS-LQDNVESPFTESQVKCVILQVLK-GLNYLHSNF 192 (224)
Q Consensus 119 ~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~-~~~~~~~~l~~~~~~~~~~~i~~-~l~~lH~~~ 192 (224)
+|...+.++ .+.+-+.+-.++.+- ....++||||++|.... .......... ...++..++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 344433333 233333333333211 23468999999875333 2221111222 2345555554 467889999
Q ss_pred ceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 193 IIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 193 iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
++|+|++|.||+++.+|.++++|||++..+
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 999999999999999999999999999765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=7.8e-15 Score=110.73 Aligned_cols=136 Identities=18% Similarity=0.172 Sum_probs=94.3
Q ss_pred eeeeccCceEEEEEEEcc------CCeEEEEEEeeccC------------C-c---------cchhH----HHHHHHhhc
Q psy13250 79 NRIGEGSYGVVYRVRDSV------QDKILALKKLFLQN------------N-T---------LTRGE----LREVTGLTK 126 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~------~~~~~avK~~~~~~------------~-~---------~~~~~----~~e~~~l~~ 126 (224)
..||.|-=+.||.|.... .+..+|+|+.+... . . ..+.. .+|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 35789999775311 0 0 01111 268888887
Q ss_pred CCC--CCeeeeeEEEEcCCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcE
Q psy13250 127 CRH--ENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL-HSNFIIHRDLKPSNL 203 (224)
Q Consensus 127 l~h--~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l-H~~~iiHrDlkp~Ni 203 (224)
+.. -++...+.+. .-+|||||++++...........++...+..+..+++.+|..| |..||+|+||++.||
T Consensus 83 l~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 753 3444555432 3479999998642211111123455666777889999999998 899999999999999
Q ss_pred EEccCCcEEEEecccccc
Q psy13250 204 LLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 204 ll~~~~~~kl~DfGla~~ 221 (224)
|+. ++.+.|+|||.|-.
T Consensus 157 L~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred EEE-CCcEEEEECCCcee
Confidence 997 57899999998854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.61 E-value=5e-16 Score=133.43 Aligned_cols=141 Identities=16% Similarity=0.142 Sum_probs=89.9
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc----------------------------------cch---
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT----------------------------------LTR--- 115 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~----------------------------------~~~--- 115 (224)
.+|+. +.||.|++|+||+|+...+|+.||||+.+..-.. ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 7899999999999999888999999998643100 001
Q ss_pred ---hHHHHHHHhhcC----CCCCeeeeeEEEEcCCcceEEEEEecccCChhHhhhh--cCC----CCCHHHHHHHHHHHH
Q psy13250 116 ---GELREVTGLTKC----RHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDN--VES----PFTESQVKCVILQVL 182 (224)
Q Consensus 116 ---~~~~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~----~l~~~~~~~~~~~i~ 182 (224)
.+.+|...+.++ .+.+.+.+-.++.+- ....+|||||+.|........ ..+ .+.+..+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 122333333332 244444433333221 235679999999854332211 111 13333333444443
Q ss_pred HHHHHHHhCCceecCCCCCcEEEccCC----cEEEEeccccccc
Q psy13250 183 KGLNYLHSNFIIHRDLKPSNLLLNDKG----CVKIVYSTYLELY 222 (224)
Q Consensus 183 ~~l~~lH~~~iiHrDlkp~Nill~~~~----~~kl~DfGla~~~ 222 (224)
...|++|+|+||.||+++.+| .++++|||++..+
T Consensus 277 ------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 277 ------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred ------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 468999999999999999988 9999999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.5e-15 Score=108.46 Aligned_cols=128 Identities=21% Similarity=0.214 Sum_probs=90.5
Q ss_pred eeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCee-eeeEEEEcCCcceEEEEEecccC
Q psy13250 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV-QLKEVVVGKSLSSIFLVMEYCEH 156 (224)
Q Consensus 78 ~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~lv~e~~~~ 156 (224)
++.|+.|.++.||+++.. +..+++|....... ......+|...+..+.+.+++ +++... .. ..++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~--~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PE--TGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CC--CCeEEEEecCC
Confidence 357899999999998864 77899997643321 123346788888777554443 344433 22 34799999998
Q ss_pred ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 157 DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFI-----IHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 157 ~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i-----iHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
...... .. .....+.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.|..
T Consensus 76 ~~l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE-----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc-----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 432211 01 113456789999999999885 9999999999999 67899999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.9e-16 Score=131.56 Aligned_cols=141 Identities=23% Similarity=0.254 Sum_probs=112.2
Q ss_pred eeccCceEEEEEE---EccCCeEEEEEEeeccCCcc--chhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 81 IGEGSYGVVYRVR---DSVQDKILALKKLFLQNNTL--TRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 81 lG~G~fg~V~~~~---~~~~~~~~avK~~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
+|+|+||.|++++ ....+..+|+|+.+...... ......|..++..++ ||.++.+...+ ......++++++.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf--qt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF--QTDGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee--ccccchhHhhhhc
Confidence 7999999999765 33457789999876432211 113344666677776 99999998888 5556899999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELYL 223 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~~ 223 (224)
.++...........+.+.....+...++.|++++|+.+|+|||+|++||+++.+|.+++.|||+++.+.
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhH
Confidence 875444444445668889999999999999999999999999999999999999999999999998764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.5e-13 Score=109.15 Aligned_cols=148 Identities=22% Similarity=0.286 Sum_probs=91.5
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccc---hhHHHHHHHhhcCCC----------CCeeeeeEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLT---RGELREVTGLTKCRH----------ENIVQLKEVVV 140 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~---~~~~~e~~~l~~l~h----------~niv~~~~~~~ 140 (224)
.+.....||.|+|+.||.+.+..+++.+|+|+......... +...+|......+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46778899999999999999999999999998876543222 233344433333221 11222122111
Q ss_pred cC------------Ccc---eEEEEEecccCChhHhhhh---cCCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy13250 141 GK------------SLS---SIFLVMEYCEHDLASLQDN---VESP---FTESQVKCVILQVLKGLNYLHSNFIIHRDLK 199 (224)
Q Consensus 141 ~~------------~~~---~~~lv~e~~~~~l~~~~~~---~~~~---l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlk 199 (224)
-. ... +.+++|+-+.+++..+... .... +.......+..|+++.+++||..|++|+||+
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 00 001 3467888888877665432 1111 1122223455889999999999999999999
Q ss_pred CCcEEEccCCcEEEEecccccc
Q psy13250 200 PSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 200 p~Nill~~~~~~kl~DfGla~~ 221 (224)
|+|++++.+|.+.|.||+....
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r 194 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVR 194 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEE
T ss_pred eeeEEEcCCCCEEEcChHHHee
Confidence 9999999999999999987653
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.3e-13 Score=98.49 Aligned_cols=140 Identities=21% Similarity=0.227 Sum_probs=98.5
Q ss_pred EeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--------CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 77 KLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--------NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 77 ~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
.+..|-+|+-+.|+++.. .|+.+.||.-.... .-..++..+|++.+.+|.--.|....-++.+.. .-.
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~--~~~ 86 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY--GGQ 86 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC--CCe
Confidence 567889999999998875 47787888543211 112345568999988876544444333444443 346
Q ss_pred EEEecccC--ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc---EEEEeccccc
Q psy13250 149 LVMEYCEH--DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC---VKIVYSTYLE 220 (224)
Q Consensus 149 lv~e~~~~--~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~---~kl~DfGla~ 220 (224)
|+|||++| ....++... ...........++..|-+.+.-||.++|+|+||..+||++..+|. +.++|||++.
T Consensus 87 i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 87 IYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 88999998 444444332 333344444788889999999999999999999999999987664 5799999985
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.5e-12 Score=95.86 Aligned_cols=130 Identities=21% Similarity=0.174 Sum_probs=86.9
Q ss_pred eeeccCceEEEEEEEccCCeEEEEEEeeccCC--------ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--------TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 80 ~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.+++|+=+.++.+... +..+.+|.-..... -...+..+|+.++.++.--.|....-+.++.. ...|+|
T Consensus 3 ~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~--~~~I~m 78 (204)
T COG3642 3 LIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD--NGLIVM 78 (204)
T ss_pred hhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC--CCEEEE
Confidence 5788999999988653 44455663221110 11234467888888775433333222332233 567999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||++|.++....... ...++..+-.-+.-||..||+|+||.++||++...+ +.+|||||+.+
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999997766333322 144566666777889999999999999999998765 99999999974
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.40 E-value=5.6e-12 Score=97.37 Aligned_cols=141 Identities=16% Similarity=0.179 Sum_probs=95.6
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCC--CeeeeeEEEEcCC-cceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHE--NIVQLKEVVVGKS-LSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~-~~~~~lv~e~~ 154 (224)
+.|+.|.++.||++.... +..+++|....... .......+|..++..+.+. ++.+++.+..... .+..|++|||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999988643 57889998654322 1344567888888887653 3455555542211 13568999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS-------------------------------------------- 190 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-------------------------------------------- 190 (224)
+|........ ...++......++.+++.+|..||+
T Consensus 83 ~G~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 83 DGRVLRDRLL-RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CCEecCCCCC-CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 8743222111 1345566666666666666666662
Q ss_pred ------------CCceecCCCCCcEEEcc--CCcEEEEecccccc
Q psy13250 191 ------------NFIIHRDLKPSNLLLND--KGCVKIVYSTYLEL 221 (224)
Q Consensus 191 ------------~~iiHrDlkp~Nill~~--~~~~kl~DfGla~~ 221 (224)
..++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 66789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.1e-12 Score=111.07 Aligned_cols=149 Identities=26% Similarity=0.315 Sum_probs=122.0
Q ss_pred cceeEeeeeec--cCceEEEEEEE--ccCCeEEEEEEee--ccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcc
Q psy13250 73 AEFEKLNRIGE--GSYGVVYRVRD--SVQDKILALKKLF--LQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 73 ~~~~~~~~lG~--G~fg~V~~~~~--~~~~~~~avK~~~--~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (224)
..+.+...+|. |.+|.||.+.. ......+|+|.-+ .........-.+|+...+++ .|+|.++.+..| ...+
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--e~~~ 191 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--EGSG 191 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc--ccCC
Confidence 34677888999 99999999887 7788899999733 33223344456677666665 499999988888 5566
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCceecCCCCCcEEEccC-CcEEEEeccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLK----GLNYLHSNFIIHRDLKPSNLLLNDK-GCVKIVYSTYLE 220 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~----~l~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfGla~ 220 (224)
..|+-+|+|+..+..........++...+..+..+... ||.++|..+++|-|+||+||+...+ ..++++|||+..
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 89999999998888877776666888889999999888 9999999999999999999999999 889999999987
Q ss_pred ccc
Q psy13250 221 LYL 223 (224)
Q Consensus 221 ~~~ 223 (224)
.+.
T Consensus 272 ~i~ 274 (524)
T KOG0601|consen 272 KIS 274 (524)
T ss_pred Ecc
Confidence 653
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.6e-13 Score=106.77 Aligned_cols=90 Identities=22% Similarity=0.332 Sum_probs=72.6
Q ss_pred CCCCeeeeeEEEEcC-------------------------CcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHH
Q psy13250 128 RHENIVQLKEVVVGK-------------------------SLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVL 182 (224)
Q Consensus 128 ~h~niv~~~~~~~~~-------------------------~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~ 182 (224)
+|||||++.+.|.++ ...++|+||.-...++..++.. ...+......++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~--~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT--RHRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc--CCCchHHHHHHHHHHH
Confidence 699999998888642 1236899999888877776654 3456777788999999
Q ss_pred HHHHHHHhCCceecCCCCCcEEEcc--CC--cEEEEecccc
Q psy13250 183 KGLNYLHSNFIIHRDLKPSNLLLND--KG--CVKIVYSTYL 219 (224)
Q Consensus 183 ~~l~~lH~~~iiHrDlkp~Nill~~--~~--~~kl~DfGla 219 (224)
+|+.|||.+||.|||+|.+|||+.- ++ .+.|+|||-+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 9999999999999999999999954 33 4678999954
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.5e-12 Score=116.19 Aligned_cols=110 Identities=36% Similarity=0.527 Sum_probs=78.8
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
.+|..++.|..|+||.||.++++.+..++|+| +..++ .++|- ++....+| +.|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~np-----------------fvv-- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNP-----------------FVV-- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCc-----------------cee--
Confidence 57999999999999999999999999999995 43221 11111 11222222 222
Q ss_pred cccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 153 YCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 153 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|+...++.. -++++... +.+++|+|+.||+|||+||+|.+|..-|.+|+.|||+++.
T Consensus 136 ---gDc~tllk~-~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~ 192 (1205)
T KOG0606|consen 136 ---GDCATLLKN-IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKK 192 (1205)
T ss_pred ---chhhhhccc-CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhh
Confidence 333333322 23444332 6789999999999999999999999999999999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.2e-11 Score=90.78 Aligned_cols=124 Identities=20% Similarity=0.192 Sum_probs=76.6
Q ss_pred EEEEEEEccCCeEEEEEEeeccCC-------------c--------cc-----hhHHHHHHHhhcCCCC--CeeeeeEEE
Q psy13250 88 VVYRVRDSVQDKILALKKLFLQNN-------------T--------LT-----RGELREVTGLTKCRHE--NIVQLKEVV 139 (224)
Q Consensus 88 ~V~~~~~~~~~~~~avK~~~~~~~-------------~--------~~-----~~~~~e~~~l~~l~h~--niv~~~~~~ 139 (224)
.||.|... .+..+|+|.-+.... . .. ....+|...|.++..- ++...+.+.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 37888763 577899997653210 0 00 1235688889888765 455666543
Q ss_pred EcCCcceEEEEEeccc--CChhHhhhhcCCCCCHHHHHHHHHHHHHHHHH-HHhCCceecCCCCCcEEEccCCcEEEEec
Q psy13250 140 VGKSLSSIFLVMEYCE--HDLASLQDNVESPFTESQVKCVILQVLKGLNY-LHSNFIIHRDLKPSNLLLNDKGCVKIVYS 216 (224)
Q Consensus 140 ~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~-lH~~~iiHrDlkp~Nill~~~~~~kl~Df 216 (224)
. -+|||||++ |.....+.... ++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.||||
T Consensus 80 --~----~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 --R----NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp --T----TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred --C----CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 2 369999999 54333333211 2234456667777775554 579999999999999999877 9999999
Q ss_pred ccccc
Q psy13250 217 TYLEL 221 (224)
Q Consensus 217 Gla~~ 221 (224)
|.|..
T Consensus 151 ~qav~ 155 (188)
T PF01163_consen 151 GQAVD 155 (188)
T ss_dssp TTEEE
T ss_pred Cccee
Confidence 98864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.8e-13 Score=117.75 Aligned_cols=149 Identities=27% Similarity=0.316 Sum_probs=111.7
Q ss_pred ceeEeeeeeccCceEEEEEEEc-cCCeEEEEEEeeccC--CccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDS-VQDKILALKKLFLQN--NTLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~-~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~l 149 (224)
.|.+.+.||+|+|+.|-.+... .....+|+|.+.... .........|..+-..+. |.|++.+++.. ......++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~--~~~~~~~~ 98 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS--SSPRSYLL 98 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc--CCCccccc
Confidence 3777778999999999877653 334556666554332 112222334555555666 99999999988 55567899
Q ss_pred EEecccCChhHhhh-hcCC-CCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEccCC-cEEEEeccccccccC
Q psy13250 150 VMEYCEHDLASLQD-NVES-PFTESQVKCVILQVLKGLNYLH-SNFIIHRDLKPSNLLLNDKG-CVKIVYSTYLELYLN 224 (224)
Q Consensus 150 v~e~~~~~l~~~~~-~~~~-~l~~~~~~~~~~~i~~~l~~lH-~~~iiHrDlkp~Nill~~~~-~~kl~DfGla~~~~~ 224 (224)
+++|..|+...... .... ..+...+.+++.|+..++.|+| ..++.|||+||+|.+++..+ .+++.|||+|..+.+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 99998764333332 3233 5677888999999999999999 99999999999999999999 999999999987753
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.9e-10 Score=87.89 Aligned_cols=132 Identities=17% Similarity=0.078 Sum_probs=85.6
Q ss_pred EEEEEEEccCCeEEEEEEeeccCC-----------ccchhHHHHHHHhhcCC-----CCCeeeeeEEEEcCCcceEEEEE
Q psy13250 88 VVYRVRDSVQDKILALKKLFLQNN-----------TLTRGELREVTGLTKCR-----HENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 88 ~V~~~~~~~~~~~~avK~~~~~~~-----------~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.|+++.. .|+.+.+|....... .......+|...+.+|. -|.+|-+...-.+......++||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555443 456788885532110 11113567777776653 33333332111111123578999
Q ss_pred ecccCC--hhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc-------CCcEEEEecccccc
Q psy13250 152 EYCEHD--LASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND-------KGCVKIVYSTYLEL 221 (224)
Q Consensus 152 e~~~~~--l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~-------~~~~kl~DfGla~~ 221 (224)
|++++. +..++... ....+......++.+++..+.-||..||+|+|+++.|||++. ++.+.+|||+.++.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999873 54454321 234566777789999999999999999999999999999985 46789999998854
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.2e-12 Score=117.42 Aligned_cols=141 Identities=21% Similarity=0.309 Sum_probs=107.3
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-cch---hHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTR---GELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
+|...+.||.+.|=+|.+|++.. | .++||++-..... ..+ +.++|++ ...+++||.+.+..+. ......||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~--~t~kAAyl 98 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL--VTDKAAYL 98 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH--HhhHHHHH
Confidence 68888999999999999998763 4 3789988655432 222 3344555 5557899999886654 23335678
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
|=+|...+|.+.+.. +.-+..-+-+.|+.|++.||.-+|..||+|+|||.+||||+.=+-+.|+||..-+
T Consensus 99 vRqyvkhnLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred HHHHHhhhhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccC
Confidence 888888777766544 3336667778899999999999999999999999999999998889999997543
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.7e-11 Score=103.82 Aligned_cols=148 Identities=25% Similarity=0.338 Sum_probs=113.8
Q ss_pred cccceeEeeeeeccCceEEEEEEEc-cCCeEEEEEEeeccCCccch--hHHHHHHHhhcC-CCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS-VQDKILALKKLFLQNNTLTR--GELREVTGLTKC-RHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~~~avK~~~~~~~~~~~--~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (224)
...+|..+..||.|.|+.|+.+... .++..|++|.+......... .-+.|+.+...+ .|.+++.++..|. ....
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~--~~r~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS--QLRQ 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc--cccc
Confidence 4568999999999999999987755 67889999977533322222 224566555554 4888888877773 3446
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC-CcEEEEeccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK-GCVKIVYSTYLE 220 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfGla~ 220 (224)
.|+-.|||.+....+.......+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||.+.
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence 78999999875544444434457788889999999999999999999999999999999986 778999999875
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.6e-10 Score=96.65 Aligned_cols=122 Identities=18% Similarity=0.259 Sum_probs=95.1
Q ss_pred EEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccCChhHhhhhcCCCCCH
Q psy13250 92 VRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTE 171 (224)
Q Consensus 92 ~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~ 171 (224)
|..+.++..+.|...+...........+-+..|+.++||||+++++.+ +..+.+|||+|-+.. +...+.. +..
T Consensus 31 ~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~--e~~~~~ylvTErV~P-l~~~lk~----l~~ 103 (690)
T KOG1243|consen 31 GTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT--EEEGTLYLVTERVRP-LETVLKE----LGK 103 (690)
T ss_pred cceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh--cccCceEEEeecccc-HHHHHHH----hHH
Confidence 445566777888877655543344556777889999999999999998 455589999999864 2222222 336
Q ss_pred HHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 172 SQVKCVILQVLKGLNYLH-SNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 172 ~~~~~~~~~i~~~l~~lH-~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
..+..-+.||+.||.||| +++++|++|.-+.|+++..|..||.+|-++.
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~ 153 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVS 153 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEe
Confidence 667778899999999997 6789999999999999999999999998764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.07 E-value=5.4e-09 Score=80.21 Aligned_cols=105 Identities=23% Similarity=0.243 Sum_probs=74.8
Q ss_pred hHHHHHHHhhcCC-----CCCeeeeeEEEEcCCcceEEEEEecccC--ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHH
Q psy13250 116 GELREVTGLTKCR-----HENIVQLKEVVVGKSLSSIFLVMEYCEH--DLASLQDNVESPFTESQVKCVILQVLKGLNYL 188 (224)
Q Consensus 116 ~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l 188 (224)
+..+|...+..+. -|..+-+...- .......++++|++++ ++..++.... ..+......++.+++..+.-|
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r-~~~~~~s~lite~l~~~~~L~~~~~~~~-~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERR-KGGGYRSYLITEALPGAQDLRDLLQQWE-QLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEc-CCCceeEEEEEEeCCCcccHHHHHHhhc-ccchhhHHHHHHHHHHHHHHH
Confidence 4566776665553 33333332211 1111356899999987 3555554422 266677788999999999999
Q ss_pred HhCCceecCCCCCcEEEccCC---cEEEEeccccccc
Q psy13250 189 HSNFIIHRDLKPSNLLLNDKG---CVKIVYSTYLELY 222 (224)
Q Consensus 189 H~~~iiHrDlkp~Nill~~~~---~~kl~DfGla~~~ 222 (224)
|.+||+|+|+++.|||++.++ .+.+|||+.++..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999987 8999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.03 E-value=6.1e-10 Score=94.31 Aligned_cols=97 Identities=26% Similarity=0.392 Sum_probs=84.9
Q ss_pred hhcCCCCCeeeeeEEEEcCCcceEEEEEeccc-CChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eecCCCCC
Q psy13250 124 LTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE-HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFI-IHRDLKPS 201 (224)
Q Consensus 124 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i-iHrDlkp~ 201 (224)
|+.+.|.|+.+|+|.+.+. ..+++|.+||. |++.+.+......+++.....++++++.||.|+|.-.| .|+.|+..
T Consensus 1 l~~l~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 4568899999999999765 58899999998 56777766656678888899999999999999997765 99999999
Q ss_pred cEEEccCCcEEEEeccccccc
Q psy13250 202 NLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 202 Nill~~~~~~kl~DfGla~~~ 222 (224)
|.+++..+.+||.|||+..+.
T Consensus 79 nClvd~~w~lklt~~Gl~~~~ 99 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLL 99 (484)
T ss_pred cceeeeeEEEEechhhhcccc
Confidence 999999999999999998754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.1e-09 Score=83.97 Aligned_cols=133 Identities=20% Similarity=0.169 Sum_probs=91.6
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC----------------------ccchhHHHHHHHhhcCCCC--
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN----------------------TLTRGELREVTGLTKCRHE-- 130 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~----------------------~~~~~~~~e~~~l~~l~h~-- 130 (224)
..+.+.||-|-=+.||.|... .+..+|+|.=+.... .......+|..+|.++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456689999999999999865 678899994332100 0112335788888887654
Q ss_pred CeeeeeEEEEcCCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc
Q psy13250 131 NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC 210 (224)
Q Consensus 131 niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 210 (224)
.+...+++ +...+|||+++|-.+.-.. +..+....++..|+.-+.-+-..||+|+|+.+=||+++++|.
T Consensus 172 ~VP~P~~~------nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAW------NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCcccc------ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 45554433 2567999999984322111 133444445555655555555899999999999999999999
Q ss_pred EEEEecccc
Q psy13250 211 VKIVYSTYL 219 (224)
Q Consensus 211 ~kl~DfGla 219 (224)
+.++||=-+
T Consensus 241 ~~vIDwPQ~ 249 (304)
T COG0478 241 IVVIDWPQA 249 (304)
T ss_pred EEEEeCccc
Confidence 999999654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.3e-08 Score=75.20 Aligned_cols=138 Identities=15% Similarity=0.097 Sum_probs=94.1
Q ss_pred eccCceEEEEEEEccCCeEEEEEEeeccC------CccchhHHHHHHHhhcCCCCCe--eeee--EEEEcCCcceEEEEE
Q psy13250 82 GEGSYGVVYRVRDSVQDKILALKKLFLQN------NTLTRGELREVTGLTKCRHENI--VQLK--EVVVGKSLSSIFLVM 151 (224)
Q Consensus 82 G~G~fg~V~~~~~~~~~~~~avK~~~~~~------~~~~~~~~~e~~~l~~l~h~ni--v~~~--~~~~~~~~~~~~lv~ 151 (224)
|+|+.+-|++.... |..+=+|+-.... .-....+.+|+..+..+..-+| .... +..-.......+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 66888889886643 3357777553110 1124567889888887653322 2222 211112233468999
Q ss_pred ecccC--ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc--EEEEecccccc
Q psy13250 152 EYCEH--DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC--VKIVYSTYLEL 221 (224)
Q Consensus 152 e~~~~--~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfGla~~ 221 (224)
|-+++ +|..++... ..+.+...-..++.+++..+.-||+.|+.|+|+-+.||+++.+|. +++|||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98884 565555332 224566667789999999999999999999999999999987777 99999977654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.8e-09 Score=79.36 Aligned_cols=59 Identities=29% Similarity=0.410 Sum_probs=51.4
Q ss_pred CChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 156 HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 156 ~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+|..++......+++..+..++.|++.||.|||+++ ||+|||++.++.+|+ ||+++..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~ 59 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFK 59 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEee
Confidence 3556666555567999999999999999999999998 999999999999999 9998754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.92 E-value=2e-08 Score=84.65 Aligned_cols=136 Identities=21% Similarity=0.237 Sum_probs=104.8
Q ss_pred ceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcC--CcceEEEEEecccC--ChhHh
Q psy13250 86 YGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGK--SLSSIFLVMEYCEH--DLASL 161 (224)
Q Consensus 86 fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~~~lv~e~~~~--~l~~~ 161 (224)
-.+.|+|....+|..|++|++.............-++..+++.|+|+|.|.++|... ....+++|++|.++ +|...
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 467799999999999999999544333332333446677899999999999888622 12368899999875 45444
Q ss_pred hhh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 162 QDN--------------VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 162 ~~~--------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+-. .+...++..++.|+.|+..||.++|+.|+.-+-|-+.+||++.+..++|..-|+..+
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceee
Confidence 321 123467899999999999999999999999999999999999998899887776544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.4e-08 Score=85.91 Aligned_cols=139 Identities=14% Similarity=0.119 Sum_probs=83.6
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccCC----------------------c----cc--------------hhHH
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN----------------------T----LT--------------RGEL 118 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~----------------------~----~~--------------~~~~ 118 (224)
+.|+.++-|+||+|+... |+.||||+.+..-. . .. -...
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 569999999999999874 99999998763200 0 00 0112
Q ss_pred HHHHHhhcC-----CCCCeeeeeEEEEcCCcceEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy13250 119 REVTGLTKC-----RHENIVQLKEVVVGKSLSSIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192 (224)
Q Consensus 119 ~e~~~l~~l-----~h~niv~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 192 (224)
+|...+.++ ..+++.-- .++. +-.+.-.|+|||++|- +.+........++...+.....++ -+..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP-~V~w-e~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVP-KVYW-EYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEec-eeeh-hccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcC
Confidence 333333332 23333322 2221 1123457999999983 322221222335533333222221 133344589
Q ss_pred ceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 193 IIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 193 iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+.|.|..|.||+++.+|.+-+.|||....+
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecC
Confidence 999999999999999999999999997643
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.1e-09 Score=85.15 Aligned_cols=139 Identities=19% Similarity=0.301 Sum_probs=105.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
..++..+..+|.+...|..|++++...+ ++.|++..... ...+.+..|.-.|+-..||||..+++.+ ....++.
T Consensus 188 d~~~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac--nsppnlv 263 (448)
T KOG0195|consen 188 DVSSLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC--NSPPNLV 263 (448)
T ss_pred chhhhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc--cCCCCce
Confidence 4456677888999999999999987544 45566654432 2345566677778888999999999999 4555889
Q ss_pred EEEecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEccCCcEEE
Q psy13250 149 LVMEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNF--IIHRDLKPSNLLLNDKGCVKI 213 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~--iiHrDlkp~Nill~~~~~~kl 213 (224)
++..||+. ++...+... .......++.+++.++++|+.|||+.. |..--|....++++++-+.+|
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltari 332 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARI 332 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhe
Confidence 99999985 555555433 224678889999999999999999864 555568889999999887665
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.83 E-value=8.4e-08 Score=74.28 Aligned_cols=135 Identities=18% Similarity=0.193 Sum_probs=88.9
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccCCccc------------------hhH------HHHHHHhhcCC--CCCe
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLT------------------RGE------LREVTGLTKCR--HENI 132 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~------------------~~~------~~e~~~l~~l~--h~ni 132 (224)
..|+.|.-+.||+|.. ..+..+|+|+......... ... .+|+..|.++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3677888899999875 4578899998864321110 011 24555555543 2333
Q ss_pred eeeeEEEEcCCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCcE
Q psy13250 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCV 211 (224)
Q Consensus 133 v~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~ 211 (224)
.+-+.+. .-.|||||++....--=.....++...++..+..+++..+.-|-. .+++|+||..=|||+. ++.+
T Consensus 133 P~Pi~~~------~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 133 PEPIAFR------NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCceeec------CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 3444443 236999999854111100112234444677788888888887766 8999999999999999 9999
Q ss_pred EEEecccccc
Q psy13250 212 KIVYSTYLEL 221 (224)
Q Consensus 212 kl~DfGla~~ 221 (224)
.|||||-|..
T Consensus 206 ~iID~~QaV~ 215 (268)
T COG1718 206 YIIDVSQAVT 215 (268)
T ss_pred EEEECccccc
Confidence 9999998854
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.80 E-value=1e-07 Score=72.88 Aligned_cols=137 Identities=18% Similarity=0.186 Sum_probs=80.4
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhH---------HHHHHHhhcCC---CCCeeeeeEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE---------LREVTGLTKCR---HENIVQLKEVVV 140 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~---------~~e~~~l~~l~---h~niv~~~~~~~ 140 (224)
.+|+..+.+-......|.+..- .+..+.+|.........++.+ .+.+..+..+. -.....++.+..
T Consensus 31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 4677777777777777766553 467888887654322222211 11222222221 122222222221
Q ss_pred c---CCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecc
Q psy13250 141 G---KSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYST 217 (224)
Q Consensus 141 ~---~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG 217 (224)
. .-....+++|||++|-.+..... +++ .+...+..++.-+|..|+.|+|..|.|+++..+ .++++||+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~ 179 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQ 179 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECc
Confidence 1 11234568999999843222111 222 234556678899999999999999999999855 49999998
Q ss_pred ccc
Q psy13250 218 YLE 220 (224)
Q Consensus 218 la~ 220 (224)
-.+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.7e-07 Score=72.95 Aligned_cols=133 Identities=17% Similarity=0.119 Sum_probs=75.5
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCe--eeeeEEEEcCCcceEEEEEecccC
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENI--VQLKEVVVGKSLSSIFLVMEYCEH 156 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~lv~e~~~~ 156 (224)
..||+|..+.||+.. +..+++|..... .......+|.+.+..+..-++ .+.+.+. +..+...++||+++|
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~--~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLV--EDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEE--ecCCeeeeeeeecCC
Confidence 678999999999732 445677866432 223445778888877653333 3444444 333456789999988
Q ss_pred Ch-----h-----------Hh----hhhcCC----CCCHHH-HHHHHHH----------HHH-HHHHHH----hCCceec
Q psy13250 157 DL-----A-----------SL----QDNVES----PFTESQ-VKCVILQ----------VLK-GLNYLH----SNFIIHR 196 (224)
Q Consensus 157 ~l-----~-----------~~----~~~~~~----~l~~~~-~~~~~~~----------i~~-~l~~lH----~~~iiHr 196 (224)
.. . .. +...+. ...... ...+..+ +.. ...+|. ...++|+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 41 0 00 000110 111000 0111100 111 122222 1247899
Q ss_pred CCCCCcEEEccCCcEEEEeccccc
Q psy13250 197 DLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 197 Dlkp~Nill~~~~~~kl~DfGla~ 220 (224)
|+.|.||+++.++ +.|+||+.|.
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcC
Confidence 9999999999888 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.1e-06 Score=66.56 Aligned_cols=127 Identities=26% Similarity=0.322 Sum_probs=87.3
Q ss_pred cceeEeeeeeccCc-eEEEEEEEccCCeEEEEEEeec---cCC------------------ccchhHHHHHHHhhcC---
Q psy13250 73 AEFEKLNRIGEGSY-GVVYRVRDSVQDKILALKKLFL---QNN------------------TLTRGELREVTGLTKC--- 127 (224)
Q Consensus 73 ~~~~~~~~lG~G~f-g~V~~~~~~~~~~~~avK~~~~---~~~------------------~~~~~~~~e~~~l~~l--- 127 (224)
.+++.++.||.|.- |.||+++.. |..+|+|.+.. ... .....+..|.+...++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 57999999999999 999999865 77999998421 100 1122345666665554
Q ss_pred CCCCe--eeeeEEEEcCC----------------cceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q psy13250 128 RHENI--VQLKEVVVGKS----------------LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLH 189 (224)
Q Consensus 128 ~h~ni--v~~~~~~~~~~----------------~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 189 (224)
.+.++ |+++|+..-.. .....||.||+.... .++... +.+|.+-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence 45566 88888875321 011246777665422 233333 456677788999
Q ss_pred hCCceecCCCCCcEEEccCCcEEEEecccc
Q psy13250 190 SNFIIHRDLKPSNLLLNDKGCVKIVYSTYL 219 (224)
Q Consensus 190 ~~~iiHrDlkp~Nill~~~~~~kl~DfGla 219 (224)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999988 5689999975
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.2e-07 Score=70.49 Aligned_cols=140 Identities=21% Similarity=0.228 Sum_probs=74.8
Q ss_pred eeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCC--CeeeeeEEEEc-CCcceEEEEEecc
Q psy13250 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHE--NIVQLKEVVVG-KSLSSIFLVMEYC 154 (224)
Q Consensus 78 ~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~-~~~~~~~lv~e~~ 154 (224)
++.|+.|..+.||++.... ..+++|..... .......+|..++..+... .+..++..... ......+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 4678999999999998764 47889976433 2334455677776665422 23455543321 2233578999999
Q ss_pred cCChhHh-----------------hh---hc---CCCCCHHH---H---HHH---------------HHHHHH-HHHHHH
Q psy13250 155 EHDLASL-----------------QD---NV---ESPFTESQ---V---KCV---------------ILQVLK-GLNYLH 189 (224)
Q Consensus 155 ~~~l~~~-----------------~~---~~---~~~l~~~~---~---~~~---------------~~~i~~-~l~~lH 189 (224)
+|..... +. .. ...+.... . ... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 8742221 00 00 01111100 0 000 011122 233333
Q ss_pred -------hCCceecCCCCCcEEEc-cCCcEEEEecccccc
Q psy13250 190 -------SNFIIHRDLKPSNLLLN-DKGCVKIVYSTYLEL 221 (224)
Q Consensus 190 -------~~~iiHrDlkp~Nill~-~~~~~kl~DfGla~~ 221 (224)
...++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 23599999999999999 667678999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=98.66 E-value=3.4e-09 Score=88.94 Aligned_cols=73 Identities=26% Similarity=0.387 Sum_probs=61.1
Q ss_pred eEEEEEecccC-ChhHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 146 SIFLVMEYCEH-DLASLQDNV--ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++||.|++|.. .+.+++... ....+...++.++.|++.|++| ++.+|||+||.||++..++.+||.||||..-
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 58999999985 455555432 2236778889999999999999 9999999999999999999999999999753
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.8e-07 Score=78.54 Aligned_cols=137 Identities=14% Similarity=0.139 Sum_probs=83.8
Q ss_pred eeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-------------------------------------cchhHHHHH
Q psy13250 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-------------------------------------LTRGELREV 121 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-------------------------------------~~~~~~~e~ 121 (224)
+.||.-+.|+||+|+.+. |+.||||+-+..-.. .+-.+.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 569999999999999875 999999976432000 011122333
Q ss_pred HHh----hcCCCCC------eeeeeEEEEcCCcceEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy13250 122 TGL----TKCRHEN------IVQLKEVVVGKSLSSIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190 (224)
Q Consensus 122 ~~l----~~l~h~n------iv~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~ 190 (224)
+.. ..+.|-+ |.++|-.+ ...-.|+||||+|. +.++-......++...+..-+.+.. ++-+-.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHh
Confidence 322 2233444 33333222 23567999999983 2222111223466555544443332 223345
Q ss_pred CCceecCCCCCcEEEcc----CCcEEEEeccccccc
Q psy13250 191 NFIIHRDLKPSNLLLND----KGCVKIVYSTYLELY 222 (224)
Q Consensus 191 ~~iiHrDlkp~Nill~~----~~~~kl~DfGla~~~ 222 (224)
.|++|.|-.|.||++.. ++.+.+.|||+...+
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 78999999999999994 668999999998754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.1e-06 Score=64.65 Aligned_cols=129 Identities=21% Similarity=0.145 Sum_probs=86.5
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCee-eeeEEEEcCCcceEEEEEec
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV-QLKEVVVGKSLSSIFLVMEY 153 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~lv~e~ 153 (224)
.+..+.|++|.+|.||++.+. +..+|+|+-..+ .....+..|.++|..+.-.++- .+|.+. + .++.|||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg--~----~~i~me~ 93 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG--E----DFIRMEY 93 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec--h----hhhhhhh
Confidence 345678999999999999865 568888865433 3456677888888887765554 344333 2 3466999
Q ss_pred ccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC-CCcEEEccCCcEEEEecccccc
Q psy13250 154 CEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLK-PSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 154 ~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlk-p~Nill~~~~~~kl~DfGla~~ 221 (224)
+.| .+...... .....+. .++++---|-..||-|..|. |..+++..++.+.||||-.|++
T Consensus 94 i~G~~L~~~~~~----~~rk~l~----~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIG----GDRKHLL----RVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhc----ccHHHHH----HHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 998 34333221 1223332 34444334557899999995 7777777777999999998873
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.49 E-value=3.8e-06 Score=77.17 Aligned_cols=81 Identities=20% Similarity=0.244 Sum_probs=52.9
Q ss_pred EeeeeeccCceEEEEEEEccCC--eEEEEEEeeccCC-ccchhHHHHHHHhhcCC-CCCe--eeeeEEEEcCC-cceEEE
Q psy13250 77 KLNRIGEGSYGVVYRVRDSVQD--KILALKKLFLQNN-TLTRGELREVTGLTKCR-HENI--VQLKEVVVGKS-LSSIFL 149 (224)
Q Consensus 77 ~~~~lG~G~fg~V~~~~~~~~~--~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~~-~~~~~l 149 (224)
.++.++.|.+..+|+......+ ..+++|+...... .......+|..+|+.+. |.++ .+++.++.+.. .+..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3577899999999998765332 4567776543221 12235678999998885 6655 56666653321 246789
Q ss_pred EEecccCC
Q psy13250 150 VMEYCEHD 157 (224)
Q Consensus 150 v~e~~~~~ 157 (224)
||||++|.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99999874
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.42 E-value=5e-06 Score=65.37 Aligned_cols=71 Identities=20% Similarity=0.110 Sum_probs=42.6
Q ss_pred eeeccCc-eEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEEEEEecccCC
Q psy13250 80 RIGEGSY-GVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIFLVMEYCEHD 157 (224)
Q Consensus 80 ~lG~G~f-g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 157 (224)
.|-.|.. ..||++... +..+.+|...... .....+|+.++..+. +--+.+++.... ..+..++|||+++|.
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~--~~~~~~lv~e~i~G~ 77 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGS--DDGRAWLLTSAVPGV 77 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEe--cCCccEEEEEeeCCc
Confidence 4455555 788988653 3567778664322 234556777766653 233445555552 224578999999874
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.29 E-value=3e-05 Score=58.99 Aligned_cols=127 Identities=20% Similarity=0.259 Sum_probs=82.1
Q ss_pred eeeeeccCceEEEEEEEccCCeEEEEEEeeccC----------------CccchhHHHHHHHhhcCC------CCCeeee
Q psy13250 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN----------------NTLTRGELREVTGLTKCR------HENIVQL 135 (224)
Q Consensus 78 ~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~~ 135 (224)
...||+|+.-.||.- ..+...+||+..... ....+...+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 357999999999953 234456788876554 111234455665544443 7889999
Q ss_pred eEEEEcCCcceEEEEEeccc---C----ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC
Q psy13250 136 KEVVVGKSLSSIFLVMEYCE---H----DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK 208 (224)
Q Consensus 136 ~~~~~~~~~~~~~lv~e~~~---~----~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~ 208 (224)
+|+.. ....+-+|+|.+. | ++..++. .+.++. ..... +-.-.+||-+.+|+.+|++|.||++...
T Consensus 83 ~G~ve--T~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 83 YGFVE--TNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred eEEEe--cCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEec
Confidence 99984 4445678888874 2 2333332 334555 33333 3334568889999999999999999753
Q ss_pred C----cEEEEe
Q psy13250 209 G----CVKIVY 215 (224)
Q Consensus 209 ~----~~kl~D 215 (224)
. .+.|+|
T Consensus 155 ~~~~~~lvlID 165 (199)
T PF10707_consen 155 DSGEFRLVLID 165 (199)
T ss_pred CCCceEEEEEe
Confidence 3 477787
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=98.28 E-value=7e-07 Score=71.58 Aligned_cols=92 Identities=25% Similarity=0.389 Sum_probs=73.3
Q ss_pred HhhcCCCCCeeeeeEEEEcC---CcceEEEEEecccC-ChhHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Q psy13250 123 GLTKCRHENIVQLKEVVVGK---SLSSIFLVMEYCEH-DLASLQDN---VESPFTESQVKCVILQVLKGLNYLHSNF--I 193 (224)
Q Consensus 123 ~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i 193 (224)
.+-++-|.|||++..+|.+. +...+.++.|||.. .+-+++.+ ....+......+++.||+.||.|||+.. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 45566799999999998643 22457889999984 44444433 3456889999999999999999999875 9
Q ss_pred eecCCCCCcEEEccCCcEEEE
Q psy13250 194 IHRDLKPSNLLLNDKGCVKIV 214 (224)
Q Consensus 194 iHrDlkp~Nill~~~~~~kl~ 214 (224)
+|+++..+-|++..+|-+|+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred ccCCcchhheeecCCceEEec
Confidence 999999999999999988873
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.19 E-value=9e-06 Score=61.41 Aligned_cols=95 Identities=24% Similarity=0.217 Sum_probs=72.3
Q ss_pred HHHHHhhcCCC-CCeeeeeEEEEcCCcceEEEEEecccCC-hhHhh--hhcCCCCCHHHHHHHHHHHHHHHHHHHh---C
Q psy13250 119 REVTGLTKCRH-ENIVQLKEVVVGKSLSSIFLVMEYCEHD-LASLQ--DNVESPFTESQVKCVILQVLKGLNYLHS---N 191 (224)
Q Consensus 119 ~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~--~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~ 191 (224)
.|..+++.+.+ +++.+++|.+ .-+++.||...+ +.... ...-...+|.....++.+++..+++++. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~C------G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSC------GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeEC------CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 46667777765 5899999998 235788999853 32110 0111236899999999999999999986 3
Q ss_pred CceecCCCCCcEEEccCCcEEEEecccc
Q psy13250 192 FIIHRDLKPSNLLLNDKGCVKIVYSTYL 219 (224)
Q Consensus 192 ~iiHrDlkp~Nill~~~~~~kl~DfGla 219 (224)
.+.-.|++++|+-++.+|.+|++|..-+
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v 109 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDV 109 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhc
Confidence 4777999999999999999999998754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.9e-05 Score=61.54 Aligned_cols=131 Identities=18% Similarity=0.250 Sum_probs=70.5
Q ss_pred eeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCe-eeeeEEEEcCCcceEEEEEecccCChh
Q psy13250 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENI-VQLKEVVVGKSLSSIFLVMEYCEHDLA 159 (224)
Q Consensus 81 lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~lv~e~~~~~l~ 159 (224)
+..|-...+|+.. ..+..+++|..........-...+|..+++.+....+ .+++... . -++||||++|...
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~G~~~ 75 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E----HWLLVEWLEGEVI 75 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEeccCccc
Confidence 4567778899876 3466777886433222211234567777776653323 2233322 2 2689999987321
Q ss_pred H---------------hhhhcCC------CCC-HHHHHHHHHHH---------HHHHHHHHh--------CCceecCCCC
Q psy13250 160 S---------------LQDNVES------PFT-ESQVKCVILQV---------LKGLNYLHS--------NFIIHRDLKP 200 (224)
Q Consensus 160 ~---------------~~~~~~~------~l~-~~~~~~~~~~i---------~~~l~~lH~--------~~iiHrDlkp 200 (224)
. .+.+.+. ++. ...+..+..++ ...+..+-. ..++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 1 1111111 111 11222222111 111222211 2489999999
Q ss_pred CcEEEccCCcEEEEeccccc
Q psy13250 201 SNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 201 ~Nill~~~~~~kl~DfGla~ 220 (224)
.||+++.++ +.|+||..|.
T Consensus 156 ~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 156 YNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CcEEEeCCC-CEEEeccccC
Confidence 999999877 7899998775
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.2e-05 Score=60.50 Aligned_cols=30 Identities=30% Similarity=0.400 Sum_probs=25.5
Q ss_pred CCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 191 NFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 191 ~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.+++|+|+.+.|||++.++..-|+||+.|.
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 358999999999999876656799999874
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=98.05 E-value=5.1e-07 Score=81.79 Aligned_cols=146 Identities=21% Similarity=0.166 Sum_probs=101.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
.+.+.+.+.+-.|+++.++.+....++-..++|....... ...+....+-.++-..++|.++...-.+ ......+
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~--~~rsP~~ 880 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF--PCRSPLP 880 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC--CCCCCcc
Confidence 3457777788889999999887776665555554432111 1112222222222233567777654443 4455789
Q ss_pred EEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 149 LVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 149 lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
++++|.+++ +...+ ...++.+.+-++.++..+..+++|||...+.|||++|.|+|+..+|..++.|||..+
T Consensus 881 L~~~~~~~~~~~Skl-~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKL-HNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred hhhHHhccCCchhhh-hcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccc
Confidence 999999764 44333 334567777788888889999999999999999999999999999999999999543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.05 E-value=0.00023 Score=59.90 Aligned_cols=75 Identities=19% Similarity=0.196 Sum_probs=49.3
Q ss_pred eeeeeccCceEEEEEEEccCCeEEEEEEeecc----CC---ccchhHHHHHHHhhcC---CCCCeeeeeEEEEcCCcceE
Q psy13250 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ----NN---TLTRGELREVTGLTKC---RHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 78 ~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~----~~---~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~ 147 (224)
.+.||.|.+..||++.....++.+.||..... .. ....+...|...|..+ ...++.+++.+. + ...
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~--~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E--ELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C--CCC
Confidence 46799999999999998654467899975311 11 1234456677776654 234566676553 3 346
Q ss_pred EEEEecccC
Q psy13250 148 FLVMEYCEH 156 (224)
Q Consensus 148 ~lv~e~~~~ 156 (224)
++|||++++
T Consensus 107 ~lVME~L~~ 115 (401)
T PRK09550 107 VTVMEDLSD 115 (401)
T ss_pred EEEEecCCC
Confidence 799999874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00029 Score=54.92 Aligned_cols=29 Identities=31% Similarity=0.518 Sum_probs=26.1
Q ss_pred CceecCCCCCcEEEcc-CCcEEEEeccccc
Q psy13250 192 FIIHRDLKPSNLLLND-KGCVKIVYSTYLE 220 (224)
Q Consensus 192 ~iiHrDlkp~Nill~~-~~~~kl~DfGla~ 220 (224)
.++|+|+.+.|||++. ++.+.|+||-.|.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 5899999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00027 Score=57.09 Aligned_cols=141 Identities=11% Similarity=0.032 Sum_probs=76.3
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCC--eeeeeEEE----EcCCcceEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHEN--IVQLKEVV----VGKSLSSIF 148 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~----~~~~~~~~~ 148 (224)
..-.+.|..|....+|+.... +..+++|+... ........|+.++..+.+.+ +.+++... .....+..+
T Consensus 16 ~~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 16 LLSFEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred hhheecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 334567888888899987643 34678887643 12233445666555553222 33332210 001123568
Q ss_pred EEEecccCChhH------------hhhhcC---CCC----------CHHHH--H--------HHHHHHHHHHHHHHh---
Q psy13250 149 LVMEYCEHDLAS------------LQDNVE---SPF----------TESQV--K--------CVILQVLKGLNYLHS--- 190 (224)
Q Consensus 149 lv~e~~~~~l~~------------~~~~~~---~~l----------~~~~~--~--------~~~~~i~~~l~~lH~--- 190 (224)
+++++++|.... .+...+ ..+ .+... . .....+..++.++-.
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 999999863210 000000 000 10000 0 011112234444443
Q ss_pred ----CCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 191 ----NFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 191 ----~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 469999999999999988778999998875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00042 Score=57.17 Aligned_cols=138 Identities=20% Similarity=0.219 Sum_probs=90.5
Q ss_pred EeeeeeccCceEEEEEEEccCCeEEEEEEeecc---------------------CCccchh----H-HHHHHHhhcCCCC
Q psy13250 77 KLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ---------------------NNTLTRG----E-LREVTGLTKCRHE 130 (224)
Q Consensus 77 ~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~---------------------~~~~~~~----~-~~e~~~l~~l~h~ 130 (224)
+-..|..|--+.||.|... .|..+|||+.+.. +....+. + -+|++-|++++..
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4456888999999998865 5667999976521 0011111 1 2466677776655
Q ss_pred CeeeeeEEEEcCCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecCCCCCcEEEccCC
Q psy13250 131 NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL-HSNFIIHRDLKPSNLLLNDKG 209 (224)
Q Consensus 131 niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~l-H~~~iiHrDlkp~Nill~~~~ 209 (224)
.|...--..+ . ...|||+|++.+.+-.-......++...+..+-.+++.-+.-| +.++++|.||.-=|+|+. +|
T Consensus 227 GIP~PePIlL-k---~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG 301 (520)
T KOG2270|consen 227 GIPCPEPILL-K---NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DG 301 (520)
T ss_pred CCCCCCceee-e---cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CC
Confidence 5433211111 1 2468999998643332222244577778888888887777765 467999999999999985 78
Q ss_pred cEEEEeccccc
Q psy13250 210 CVKIVYSTYLE 220 (224)
Q Consensus 210 ~~kl~DfGla~ 220 (224)
.+.|||-+-+.
T Consensus 302 ~lyiIDVSQSV 312 (520)
T KOG2270|consen 302 KLYIIDVSQSV 312 (520)
T ss_pred EEEEEEccccc
Confidence 89999988764
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00081 Score=54.98 Aligned_cols=30 Identities=20% Similarity=0.208 Sum_probs=26.1
Q ss_pred CCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 191 NFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 191 ~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.+++|+|+.|.||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 479999999999999966556899999885
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00077 Score=55.79 Aligned_cols=73 Identities=18% Similarity=0.190 Sum_probs=45.0
Q ss_pred eeeccCceEEEEEEEccCCeEEEEEEeec-----c--CCccchhHHHHHHHhhcCC--CC-CeeeeeEEEEcCCcceEEE
Q psy13250 80 RIGEGSYGVVYRVRDSVQDKILALKKLFL-----Q--NNTLTRGELREVTGLTKCR--HE-NIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 80 ~lG~G~fg~V~~~~~~~~~~~~avK~~~~-----~--~~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~~~l 149 (224)
.||.|....||++.....++.++||.... . -.-...+...|...|+... -| .+.++|.+- ++ ...+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~e--~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--TE--MAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--cc--ccee
Confidence 57999999999999754446789996531 1 1222344455666665532 23 455565443 32 4568
Q ss_pred EEecccC
Q psy13250 150 VMEYCEH 156 (224)
Q Consensus 150 v~e~~~~ 156 (224)
|||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9999853
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0021 Score=52.22 Aligned_cols=79 Identities=14% Similarity=0.058 Sum_probs=49.2
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCC---CCeeeeeEEEEcC-CcceEEEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRH---ENIVQLKEVVVGK-SLSSIFLV 150 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~~-~~~~~~lv 150 (224)
..-.+.||.|..+.||+..... + .+.+|..+. ......+..|...|+.+.- -.+.++++.+... ..+..+||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQ-G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hheeeecCCccceeEEEEEcCC-C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 3445679999999999876432 3 455665321 1123456678777776642 3456666665322 23457999
Q ss_pred EecccCC
Q psy13250 151 MEYCEHD 157 (224)
Q Consensus 151 ~e~~~~~ 157 (224)
||++++.
T Consensus 92 mE~i~G~ 98 (297)
T PRK10593 92 LERLRGV 98 (297)
T ss_pred EeccCCE
Confidence 9998863
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=97.64 E-value=4.8e-05 Score=61.59 Aligned_cols=131 Identities=16% Similarity=0.106 Sum_probs=81.6
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC-----------------Cccc-----hhHHHHHHHhhcCCC-C
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN-----------------NTLT-----RGELREVTGLTKCRH-E 130 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~-----------------~~~~-----~~~~~e~~~l~~l~h-~ 130 (224)
-+.+.++||-|.-+.||.+.+. .|...++|.-.+.. ...+ -...+|+..|+.+.- -
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4677899999999999998765 46677777332110 0001 123467777777642 2
Q ss_pred C-eeeeeEEEEcCCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC
Q psy13250 131 N-IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG 209 (224)
Q Consensus 131 n-iv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~ 209 (224)
. +.+.++ .+..++|||++.|-.+..... ......+ ...+..-+.-|-.+|+||+|..-=||++..++
T Consensus 172 fpVPkpiD------~~RH~Vvmelv~g~Pl~~v~~---v~d~~~l---y~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 172 FPVPKPID------HNRHCVVMELVDGYPLRQVRH---VEDPPTL---YDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCCccc------ccceeeHHHhhcccceeeeee---cCChHHH---HHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 1 222222 235789999998732221111 1122222 22233334456789999999999999999999
Q ss_pred cEEEEecc
Q psy13250 210 CVKIVYST 217 (224)
Q Consensus 210 ~~kl~DfG 217 (224)
.+++|||=
T Consensus 240 ~i~vIDFP 247 (465)
T KOG2268|consen 240 KIVVIDFP 247 (465)
T ss_pred CEEEeech
Confidence 99999994
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00099 Score=54.05 Aligned_cols=29 Identities=24% Similarity=0.378 Sum_probs=26.2
Q ss_pred CceecCCCCCcEEEccC----CcEEEEeccccc
Q psy13250 192 FIIHRDLKPSNLLLNDK----GCVKIVYSTYLE 220 (224)
Q Consensus 192 ~iiHrDlkp~Nill~~~----~~~kl~DfGla~ 220 (224)
.++|+|+.+.|||++.+ +.+.+|||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999985 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0018 Score=52.74 Aligned_cols=29 Identities=17% Similarity=0.374 Sum_probs=26.9
Q ss_pred CceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 192 FIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 192 ~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.++|+|+.+.||+++..+-+-++||+++.
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~ 227 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELAT 227 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEeccccc
Confidence 48999999999999999889999999985
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0053 Score=51.80 Aligned_cols=74 Identities=19% Similarity=0.315 Sum_probs=47.7
Q ss_pred EeeeeeccCceEEEEEEEccCCeEEEEEEeecc----CC---ccchhHHHHHHHhhcCC---CCCeeeeeEEEEcCCcce
Q psy13250 77 KLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ----NN---TLTRGELREVTGLTKCR---HENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 77 ~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~----~~---~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~ 146 (224)
..+.||.|....||+.... +..++||.-... .. ....+...|...|+.+. ...+.+++.+. ++ .
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d--ed--~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD--RT--M 109 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC--CC--C
Confidence 3577899999999998863 446889966411 11 13344455666665543 24667777665 32 4
Q ss_pred EEEEEecccC
Q psy13250 147 IFLVMEYCEH 156 (224)
Q Consensus 147 ~~lv~e~~~~ 156 (224)
-+++||++++
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 5788999965
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0039 Score=51.68 Aligned_cols=29 Identities=21% Similarity=0.432 Sum_probs=25.7
Q ss_pred CceecCCCCCcEEEcc-CCcEEEEeccccc
Q psy13250 192 FIIHRDLKPSNLLLND-KGCVKIVYSTYLE 220 (224)
Q Consensus 192 ~iiHrDlkp~Nill~~-~~~~kl~DfGla~ 220 (224)
.++|+|+++.|||++. ++.+.++||..|.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 5899999999999986 4689999998875
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0012 Score=54.46 Aligned_cols=75 Identities=15% Similarity=0.212 Sum_probs=53.8
Q ss_pred CcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 143 SLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN-FIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 143 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+..+.|++|++.++.+...- .-.++++..|+.+.+.-+.-+..+ ..-|||+.-.||||+ +|++.||||-++|.
T Consensus 297 e~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 34467888888766443221 134566777777766555544433 588999999999999 99999999999986
Q ss_pred cc
Q psy13250 222 YL 223 (224)
Q Consensus 222 ~~ 223 (224)
-+
T Consensus 371 ~~ 372 (488)
T COG5072 371 SY 372 (488)
T ss_pred cc
Confidence 43
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=97.31 E-value=4.4e-05 Score=66.53 Aligned_cols=135 Identities=18% Similarity=0.166 Sum_probs=91.0
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCC-eeeeeEEEEcCCcceEEEEEec
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHEN-IVQLKEVVVGKSLSSIFLVMEY 153 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~lv~e~ 153 (224)
+....-.++|+++++++.+...+...+ .+.+... .....+++.|.+++||| .+..++.+ +.....++.|++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~--~~E~~~~i~~~i 315 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDY--DGEDYLWIPMRI 315 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccC--Ccccccchhhhh
Confidence 455667899999999998876555444 5544322 33445788999999999 55554444 455688999999
Q ss_pred ccCC--hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 154 CEHD--LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 154 ~~~~--l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+.++ .........-.+.+.....+.+.-.++++++|+.-=+||| ||+..+ +..+..||+.+.-+
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L 381 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQL 381 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCccc
Confidence 9865 1111111111233444455666677889999988778998 777654 77899999887644
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0026 Score=53.33 Aligned_cols=74 Identities=19% Similarity=0.068 Sum_probs=46.2
Q ss_pred eeeeeccCceEEEEEEEccCCeEEEEEEeec----c--CCccchhHHHHHHHhhcCC---CCCeeeeeEEEEcCCcceEE
Q psy13250 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFL----Q--NNTLTRGELREVTGLTKCR---HENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 78 ~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~----~--~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~ 148 (224)
.+.||.|....||++.+...+..++||.... . -.-...+..-|...|+... -..+.++|.+- ++ ...
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e--~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--SV--MNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cH--Hhh
Confidence 5788999999999999743356788996531 1 1122344455776666542 23455665442 22 456
Q ss_pred EEEeccc
Q psy13250 149 LVMEYCE 155 (224)
Q Consensus 149 lv~e~~~ 155 (224)
+|||+++
T Consensus 110 ~vMEdL~ 116 (409)
T PRK12396 110 CVMEDLS 116 (409)
T ss_pred HHHHhCc
Confidence 8899885
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0056 Score=49.16 Aligned_cols=29 Identities=21% Similarity=0.476 Sum_probs=24.9
Q ss_pred CceecCCCCCcEEEccCCc-EEEEeccccc
Q psy13250 192 FIIHRDLKPSNLLLNDKGC-VKIVYSTYLE 220 (224)
Q Consensus 192 ~iiHrDlkp~Nill~~~~~-~kl~DfGla~ 220 (224)
.++|+|+.|.|||++.++. .-|+||+.|.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcc
Confidence 4899999999999997565 4699999875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0077 Score=48.61 Aligned_cols=75 Identities=15% Similarity=0.123 Sum_probs=41.2
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC---CCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC---RHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.+..+.++.|....+|+.. ..+..+.+|.-.. .....+..|..-|+.+ .--.+.+.+.+.... +.-||+|
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~--~~~fLll 91 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD--DDAFLLL 91 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S--SCCEEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec--CCceEEE
Confidence 4456778999999999877 5677888997652 2233445566555554 344566666666333 3458999
Q ss_pred ecccC
Q psy13250 152 EYCEH 156 (224)
Q Consensus 152 e~~~~ 156 (224)
||++.
T Consensus 92 e~l~~ 96 (288)
T PF03881_consen 92 EFLEM 96 (288)
T ss_dssp E----
T ss_pred EeecC
Confidence 99874
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.02 Score=47.19 Aligned_cols=28 Identities=32% Similarity=0.497 Sum_probs=24.9
Q ss_pred ceecCCCCCcEEEcc-CCcEEEEeccccc
Q psy13250 193 IIHRDLKPSNLLLND-KGCVKIVYSTYLE 220 (224)
Q Consensus 193 iiHrDlkp~Nill~~-~~~~kl~DfGla~ 220 (224)
++|.|+.+.|||++. ++.+++|||..|-
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 5789999998874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0033 Score=51.18 Aligned_cols=30 Identities=23% Similarity=0.365 Sum_probs=27.2
Q ss_pred CCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 191 NFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 191 ~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 679999999999999998877899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.0065 Score=49.38 Aligned_cols=29 Identities=28% Similarity=0.336 Sum_probs=25.6
Q ss_pred CCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 191 NFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 191 ~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57899999999999987 678999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.031 Score=43.36 Aligned_cols=98 Identities=21% Similarity=0.222 Sum_probs=59.4
Q ss_pred EEEEEeecc-CCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHH
Q psy13250 101 LALKKLFLQ-NNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVIL 179 (224)
Q Consensus 101 ~avK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ 179 (224)
..+|++... ..-....+..+.++++++. .|+++.. ++....-+++|.|..-.. .. ..++.
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N----Dn~~~yGvIlE~Cy~~~i---------~~----~N~i~ 148 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN----DNNYKYGVILERCYKIKI---------NF----SNFIT 148 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec----CCCceeEEEEeeccCccc---------ch----hHHHH
Confidence 345555322 2213334456677777664 4666541 233355688888853110 00 11111
Q ss_pred HHHHHHHHHHh--CCceecCCCCCcEEEccCCcEEEEecc
Q psy13250 180 QVLKGLNYLHS--NFIIHRDLKPSNLLLNDKGCVKIVYST 217 (224)
Q Consensus 180 ~i~~~l~~lH~--~~iiHrDlkp~Nill~~~~~~kl~DfG 217 (224)
.=+.+|.-.|+ .+.+|+|-.|+||+-+..|.+||.|=+
T Consensus 149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence 12456777884 469999999999999999999999854
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.11 Score=43.72 Aligned_cols=29 Identities=17% Similarity=0.151 Sum_probs=23.8
Q ss_pred CCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 191 NFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 191 ~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
...+|.|+-+.||+.+ ++.+.+|||-.|.
T Consensus 227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEec-CCCEEEEEecccc
Confidence 3579999999999975 4569999997764
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.0055 Score=46.10 Aligned_cols=28 Identities=21% Similarity=0.418 Sum_probs=24.8
Q ss_pred CceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 192 FIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 192 ~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
..+|+|+.|.||++..+| +++|||+.|.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 469999999999998777 8999999874
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.0041 Score=54.86 Aligned_cols=40 Identities=25% Similarity=0.530 Sum_probs=36.2
Q ss_pred HHHHHHHHHh-CCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 181 VLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 181 i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
++.|+.|+|. .++||+.|.|++|.++..|.+||+.|+++.
T Consensus 108 v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v 148 (700)
T KOG2137|consen 108 VADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCV 148 (700)
T ss_pred ccchhhhhccCcceeecccchhheeeccCcceeeccchhhh
Confidence 4489999995 589999999999999999999999999874
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.021 Score=43.43 Aligned_cols=31 Identities=19% Similarity=0.257 Sum_probs=26.3
Q ss_pred CCceecCCCCCcEEEccCC-----cEEEEecccccc
Q psy13250 191 NFIIHRDLKPSNLLLNDKG-----CVKIVYSTYLEL 221 (224)
Q Consensus 191 ~~iiHrDlkp~Nill~~~~-----~~kl~DfGla~~ 221 (224)
..++|+|+.+.||++..++ .+.|+||..++.
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 4689999999999998654 689999998763
|
subfamily of choline kinases |
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.0013 Score=56.00 Aligned_cols=73 Identities=26% Similarity=0.453 Sum_probs=60.3
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEc
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVG 141 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~ 141 (224)
.+..++|+....+|.|+||+|+.+.....+..+|||++...+.. ...+.++|...+..+.|++++.+...|..
T Consensus 45 sr~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~ 118 (516)
T KOG1033|consen 45 SREANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYE 118 (516)
T ss_pred hhhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceec
Confidence 44567899999999999999999998877879999999765543 34566788888999999999999887753
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.016 Score=47.63 Aligned_cols=28 Identities=32% Similarity=0.438 Sum_probs=26.0
Q ss_pred ceecCCCCCcEEEccCCc-EEEEeccccc
Q psy13250 193 IIHRDLKPSNLLLNDKGC-VKIVYSTYLE 220 (224)
Q Consensus 193 iiHrDlkp~Nill~~~~~-~kl~DfGla~ 220 (224)
+||.|+.|.||+++.+.. +.++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999999885 8999999886
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.24 Score=42.64 Aligned_cols=28 Identities=25% Similarity=0.599 Sum_probs=23.5
Q ss_pred CceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 192 FIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 192 ~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.++|.|+-+.|||.+.+ .++||||-.|.
T Consensus 285 VfCHNDl~~~NiL~~~~-~l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNK-CLRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCC-CEEEEeecccc
Confidence 47999999999987654 49999997764
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.0085 Score=45.95 Aligned_cols=29 Identities=38% Similarity=0.669 Sum_probs=20.9
Q ss_pred CceecCCCCCcEEE-ccCCcEEEEeccccc
Q psy13250 192 FIIHRDLKPSNLLL-NDKGCVKIVYSTYLE 220 (224)
Q Consensus 192 ~iiHrDlkp~Nill-~~~~~~kl~DfGla~ 220 (224)
.+.|.|+.+.|||+ +.++.++||||-.|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 58999999999999 889999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.043 Score=46.42 Aligned_cols=133 Identities=14% Similarity=0.097 Sum_probs=80.6
Q ss_pred eeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhc-CCCCCeeeeeEEE-----Ec-CCcceEEEE
Q psy13250 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTK-CRHENIVQLKEVV-----VG-KSLSSIFLV 150 (224)
Q Consensus 78 ~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~-----~~-~~~~~~~lv 150 (224)
...||+|+-+.+|-.... +.. +.|+..........+ ....|.+ -.||-+-. .-.| .+ +....+-+.
T Consensus 16 gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~-rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPAAQAQ---KVAELAATPDAPLLNY-RVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CccccCCccceeeecchh--hch-hheeecCCCchHHHH---HHHHhccCCCCcchhh-hhcccHHHhhCCCccceeEEe
Confidence 457999999999964432 122 235443222111111 1222222 23443221 0011 11 122236678
Q ss_pred EecccCC--hhHhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecc
Q psy13250 151 MEYCEHD--LASLQDN-----VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYST 217 (224)
Q Consensus 151 ~e~~~~~--l~~~~~~-----~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG 217 (224)
|..+.+- ...++.- ......|...++.++.++.+..-||..|-.-+|+.++|+|+.+++.+.|+|--
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc
Confidence 8887752 2222221 12246789999999999999999999999999999999999999999998753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.028 Score=45.84 Aligned_cols=29 Identities=14% Similarity=0.186 Sum_probs=27.0
Q ss_pred CceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 192 FIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 192 ~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
+++|+|+.++|+|++.++.+.++||-.+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 69999999999999999999999998775
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.37 E-value=0.031 Score=44.71 Aligned_cols=29 Identities=41% Similarity=0.610 Sum_probs=26.5
Q ss_pred CceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 192 FIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 192 ~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
-++|.|+.|+|+|.+..|.++||||--|.
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg 182 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAG 182 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCC
Confidence 48999999999999999999999997664
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.70 E-value=0.026 Score=53.45 Aligned_cols=30 Identities=17% Similarity=0.240 Sum_probs=26.1
Q ss_pred CCceecCCCCCcEEEccCC--cEE-EEeccccc
Q psy13250 191 NFIIHRDLKPSNLLLNDKG--CVK-IVYSTYLE 220 (224)
Q Consensus 191 ~~iiHrDlkp~Nill~~~~--~~k-l~DfGla~ 220 (224)
.++||.|+.+.|||++.++ .+. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 5799999999999999875 565 99999875
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.95 E-value=0.078 Score=50.15 Aligned_cols=31 Identities=13% Similarity=0.061 Sum_probs=25.5
Q ss_pred hCCceecCCCCCcEEEccCC--c---EEEEeccccc
Q psy13250 190 SNFIIHRDLKPSNLLLNDKG--C---VKIVYSTYLE 220 (224)
Q Consensus 190 ~~~iiHrDlkp~Nill~~~~--~---~kl~DfGla~ 220 (224)
..++||.|+.+.|||++.+. . .-|+|||-+.
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 36799999999999998753 3 3799999875
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 224 | ||||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-25 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-25 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-25 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-25 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-23 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-23 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-22 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-22 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-22 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-22 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-22 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-22 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-22 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-22 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-22 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-22 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-21 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-21 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-20 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-19 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-19 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-19 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-19 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-19 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-18 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-18 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-18 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-18 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-18 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-18 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-18 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-18 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-18 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-17 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-17 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-16 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-16 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-16 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-15 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-15 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-15 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-15 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-15 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-15 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-14 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-14 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 8e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-10 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-10 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-10 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-10 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-09 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-09 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 9e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-08 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 9e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 9e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-06 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 3e-06 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 3e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 7e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 7e-06 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 8e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 9e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 9e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-05 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-05 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-05 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-05 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-04 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-04 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-04 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-04 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 4e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 5e-04 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-04 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 5e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 6e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-04 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-04 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-04 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 7e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-04 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 8e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-04 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 8e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 8e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-04 |
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-68
Identities = 61/163 (37%), Positives = 97/163 (59%), Gaps = 12/163 (7%)
Query: 61 LEQDCFGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT----LTRG 116
+ C V+++EKL +IG+G++G V++ R + +ALKK+ ++N +T
Sbjct: 5 YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT-- 62
Query: 117 ELREVTGLTKCRHENIVQLKEVVVGKSL------SSIFLVMEYCEHDLASLQDNVESPFT 170
LRE+ L +HEN+V L E+ K+ SI+LV ++CEHDLA L NV FT
Sbjct: 63 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFT 122
Query: 171 ESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
S++K V+ +L GL Y+H N I+HRD+K +N+L+ G +K+
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKL 165
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 8e-65
Identities = 54/149 (36%), Positives = 87/149 (58%), Gaps = 7/149 (4%)
Query: 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRG-----ELREVTGL 124
+EKL+ +GEG + VY+ RD ++I+A+KK+ L + + + LRE+ L
Sbjct: 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLL 66
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKG 184
+ H NI+ L + KS +I LV ++ E DL + + T S +K +L L+G
Sbjct: 67 QELSHPNIIGLLDAFGHKS--NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
L YLH ++I+HRDLKP+NLLL++ G +K+
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKL 153
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 1e-63
Identities = 51/157 (32%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-----LREVT- 122
+ +E + IG G+YG VY+ RD +ALK + + N G +REV
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 123 --GLTKCRHENIVQLKEVVVGKSL---SSIFLVMEYCEHDLASLQDNVESP-FTESQVKC 176
L H N+V+L +V + LV E+ + DL + D P +K
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD 124
Query: 177 VILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
++ Q L+GL++LH+N I+HRDLKP N+L+ G VK+
Sbjct: 125 LMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKL 161
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 9e-63
Identities = 54/148 (36%), Positives = 88/148 (59%), Gaps = 12/148 (8%)
Query: 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE------LREVTGLT 125
+ ++EKL +IGEG+YG V++ ++ +I+ALK++ L ++ E LRE+ L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD----EGVPSSALREICLLK 56
Query: 126 KCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGL 185
+ +H+NIV+L +V+ + LV E+C+ DL D+ VK + Q+LKGL
Sbjct: 57 ELKHKNIVRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ HS ++HRDLKP NLL+N G +K+
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKL 142
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-62
Identities = 55/161 (34%), Positives = 94/161 (58%), Gaps = 13/161 (8%)
Query: 59 EILEQDCFGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE- 117
++ + +++KL ++GEG+YGVVY+ +DS Q +I+ALK++ L E
Sbjct: 7 HSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAED----EG 61
Query: 118 -----LREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTES 172
+RE++ L + H NIV L +V+ + + LV E+ E DL + D ++ +S
Sbjct: 62 IPSTAIREISLLKELHHPNIVSLIDVIHSER--CLTLVFEFMEKDLKKVLDENKTGLQDS 119
Query: 173 QVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
Q+K + Q+L+G+ + H + I+HRDLKP NLL+N G +K+
Sbjct: 120 QIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKL 160
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-62
Identities = 53/159 (33%), Positives = 88/159 (55%), Gaps = 14/159 (8%)
Query: 67 GKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQ-DKILALKKLFLQNNT----LTRGELREV 121
G CR ++E + IGEG+YG V++ RD + +ALK++ +Q L+ +REV
Sbjct: 5 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS--TIREV 62
Query: 122 T---GLTKCRHENIVQLKEVVVGKSL---SSIFLVMEYCEHDLASLQDNVESPF-TESQV 174
L H N+V+L +V + + LV E+ + DL + D V P +
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122
Query: 175 KCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
K ++ Q+L+GL++LHS+ ++HRDLKP N+L+ G +K+
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL 161
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 9e-60
Identities = 49/153 (32%), Positives = 86/153 (56%), Gaps = 18/153 (11%)
Query: 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE------LREVTGLT 125
++F++L ++G G+Y VY+ + +ALK++ L + E +RE++ +
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-----EGTPSTAIREISLMK 58
Query: 126 KCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQD-----NVESPFTESQVKCVILQ 180
+ +HENIV+L +V+ ++ + LV E+ ++DL D N + VK Q
Sbjct: 59 ELKHENIVRLYDVIHTEN--KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 181 VLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+L+GL + H N I+HRDLKP NLL+N +G +K+
Sbjct: 117 LLQGLAFCHENKILHRDLKPQNLLINKRGQLKL 149
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-59
Identities = 54/148 (36%), Positives = 85/148 (57%), Gaps = 13/148 (8%)
Query: 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE------LREVTGLT 125
+ ++ L +IGEG+YGVVY+ +++ + ALKK+ L+ E +RE++ L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKED----EGIPSTTIREISILK 55
Query: 126 KCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGL 185
+ +H NIV+L +V+ K + LV E+ + DL L D E K +LQ+L G+
Sbjct: 56 ELKHSNIVKLYDVIHTKK--RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
Y H ++HRDLKP NLL+N +G +KI
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKI 141
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-59
Identities = 53/149 (35%), Positives = 90/149 (60%), Gaps = 13/149 (8%)
Query: 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE------LREVTGLT 125
+ F+K+ +IGEG+YGVVY+ R+ + +++ALKK+ L T E +RE++ L
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET----EGVPSTAIREISLLK 57
Query: 126 KCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKG 184
+ H NIV+L +V+ ++ ++LV E+ DL D + +K + Q+L+G
Sbjct: 58 ELNHPNIVKLLDVIHTEN--KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQG 115
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
L + HS+ ++HRDLKP NLL+N +G +K+
Sbjct: 116 LAFCHSHRVLHRDLKPQNLLINTEGAIKL 144
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 2e-59
Identities = 48/164 (29%), Positives = 88/164 (53%), Gaps = 18/164 (10%)
Query: 61 LEQDCFGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE--- 117
+ ++ + ++ ++GEG+YG VY+ D+V ++ +A+K++ L++ E
Sbjct: 22 MSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH----EEEGVP 77
Query: 118 ---LREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQV 174
+REV+ L + +H NI++LK V+ + L+ EY E+DL D + +
Sbjct: 78 GTAIREVSLLKELQHRNIIELKSVIHHNH--RLHLIFEYAENDLKKYMDK-NPDVSMRVI 134
Query: 175 KCVILQVLKGLNYLHSNFIIHRDLKPSNLLLN-----DKGCVKI 213
K + Q++ G+N+ HS +HRDLKP NLLL+ + +KI
Sbjct: 135 KSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKI 178
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 3e-59
Identities = 51/148 (34%), Positives = 87/148 (58%), Gaps = 13/148 (8%)
Query: 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE------LREVTGLT 125
+ + KL+++GEG+Y VY+ + + D ++ALK++ L++ E +REV+ L
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-----EGAPCTAIREVSLLK 55
Query: 126 KCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGL 185
+H NIV L +++ + S+ LV EY + DL D+ + VK + Q+L+GL
Sbjct: 56 DLKHANIVTLHDIIHTEK--SLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
Y H ++HRDLKP NLL+N++G +K+
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKL 141
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-56
Identities = 47/149 (31%), Positives = 84/149 (56%), Gaps = 8/149 (5%)
Query: 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----LREVTGL 124
+++ ++E L +GEGSYG+V + R+ +I+A+KK ++ + +RE+ L
Sbjct: 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD--KMVKKIAMREIKLL 78
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKG 184
+ RHEN+V L EV K +LV E+ +H + + + V+ + Q++ G
Sbjct: 79 KQLRHENLVNLLEVCKKKK--RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIING 136
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ + HS+ IIHRD+KP N+L++ G VK+
Sbjct: 137 IGFCHSHNIIHRDIKPENILVSQSGVVKL 165
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 7e-55
Identities = 49/161 (30%), Positives = 88/161 (54%), Gaps = 17/161 (10%)
Query: 68 KCRNVAEFEKLN-RIGEGSYGVVY--RVRDSVQDKILALKKLFLQNNTLTRGELREVTGL 124
+ R FE ++G G+YG VY + +D DK ALK++ +++ RE+ L
Sbjct: 15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMS--ACREIALL 72
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQD--------NVESPFTESQVKC 176
+ +H N++ L++V + + ++L+ +Y EHDL + VK
Sbjct: 73 RELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 177 VILQVLKGLNYLHSNFIIHRDLKPSNLLL----NDKGCVKI 213
++ Q+L G++YLH+N+++HRDLKP+N+L+ ++G VKI
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 8e-55
Identities = 50/144 (34%), Positives = 79/144 (54%), Gaps = 8/144 (5%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTKCRH 129
++EK+ +IGEGSYGVV++ R+ +I+A+KK + LRE+ L + +H
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD--PVIKKIALREIRMLKQLKH 61
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
N+V L EV K + LV EYC+H + D + E VK + Q L+ +N+ H
Sbjct: 62 PNLVNLLEVFRRKR--RLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
+ IHRD+KP N+L+ +K+
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKL 143
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-42
Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 20/160 (12%)
Query: 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRH 129
R +F+++ IG G +G V++ + + K +K++ N REV L K H
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDH 63
Query: 130 ENIVQLKEVVVGKSLSS--------------IFLVMEYCEH-DLAS-LQDNVESPFTESQ 173
NIV G +F+ ME+C+ L ++ +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 174 VKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ Q+ KG++Y+HS +I+RDLKPSN+ L D VKI
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-41
Identities = 40/143 (27%), Positives = 69/143 (48%), Gaps = 5/143 (3%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLT--RGELREVTGLTK-CRHE 130
F++L+R+G GSYG V++VR ++ A+K+ +L EV K +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
V+L++ ++L E C L + + E+QV + L L +LHS
Sbjct: 118 CCVRLEQAWEEGG--ILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
++H D+KP+N+ L +G K+
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKL 198
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-40
Identities = 44/144 (30%), Positives = 82/144 (56%), Gaps = 6/144 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTGLTKCRHENI 132
+E + IG GSYG V D ++ +++A+KK+ ++ + LRE+ L + H+++
Sbjct: 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 133 VQLKEVVVGKSLSS---IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
V++ ++V+ K + +++V+E + D L TE +K ++ +L G+ Y+H
Sbjct: 115 VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVH 173
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
S I+HRDLKP+N L+N VK+
Sbjct: 174 SAGILHRDLKPANCLVNQDCSVKV 197
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-40
Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTKCRH 129
++ +L +IGEGS+G V+ + + +K++ + ++ E REV L +H
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR--MSSKEREESRREVAVLANMKH 82
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNY 187
NIVQ +E S+++VM+YCE DL + F E Q+ +Q+ L +
Sbjct: 83 PNIVQYRESFEENG--SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
+H I+HRD+K N+ L G V++
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQL 166
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-39
Identities = 50/153 (32%), Positives = 81/153 (52%), Gaps = 15/153 (9%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTKCRH 129
++E L IG GSYG ++R KIL K+L + +T E + EV L + +H
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS--MTEAEKQMLVSEVNLLRELKH 64
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASL---QDNVESPFTESQVKCVILQVLKGL 185
NIV+ + ++ ++ +++++VMEYCE DLAS+ E V V+ Q+ L
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 186 NYLHS-----NFIIHRDLKPSNLLLNDKGCVKI 213
H + ++HRDLKP+N+ L+ K VK+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 157
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-39
Identities = 51/204 (25%), Positives = 84/204 (41%), Gaps = 17/204 (8%)
Query: 19 GNPESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAE-FEK 77
G P + + P RD + VT ++ G R +
Sbjct: 3 GRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVT----TVVATPGQGPDRPQEVSYTD 58
Query: 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
IG GS+GVVY+ + +++A+KK+ R + RE+ + K H NIV+L+
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRY 114
Query: 138 VVVGKSLSS----IFLVMEYCEHDLASLQDNVES---PFTESQVKCVILQVLKGLNYLHS 190
+ LV++Y + + + VK + Q+ + L Y+HS
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 191 NFIIHRDLKPSNLLLN-DKGCVKI 213
I HRD+KP NLLL+ D +K+
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKL 198
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-39
Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCR 128
R + +FE + +G G +GVV+ ++ V D A+K++ L N L R + +REV L K
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 129 HENIVQLKEV----------VVGKSLSSIFLVMEYCEH-DLASL--QDNVESPFTESQVK 175
H IV+ +++ M+ C +L S
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 176 CVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ LQ+ + + +LHS ++HRDLKPSN+ VK+
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-39
Identities = 46/156 (29%), Positives = 79/156 (50%), Gaps = 13/156 (8%)
Query: 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRH 129
R ++FE++ +G+G++G V + R+++ + A+KK+ L+ L EV L H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLST-ILSEVMLLASLNH 61
Query: 130 ENIVQLKEV-----------VVGKSLSSIFLVMEYCE-HDLASLQDNVESPFTESQVKCV 177
+ +V+ K S++F+ MEYCE L L + + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 178 ILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
Q+L+ L+Y+HS IIHRDLKP N+ +++ VKI
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 6e-39
Identities = 34/147 (23%), Positives = 69/147 (46%), Gaps = 9/147 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE---LREVTGLTKCRHE 130
F +IG G + VYR + +ALKK+ + + + ++E+ L + H
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEH-DLASL---QDNVESPFTESQVKCVILQVLKGLN 186
N+++ + + + +V+E + DL+ + + E V +Q+ L
Sbjct: 93 NVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
++HS ++HRD+KP+N+ + G VK+
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKL 177
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-38
Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 9/148 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLT--RGELREVTGLTK-CRHE 130
EF +L +IG G +G V++ + I A+K+ + LREV +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCE----HDLASLQDNVESPFTESQVKCVILQVLKGLN 186
++V+ + + EYC D S + S F E+++K ++LQV +GL
Sbjct: 72 HVVRYFSAWAEDD--HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
Y+HS ++H D+KPSN+ ++
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAA 157
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-37
Identities = 38/141 (26%), Positives = 76/141 (53%), Gaps = 3/141 (2%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
+E + +G+G++G VY+ ++ + A K + ++ + E+ L C H IV+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 135 LKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFI 193
L +++++E+C + ++ ++ TE Q++ V Q+L+ LN+LHS I
Sbjct: 81 LLGAYYHDG--KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRI 138
Query: 194 IHRDLKPSNLLLNDKGCVKIV 214
IHRDLK N+L+ +G +++
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLA 159
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-37
Identities = 46/148 (31%), Positives = 80/148 (54%), Gaps = 14/148 (9%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCRHENI 132
+ + IG GSYG VY D +K +A+KK+ ++ + LRE+T L + + + I
Sbjct: 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 133 VQLKEVVVGKSLSS---IFLVMEYCEHDLA----SLQDNVESPFTESQVKCVILQVLKGL 185
++L ++++ L +++V+E + DL + TE +K ++ +L G
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPI-----FLTEEHIKTILYNLLLGE 142
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
N++H + IIHRDLKP+N LLN VK+
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKV 170
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-37
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 16 QDDGNPESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGE-PIEILEQDCFGKCRNVAE 74
D P + + +P + + + + P ++
Sbjct: 10 HDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKL-------------- 55
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE---LREVTGLTKCRHEN 131
F L IG GS+G VY RD +++A+KK+ ++EV L K RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
+Q + + + + +LVMEYC + L + + P E ++ V L+GL YLHS+
Sbjct: 116 TIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
+IHRD+K N+LL++ G VK+
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKL 195
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-37
Identities = 35/147 (23%), Positives = 67/147 (45%), Gaps = 10/147 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
+ + ++GEG + V V ALK++ RE H NI++
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 135 LKEVVVGKSLSS--IFLVMEYCEHDLASLQDNVE------SPFTESQVKCVILQVLKGLN 186
L + + + +L++ + + +L + +E + TE Q+ ++L + +GL
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKR--GTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+H+ HRDLKP+N+LL D+G +
Sbjct: 149 AIHAKGYAHRDLKPTNILLGDEGQPVL 175
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-36
Identities = 46/141 (32%), Positives = 76/141 (53%), Gaps = 7/141 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
+ + +IG+G+ G VY D + +A++++ LQ + E+ + + ++ NIV
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 135 LKE-VVVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNF 192
+ +VG L ++VMEY SL D V E+ E Q+ V + L+ L +LHSN
Sbjct: 82 YLDSYLVGDEL---WVVMEYLA--GGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 193 IIHRDLKPSNLLLNDKGCVKI 213
+IHRD+K N+LL G VK+
Sbjct: 137 VIHRDIKSDNILLGMDGSVKL 157
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-36
Identities = 50/153 (32%), Positives = 86/153 (56%), Gaps = 17/153 (11%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
+ L +G G G+V+ D+ DK +A+KK+ L + + LRE+ + + H+NIV+
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 135 LKEVV------------VGKSLSSIFLVMEYCEHDLASLQDNVES-PFTESQVKCVILQV 181
+ E++ L+S+++V EY E DLA++ +E P E + + Q+
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANV---LEQGPLLEEHARLFMYQL 129
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLLNDKGC-VKI 213
L+GL Y+HS ++HRDLKP+NL +N + +KI
Sbjct: 130 LRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-36
Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 12/143 (8%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
R+G GS+G V+R++D A+KK+ L+ + E+ IV
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVP 114
Query: 135 LKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLHSNF 192
L V +IF ME E SL ++ E + + Q L+GL YLH+
Sbjct: 115 LYGAVREGPWVNIF--MELLEG--GSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170
Query: 193 IIHRDLKPSNLLLNDKGC-VKIV 214
I+H D+K N+LL+ G +
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALC 193
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-36
Identities = 43/141 (30%), Positives = 75/141 (53%), Gaps = 7/141 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
+ +IGEGS G+V R+ + +A+K + L+ EV + +H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 135 LKE-VVVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNF 192
+ + +VG+ L +++ME+ + +L D V + E Q+ V VL+ L YLH+
Sbjct: 107 MYKSYLVGEEL---WVLMEFLQ--GGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 193 IIHRDLKPSNLLLNDKGCVKI 213
+IHRD+K ++LL G VK+
Sbjct: 162 VIHRDIKSDSILLTLDGRVKL 182
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-35
Identities = 52/203 (25%), Positives = 86/203 (42%), Gaps = 28/203 (13%)
Query: 19 GNPESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKL 78
G+ +A + D +K + + + TGE EI +
Sbjct: 1 GSFTMSNAPLNGVKLNPLDDPNKV--IKVLASDGKTGEQREI-------------AYTNC 45
Query: 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEV 138
IG GS+GVV++ + D++ A+KK+ R + RE+ + +H N+V LK
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEV-AIKKVLQD----KRFKNRELQIMRIVKHPNVVDLKAF 100
Query: 139 VV----GKSLSSIFLVMEYCEHDLASLQDNVES---PFTESQVKCVILQVLKGLNYLHSN 191
K + LV+EY + + +K + Q+L+ L Y+HS
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 192 FIIHRDLKPSNLLLN-DKGCVKI 213
I HRD+KP NLLL+ G +K+
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKL 183
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-35
Identities = 46/142 (32%), Positives = 85/142 (59%), Gaps = 6/142 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRHENIV 133
F KL +IG+GS+G V++ D+ K++A+K + L+ ++ +E+T L++C +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 134 QLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES-PFTESQVKCVILQVLKGLNYLHSNF 192
+ + + ++++MEY S D +E P E+Q+ ++ ++LKGL+YLHS
Sbjct: 84 KYYGSYLKDT--KLWIIMEYLG--GGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 193 IIHRDLKPSNLLLNDKGCVKIV 214
IHRD+K +N+LL++ G VK+
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLA 161
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-35
Identities = 45/145 (31%), Positives = 78/145 (53%), Gaps = 9/145 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCRHENI 132
+ +G G+YG V D + +A+KKL Q+ + RE+ L +HEN+
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 85
Query: 133 VQLKEVVV----GKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
+ L +V ++ +LVM + + DL + + F+E +++ ++ Q+LKGL Y+
Sbjct: 86 IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKI---MGLKFSEEKIQYLVYQMLKGLKYI 142
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
HS ++HRDLKP NL +N+ +KI
Sbjct: 143 HSAGVVHRDLKPGNLAVNEDCELKI 167
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-35
Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 18/149 (12%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENI 132
+FEK++ +G G+ GVV++V ++A K + L+ R + +RE+ L +C I
Sbjct: 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 133 VQ-----LKEVVVGKSLSSIFLVMEYCEHDLASLQD--NVESPFTESQVKCVILQVLKGL 185
V + I + ME+ D SL E + V + V+KGL
Sbjct: 94 VGFYGAFYSD-------GEISICMEHM--DGGSLDQVLKKAGRIPEQILGKVSIAVIKGL 144
Query: 186 NYLHSNF-IIHRDLKPSNLLLNDKGCVKI 213
YL I+HRD+KPSN+L+N +G +K+
Sbjct: 145 TYLREKHKIMHRDVKPSNILVNSRGEIKL 173
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-35
Identities = 50/143 (34%), Positives = 88/143 (61%), Gaps = 7/143 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCR-HEN 131
+E + ++G+G+YG+V++ D +++A+KK+F QN+T + RE+ LT+ HEN
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES-PFTESQVKCVILQVLKGLNYLHS 190
IV L V+ + ++LV +Y E DL ++ + + + V+ Q++K + YLHS
Sbjct: 71 IVNLLNVLRADNDRDVYLVFDYMETDLHAV---IRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
++HRD+KPSN+LLN + VK+
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKV 150
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-35
Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 14/147 (9%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL--FLQNNTLTRGELREVTGLTKCRHENI 132
F+ + +GEG+YGVV +I+A+KK+ F LRE+ L +HENI
Sbjct: 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENI 71
Query: 133 VQLKEVVVGKSLSS---IFLVMEYCEHDLA---SLQDNVESPFTESQVKCVILQVLKGLN 186
+ + + S + ++++ E + DL S Q ++ ++ I Q L+ +
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQ-----MLSDDHIQYFIYQTLRAVK 126
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
LH + +IHRDLKPSNLL+N +K+
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKV 153
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-35
Identities = 44/167 (26%), Positives = 75/167 (44%), Gaps = 16/167 (9%)
Query: 62 EQDCFGKCRNVAE-FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF-----------LQ 109
+D + + + I GSYG V DS + A+K++F L
Sbjct: 10 MRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPV-AIKRVFNTVSDGRTVNILS 68
Query: 110 NNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS---IFLVMEYCEHDLASLQDNVE 166
++ L + LRE+ L H NI+ L+++ V + ++LV E DLA + +
Sbjct: 69 DSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR 128
Query: 167 SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ ++ + +L GL+ LH ++HRDL P N+LL D + I
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-35
Identities = 44/144 (30%), Positives = 78/144 (54%), Gaps = 11/144 (7%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
F+ L ++GEGSYG VY+ +I+A+K++ ++++ + ++E++ + +C ++V+
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPHVVK 88
Query: 135 LKEV-VVGKSLSSIFLVMEYCEHDLASLQD---NVESPFTESQVKCVILQVLKGLNYLHS 190
L ++VMEYC S+ D TE ++ ++ LKGL YLH
Sbjct: 89 YYGSYFKNTDL---WIVMEYCG--AGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 191 NFIIHRDLKPSNLLLNDKGCVKIV 214
IHRD+K N+LLN +G K+
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLA 167
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-35
Identities = 45/171 (26%), Positives = 81/171 (47%), Gaps = 13/171 (7%)
Query: 54 TGEPIEILEQDCFGKCRNVAE-FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT 112
+ P L++ R+ A FE + +G G+YG VY+ R ++ A+K + + +
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE 63
Query: 113 LTRGELREVTGLTK-CRHENIVQLKE----VVVGKSLSSIFLVMEYCEHDLASLQDNVES 167
+E+ L K H NI ++LVME+C S+ D +++
Sbjct: 64 EEE-IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG--AGSVTDLIKN 120
Query: 168 ----PFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
E + + ++L+GL++LH + +IHRD+K N+LL + VK+V
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 171
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-34
Identities = 37/145 (25%), Positives = 69/145 (47%), Gaps = 11/145 (7%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRH-- 129
+ L +IG G V++V + + +I A+K + L+ N E+ L K +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEHDLAS-LQDNVESPFTESQVKCVILQVLKGLNYL 188
+ I++L + + I++VME DL S L+ + K +L+ ++ +
Sbjct: 88 DKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTI 143
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
H + I+H DLKP+N L+ G +K+
Sbjct: 144 HQHGIVHSDLKPANFLI-VDGMLKL 167
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-34
Identities = 38/151 (25%), Positives = 70/151 (46%), Gaps = 18/151 (11%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVT-GLTKCRHEN 131
+ E + +G G+YGVV ++R +I+A+K++ N+ + L ++ +
Sbjct: 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF 67
Query: 132 IVQ-----LKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES---PFTESQVKCVILQVLK 183
V +E +++ ME + L V E + + + ++K
Sbjct: 68 TVTFYGALFRE-------GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 184 GLNYLHSNF-IIHRDLKPSNLLLNDKGCVKI 213
L +LHS +IHRD+KPSN+L+N G VK+
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKM 151
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-34
Identities = 37/152 (24%), Positives = 69/152 (45%), Gaps = 19/152 (12%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREV-TGLTKCRHEN 131
+ + L IG G+YG V ++ +I+A+K++ + + + L ++ +
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 132 IVQ-----LKEVVVGKSLSSIFLVMEYC----EHDLASLQDNVESPFTESQVKCVILQVL 182
IVQ +E ++ ME + + ++ E + + L +
Sbjct: 83 IVQFYGALFRE-------GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATV 135
Query: 183 KGLNYLHSNF-IIHRDLKPSNLLLNDKGCVKI 213
K LN+L N IIHRD+KPSN+LL+ G +K+
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDRSGNIKL 167
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-34
Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 13/150 (8%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRHENI 132
++E IG G+ VV + + + +A+K++ L+ + EL +E+ +++C H NI
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 133 VQLKE-VVVGKSLSSIFLVMEYCE----HDL----ASLQDNVESPFTESQVKCVILQVLK 183
V VV L +LVM+ D+ + ++ ES + ++ +VL+
Sbjct: 76 VSYYTSFVVKDEL---WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
GL YLH N IHRD+K N+LL + G V+I
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-34
Identities = 38/160 (23%), Positives = 67/160 (41%), Gaps = 13/160 (8%)
Query: 66 FGKCRNVAE-FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGL 124
+ R + F+ G+G++G V ++ +A+KK+ R EL+ + L
Sbjct: 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR-ELQIMQDL 73
Query: 125 TKCRHENIVQLKEVVVGKSLSS-----IFLVMEYCEHDLASL---QDNVESPFTESQVKC 176
H NIVQL+ + +VMEY L + +K
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV 133
Query: 177 VILQVLKGLNYLH--SNFIIHRDLKPSNLLLNDKGCV-KI 213
+ Q+++ + LH S + HRD+KP N+L+N+ K+
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-33
Identities = 43/147 (29%), Positives = 78/147 (53%), Gaps = 9/147 (6%)
Query: 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCRHE 130
++ L IG G+ G+V D++ ++ +A+KKL QN T + RE+ + H+
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 131 NIVQLKEVVV----GKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLN 186
NI+ L V + +++VME + +L + ++ ++ ++ Q+L G+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQV---IQMELDHERMSYLLYQMLCGIK 141
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+LHS IIHRDLKPSN+++ +KI
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKI 168
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-33
Identities = 37/148 (25%), Positives = 69/148 (46%), Gaps = 11/148 (7%)
Query: 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCR 128
+ L +IG G V++V + + +I A+K + L+ N E+ L K +
Sbjct: 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQ 65
Query: 129 H--ENIVQLKEVVVGKSLSSIFLVMEYCEHDLAS-LQDNVESPFTESQVKCVILQVLKGL 185
+ I++L + + I++VME DL S L+ + K +L+ +
Sbjct: 66 QHSDKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAV 121
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ +H + I+H DLKP+N L+ G +K+
Sbjct: 122 HTIHQHGIVHSDLKPANFLI-VDGMLKL 148
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-33
Identities = 41/199 (20%), Positives = 81/199 (40%), Gaps = 11/199 (5%)
Query: 20 NPESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLN 79
+ P + +KF ++ + T + + + L
Sbjct: 3 HHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILK 62
Query: 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRH--ENIVQL 135
+IG G V++V + + +I A+K + L+ N E+ L K + + I++L
Sbjct: 63 QIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 136 KEVVVGKSLSSIFLVMEYCEHDLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
+ + I++VME DL S L+ + K +L+ ++ +H + I+
Sbjct: 122 YDYEITDQ--YIYMVMECGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIV 177
Query: 195 HRDLKPSNLLLNDKGCVKI 213
H DLKP+N L+ G +K+
Sbjct: 178 HSDLKPANFLI-VDGMLKL 195
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 15/151 (9%)
Query: 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTK-CR 128
+ + E L +G G+ G V+++R ++A+K++ N L ++ + K
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD 82
Query: 129 HENIVQ-----LKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLK 183
IVQ + + +F+ ME L+ ++ P E + + + ++K
Sbjct: 83 CPYIVQCFGTFITN-------TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 184 GLNYLHSNF-IIHRDLKPSNLLLNDKGCVKI 213
L YL +IHRD+KPSN+LL+++G +K+
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKL 166
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-33
Identities = 49/147 (33%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCRHE 130
A + L +G G+YG V D +A+KKL+ Q+ + RE+ L RHE
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 131 NIVQLKEVVV----GKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLN 186
N++ L +V + +LVM + DL L + E +++ ++ Q+LKGL
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLR 142
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
Y+H+ IIHRDLKP NL +N+ +KI
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKI 169
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-33
Identities = 49/145 (33%), Positives = 86/145 (59%), Gaps = 10/145 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL--FLQNNTLTRGELREVTGLTKCRHENI 132
+ L+ IGEG+YG+V D++ +A+KK+ F ++ T + LRE+ L + RHENI
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENI 87
Query: 133 VQLKEVVVGKSLSS---IFLVMEYCEHDLASLQDNVES-PFTESQVKCVILQVLKGLNYL 188
+ + +++ ++ +++V + E DL L +++ + + + Q+L+GL Y+
Sbjct: 88 IGINDIIRAPTIEQMKDVYIVQDLMETDLYKL---LKTQHLSNDHICYFLYQILRGLKYI 144
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
HS ++HRDLKPSNLLLN +KI
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKI 169
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-33
Identities = 30/148 (20%), Positives = 62/148 (41%), Gaps = 12/148 (8%)
Query: 75 FEKLNRIGEG--SYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL--REVTGLTKCRHE 130
+E L IG+G V R + + ++++ L+ + E+ H
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCE----HDLASLQDNVESPFTESQVKCVILQVLKGLN 186
NIV + + + +++V + DL + + E + ++ VLK L+
Sbjct: 87 NIVPYRATFIADN--ELWVVTSFMAYGSAKDL--ICTHFMDGMNELAIAYILQGVLKALD 142
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
Y+H +HR +K S++L++ G V +
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLS 170
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-33
Identities = 38/149 (25%), Positives = 67/149 (44%), Gaps = 9/149 (6%)
Query: 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGELREVTGLTK 126
R+ + + +G+G + + + D+ ++ A K K L E++
Sbjct: 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 71
Query: 127 CRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKG 184
H+++V + +F+V+E C SL + + TE + + + Q++ G
Sbjct: 72 LAHQHVVGFHGFF--EDNDFVFVVLELCRR--RSLLELHKRRKALTEPEARYYLRQIVLG 127
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YLH N +IHRDLK NL LN+ VKI
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFLNEDLEVKI 156
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-32
Identities = 38/149 (25%), Positives = 67/149 (44%), Gaps = 9/149 (6%)
Query: 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGELREVTGLTK 126
R+ + + +G+G + + + D+ ++ A K K L E++
Sbjct: 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 97
Query: 127 CRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKG 184
H+++V + +F+V+E C SL + + TE + + + Q++ G
Sbjct: 98 LAHQHVVGFHGFF--EDNDFVFVVLELCRR--RSLLELHKRRKALTEPEARYYLRQIVLG 153
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YLH N +IHRDLK NL LN+ VKI
Sbjct: 154 CQYLHRNRVIHRDLKLGNLFLNEDLEVKI 182
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-32
Identities = 43/138 (31%), Positives = 70/138 (50%), Gaps = 6/138 (4%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVV 140
+G+G+YG+VY RD +A+K++ +++ ++ E+ +H+NIVQ
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 141 GKSLSSIFLVMEYCEHD-LASLQDNVESPF--TESQVKCVILQVLKGLNYLHSNFIIHRD 197
IF ME L++L + P E + Q+L+GL YLH N I+HRD
Sbjct: 90 ENGFIKIF--MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 198 LKPSNLLLNDK-GCVKIV 214
+K N+L+N G +KI
Sbjct: 148 IKGDNVLINTYSGVLKIS 165
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 4e-32
Identities = 40/150 (26%), Positives = 78/150 (52%), Gaps = 10/150 (6%)
Query: 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF---LQNNTLTRGELREVTGLTK 126
+ +F+ N +G+GS+ VYR +A+K + + + + EV +
Sbjct: 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 127 CRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES---PFTESQVKCVILQVLK 183
+H +I++L + + ++LV+E C + + +++ PF+E++ + + Q++
Sbjct: 68 LKHPSILELYNYF--EDSNYVYLVLEMCHN--GEMNRYLKNRVKPFSENEARHFMHQIIT 123
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
G+ YLHS+ I+HRDL SNLLL +KI
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNMNIKI 153
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-32
Identities = 46/145 (31%), Positives = 78/145 (53%), Gaps = 9/145 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCRHENI 132
++ L IG G+ G+V D+V D+ +A+KKL QN T + RE+ + H+NI
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 133 VQLKEVVV----GKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
+ L V + ++LVME + +L + ++ ++ ++ Q+L G+ +L
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV---IQMELDHERMSYLLYQMLCGIKHL 180
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
HS IIHRDLKPSN+++ +KI
Sbjct: 181 HSAGIIHRDLKPSNIVVKSDCTLKI 205
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-32
Identities = 49/146 (33%), Positives = 80/146 (54%), Gaps = 10/146 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL--QNNTLTRGELREVTGLTKCRHENI 132
++ L+ +G G+YG V D+ +A+KKL Q+ + RE+ L +HEN+
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 133 VQLKEVVV----GKSLSSIFLVMEYCEHDLASLQDNVES-PFTESQVKCVILQVLKGLNY 187
+ L +V + + ++LV DL ++ V+ T+ V+ +I Q+L+GL Y
Sbjct: 91 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLKY 147
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
+HS IIHRDLKPSNL +N+ +KI
Sbjct: 148 IHSADIIHRDLKPSNLAVNEDCELKI 173
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-31
Identities = 36/149 (24%), Positives = 70/149 (46%), Gaps = 8/149 (5%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN-NTLTRGELREVTGLTKCRHENI 132
+ + +G+G+ V+R R + A+K + ++RE L K H+NI
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEH-DLASL--QDNVESPFTESQVKCVILQVLKGLNYLH 189
V+L + + L+ME+C L ++ + + ES+ V+ V+ G+N+L
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 190 SNFIIHRDLKPSNLLL----NDKGCVKIV 214
N I+HR++KP N++ + + K+
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-31
Identities = 52/139 (37%), Positives = 75/139 (53%), Gaps = 7/139 (5%)
Query: 81 IGEGSYGVVYRVRD-----SVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQL 135
+GEGSYG V V D KIL KKL N + +E+ L + RH+N++QL
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK-KEIQLLRRLRHKNVIQL 71
Query: 136 KEVVVGKSLSSIFLVMEYCEHDLASLQDN-VESPFTESQVKCVILQVLKGLNYLHSNFII 194
+V+ + +++VMEYC + + D+ E F Q Q++ GL YLHS I+
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131
Query: 195 HRDLKPSNLLLNDKGCVKI 213
H+D+KP NLLL G +KI
Sbjct: 132 HKDIKPGNLLLTTGGTLKI 150
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-31
Identities = 42/150 (28%), Positives = 64/150 (42%), Gaps = 11/150 (7%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-HENIV 133
+ EG + VY +D + ALK+L R ++EV + K H NIV
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 134 QLKEVVVGKSLSS------IFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGL 185
Q S L+ E C+ L +ES P + V + Q + +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 186 NYLHSN--FIIHRDLKPSNLLLNDKGCVKI 213
++H IIHRDLK NLLL+++G +K+
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKL 179
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-31
Identities = 33/144 (22%), Positives = 64/144 (44%), Gaps = 3/144 (2%)
Query: 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHE 130
++ +G+G +G +V +++ +K+L + R L+EV + H
Sbjct: 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHP 67
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
N+++ V+ + + EY + L + +++S + SQ + G+ YLH
Sbjct: 68 NVLKFIGVLYKDK--RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
S IIHRDL N L+ + V +
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVV 149
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-31
Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 19/155 (12%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-------LREVTGLTK 126
E E +IG+G +G+V++ R ++A+K L L ++ REV ++
Sbjct: 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 127 CRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGL 185
H NIV+L G + +VME+ DL + P S ++L + G+
Sbjct: 80 LNHPNIVKL----YGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGI 135
Query: 186 NYLHSN--FIIHRDLKPSNLLLNDKG-----CVKI 213
Y+ + I+HRDL+ N+ L C K+
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-31
Identities = 48/147 (32%), Positives = 74/147 (50%), Gaps = 9/147 (6%)
Query: 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF---LQNNTLTRGELREVTGLTKCR 128
+ +FE +G+G +G VY R+ ILALK LF L+ + REV + R
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNV--ESPFTESQVKCVILQVLKGLN 186
H NI++L + ++L++EY ++ + S F E + I ++ L+
Sbjct: 68 HPNILRLYGYF--HDATRVYLILEYAPL--GTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
Y HS +IHRD+KP NLLL G +KI
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKI 150
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-30
Identities = 46/147 (31%), Positives = 71/147 (48%), Gaps = 17/147 (11%)
Query: 74 EFEKLNRIGEGSYGVVYR--VRDSVQDKILALKKLFLQNNTLTRGE--LREVTGLTKCRH 129
+ RIG GS+G VY+ V A+K L + T + + EV L K RH
Sbjct: 25 QITVGQRIGSGSFGTVYKGKWHGDV-----AVKMLNVTAPTPQQLQAFKNEVGVLRKTRH 79
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQD---NVESPFTESQVKCVILQVLKGLN 186
NI+ L+ +V ++CE +SL E+ F ++ + Q +G++
Sbjct: 80 VNILLFMGYSTAPQLA---IVTQWCEG--SSLYHHLHASETKFEMKKLIDIARQTARGMD 134
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YLH+ IIHRDLK +N+ L++ VKI
Sbjct: 135 YLHAKSIIHRDLKSNNIFLHEDNTVKI 161
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-30
Identities = 35/145 (24%), Positives = 68/145 (46%), Gaps = 13/145 (8%)
Query: 74 EFEKLNRIGEGSYGVVYR--VRDSVQDKILALKKLFLQNNTLTRGE--LREVTGLTKCRH 129
+ E IG+G +G VY V A++ + ++ + + + REV + RH
Sbjct: 34 QLEIGELIGKGRFGQVYHGRWHGEV-----AIRLIDIERDNEDQLKAFKREVMAYRQTRH 88
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
EN+V + + ++ C+ L S+ + + ++ + + +++KG+ YL
Sbjct: 89 ENVVLFMGACMSPP--HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
H+ I+H+DLK N+ D G V I
Sbjct: 147 HAKGILHKDLKSKNVFY-DNGKVVI 170
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-30
Identities = 32/142 (22%), Positives = 68/142 (47%), Gaps = 10/142 (7%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTK-CRHENIV 133
++ + ++G G Y V+ + ++ + +K L + RE+ L NI+
Sbjct: 38 YQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNII 94
Query: 134 QLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
L ++V + LV E+ + D L T+ ++ + ++LK L+Y HS
Sbjct: 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG 150
Query: 193 IIHRDLKPSNLLLNDKGC-VKI 213
I+HRD+KP N++++ + +++
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRL 172
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-30
Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 19/149 (12%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
E E +G G++GVV + + + K +A+K++ ++ + + E+ L++ H NIV
Sbjct: 9 EIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIV 64
Query: 134 QLKEVVVGKSLSSIFLVMEYCEHDLASLQD-----NVESPFTESQVKCVILQVLKGLNYL 188
+L G L+ + LVMEY E SL + +T + LQ +G+ YL
Sbjct: 65 KL----YGACLNPVCLVMEYAEGG--SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 189 HS---NFIIHRDLKPSNLLLNDKG-CVKI 213
HS +IHRDLKP NLLL G +KI
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKI 147
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-30
Identities = 36/149 (24%), Positives = 70/149 (46%), Gaps = 8/149 (5%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN-NTLTRGELREVTGLTKCRHENI 132
+ + +G+G+ V+R R + A+K + ++RE L K H+NI
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEH-DLASL--QDNVESPFTESQVKCVILQVLKGLNYLH 189
V+L + + L+ME+C L ++ + + ES+ V+ V+ G+N+L
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 190 SNFIIHRDLKPSNLLL----NDKGCVKIV 214
N I+HR++KP N++ + + K+
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-30
Identities = 22/151 (14%), Positives = 58/151 (38%), Gaps = 12/151 (7%)
Query: 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE--LREVTGLTKCR 128
+ + L ++ E G +++ R Q + +K L +++ + + E L
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS 65
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCE----HDLASLQDNVESPFTESQVKCVILQVLKG 184
H N++ + L+ + +++ L + +SQ L + +G
Sbjct: 66 HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNV--LHEGTNFVVDQSQAVKFALDMARG 123
Query: 185 LNYLHS--NFIIHRDLKPSNLLLNDKGCVKI 213
+ +LH+ I L ++++++ +I
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARI 154
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-30
Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 29/161 (18%)
Query: 81 IGEGSYGVVYRVRDSVQD-----KILALKKLFLQNNTLTRGEL----------------- 118
IG+GSYGVV + + K+L+ KKL Q R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 119 ----REVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES-PFTESQ 173
+E+ L K H N+V+L EV+ + +++V E + + P +E Q
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ--GPVMEVPTLKPLSEDQ 138
Query: 174 VKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
+ ++KG+ YLH IIHRD+KPSNLL+ + G +KI
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIA 179
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-29
Identities = 54/199 (27%), Positives = 81/199 (40%), Gaps = 31/199 (15%)
Query: 24 HDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLNRIGE 83
H P + IP ++ + + + G+ ++I + +IG
Sbjct: 4 HHHHHPMSDYDIPTTENLYFQGA------MDGDDMDI----------PWCDLNIKEKIGA 47
Query: 84 GSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE--LREVTGLTKCRHENIVQLKEVVVG 141
GS+G V+R +A+K L Q+ R LREV + + RH NIV V
Sbjct: 48 GSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105
Query: 142 KSLSSIFLVMEYCEHDLASLQD-----NVESPFTESQVKCVILQVLKGLNYLHSN--FII 194
SI V EY SL E + + V KG+NYLH+ I+
Sbjct: 106 PPNLSI--VTEYLSR--GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HR+LK NLL++ K VK+
Sbjct: 162 HRNLKSPNLLVDKKYTVKV 180
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-29
Identities = 36/140 (25%), Positives = 65/140 (46%), Gaps = 13/140 (9%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENI 132
F + +G G+ G + R ++ +A+K++ + + REV L + H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNV 80
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESP---FTESQVKCVILQVLKGLNYLH 189
++ K ++ +E C A+LQ+ VE + ++ Q GL +LH
Sbjct: 81 IRYFCTE--KDRQFQYIAIELCA---ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 190 SNFIIHRDLKPSNLLLNDKG 209
S I+HRDLKP N+L++
Sbjct: 136 SLNIVHRDLKPHNILISMPN 155
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-29
Identities = 39/179 (21%), Positives = 65/179 (36%), Gaps = 44/179 (24%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
+ +G GS+G+V V D K ALKK+ R + RE+ + H NI++
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIK 64
Query: 135 LKEVVVGKSLSS------------------------------------IFLVMEYCEHDL 158
L + + ++MEY L
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL 124
Query: 159 ASLQDNVES---PFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCV-KI 213
+ + + + I Q+ + + ++HS I HRD+KP NLL+N K K+
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKL 183
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-28
Identities = 42/147 (28%), Positives = 69/147 (46%), Gaps = 15/147 (10%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF---LQNNTLTRGELREVTGLTKCRHEN 131
F+ +G+G +G VY R+ I+ALK LF L+ + RE+ + RH N
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCE-----HDLASLQDNVESPFTESQVKCVILQVLKGLN 186
I+++ I+L++E+ +L F E + + ++ L+
Sbjct: 76 ILRMYNYF--HDRKRIYLMLEFAPRGELYKELQKHG-----RFDEQRSATFMEELADALH 128
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
Y H +IHRD+KP NLL+ KG +KI
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKI 155
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 33/165 (20%), Positives = 65/165 (39%), Gaps = 30/165 (18%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF-----------------LQNNTLTRGE 117
+ + + +G + + +K ALKK + +
Sbjct: 33 YRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 118 LREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE--------HDLASLQDNVESPF 169
E+ +T ++E + + ++ + ++++ EY E L N
Sbjct: 91 KNELQIITDIKNEYCLTCEGII--TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 170 TESQVKCVILQVLKGLNYLHSNF-IIHRDLKPSNLLLNDKGCVKI 213
+KC+I VL +Y+H+ I HRD+KPSN+L++ G VK+
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKL 193
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-28
Identities = 45/151 (29%), Positives = 67/151 (44%), Gaps = 16/151 (10%)
Query: 75 FEKLN-RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELR----EVTGLTKCRH 129
F K + IG GS+ VY+ D+ +A +L + LT+ E + E L +H
Sbjct: 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK--LTKSERQRFKEEAEMLKGLQH 84
Query: 130 ENIVQLK--EVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGL 185
NIV+ K I LV E +L+ ++ ++ Q+LKGL
Sbjct: 85 PNIVRFYDSWESTVKGKKCIVLVTELMTS--GTLKTYLKRFKVMKIKVLRSWCRQILKGL 142
Query: 186 NYLHSN--FIIHRDLKPSNLLLNDK-GCVKI 213
+LH+ IIHRDLK N+ + G VKI
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 173
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-27
Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 22/149 (14%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK-----KLFLQNNTLTRGEL-REVTGLTKCRHENIVQ 134
+G G + +V + R K A K +L ++R E+ REV L + RH NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 135 LKEVVVGKSLSSIFLVMEYC---EHDLASLQDNV--ESPFTESQVKCVILQVLKGLNYLH 189
L ++ K+ + L++E E L D + + TE + + Q+L G++YLH
Sbjct: 73 LHDIFENKT--DVVLILELVSGGE-----LFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 190 SNFIIHRDLKPSNLLLNDKGC----VKIV 214
S I H DLKP N++L DK +K++
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLI 154
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 9e-27
Identities = 45/156 (28%), Positives = 68/156 (43%), Gaps = 11/156 (7%)
Query: 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCR 128
+ +E R+G G +G V R + +A+K+ + + R E+ + K
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 129 HENIVQLKEVVVGKS----LSSIFLVMEYCEH-DLASL--QDNVESPFTESQVKCVILQV 181
H N+V +EV G L MEYCE DL Q E ++ ++ +
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLL---NDKGCVKIV 214
L YLH N IIHRDLKP N++L + KI+
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 38/151 (25%), Positives = 70/151 (46%), Gaps = 20/151 (13%)
Query: 70 RNVAEFEKLNR-IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC- 127
+++ + +G GS G V + S Q + +A+K++ + + E+ LT+
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESD 66
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESP---------FTESQVKCVI 178
H N+++ + +++ +E C +LQD VES E ++
Sbjct: 67 DHPNVIRYYCSE--TTDRFLYIALELCN---LNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 179 LQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG 209
Q+ G+ +LHS IIHRDLKP N+L++
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSS 152
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-26
Identities = 35/152 (23%), Positives = 66/152 (43%), Gaps = 14/152 (9%)
Query: 66 FGKCRNVAEFEKLNR-IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL----RE 120
+ + R +G G++G V+ V + +K + N ++ + E
Sbjct: 14 LYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTI---NKDRSQVPMEQIEAE 70
Query: 121 VTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE----HDLASLQDNVESPFTESQVKC 176
+ L H NI+++ EV + ++++VME CE + +E V
Sbjct: 71 IEVLKSLDHPNIIKIFEVF--EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128
Query: 177 VILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK 208
++ Q++ L Y HS ++H+DLKP N+L D
Sbjct: 129 LMKQMMNALAYFHSQHVVHKDLKPENILFQDT 160
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 42/215 (19%), Positives = 77/215 (35%), Gaps = 22/215 (10%)
Query: 14 KVQDDGNPESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVA 73
+ Q S + + + + + N E + +
Sbjct: 34 REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY 93
Query: 74 EFEKLNR-IGEGSYGVVYRVRDSVQDKILALK-----KLFLQNNTLTRGE---LREVTGL 124
+ IG G VV R A+K L L RE L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 125 TK-CRHENIVQLKEVVVGKSLSSIFLVMEYCE-----HDLASLQDNVESPFTESQVKCVI 178
+ H +I+ L + +S S +FLV + L + +E + + ++
Sbjct: 154 RQVAGHPHIITLIDSY--ESSSFMFLVFDLMRKGELFDYLTE-----KVALSEKETRSIM 206
Query: 179 LQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+L+ +++LH+N I+HRDLKP N+LL+D +++
Sbjct: 207 RSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRL 241
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 48/227 (21%), Positives = 91/227 (40%), Gaps = 22/227 (9%)
Query: 1 MKVQDDGNPERAMKVQDDGNPESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEI 60
+ ++ D ++A + + + + +KR L + P
Sbjct: 14 LGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPF 73
Query: 61 LEQDCFGKCRNVAEF---EKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE 117
+ K V F K +G G +G V++ ++ LA K ++ + E
Sbjct: 74 DHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAK--IIKTRGMKDKE 131
Query: 118 --LREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC---EHDLASLQDNV---ESPF 169
E++ + + H N++QL + K+ I LVMEY E L D +
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKN--DIVLVMEYVDGGE-----LFDRIIDESYNL 184
Query: 170 TESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG--CVKIV 214
TE + Q+ +G+ ++H +I+H DLKP N+L ++ +KI+
Sbjct: 185 TELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKII 231
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 24/167 (14%), Positives = 48/167 (28%), Gaps = 33/167 (19%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALKKLF---LQNNTLTRGELREVTGLTKCRHENIVQ-- 134
+ G VV+ VRD + + ALK + + + E+ +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 135 ----------------------LKEVVVGKSLSSIFLVMEYCEHDLASLQD------NVE 166
L ++++ L+M DL L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 167 SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ + Q+++ L S ++H P NL + G + +
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLML 235
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 23/163 (14%)
Query: 68 KCRNVAEFEKLNR-IGEGSYGVVYRVRDSVQDKILALK-----KLFLQNNTLTRGEL-RE 120
K + V +F + +G G + +V + R+ A K + + R E+ RE
Sbjct: 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 121 VTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC---EHDLASLQDNV--ESPFTESQVK 175
V+ L + H NI+ L +V ++ + + L++E E L D + + +E +
Sbjct: 66 VSILRQVLHPNIITLHDVY--ENRTDVVLILELVSGGE-----LFDFLAQKESLSEEEAT 118
Query: 176 CVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC----VKIV 214
I Q+L G+NYLH+ I H DLKP N++L DK +K++
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI 161
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 37/138 (26%), Positives = 63/138 (45%), Gaps = 13/138 (9%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK-----KLFLQNNTLTRGELREVTGLTKCRHENIVQL 135
IG+G + VV R + + A+K K T RE + +H +IV+L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 136 KEVVVGKSLSSIFLVMEYCE-----HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
E S +++V E+ + ++ + + ++E+ + Q+L+ L Y H
Sbjct: 92 LETY--SSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 191 NFIIHRDLKPSNLLLNDK 208
N IIHRD+KP +LL K
Sbjct: 149 NNIIHRDVKPHCVLLASK 166
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 23/163 (14%)
Query: 68 KCRNVAEFEKLNR-IGEGSYGVVYRVRDSVQDKILALK-----KLFLQNNTLTRGEL-RE 120
K + V +F + +G G + +V + R+ A K + ++R E+ RE
Sbjct: 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 121 VTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC---EHDLASLQDNV--ESPFTESQVK 175
V+ L + H N++ L +V ++ + L++E E L D + + +E +
Sbjct: 66 VSILRQVLHHNVITLHDVYENRT--DVVLILELVSGGE-----LFDFLAQKESLSEEEAT 118
Query: 176 CVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK----GCVKIV 214
I Q+L G+NYLH+ I H DLKP N++L DK +K++
Sbjct: 119 SFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLI 161
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-26
Identities = 43/156 (27%), Positives = 65/156 (41%), Gaps = 17/156 (10%)
Query: 70 RNVA-EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR 128
R VA + L +G+G YG V+R Q + +A+K ++ E E+ R
Sbjct: 4 RTVARDITLLECVGKGRYGEVWRGS--WQGENVAVKIFSSRDEKSWFRE-TELYNTVMLR 60
Query: 129 HENIVQLKEVVVGKSLSSI--FLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGL 185
HENI+ + SS +L+ Y E SL D + + ++L + GL
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEM--GSLYDYLQLTTLDTVSCLRIVLSIASGL 118
Query: 186 NYLHS--------NFIIHRDLKPSNLLLNDKGCVKI 213
+LH I HRDLK N+L+ G I
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-26
Identities = 45/211 (21%), Positives = 82/211 (38%), Gaps = 14/211 (6%)
Query: 13 MKVQDDGNPESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNV 72
M G P+ P P + + K +
Sbjct: 1 MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAII 60
Query: 73 AEFEKLNR-IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHE 130
+++ ++ +G G G V ++ + + ALK L Q+ R REV + +
Sbjct: 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--QDCPKAR---REVELHWRASQCP 115
Query: 131 NIVQLKEVV--VGKSLSSIFLVMEYCEHD--LASLQDNVESPFTESQVKCVILQVLKGLN 186
+IV++ +V + + +VME + + +QD + FTE + ++ + + +
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 187 YLHSNFIIHRDLKPSNLLLNDKG---CVKIV 214
YLHS I HRD+KP NLL K +K+
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLT 206
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-26
Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 22/149 (14%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK-----KLFLQNNTLTRGEL-REVTGLTKCRHENIVQ 134
+G G + VV + R+ A K + ++R ++ REV+ L + +H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 135 LKEVVVGKSLSSIFLVMEYC---EHDLASLQDNV--ESPFTESQVKCVILQVLKGLNYLH 189
L EV K+ + L++E E L D + + TE + + Q+L G+ YLH
Sbjct: 79 LHEVYENKT--DVILILELVAGGE-----LFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 190 SNFIIHRDLKPSNLLLNDKGC----VKIV 214
S I H DLKP N++L D+ +KI+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKII 160
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-26
Identities = 38/151 (25%), Positives = 66/151 (43%), Gaps = 16/151 (10%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
+ + + +IG+G YG V+ + + + +A+K F E E+ RHENI+
Sbjct: 38 QIQMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEASWFRE-TEIYQTVLMRHENIL 94
Query: 134 QLKEVVVGKSLSSI--FLVMEYCEHDLASLQDNVES-PFTESQVKCVILQVLKGLNYLHS 190
+ + S +L+ +Y E+ SL D ++S + + + GL +LH+
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHEN--GSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHT 152
Query: 191 NF--------IIHRDLKPSNLLLNDKGCVKI 213
I HRDLK N+L+ G I
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-25
Identities = 40/156 (25%), Positives = 64/156 (41%), Gaps = 18/156 (11%)
Query: 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHE 130
++ + L IG G YG VY+ + ++ +A+K N E + + + H+
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNFINE-KNIYRVPLMEHD 67
Query: 131 NIVQL---KEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVI-LQVLKGLN 186
NI + E V LVMEY + SL + ++ C + V +GL
Sbjct: 68 NIARFIVGDERVTADGRMEYLLVMEYYPN--GSLXKYLSLHTSDWVSSCRLAHSVTRGLA 125
Query: 187 YLHSNF---------IIHRDLKPSNLLLNDKGCVKI 213
YLH+ I HRDL N+L+ + G I
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVI 161
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 41/175 (23%), Positives = 75/175 (42%), Gaps = 15/175 (8%)
Query: 50 MNFVTGEPIEILEQDCFGKCRNVAEFEKLNR--IGEGSYGVVYRVRDSVQDKILALKKLF 107
+ +E+L Q K V + +L++ +G G G V + ALK L
Sbjct: 4 HHHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL- 62
Query: 108 LQNNTLTRGELREVTGLTKC-RHENIVQLKEVV--VGKSLSSIFLVMEYCEHD--LASLQ 162
++ R +EV + +IV + +V + + ++ME E + +Q
Sbjct: 63 -YDSPKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQ 118
Query: 163 DNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG---CVKIV 214
+ + FTE + ++ + + +LHS+ I HRD+KP NLL K +K+
Sbjct: 119 ERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-25
Identities = 39/148 (26%), Positives = 65/148 (43%), Gaps = 22/148 (14%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK-----KLFLQNNTLTRGE----LREVTGLTK-CRHE 130
+G G VV R K A+K + + L+EV L K H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCE-----HDLASLQDNVESPFTESQVKCVILQVLKGL 185
NI+QLK+ ++ + FLV + + L + +E + + ++ +L+ +
Sbjct: 85 NIIQLKDTY--ETNTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVI 137
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
LH I+HRDLKP N+LL+D +K+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKL 165
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-25
Identities = 36/153 (23%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
+ L G +G V++ + + ++ +A+K +Q+ + E EV L +HENI+
Sbjct: 25 PLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSWQNE-YEVYSLPGMKHENIL 81
Query: 134 QL--KEVVVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHS 190
Q E ++L+ + E SL D + + + +++ + + +GL YLH
Sbjct: 82 QFIGAEKRGTSVDVDLWLITAFHEK--GSLSDFLKANVVSWNELCHIAETMARGLAYLHE 139
Query: 191 N----------FIIHRDLKPSNLLLNDKGCVKI 213
+ I HRD+K N+LL + I
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-25
Identities = 38/204 (18%), Positives = 86/204 (42%), Gaps = 21/204 (10%)
Query: 19 GNPESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKL 78
G+ H + + + K + + +P+E+ K +V ++ +
Sbjct: 3 GSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEV-------KQGSVYDYYDI 55
Query: 79 NR-IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE--LREVTGLTKCRHENIVQL 135
+G G++GVV+R + ++ K F+ E++ + + H ++ L
Sbjct: 56 LEELGSGAFGVVHRCVEKATGRVFVAK--FINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 136 KEVVVGKSLSSIFLVMEYCEHDLASLQDNV---ESPFTESQVKCVILQVLKGLNYLHSNF 192
+ + + L++E+ L D + + +E++V + Q +GL ++H +
Sbjct: 114 HDAF--EDKYEMVLILEFLSG--GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169
Query: 193 IIHRDLKPSNLLLNDKG--CVKIV 214
I+H D+KP N++ K VKI+
Sbjct: 170 IVHLDIKPENIMCETKKASSVKII 193
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 5e-25
Identities = 39/151 (25%), Positives = 60/151 (39%), Gaps = 16/151 (10%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
IG+G +G V+R + + + +A+K + E E+ RHENI+
Sbjct: 43 TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFRE-AEIYQTVMLRHENIL 99
Query: 134 QLKEVVVGKSLSSI--FLVMEYCEHDLASLQDNVES-PFTESQVKCVILQVLKGLNYLHS 190
+ + +LV +Y EH SL D + T + + L GL +LH
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHG--SLFDYLNRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 191 NF--------IIHRDLKPSNLLLNDKGCVKI 213
I HRDLK N+L+ G I
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-25
Identities = 33/155 (21%), Positives = 73/155 (47%), Gaps = 19/155 (12%)
Query: 70 RNVAEFEKLNR-IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKC 127
+ + E + +G G +G+V+R ++ K K F++ + + +E++ L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK--FVKVKGTDQVLVKKEISILNIA 58
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYC---EHDLASLQDNV---ESPFTESQVKCVILQV 181
RH NI+ L E +S+ + ++ E+ + + + + E ++ + QV
Sbjct: 59 RHRNILHLHESF--ESMEELVMIFEFISGLD-----IFERINTSAFELNEREIVSYVHQV 111
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLLNDK--GCVKIV 214
+ L +LHS+ I H D++P N++ + +KI+
Sbjct: 112 CEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKII 146
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-25
Identities = 39/144 (27%), Positives = 66/144 (45%), Gaps = 17/144 (11%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVV 139
+G G G V ++ + + ALK L Q+ R REV + + +IV++ +V
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKML--QDCPKAR---REVELHWRASQCPHIVRIVDVY 80
Query: 140 --VGKSLSSIFLVMEYCE----HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFI 193
+ + +VME + +QD + FTE + ++ + + + YLHS I
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFS--RIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 138
Query: 194 IHRDLKPSNLLLNDKG---CVKIV 214
HRD+KP NLL K +K+
Sbjct: 139 AHRDVKPENLLYTSKRPNAILKLT 162
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-24
Identities = 38/147 (25%), Positives = 61/147 (41%), Gaps = 19/147 (12%)
Query: 71 NVAEFEKLNR-IGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGELREVTGLTK 126
++ ++ L IG GS+G V A K K F+++ + +E+ +
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKS 62
Query: 127 CRHENIVQLKEVVVGKSLSSIFLVMEYCE-----HDLASLQDNVESPFTESQVKCVILQV 181
H NI++L E + + I+LVME C + + F ES ++ V
Sbjct: 63 LDHPNIIRLYETF--EDNTDIYLVMELCTGGELFERVVH-----KRVFRESDAARIMKDV 115
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLLNDK 208
L + Y H + HRDLKP N L
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTD 142
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-24
Identities = 40/156 (25%), Positives = 63/156 (40%), Gaps = 22/156 (14%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL----REVTGLTKCRH 129
E IG G +G VYR +A+K + + +E +H
Sbjct: 8 ELTLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYL 188
NI+ L+ V + + ++ LVME+ L + + +Q+ +G+NYL
Sbjct: 66 PNIIALRGVCLKEP--NLCLVMEFARG--GPLNRVLSGKRIPPDILVNWAVQIARGMNYL 121
Query: 189 HSN---FIIHRDLKPSNLLLNDKG--------CVKI 213
H IIHRDLK SN+L+ K +KI
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 47/151 (31%), Positives = 72/151 (47%), Gaps = 15/151 (9%)
Query: 66 FGKCRNVAEFEKLNR-IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE--LREVT 122
AE + +G+GS+G V + +D + + A+K + + LREV
Sbjct: 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVE 73
Query: 123 GLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC---EHDLASLQDNVES--PFTESQVKCV 177
L K H NI++L E++ S S ++V E E L D + F+E +
Sbjct: 74 LLKKLDHPNIMKLFEILEDSS--SFYIVGELYTGGE-----LFDEIIKRKRFSEHDAARI 126
Query: 178 ILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK 208
I QV G+ Y+H + I+HRDLKP N+LL K
Sbjct: 127 IKQVFSGITYMHKHNIVHRDLKPENILLESK 157
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 1e-24
Identities = 42/146 (28%), Positives = 66/146 (45%), Gaps = 23/146 (15%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK-----KLFLQNNTLTRGELREVTGLTKCRHENIVQL 135
+G+G++ VV R A K KL ++ RE K +H NIV+L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVRL 70
Query: 136 KEVVVGKSLSSIFLVMEYCE-----HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
+ + +S +LV + D+ + ++E+ I Q+L+ + Y HS
Sbjct: 71 HDSIQEES--FHYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHS 123
Query: 191 NFIIHRDLKPSNLLLNDKG---CVKI 213
N I+HR+LKP NLLL K VK+
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKL 149
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 49/147 (33%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 68 KCRNVAEFEKLNR-IGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGELREVTG 123
++ K R +G+GS+G V +D + + A+K K ++ T LREV
Sbjct: 20 STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79
Query: 124 LTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNV--ESPFTESQVKCVILQV 181
L + H NI++L E + +LV E L D + F+E +I QV
Sbjct: 80 LKQLDHPNIMKLYEFF--EDKGYFYLVGEVYTG--GELFDEIISRKRFSEVDAARIIRQV 135
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLLNDK 208
L G+ Y+H N I+HRDLKP NLLL K
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESK 162
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-24
Identities = 51/192 (26%), Positives = 81/192 (42%), Gaps = 15/192 (7%)
Query: 20 NPESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLN 79
+ S + S A + V I+ +D FE +
Sbjct: 5 HHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSD-----FFEVES 59
Query: 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRHENIVQLKEV 138
+G G+ +VYR + K ALK L T+ + + E+ L + H NI++LKE+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL---KKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 139 VVGKSLSSIFLVMEYCEH-DLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHR 196
++ + I LV+E +L VE ++E + Q+L+ + YLH N I+HR
Sbjct: 117 F--ETPTEISLVLELVTGGEL--FDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHR 172
Query: 197 DLKPSNLLLNDK 208
DLKP NLL
Sbjct: 173 DLKPENLLYATP 184
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-24
Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 17/152 (11%)
Query: 66 FGKCRNVAEFEKLNR-IGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGELREV 121
AE + +G+GS+G V + +D + + A+K K +N + REV
Sbjct: 14 LYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL-REV 72
Query: 122 TGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE-----HDLASLQDNVESPFTESQVKC 176
L K H NI++L E++ + SS ++V E ++ F+E
Sbjct: 73 ELLKKLDHPNIMKLFEIL--EDSSSFYIVGELYTGGELFDEIIK-----RKRFSEHDAAR 125
Query: 177 VILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK 208
+I QV G+ Y+H + I+HRDLKP N+LL K
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESK 157
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-24
Identities = 43/137 (31%), Positives = 65/137 (47%), Gaps = 18/137 (13%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
+G G++ V+ V+ + K+ ALK K ++ E+ L K +HENIV L++
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLED 73
Query: 138 VVVGKSLSSIFLVMEYCE-----HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
+ +S + +LVM+ + +TE VI QVL + YLH N
Sbjct: 74 IY--ESTTHYYLVMQLVSGGELFDRILE-----RGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 193 IIHRDLKPSNLLLNDKG 209
I+HRDLKP NLL
Sbjct: 127 IVHRDLKPENLLYLTPE 143
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-24
Identities = 39/140 (27%), Positives = 72/140 (51%), Gaps = 13/140 (9%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-HENIVQLKEVV 139
+GEGS+ + + ++ A+K + + T+ +E+T L C H NIV+L EV
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLHEVF 75
Query: 140 VGKSLSSIFLVMEYCEH-DLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRD 197
FLVME +L + + F+E++ ++ +++ ++++H ++HRD
Sbjct: 76 --HDQLHTFLVMELLNGGEL--FERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 198 LKPSNLLLNDKG---CVKIV 214
LKP NLL D+ +KI+
Sbjct: 132 LKPENLLFTDENDNLEIKII 151
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 33/149 (22%), Positives = 63/149 (42%), Gaps = 15/149 (10%)
Query: 68 KCRNVAEFEKLNR-IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE--LREVTGL 124
C E +L +G+G++ VV R + + A + + + + RE
Sbjct: 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARIC 64
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCE-----HDLASLQDNVESPFTESQVKCVIL 179
+H NIV+L + + +L+ + D+ + ++E+ I
Sbjct: 65 RLLKHPNIVRLHDSI--SEEGHHYLIFDLVTGGELFEDIVA-----REYYSEADASHCIQ 117
Query: 180 QVLKGLNYLHSNFIIHRDLKPSNLLLNDK 208
Q+L+ + + H ++HR+LKP NLLL K
Sbjct: 118 QILEAVLHCHQMGVVHRNLKPENLLLASK 146
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-24
Identities = 40/141 (28%), Positives = 67/141 (47%), Gaps = 15/141 (10%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVV 139
IG GSY V R + A+K + + R E+ L + +H NI+ LK+V
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEIEILLRYGQHPNIITLKDVY 85
Query: 140 VGKSLSSIFLVMEYCEH-DLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRD 197
+++V E + +L L + F+E + V+ + K + YLH+ ++HRD
Sbjct: 86 --DDGKYVYVVTELMKGGEL--LDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRD 141
Query: 198 LKPSNLLLNDKG----CVKIV 214
LKPSN+L D+ ++I
Sbjct: 142 LKPSNILYVDESGNPESIRIC 162
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-24
Identities = 41/146 (28%), Positives = 65/146 (44%), Gaps = 18/146 (12%)
Query: 81 IGEGSYGVVYRVRD-----SVQDKILALKKLFLQNNTLTRGEL---REVTGLTKCRHENI 132
+G G+ G V + V KI++ +K + + L E+ L K H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHS 190
+++K + ++V+E E +L V E+ K Q+L + YLH
Sbjct: 78 IKIKNFFDAED---YYIVLELMEGGEL--FDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 132
Query: 191 NFIIHRDLKPSNLLLNDKG---CVKI 213
N IIHRDLKP N+LL+ + +KI
Sbjct: 133 NGIIHRDLKPENVLLSSQEEDCLIKI 158
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-24
Identities = 51/189 (26%), Positives = 76/189 (40%), Gaps = 22/189 (11%)
Query: 24 HDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLNRIGE 83
H S+ + Q + + G + + K +G
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKG------------HLSEMYQRVKK--LGS 47
Query: 84 GSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE--LREVTGLTKCRHENIVQLKEVVVG 141
G+YG V RD V A+K + + + + L EV L H NI++L +
Sbjct: 48 GAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-- 105
Query: 142 KSLSSIFLVMEYCEHDLASLQDNV--ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLK 199
+ + +LVME + L D + F E +I QVL G+ YLH + I+HRDLK
Sbjct: 106 EDKRNYYLVMECYKG--GELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLK 163
Query: 200 PSNLLLNDK 208
P NLLL K
Sbjct: 164 PENLLLESK 172
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-24
Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 18/146 (12%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTKCRH-ENIVQL 135
+G G + VV + + A K FL+ + L E+ L + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAK--FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94
Query: 136 KEVVVGKSLSSIFLVMEYCE----HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
EV S I L++EY L + +E+ V +I Q+L+G+ YLH N
Sbjct: 95 HEVYENTS--EIILILEYAAGGEIFSL--CLPELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 192 FIIHRDLKPSNLLLNDK---GCVKIV 214
I+H DLKP N+LL+ G +KIV
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIV 176
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-24
Identities = 45/194 (23%), Positives = 70/194 (36%), Gaps = 48/194 (24%)
Query: 66 FGKCRNVAEFEKLNR-IGEGSYGVVYRVRDSVQDKILALK-----KLFLQNNTLTRGELR 119
G + + L IG+GSYGVV ++ I A+K K+ N
Sbjct: 18 GGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT 77
Query: 120 EVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE------------------------ 155
EV + K H NI +L EV + I LVME C
Sbjct: 78 EVRLMKKLHHPNIARLYEVY--EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 156 ----------------HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLK 199
+ +++++ E + ++ Q+ L+YLH+ I HRD+K
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIK 195
Query: 200 PSNLLLNDKGCVKI 213
P N L + +I
Sbjct: 196 PENFLFSTNKSFEI 209
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-24
Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 10/140 (7%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-HENIVQLKEVV 139
+GEG++ V + + + A+K + Q + REV L +C+ H N+++L E
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 140 VGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLHSNFIIHRD 197
+ +LV E S+ ++ F E + V+ V L++LH+ I HRD
Sbjct: 81 EEED--RFYLVFEKMRG--GSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 198 LKPSNLLLNDKG---CVKIV 214
LKP N+L VKI
Sbjct: 137 LKPENILCEHPNQVSPVKIC 156
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 7e-24
Identities = 40/146 (27%), Positives = 66/146 (45%), Gaps = 18/146 (12%)
Query: 81 IGEGSYGVVYRVRD-----SVQDKILALKKLFLQNNTLTRGEL---REVTGLTKCRHENI 132
+G G+ G V + V +I++ +K + + L E+ L K H I
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVES-PFTESQVKCVILQVLKGLNYLHS 190
+++K + ++V+E E +L V + E+ K Q+L + YLH
Sbjct: 203 IKIKNFFDAED---YYIVLELMEGGEL--FDKVVGNKRLKEATCKLYFYQMLLAVQYLHE 257
Query: 191 NFIIHRDLKPSNLLLNDKG---CVKI 213
N IIHRDLKP N+LL+ + +KI
Sbjct: 258 NGIIHRDLKPENVLLSSQEEDCLIKI 283
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 8e-24
Identities = 39/217 (17%), Positives = 87/217 (40%), Gaps = 20/217 (9%)
Query: 7 GNPERAMKVQDDGNPESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCF 66
P + + D + + + + + + + + +E
Sbjct: 94 CEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEI--- 150
Query: 67 GKCRNVAEFEKLNR-IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE--LREVTG 123
K +V + ++ +G G++GVV+RV + A K F+ + E +E+
Sbjct: 151 -KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAK--FVMTPHESDKETVRKEIQT 207
Query: 124 LTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE----HDLASLQDNVESPFTESQVKCVIL 179
++ RH +V L + + + + ++ E+ + + + N +E + +
Sbjct: 208 MSVLRHPTLVNLHDAF--EDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMR 262
Query: 180 QVLKGLNYLHSNFIIHRDLKPSNLLLNDKG--CVKIV 214
QV KGL ++H N +H DLKP N++ K +K++
Sbjct: 263 QVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLI 299
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 8e-24
Identities = 39/137 (28%), Positives = 63/137 (45%), Gaps = 18/137 (13%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL----REVTGLTKCRHENIVQLK 136
+G+G++ VV R A K + L+ + RE K +H NIV+L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAK--IINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 137 EVVVGKSLSSIFLVMEYCE-----HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
+ + + S +LV + D+ + ++E+ I Q+L+ + Y HSN
Sbjct: 95 DSI--QEESFHYLVFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHSN 147
Query: 192 FIIHRDLKPSNLLLNDK 208
I+HR+LKP NLLL K
Sbjct: 148 GIVHRNLKPENLLLASK 164
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 3e-23
Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 15/140 (10%)
Query: 81 IGEGSYGVVYRVRD-----SVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQL 135
+GEG+YG V + +V KI+ +K+ + + +E+ HEN+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIK-KEICINKMLNHENVVKF 70
Query: 136 KEVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLHSNFI 193
+ + +L +EYC L D +E E + Q++ G+ YLH I
Sbjct: 71 YGHR--REGNIQYLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 194 IHRDLKPSNLLLNDKGCVKI 213
HRD+KP NLLL+++ +KI
Sbjct: 127 THRDIKPENLLLDERDNLKI 146
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 4e-23
Identities = 37/139 (26%), Positives = 69/139 (49%), Gaps = 9/139 (6%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
+G G++G V + +A+K + +++ + RE+ L RH +I++L +
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 138 VVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLHSNFIIH 195
V+ + + F+VMEY L D + E + + + Q+L ++Y H + ++H
Sbjct: 79 VI--STPTDFFMVMEYVSG--GELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVH 134
Query: 196 RDLKPSNLLLNDKGCVKIV 214
RDLKP N+LL+ KI
Sbjct: 135 RDLKPENVLLDAHMNAKIA 153
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-23
Identities = 39/143 (27%), Positives = 63/143 (44%), Gaps = 19/143 (13%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGE----------LREVTGLTKC 127
+G G+YG V ++ A+K K + E++ L
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNV--ESPFTESQVKCVILQVLKGL 185
H NI++L +V K +LV E+ E L + + F E ++ Q+L G+
Sbjct: 104 DHPNIIKLFDVFEDKK--YFYLVTEFYEG--GELFEQIINRHKFDECDAANIMKQILSGI 159
Query: 186 NYLHSNFIIHRDLKPSNLLLNDK 208
YLH + I+HRD+KP N+LL +K
Sbjct: 160 CYLHKHNIVHRDIKPENILLENK 182
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-23
Identities = 40/140 (28%), Positives = 67/140 (47%), Gaps = 15/140 (10%)
Query: 81 IGEGSYGVVYRVRD-----SVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQL 135
+GEG+YG V + +V KI+ +K+ + + +E+ HEN+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIK-KEICINKMLNHENVVKF 70
Query: 136 KEVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLHSNFI 193
+ + +L +EYC L D +E E + Q++ G+ YLH I
Sbjct: 71 YGHR--REGNIQYLFLEYCSG--GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 194 IHRDLKPSNLLLNDKGCVKI 213
HRD+KP NLLL+++ +KI
Sbjct: 127 THRDIKPENLLLDERDNLKI 146
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 93.9 bits (233), Expect = 8e-23
Identities = 25/147 (17%), Positives = 51/147 (34%), Gaps = 12/147 (8%)
Query: 74 EFEKLNRIGEGSYGVVYRVR-----DSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR 128
+ +GEG++ VY D+ + LK N + + L
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEHD-----LASLQDNVESPFTESQVKCVILQVLK 183
++ + ++ LV E + + ++ E + V +++L
Sbjct: 126 QHMFMKFYSAHLFQN--GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGC 210
+ +H IIH D+KP N +L +
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFL 210
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 1e-22
Identities = 35/143 (24%), Positives = 65/143 (45%), Gaps = 14/143 (9%)
Query: 80 RIGEGSYGVVYRVRD-SVQDKILALKKLFLQNNTLT----RGELREVTGLTKCRHENIVQ 134
I G G +Y D +V + + LK L + E + + + H +IVQ
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV---HPSIVQ 143
Query: 135 LKEVVVGKSLSSI---FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
+ V ++VMEY SL+ + ++ +L++L L+YLHS
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQ--SLKRSKGQKLPVAEAIAYLLEILPALSYLHSI 201
Query: 192 FIIHRDLKPSNLLLNDKGCVKIV 214
+++ DLKP N++L ++ +K++
Sbjct: 202 GLVYNDLKPENIMLTEEQ-LKLI 223
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-22
Identities = 41/139 (29%), Positives = 70/139 (50%), Gaps = 10/139 (7%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
IG+G++ V R + + +A+K K L +L + REV + H NIV+L E
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 138 VVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLHSNFIIH 195
V+ ++ +++L+MEY + D + + E + + Q++ + Y H I+H
Sbjct: 82 VI--ETEKTLYLIMEYASG--GEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVH 137
Query: 196 RDLKPSNLLLNDKGCVKIV 214
RDLK NLLL+ +KI
Sbjct: 138 RDLKAENLLLDADMNIKIA 156
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-22
Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 11/148 (7%)
Query: 74 EFEKLNRIGEGSYGVVYR-VRDSVQDK---ILALKKLFLQNNTLTRGE--LREVTGLTKC 127
+ L ++G+G++G V D +QD ++A+KKL Q++T RE+ L
Sbjct: 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSL 68
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGL 185
+H+NIV+ K V ++ L+MEY + L LQ + + ++ Q+ KG+
Sbjct: 69 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGM 127
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YL + IHRDL N+L+ ++ VKI
Sbjct: 128 EYLGTKRYIHRDLATRNILVENENRVKI 155
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-22
Identities = 44/139 (31%), Positives = 73/139 (52%), Gaps = 10/139 (7%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
+GEGS+G V + +ALK + L+ + + RE++ L RH +I++L +
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 138 VVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLHSNFIIH 195
V+ + + I +V+EY +L D + TE + + Q++ + Y H + I+H
Sbjct: 77 VI--TTPTDIVMVIEYAGGELF---DYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVH 131
Query: 196 RDLKPSNLLLNDKGCVKIV 214
RDLKP NLLL+D VKI
Sbjct: 132 RDLKPENLLLDDNLNVKIA 150
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-22
Identities = 34/145 (23%), Positives = 64/145 (44%), Gaps = 14/145 (9%)
Query: 81 IGEGSYGVVY---RVRD--SVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRHE--NI 132
+G G +G VY RV D V K + ++ + EV L K +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLHS 190
++L + + S L++E E L D + E + QVL+ + + H+
Sbjct: 111 IRLLDWF--ERPDSFVLILERPEPV-QDLFDFITERGALQEELARSFFWQVLEAVRHCHN 167
Query: 191 NFIIHRDLKPSNLLLN-DKGCVKIV 214
++HRD+K N+L++ ++G +K++
Sbjct: 168 CGVLHRDIKDENILIDLNRGELKLI 192
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 4e-22
Identities = 21/168 (12%), Positives = 53/168 (31%), Gaps = 34/168 (20%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALKKLFL-------------------------QNNTLT 114
+G+ D + + + +N
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 115 RGELREVTGLTKCRHENIVQLKEVVVGKSLSSI---FLVMEYCEHDLASLQDNVES---- 167
+ LR + + ++ V + + + F + + +L + + + S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 168 --PFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ LQV++ L LH ++H L+P +++L+ +G V +
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL 252
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-22
Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 17/148 (11%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ----NNTLTR--GELREVTGLTKCR 128
++ ++++G G VY D++ + +A+K +F+ TL R E+ + L+
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS--- 69
Query: 129 HENIVQLKEVV--VGKSLSSIFLVMEYCE-HDLASLQDNVESPFTESQVKCVILQVLKGL 185
H+NIV + V + +LVMEY E L+ ++ P + Q+L G+
Sbjct: 70 HQNIVS----MIDVDEEDDCYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGI 124
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ H I+HRD+KP N+L++ +KI
Sbjct: 125 KHAHDMRIVHRDIKPQNILIDSNKTLKI 152
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-22
Identities = 39/147 (26%), Positives = 66/147 (44%), Gaps = 8/147 (5%)
Query: 74 EFEKLNRIGEGSYGVVYR---VRDSVQDKIL-ALKKLFLQNNTLTRGE-LREVTGLTKCR 128
+++ +GEG +G V + A+K L ++ + +E+ L
Sbjct: 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 81
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLN 186
HENIV+ K + + I L+ME+ L L N ++ Q +Q+ KG++
Sbjct: 82 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMD 140
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YL S +HRDL N+L+ + VKI
Sbjct: 141 YLGSRQYVHRDLAARNVLVESEHQVKI 167
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 9e-22
Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 11/148 (7%)
Query: 74 EFEKLNRIGEGSYGVVYR-VRDSVQDK---ILALKKLFLQNNTLTRGE--LREVTGLTKC 127
+ L ++G+G++G V D +QD ++A+KKL Q++T RE+ L
Sbjct: 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDFEREIEILKSL 99
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGL 185
+H+NIV+ K V ++ L+MEY + L LQ + + ++ Q+ KG+
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGM 158
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YL + IHRDL N+L+ ++ VKI
Sbjct: 159 EYLGTKRYIHRDLATRNILVENENRVKI 186
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-21
Identities = 41/147 (27%), Positives = 71/147 (48%), Gaps = 9/147 (6%)
Query: 74 EFEKLNRIGEGSYGVVYR-VRDSVQDKI---LALKKLFLQNNTLTRGE-LREVTGLTKCR 128
+ ++++G+G++G V D + D +A+K+L + + + RE+ L
Sbjct: 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ-HSGPDQQRDFQREIQILKALH 82
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLN 186
+ IV+ + V G S+ LVMEY L LQ + + S++ Q+ KG+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGME 141
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YL S +HRDL N+L+ + VKI
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAHVKI 168
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-21
Identities = 20/139 (14%), Positives = 52/139 (37%), Gaps = 7/139 (5%)
Query: 78 LNRIGEGSYGVVYRVRDSVQDKILALKKL---FLQNNTLTRGELREVTGLTKCRHENIVQ 134
L G ++ D+ D+ +AL + + + + + L L++ + +
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 135 LKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
+ +VV ++ +V E+ SLQ+ ++ + + + + H +
Sbjct: 96 VLDVVHTRAGG--LVVAEWIRG--GSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVA 151
Query: 195 HRDLKPSNLLLNDKGCVKI 213
PS + ++ G V +
Sbjct: 152 LSIDHPSRVRVSIDGDVVL 170
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-21
Identities = 29/147 (19%), Positives = 61/147 (41%), Gaps = 19/147 (12%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGEL-----REVTGLTKCRHENI 132
+G G++G V+ D ++K + +K K + + E+ L++ H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEH-----DLASLQDNVESPFTESQVKCVILQVLKGLNY 187
+++ ++ ++ LVME E + Q++ + Y
Sbjct: 92 IKVLDIF--ENQGFFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASYIFRQLVSAVGY 145
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKIV 214
L IIHRD+K N+++ + +K++
Sbjct: 146 LRLKDIIHRDIKDENIVIAEDFTIKLI 172
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 2e-21
Identities = 22/168 (13%), Positives = 53/168 (31%), Gaps = 34/168 (20%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT----------------LTRGELREVTG 123
+G+ D + + + L RG +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 124 LTKCR------------HENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES---- 167
R + +++++ + S F + + +L + + + S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 168 --PFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ LQV++ L LH ++H L+P +++L+ +G V +
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL 247
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-21
Identities = 40/139 (28%), Positives = 72/139 (51%), Gaps = 9/139 (6%)
Query: 81 IGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
+G G++G V + + +A+K + +++ + RE+ L RH +I++L +
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 138 VVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLHSNFIIH 195
V+ + S IF+VMEY L D + E + + + Q+L G++Y H + ++H
Sbjct: 84 VI--STPSDIFMVMEYVSG--GELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVH 139
Query: 196 RDLKPSNLLLNDKGCVKIV 214
RDLKP N+LL+ KI
Sbjct: 140 RDLKPENVLLDAHMNAKIA 158
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-21
Identities = 37/150 (24%), Positives = 68/150 (45%), Gaps = 12/150 (8%)
Query: 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNN--TLTRGELREVTGL 124
+FE L IG G++ V V+ ++ A+K + L+ + R E R+V L
Sbjct: 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE-RDV--L 115
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLK 183
I QL + + ++LVMEY DL +L + + +++
Sbjct: 116 VNGDRRWITQLHFAF--QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVM 173
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
++ +H +HRD+KP N+LL+ G +++
Sbjct: 174 AIDSVHRLGYVHRDIKPDNILLDRCGHIRL 203
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-21
Identities = 39/148 (26%), Positives = 66/148 (44%), Gaps = 13/148 (8%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL---FLQNNTLT---RGELREVTGLTKCR 128
+E +G G V+ RD + +A+K L ++ + R E + L
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN--- 70
Query: 129 HENIVQLKEV--VVGKSLSSIFLVMEYCE-HDLASLQDNVESPFTESQVKCVILQVLKGL 185
H IV + + + ++VMEY + L + E P T + VI + L
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQAL 129
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
N+ H N IIHRD+KP+N++++ VK+
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKV 157
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-21
Identities = 32/142 (22%), Positives = 63/142 (44%), Gaps = 13/142 (9%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALKKL---FLQNNTLT---RGELREVTGLTKCRHENIV 133
+G G G VY D+V+++I+ALK + + + E R L ++V
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ---EPHVV 97
Query: 134 QLKEVVVGKSLSSIFLVMEYCE-HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
+ + G+ +++ M DLA++ + P + ++ Q+ L+ H+
Sbjct: 98 PIHDF--GEIDGQLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 193 IIHRDLKPSNLLLNDKGCVKIV 214
HRD+KP N+L++ +V
Sbjct: 155 ATHRDVKPENILVSADDFAYLV 176
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-21
Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 16/156 (10%)
Query: 72 VAEFEKLNRIGEGSYGVVY---RVRD--SVQDKILALKKLFLQNNTLTRGEL-REVTGLT 125
AE+ +G+G +G V+ R+ D V K++ ++ + EV L
Sbjct: 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 126 KCR----HENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVIL 179
K H +++L + + LV+E L D + P E +C
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQE--GFMLVLERPLPA-QDLFDYITEKGPLGEGPSRCFFG 146
Query: 180 QVLKGLNYLHSNFIIHRDLKPSNLLLN-DKGCVKIV 214
QV+ + + HS ++HRD+K N+L++ +GC K++
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLI 182
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 5e-21
Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 10/147 (6%)
Query: 74 EFEKLNRIGEGSYGVVYR----VRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCR 128
+K+ +GEG +G V + +++A+K L R +E+ L
Sbjct: 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY 91
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLN 186
HE+I++ K +S+ LVMEY L L + +Q+ Q+ +G+
Sbjct: 92 HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMA 148
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YLH+ IHRDL N+LL++ VKI
Sbjct: 149 YLHAQHYIHRDLAARNVLLDNDRLVKI 175
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 7e-21
Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 12/150 (8%)
Query: 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTL--TRGELREVTGL 124
+ +FE L IG G++G V V+ DK+ A+K L L+ R E R+V L
Sbjct: 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE-RDV--L 128
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLK 183
+ I L + ++++LVM+Y DL +L E E + + +++
Sbjct: 129 VNGDSKWITTLHYAF--QDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVI 186
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
++ +H +HRD+KP N+L++ G +++
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILMDMNGHIRL 216
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 8e-21
Identities = 42/149 (28%), Positives = 77/149 (51%), Gaps = 11/149 (7%)
Query: 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCR 128
+ ++ + IG G++GV +RD + +++A+K +++ + RE+ R
Sbjct: 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVK--YIERGAAIDENVQREIINHRSLR 74
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLN 186
H NIV+ KEV++ + + ++MEY L + + + F+E + + Q+L G++
Sbjct: 75 HPNIVRFKEVILTPT--HLAIIMEYASG--GELYERICNAGRFSEDEARFFFQQLLSGVS 130
Query: 187 YLHSNFIIHRDLKPSNLLL--NDKGCVKI 213
Y HS I HRDLK N LL + +KI
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKI 159
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 88.0 bits (217), Expect = 8e-21
Identities = 35/197 (17%), Positives = 67/197 (34%), Gaps = 49/197 (24%)
Query: 66 FGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRG--------- 116
F C + ++ +IGEG +G V++ +A+K + ++ L G
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 117 --------ELREVTGLTKCRHENIVQLKEVVVGK-------------------------- 142
EL ++G R E + L V +
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 143 --SLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF-IIHRDLK 199
+F+V+E+ + L+ + + K ++ Q+ L ++ HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGI-DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLH 189
Query: 200 PSNLLLNDKGCVKIVYS 216
N+LL K+ Y+
Sbjct: 190 WGNVLLKKTSLKKLHYT 206
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 2e-20
Identities = 38/143 (26%), Positives = 66/143 (46%), Gaps = 6/143 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENI 132
+ +IG G++G V+ R + ++A+K + + L+E L + H NI
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI 174
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHS 190
V+L V K I++VME + D + L+ ++ ++ + G+ YL S
Sbjct: 175 VRLIGVCTQKQ--PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQM-VGDAAAGMEYLES 231
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
IHRDL N L+ +K +KI
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKI 254
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-20
Identities = 38/147 (25%), Positives = 70/147 (47%), Gaps = 15/147 (10%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTL--TRGELREVTGLTKCR 128
F+ +GEGS+ V R+ + A+K L ++ N + E R+V +++
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE-RDV--MSRLD 88
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLN 186
H V+L + ++ + Y ++ +L ++ F E+ + +++ L
Sbjct: 89 HPFFVKLYFTF--QDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALE 144
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YLH IIHRDLKP N+LLN+ ++I
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHIQI 171
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-20
Identities = 38/142 (26%), Positives = 67/142 (47%), Gaps = 7/142 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
E + L IG+G +G V + +A+K + +N+ + L E + +T+ RH N+V
Sbjct: 22 ELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 134 QLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
QL V+ + +++V EY L L+ S + L V + + YL N
Sbjct: 78 QL-LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
+HRDL N+L+++ K+
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKV 158
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 1e-19
Identities = 35/199 (17%), Positives = 63/199 (31%), Gaps = 59/199 (29%)
Query: 74 EFEKLNRIGEGSYGVVYRVR----------------------DSVQDKILALKKLFLQNN 111
+FE + +G G +GVV+ + + V ++ AL KL
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 112 TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS------------------------- 146
E + + LK+ LSS
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 147 ---------IFLVMEYCEH-DLASL--QDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
+++ M+ C +L + + +Q+ + + +LHS ++
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HRDLKPSN+ VK+
Sbjct: 187 HRDLKPSNIFFTMDDVVKV 205
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-19
Identities = 39/142 (27%), Positives = 68/142 (47%), Gaps = 7/142 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
E + L IG+G +G V + +A+K + +N+ + L E + +T+ RH N+V
Sbjct: 194 ELKLLQTIGKGEFGDVML--GDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 134 QLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
QL V+V + +++V EY L L+ S + L V + + YL N
Sbjct: 250 QLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
+HRDL N+L+++ K+
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKV 330
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-19
Identities = 35/147 (23%), Positives = 71/147 (48%), Gaps = 11/147 (7%)
Query: 74 EFEKLNRIGEGSYGVVYR---VRDSVQDKIL-ALKKLFLQNNTLTRGE-LREVTGLTKCR 128
EF+K+ +G G++G VY+ + + + KI A+K+L + E L E +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLN 186
+ ++ +L + + S++ L+ + L ++++ + + +Q+ KG+N
Sbjct: 76 NPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMN 131
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YL ++HRDL N+L+ VKI
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKI 158
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-19
Identities = 40/146 (27%), Positives = 68/146 (46%), Gaps = 14/146 (9%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTL--TRGELREVTGLTKCR 128
+E + IG G++G V VR K+ A+K L ++ + E R++ +
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE-RDI--MAFAN 127
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCE-HDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
+VQL + +++VMEY DL +L E + +V+ L+
Sbjct: 128 SPWVVQLFYAF--QDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDA 183
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
+HS IHRD+KP N+LL+ G +K+
Sbjct: 184 IHSMGFIHRDVKPDNMLLDKSGHLKL 209
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-19
Identities = 30/143 (20%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENI 132
+ ++G G +G V+ + K+ A+K + + +++ L E + +H+ +
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTM--KPGSMSVEAFLAEANVMKTLQHDKL 245
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHS 190
V+L VV + I+++ E+ L L+ + S ++ Q+ +G+ ++
Sbjct: 246 VKLHAVVTKEP---IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
IHRDL+ +N+L++ KI
Sbjct: 303 RNYIHRDLRAANILVSASLVCKI 325
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 4e-19
Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 21/151 (13%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNN--TLTRGELREVTGLTKCR 128
F + +G+G +G V + K+ A KKL + + E +++ L K
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNE-KQI--LEKVN 242
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCE------HDLASLQDNVESPFTESQVKCVILQVL 182
+V L ++ ++ LV+ H + ++ F E++ ++
Sbjct: 243 SRFVVSLAYAY--ETKDALCLVLTLMNGGDLKFH----IYHMGQAGFPEARAVFYAAEIC 296
Query: 183 KGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
GL LH I++RDLKP N+LL+D G ++I
Sbjct: 297 CGLEDLHRERIVYRDLKPENILLDDHGHIRI 327
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 9e-19
Identities = 50/241 (20%), Positives = 81/241 (33%), Gaps = 36/241 (14%)
Query: 2 KVQDDGNPERAMKVQDDGNPESHDATKPSTTQSI------PDPQSKFAKRRDVLMNFVTG 55
D P++A ++ F ++ +
Sbjct: 97 TADDALRPQKAQALRAAYLEPQAQLFCSFLDAETVARARAGAGDGLFQPLLRAVLAHLGQ 156
Query: 56 EPI-EILEQDCFGKCR----------NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALK 104
P E L+ F + F +G G +G V+ + K+ A K
Sbjct: 157 APFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACK 216
Query: 105 KL----FLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE--- 155
KL + E +++ L K IV L ++ + + LVM
Sbjct: 217 KLNKKRLKKRKGYQGAMVE-KKI--LAKVHSRFIVSLAYAF--ETKTDLCLVMTIMNGGD 271
Query: 156 ---HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVK 212
H +D F E + Q++ GL +LH II+RDLKP N+LL+D G V+
Sbjct: 272 IRYHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR 329
Query: 213 I 213
I
Sbjct: 330 I 330
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-18
Identities = 40/153 (26%), Positives = 73/153 (47%), Gaps = 23/153 (15%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTL--TRGELREVTGLTKC 127
+F+++ +G GS+G V V+ A+K L ++ + T E + + L
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE-KRI--LQAV 98
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCE------HDLASLQDNVESPFTESQVKCVILQV 181
+V+L+ K S++++VMEY H L+ F+E + Q+
Sbjct: 99 NFPFLVKLEFSF--KDNSNLYMVMEYVAGGEMFSH----LRR--IGRFSEPHARFYAAQI 150
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
+ YLHS +I+RDLKP NLL++ +G +++
Sbjct: 151 VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-18
Identities = 34/146 (23%), Positives = 64/146 (43%), Gaps = 10/146 (6%)
Query: 74 EFEKLNRIGEGSYGVVYR--VRDSVQDKIL-ALKKLFLQNNTLTRGE-LREVTGLTKCRH 129
+ +GEG +G VY + +KI A+K + + + E + H
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH 72
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNY 187
+IV+L ++ +++ME + +L L+ N ++ + LQ+ K + Y
Sbjct: 73 PHIVKLIGII---EEEPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAY 128
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
L S +HRD+ N+L+ CVK+
Sbjct: 129 LESINCVHRDIAVRNILVASPECVKL 154
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 33/143 (23%), Positives = 65/143 (45%), Gaps = 7/143 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENI 132
+ +++G G YG VY +A+K L + +T+ E L+E + + +H N+
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHS 190
VQL V + +++ E+ + +L L++ + + + Q+ + YL
Sbjct: 279 VQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
IHR+L N L+ + VK+
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKV 359
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-18
Identities = 35/143 (24%), Positives = 73/143 (51%), Gaps = 9/143 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENI 132
+ + R+G G +G V+ + K+ A+K L + +++ L E + + +H+ +
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL--KQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHS 190
V+L VV + I+++ EY E+ L L+ T +++ + Q+ +G+ ++
Sbjct: 71 VRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
IHRDL+ +N+L++D KI
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKI 150
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-18
Identities = 34/143 (23%), Positives = 65/143 (45%), Gaps = 7/143 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENI 132
+ +++G G YG VY +A+K L + +T+ E L+E + + +H N+
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHS 190
VQL V + +++ E+ + +L L++ + + + Q+ + YL
Sbjct: 72 VQLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
IHRDL N L+ + VK+
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKV 152
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-18
Identities = 49/158 (31%), Positives = 72/158 (45%), Gaps = 29/158 (18%)
Query: 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALK---KLFLQNNTLTRGELREVTGLTKC 127
N FE L IG+GS+G V V+ + K+ A+K K R +E+ +
Sbjct: 13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 128 RHENIVQLKEVVVGKSLSS------IFLVMEYCE------HDLASLQDNVESPFTESQVK 175
H +V L S +F+V++ H LQ NV F E VK
Sbjct: 73 EHPFLVNLW--------YSFQDEEDMFMVVDLLLGGDLRYH----LQQNVH--FKEETVK 118
Query: 176 CVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
I +++ L+YL + IIHRD+KP N+LL++ G V I
Sbjct: 119 LFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHI 156
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-18
Identities = 35/142 (24%), Positives = 63/142 (44%), Gaps = 7/142 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
++G+G +G V+ + ++ A+K L L+E + K RHE +V
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 134 QLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
QL VV + I++V EY L L+ Q+ + Q+ G+ Y+
Sbjct: 243 QLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
+HRDL+ +N+L+ + K+
Sbjct: 300 NYVHRDLRAANILVGENLVCKV 321
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-18
Identities = 33/147 (22%), Positives = 65/147 (44%), Gaps = 11/147 (7%)
Query: 74 EFEKLNRIGEGSYGVVYR---VRDSVQDKIL-ALKKLFLQNNTLTRGE-LREVTGLTKCR 128
E KL +G G +G V++ + + KI +K + ++ + + +
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLN 186
H +IV+L + G SS+ LV +Y L ++ + + +Q+ KG+
Sbjct: 74 HAHIVRLLGLCPG---SSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMY 129
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YL + ++HR+L N+LL V++
Sbjct: 130 YLEEHGMVHRNLAARNVLLKSPSQVQV 156
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-18
Identities = 43/148 (29%), Positives = 66/148 (44%), Gaps = 12/148 (8%)
Query: 74 EFEKLNRIGEGSYGVVYR------VRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC 127
+ L ++G+GS+GVV R +V + LK L +REV +
Sbjct: 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 78
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGL 185
H N+++L VV+ + +V E L L+ + + F + +QV +G+
Sbjct: 79 DHRNLIRLYGVVLT---PPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGM 134
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YL S IHRDL NLLL + VKI
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKI 162
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 3e-18
Identities = 36/143 (25%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENI 132
++G+G +G V+ + ++ A+K L + T++ L+E + K RHE +
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL--KPGTMSPEAFLQEAQVMKKLRHEKL 324
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHS 190
VQL VV + I++V EY L L+ Q+ + Q+ G+ Y+
Sbjct: 325 VQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
+HRDL+ +N+L+ + K+
Sbjct: 382 MNYVHRDLRAANILVGENLVCKV 404
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-18
Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 14/145 (9%)
Query: 78 LNRIGEGSYGVVYR--VRDSVQDKIL-ALKKLFLQNNTLTRGE----LREVTGLTKCRHE 130
IG G +G VY + D+ KI A+K L N GE L E + H
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGIIMKDFSHP 86
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYL 188
N++ L + +S S +V+ Y +H DL + +++ T + LQV KG+ YL
Sbjct: 87 NVLSL-LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYL 144
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
S +HRDL N +L++K VK+
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKV 169
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-18
Identities = 39/143 (27%), Positives = 69/143 (48%), Gaps = 9/143 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENI 132
E + IG G +G+V+ +DK+ A+K + + ++ + + E + K H +
Sbjct: 9 ELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTI--REGAMSEEDFIEEAEVMMKLSHPKL 65
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHS 190
VQL V + ++ I LV E+ EH L+ L+ F + + L V +G+ YL
Sbjct: 66 VQLYGVCLEQA--PICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
+IHRDL N L+ + +K+
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKV 145
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 4e-18
Identities = 44/151 (29%), Positives = 69/151 (45%), Gaps = 23/151 (15%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTL--TRGELREVTGLTKCR 128
F+ L +G GS+G V+ +R + A+K L ++ + T E R + L+
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE-RLM--LSIVT 64
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCE------HDLASLQDNVESPFTESQVKCVILQVL 182
H I+++ + IF++M+Y E L+ F K +V
Sbjct: 65 HPFIIRMWGTF--QDAQQIFMIMDYIEGGELFSL----LRK--SQRFPNPVAKFYAAEVC 116
Query: 183 KGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
L YLHS II+RDLKP N+LL+ G +KI
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKI 147
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-18
Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 15/147 (10%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTL--TRGELREVTGLTKCR 128
F+ L +G+G++G V VR+ + A+K L + + + T E V L R
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE-SRV--LQNTR 63
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLN 186
H + LK ++ + VMEY +L L E FTE + + +++ L
Sbjct: 64 HPFLTALKYAF--QTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALE 119
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YLHS +++RD+K NL+L+ G +KI
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKI 146
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 5e-18
Identities = 49/212 (23%), Positives = 81/212 (38%), Gaps = 15/212 (7%)
Query: 11 RAMKVQDDGNPESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCR 70
DG + + ++ F V ++ P +
Sbjct: 28 PRGSPGLDGICSIEELSTSLYKKA-GSENLYFQGANTVHIDLSALNPELVQAVQHVVIGP 86
Query: 71 NVAEFEKLNRIGEGSYGVVYR--VRDSVQDKIL-ALKKLFLQNNTLTRGE----LREVTG 123
+ IG G +G VY + D+ KI A+K L N GE L E
Sbjct: 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL---NRITDIGEVSQFLTEGII 143
Query: 124 LTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQV 181
+ H N++ L + +S S +V+ Y +H DL + +++ T + LQV
Sbjct: 144 MKDFSHPNVLSL-LGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQV 201
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
KG+ +L S +HRDL N +L++K VK+
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKV 233
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 8e-18
Identities = 35/147 (23%), Positives = 71/147 (48%), Gaps = 11/147 (7%)
Query: 74 EFEKLNRIGEGSYGVVYR---VRDSVQDKIL-ALKKLFLQNNTLTRGE-LREVTGLTKCR 128
EF+K+ +G G++G VY+ + + + KI A+K+L + E L E +
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLN 186
+ ++ +L + + S++ L+ + L ++++ + + +Q+ KG+N
Sbjct: 76 NPHVCRLLGICLT---STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMN 131
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YL ++HRDL N+L+ VKI
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKI 158
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-17
Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 30/227 (13%)
Query: 3 VQDDGNPERAMKVQDDGNPESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILE 62
+Q ER V+ PE + + + + A D +
Sbjct: 78 LQWTTVIERTFHVE---TPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEM 134
Query: 63 QDCFGKCRN---VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTL-- 113
+ K ++ + EFE L +G+G++G V V++ + A+K L + + +
Sbjct: 135 EVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAH 194
Query: 114 TRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCE------HDLASLQDNVES 167
T E V L RH + LK ++ + VMEY H L E
Sbjct: 195 TLTE-NRV--LQNSRHPFLTALKYSF--QTHDRLCFVMEYANGGELFFH----LSR--ER 243
Query: 168 PFTESQVKCVILQVLKGLNYLHSNF-IIHRDLKPSNLLLNDKGCVKI 213
F+E + + +++ L+YLHS +++RDLK NL+L+ G +KI
Sbjct: 244 VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKI 290
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-17
Identities = 40/154 (25%), Positives = 67/154 (43%), Gaps = 9/154 (5%)
Query: 66 FGKCRNVAEFEKLNRIGEGSYGVVYR--VRDSVQDKIL-ALKKLFLQNNTLTRGE-LREV 121
F + + IG G G V +R Q + A+K L R + L E
Sbjct: 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEA 101
Query: 122 TGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVIL 179
+ + + H NI++L+ VV +V EY E+ L + L+ + + FT Q+ ++
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGR--LAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLR 158
Query: 180 QVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
V G+ YL +HRDL N+L++ K+
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKV 192
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-17
Identities = 37/140 (26%), Positives = 62/140 (44%), Gaps = 11/140 (7%)
Query: 80 RIGEGSYGVVYR--VRDSVQDKILALKKLFLQNNTLTRGE--LREVTGLTKCRHENIVQL 135
+G G++G V + + K +A+K L + N + L E + + + IV++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 136 KEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSNFI 193
+ +S LVME E L LQ N + + ++ QV G+ YL +
Sbjct: 84 IGICEAES---WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 194 IHRDLKPSNLLLNDKGCVKI 213
+HRDL N+LL + KI
Sbjct: 139 VHRDLAARNVLLVTQHYAKI 158
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-17
Identities = 37/139 (26%), Positives = 60/139 (43%), Gaps = 9/139 (6%)
Query: 80 RIGEGSYGVVYRVRDSVQDKIL--ALKKLFLQNNTLTRGE-LREVTGLTKCRHENIVQLK 136
+G G++G V + ++ K + A+K L E +RE + + + IV+L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 137 EVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
V ++ + LVME L L S V ++ QV G+ YL +
Sbjct: 77 GVCQAEA---LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HRDL N+LL ++ KI
Sbjct: 133 HRDLAARNVLLVNRHYAKI 151
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-17
Identities = 40/145 (27%), Positives = 68/145 (46%), Gaps = 13/145 (8%)
Query: 74 EFEKLNRIGEGSYGVVYR--VRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHE 130
+ L +G G +GVV R +A+K + + +++ E + E + HE
Sbjct: 25 DLTFLKELGTGQFGVVKYGKWRGQYD---VAIKMI--KEGSMSEDEFIEEAKVMMNLSHE 79
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYL 188
+VQL V + IF++ EY + L + L++ F Q+ + V + + YL
Sbjct: 80 KLVQLYGVCTKQR--PIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYL 136
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
S +HRDL N L+ND+G VK+
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKV 161
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 2e-17
Identities = 45/212 (21%), Positives = 86/212 (40%), Gaps = 17/212 (8%)
Query: 13 MKVQDDGNPESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRN- 71
+ Q++G + + + Q + + + + R+
Sbjct: 278 LLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDR 337
Query: 72 --VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTL--TRGELREVTG 123
+ +F L +G+GS+G V D++ A+K L +Q++ + T E + V
Sbjct: 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE-KRVL- 395
Query: 124 LTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DL-ASLQDNVESPFTESQVKCVILQV 181
+ + QL +++ ++ VMEY DL +Q F E ++
Sbjct: 396 ALPGKPPFLTQLHSCF--QTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEI 451
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
GL +L S II+RDLK N++L+ +G +KI
Sbjct: 452 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKI 483
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-17
Identities = 35/147 (23%), Positives = 67/147 (45%), Gaps = 10/147 (6%)
Query: 74 EFEKLNRIGEGSYGVVY----RVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCR 128
+ IG G +G VY + ++ +A+K L R + L E + +
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 104
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLN 186
H NI++L+ V+ + ++ EY E+ L L++ + F+ Q+ ++ + G+
Sbjct: 105 HHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMK 161
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
YL + +HRDL N+L+N K+
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKV 188
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 79.2 bits (195), Expect = 3e-17
Identities = 37/147 (25%), Positives = 69/147 (46%), Gaps = 12/147 (8%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNN--TLTRGELREVTGLTKCR 128
F IG G +G VY R + K+ A+K L TL E ++ ++
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLN 186
IV + + + +++ DL L F+E+ ++ +++ GL
Sbjct: 251 CPFIVCMSYAF--HTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLE 306
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
++H+ F+++RDLKP+N+LL++ G V+I
Sbjct: 307 HMHNRFVVYRDLKPANILLDEHGHVRI 333
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-17
Identities = 43/183 (23%), Positives = 81/183 (44%), Gaps = 11/183 (6%)
Query: 37 DPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLNRIGEGSYGVVYR--VRD 94
+ K R + +P + + + F K + +G G +G V ++
Sbjct: 11 NGHLKLPGLRTFVDPHTFEDPTQTVHE--FAKELDATNISIDKVVGAGEFGEVCSGRLKL 68
Query: 95 SVQDKIL-ALKKLFLQNNTLTRGE-LREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152
+ +I A+K L + R + L E + + + H NI++L+ VV + +V E
Sbjct: 69 PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK--PVMIVTE 126
Query: 153 YCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC 210
Y E+ L S L+ + ++ FT Q+ ++ + G+ YL +HRDL N+L+N
Sbjct: 127 YMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV 185
Query: 211 VKI 213
K+
Sbjct: 186 CKV 188
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-17
Identities = 37/146 (25%), Positives = 67/146 (45%), Gaps = 10/146 (6%)
Query: 74 EFEKLNRIGEGSYGVVYR---VRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRH 129
E IGEG +G V++ + +A+K + R + L+E + + H
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNY 187
+IV+L V+ + ++++ME C +L S LQ + + + Q+ L Y
Sbjct: 76 PHIVKLIGVITE---NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAY 131
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
L S +HRD+ N+L++ CVK+
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKL 157
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 5e-17
Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 37/159 (23%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQ---DKILALKKL----FLQNNTL-TRGELREVTGLTK 126
FE L +G+GS+G V+ V+ ++ A+K L + + T+ E R++ L +
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME-RDI--LVE 82
Query: 127 CRHENIVQLKEVVVGKSLSS------IFLVMEYCE------HDLASLQDNVESPFTESQV 174
H IV+L + ++L++++ L E FTE V
Sbjct: 83 VNHPFIVKLH--------YAFQTEGKLYLILDFLRGGDLFTR----LSK--EVMFTEEDV 128
Query: 175 KCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
K + ++ L++LHS II+RDLKP N+LL+++G +K+
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKL 167
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 6e-17
Identities = 35/139 (25%), Positives = 59/139 (42%), Gaps = 9/139 (6%)
Query: 80 RIGEGSYGVVYRVRDSVQDKIL--ALKKLFLQNNTLTRGE-LREVTGLTKCRHENIVQLK 136
+G G++G V + ++ K + A+K L E +RE + + + IV+L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 137 EVVVGKSLSSIFLVMEYCEHD--LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
V ++ + LVME L S V ++ QV G+ YL +
Sbjct: 403 GVCQAEA---LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HR+L N+LL ++ KI
Sbjct: 459 HRNLAARNVLLVNRHYAKI 477
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-17
Identities = 31/153 (20%), Positives = 61/153 (39%), Gaps = 19/153 (12%)
Query: 78 LNRIGEGSYGVVYR--VRDSVQDKIL-ALKKLFLQNNTLTRGE----LREVTGLTKCRHE 130
+G+G +G V ++ + A+K L + + + + LRE + + H
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKML--KADIIASSDIEEFLREAACMKEFDHP 85
Query: 131 NIVQLKEVVV----GKSLSSIFLVMEYCEH-DL-----ASLQDNVESPFTESQVKCVILQ 180
++ +L V + L +++ + +H DL AS + ++
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145
Query: 181 VLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ G+ YL S IHRDL N +L + V +
Sbjct: 146 IACGMEYLSSRNFIHRDLAARNCMLAEDMTVCV 178
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 8e-17
Identities = 41/199 (20%), Positives = 77/199 (38%), Gaps = 12/199 (6%)
Query: 21 PESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLNR 80
S + Q + ++ D + + + R E
Sbjct: 340 LPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRE--RIELGRC 397
Query: 81 IGEGSYGVVYR--VRDSVQDKIL-ALKKLFLQNNTLTRGE-LREVTGLTKCRHENIVQLK 136
IGEG +G V++ + A+K + R + L+E + + H +IV+L
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 137 EVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
V+ + ++++ME C +L S LQ + + + Q+ L YL S +
Sbjct: 458 GVITE---NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFV 513
Query: 195 HRDLKPSNLLLNDKGCVKI 213
HRD+ N+L++ CVK+
Sbjct: 514 HRDIAARNVLVSSNDCVKL 532
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-16
Identities = 37/145 (25%), Positives = 67/145 (46%), Gaps = 13/145 (8%)
Query: 74 EFEKLNRIGEGSYGVVYR--VRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHE 130
E L +G G +GVV + +A+K + + +++ E +E + K H
Sbjct: 9 EITLLKELGSGQFGVVKLGKWKGQYD---VAVKMI--KEGSMSEDEFFQEAQTMMKLSHP 63
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYL 188
+V+ V + I++V EY + L + L+ + SQ+ + V +G+ +L
Sbjct: 64 KLVKFYGVCSKEY--PIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFL 120
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
S+ IHRDL N L++ CVK+
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKV 145
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-16
Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 24/155 (15%)
Query: 78 LNRIGEGSYGVVYR--VRDSVQDK---ILALKKLFLQNNTLTRGE----LREVTGLTKCR 128
+G+GS+G+VY + V+D+ +A+K + N + E L E + + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV---NEAASMRERIEFLNEASVMKEFN 86
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS---------LQDNVESPFTESQVKCVI 178
++V+L VV ++ME DL S + V +P + S++ +
Sbjct: 87 CHHVVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 179 LQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
++ G+ YL++N +HRDL N ++ + VKI
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-16
Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 39/161 (24%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSV---QDKILA---LKKLFLQNNTL----TRGELREVTGL 124
FE L +G+G YG V++VR KI A LKK + N T+ E R + L
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE-RNI--L 75
Query: 125 TKCRHENIVQLKEVVVGKSLSS------IFLVMEYCE------HDLASLQDNVESPFTES 172
+ +H IV L + ++L++EY L+ E F E
Sbjct: 76 EEVKHPFIVDLI--------YAFQTGGKLYLILEYLSGGELFMQ----LER--EGIFMED 121
Query: 173 QVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ ++ L +LH II+RDLKP N++LN +G VK+
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKL 162
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-16
Identities = 41/147 (27%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTL--TRGELREVTGLTKCR 128
F L +G+GS+G V D++ A+K L +Q++ + T E + V +
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVE-KRVL-ALPGK 79
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DL-ASLQDNVESPFTESQVKCVILQVLKGLN 186
+ QL +++ ++ VMEY DL +Q F E ++ GL
Sbjct: 80 PPFLTQLHSCF--QTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVFYAAEIAIGLF 135
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+L S II+RDLK N++L+ +G +KI
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKI 162
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-16
Identities = 43/151 (28%), Positives = 68/151 (45%), Gaps = 22/151 (14%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALK----KLFLQNNTL--TRGELREVTGLTKCR 128
F L IG+GS+G V R ++ A+K K L+ E R V L +
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSE-RNVL-LKNVK 97
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCE------HDLASLQDNVESPFTESQVKCVILQVL 182
H +V L ++ ++ V++Y H LQ E F E + + ++
Sbjct: 98 HPFLVGLHFSF--QTADKLYFVLDYINGGELFYH----LQR--ERCFLEPRARFYAAEIA 149
Query: 183 KGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
L YLHS I++RDLKP N+LL+ +G + +
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGHIVL 180
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-16
Identities = 30/150 (20%), Positives = 62/150 (41%), Gaps = 14/150 (9%)
Query: 78 LNRIGEGSYGVVYR--VRDSVQDKIL-ALKKLFLQNNTLTRGE--LREVTGLTKCRHENI 132
+GEG +G V ++ + A+K + L N++ E L E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 133 VQLKEVVV---GKSLSSIFLVMEYCEH-DL-----ASLQDNVESPFTESQVKCVILQVLK 183
++L V + + + +++ + ++ DL S + + ++ +
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
G+ YL + +HRDL N +L D V +
Sbjct: 159 GMEYLSNRNFLHRDLAARNCMLRDDMTVCV 188
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-16
Identities = 38/144 (26%), Positives = 65/144 (45%), Gaps = 14/144 (9%)
Query: 79 NRIGEGSYGVVYR--VRDSVQDKIL-ALKKLFLQNNTLTRGE----LREVTGLTKCRHEN 131
IG+G +GVVY D Q++I A+K L + + LRE + H N
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL---SRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLH 189
++ L ++ +++ Y H DL ++ +P + + LQV +G+ YL
Sbjct: 84 VLAL-IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG-LQVARGMEYLA 141
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
+HRDL N +L++ VK+
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKV 165
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 5e-16
Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 22/151 (14%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTL--TRGELREVTGLTKCR 128
F+ L IG GSY V VR D+I A+K + + + + E + V
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTE-KHVFEQA-SN 68
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCE------HDLASLQDNVESPFTESQVKCVILQVL 182
H +V L ++ S +F V+EY H +Q + E + ++
Sbjct: 69 HPFLVGLHSCF--QTESRLFFVIEYVNGGDLMFH----MQR--QRKLPEEHARFYSAEIS 120
Query: 183 KGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
LNYLH II+RDLK N+LL+ +G +K+
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKL 151
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-16
Identities = 48/205 (23%), Positives = 78/205 (38%), Gaps = 29/205 (14%)
Query: 21 PESHDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLNR 80
HD P+T + E + E + +F+ L
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSGIEEE-------KEAMNTRESGKASSSLGLQDFDLLRV 59
Query: 81 IGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTL--TRGELREVTGLTKCRHENIVQ 134
IG GSY V VR D+I A++ + + + + E + V H +V
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTE-KHVFEQA-SNHPFLVG 117
Query: 135 LKEVVVGKSLSSIFLVMEYCE------HDLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
L ++ S +F V+EY H +Q + E + ++ LNYL
Sbjct: 118 LHSCF--QTESRLFFVIEYVNGGDLMFH----MQR--QRKLPEEHARFYSAEISLALNYL 169
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
H II+RDLK N+LL+ +G +K+
Sbjct: 170 HERGIIYRDLKLDNVLLDSEGHIKL 194
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 1e-15
Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 24/152 (15%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTL--TRGELREVTGLTKC- 127
FE + +G+GS+G V R + A+K L LQ++ + T E + + L+
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE-KRI--LSLAR 81
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCE------HDLASLQDNVESPFTESQVKCVILQV 181
H + QL ++ +F VME+ H +Q F E++ + ++
Sbjct: 82 NHPFLTQLFCCF--QTPDRLFFVMEFVNGGDLMFH----IQK--SRRFDEARARFYAAEI 133
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ L +LH II+RDLK N+LL+ +G K+
Sbjct: 134 ISALMFLHDKGIIYRDLKLDNVLLDHEGHCKL 165
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-15
Identities = 40/152 (26%), Positives = 60/152 (39%), Gaps = 18/152 (11%)
Query: 78 LNRIGEGSYGVVYR--VRDSVQDK---ILALKKLFLQNNTLTRGE-LREVTGLTKCRHEN 131
+ +G G++G VY V D +A+K L + + L E ++K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEH-DLAS------LQDNVESPFTESQVKCVILQVLKG 184
IV+ V + F++ME DL S + + S + V + G
Sbjct: 95 IVRCIGVSLQSL--PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKG---CVKI 213
YL N IHRD+ N LL G KI
Sbjct: 153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-15
Identities = 32/146 (21%), Positives = 64/146 (43%), Gaps = 18/146 (12%)
Query: 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCR-------- 128
+ ++G G + V+ +D V + +A+K ++ + T E+ L +
Sbjct: 24 VRKLGWGHFSTVWLAKDMVNNTHVAMK--IVRGDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 129 ---HENIVQLKE--VVVGKSLSSIFLVMEYCEHDLAS-LQDNVESPFTESQVKCVILQVL 182
+I++L + G + + +V E +L + ++ VK + Q+L
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 183 KGLNYLHSNF-IIHRDLKPSNLLLND 207
GL+Y+H IIH D+KP N+L+
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEI 167
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-15
Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 28/156 (17%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQ---DKILALKKL----FLQNNTL---TRGELREVTGL 124
FE L +G G+YG V+ VR K+ A+K L +Q TR E R+V L
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE-RQV--L 112
Query: 125 TKCRHEN-IVQLKEVVVGKSLSSIFLVMEYCE------HDLASLQDNVESPFTESQVKCV 177
R +V L ++ + + L+++Y H L FTE +V+
Sbjct: 113 EHIRQSPFLVTLHYAF--QTETKLHLILDYINGGELFTH----LSQ--RERFTEHEVQIY 164
Query: 178 ILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ +++ L +LH II+RD+K N+LL+ G V +
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVL 200
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-15
Identities = 39/157 (24%), Positives = 65/157 (41%), Gaps = 34/157 (21%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTL--TRGELREVTGLTKCR 128
F +G+GS+G V+ ++ A+K L L ++ + T E + V
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE-KRVL-SLAWE 76
Query: 129 HENIVQLKEVVVGKSLSS------IFLVMEYCE------HDLASLQDNVESPFTESQVKC 176
H + + + +F VMEY H +Q F S+
Sbjct: 77 HPFLTHMF--------CTFQTKENLFFVMEYLNGGDLMYH----IQS--CHKFDLSRATF 122
Query: 177 VILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+++ GL +LHS I++RDLK N+LL+ G +KI
Sbjct: 123 YAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKI 159
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-15
Identities = 41/160 (25%), Positives = 61/160 (38%), Gaps = 30/160 (18%)
Query: 78 LNRIGEGSYGVVYR-----VRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTKCR 128
+GEG++G V+ + ++A+K L + RE LT +
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL----KEASESARQDFQREAELLTMLQ 101
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DL--------------ASLQDNVESPFTESQ 173
H++IV+ V + +V EY H DL A +D P Q
Sbjct: 102 HQHIVRFFGVCTEGR--PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 174 VKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ V QV G+ YL +HRDL N L+ VKI
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI 199
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-15
Identities = 40/152 (26%), Positives = 61/152 (40%), Gaps = 18/152 (11%)
Query: 78 LNRIGEGSYGVVYR--VRDSVQDK---ILALKKLFLQNNTLTRGE-LREVTGLTKCRHEN 131
+ +G G++G VY V D +A+K L + + L E ++K H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDN-----VESPFTESQVKCVILQVLKG 184
IV+ V + F+++E DL S L++ S + V + G
Sbjct: 136 IVRCIGVSLQSL--PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 185 LNYLHSNFIIHRDLKPSNLLLNDKG---CVKI 213
YL N IHRD+ N LL G KI
Sbjct: 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 5e-15
Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 24/158 (15%)
Query: 78 LNRIGEGSYGVVYR-----VRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHEN 131
+ +GE +G VY+ Q + +A+K L + R E E + +H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDN--------------VESPFTESQVK 175
+V L VV + ++ YC H DL L V+S
Sbjct: 74 VVCLLGVVTKDQ--PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 176 CVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
++ Q+ G+ YL S+ ++H+DL N+L+ DK VKI
Sbjct: 132 HLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKI 169
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 8e-15
Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 25/152 (16%)
Query: 75 FEKLNRIGEGSYGVVYR--VRDSVQDKILALKKLFLQNNTLTRGE---LREVTGLTKCRH 129
F+ IG G +G VY+ +RD + +ALK+ ++G E+ L+ CRH
Sbjct: 41 FDHKFLIGHGVFGKVYKGVLRDGAK---VALKRR---TPESSQGIEEFETEIETLSFCRH 94
Query: 130 ENIVQLKEVVVG--KSLSSIFLVMEYCEHDLASLQD------NVESPFTESQVKCVILQV 181
++V L +G + + L+ +Y E+ +L+ + Q + +
Sbjct: 95 PHLVSL----IGFCDERNEMILIYKYMENG--NLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+GL+YLH+ IIHRD+K N+LL++ KI
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKI 180
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-15
Identities = 27/159 (16%), Positives = 59/159 (37%), Gaps = 24/159 (15%)
Query: 74 EFEKLNRIGEGSYGVVYR------VRDSVQDKIL-ALKKLFLQNNTLTRGE--LREVTGL 124
+ +G+G++ +++ + LK L E + +
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--DKAHRNYSESFFEAASMM 66
Query: 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVL 182
+K H+++V V V LV E+ + L + L+ N ++ V Q+
Sbjct: 67 SKLSHKHLVLNYGVCVCGD--ENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLA 123
Query: 183 KGLNYLHSNFIIHRDLKPSNLLLN--------DKGCVKI 213
+++L N +IH ++ N+LL + +K+
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-14
Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 12/147 (8%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHE--- 130
+E L IG+GS+G V + D + +ALK ++N R E+ L R +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALK--MVRNEKRFHRQAAEEIRILEHLRKQDKD 156
Query: 131 ---NIVQLKEVVVGKSLSSIFLVMEYCEHDLAS-LQDNVESPFTESQVKCVILQVLKGLN 186
N++ + E ++ I + E +L ++ N F+ V+ +L+ L+
Sbjct: 157 NTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
LH N IIH DLKP N+LL +G I
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGI 241
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-14
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 27/159 (16%)
Query: 78 LNRIGEGSYGVVYR-----VRDSVQDKILALKKLFLQNNTLT-RGE-LREVTGLTKCRHE 130
+GEG++G V+ + + ++A+K L ++ TL R + RE LT +HE
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--KDPTLAARKDFQREAELLTNLQHE 77
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDN--------------VESPFTESQV 174
+IV+ V + +V EY +H DL L+ + + SQ+
Sbjct: 78 HIVKFYGVCGDGD--PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 175 KCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ Q+ G+ YL S +HRDL N L+ VKI
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKI 174
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-13
Identities = 35/158 (22%), Positives = 66/158 (41%), Gaps = 28/158 (17%)
Query: 79 NRIGEGSYGVVYR--VRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTK-CRHEN 131
+ IGEG++G V + ++ A+K++ ++ + E+ L K H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEH-DL---------------ASLQDNVESPFTESQVK 175
I+ L + ++L +EY H +L ++ ++ S + Q+
Sbjct: 88 IINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 145
Query: 176 CVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
V +G++YL IHRDL N+L+ + KI
Sbjct: 146 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 183
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-13
Identities = 35/212 (16%), Positives = 71/212 (33%), Gaps = 35/212 (16%)
Query: 24 HDATKPSTTQSIPDPQSKFAKRRDVLMNFVTGEPIEILEQDCFGKCRNVAEFEKLNRIGE 83
H S+ + F L TG + D G+ +++ +
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMTTSLEALPTGTVL----TDKSGR-----QWKLKSFQTR 52
Query: 84 GSYGVVYRVRD--------SVQDKILALK------KLFLQNNTLTRG----ELREVTGLT 125
+ G++Y Q + +LK +LF + N R ++ + L
Sbjct: 53 DNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLY 112
Query: 126 KCRHENIVQLKEVVVGKSLSSI---FLVMEYCEHDLASL-QDNVESPFTESQVKCVILQV 181
I +G + FLV+ L S + + +E V V ++
Sbjct: 113 STPLLAIPT----CMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRL 168
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
L L +LH N +H ++ N+ ++ + ++
Sbjct: 169 LDALEFLHENEYVHGNVTAENIFVDPEDQSQV 200
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-13
Identities = 38/152 (25%), Positives = 69/152 (45%), Gaps = 15/152 (9%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHE--- 130
F + ++G+G++G V + K A+K ++N TR E L K +++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVK--VVRNIKKYTRSAKIEADILKKIQNDDIN 94
Query: 131 --NIVQLKEVVVGKSLSSIFLVME---YCEHDLASLQDNVESPFTESQVKCVILQVLKGL 185
NIV+ + + L+ E +++ + N + F +K +++LK L
Sbjct: 95 NNNIVKYHGKFMYYD--HMCLIFEPLGPSLYEI--ITRNNYNGFHIEDIKLYCIEILKAL 150
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKIVYST 217
NYL + H DLKP N+LL+D K + +
Sbjct: 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITV 182
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-13
Identities = 34/143 (23%), Positives = 57/143 (39%), Gaps = 17/143 (11%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALK--KLFLQNNTLTR-----GELREVTGLTKCRHENI 132
+IG GS+G +Y D + +A+K + ++ L ++ G+ R
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC-- 73
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
G +VME L L + F+ V + Q++ + Y+HS
Sbjct: 74 --------GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 193 IIHRDLKPSNLLLNDKGCVKIVY 215
IHRD+KP N L+ +VY
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVY 148
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-13
Identities = 38/169 (22%), Positives = 65/169 (38%), Gaps = 38/169 (22%)
Query: 78 LNRIGEGSYGVVYR--VRDSVQDK---ILALKKLFLQNNTLTRGE----LREVTGLTKCR 128
+ IGEG++G V++ + + ++A+K L + RE + +
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFD 108
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DL-----------------------ASLQDN 164
+ NIV+L V + L+ EY + DL A +
Sbjct: 109 NPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 165 VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
P + ++ C+ QV G+ YL +HRDL N L+ + VKI
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 215
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 5e-13
Identities = 33/152 (21%), Positives = 57/152 (37%), Gaps = 18/152 (11%)
Query: 80 RIGEGSYGVVYRVRD----SVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQL 135
IG+G +G +Y SV + K+ +N EL+ K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 136 KEVVVGKSLSSI--------------FLVMEYCEHDLASLQDNVESPFTESQVKCVILQV 181
+ + F++M+ DL + + F+ V + L++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161
Query: 182 LKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
L L Y+H + +H D+K SNLLLN K ++
Sbjct: 162 LDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 5e-13
Identities = 46/155 (29%), Positives = 73/155 (47%), Gaps = 19/155 (12%)
Query: 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTR-GE---LREVTGLT 125
N++GEG +GVVY+ V + +A+KKL + T + +E+ +
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKGY--VNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMA 85
Query: 126 KCRHENIVQLKEVVVGKSLSSI--FLVMEYCEHDLASLQD-----NVESPFTESQVKCVI 178
KC+HEN+V+L +G S LV Y + SL D + P + +
Sbjct: 86 KCQHENLVEL----LGFSSDGDDLCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKIA 139
Query: 179 LQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
G+N+LH N IHRD+K +N+LL++ KI
Sbjct: 140 QGAANGINFLHENHHIHRDIKSANILLDEAFTAKI 174
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 8e-13
Identities = 42/141 (29%), Positives = 65/141 (46%), Gaps = 13/141 (9%)
Query: 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR--------H 129
+ ++G G + V+ D K +A+K + T L E+ L R
Sbjct: 42 IRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 130 ENIVQLKE--VVVGKSLSSIFLVMEYCEHDLASLQD-NVESPFTESQVKCVILQVLKGLN 186
E +VQL + + G + + I +V E H L + VK +I QVL+GL+
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 187 YLHS-NFIIHRDLKPSNLLLN 206
YLH+ IIH D+KP N+LL+
Sbjct: 161 YLHTKCRIIHTDIKPENILLS 181
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 9e-13
Identities = 32/143 (22%), Positives = 57/143 (39%), Gaps = 17/143 (11%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALK--KLFLQNNTLTR-----GELREVTGLTKCRHENI 132
+IG GS+G +Y + ++ +A+K + ++ L L+ TG+ R
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWF-- 71
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
G LVM+ L L + + V + Q++ + ++HS
Sbjct: 72 --------GVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 193 IIHRDLKPSNLLLNDKGCVKIVY 215
+HRD+KP N L+ VY
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVY 146
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-12
Identities = 40/162 (24%), Positives = 67/162 (41%), Gaps = 30/162 (18%)
Query: 78 LNRIGEGSYGVVYR-----VRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTK-C 127
+G G++G V + + + +A+K L T E + E+ L
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIG 88
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEH-DL---------------ASLQDNVESPFTE 171
H N+V L K + +++E+C+ +L + +D + T
Sbjct: 89 HHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 172 SQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ C QV KG+ +L S IHRDL N+LL++K VKI
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 189
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 1e-12
Identities = 33/128 (25%), Positives = 55/128 (42%), Gaps = 7/128 (5%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALK--KLFLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
RIGEGS+GV++ + + ++ +A+K L E R L C I +
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD-EYRTYKLLAGCTG--IPNVYY 73
Query: 138 VVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRD 197
G+ LV++ L L D F+ V Q+L + +H +++RD
Sbjct: 74 --FGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD 131
Query: 198 LKPSNLLL 205
+KP N L+
Sbjct: 132 IKPDNFLI 139
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 3e-12
Identities = 38/161 (23%), Positives = 59/161 (36%), Gaps = 27/161 (16%)
Query: 78 LNRIGEGSYGVVYR-----VRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTK-CRHE 130
+G G++G V + S +A+K L + R + E+ L+ H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEH-DL-----------------ASLQDNVESPFTES 172
NIV L ++ EYC + DL ++ ++ E
Sbjct: 88 NIVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 173 QVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ QV KG+ +L S IHRDL N+LL KI
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKI 186
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-12
Identities = 41/151 (27%), Positives = 74/151 (49%), Gaps = 19/151 (12%)
Query: 75 FEKLNRIGEGSYGVVYR--VRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHEN 131
F N +G G +G VY+ + D ++A+K+L + + EV ++ H N
Sbjct: 32 FSNKNILGRGGFGKVYKGRLADG---TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 132 IVQLKEVVVGKSLSSI--FLVMEYCEHD-LAS-LQDNVES--PFTESQVKCVILQVLKGL 185
+++L G ++ LV Y + +AS L++ ES P + + + L +GL
Sbjct: 89 LLRL----RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGL 144
Query: 186 NYLHSNF---IIHRDLKPSNLLLNDKGCVKI 213
YLH + IIHRD+K +N+LL+++ +
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-12
Identities = 33/153 (21%), Positives = 61/153 (39%), Gaps = 17/153 (11%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDK-ILALKKLFLQNN-TLTRGELREVTGLTKCRHE-- 130
+E + +GEG++G V D + K +ALK ++N E+ L K + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALK--IIRNVGKYREAARLEINVLKKIKEKDK 78
Query: 131 ----NIVQLKEVVVGKSLSSIFLVME---YCEHDLASLQDNVESPFTESQVKCVILQVLK 183
V + + + + E + L++N P+ V+ + Q+
Sbjct: 79 ENKFLCVLMSDWFNFHG--HMCIAFELLGKNTFEF--LKENNFQPYPLPHVRHMAYQLCH 134
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYS 216
L +LH N + H DLKP N+L + +
Sbjct: 135 ALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 6e-12
Identities = 31/128 (24%), Positives = 58/128 (45%), Gaps = 7/128 (5%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALK--KLFLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
+IG G++G + ++ ++ +A+K + + L E R L I Q+
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL-EYRFYKQLGSGDG--IPQVYY 72
Query: 138 VVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRD 197
G +V+E L L D + F+ V + +Q++ + Y+HS +I+RD
Sbjct: 73 F--GPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRD 130
Query: 198 LKPSNLLL 205
+KP N L+
Sbjct: 131 VKPENFLI 138
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-12
Identities = 34/164 (20%), Positives = 65/164 (39%), Gaps = 33/164 (20%)
Query: 78 LNRIGEGSYGVVYR------VRDSVQDKIL-ALKKLFLQNNTLTRGE----LREVTGLTK 126
+GEG++G V +D ++ + A+K L + T + + E+ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKM 96
Query: 127 -CRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DL---------------ASLQDNVESPF 169
+H+NI+ L +++++EY +L + E
Sbjct: 97 IGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 170 TESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
T + Q+ +G+ YL S IHRDL N+L+ + +KI
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 198
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-12
Identities = 36/150 (24%), Positives = 63/150 (42%), Gaps = 17/150 (11%)
Query: 75 FEKLNRIGEGSYGVVYRVRDS-VQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHE-- 130
+E ++ +GEG++G V D + +A+K ++N E+ L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVK--IVKNVDRYCEAARSEIQVLEHLNTTDP 73
Query: 131 ----NIVQLKEVVVGKSLSSIFLVME---YCEHDLASLQDNVESPFTESQVKCVILQVLK 183
VQ+ E I +V E +D +++N PF ++ + Q+ K
Sbjct: 74 NSTFRCVQMLEWFEHHG--HICIVFELLGLSTYDF--IKENGFLPFRLDHIRKMAYQICK 129
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+N+LHSN + H DLKP N+L +
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEA 159
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 8e-12
Identities = 34/164 (20%), Positives = 64/164 (39%), Gaps = 33/164 (20%)
Query: 78 LNRIGEGSYGVVYR------VRDSVQDKIL-ALKKLFLQNNTLTRGE----LREVTGLTK 126
+GEG +G V +D ++ + A+K L + T + + E+ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKM 142
Query: 127 -CRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DL---------------ASLQDNVESPF 169
+H+NI+ L +++++EY +L + E
Sbjct: 143 IGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 170 TESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
T + Q+ +G+ YL S IHRDL N+L+ + +KI
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 244
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 1e-11
Identities = 34/150 (22%), Positives = 62/150 (41%), Gaps = 17/150 (11%)
Query: 80 RIGEGSYGVVYRVRDSVQDKILALK--KLFLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
+IG G +G++Y + + + A K+ Q N EL+ + K ++
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 138 VVVGKSLSSI--------------FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLK 183
+ + F+VME DL + + F +S V + +++L
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT-FKKSTVLQLGIRMLD 162
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
L Y+H N +H D+K +NLLL K ++
Sbjct: 163 VLEYIHENEYVHGDIKAANLLLGYKNPDQV 192
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-11
Identities = 34/169 (20%), Positives = 63/169 (37%), Gaps = 38/169 (22%)
Query: 78 LNRIGEGSYGVVYR-----VRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTKCR 128
+GEG +G V + ++ +A+K L + E L E L +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML---KENASPSELRDLLSEFNVLKQVN 84
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEH-DL-----------------------ASLQDN 164
H ++++L + L++EY ++ L +SL
Sbjct: 85 HPHVIKLYGACSQDG--PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 165 VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
E T + Q+ +G+ YL ++HRDL N+L+ + +KI
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKI 191
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-11
Identities = 36/160 (22%), Positives = 60/160 (37%), Gaps = 29/160 (18%)
Query: 78 LNRIGEGSYGVVYR-----VRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTK-C 127
+G G++G V + +A+K L +T E + E+ ++
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML---KSTAHADEKEALMSELKIMSHLG 107
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEH-DL-------------ASLQDNVESPFTESQ 173
+HENIV L + ++ EYC + DL S +
Sbjct: 108 QHENIVNLLGACTHGG--PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 174 VKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ QV +G+ +L S IHRD+ N+LL + KI
Sbjct: 166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKI 205
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-11
Identities = 35/164 (21%), Positives = 63/164 (38%), Gaps = 33/164 (20%)
Query: 78 LNRIGEGSYGVVYR------VRDSVQDKIL-ALKKLFLQNNTLTRGE----LREVTGLTK 126
+GEG++G V +D A+K L + T + + E+ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---KSDATEKDLSDLISEMEMMKM 130
Query: 127 -CRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DL---------------ASLQDNVESPF 169
+H+NI+ L +++++EY +L + N E
Sbjct: 131 IGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 170 TESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ + QV +G+ YL S IHRDL N+L+ + +KI
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI 232
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-11
Identities = 38/149 (25%), Positives = 65/149 (43%), Gaps = 14/149 (9%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHE--- 130
+E + IG+GS+G V + D V+ + +A+K ++N EV L
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIK--IIKNKKAFLNQAQIEVRLLELMNKHDTE 113
Query: 131 ---NIVQLKEVVVGKSLSSIFLVMEYCEHDLAS-LQDNVESPFTESQVKCVILQVLKGLN 186
IV LK + ++ + LV E ++L L++ + + + Q+ L
Sbjct: 114 MKYYIVHLKRHFMFRN--HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 187 YLHSNF--IIHRDLKPSNLLLNDKGCVKI 213
+L + IIH DLKP N+LL + I
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAI 200
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-10
Identities = 39/169 (23%), Positives = 62/169 (36%), Gaps = 38/169 (22%)
Query: 78 LNRIGEGSYGVVYR-----VRDSVQDKILALKKLFLQNNTLTRGE----LREVTGLTK-C 127
+G G++G V + + +A+K L E + E+ +T+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSEREALMSELKMMTQLG 106
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEH-DL----------------------ASLQDN 164
HENIV L I+L+ EYC + DL ++
Sbjct: 107 SHENIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 165 VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ T + C QV KG+ +L +HRDL N+L+ VKI
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKI 213
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-05
Identities = 21/61 (34%), Positives = 31/61 (50%)
Query: 153 YCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVK 212
+ + +D + T + C QV KG+ +L S IHRDL N+LL++K VK
Sbjct: 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVK 233
Query: 213 I 213
I
Sbjct: 234 I 234
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 224 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.98 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.98 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.98 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.98 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.98 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.98 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.98 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.98 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.98 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.98 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.98 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.98 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.98 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.98 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.98 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.98 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.98 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.98 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.98 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.97 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.97 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.97 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.97 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.97 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.97 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.97 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.97 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.97 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.97 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.97 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.97 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.97 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.97 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.97 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.97 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.96 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.96 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.96 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.96 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.96 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.96 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.96 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.96 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.96 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.96 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.95 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.95 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.85 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.58 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.45 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.38 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.99 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.83 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.72 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.71 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.69 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.64 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.5 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.33 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.05 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.9 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.87 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.87 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.67 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.6 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.52 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.47 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.45 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.44 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.77 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.48 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.51 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.83 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.76 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 90.4 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.98 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 82.16 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.73 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=292.23 Aligned_cols=147 Identities=29% Similarity=0.442 Sum_probs=132.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
...|+++++||+|+||+||+|.+..+++.||||++........+.+.+|+.+|+.++|||||++++++..+ +.+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--CEEEEEE
Confidence 45799999999999999999999999999999999876666667788999999999999999999999644 5899999
Q ss_pred ecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+|+ |..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 151 Ey~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 220 (346)
T 4fih_A 151 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220 (346)
T ss_dssp CCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceec
Confidence 999875 5544433 56999999999999999999999999999999999999999999999999999865
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=282.96 Aligned_cols=147 Identities=24% Similarity=0.357 Sum_probs=131.2
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc---CCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ---NNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++++.||+|+||+||+|++..+++.||||++... .....+.+.+|+.+|+.++|||||++++++. +.+.+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~--~~~~~yi 109 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ--DDEKLYF 109 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--eCCEEEE
Confidence 5799999999999999999999999999999999743 2234456789999999999999999999995 4558999
Q ss_pred EEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||||+| +|...+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 9999987 56655544 567999999999999999999999999999999999999999999999999999865
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=293.93 Aligned_cols=148 Identities=28% Similarity=0.435 Sum_probs=133.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..+.|+++++||+|+||+||+|.+..+++.||||++........+.+.+|+.+|+.++|||||+++++|... +.+|||
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--~~~~iV 226 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG--DELWVV 226 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC--CEEEEE
Confidence 446799999999999999999999999999999999876666667788999999999999999999999654 589999
Q ss_pred EecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+|+ |..++. ...+++..+..++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+
T Consensus 227 mEy~~gG~L~~~i~--~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~ 297 (423)
T 4fie_A 227 MEFLEGGALTDIVT--HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297 (423)
T ss_dssp EECCTTEEHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEEC
T ss_pred EeCCCCCcHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceEC
Confidence 9999875 544443 356999999999999999999999999999999999999999999999999999865
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=274.84 Aligned_cols=149 Identities=28% Similarity=0.450 Sum_probs=126.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
.+++|++.+.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+|+.++|||||++++++. ..+.+
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~ 88 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK--SKDEI 88 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE--ECCEE
Confidence 4578999999999999999999999999999999986432 233456789999999999999999999995 44589
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||||||+|++.+.+.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 89 ~ivmEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 162 (275)
T 3hyh_A 89 IMVIEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIM 162 (275)
T ss_dssp EEEEECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---
T ss_pred EEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeec
Confidence 99999998888877665 567999999999999999999999999999999999999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=281.47 Aligned_cols=150 Identities=28% Similarity=0.460 Sum_probs=126.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
.+++|++++.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.+|++++|||||++++++.+ .+.+|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~--~~~~y 99 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE--NGSLY 99 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE--CCEEE
Confidence 35789999999999999999999999999999999975432 234567899999999999999999999954 45899
Q ss_pred EEEecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||||+| +|..++... ...+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 175 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence 99999986 566666543 345799999999999999999999999999999999999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=280.67 Aligned_cols=149 Identities=34% Similarity=0.575 Sum_probs=132.3
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcC----Ccce
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGK----SLSS 146 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~~ 146 (224)
++|++++.||+|+||+||+|.+..+++.||||++..... ...+.+++|+.+|+.++|||||++++++... ..+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999999999999999864332 2345678999999999999999999987532 2357
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||||||+|++..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 134 ~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence 999999999888777654 567999999999999999999999999999999999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=273.97 Aligned_cols=144 Identities=27% Similarity=0.318 Sum_probs=127.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..+.|++.++||+|+||+||+|++..+++.||||++.... ...+|+.+|+.++|||||++++++.+ .+.+|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~--~~~~~iv 128 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVRE--GPWVNIF 128 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 4567999999999999999999999999999999996432 23579999999999999999999954 4589999
Q ss_pred EecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC-cEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG-CVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfGla~~~ 222 (224)
||||+| +|..++.. .+.+++..++.++.||+.||+|||+++||||||||+|||++.+| .+||+|||+|+.+
T Consensus 129 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp ECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred EeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 999986 56555544 56799999999999999999999999999999999999999998 5999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=271.78 Aligned_cols=148 Identities=28% Similarity=0.368 Sum_probs=123.2
Q ss_pred ccceeEeeeeeccCceEEEEEEEc---cCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDS---VQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
.++|++++.||+|+||+||+|++. .+++.||+|++..... .....+.+|+.+|++++|||||++++++.+ .+.
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~ 100 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT--EGK 100 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE--TTE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE--CCE
Confidence 467999999999999999999874 4678999999864321 233456789999999999999999999954 458
Q ss_pred EEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||||||+|+ |...+.. .+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 101 ~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999864 5555544 567999999999999999999999999999999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=268.27 Aligned_cols=150 Identities=27% Similarity=0.357 Sum_probs=127.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEc-----cCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS-----VQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
..++|.+.+.||+|+||+||+|++. .++..||||+++.......+.+.+|+.+|++++|||||++++++. +.+
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~--~~~ 88 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV--EGD 88 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSS
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe--eCC
Confidence 3467999999999999999999875 357899999997655455667889999999999999999999995 445
Q ss_pred eEEEEEecccC-ChhHhhhhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEE
Q psy13250 146 SIFLVMEYCEH-DLASLQDNV------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVK 212 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~k 212 (224)
.+|||||||++ +|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+|
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 89999999986 566655432 24699999999999999999999999999999999999999999999
Q ss_pred EEeccccccc
Q psy13250 213 IVYSTYLELY 222 (224)
Q Consensus 213 l~DfGla~~~ 222 (224)
|+|||+|+..
T Consensus 169 i~DFGla~~~ 178 (299)
T 4asz_A 169 IGDFGMSRDV 178 (299)
T ss_dssp ECCCSCHHHH
T ss_pred ECCcccceec
Confidence 9999999854
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=270.08 Aligned_cols=150 Identities=27% Similarity=0.489 Sum_probs=123.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc------
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSL------ 144 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 144 (224)
.++|++++.||+|+||+||+|+++.+++.||||++...... ..+.+.+|+.+|++++|||||+++++|...+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 46799999999999999999999999999999999765443 34567899999999999999999999864332
Q ss_pred ----ceEEEEEecccCC-hhHhhhhcCCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEec
Q psy13250 145 ----SSIFLVMEYCEHD-LASLQDNVESP---FTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYS 216 (224)
Q Consensus 145 ----~~~~lv~e~~~~~-l~~~~~~~~~~---l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~Df 216 (224)
..+|||||||.++ +..++.. ... ..+..++.++.||+.||+|||++||+||||||+|||++.+|.+||+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~-~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHT-CCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHh-cCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 2479999999864 5555543 332 456778899999999999999999999999999999999999999999
Q ss_pred cccccc
Q psy13250 217 TYLELY 222 (224)
Q Consensus 217 Gla~~~ 222 (224)
|+|+.+
T Consensus 163 Gla~~~ 168 (299)
T 4g31_A 163 GLVTAM 168 (299)
T ss_dssp CCC---
T ss_pred ccceec
Confidence 999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=263.84 Aligned_cols=147 Identities=28% Similarity=0.301 Sum_probs=126.4
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEc--CCcceEEEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVG--KSLSSIFLV 150 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~~~lv 150 (224)
|++.++||+|+||+||+|.+..++..||+|++..... ...+.+.+|+.+|++++|||||++++++.. .....+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4778889999999999999999999999999865432 234567899999999999999999999854 234578999
Q ss_pred EecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEcc-CCcEEEEeccccccc
Q psy13250 151 MEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF--IIHRDLKPSNLLLND-KGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--iiHrDlkp~Nill~~-~~~~kl~DfGla~~~ 222 (224)
||||+++ |..++. ..+.+++..++.++.||+.||+|||+++ |+||||||+|||++. +|.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLK-RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 9999875 555544 4567999999999999999999999998 999999999999985 799999999999853
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=266.25 Aligned_cols=149 Identities=26% Similarity=0.321 Sum_probs=124.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEc-----cCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDS-----VQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..+|.+.++||+|+||+||+|++. .++..||||++........+.+.+|+.+|++++|||||++++++. ....
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~--~~~~ 117 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT--EGRP 117 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCE
Confidence 467999999999999999999865 357899999997555455667889999999999999999999994 4458
Q ss_pred EEEEEecccC-ChhHhhhhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcE
Q psy13250 147 IFLVMEYCEH-DLASLQDNV--------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCV 211 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~--------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 211 (224)
+|||||||++ +|..++... ..++++..++.|+.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcE
Confidence 9999999986 455554432 2468999999999999999999999999999999999999999999
Q ss_pred EEEeccccccc
Q psy13250 212 KIVYSTYLELY 222 (224)
Q Consensus 212 kl~DfGla~~~ 222 (224)
||+|||+|+.+
T Consensus 198 Ki~DFGla~~~ 208 (329)
T 4aoj_A 198 KIGDFGMSRDI 208 (329)
T ss_dssp EECCCC-----
T ss_pred EEcccccceec
Confidence 99999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=261.82 Aligned_cols=147 Identities=29% Similarity=0.371 Sum_probs=126.2
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
...+++++.++||+|+||+||+|++.. .+|||+++.... ...+.+.+|+.+|++++|||||++++++.. +.+
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---~~~ 106 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---DNL 106 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSC
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC---CeE
Confidence 355789999999999999999998542 589998865432 234567899999999999999999998742 368
Q ss_pred EEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||||||++ +|.+.+......+++..+..++.||+.||.|||+++||||||||+|||++.++.+||+|||+|+..
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 999999986 566666666678999999999999999999999999999999999999999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=259.38 Aligned_cols=150 Identities=25% Similarity=0.372 Sum_probs=126.4
Q ss_pred cccceeEeeeeeccCceEEEEEEEc-----cCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS-----VQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
..+++++.++||+|+||+||+|... .+++.||||++..... ...+.+.+|+.+|++++|||||++++++. ..
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~--~~ 101 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT--KD 101 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC--SS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE--EC
Confidence 4567899999999999999999863 3578999999865433 33467889999999999999999999994 44
Q ss_pred ceEEEEEecccC-ChhHhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNV---------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK 208 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~ 208 (224)
+.+|||||||++ +|..++... ...+++..+..++.||+.||.|||+++||||||||+|||++.+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 578999999986 566655332 2458999999999999999999999999999999999999999
Q ss_pred CcEEEEeccccccc
Q psy13250 209 GCVKIVYSTYLELY 222 (224)
Q Consensus 209 ~~~kl~DfGla~~~ 222 (224)
+.+||+|||+|+.+
T Consensus 182 ~~~Ki~DFGlar~~ 195 (308)
T 4gt4_A 182 LNVKISDLGLFREV 195 (308)
T ss_dssp GCEEECCSCCBCGG
T ss_pred CCEEECCcccceec
Confidence 99999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=274.19 Aligned_cols=151 Identities=22% Similarity=0.343 Sum_probs=128.1
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---Cccch---hHHHHHHHhhcCCCCCeeeeeEEEEcC
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTR---GELREVTGLTKCRHENIVQLKEVVVGK 142 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~ 142 (224)
...+++|++++.||+|+||+||+|++..+++.||||++.... ..... ....++.+++.++|||||+++++|.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~-- 262 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-- 262 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE--
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE--
Confidence 345689999999999999999999999999999999996432 11112 2233456777889999999999995
Q ss_pred CcceEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 143 SLSSIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 143 ~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+.+.+|||||||.|+ |...+.. .+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.
T Consensus 263 ~~~~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 263 TPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ECCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 455899999999865 5555544 57799999999999999999999999999999999999999999999999999986
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
+
T Consensus 342 ~ 342 (689)
T 3v5w_A 342 F 342 (689)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=257.18 Aligned_cols=153 Identities=24% Similarity=0.323 Sum_probs=128.0
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccC-----CeEEEEEEeeccCC-ccchhHHHHHHHhhcCCC-CCeeeeeEEEEc
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQ-----DKILALKKLFLQNN-TLTRGELREVTGLTKCRH-ENIVQLKEVVVG 141 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~ 141 (224)
..+.++|++.+.||+|+||+||+|.+..+ ++.||||.+..... ...+.+.+|+.+|.++.| ||||++++++..
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~ 139 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 139 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe
Confidence 44567899999999999999999997654 36899999865433 234567899999999965 899999999853
Q ss_pred CCcceEEEEEecccC-ChhHhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy13250 142 KSLSSIFLVMEYCEH-DLASLQDNV---------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL 205 (224)
Q Consensus 142 ~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill 205 (224)
+ .+.+|||||||++ +|..++... ...+++..+..++.||+.||+|||+++||||||||+|||+
T Consensus 140 ~-~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl 218 (353)
T 4ase_A 140 P-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 218 (353)
T ss_dssp T-TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred c-CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence 3 3468999999986 465555432 2358999999999999999999999999999999999999
Q ss_pred ccCCcEEEEeccccccc
Q psy13250 206 NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 206 ~~~~~~kl~DfGla~~~ 222 (224)
+.++.+||+|||+|+.+
T Consensus 219 ~~~~~vKi~DFGlar~~ 235 (353)
T 4ase_A 219 SEKNVVKICDFGLARDI 235 (353)
T ss_dssp CGGGCEEECCCGGGSCT
T ss_pred CCCCCEEECcchhhhhc
Confidence 99999999999999865
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=249.73 Aligned_cols=145 Identities=25% Similarity=0.295 Sum_probs=119.9
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc--ceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSL--SSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~~~lv 150 (224)
.+|.+.++||+|+||+||+|++ +++.||||++...... ......|+..+.+++|||||++++++..+.. ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 4689999999999999999987 5899999998643211 1122346666778999999999999975432 368999
Q ss_pred EecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 151 MEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN--------FIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~--------~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||||++ +|...+.. ..++++.+..++.|++.||.|||++ +|+||||||+|||++.++++||+|||+|+.
T Consensus 80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999986 45555543 4689999999999999999999987 999999999999999999999999999975
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
.
T Consensus 158 ~ 158 (303)
T 3hmm_A 158 H 158 (303)
T ss_dssp E
T ss_pred c
Confidence 4
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=268.72 Aligned_cols=150 Identities=21% Similarity=0.358 Sum_probs=133.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++++.||+|+||+||+|.++.+++.||+|++........+.+.+|+.+|+.++|||||+++++|. ..+.+|||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~--~~~~~~iv 232 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE--DDNEMVMI 232 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE--CSSEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE--ECCEEEEE
Confidence 3578999999999999999999999999999999987655445566789999999999999999999995 45689999
Q ss_pred EecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC--CcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK--GCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~--~~~kl~DfGla~~~ 222 (224)
||||+| +|...+....+.+++..++.++.||+.||.|||+++|+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 999986 5666666556789999999999999999999999999999999999999864 89999999999865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=252.45 Aligned_cols=142 Identities=25% Similarity=0.368 Sum_probs=122.8
Q ss_pred cceeEeeeeeccCceEEEEEEEc---cCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDS---VQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~---~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (224)
++|++.+.||+|+||+||+|+++ .+++.||+|++.... ....+.+|+.+|+.+ .||||+++++++.. .+.+|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK--NDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CCEEE
Confidence 56999999999999999999875 467899999885432 345677899999988 69999999999954 45899
Q ss_pred EEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC-CcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK-GCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfGla~~~ 222 (224)
||||||++ ++...+ ..+++..++.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 97 lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~ 168 (361)
T 4f9c_A 97 IAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGT 168 (361)
T ss_dssp EEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCccc
Confidence 99999986 455554 248999999999999999999999999999999999999887 89999999999754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=230.57 Aligned_cols=148 Identities=36% Similarity=0.672 Sum_probs=133.8
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc--cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
++|++.+.||+|+||+||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 79 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe--CCEEEEE
Confidence 5799999999999999999999999999999998754432 23566789999999999999999999954 4589999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+++++...+....+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 80 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~ 151 (292)
T 3o0g_A 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 999999888887777788999999999999999999999999999999999999999999999999999754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=235.43 Aligned_cols=149 Identities=26% Similarity=0.414 Sum_probs=130.7
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++. ..+.+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE--TEKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCEEE
Confidence 46789999999999999999999999999999999865432 23456779999999999999999999994 455899
Q ss_pred EEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+++ ++...+.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 91 lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 164 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164 (328)
T ss_dssp EEECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred EEEECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence 99999976 45555444 467999999999999999999999999999999999999999999999999999754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=234.26 Aligned_cols=149 Identities=26% Similarity=0.380 Sum_probs=129.7
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc---CCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ---NNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|++++.||+|+||+||+|++..+++.||+|++... .........+|+.+++.++||||+++++++.. .+.+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~--~~~~ 80 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC--SSEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe--CCEE
Confidence 457899999999999999999999999999999998653 22334567789999999999999999999954 4589
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|+||||+.++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 154 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE 154 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence 99999998754433333356799999999999999999999999999999999999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=245.91 Aligned_cols=150 Identities=29% Similarity=0.504 Sum_probs=123.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC---cce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKS---LSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~ 146 (224)
.++|++.+.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.+|+.++||||+++++++.... ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 3679999999999999999999999999999998864322 23456789999999999999999999985432 257
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+||||+++++..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 132 ~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 999999999888777654 567999999999999999999999999999999999999999999999999999864
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=235.20 Aligned_cols=148 Identities=25% Similarity=0.337 Sum_probs=127.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++++.||+|+||+||+|++..+++.||+|++.... ........+|..++..+ .||||+++++++. ..+.
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~~~ 98 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ--TPDR 98 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE--eCCE
Confidence 4578999999999999999999999999999999987432 22344567888888887 7999999999995 4458
Q ss_pred EEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 147 IFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+|+||||+.++ +...+. ....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 99 ~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQ-KSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999875 544443 356799999999999999999999999999999999999999999999999999985
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-34 Score=236.70 Aligned_cols=149 Identities=26% Similarity=0.345 Sum_probs=127.7
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++++.||+|+||+||+|++..+++.+|+|++.... ........+|..++.++ +||||+++++++. ....
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~--~~~~ 127 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ--TESR 127 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE--CSSE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE--ECCE
Confidence 4678999999999999999999999999999999997542 22344567888888776 8999999999995 4458
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+|+||||+.++.+.......+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 999999998754443333456799999999999999999999999999999999999999999999999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=238.25 Aligned_cols=151 Identities=25% Similarity=0.341 Sum_probs=131.9
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
...++|++.+.||+|+||+||+|++..+++.||+|++.... ......+.+|..++..++||||+++++++. ....
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~--~~~~ 148 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ--DDNN 148 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE--CSSE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--eCCE
Confidence 34578999999999999999999999999999999986422 223344678999999999999999999995 4458
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+|||||.+ +|..++......+++..++.++.|++.||.|||+++|+||||||+|||++.+|.+||+|||+|+.+
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 9999999975 566666655678999999999999999999999999999999999999999999999999999754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=227.29 Aligned_cols=150 Identities=23% Similarity=0.363 Sum_probs=134.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||+||+|.+..++..+|+|++........+.+.+|+.+++.++||||+++++++... ...|+|
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~lv 85 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD--KRLNFI 85 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC--CeeEEE
Confidence 456899999999999999999999999999999988655445566778999999999999999999999643 589999
Q ss_pred EecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ ++..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLM 158 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence 999986 566666665678999999999999999999999999999999999999999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=228.27 Aligned_cols=149 Identities=37% Similarity=0.654 Sum_probs=130.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
-.++|++++.||+|+||+||+|.+. +++.+|+|++..... .....+.+|+.+++.++||||+++++++ .....+|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~--~~~~~~~ 95 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI--HSERCLT 95 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE--CCSSCEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE--ccCCEEE
Confidence 3467999999999999999999986 588999999865432 2235677999999999999999999999 4556899
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+++++...+......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 96 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp EEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence 99999999888888776777999999999999999999999999999999999999999999999999999754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-33 Score=234.72 Aligned_cols=151 Identities=28% Similarity=0.407 Sum_probs=132.1
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
...++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~ 89 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD--EED 89 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCE
Confidence 35678999999999999999999999999999999986432 2334567789999999999999999999954 458
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+||||+.++.+.........+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 9999999987544444444667999999999999999999999999999999999999999999999999999754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=233.85 Aligned_cols=149 Identities=26% Similarity=0.365 Sum_probs=121.4
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHH-hhcCCCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTG-LTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++++.||+|+||+||+|++..++..||+|++..... .......+|..+ ++.++||||+++++++.. .+.
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~--~~~ 113 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT--ADK 113 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC--SSE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe--CCE
Confidence 45689999999999999999999999999999999875432 223345566665 567899999999999954 458
Q ss_pred EEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+||||+.++ +...+. ....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 114 ~~lv~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQ-RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999875 544444 3567999999999999999999999999999999999999999999999999999853
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=228.66 Aligned_cols=149 Identities=30% Similarity=0.414 Sum_probs=129.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|++.+.||+|+||+||+|++..+++.||+|++.... ........+|..+++.+.||||+++++++. ....+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~--~~~~~ 81 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ--DAQQI 81 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE--CSSEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE--eCCEE
Confidence 4578999999999999999999999999999999986432 123445678999999999999999999995 44589
Q ss_pred EEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||+.+ ++..++. ....+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 82 ~lv~e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp EEEECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EEEEeCCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceec
Confidence 999999986 4555544 4567999999999999999999999999999999999999999999999999999754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=230.54 Aligned_cols=148 Identities=28% Similarity=0.342 Sum_probs=128.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++++.||+|+||.||+|++..+++.||+|++..... .....+.+|..++..+ +||||+++++++.. ...
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 84 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 84 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCE
Confidence 45789999999999999999999999999999999975432 2234456888888887 89999999999954 458
Q ss_pred EEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 147 IFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+|+||||+.++ +...+. ....+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 85 ~~lv~e~~~gg~L~~~l~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEEEECCCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEEEEeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence 99999999864 544444 346799999999999999999999999999999999999999999999999999975
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=226.37 Aligned_cols=149 Identities=26% Similarity=0.446 Sum_probs=131.7
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
...++|++.+.||+|+||+||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.. .+.+|+
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~~l 94 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV--GDELWV 94 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE--CCEEEE
Confidence 345689999999999999999999999999999999977665556677899999999999999999999954 348999
Q ss_pred EEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+.+ ++..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 95 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp EEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 9999976 45555443 36899999999999999999999999999999999999999999999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-33 Score=224.47 Aligned_cols=147 Identities=35% Similarity=0.609 Sum_probs=131.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
++|++++.||+|+||+||+|.+ .+++.+|+|++..... .....+.+|+.+++.++||||+++++++.. .+.+|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv 78 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc--CCeEEEE
Confidence 5799999999999999999998 5788999999865432 234567799999999999999999999954 4589999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+++++...+....+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (288)
T 1ob3_A 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF 150 (288)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred EEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence 999999888887776678999999999999999999999999999999999999999999999999998753
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-33 Score=225.25 Aligned_cols=151 Identities=29% Similarity=0.452 Sum_probs=127.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--------------------------ccchhHHHHHHHh
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--------------------------TLTRGELREVTGL 124 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--------------------------~~~~~~~~e~~~l 124 (224)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 45789999999999999999999999999999999864321 1134577899999
Q ss_pred hcCCCCCeeeeeEEEEcCCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q psy13250 125 TKCRHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLL 204 (224)
Q Consensus 125 ~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nil 204 (224)
+.++||||+++++++.......+|+||||++++.+..+.. ...+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL 169 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 9999999999999997655678999999998654333322 457999999999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccc
Q psy13250 205 LNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 205 l~~~~~~kl~DfGla~~~ 222 (224)
++.++.+||+|||+|+.+
T Consensus 170 ~~~~~~~kl~Dfg~~~~~ 187 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEF 187 (298)
T ss_dssp ECTTSCEEECCCTTCEEC
T ss_pred ECCCCCEEEecCCCcccc
Confidence 999999999999999754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=230.27 Aligned_cols=149 Identities=29% Similarity=0.418 Sum_probs=132.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc---CCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ---NNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
.+++|++.+.||+|+||+||+|.+..++..||+|++... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~ 84 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT--PTDI 84 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEE
Confidence 467899999999999999999999999999999998643 22334567899999999999999999999954 4589
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||+++++...+.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 85 ~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 85 VMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158 (336)
T ss_dssp EEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred EEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence 99999998888777655 356999999999999999999999999999999999999999999999999999754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-33 Score=230.31 Aligned_cols=149 Identities=25% Similarity=0.342 Sum_probs=127.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++.+.||+|+||+||+|++..+++.||+|++.... ........+|..++..+ +||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~--~~~ 92 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KEN 92 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe--CCE
Confidence 4578999999999999999999999999999999987532 22344566788888775 89999999999954 458
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+||||+.+ ++...+.. ...+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 9999999986 45555443 457999999999999999999999999999999999999999999999999999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-33 Score=232.85 Aligned_cols=148 Identities=24% Similarity=0.336 Sum_probs=123.4
Q ss_pred ccccceeEe-eeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHh-hcCCCCCeeeeeEEEEc--CCcc
Q psy13250 70 RNVAEFEKL-NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGL-TKCRHENIVQLKEVVVG--KSLS 145 (224)
Q Consensus 70 ~~~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~--~~~~ 145 (224)
...++|.+. +.||+|+||+||+|.+..+++.||+|++.. .....+|+.++ +..+||||+++++++.. ....
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 345678887 689999999999999999999999998852 24456788776 44689999999998853 2345
Q ss_pred eEEEEEecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc---CCcEEEEeccccc
Q psy13250 146 SIFLVMEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND---KGCVKIVYSTYLE 220 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~---~~~~kl~DfGla~ 220 (224)
.+|+|||||.+ ++...+... ...+++..+..++.||+.||.|||+++|+||||||+|||++. ++.+||+|||+|+
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 79999999986 566665543 235999999999999999999999999999999999999998 7899999999997
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
..
T Consensus 213 ~~ 214 (400)
T 1nxk_A 213 ET 214 (400)
T ss_dssp EC
T ss_pred cc
Confidence 54
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-33 Score=235.14 Aligned_cols=149 Identities=27% Similarity=0.320 Sum_probs=129.9
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc---CCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ---NNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
...++|++++.||+|+||+||+|++..+++.||+|++... .......+.+|..+++.++||||+++++++. ....
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~ 143 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ--DDRY 143 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE--CSSE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE--ECCE
Confidence 3567899999999999999999999999999999998642 2233455778999999999999999999995 4458
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+|||||.+ ++..++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 144 ~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 9999999976 45555543 46999999999999999999999999999999999999999999999999999754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=227.50 Aligned_cols=149 Identities=25% Similarity=0.382 Sum_probs=127.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++. ..+..|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR--EGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe--cCCeEEEE
Confidence 5689999999999999999999999999999999865433 23456778999999999999999999995 44589999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.++.+.........+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeecccee
Confidence 999987433333344567999999999999999999999999999999999999999999999999999754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-33 Score=228.35 Aligned_cols=148 Identities=26% Similarity=0.386 Sum_probs=128.9
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc------cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT------LTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
.+.|++.+.||+|+||.||+|.+..++..+|+|.+...... ....+.+|+.+++.+.||||+++++++. ...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~ 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE--NRT 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSS
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE--eCC
Confidence 45799999999999999999999999999999998754322 2345679999999999999999999994 445
Q ss_pred eEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC----cEEEEeccccc
Q psy13250 146 SIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG----CVKIVYSTYLE 220 (224)
Q Consensus 146 ~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~----~~kl~DfGla~ 220 (224)
.+|+||||+.++ +..++ .....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 89 ~~~lv~e~~~gg~L~~~l-~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 89 DVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp EEEEEEECCCSCBHHHHH-TTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred EEEEEEEcCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 899999999764 55554 4456799999999999999999999999999999999999998877 79999999997
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
.+
T Consensus 168 ~~ 169 (361)
T 2yab_A 168 EI 169 (361)
T ss_dssp EC
T ss_pred Ec
Confidence 54
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-33 Score=234.75 Aligned_cols=151 Identities=22% Similarity=0.277 Sum_probs=131.8
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
...++|++++.||+|+||+||+|++..+++.||+|++.... ......+.+|..++..++||||+++++++.+ .+.
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~--~~~ 135 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD--ENY 135 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC--SSE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCE
Confidence 35678999999999999999999999999999999986422 1233456789999999999999999999954 458
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+||||+.+ ++..++......+++..++.++.||+.||+|||+++|+||||||+|||++.+|.+||+|||+|+.+
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheec
Confidence 9999999975 566666655557999999999999999999999999999999999999999999999999999754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=233.98 Aligned_cols=149 Identities=33% Similarity=0.567 Sum_probs=124.9
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc--CCccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ--NNTLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 148 (224)
.++|++++.||+|+||.||+|.+..+++.||+|++... .........+|+.++..+. ||||+++++++...+...+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46799999999999999999999999999999988532 2233456678999999997 99999999999766666899
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||||++++...+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 88 lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 88 LVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 9999999887777654 46899999999999999999999999999999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=229.51 Aligned_cols=149 Identities=26% Similarity=0.399 Sum_probs=130.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|++++.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~ 116 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--CCEE
Confidence 4678999999999999999999999999999999986432 2334567789999999999999999999954 4589
Q ss_pred EEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||+.+ ++...+.. .+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 117 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~ 191 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceec
Confidence 999999976 55555544 457999999999999999999999999999999999999999999999999999754
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=229.90 Aligned_cols=148 Identities=26% Similarity=0.341 Sum_probs=128.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++++.||+|+||+||+|++..+++.||+|++.... ........+|..++..+ .||||+++++++. ..+.
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~--~~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--TMDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE--CSSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE--cCCE
Confidence 4678999999999999999999999999999999987532 23345567888888887 7999999999995 4458
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+|+||||+.+ ++...+.. .+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 96 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 9999999986 45555443 45799999999999999999999999999999999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-33 Score=223.02 Aligned_cols=148 Identities=26% Similarity=0.433 Sum_probs=129.2
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
.++|++.+.||+|+||.||+|.+..++..+|+|.+..... ...+.+.+|+..+..++||||+++++++. ..+..|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~--~~~~~~ 87 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE--EDDCYY 87 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE--CSSEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee--eCCeEE
Confidence 3579999999999999999999999999999998865432 22356678999999999999999999984 455899
Q ss_pred EEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+++ ++..++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 88 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 99999987 45555443 467999999999999999999999999999999999999999999999999999754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=235.88 Aligned_cols=150 Identities=31% Similarity=0.478 Sum_probs=132.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc---ce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL---SS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~ 146 (224)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+|+.++|+||+++++++..... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4679999999999999999999999999999999864322 234567899999999999999999999864422 57
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+||||+++++...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 105 ~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 999999999888777654 566999999999999999999999999999999999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=237.98 Aligned_cols=148 Identities=30% Similarity=0.487 Sum_probs=128.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc--CCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC----cc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ--NNTLTRGELREVTGLTKCRHENIVQLKEVVVGKS----LS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 145 (224)
.++|++++.||+|+||+||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999999999999999998643 2233456779999999999999999999986432 24
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+|+||||+++++...+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 141 ~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 214 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214 (464)
T ss_dssp EEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred eEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence 689999999988776654 34899999999999999999999999999999999999999999999999999753
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-33 Score=225.85 Aligned_cols=152 Identities=26% Similarity=0.369 Sum_probs=131.8
Q ss_pred cccceeEeeeeeccCceEEEEEE----EccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVR----DSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++++.||+|+||.||+|+ +..+++.||+|++........+.+.+|+.+++.++||||+++++++.......
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 44689999999999999999998 56688999999987555445567789999999999999999999986544456
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+||||+.+ ++..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 8999999975 676666665556999999999999999999999999999999999999999999999999999754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-33 Score=226.58 Aligned_cols=149 Identities=32% Similarity=0.543 Sum_probs=118.1
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|++++.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++. ..+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH--TENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC--CTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE--ECCeEEEE
Confidence 3579999999999999999999999999999999875543 33466789999999999999999999994 45689999
Q ss_pred EecccCChhHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNV-----ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+++++..++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 82 FEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp EECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 999998887766543 245899999999999999999999999999999999999999999999999999754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=227.93 Aligned_cols=153 Identities=39% Similarity=0.670 Sum_probs=135.0
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC----
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKS---- 143 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---- 143 (224)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 456789999999999999999999999999999998865432 23456779999999999999999999986533
Q ss_pred --cceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 144 --LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 144 --~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.+.+|+||||+++++...+......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 94 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp ---CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 346899999999988888777667899999999999999999999999999999999999999999999999999975
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
+
T Consensus 174 ~ 174 (351)
T 3mi9_A 174 F 174 (351)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-33 Score=227.59 Aligned_cols=148 Identities=34% Similarity=0.594 Sum_probs=130.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
++|++++.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.. ....|+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT--EKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC--SSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee--CCEEEEEe
Confidence 5799999999999999999999999999999998654322 22345579999999999999999999954 45799999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+++++...+......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 150 (324)
T 3mtl_A 80 EYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAK 150 (324)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred cccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence 99999888888776677999999999999999999999999999999999999999999999999998743
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=224.24 Aligned_cols=152 Identities=25% Similarity=0.446 Sum_probs=127.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc-----
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL----- 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----- 144 (224)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.....
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 35689999999999999999999999999999999975443 234567899999999999999999998864321
Q ss_pred --------------------------------------------------ceEEEEEecccCC-hhHhhhhcC--CCCCH
Q psy13250 145 --------------------------------------------------SSIFLVMEYCEHD-LASLQDNVE--SPFTE 171 (224)
Q Consensus 145 --------------------------------------------------~~~~lv~e~~~~~-l~~~~~~~~--~~l~~ 171 (224)
..+|+|||||.++ +..++.... ...++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 2389999999874 555544322 23566
Q ss_pred HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 172 SQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 172 ~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 214 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCccccc
Confidence 778999999999999999999999999999999999999999999999764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=225.38 Aligned_cols=150 Identities=25% Similarity=0.290 Sum_probs=130.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCC---eEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQD---KILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~---~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++.+.||+|+||.||+|.+..++ ..||+|++..... ...+.+.+|+.+++.++||||+++++++ .....
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~ 124 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV--TRGRL 124 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE--CGGGC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE--EeCCc
Confidence 4568999999999999999999987544 4699999875432 2345678999999999999999999999 44557
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.|+||||+++ ++..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 8999999976 566666555668999999999999999999999999999999999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=223.39 Aligned_cols=148 Identities=22% Similarity=0.353 Sum_probs=129.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++.+.||+|+||.||+|.+..++..+|+|.+.... .....+.+|+.+++.++||||+++++++.. .+.+|+||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES--MEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEec--CCEEEEEE
Confidence 457999999999999999999999999999999886432 234456789999999999999999999954 45899999
Q ss_pred ecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc--CCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND--KGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~--~~~~kl~DfGla~~~ 222 (224)
|||++ ++...+......+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+.+
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 99986 566666554557999999999999999999999999999999999999997 789999999999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=227.67 Aligned_cols=149 Identities=34% Similarity=0.537 Sum_probs=132.9
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
.+.|++++.||+|+||+||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++... +..|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--~~~~ 130 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAW 130 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC--CeEE
Confidence 3569999999999999999999999999999999875432 2234567899999999999999999999644 4899
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+.|++...+......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 131 lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 99999998888877666778999999999999999999999999999999999999999999999999999754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=228.07 Aligned_cols=151 Identities=21% Similarity=0.287 Sum_probs=127.6
Q ss_pred ccccceeEeeeeeccCceEEEEEEEc-------cCCeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDS-------VQDKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVV 140 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~-------~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~ 140 (224)
...++|++.+.||+|+||.||+|++. .++..||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 35578999999999999999999874 3456899999865432 2345678999999999 8999999999994
Q ss_pred cCCcceEEEEEecccC-ChhHhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q psy13250 141 GKSLSSIFLVMEYCEH-DLASLQDNVE---------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLL 204 (224)
Q Consensus 141 ~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nil 204 (224)
..+.+|+||||+.+ +|..++.... ..+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 158 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 158 --QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp --SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred --cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 45579999999986 5666655432 34889999999999999999999999999999999999
Q ss_pred EccCCcEEEEeccccccc
Q psy13250 205 LNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 205 l~~~~~~kl~DfGla~~~ 222 (224)
++.++.+||+|||+|+.+
T Consensus 236 l~~~~~~kl~DFG~a~~~ 253 (370)
T 2psq_A 236 VTENNVMKIADFGLARDI 253 (370)
T ss_dssp ECTTCCEEECCCSSCEET
T ss_pred ECCCCCEEEccccCCccc
Confidence 999999999999999754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-33 Score=235.43 Aligned_cols=150 Identities=27% Similarity=0.377 Sum_probs=122.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc---CCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ---NNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|++.+.||+|+||.||+|.+..++..||+|++... .......+.+|+.+++.++||||+.+++++.. .+.+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~ 223 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT--HDRL 223 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE--TTEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee--CCEE
Confidence 457899999999999999999999999999999998743 22334556789999999999999999999954 4589
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||++++.+.........+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+..
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999875444333445679999999999999999999998 99999999999999999999999999999753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-33 Score=224.11 Aligned_cols=148 Identities=28% Similarity=0.403 Sum_probs=127.6
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.++||+|+||+||+|.+..+++.||||++..... ........|+..+..+ .|+||+++++++.. .+.+|+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~l 134 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILYL 134 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEEE
Confidence 579999999999999999999999999999998754322 2223345566555544 89999999999954 458999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+++++...+......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 135 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999998888887777778999999999999999999999999999999999999999999999999998754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-32 Score=223.73 Aligned_cols=149 Identities=30% Similarity=0.369 Sum_probs=121.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEc---cCCeEEEEEEeeccC----CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS---VQDKILALKKLFLQN----NTLTRGELREVTGLTKCRHENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~~avK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (224)
..++|++.+.||+|+||.||+|++. .+++.+|+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 92 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-- 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--
Confidence 3467999999999999999999985 688999999986432 1233456789999999999999999999954
Q ss_pred cceEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 144 LSSIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 144 ~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+.+|+||||+.++ +...+.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred CCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 45899999999864 5444443 467999999999999999999999999999999999999999999999999998753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-32 Score=222.04 Aligned_cols=148 Identities=26% Similarity=0.383 Sum_probs=128.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc------cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT------LTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
.+.|++.+.||+|+||.||+|.+..++..+|+|++...... ....+.+|+.+++.++||||+++++++. ...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~ 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE--NKT 87 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSS
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE--eCC
Confidence 35799999999999999999999999999999998754321 2345779999999999999999999995 445
Q ss_pred eEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC----cEEEEeccccc
Q psy13250 146 SIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG----CVKIVYSTYLE 220 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~----~~kl~DfGla~ 220 (224)
.+|+||||+.+ ++..++ .....+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+|+
T Consensus 88 ~~~lv~e~~~~~~L~~~l-~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 88 DVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEEEECCCSCBHHHHH-TTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEEcCCCCCHHHHH-HhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 89999999976 455554 3456799999999999999999999999999999999999999887 89999999997
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
.+
T Consensus 167 ~~ 168 (326)
T 2y0a_A 167 KI 168 (326)
T ss_dssp EC
T ss_pred EC
Confidence 54
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-32 Score=221.96 Aligned_cols=151 Identities=24% Similarity=0.332 Sum_probs=130.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++........|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 4579999999999999999999999999999999865432 234556789999999999999999999976666688999
Q ss_pred EecccC-ChhHhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----ccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVE--SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL----NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill----~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ ++..++.... ..+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 999985 5655554432 238999999999999999999999999999999999999 77888999999999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-32 Score=228.24 Aligned_cols=151 Identities=25% Similarity=0.325 Sum_probs=131.5
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
...++|++.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+|+.++||||+++++++. ....+|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~ 188 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT--QKQPIY 188 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC--SSSSCE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe--cCCCcE
Confidence 355789999999999999999999998999999998864322 23346778999999999999999999994 445789
Q ss_pred EEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+++ ++..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 99999975 566666655556999999999999999999999999999999999999999999999999999753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=223.17 Aligned_cols=150 Identities=25% Similarity=0.327 Sum_probs=126.5
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc--ce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL--SS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~ 146 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+..+..++||||+++++++..... ..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4579999999999999999999999999999999875432 223456789999999999999999998864332 24
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.|+||||+++ ++..++.. .+.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 6999999976 45555443 467999999999999999999999999999999999999999999999999999754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-32 Score=230.67 Aligned_cols=148 Identities=22% Similarity=0.275 Sum_probs=126.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.++|++.+.||+|+||+||+|.+..++..+|+|++..... .....+.+|+.+++.++||||+++++++. ..+..|+
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~--~~~~~~l 87 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS--EEGHHYL 87 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE--CSSEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE--ECCEEEE
Confidence 4579999999999999999999999999999999875432 22345678999999999999999999994 4558999
Q ss_pred EEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---cCCcEEEEeccccccc
Q psy13250 150 VMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLN---DKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~---~~~~~kl~DfGla~~~ 222 (224)
|||||.++ +...+.. ...+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||+|+.+
T Consensus 88 v~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999874 5455444 56799999999999999999999999999999999999998 4578999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-32 Score=220.15 Aligned_cols=149 Identities=34% Similarity=0.609 Sum_probs=131.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc--cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.++|++++.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.++++++||||+++++++.. .+..|+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR--KRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec--CCeEEE
Confidence 35799999999999999999999999999999988654332 23456789999999999999999999954 458999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||++++++..+......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+|+.+
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL 152 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence 9999998776666665677999999999999999999999999999999999999999999999999999754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-32 Score=233.30 Aligned_cols=149 Identities=28% Similarity=0.432 Sum_probs=130.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.. .+.+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~--~~~~ 91 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST--PSDI 91 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEE
Confidence 4578999999999999999999999999999999986432 1234567789999999999999999999954 4589
Q ss_pred EEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||+.++ +...+ ...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 92 ~lv~E~~~gg~L~~~l-~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 92 FMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEEEECCSSEEHHHHT-TSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEEeCCCCCcHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 9999999764 54444 44567999999999999999999999999999999999999999999999999999764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=223.88 Aligned_cols=147 Identities=21% Similarity=0.266 Sum_probs=130.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.+ .||||+.+++++.. ....|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEE
Confidence 357999999999999999999999999999999886443 344678899999999 99999999999854 4588999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc-----EEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC-----VKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~-----~kl~DfGla~~~ 222 (224)
|||+++++..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+|+.+
T Consensus 84 ~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 84 LELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999977788877766678999999999999999999999999999999999999999887 999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-32 Score=224.73 Aligned_cols=148 Identities=27% Similarity=0.325 Sum_probs=127.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.++|++.+.||+|+||.||+|.+..++..+|+|++..... .....+.+|+.+++.++||||+++++++.. .+..|+
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~l 105 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE--ESFHYL 105 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe--CCEEEE
Confidence 3579999999999999999999999999999999875432 223456789999999999999999999954 458999
Q ss_pred EEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC---cEEEEeccccccc
Q psy13250 150 VMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG---CVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~---~~kl~DfGla~~~ 222 (224)
||||+.++ +...+. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++ .+||+|||+|+.+
T Consensus 106 v~e~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 106 VFDLVTGGELFEDIV-AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp EECCCCSCBHHHHHT-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred EEecCCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 99999874 544443 356799999999999999999999999999999999999998654 5999999999754
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-32 Score=225.66 Aligned_cols=147 Identities=30% Similarity=0.481 Sum_probs=126.7
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++++.||+|+||+||++.+..+++.||+|++.... .....+.+|+..++.++||||+++++++.. ...+|+|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~~lv 94 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAII 94 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEee--CCEEEEE
Confidence 3467999999999999999999999999999999986433 334567799999999999999999999954 4589999
Q ss_pred EecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc--EEEEecccccc
Q psy13250 151 MEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC--VKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfGla~~ 221 (224)
|||+.+ ++...+.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+|+.
T Consensus 95 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 95 MEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp EECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 999976 45554433 457999999999999999999999999999999999999987765 99999999873
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-32 Score=223.31 Aligned_cols=149 Identities=32% Similarity=0.600 Sum_probs=126.8
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
..++|++.+.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.. ...+|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 109 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH--NHRLH 109 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE--TTEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec--CCEEE
Confidence 35679999999999999999999999999999999865432 224456789999999999999999999954 45899
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-----cCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLN-----DKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~-----~~~~~kl~DfGla~~~ 222 (224)
+||||+++++..++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++ ..+.+||+|||+|+.+
T Consensus 110 lv~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 9999999887777655 45699999999999999999999999999999999999995 4556999999999753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-32 Score=226.21 Aligned_cols=149 Identities=19% Similarity=0.327 Sum_probs=130.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++.+.||+|+||.||+|.+..+++.+|+|++..........+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED--KYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC--SSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe--CCEEEEEE
Confidence 4679999999999999999999999999999999875543344567889999999999999999999954 45899999
Q ss_pred ecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc--CCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND--KGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~--~~~~kl~DfGla~~~ 222 (224)
||+.+ ++...+......+++..+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||+|+.+
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence 99986 565555554557999999999999999999999999999999999999974 477999999999754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-32 Score=227.40 Aligned_cols=149 Identities=19% Similarity=0.237 Sum_probs=129.6
Q ss_pred cccceeEeeeeecc--CceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEG--SYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G--~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++.+.||+| +||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.. .+.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA--DNE 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE--CCE
Confidence 46789999999999 999999999999999999999975432 233456789999999999999999999964 448
Q ss_pred EEEEEecccCC-hhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 147 IFLVMEYCEHD-LASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~~~-l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+|+|||||.++ +..++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++..
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999864 55554442 35699999999999999999999999999999999999999999999999998854
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-32 Score=225.42 Aligned_cols=150 Identities=36% Similarity=0.622 Sum_probs=127.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-----ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-----TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++. ...
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~ 85 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--HKS 85 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC--CTT
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe--eCC
Confidence 35679999999999999999999999999999999864322 12346778999999999999999999994 455
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..|+||||+++++...+......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 86 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 86 NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred ceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 89999999999888777766667999999999999999999999999999999999999999999999999999754
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-32 Score=222.12 Aligned_cols=149 Identities=23% Similarity=0.329 Sum_probs=129.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|.+.+.||+|+||.||++.+..+++.+|+|++..... .....+.+|+.+++.++|+||+++++++.. .+.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~ 116 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFV 116 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--CCeE
Confidence 34679999999999999999999999999999999865422 234556789999999999999999999954 4589
Q ss_pred EEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||+.++ +..++. ....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.+
T Consensus 117 ~lv~e~~~~~~L~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 117 FVVLELCRRRSLLELHK-RRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EEEECCCTTCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999864 544443 3467999999999999999999999999999999999999999999999999999754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-32 Score=220.86 Aligned_cols=152 Identities=26% Similarity=0.362 Sum_probs=134.1
Q ss_pred cccceeEeeeeeccCceEEEEEE----EccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVR----DSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~----~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++.+.||+|+||.||+|+ +..++..||+|++........+.+.+|+.+++.++|+||+++++++.......
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 45689999999999999999999 46688999999987655445566789999999999999999999987666678
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+||||+++ ++..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 9999999965 566666554567999999999999999999999999999999999999999999999999999754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=227.50 Aligned_cols=147 Identities=16% Similarity=0.160 Sum_probs=121.0
Q ss_pred cccceeEeeeeeccCceEEEEE-----EEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC---CCCeeeeeEEEEcC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRV-----RDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR---HENIVQLKEVVVGK 142 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~-----~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~ 142 (224)
..++|.+.+.||+|+||+||+| .+..+++.||+|++... ....+.+|+.++..+. |+||+.+++++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~- 138 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF- 138 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC-
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec-
Confidence 3467999999999999999999 46678899999998543 2345566777666665 9999999999954
Q ss_pred CcceEEEEEecccC-ChhHhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc----------
Q psy13250 143 SLSSIFLVMEYCEH-DLASLQDN----VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND---------- 207 (224)
Q Consensus 143 ~~~~~~lv~e~~~~-~l~~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~---------- 207 (224)
.+..|+|||||++ +|..++.. ....+++..+..++.|++.||+|||+++|+||||||+|||++.
T Consensus 139 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 139 -QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp -SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred -CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 4478999999985 56665543 3456999999999999999999999999999999999999998
Q ss_pred -CCcEEEEeccccccc
Q psy13250 208 -KGCVKIVYSTYLELY 222 (224)
Q Consensus 208 -~~~~kl~DfGla~~~ 222 (224)
++.+||+|||+|+.+
T Consensus 218 ~~~~~kl~DFG~a~~~ 233 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDM 233 (365)
T ss_dssp -CTTEEECCCTTCEEG
T ss_pred ccCCEEEeeCchhhhh
Confidence 899999999999643
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-32 Score=224.02 Aligned_cols=148 Identities=25% Similarity=0.367 Sum_probs=125.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcC--------
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGK-------- 142 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------- 142 (224)
..++|++.+.||+|+||+||+|.+..+++.||+|++..... ...+|+.+++.++||||+++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 34679999999999999999999999999999998864322 234799999999999999999998532
Q ss_pred ----------------------------CcceEEEEEecccCChhHhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy13250 143 ----------------------------SLSSIFLVMEYCEHDLASLQD---NVESPFTESQVKCVILQVLKGLNYLHSN 191 (224)
Q Consensus 143 ----------------------------~~~~~~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 191 (224)
....+++||||+++++...+. .....+++..+..++.|++.||.|||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp -----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 223589999999987665543 3456799999999999999999999999
Q ss_pred CceecCCCCCcEEEc-cCCcEEEEeccccccc
Q psy13250 192 FIIHRDLKPSNLLLN-DKGCVKIVYSTYLELY 222 (224)
Q Consensus 192 ~iiHrDlkp~Nill~-~~~~~kl~DfGla~~~ 222 (224)
||+||||||+|||++ .++.+||+|||+|+.+
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 192 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKL 192 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEEC
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCccc
Confidence 999999999999998 6889999999999854
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-32 Score=215.70 Aligned_cols=150 Identities=16% Similarity=0.174 Sum_probs=130.7
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCC-------eEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQD-------KILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~-------~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (224)
..++|++.+.||+|+||.||+|.+..++ ..+|+|.+........+.+.+|+.+++.++||||+++++++. .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~ 83 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV--C 83 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC--C
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE--e
Confidence 4568999999999999999999988766 579999987655555667889999999999999999999994 4
Q ss_pred cceEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc--------EEEE
Q psy13250 144 LSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC--------VKIV 214 (224)
Q Consensus 144 ~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~--------~kl~ 214 (224)
.+..|+||||+.+ ++..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++. +||+
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeec
Confidence 4578999999985 666666655555999999999999999999999999999999999999999887 9999
Q ss_pred eccccccc
Q psy13250 215 YSTYLELY 222 (224)
Q Consensus 215 DfGla~~~ 222 (224)
|||+++..
T Consensus 164 Dfg~~~~~ 171 (289)
T 4fvq_A 164 DPGISITV 171 (289)
T ss_dssp CCCSCTTT
T ss_pred cCcccccc
Confidence 99999654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.5e-32 Score=218.85 Aligned_cols=147 Identities=25% Similarity=0.365 Sum_probs=129.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
..|...+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++... +..|+|||
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 122 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG--EELWVLME 122 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEEEEC
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC--CEEEEEEe
Confidence 3588888999999999999999989999999999766555566778999999999999999999999643 48999999
Q ss_pred cccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+.++.+..+.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 123 ~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 191 (321)
T 2c30_A 123 FLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191 (321)
T ss_dssp CCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeec
Confidence 998754443333 356999999999999999999999999999999999999999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.5e-32 Score=217.63 Aligned_cols=151 Identities=34% Similarity=0.584 Sum_probs=126.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-----ccchhHHHHHHHhhcC---CCCCeeeeeEEEEcCC
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-----TLTRGELREVTGLTKC---RHENIVQLKEVVVGKS 143 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~ 143 (224)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... .......+|+.+++.+ .||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 4679999999999999999999999999999999874331 2234556777766655 5999999999986543
Q ss_pred c---ceEEEEEecccCChhHhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccc
Q psy13250 144 L---SSIFLVMEYCEHDLASLQDNVES-PFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYL 219 (224)
Q Consensus 144 ~---~~~~lv~e~~~~~l~~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla 219 (224)
. ..+|++|||+++++..++..... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 2 25899999999988877765433 4999999999999999999999999999999999999999999999999999
Q ss_pred ccc
Q psy13250 220 ELY 222 (224)
Q Consensus 220 ~~~ 222 (224)
+.+
T Consensus 168 ~~~ 170 (308)
T 3g33_A 168 RIY 170 (308)
T ss_dssp TTS
T ss_pred ccc
Confidence 754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.5e-32 Score=234.31 Aligned_cols=151 Identities=25% Similarity=0.305 Sum_probs=130.1
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+|+.++||||+++++++.. .+.
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~ 258 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET--KDA 258 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee--CCE
Confidence 35578999999999999999999999999999999986432 2234456789999999999999999999954 458
Q ss_pred EEEEEecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+||||+.| ++...+... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999976 455554433 234999999999999999999999999999999999999999999999999999764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=9.7e-32 Score=226.12 Aligned_cols=146 Identities=28% Similarity=0.431 Sum_probs=124.3
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcC----CcceEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGK----SLSSIF 148 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~~~~ 148 (224)
.+|++.+.||+|+||+||+|.+..+++.||||++.... ....+|+.+|+.++||||+++++++... ....++
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46999999999999999999999999999999886432 2234799999999999999999888532 233578
Q ss_pred EEEecccCChhHhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC-CcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQD---NVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK-GCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfGla~~~ 222 (224)
+||||+++++...+. .....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999999987665543 335679999999999999999999999999999999999999965 56899999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-31 Score=211.61 Aligned_cols=148 Identities=24% Similarity=0.346 Sum_probs=129.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||.||+|.+. .+..+|+|++.... ...+.+.+|+.++++++||||+++++++. .....|+|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 83 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL--EQAPICLV 83 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSEEEE
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCceEEE
Confidence 4568999999999999999999987 57789999986443 23456789999999999999999999994 44579999
Q ss_pred EecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+++ ++..++......+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+|+..
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 156 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccc
Confidence 999986 466666555667999999999999999999999999999999999999999999999999999854
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-31 Score=215.77 Aligned_cols=151 Identities=25% Similarity=0.316 Sum_probs=128.8
Q ss_pred ccceeEeeeeeccCceEEEEEE----EccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVR----DSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~----~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
...|++.+.||+|+||.||+|. +..+++.||+|++..... .....+.+|+.+++.++||||+++++++.......
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 3469999999999999999998 567899999999875433 23456778999999999999999999997665567
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+||||+.+ ++..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 9999999976 676666566677999999999999999999999999999999999999999999999999999754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9e-32 Score=213.87 Aligned_cols=148 Identities=26% Similarity=0.309 Sum_probs=130.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++.+.||+|+||.||+|.+..++..+|+|++..........+.+|+.+++.++||||+++++++. .....|+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE--DNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCCeEEEEE
Confidence 457999999999999999999999999999999987655555667889999999999999999999995 445899999
Q ss_pred ecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---ccCCcEEEEeccccccc
Q psy13250 152 EYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL---NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfGla~~~ 222 (224)
||+.++ +...+.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 86 ELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp ECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred eccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 999864 5444443 4669999999999999999999999999999999999999 78899999999999754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=224.35 Aligned_cols=148 Identities=27% Similarity=0.325 Sum_probs=126.2
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC-----CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN-----NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
+.|++.+.||+|+||+||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.. .+.+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~ 101 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS--DGML 101 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe--CCEE
Confidence 46999999999999999999999999999999986432 1134567899999999999999999999954 4589
Q ss_pred EEEEecccC-ChhHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc---EEEEeccccc
Q psy13250 148 FLVMEYCEH-DLASLQDNV---ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC---VKIVYSTYLE 220 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~---~kl~DfGla~ 220 (224)
|+|||||.+ ++...+... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+|+
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 999999986 454444322 345899999999999999999999999999999999999987665 9999999997
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
.+
T Consensus 182 ~~ 183 (351)
T 3c0i_A 182 QL 183 (351)
T ss_dssp EC
T ss_pred Ee
Confidence 54
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.9e-32 Score=223.81 Aligned_cols=148 Identities=21% Similarity=0.251 Sum_probs=121.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--------ccchhHHHHHHHhhcCC---------CCCee
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--------TLTRGELREVTGLTKCR---------HENIV 133 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~niv 133 (224)
..++|++.+.||+|+||+||+|++ +++.||+|++..... ...+.+.+|+.+++.++ ||||+
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 356799999999999999999997 689999999976532 12256678888887775 77777
Q ss_pred eeeEEEEcC----------------------------CcceEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHH
Q psy13250 134 QLKEVVVGK----------------------------SLSSIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKG 184 (224)
Q Consensus 134 ~~~~~~~~~----------------------------~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~ 184 (224)
.+.+.+... ....+|+|||||.++ ++..+.. ..+++..++.++.||+.|
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHH
Confidence 777765311 246899999999765 5555433 568999999999999999
Q ss_pred HHHHH-hCCceecCCCCCcEEEccCC--------------------cEEEEeccccccc
Q psy13250 185 LNYLH-SNFIIHRDLKPSNLLLNDKG--------------------CVKIVYSTYLELY 222 (224)
Q Consensus 185 l~~lH-~~~iiHrDlkp~Nill~~~~--------------------~~kl~DfGla~~~ 222 (224)
|.||| +++|+||||||+|||++.++ .+||+|||+|+.+
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~ 232 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEE
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEec
Confidence 99999 99999999999999999987 8999999999865
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.6e-32 Score=221.75 Aligned_cols=149 Identities=20% Similarity=0.332 Sum_probs=128.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--------ccchhHHHHHHHhhcCCCCCeeeeeEEEEcC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--------TLTRGELREVTGLTKCRHENIVQLKEVVVGK 142 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~ 142 (224)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~-- 99 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE-- 99 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE--
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 34679999999999999999999999999999999875431 12345678999999999999999999994
Q ss_pred CcceEEEEEecccC--ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 143 SLSSIFLVMEYCEH--DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 143 ~~~~~~lv~e~~~~--~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
..+.+|+||||+.+ ++..++ .....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFI-DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHH-HTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEEeCCCCccHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 44589999999865 444444 445679999999999999999999999999999999999999999999999999997
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
.+
T Consensus 179 ~~ 180 (335)
T 3dls_A 179 YL 180 (335)
T ss_dssp EC
T ss_pred EC
Confidence 54
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.98 E-value=5.3e-32 Score=239.59 Aligned_cols=150 Identities=25% Similarity=0.328 Sum_probs=128.9
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc---CCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcc
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ---NNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (224)
...++|++++.||+|+||+||+|++..+++.||||++... ..........|..++..+ +|+||+.+++++ ...+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~--~~~~ 415 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF--QTMD 415 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC--BCSS
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE--EeCC
Confidence 3467899999999999999999999999999999998743 223445667888888877 799999999998 4556
Q ss_pred eEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+||||||+.++ |...+. ..+.+++..++.++.||+.||+|||+++|+||||||+|||++.+|.+||+|||+|+..
T Consensus 416 ~~~lV~E~~~gg~L~~~l~-~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQ-QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEEEEECCCSCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEEeCcCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 899999999875 544444 3467999999999999999999999999999999999999999999999999999853
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=2.8e-32 Score=226.13 Aligned_cols=150 Identities=25% Similarity=0.351 Sum_probs=124.4
Q ss_pred cccceeEeeeeeccCceEEEEEEEc---cCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS---VQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++.+.||+|+||.||+|++. .++..||+|.+..... ...+.+.+|+.++++++||||+++++++. ....
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~ 120 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT--KSKP 120 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--eCCc
Confidence 4568999999999999999999876 4567899999865432 23456789999999999999999999994 4457
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.|+||||+++ ++..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 8999999975 666666655567999999999999999999999999999999999999999999999999999764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.8e-32 Score=220.11 Aligned_cols=150 Identities=31% Similarity=0.565 Sum_probs=131.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc--cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.. .+..|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~ 100 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK--KKRWY 100 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec--CCEEE
Confidence 457899999999999999999999999999999988654332 23445689999999999999999999954 45899
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||++++++..+......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 99999998877776666678999999999999999999999999999999999999999999999999999753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.3e-32 Score=224.85 Aligned_cols=151 Identities=24% Similarity=0.332 Sum_probs=129.9
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++........|+|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4579999999999999999999999999999999864332 234556789999999999999999999976666688999
Q ss_pred EecccC-ChhHhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----ccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVE--SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL----NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill----~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ ++..++.... ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999986 5555554422 239999999999999999999999999999999999999 77788999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=8.5e-32 Score=223.20 Aligned_cols=146 Identities=25% Similarity=0.365 Sum_probs=121.8
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
|...+.||+|+||.||+|.+..++..||+|++........+.+.+|+.++++++||||+++++++.. .+.+|+||||+
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~E~~ 168 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES--KNDIVLVMEYV 168 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEEEECC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEEeCC
Confidence 3446789999999999999999999999999876544455677899999999999999999999954 45899999999
Q ss_pred cC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE--ccCCcEEEEeccccccc
Q psy13250 155 EH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL--NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 155 ~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill--~~~~~~kl~DfGla~~~ 222 (224)
++ ++...+......+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 86 5666665545579999999999999999999999999999999999999 56788999999999764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.98 E-value=3.4e-32 Score=225.10 Aligned_cols=149 Identities=32% Similarity=0.535 Sum_probs=123.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC----cc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKS----LS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 145 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 3579999999999999999999999999999998854322 23456779999999999999999999986432 13
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+|+||||+++++..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 104 ~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 104 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 5799999997777776654 56999999999999999999999999999999999999999999999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-31 Score=213.65 Aligned_cols=149 Identities=32% Similarity=0.459 Sum_probs=129.1
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
...++|++.+.||+|+||.||+|.+..++..+|+|++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~ 83 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATR 83 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec--CCE
Confidence 35678999999999999999999999999999999986432 1234556789999999999999999999954 458
Q ss_pred EEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 147 IFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.|+||||++++ +...+.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EEEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEecccccc
Confidence 99999999864 5444443 45699999999999999999999999999999999999999999999999999854
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=6.2e-32 Score=222.28 Aligned_cols=153 Identities=24% Similarity=0.349 Sum_probs=127.3
Q ss_pred cccccceeEeeeeeccCceEEEEEE-----EccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEc
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVR-----DSVQDKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVG 141 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~-----~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 141 (224)
....++|++.+.||+|+||.||+|. +..+++.||+|++..... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 3456789999999999999999998 445678999999865432 2335678999999999 78999999999854
Q ss_pred CCcceEEEEEecccC-ChhHhhhhcCC-----------------------------------------------------
Q psy13250 142 KSLSSIFLVMEYCEH-DLASLQDNVES----------------------------------------------------- 167 (224)
Q Consensus 142 ~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------------------------------------- 167 (224)
. ...+|+||||+.+ ++..++.....
T Consensus 98 ~-~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 98 P-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp T-TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred C-CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 3 3458999999986 45555543221
Q ss_pred ------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 168 ------------PFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 168 ------------~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 243 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 243 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence 2889999999999999999999999999999999999999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.7e-31 Score=221.22 Aligned_cols=148 Identities=28% Similarity=0.461 Sum_probs=126.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC----cc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKS----LS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 145 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.... ..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4689999999999999999999999999999999865322 23455678999999999999999999985432 23
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+|+||||+++++...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 104 ~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 177 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177 (371)
T ss_dssp EEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred ceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence 789999999988777664 35899999999999999999999999999999999999999999999999999753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.98 E-value=8e-32 Score=222.50 Aligned_cols=151 Identities=23% Similarity=0.294 Sum_probs=124.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccC-----CeEEEEEEeeccCCcc-----------chhHHHHHHHhhcCCCCCeeee
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQ-----DKILALKKLFLQNNTL-----------TRGELREVTGLTKCRHENIVQL 135 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~~~avK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~ 135 (224)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++....... ....++|+..+..+.|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45799999999999999999998764 5789999986543211 1223455666778899999999
Q ss_pred eEEEEcCC--cceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--cCCcE
Q psy13250 136 KEVVVGKS--LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLN--DKGCV 211 (224)
Q Consensus 136 ~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~--~~~~~ 211 (224)
++++.... ....|+||||+++++..++......+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred EeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 99986432 246899999996677777776567899999999999999999999999999999999999999 88999
Q ss_pred EEEeccccccc
Q psy13250 212 KIVYSTYLELY 222 (224)
Q Consensus 212 kl~DfGla~~~ 222 (224)
||+|||+|+.+
T Consensus 194 kl~DFG~a~~~ 204 (364)
T 3op5_A 194 YLVDYGLAYRY 204 (364)
T ss_dssp EECCCTTCEES
T ss_pred EEEECCcceec
Confidence 99999999754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.98 E-value=3.2e-31 Score=211.28 Aligned_cols=148 Identities=25% Similarity=0.342 Sum_probs=126.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||.||++.+. ++..||+|++.... .....+.+|+.++..++||||+++++++ ......|+|
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv 97 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC--TKQRPIFII 97 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSSSEEEE
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEE--ecCCCeEEE
Confidence 4568999999999999999999876 67789999986443 2345678999999999999999999999 445589999
Q ss_pred EecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ ++..++......+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+|+.+
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 999975 566666554567999999999999999999999999999999999999999999999999999754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=230.64 Aligned_cols=151 Identities=28% Similarity=0.338 Sum_probs=130.2
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
...++|++.+.||+|+||+||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~--~~~ 259 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET--KTD 259 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee--CCE
Confidence 34578999999999999999999999999999999986432 1233556789999999999999999999854 458
Q ss_pred EEEEEecccCC-hhHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHD-LASLQDNV---ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~-l~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+||||+.|+ +...+... ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999864 55444432 346999999999999999999999999999999999999999999999999999754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=218.71 Aligned_cols=144 Identities=27% Similarity=0.403 Sum_probs=122.5
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|++.+.||+|+||+||+|.+..+++.||+|++..... ...+|+.++.++ .||||+++++++. ....+|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~--~~~~~~lv 94 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYD--DGKYVYVV 94 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEE--CSSEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEE--cCCEEEEE
Confidence 4579999999999999999999999999999999865432 345678777776 7999999999994 45589999
Q ss_pred EecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC----CcEEEEeccccccc
Q psy13250 151 MEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK----GCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~----~~~kl~DfGla~~~ 222 (224)
||||.++ +...+. ....+++..+..++.|++.||.|||++||+||||||+|||+..+ +.+||+|||+|+.+
T Consensus 95 ~E~~~gg~L~~~i~-~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 95 TELMKGGELLDKIL-RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp ECCCCSCBHHHHHH-TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EeCCCCCcHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999864 555444 35679999999999999999999999999999999999998543 35999999999754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=219.60 Aligned_cols=146 Identities=30% Similarity=0.370 Sum_probs=117.9
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.++++++||||+++++++.. ...+|+||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 127 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET--PTEISLVL 127 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC--SSEEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec--CCeEEEEE
Confidence 356999999999999999999999999999999986432 33456789999999999999999999954 45899999
Q ss_pred ecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc---CCcEEEEeccccccc
Q psy13250 152 EYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND---KGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~---~~~~kl~DfGla~~~ 222 (224)
||+.++ +...+. ....+++..+..++.|++.||.|||+++|+||||||+|||++. ++.+||+|||+|+..
T Consensus 128 e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 128 ELVTGGELFDRIV-EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCCSCBHHHHHT-TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred EeCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 999864 544443 4567999999999999999999999999999999999999976 889999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=215.13 Aligned_cols=147 Identities=31% Similarity=0.415 Sum_probs=122.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
..++|++.+.||+|+||+||+|.+ ++..+|+|++..... .....+.+|+.++++++||||+++++++. ....+|
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~ 110 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT--QPPNLS 110 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--STTCCE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE--ECCceE
Confidence 456899999999999999999986 588899998865432 22345678999999999999999999994 445789
Q ss_pred EEEecccC-ChhHhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVE--SPFTESQVKCVILQVLKGLNYLHSNF--IIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+||||+.+ ++..++.... ..+++..+..++.|++.||.|||++| |+||||||+|||++.++.+||+|||+|+.
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 99999986 4555554322 13899999999999999999999999 99999999999999999999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=219.68 Aligned_cols=149 Identities=32% Similarity=0.554 Sum_probs=130.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC---cceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKS---LSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~ 147 (224)
.++|++++.||+|+||.||+|.+..++..||+|++..... .....+.+|+.++..++||||+++++++.... ....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 3579999999999999999999999999999999864332 23356779999999999999999999985432 2468
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||+++++...+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 106 ~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999999888777654 46999999999999999999999999999999999999999999999999999754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=216.59 Aligned_cols=148 Identities=26% Similarity=0.345 Sum_probs=126.9
Q ss_pred ccceeEe-eeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEE
Q psy13250 72 VAEFEKL-NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 72 ~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~l 149 (224)
.+.|++. +.||+|+||.||+|.+..+++.||+|++..........+.+|+..+.++ +||||+++++++.. .+.+|+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~--~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE--EDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee--CCEEEE
Confidence 3568885 7899999999999999999999999999766555566778999999884 79999999999954 458999
Q ss_pred EEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc---EEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC---VKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~---~kl~DfGla~~~ 222 (224)
||||+.+ ++...+.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999985 55555544 457999999999999999999999999999999999999998776 999999998743
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=210.35 Aligned_cols=150 Identities=27% Similarity=0.427 Sum_probs=131.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... ......+.+|+.++..++||||+++++++.. .+..
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 86 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED--SNYV 86 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC--SSEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc--CCeE
Confidence 4568999999999999999999999999999999986432 1233567789999999999999999999954 4589
Q ss_pred EEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||+++ ++..++......+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 999999976 565566555567999999999999999999999999999999999999999999999999998753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=214.70 Aligned_cols=146 Identities=23% Similarity=0.393 Sum_probs=127.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~l 149 (224)
..++|++.+.||+|+||.||+|.+..+++.||+|++.. ...+.+.+|+.+++.+. ||||+++++++........++
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 45789999999999999999999999999999999853 23456788999999997 999999999997655678999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC-cEEEEeccccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG-CVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfGla~~~ 222 (224)
||||+.++.+..+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+|+.+
T Consensus 111 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999998654433332 389999999999999999999999999999999999999877 8999999999754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=219.34 Aligned_cols=151 Identities=26% Similarity=0.375 Sum_probs=128.9
Q ss_pred ccccceeEeeeeeccCceEEEEEEEc-----cCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDS-----VQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKS 143 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (224)
...++|++.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.+++.++||||+++++++. .
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~ 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA--V 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--S
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc--c
Confidence 35678999999999999999999987 3458999999865432 23456778999999999999999999994 4
Q ss_pred cceEEEEEecccC-ChhHhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy13250 144 LSSIFLVMEYCEH-DLASLQDNVE-----------------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLK 199 (224)
Q Consensus 144 ~~~~~lv~e~~~~-~l~~~~~~~~-----------------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlk 199 (224)
.+..|+||||+.+ ++..++.... ..+++..++.++.|++.||.|||+++|+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 5578999999986 5666555421 568999999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEEeccccccc
Q psy13250 200 PSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 200 p~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+|||++.++.+||+|||+++.+
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~ 224 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNI 224 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHH
T ss_pred cceEEECCCCeEEEeecCCCccc
Confidence 99999999999999999998753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=227.66 Aligned_cols=148 Identities=30% Similarity=0.429 Sum_probs=128.5
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
.++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++. ..+.+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~ 102 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE--DKGYFY 102 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE--eCCEEE
Confidence 357999999999999999999999999999999986543 233456789999999999999999999995 455899
Q ss_pred EEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---ccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL---NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfGla~~~ 222 (224)
+||||+.++ +...+. ....+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 103 lv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 103 LVGEVYTGGELFDEII-SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEECCCCSCBHHHHHH-TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEecCCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 999999865 444443 45679999999999999999999999999999999999999 46789999999999754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=219.51 Aligned_cols=150 Identities=27% Similarity=0.421 Sum_probs=128.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCcc-----------chhHHHHHHHhhcCCCCCeeeeeEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTL-----------TRGELREVTGLTKCRHENIVQLKEVV 139 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~~~ 139 (224)
..++|++.+.||+|+||.||+|.+.. +..||+|++....... .+.+.+|+.+++.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 34679999999999999999998864 8899999886432211 25678999999999999999999998
Q ss_pred Ec---CCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEec
Q psy13250 140 VG---KSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYS 216 (224)
Q Consensus 140 ~~---~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~Df 216 (224)
.. .....+|+||||+++++...+......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp EECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred EeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 64 233478999999999888888776668999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q psy13250 217 TYLEL 221 (224)
Q Consensus 217 Gla~~ 221 (224)
|+|+.
T Consensus 179 g~~~~ 183 (362)
T 3pg1_A 179 NLARE 183 (362)
T ss_dssp TC---
T ss_pred Ccccc
Confidence 99964
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=215.47 Aligned_cols=148 Identities=25% Similarity=0.391 Sum_probs=128.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc------cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT------LTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
.++|++.+.||+|+||.||+|.+..++..+|+|++...... ....+.+|+.+++.+.||||+++++++. ...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~ 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE--NRT 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSS
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe--cCC
Confidence 45799999999999999999999999999999998754322 2345778999999999999999999995 445
Q ss_pred eEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC----cEEEEeccccc
Q psy13250 146 SIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG----CVKIVYSTYLE 220 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~----~~kl~DfGla~ 220 (224)
..|+||||+.+ ++..++. ....+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 89 ~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 89 DVVLILELVSGGELFDFLA-QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEEEECCCCSCBHHHHHH-TCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEEEcCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 89999999976 5555554 456799999999999999999999999999999999999999988 79999999997
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
.+
T Consensus 168 ~~ 169 (321)
T 2a2a_A 168 EI 169 (321)
T ss_dssp EC
T ss_pred ec
Confidence 54
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=216.85 Aligned_cols=152 Identities=26% Similarity=0.361 Sum_probs=131.2
Q ss_pred cccceeEeeeeeccCceEEEEEEE----ccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRD----SVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~----~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++.+.||+|+||.||+|+. ..+++.||+|++........+.+.+|+.+++.++||||+++++++.......
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 345799999999999999999984 5678999999987655555567789999999999999999999986555557
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+||||+++ ++..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 8999999976 677777665567999999999999999999999999999999999999999999999999999754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=228.32 Aligned_cols=148 Identities=32% Similarity=0.472 Sum_probs=123.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.++|++++.||+|+||+||+|.+..++..+|+|++.... ......+.+|+.+++.++||||+++++++. ....+|+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE--DKRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE--eCCEEEE
Confidence 346999999999999999999999999999999987543 233566789999999999999999999995 4458999
Q ss_pred EEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC---CcEEEEeccccccc
Q psy13250 150 VMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK---GCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~---~~~kl~DfGla~~~ 222 (224)
|||||.++ +...+.. ...+++..+..++.|++.||.|||++||+||||||+|||++.. +.+||+|||+|+.+
T Consensus 114 v~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 114 VMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999874 5454443 4679999999999999999999999999999999999999764 45999999999764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=225.76 Aligned_cols=150 Identities=15% Similarity=0.201 Sum_probs=121.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHH---HHhhcCCCCCeeeee-------E
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREV---TGLTKCRHENIVQLK-------E 137 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~---~~l~~l~h~niv~~~-------~ 137 (224)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+ ..++.++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3568999999999999999999998899999999987432 23345667898 555666899999988 5
Q ss_pred EEEcCCc----------c-----eEEEEEecccCChhHhhhhcCCCCC-------HHHHHHHHHHHHHHHHHHHhCCcee
Q psy13250 138 VVVGKSL----------S-----SIFLVMEYCEHDLASLQDNVESPFT-------ESQVKCVILQVLKGLNYLHSNFIIH 195 (224)
Q Consensus 138 ~~~~~~~----------~-----~~~lv~e~~~~~l~~~~~~~~~~l~-------~~~~~~~~~~i~~~l~~lH~~~iiH 195 (224)
++..... + ..|+||||++|+|..++... ..++ +..+..++.|++.||.|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 5543211 0 37899999988887776643 2233 4778889999999999999999999
Q ss_pred cCCCCCcEEEccCCcEEEEecccccc
Q psy13250 196 RDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 196 rDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|||||+|||++.++.+||+|||+|+.
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~ 255 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVR 255 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEE
T ss_pred CCCCHHHEEEcCCCCEEEEechhhee
Confidence 99999999999999999999999974
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=212.66 Aligned_cols=150 Identities=22% Similarity=0.289 Sum_probs=129.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|.+.+.||+|+||.||+|.+..+++.+|+|++..... .....+.+|+.+++.+.||||+++++++.. .+..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~ 90 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED--NDFV 90 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc--CCEE
Confidence 45689999999999999999999999999999999865422 234456789999999999999999999954 4589
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||++++.+..+......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 999999986443333333567999999999999999999999999999999999999999999999999999753
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=215.07 Aligned_cols=151 Identities=34% Similarity=0.498 Sum_probs=130.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC----CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN----NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
.++|++.+.||+|+||.||+|.+..++..+|+|++.... ......+.+|+.+++.++||||+++++++........
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 467999999999999999999999999999999986432 2234567889999999999999999999876666689
Q ss_pred EEEEecccCChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||+.+++...+... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.+
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 999999998876665543 456999999999999999999999999999999999999999999999999999754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=216.69 Aligned_cols=144 Identities=27% Similarity=0.467 Sum_probs=122.4
Q ss_pred cceeEe---eeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEE
Q psy13250 73 AEFEKL---NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 73 ~~~~~~---~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 148 (224)
.+|++. +.||+|+||.||+|.+..+++.||+|++... ......+|+..++.+. ||||+++++++. .....|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~--~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFH--DQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEE--cCCEEE
Confidence 356664 7899999999999999999999999998543 3345678999999997 999999999995 445899
Q ss_pred EEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC---cEEEEeccccccc
Q psy13250 149 LVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG---CVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~---~~kl~DfGla~~~ 222 (224)
+||||+.++ +...+. ....+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+|+..
T Consensus 83 lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 83 LVMELLNGGELFERIK-KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEECCCCSCBHHHHHH-HCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEccCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 999999874 555544 456799999999999999999999999999999999999998766 8999999999753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=221.94 Aligned_cols=149 Identities=25% Similarity=0.285 Sum_probs=124.1
Q ss_pred cccceeEeeeeeccCceEEEEEE-----EccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVR-----DSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~-----~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
..++|++.+.||+|+||+||+|. +..++..||+|++..... .....+.+|+.+++.++||||+++++++. ..
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~--~~ 146 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL--QS 146 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe--cC
Confidence 45789999999999999999999 445778999999864322 23445778999999999999999999994 44
Q ss_pred ceEEEEEecccC-ChhHhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC---cEEEE
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNVE------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG---CVKIV 214 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~---~~kl~ 214 (224)
...|+||||+.+ +|..++.... ..+++..++.++.|++.||.|||++||+||||||+|||++.+| .+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 578999999976 6666665432 3589999999999999999999999999999999999999655 49999
Q ss_pred ecccccc
Q psy13250 215 YSTYLEL 221 (224)
Q Consensus 215 DfGla~~ 221 (224)
|||+|+.
T Consensus 227 DFG~a~~ 233 (367)
T 3l9p_A 227 DFGMARD 233 (367)
T ss_dssp CCHHHHH
T ss_pred CCccccc
Confidence 9999974
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=216.73 Aligned_cols=150 Identities=26% Similarity=0.395 Sum_probs=131.9
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-CCCeeeeeEEEEc------CCcc
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-HENIVQLKEVVVG------KSLS 145 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~------~~~~ 145 (224)
.+|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+..+.++. ||||+++++++.. ....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 47999999999999999999999999999999986655555567788999999996 9999999999852 3345
Q ss_pred eEEEEEecccCChhHhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDN--VESPFTESQVKCVILQVLKGLNYLHSNF--IIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
.+|++|||+.+++..++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 187 (337)
T 3ll6_A 108 EFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT 187 (337)
T ss_dssp EEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBC
T ss_pred eEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcccee
Confidence 6899999999888776654 3456999999999999999999999999 99999999999999999999999999975
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
+
T Consensus 188 ~ 188 (337)
T 3ll6_A 188 I 188 (337)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=222.69 Aligned_cols=148 Identities=25% Similarity=0.301 Sum_probs=124.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--------CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--------NTLTRGELREVTGLTKCRHENIVQLKEVVVGKS 143 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (224)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+|++++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES--
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec--
Confidence 467999999999999999999999999999999986532 1122356789999999999999999999842
Q ss_pred cceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC---cEEEEeccccc
Q psy13250 144 LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG---CVKIVYSTYLE 220 (224)
Q Consensus 144 ~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~---~~kl~DfGla~ 220 (224)
...|+||||+.++.+.........+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||+|||+|+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred -CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 35899999998753333333456799999999999999999999999999999999999997654 59999999997
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
.+
T Consensus 291 ~~ 292 (419)
T 3i6u_A 291 IL 292 (419)
T ss_dssp SC
T ss_pred ec
Confidence 64
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=228.95 Aligned_cols=149 Identities=21% Similarity=0.304 Sum_probs=131.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
...+|++.+.||+|+||.||+|.+..++..||||.+.... ...+.+.+|+.+|++++||||+++++++. ....+|+|
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~--~~~~~~lv 294 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYII 294 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEe--cCCcEEEE
Confidence 4568999999999999999999999999999999986443 33567889999999999999999999994 44578999
Q ss_pred EecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ +|..++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 999985 566666543 346899999999999999999999999999999999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=212.39 Aligned_cols=150 Identities=23% Similarity=0.372 Sum_probs=120.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-cchhH-HHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGE-LREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~-~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... ..... .++...++.+.||||+++++++.. .+..|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~--~~~~~ 82 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR--EGDVW 82 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSSEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec--cCCEE
Confidence 457899999999999999999999999999999998654322 22222 344445788899999999999954 45799
Q ss_pred EEEecccCChhHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDN---VESPFTESQVKCVILQVLKGLNYLHSN-FIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+++++..++.. ....+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||+|+.+
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9999999877665443 356799999999999999999999998 9999999999999999999999999999754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=216.76 Aligned_cols=149 Identities=21% Similarity=0.258 Sum_probs=126.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeE----EEEEEeeccC-CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKI----LALKKLFLQN-NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~----~avK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
..++|++.+.||+|+||+||+|.+..++.. +|+|.+.... ......+.+|+..+..++||||+++++++. ..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~---~~ 87 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP---GS 87 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC---BS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc---CC
Confidence 456899999999999999999999877765 6777664332 233456678999999999999999999883 24
Q ss_pred eEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..|+||||+.+ ++...+......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 68999999985 566666555567999999999999999999999999999999999999999999999999999864
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=207.93 Aligned_cols=148 Identities=24% Similarity=0.304 Sum_probs=128.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||.||+|.+. ++..+|+|++.... .....+.+|+..+..++||||+++++++ ......|+|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~lv 81 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC--SKEYPIYIV 81 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEE--CSSSSEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEE--ccCCceEEE
Confidence 4568999999999999999999876 56779999986443 2345678999999999999999999999 445579999
Q ss_pred EecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+++ ++..++......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+|+..
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 154 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEEC
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceec
Confidence 999976 466666555556999999999999999999999999999999999999999999999999999754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=214.07 Aligned_cols=151 Identities=23% Similarity=0.347 Sum_probs=129.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcC--CcceEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGK--SLSSIFL 149 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~~~~~l 149 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++... .....|+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 46799999999999999999999999999999998765545556778999999999999999999998632 3457899
Q ss_pred EEecccC-ChhHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDN---VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+.+ ++...+.. ....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999987 56555544 3567999999999999999999999999999999999999999999999999988643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=213.89 Aligned_cols=150 Identities=21% Similarity=0.289 Sum_probs=127.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEc-----cCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS-----VQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
..++|.+.+.||+|+||.||+|.+. .++..+|+|++..... ...+.+.+|+.+++.++||||+++++++. ..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~ 98 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS--QD 98 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe--cC
Confidence 4568999999999999999999873 4458999999864432 23456778999999999999999999984 45
Q ss_pred ceEEEEEecccC-ChhHhhhhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNVE-----------------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKP 200 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~~-----------------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp 200 (224)
+..|+||||+.+ ++..++.... ..+++..+..++.|++.||.|||+++|+||||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 578999999985 5665554422 2388999999999999999999999999999999
Q ss_pred CcEEEccCCcEEEEeccccccc
Q psy13250 201 SNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 201 ~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||++.++.+||+|||+|+.+
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~ 200 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDV 200 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEEC
T ss_pred heEEEcCCCCEEEccccccccc
Confidence 9999999999999999999754
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-31 Score=213.04 Aligned_cols=149 Identities=34% Similarity=0.652 Sum_probs=128.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.++|++.+.||+|+||.||+|.+..+++.+|+|++..... .....+.+|+..+++++||||+++++++.. .+..|+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 79 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYL 79 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEec--CCceEE
Confidence 4679999999999999999999999999999998865432 234567899999999999999999999954 358999
Q ss_pred EEecccCChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+.+++..++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+
T Consensus 80 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 153 (299)
T 2r3i_A 80 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 153 (299)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred EEEcccCCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCCCEEECcchhhhhc
Confidence 99999988877766543 46899999999999999999999999999999999999999999999999998653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=218.05 Aligned_cols=148 Identities=25% Similarity=0.348 Sum_probs=127.1
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-----CCCeeeeeEEEEcCCcce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-----HENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~ 146 (224)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... .......+|+.+++.+. ||||+++++++... +.
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~--~~ 110 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY--DH 110 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--TE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC--Ce
Confidence 467999999999999999999999999999999885322 23344567888888876 99999999999543 58
Q ss_pred EEEEEecccCChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc------------------
Q psy13250 147 IFLVMEYCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND------------------ 207 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~------------------ 207 (224)
+|+||||+++++..++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 111 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 111 MCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred eEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 99999999777877766543 35999999999999999999999999999999999999975
Q ss_pred -------CCcEEEEeccccccc
Q psy13250 208 -------KGCVKIVYSTYLELY 222 (224)
Q Consensus 208 -------~~~~kl~DfGla~~~ 222 (224)
++.+||+|||+|+..
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~ 212 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFK 212 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEET
T ss_pred ccccccCCCCEEEEeccCceec
Confidence 789999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=227.92 Aligned_cols=148 Identities=31% Similarity=0.459 Sum_probs=127.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.++|++.+.||+|+||+||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++. ....+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--~~~~~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE--DSSSFYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE--cCCEEEE
Confidence 357999999999999999999999999999999986432 233456789999999999999999999995 4558999
Q ss_pred EEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---cCCcEEEEeccccccc
Q psy13250 150 VMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLN---DKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~---~~~~~kl~DfGla~~~ 222 (224)
|||||.++ +...+.. ...+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||+|+.+
T Consensus 99 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 99 VGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999864 5454443 46799999999999999999999999999999999999995 4567999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=227.05 Aligned_cols=148 Identities=28% Similarity=0.446 Sum_probs=125.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-------------ccchhHHHHHHHhhcCCCCCeeeeeEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-------------TLTRGELREVTGLTKCRHENIVQLKEV 138 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~~ 138 (224)
.++|++++.||+|+||+||+|.+..++..+|+|++..... ...+.+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4679999999999999999999999999999999864321 223456789999999999999999999
Q ss_pred EEcCCcceEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC---cEEEE
Q psy13250 139 VVGKSLSSIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG---CVKIV 214 (224)
Q Consensus 139 ~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~---~~kl~ 214 (224)
+. ....+|+|||||.++ +...+.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+
T Consensus 115 ~~--~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 115 FE--DKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EE--CSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EE--cCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 95 455899999999864 5555544 46799999999999999999999999999999999999999876 69999
Q ss_pred eccccccc
Q psy13250 215 YSTYLELY 222 (224)
Q Consensus 215 DfGla~~~ 222 (224)
|||+|+.+
T Consensus 192 Dfg~a~~~ 199 (504)
T 3q5i_A 192 DFGLSSFF 199 (504)
T ss_dssp CCTTCEEC
T ss_pred ECCCCEEc
Confidence 99999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=213.26 Aligned_cols=148 Identities=26% Similarity=0.456 Sum_probs=128.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||.||+|.+..++..+|+|++..........+.+|+.+++.++||||+++++++.. .+..|+|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH--DGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--C-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee--CCeEEEE
Confidence 34679999999999999999999999999999999876555556778899999999999999999999954 3589999
Q ss_pred EecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 151 MEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 151 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
|||++++ +..++......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 165 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA 165 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCc
Confidence 9999875 544555546679999999999999999999999999999999999999999999999999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-31 Score=214.03 Aligned_cols=149 Identities=33% Similarity=0.576 Sum_probs=125.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEc----------
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVG---------- 141 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------- 141 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4679999999999999999999999999999999876554555677899999999999999999998742
Q ss_pred --CCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-cCCcEEEEeccc
Q psy13250 142 --KSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLN-DKGCVKIVYSTY 218 (224)
Q Consensus 142 --~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~-~~~~~kl~DfGl 218 (224)
......|+||||+++++...+. .+.+++..+..++.|++.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 90 ~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~ 167 (320)
T 2i6l_A 90 SLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL 167 (320)
T ss_dssp -CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTT
T ss_pred cccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCcc
Confidence 2235789999999987777664 35699999999999999999999999999999999999997 567999999999
Q ss_pred cccc
Q psy13250 219 LELY 222 (224)
Q Consensus 219 a~~~ 222 (224)
++.+
T Consensus 168 ~~~~ 171 (320)
T 2i6l_A 168 ARIM 171 (320)
T ss_dssp CBCC
T ss_pred cccc
Confidence 9753
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=216.47 Aligned_cols=147 Identities=22% Similarity=0.328 Sum_probs=125.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC--cceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKS--LSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--~~~~~ 148 (224)
..++|++.+.||+|+||+||+|++. ++.||+|++..... ......+|+..+.+++||||+++++++.... ...+|
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 4568999999999999999999875 78999999864432 2334456888999999999999999986543 34589
Q ss_pred EEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCcEEEccCCcEEEEecc
Q psy13250 149 LVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN----------FIIHRDLKPSNLLLNDKGCVKIVYST 217 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~----------~iiHrDlkp~Nill~~~~~~kl~DfG 217 (224)
+||||+.+ ++..++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 99 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 99999986 56666544 4599999999999999999999999 99999999999999999999999999
Q ss_pred ccccc
Q psy13250 218 YLELY 222 (224)
Q Consensus 218 la~~~ 222 (224)
+|+.+
T Consensus 177 ~a~~~ 181 (322)
T 3soc_A 177 LALKF 181 (322)
T ss_dssp TCEEE
T ss_pred ccccc
Confidence 99754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=210.69 Aligned_cols=149 Identities=26% Similarity=0.400 Sum_probs=128.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|.+.+.||+|+||.||+|.+..++..+|+|++...... ....+.+|+.+++.++||||+++++++. .....|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~~~lv 98 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE--DYHNMYIV 98 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee--cCCeEEEE
Confidence 35799999999999999999999999999999998765432 3456778999999999999999999995 44589999
Q ss_pred EecccC-ChhHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---ccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDN---VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL---NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ ++...+.. ....+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999986 55555432 24679999999999999999999999999999999999999 45678999999999754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-31 Score=214.94 Aligned_cols=148 Identities=26% Similarity=0.359 Sum_probs=128.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||.||+|.+. ++..||+|++........+.+.+|+.+++.++||||+++++++ ...+..|+|
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~~~~lv 113 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC--DERNEMILI 113 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC--CCTTCCEEE
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE--cCCCeEEEE
Confidence 4568999999999999999999964 6889999988765555556778999999999999999999998 445588999
Q ss_pred EecccC-ChhHhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 151 MEYCEH-DLASLQDNVE---SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|||+.+ ++...+.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 999986 5555543322 2589999999999999999999999999999999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=220.49 Aligned_cols=149 Identities=26% Similarity=0.361 Sum_probs=126.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEc---cCCeEEEEEEeeccC----CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS---VQDKILALKKLFLQN----NTLTRGELREVTGLTKC-RHENIVQLKEVVVGK 142 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~~avK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 142 (224)
..++|++.+.||+|+||.||+|++. .+++.||+|++.... ......+.+|+.++..+ .||||+.+++++..
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 130 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT- 130 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-
Confidence 4578999999999999999999984 478999999886432 12334556788899888 69999999999854
Q ss_pred CcceEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 143 SLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 143 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
...+|+||||+.+ ++...+.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 131 -~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 131 -ETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp -TTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred -CceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 3489999999986 45555543 45799999999999999999999999999999999999999999999999999975
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
+
T Consensus 209 ~ 209 (355)
T 1vzo_A 209 F 209 (355)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-31 Score=222.32 Aligned_cols=149 Identities=25% Similarity=0.347 Sum_probs=128.8
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
....++|++.+.||+|+||.||+|.+. +..||||++... ...+.+.+|+.+|++++||||+++++++... ...+|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~~ 263 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLY 263 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECT-TSCEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcC-CCceE
Confidence 445678999999999999999999875 779999998643 2456788999999999999999999998643 34789
Q ss_pred EEEecccC-ChhHhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVES-PFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+.+ +|..++..... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 99999986 66666655433 3799999999999999999999999999999999999999999999999999753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=215.74 Aligned_cols=149 Identities=21% Similarity=0.328 Sum_probs=122.4
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeE----EEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKI----LALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~----~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
..++|++.+.||+|+||+||+|.+..++.. +|+|.+..... ...+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 89 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence 346799999999999999999998777655 47776643322 3445678999999999999999999999643
Q ss_pred eEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..++++||+.+ ++...+......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 47889999875 566666666678999999999999999999999999999999999999999999999999999754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=209.97 Aligned_cols=147 Identities=20% Similarity=0.257 Sum_probs=129.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+|+..+..+ .|+|++.+++++. .....|+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecC--CCceeEEE
Confidence 45799999999999999999999999999999988543 2345677899999998 7999999999884 34589999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc-----EEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC-----VKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~-----~kl~DfGla~~~ 222 (224)
|||+++++..++......+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+|+.+
T Consensus 85 ~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 85 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999977788887766667999999999999999999999999999999999999988776 999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.7e-31 Score=212.56 Aligned_cols=148 Identities=30% Similarity=0.431 Sum_probs=126.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|.+.+.||+|+||.||+|.+..+++.+|+|++..........+.+|+.+++.++||||+++++++. .....|+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE--STTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc--cCCEEEEEE
Confidence 357999999999999999999999999999999987654444556778999999999999999999985 445899999
Q ss_pred ecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---ccCCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL---NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfGla~~~ 222 (224)
||+++ ++...+.. .+.+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||+++..
T Consensus 86 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 86 QLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred EcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 99986 55555543 4579999999999999999999999999999999999999 77899999999998743
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=221.72 Aligned_cols=148 Identities=32% Similarity=0.496 Sum_probs=116.7
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcC----Ccce
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGK----SLSS 146 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~~ 146 (224)
++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++... ....
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 579999999999999999999999999999999864322 2345677999999999999999999998532 1246
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|++||++++++..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 109 ~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 109 VYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred EEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 899999998777666543 56999999999999999999999999999999999999999999999999999754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-31 Score=218.32 Aligned_cols=150 Identities=21% Similarity=0.293 Sum_probs=127.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccC-------CeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQ-------DKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVG 141 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~-------~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 141 (224)
..++|++.+.||+|+||.||+|.+..+ +..+|+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~- 145 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT- 145 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec-
Confidence 456899999999999999999997533 36799999865433 2335677999999999 8999999999994
Q ss_pred CCcceEEEEEecccC-ChhHhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy13250 142 KSLSSIFLVMEYCEH-DLASLQDNVE---------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL 205 (224)
Q Consensus 142 ~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill 205 (224)
..+.+|+||||+.+ +|..++.... ..+++..++.++.|++.||.|||+++|+||||||+|||+
T Consensus 146 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 146 -QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp -SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred -cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 45578999999986 5666655432 358999999999999999999999999999999999999
Q ss_pred ccCCcEEEEeccccccc
Q psy13250 206 NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 206 ~~~~~~kl~DfGla~~~ 222 (224)
+.++.+||+|||+|+.+
T Consensus 225 ~~~~~~kL~DFG~a~~~ 241 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDI 241 (382)
T ss_dssp CTTCCEEECSCSCCCCS
T ss_pred cCCCcEEEcccCccccc
Confidence 99999999999999754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=220.40 Aligned_cols=150 Identities=17% Similarity=0.179 Sum_probs=112.2
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHH---HHHhhcCCCCCeeeee-------EE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELRE---VTGLTKCRHENIVQLK-------EV 138 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e---~~~l~~l~h~niv~~~-------~~ 138 (224)
..+|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+| +..|+. .||||++++ ++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence 4569999999999999999999999999999999976442 223344556 455555 799988754 44
Q ss_pred EEcCCc---------------ceEEEEEecccCChhHhhhhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCceecC
Q psy13250 139 VVGKSL---------------SSIFLVMEYCEHDLASLQDNVESPFTESQV------KCVILQVLKGLNYLHSNFIIHRD 197 (224)
Q Consensus 139 ~~~~~~---------------~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~------~~~~~~i~~~l~~lH~~~iiHrD 197 (224)
+..... ..+|+|||||+++|..++......+.+... ..++.|++.||.|||++||+|||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 432221 458999999998888877764444555555 67779999999999999999999
Q ss_pred CCCCcEEEccCCcEEEEeccccccc
Q psy13250 198 LKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 198 lkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+|||++.+|.+||+|||+|+..
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~ 244 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKV 244 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEET
T ss_pred CCHHHEEECCCCCEEEEecceeeec
Confidence 9999999999999999999999754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.9e-31 Score=209.94 Aligned_cols=148 Identities=28% Similarity=0.463 Sum_probs=129.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|++.+.||+|+||.||+|.+..++..+|+|++.... ......+.+|+.+++.++||||+++++++.. .+..
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 89 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD--RKRI 89 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc--CCEE
Confidence 4578999999999999999999999999999999986432 2234567789999999999999999999954 4589
Q ss_pred EEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 148 FLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
|+||||+.+ ++...+.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQK-HGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 999999986 55555544 45699999999999999999999999999999999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-31 Score=209.47 Aligned_cols=148 Identities=26% Similarity=0.414 Sum_probs=128.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|++.+.||+|+||.||+|.+..+++.+|+|++..... .....+.+|+.+++.++||||+++++++.. .+..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv 83 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLF 83 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc--CCEEEEE
Confidence 4679999999999999999999999999999999875433 234566789999999999999999999854 4588999
Q ss_pred EecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+++ ++...+ .....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+
T Consensus 84 ~e~~~~~~L~~~l-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 84 LEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp EECCTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 999986 454444 33557999999999999999999999999999999999999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=209.70 Aligned_cols=149 Identities=23% Similarity=0.322 Sum_probs=121.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccC---CeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQ---DKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++.+.||+|+||.||+|.+..+ +..+|+|.+..... ...+.+.+|+..++.++||||+++++++. . +.
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~-~~ 89 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--E-NP 89 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--S-SS
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc--c-Cc
Confidence 456899999999999999999998643 56799998764332 23456778999999999999999999983 2 36
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.|+||||+.+ ++..++......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 8999999986 566666655557999999999999999999999999999999999999999999999999999754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=216.00 Aligned_cols=152 Identities=20% Similarity=0.262 Sum_probs=116.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCe---EEEEEEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDK---ILALKKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~---~~avK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
..++|++.+.||+|+||.||+|.+..++. .||+|++.... ....+.+.+|+.+++.++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 45679999999999999999999876664 79999886542 23456678999999999999999999998654321
Q ss_pred ----eEEEEEecccC-ChhHhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEe
Q psy13250 146 ----SIFLVMEYCEH-DLASLQDNV-----ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVY 215 (224)
Q Consensus 146 ----~~~lv~e~~~~-~l~~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~D 215 (224)
..|+||||+.+ ++..++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEee
Confidence 24899999987 455544322 12589999999999999999999999999999999999999999999999
Q ss_pred ccccccc
Q psy13250 216 STYLELY 222 (224)
Q Consensus 216 fGla~~~ 222 (224)
||+|+.+
T Consensus 181 fg~a~~~ 187 (323)
T 3qup_A 181 FGLSRKI 187 (323)
T ss_dssp CCC----
T ss_pred ccccccc
Confidence 9999754
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-31 Score=215.49 Aligned_cols=149 Identities=28% Similarity=0.485 Sum_probs=130.1
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcC---CcceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGK---SLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~---~~~~~ 147 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++... .....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4679999999999999999999999999999999864332 2344567899999999999999999987532 12578
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||+.+++...+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 90 ~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999999887776654 46999999999999999999999999999999999999999999999999999754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.7e-31 Score=208.79 Aligned_cols=148 Identities=27% Similarity=0.319 Sum_probs=127.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.++|++.+.||+|+||.||+|.+..++..+|+|++..... .....+.+|+.++++++||||+++++++. .....|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ--EESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE--cCCEEEE
Confidence 4679999999999999999999999999999999875432 22345678999999999999999999995 4458899
Q ss_pred EEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc---EEEEeccccccc
Q psy13250 150 VMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC---VKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~---~kl~DfGla~~~ 222 (224)
||||+.++ +...+.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++. +||+|||+|...
T Consensus 83 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 83 VFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999874 4444443 466999999999999999999999999999999999999987665 999999999653
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=213.81 Aligned_cols=151 Identities=26% Similarity=0.332 Sum_probs=126.2
Q ss_pred ccccceeEeeeeeccCceEEEEEEEc-----cCCeEEEEEEeeccC-CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcC
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDS-----VQDKILALKKLFLQN-NTLTRGELREVTGLTKC-RHENIVQLKEVVVGK 142 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~~avK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~ 142 (224)
...++|++.+.||+|+||.||+|.+. .++..||+|++.... ......+.+|+.++.++ .||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-- 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT-- 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe--
Confidence 35578999999999999999999973 456789999986433 23456678999999999 8999999999994
Q ss_pred CcceEEEEEecccC-ChhHhhhhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy13250 143 SLSSIFLVMEYCEH-DLASLQDNVES----------------------PFTESQVKCVILQVLKGLNYLHSNFIIHRDLK 199 (224)
Q Consensus 143 ~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlk 199 (224)
..+..|+||||+++ ++..++..... .+++..+..++.|++.||.|||++||+|||||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 44579999999976 66666654332 37899999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEEeccccccc
Q psy13250 200 PSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 200 p~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+|||++.++.+||+|||+|+.+
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~ 222 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDI 222 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCG
T ss_pred hhhEEEcCCCcEEeCCCccCccc
Confidence 99999999999999999999754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=207.89 Aligned_cols=149 Identities=26% Similarity=0.408 Sum_probs=129.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... ......+.+|+..++.++||||+++++++.. .+..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~ 86 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST--PTDF 86 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCeE
Confidence 4578999999999999999999999999999999986432 2234567789999999999999999999854 4589
Q ss_pred EEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||+.+ ++...+.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++..
T Consensus 87 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 999999976 56555544 456999999999999999999999999999999999999999999999999999754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=205.28 Aligned_cols=148 Identities=24% Similarity=0.337 Sum_probs=129.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||.||+|.+. ++..+|+|.+..... ..+.+.+|+..++.++||||+++++++. ..+..|+|
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 81 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL--EQAPICLV 81 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSSCEEE
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCCeEEE
Confidence 4568999999999999999999986 677899999865432 3456789999999999999999999994 44578999
Q ss_pred EecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+++ ++..++......+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 154 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGB
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccc
Confidence 999975 566666665567999999999999999999999999999999999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=212.65 Aligned_cols=149 Identities=20% Similarity=0.321 Sum_probs=126.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc---cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT---LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+..++.++||||+++++++.. .+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~ 109 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI--DGQL 109 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee--CCeE
Confidence 457899999999999999999999999999999998644221 23556789999999999999999999854 4589
Q ss_pred EEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||+++ ++..++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 999999987 55555544 467999999999999999999999999999999999999999999999999998653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=212.02 Aligned_cols=146 Identities=27% Similarity=0.332 Sum_probs=123.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--------ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--------TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 87 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-- 87 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--
Confidence 579999999999999999999999999999998864321 2234567899999999999999999998532
Q ss_pred ceEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc---EEEEeccccc
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC---VKIVYSTYLE 220 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~---~kl~DfGla~ 220 (224)
..|+||||+.+ ++...+. ....+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++
T Consensus 88 -~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 165 (322)
T 2ycf_A 88 -DYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165 (322)
T ss_dssp -SEEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred -ceEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence 48999999986 4555443 3567999999999999999999999999999999999999987665 9999999997
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
.+
T Consensus 166 ~~ 167 (322)
T 2ycf_A 166 IL 167 (322)
T ss_dssp EC
T ss_pred ec
Confidence 54
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-31 Score=218.25 Aligned_cols=148 Identities=28% Similarity=0.450 Sum_probs=129.4
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
..++|++.+.||+|+||.||+|.+..++..+|+|++..... .....+.+|+.+++.++||||+++++++.. .+..|+
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~l 108 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISI 108 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE--TTEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE--CCEEEE
Confidence 45689999999999999999999999999999999875432 234567799999999999999999999964 458999
Q ss_pred EEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 150 VMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN-FIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||||+++ ++..++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 109 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp EECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 9999986 55555544 45799999999999999999999986 999999999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.2e-31 Score=210.27 Aligned_cols=150 Identities=29% Similarity=0.461 Sum_probs=130.5
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcC---------
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGK--------- 142 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------- 142 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457999999999999999999999999999999886432 2345677899999999999999999988642
Q ss_pred --CcceEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccc
Q psy13250 143 --SLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYL 219 (224)
Q Consensus 143 --~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla 219 (224)
.....|+||||+++ ++..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 163 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA 163 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcch
Confidence 24578999999976 677676655556889999999999999999999999999999999999999999999999999
Q ss_pred ccc
Q psy13250 220 ELY 222 (224)
Q Consensus 220 ~~~ 222 (224)
+.+
T Consensus 164 ~~~ 166 (303)
T 1zy4_A 164 KNV 166 (303)
T ss_dssp SCT
T ss_pred hhc
Confidence 754
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=208.77 Aligned_cols=149 Identities=28% Similarity=0.425 Sum_probs=126.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 148 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+|+..+..+ +||||+++++++.. .+..|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~--~~~~~ 87 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE--DDHML 87 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE--TTEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec--CCeEE
Confidence 4679999999999999999999999999999999875422 3345667899999888 99999999999954 44899
Q ss_pred EEEecccC-ChhHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC----------------
Q psy13250 149 LVMEYCEH-DLASLQDNV---ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK---------------- 208 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~---------------- 208 (224)
+||||+++ ++..++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 99999976 666655442 2569999999999999999999999999999999999999854
Q ss_pred ---CcEEEEeccccccc
Q psy13250 209 ---GCVKIVYSTYLELY 222 (224)
Q Consensus 209 ---~~~kl~DfGla~~~ 222 (224)
..+||+|||+++..
T Consensus 168 ~~~~~~kl~Dfg~~~~~ 184 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRI 184 (289)
T ss_dssp --CCCEEECCCTTCEET
T ss_pred CCceEEEEccccccccc
Confidence 47999999998754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=207.53 Aligned_cols=147 Identities=27% Similarity=0.414 Sum_probs=127.6
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc------cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT------LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
++|++.+.||+|+||.||+|.+..+++.+|+|.+...... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~ 82 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN--KTD 82 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC--CCe
Confidence 4699999999999999999999999999999998754321 24557789999999999999999999954 458
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC----cEEEEecccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG----CVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~----~~kl~DfGla~~ 221 (224)
.|+||||+.+ ++..++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++ .+||+|||+++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999975 55555543 45799999999999999999999999999999999999999877 899999999975
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
+
T Consensus 162 ~ 162 (283)
T 3bhy_A 162 I 162 (283)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=207.79 Aligned_cols=147 Identities=26% Similarity=0.341 Sum_probs=127.2
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCcc-------chhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTL-------TRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.+++.++||||+++++++. ..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~ 95 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH--NP 95 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET--TT
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec--CC
Confidence 467999999999999999999999999999999986543322 156778999999999999999999984 32
Q ss_pred ceEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEccCCc-----EEEEec
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF--IIHRDLKPSNLLLNDKGC-----VKIVYS 216 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--iiHrDlkp~Nill~~~~~-----~kl~Df 216 (224)
.++||||+.+ ++...+......+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+||
T Consensus 96 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 --PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp --TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred --CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 2799999984 666666666668999999999999999999999999 999999999999988876 999999
Q ss_pred cccccc
Q psy13250 217 TYLELY 222 (224)
Q Consensus 217 Gla~~~ 222 (224)
|+|+..
T Consensus 174 g~~~~~ 179 (287)
T 4f0f_A 174 GLSQQS 179 (287)
T ss_dssp TTCBCC
T ss_pred Cccccc
Confidence 999743
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=217.83 Aligned_cols=146 Identities=29% Similarity=0.463 Sum_probs=122.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC----cceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKS----LSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~ 147 (224)
..+|++.+.||+|+||+||+|.+..++. +|+|++.... ....+|+.+++.++||||+++++++.... ...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 4579999999999999999999887665 8888775332 22236999999999999999999986422 2348
Q ss_pred EEEEecccCChhHhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-cCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQD---NVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLN-DKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~-~~~~~kl~DfGla~~~ 222 (224)
|+||||+++++..... .....+++..++.++.|++.||.|||++||+||||||+|||++ .++.+||+|||+|+.+
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 8999999987665433 2356799999999999999999999999999999999999999 7999999999999764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=213.20 Aligned_cols=150 Identities=22% Similarity=0.331 Sum_probs=125.4
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCC----eEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQD----KILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
...+|++.+.||+|+||.||+|.+..++ ..||+|.+..... .....+.+|+.+++.++||||+++++++ ...+
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~--~~~~ 119 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI--SKYK 119 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE--ecCC
Confidence 4567999999999999999999876543 4699999865432 2334567899999999999999999998 4456
Q ss_pred eEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..|+||||+.+ ++..++......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 89999999986 566666655577999999999999999999999999999999999999999999999999999754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=209.22 Aligned_cols=151 Identities=26% Similarity=0.269 Sum_probs=126.7
Q ss_pred cccceeEeeeeeccCceEEEEEEEccC---CeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQ---DKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
...+|++.+.||+|+||.||+|.+..+ ...+|+|.+..... ...+.+.+|+.++++++||||+++++++.. ..+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~ 101 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR-SEGS 101 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC-SSSC
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc-CCCc
Confidence 345799999999999999999986543 34689998764332 234567789999999999999999998753 3357
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.|+||||+.+ ++..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 8999999987 666666655667899999999999999999999999999999999999999999999999999754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-31 Score=209.49 Aligned_cols=149 Identities=21% Similarity=0.309 Sum_probs=130.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||.||+|.+..++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++. .....|+|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEc--cCCCEEEE
Confidence 5578999999999999999999999999999999986432 33456789999999999999999999984 45579999
Q ss_pred EecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ ++..++... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+|+..
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 999985 566665543 345899999999999999999999999999999999999999999999999999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=209.25 Aligned_cols=148 Identities=28% Similarity=0.384 Sum_probs=128.1
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---------ccchhHHHHHHHhhcCC-CCCeeeeeEEEEc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---------TLTRGELREVTGLTKCR-HENIVQLKEVVVG 141 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~ 141 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++++. ||||+++++++.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~- 94 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE- 94 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE-
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec-
Confidence 4679999999999999999999999999999999875431 12345578999999995 999999999994
Q ss_pred CCcceEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 142 KSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 142 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.....|+||||+++ ++..++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 95 -~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 95 -TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp -CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred -cCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 44589999999986 55555544 4679999999999999999999999999999999999999999999999999987
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
.+
T Consensus 173 ~~ 174 (298)
T 1phk_A 173 QL 174 (298)
T ss_dssp EC
T ss_pred hc
Confidence 53
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=207.15 Aligned_cols=153 Identities=26% Similarity=0.274 Sum_probs=129.5
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcC--Cc
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGK--SL 144 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--~~ 144 (224)
......|++.+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 3445669999999999999999999999999999998875432 2345567899999999999999999988542 34
Q ss_pred ceEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEc-cCCcEEEEeccccc
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF--IIHRDLKPSNLLLN-DKGCVKIVYSTYLE 220 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--iiHrDlkp~Nill~-~~~~~kl~DfGla~ 220 (224)
..+|+||||+++ ++..++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++ .++.+||+|||+|+
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred ceEEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 568999999976 45555543 467999999999999999999999999 99999999999998 78999999999996
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
..
T Consensus 181 ~~ 182 (290)
T 1t4h_A 181 LK 182 (290)
T ss_dssp GC
T ss_pred cc
Confidence 43
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-31 Score=214.72 Aligned_cols=147 Identities=24% Similarity=0.358 Sum_probs=126.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCC--CCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRH--ENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~ 146 (224)
..++|++.+.||+|+||.||++.+. ++..||+|++..... .....+.+|+.++..+.| +||+++++++.. ...
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~ 83 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQY 83 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--CCE
Confidence 3457999999999999999999875 688999999875432 223556789999999976 999999999954 458
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+|||+.++++..++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++ ++.+||+|||+|+.+
T Consensus 84 ~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 84 IYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EEEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 999999877777777665 56799999999999999999999999999999999999997 688999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-31 Score=221.01 Aligned_cols=148 Identities=32% Similarity=0.608 Sum_probs=119.6
Q ss_pred cceeE-eeeeeccCceEEEEEEEc--cCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEK-LNRIGEGSYGVVYRVRDS--VQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~-~~~lG~G~fg~V~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
+.|++ .++||+|+||+||+|.+. .++..||+|++... .....+.+|+.+|+.++||||+++++++.......+|+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 45776 457999999999999976 46889999988533 33456789999999999999999999997666678999
Q ss_pred EEecccCChhHhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE----ccCCcEEEEecc
Q psy13250 150 VMEYCEHDLASLQDNV--------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL----NDKGCVKIVYST 217 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~--------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill----~~~~~~kl~DfG 217 (224)
||||+++++...+... ...+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 98 v~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 177 (405)
T 3rgf_A 98 LFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177 (405)
T ss_dssp EEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred EEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence 9999999877765422 1248999999999999999999999999999999999999 678899999999
Q ss_pred ccccc
Q psy13250 218 YLELY 222 (224)
Q Consensus 218 la~~~ 222 (224)
+|+.+
T Consensus 178 ~a~~~ 182 (405)
T 3rgf_A 178 FARLF 182 (405)
T ss_dssp CCC--
T ss_pred Cceec
Confidence 99754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=220.99 Aligned_cols=149 Identities=19% Similarity=0.297 Sum_probs=127.9
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
....++|++.+.||+|+||.||+|.+. .+..||||++.... ...+.+.+|+.+|+.++||||+++++++. ...+|
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~---~~~~~ 258 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT---KEPIY 258 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCE
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe---CCccE
Confidence 345678999999999999999999986 46789999986543 34567889999999999999999999984 34689
Q ss_pred EEEecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+.+ ++..++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 334 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVI 334 (454)
T ss_dssp EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence 99999976 566665433 236889999999999999999999999999999999999999999999999999865
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=216.46 Aligned_cols=149 Identities=30% Similarity=0.381 Sum_probs=124.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc-----CCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ-----NNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
.++|++.+.||+|+||.||+|.+..++..+|+|++... .......+.+|+.+++.++||||+++++++.. .+.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~ 102 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED--EQY 102 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC--SSE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc--CCe
Confidence 35799999999999999999999999999999998643 12334567889999999999999999999954 458
Q ss_pred EEEEEecccC-ChhHhhhhc---------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q psy13250 147 IFLVMEYCEH-DLASLQDNV---------------------------------------ESPFTESQVKCVILQVLKGLN 186 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~---------------------------------------~~~l~~~~~~~~~~~i~~~l~ 186 (224)
.|+||||+++ ++...+... ...+++..+..++.|++.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 9999999976 454444210 112467788899999999999
Q ss_pred HHHhCCceecCCCCCcEEEccCC--cEEEEeccccccc
Q psy13250 187 YLHSNFIIHRDLKPSNLLLNDKG--CVKIVYSTYLELY 222 (224)
Q Consensus 187 ~lH~~~iiHrDlkp~Nill~~~~--~~kl~DfGla~~~ 222 (224)
|||+++|+||||||+|||++.++ .+||+|||+|+.+
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~ 220 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEF 220 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEG
T ss_pred HHHHCCccccCCChhhEEEecCCCceEEEeeccccccc
Confidence 99999999999999999998776 8999999999754
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9e-31 Score=216.79 Aligned_cols=147 Identities=31% Similarity=0.494 Sum_probs=125.6
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc----e
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS----S 146 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----~ 146 (224)
++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++...... .
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 579999999999999999999999999999999864322 2345667899999999999999999999543321 2
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.|+||||+.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 122 ~~lv~e~~~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 122 FYLVMPFMQTDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CEEEEECCCEEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred EEEEEccccccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 4999999998776655 345999999999999999999999999999999999999999999999999999743
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=210.04 Aligned_cols=154 Identities=19% Similarity=0.231 Sum_probs=122.4
Q ss_pred cccccceeEeeeeeccCceEEEEEEEcc---CCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSV---QDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKS 143 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~---~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (224)
....++|.+.+.||+|+||.||+|.... ++..||+|.+..... .....+.+|+..+++++||||+++++++....
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 3455789999999999999999998764 556899999865432 22355778999999999999999999986543
Q ss_pred cc---eEEEEEecccC-ChhHhhh-----hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEE
Q psy13250 144 LS---SIFLVMEYCEH-DLASLQD-----NVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214 (224)
Q Consensus 144 ~~---~~~lv~e~~~~-~l~~~~~-----~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~ 214 (224)
.. ..|+||||+.+ ++..++. .....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence 22 46999999986 4555542 223569999999999999999999999999999999999999999999999
Q ss_pred eccccccc
Q psy13250 215 YSTYLELY 222 (224)
Q Consensus 215 DfGla~~~ 222 (224)
|||+++.+
T Consensus 190 Dfg~~~~~ 197 (313)
T 3brb_A 190 DFGLSKKI 197 (313)
T ss_dssp SCSCC---
T ss_pred ecCcceec
Confidence 99999754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=210.24 Aligned_cols=150 Identities=25% Similarity=0.284 Sum_probs=127.9
Q ss_pred cccceeEeeeeeccCceEEEEEEE-----ccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRD-----SVQDKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (224)
..++|++.+.||+|+||.||+|.+ ..++..||+|++..... ...+.+.+|+.+++++ +||||+++++++. .
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--~ 98 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT--I 98 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--S
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe--c
Confidence 456899999999999999999985 35678999999875433 2345677899999999 9999999999994 4
Q ss_pred cceEEEEEecccC-ChhHhhhhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy13250 144 LSSIFLVMEYCEH-DLASLQDNVES-----------------PFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL 205 (224)
Q Consensus 144 ~~~~~lv~e~~~~-~l~~~~~~~~~-----------------~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill 205 (224)
.+..|+||||+.+ ++..++..... .+++..+..++.|++.||.|||+++|+||||||+||++
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 4578999999976 56666554332 48999999999999999999999999999999999999
Q ss_pred ccCCcEEEEeccccccc
Q psy13250 206 NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 206 ~~~~~~kl~DfGla~~~ 222 (224)
+.++.+||+|||+|+.+
T Consensus 179 ~~~~~~kl~Dfg~~~~~ 195 (313)
T 1t46_A 179 THGRITKICDFGLARDI 195 (313)
T ss_dssp ETTTEEEECCCGGGSCT
T ss_pred cCCCCEEEccccccccc
Confidence 99999999999999754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=211.77 Aligned_cols=150 Identities=21% Similarity=0.298 Sum_probs=125.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEc-------cCCeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS-------VQDKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVG 141 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~-------~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 141 (224)
..++|++.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~- 111 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT- 111 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc-
Confidence 4578999999999999999999975 3567899999865432 2345567899999999 8999999999994
Q ss_pred CCcceEEEEEecccC-ChhHhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy13250 142 KSLSSIFLVMEYCEH-DLASLQDNVE---------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL 205 (224)
Q Consensus 142 ~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill 205 (224)
..+.+|+||||+.+ ++..++.... ..+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 112 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 112 -QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp -SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred -cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 45588999999986 5666555432 248999999999999999999999999999999999999
Q ss_pred ccCCcEEEEeccccccc
Q psy13250 206 NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 206 ~~~~~~kl~DfGla~~~ 222 (224)
+.++.+||+|||+|+.+
T Consensus 191 ~~~~~~kL~Dfg~~~~~ 207 (334)
T 2pvf_A 191 TENNVMKIADFGLARDI 207 (334)
T ss_dssp CTTCCEEECCCTTCEEC
T ss_pred cCCCCEEEccccccccc
Confidence 99999999999999754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=206.84 Aligned_cols=147 Identities=29% Similarity=0.498 Sum_probs=127.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEc----------
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVG---------- 141 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---------- 141 (224)
..+|++.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 357999999999999999999999899999999986442 456789999999999999999998743
Q ss_pred ----CCcceEEEEEecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEe
Q psy13250 142 ----KSLSSIFLVMEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVY 215 (224)
Q Consensus 142 ----~~~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~D 215 (224)
.....+|+||||+++ ++..++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~D 165 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGD 165 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECC
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECc
Confidence 123468999999987 566665543 35699999999999999999999999999999999999999999999999
Q ss_pred ccccccc
Q psy13250 216 STYLELY 222 (224)
Q Consensus 216 fGla~~~ 222 (224)
||+++.+
T Consensus 166 fg~~~~~ 172 (284)
T 2a19_B 166 FGLVTSL 172 (284)
T ss_dssp CTTCEES
T ss_pred chhheec
Confidence 9998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-31 Score=208.70 Aligned_cols=152 Identities=32% Similarity=0.469 Sum_probs=130.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
..++|++.+.||+|+||.||+|.+..+++.+|+|.+..... ...+.+.+|+..++.++||||+++++++.+.....+|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 35689999999999999999999999999999999875432 2345567899999999999999999988766667899
Q ss_pred EEEecccC-ChhHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEccCCcEEEEecccc
Q psy13250 149 LVMEYCEH-DLASLQDNV---ESPFTESQVKCVILQVLKGLNYLHSNF-----IIHRDLKPSNLLLNDKGCVKIVYSTYL 219 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~-----iiHrDlkp~Nill~~~~~~kl~DfGla 219 (224)
+||||+++ ++..++... ...+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 99999986 566655432 345999999999999999999999999 999999999999999999999999998
Q ss_pred ccc
Q psy13250 220 ELY 222 (224)
Q Consensus 220 ~~~ 222 (224)
+.+
T Consensus 164 ~~~ 166 (279)
T 2w5a_A 164 RIL 166 (279)
T ss_dssp HHC
T ss_pred eee
Confidence 753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=211.70 Aligned_cols=149 Identities=21% Similarity=0.324 Sum_probs=124.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEE----EEEEeeccC-CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKIL----ALKKLFLQN-NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~----avK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
..++|++.+.||+|+||.||+|.+..++..+ |+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--- 89 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 89 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS---
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC---
Confidence 3467999999999999999999998777654 666654332 23446678999999999999999999999643
Q ss_pred eEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..++++||+.+ ++...+......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 90 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 47889999875 566666666677999999999999999999999999999999999999999999999999999754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=210.55 Aligned_cols=150 Identities=22% Similarity=0.287 Sum_probs=126.7
Q ss_pred cccceeEeeeeeccCceEEEEEEEc-----cCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS-----VQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
..++|++.+.||+|+||.||+|.+. .++..||+|.+..... .....+.+|+.+++.++||||+++++++. ..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~ 100 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--QG 100 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC--SS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEc--cC
Confidence 4467999999999999999999876 3578899998864332 22345678999999999999999999984 44
Q ss_pred ceEEEEEecccC-ChhHhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEE
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNVE---------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~~---------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~ 214 (224)
...|+||||+.+ ++..++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence 578999999986 5665554321 457899999999999999999999999999999999999999999999
Q ss_pred eccccccc
Q psy13250 215 YSTYLELY 222 (224)
Q Consensus 215 DfGla~~~ 222 (224)
|||+++..
T Consensus 181 Dfg~~~~~ 188 (322)
T 1p4o_A 181 DFGMTRDI 188 (322)
T ss_dssp CTTCCCGG
T ss_pred cCcccccc
Confidence 99999754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=208.85 Aligned_cols=147 Identities=28% Similarity=0.508 Sum_probs=125.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++.+.||+|+||.||+|.+..++..||+|.+.... ....+.+|+.+++.++||||+++++++.. .+.+|+||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~ 103 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK--NTDLWIVM 103 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe--CCEEEEEe
Confidence 457999999999999999999999999999999986542 35667899999999999999999999864 34799999
Q ss_pred ecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+++ ++..++......+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++.+
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 175 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence 99987 566666545678999999999999999999999999999999999999999999999999999654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-30 Score=207.15 Aligned_cols=145 Identities=26% Similarity=0.342 Sum_probs=120.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhc--CCCCCeeeeeEEEEc--CCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTK--CRHENIVQLKEVVVG--KSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~--~~~~~ 146 (224)
..++|++.+.||+|+||+||+|.+ +++.||+|++... ......+|..++.. ++||||+++++++.. .....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 346899999999999999999987 6889999988543 23344556655555 799999999998653 23456
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEEccCCcEEEEecc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLH--------SNFIIHRDLKPSNLLLNDKGCVKIVYST 217 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--------~~~iiHrDlkp~Nill~~~~~~kl~DfG 217 (224)
+|+||||+.+ ++..++. ...+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||
T Consensus 81 ~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence 8999999986 5555553 356999999999999999999999 9999999999999999999999999999
Q ss_pred ccccc
Q psy13250 218 YLELY 222 (224)
Q Consensus 218 la~~~ 222 (224)
+|+.+
T Consensus 159 ~a~~~ 163 (301)
T 3q4u_A 159 LAVMH 163 (301)
T ss_dssp TCEEE
T ss_pred Ceeec
Confidence 99754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=207.46 Aligned_cols=146 Identities=30% Similarity=0.527 Sum_probs=128.1
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+.|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.+.||||+++++++... ...|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD--TKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEE
Confidence 469999999999999999999999999999999875543 3345678899999999999999999999643 4899999
Q ss_pred ecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||++++ +..++. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+
T Consensus 100 e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 100 EYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169 (303)
T ss_dssp ECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceec
Confidence 999874 444443 357999999999999999999999999999999999999999999999999999754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=216.90 Aligned_cols=146 Identities=24% Similarity=0.348 Sum_probs=124.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCC--CCCeeeeeEEEEcCCcceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCR--HENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~ 147 (224)
..+|++.+.||+|+||+||+|.+.. +..||||++..... .....+.+|+.+|..+. |+||+++++++.. .+.+
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~--~~~~ 131 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 131 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec--CCEE
Confidence 3469999999999999999999865 88999999875432 23456788999999986 5999999999854 3479
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+|||+..+++..++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++ ++.+||+|||+|+.+
T Consensus 132 ~lv~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEEEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 99999766777777665 45789999999999999999999999999999999999995 689999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=214.46 Aligned_cols=147 Identities=24% Similarity=0.397 Sum_probs=127.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc--------cchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--------LTRGELREVTGLTKC-RHENIVQLKEVVVGKS 143 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (224)
++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.++..+ .||||+.+++++..
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-- 171 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES-- 171 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB--
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee--
Confidence 5799999999999999999999989999999998754321 133456899999998 79999999999854
Q ss_pred cceEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 144 LSSIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 144 ~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
....|+||||+.++ +..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..+
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 45899999999874 5555443 457999999999999999999999999999999999999999999999999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=210.53 Aligned_cols=149 Identities=25% Similarity=0.354 Sum_probs=126.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEE--EEEEeeccC-CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKIL--ALKKLFLQN-NTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~--avK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++.+.||+|+||.||+|.+..++..+ |+|.+.... ....+.+.+|+.+++++ +||||+++++++.. .+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~ 100 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGY 100 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--TTE
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee--CCc
Confidence 4578999999999999999999998888765 899886432 23455678899999999 89999999999954 458
Q ss_pred EEEEEecccC-ChhHhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVE---------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC 210 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 210 (224)
+|+||||+++ ++..++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe
Confidence 9999999976 5666654432 36999999999999999999999999999999999999999999
Q ss_pred EEEEecccccc
Q psy13250 211 VKIVYSTYLEL 221 (224)
Q Consensus 211 ~kl~DfGla~~ 221 (224)
+||+|||+++.
T Consensus 181 ~kL~Dfg~~~~ 191 (327)
T 1fvr_A 181 AKIADFGLSRG 191 (327)
T ss_dssp EEECCTTCEES
T ss_pred EEEcccCcCcc
Confidence 99999999863
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=216.10 Aligned_cols=150 Identities=25% Similarity=0.258 Sum_probs=121.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccC---CeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQ---DKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
...|++.+.||+|+||+||+|.+... ...+|+|.+..... ...+.+.+|+.++++++||||+++++++... .+..
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~ 166 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSP 166 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC-SSCC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CCCe
Confidence 34688999999999999999987543 24689998764322 3345678999999999999999999987533 3478
Q ss_pred EEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||+.+ ++..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccc
Confidence 999999986 676666655567899999999999999999999999999999999999999999999999999754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-30 Score=206.69 Aligned_cols=142 Identities=15% Similarity=0.142 Sum_probs=121.8
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc---cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT---LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+..+..+.||||+++++++.. .+..|+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~--~~~~~l 108 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT--RAGGLV 108 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE--CCcEEE
Confidence 5799999999999999999999999999999998754322 23567889999999999999999999954 358999
Q ss_pred EEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccc
Q psy13250 150 VMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYL 219 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla 219 (224)
||||+++ ++..++.. + .....+..++.|++.||.|||++||+||||||+|||++.+|.+||+++|..
T Consensus 109 v~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc
Confidence 9999986 45555432 2 466678899999999999999999999999999999999999999988764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=214.05 Aligned_cols=151 Identities=25% Similarity=0.361 Sum_probs=118.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC-----cc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKS-----LS 145 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~ 145 (224)
..++|++.+.||+|+||.||+|.+..++..||+|++.... .....+.+++..+..++||||+++++++.... ..
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 4568999999999999999999999999999999885432 33456677888888899999999999986422 22
Q ss_pred eEEEEEecccCChhHhhh---hcCCCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEcc-CCcEEEEecccc
Q psy13250 146 SIFLVMEYCEHDLASLQD---NVESPFTESQVKCVILQVLKGLNYLH--SNFIIHRDLKPSNLLLND-KGCVKIVYSTYL 219 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH--~~~iiHrDlkp~Nill~~-~~~~kl~DfGla 219 (224)
.+|+||||+++++...+. .....+++..+..++.|++.||.||| ++||+||||||+|||++. ++.+||+|||+|
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 488999999988665443 24567899999999999999999999 999999999999999997 899999999999
Q ss_pred ccc
Q psy13250 220 ELY 222 (224)
Q Consensus 220 ~~~ 222 (224)
+.+
T Consensus 180 ~~~ 182 (360)
T 3e3p_A 180 KKL 182 (360)
T ss_dssp BCC
T ss_pred eec
Confidence 764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-30 Score=206.26 Aligned_cols=148 Identities=22% Similarity=0.233 Sum_probs=125.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++..+.|++++..+..+.. .....|+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~lv~ 84 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMVM 84 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecC-CCCceEEEE
Confidence 467999999999999999999999999999999865433 33457789999999999888877766643 345789999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---ccCCcEEEEeccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL---NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfGla~~~ 222 (224)
||+++++..++......+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999778888877666789999999999999999999999999999999999999 78999999999999754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=216.92 Aligned_cols=137 Identities=30% Similarity=0.400 Sum_probs=116.9
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC--------CCCeeeeeEEEEc--
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR--------HENIVQLKEVVVG-- 141 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~~-- 141 (224)
.++|++.+.||+|+||+||+|.+..+++.||+|++... ......+.+|+.+++.++ |+||+++++.+..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 35799999999999999999999999999999998633 223455678888888875 7889999998852
Q ss_pred CCcceEEEEEecccCChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEccCC
Q psy13250 142 KSLSSIFLVMEYCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSN-FIIHRDLKPSNLLLNDKG 209 (224)
Q Consensus 142 ~~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~-~iiHrDlkp~Nill~~~~ 209 (224)
.....+|+||||+++++...+.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 2445799999999988887766543 5699999999999999999999998 999999999999999776
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-30 Score=208.21 Aligned_cols=150 Identities=23% Similarity=0.397 Sum_probs=123.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
..++|++.+.||+|+||.||+|.+..++..+|+|++..... .....+.+|+..++.++||||+++++++... +..
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~ 107 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED--NEL 107 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET--TEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC--CcE
Confidence 35679999999999999999999999999999999875322 2345567899999999999999999999643 489
Q ss_pred EEEEecccC-ChhHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEH-DLASLQDN---VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||+.+ ++..++.. ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.+
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999987 55555432 3556899999999999999999999999999999999999999999999999998754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-30 Score=207.35 Aligned_cols=152 Identities=32% Similarity=0.570 Sum_probs=127.8
Q ss_pred cccceeEeeeeeccCceEEEEEEEc-cCCeEEEEEEeeccCC--ccchhHHHHHHHhhcC---CCCCeeeeeEEEEc---
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS-VQDKILALKKLFLQNN--TLTRGELREVTGLTKC---RHENIVQLKEVVVG--- 141 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~--- 141 (224)
..++|++.+.||+|+||.||+|.+. .+++.||+|++..... .......+|+.+++.+ .||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4468999999999999999999995 6789999998865432 2234556777766655 89999999998852
Q ss_pred CCcceEEEEEecccCChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 142 KSLSSIFLVMEYCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 142 ~~~~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
......|+||||+++++..++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 2445789999999988887776543 359999999999999999999999999999999999999999999999999997
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
.+
T Consensus 169 ~~ 170 (326)
T 1blx_A 169 IY 170 (326)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-30 Score=225.23 Aligned_cols=148 Identities=23% Similarity=0.262 Sum_probs=125.9
Q ss_pred ccceeEee-eeeccCceEEEEEEEc--cCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 72 VAEFEKLN-RIGEGSYGVVYRVRDS--VQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~-~lG~G~fg~V~~~~~~--~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
.+++.+.+ .||+|+||.||+|.+. .++..||||++..... ...+.+.+|+.+|+.++||||+++++++.. +.+
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~---~~~ 410 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 410 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES---SSE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc---CCe
Confidence 34566666 8999999999999875 3456799999875432 345677899999999999999999999853 358
Q ss_pred EEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+|||||.++ +..++......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 9999999864 65566555667999999999999999999999999999999999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=209.54 Aligned_cols=146 Identities=27% Similarity=0.361 Sum_probs=125.0
Q ss_pred eeEeeeeeccCceEEEEEEE----ccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVRD----SVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~----~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
|++++.||+|+||+||++.. ..+++.||+|++..... .....+.+|+.+++.++||||+++++++.......+|+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 59999999999999988754 45789999999875433 23455788999999999999999999997765678999
Q ss_pred EEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+++ ++..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 113 v~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999986 55555543 34999999999999999999999999999999999999999999999999999754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=218.13 Aligned_cols=147 Identities=27% Similarity=0.360 Sum_probs=125.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC------CCCCeeeeeEEEEcCCcc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC------RHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~ 145 (224)
..+|++.+.||+|+||+||+|.+..+++.||+|++.... .......+|+.++..+ .|+||+.+++.+.. ..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--TT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--CC
Confidence 457999999999999999999999999999999986432 2234455666666554 67899999999954 35
Q ss_pred eEEEEEecccCChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc--EEEEecccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC--VKIVYSTYLEL 221 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfGla~~ 221 (224)
.+|+||||+.+++..++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++. +||+|||+|+.
T Consensus 173 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 173 HICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred eEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 899999999988888776543 45999999999999999999999999999999999999999987 99999999964
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=213.59 Aligned_cols=150 Identities=23% Similarity=0.288 Sum_probs=120.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEcc---CCeEEEEEEeeccCCc-----------cchhHHHHHHHhhcCCCCCeeeeeE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSV---QDKILALKKLFLQNNT-----------LTRGELREVTGLTKCRHENIVQLKE 137 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~---~~~~~avK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~~~~ 137 (224)
.++|++.+.||+|+||.||+|.+.. ++..+|+|++...... ....+.+|+..+..+.||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4579999999999999999999986 7889999988754321 1233557788889999999999999
Q ss_pred EEEcC--CcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC--cEEE
Q psy13250 138 VVVGK--SLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG--CVKI 213 (224)
Q Consensus 138 ~~~~~--~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~--~~kl 213 (224)
++... .....|+||||+++++..++.. .+.+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERLGIDLQKISGQ-NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECEEEEHHHHCBG-GGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEeccCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 98652 2468999999996566666554 34799999999999999999999999999999999999999887 9999
Q ss_pred Eeccccccc
Q psy13250 214 VYSTYLELY 222 (224)
Q Consensus 214 ~DfGla~~~ 222 (224)
+|||+|+.+
T Consensus 195 ~Dfg~a~~~ 203 (345)
T 2v62_A 195 ADYGLSYRY 203 (345)
T ss_dssp CCCTTCEES
T ss_pred EeCCCceec
Confidence 999999754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-30 Score=206.46 Aligned_cols=149 Identities=24% Similarity=0.269 Sum_probs=125.2
Q ss_pred cceeEeeeeeccCceEEEEEEEccCC---eEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQD---KILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~---~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
-.|.+.+.||+|+||+||+|.+..++ ..+|+|.+..... ...+.+.+|+.+++.++||||+++++++.... ...+
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 99 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE-GLPH 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS-SCCE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC-CCcE
Confidence 35788899999999999999975544 3799998864333 23456778999999999999999999985433 3458
Q ss_pred EEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
++|||+.+ ++...+......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 99999965 666666665677999999999999999999999999999999999999999999999999999743
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.8e-30 Score=204.80 Aligned_cols=147 Identities=24% Similarity=0.332 Sum_probs=125.2
Q ss_pred cccceeEe-eeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHh-hcCCCCCeeeeeEEEEc--CCcce
Q psy13250 71 NVAEFEKL-NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGL-TKCRHENIVQLKEVVVG--KSLSS 146 (224)
Q Consensus 71 ~~~~~~~~-~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~--~~~~~ 146 (224)
..++|.+. +.||+|+||.||+|.+..+++.||+|++.. .....+|+..+ +...||||+++++++.. .....
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 45678888 779999999999999999999999999852 34566788777 56799999999998853 23557
Q ss_pred EEEEEecccC-ChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc---CCcEEEEecccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND---KGCVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~---~~~~kl~DfGla~~ 221 (224)
+|+||||+.+ ++...+.... ..+++..+..++.|++.||.|||+++|+||||||+|||++. ++.+||+|||+|+.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 8999999986 6666665542 36999999999999999999999999999999999999998 78899999999976
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
.
T Consensus 170 ~ 170 (299)
T 3m2w_A 170 T 170 (299)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=210.32 Aligned_cols=151 Identities=25% Similarity=0.352 Sum_probs=126.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEc-----cCCeEEEEEEeeccCCc-cchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS-----VQDKILALKKLFLQNNT-LTRGELREVTGLTKC-RHENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (224)
..++|++.+.||+|+||.||+|.+. .+++.||+|++...... ..+.+.+|+.++..+ +||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 4578999999999999999999853 46789999998654332 334567899999998 799999999998543
Q ss_pred cceEEEEEecccC-ChhHhhhhcCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc
Q psy13250 144 LSSIFLVMEYCEH-DLASLQDNVES---------------PFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND 207 (224)
Q Consensus 144 ~~~~~lv~e~~~~-~l~~~~~~~~~---------------~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~ 207 (224)
...+|+||||+.+ ++..++..... .+++..+..++.|++.||.|||+++|+||||||+||+++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 3468999999986 56665554322 2889999999999999999999999999999999999999
Q ss_pred CCcEEEEeccccccc
Q psy13250 208 KGCVKIVYSTYLELY 222 (224)
Q Consensus 208 ~~~~kl~DfGla~~~ 222 (224)
++.+||+|||+|+.+
T Consensus 184 ~~~~kl~Dfg~~~~~ 198 (316)
T 2xir_A 184 KNVVKICDFGLARDI 198 (316)
T ss_dssp GGCEEECCCGGGSCT
T ss_pred CCCEEECCCcccccc
Confidence 999999999999754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-31 Score=210.96 Aligned_cols=150 Identities=29% Similarity=0.461 Sum_probs=113.4
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
..++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+..+..++||||+++++++... +..|+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~l 90 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK--DELWL 90 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS--SCEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec--CCcEE
Confidence 45789999999999999999999988899999998864432 3345667899999999999999999999544 47999
Q ss_pred EEecccC-ChhHhhhh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 150 VMEYCEH-DLASLQDN-------VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~-------~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
||||+.+ ++..++.. ....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999976 55555442 245689999999999999999999999999999999999999999999999999865
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
+
T Consensus 171 ~ 171 (303)
T 2vwi_A 171 L 171 (303)
T ss_dssp C
T ss_pred e
Confidence 3
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-30 Score=205.92 Aligned_cols=148 Identities=24% Similarity=0.286 Sum_probs=124.1
Q ss_pred cccceeEee-eeeccCceEEEEEEE--ccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 71 NVAEFEKLN-RIGEGSYGVVYRVRD--SVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 71 ~~~~~~~~~-~lG~G~fg~V~~~~~--~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
..++|++.+ .||+|+||.||+|.+ ..++..+|+|++..... ...+.+.+|+.+++.++||||+++++++. .+
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~ 90 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---AE 90 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE---SS
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC---CC
Confidence 346799998 999999999999954 55678999999865432 22456778999999999999999999983 23
Q ss_pred eEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..|+||||+.++ +..++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.+
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 689999999864 5555443 567999999999999999999999999999999999999999999999999999754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=212.93 Aligned_cols=147 Identities=31% Similarity=0.495 Sum_probs=126.6
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc----ce
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL----SS 146 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----~~ 146 (224)
++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++..... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 579999999999999999999999999999999864322 224566789999999999999999999854332 23
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.|+||||+.+++..... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 104 FYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred EEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 59999999987665543 35999999999999999999999999999999999999999999999999999753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-30 Score=210.97 Aligned_cols=150 Identities=23% Similarity=0.275 Sum_probs=127.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCC-----eEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQD-----KILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~-----~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (224)
..++|++.+.||+|+||.||+|.+..++ ..+|+|.+..... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~--~ 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT--H 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--S
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe--c
Confidence 4568999999999999999999987655 3799998865432 2345677899999999 8999999999994 4
Q ss_pred cceEEEEEecccC-ChhHhhhhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC
Q psy13250 144 LSSIFLVMEYCEH-DLASLQDNV-------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG 209 (224)
Q Consensus 144 ~~~~~lv~e~~~~-~l~~~~~~~-------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~ 209 (224)
.+.+|+||||+.+ ++..++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 4579999999986 566655432 34589999999999999999999999999999999999999999
Q ss_pred cEEEEeccccccc
Q psy13250 210 CVKIVYSTYLELY 222 (224)
Q Consensus 210 ~~kl~DfGla~~~ 222 (224)
.+||+|||+|+.+
T Consensus 202 ~~kl~Dfg~~~~~ 214 (333)
T 2i1m_A 202 VAKIGDFGLARDI 214 (333)
T ss_dssp EEEBCCCGGGCCG
T ss_pred eEEECcccccccc
Confidence 9999999999754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-30 Score=208.80 Aligned_cols=150 Identities=24% Similarity=0.377 Sum_probs=126.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHH-HhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVT-GLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+|+. .++.++||||+++++++.. .+..|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~--~~~~~ 97 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR--EGDCW 97 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC--SSEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe--CCceE
Confidence 45789999999999999999999999999999999875432 22334455655 6777899999999999954 45899
Q ss_pred EEEecccCChhHhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDN----VESPFTESQVKCVILQVLKGLNYLHSN-FIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+.+++..++.. ....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+++.+
T Consensus 98 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 98 ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 9999999877665542 256799999999999999999999999 9999999999999999999999999999754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-30 Score=205.78 Aligned_cols=149 Identities=28% Similarity=0.353 Sum_probs=126.1
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|.....||+|+||.||+|.+..++..||+|.+..........+.+|+.+++.++||||+++++++.. .+..++||
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~ 98 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE--NGFIKIFM 98 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe--CCcEEEEE
Confidence 4456666789999999999999999999999999876655556778899999999999999999999954 44899999
Q ss_pred ecccC-ChhHhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc-CCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNVE--SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND-KGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~-~~~~kl~DfGla~~~ 222 (224)
||+.+ ++..++.... ..+++..+..++.|++.||.|||++||+||||||+||+++. ++.+||+|||+++.+
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 99 EQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp ECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 99975 5655555432 24678999999999999999999999999999999999998 899999999999754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-30 Score=210.92 Aligned_cols=149 Identities=22% Similarity=0.402 Sum_probs=128.1
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCcc---c--------------hhHHHHHHHhhcCCCCCe
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTL---T--------------RGELREVTGLTKCRHENI 132 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~---~--------------~~~~~e~~~l~~l~h~ni 132 (224)
...++|++.+.||+|+||.||+|.+ ++..||+|++....... . ..+.+|+.+++.++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3457899999999999999999998 89999999987432211 1 667899999999999999
Q ss_pred eeeeEEEEcCCcceEEEEEecccC-ChhHh------hhhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcE
Q psy13250 133 VQLKEVVVGKSLSSIFLVMEYCEH-DLASL------QDNV-ESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNL 203 (224)
Q Consensus 133 v~~~~~~~~~~~~~~~lv~e~~~~-~l~~~------~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Ni 203 (224)
+++++++.. .+..|+||||+++ ++..+ +... ...+++..+..++.|++.||.|||+ +||+||||||+||
T Consensus 106 ~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 106 LTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp CCCSEEEES--SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred ceEEEEEee--CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999954 4589999999987 55554 3221 4679999999999999999999999 9999999999999
Q ss_pred EEccCCcEEEEeccccccc
Q psy13250 204 LLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 204 ll~~~~~~kl~DfGla~~~ 222 (224)
+++.++.+||+|||+++.+
T Consensus 184 l~~~~~~~kl~dfg~~~~~ 202 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYM 202 (348)
T ss_dssp EECTTSCEEECCCTTCEEC
T ss_pred EEcCCCcEEEecccccccc
Confidence 9999999999999999764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=225.60 Aligned_cols=145 Identities=24% Similarity=0.287 Sum_probs=121.9
Q ss_pred ceeEe-eeeeccCceEEEEEEE--ccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 74 EFEKL-NRIGEGSYGVVYRVRD--SVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 74 ~~~~~-~~lG~G~fg~V~~~~~--~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
.+.+. +.||+|+||.||+|.+ ..++..||||+++.... ...+.+.+|+.+|+.++||||+++++++.. ...|
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~---~~~~ 445 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWM 445 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCEE
Confidence 34443 4799999999999955 45668999999875432 234667899999999999999999999843 3589
Q ss_pred EEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||||.++ |..++ .....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 446 lv~E~~~~g~L~~~l-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 446 LVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp EEEECCTTEEHHHHH-HHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred EEEEccCCCCHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 999999875 55444 44667999999999999999999999999999999999999999999999999999754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-30 Score=206.76 Aligned_cols=151 Identities=28% Similarity=0.452 Sum_probs=129.7
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC----cc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKS----LS 145 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~----~~ 145 (224)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+..++++ .||||+++++++.... ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 4567999999999999999999999999999999986543 3345677899999988 7999999999997533 45
Q ss_pred eEEEEEecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+|+||||+++ ++..++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 79999999986 566665543 356899999999999999999999999999999999999999999999999998753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=203.51 Aligned_cols=148 Identities=22% Similarity=0.233 Sum_probs=128.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.+.|++++..+..+.. .....|+||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA-EGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEE-ETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccC-CCCceEEEE
Confidence 467999999999999999999999999999999886443 33567889999999999887776665543 345789999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---ccCCcEEEEeccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL---NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfGla~~~ 222 (224)
||+++++..++......+++..+..++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999777888777666789999999999999999999999999999999999999 48899999999999754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-30 Score=202.20 Aligned_cols=147 Identities=27% Similarity=0.344 Sum_probs=118.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC----ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN----TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++.+.||+|+||.||+|.+. +..+|+|++..... ...+.+.+|+.+++.++||||+++++++. ..+.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~ 80 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL--KEPN 80 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--CC--
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--cCCc
Confidence 4578999999999999999999975 88999998865432 22356678999999999999999999994 4457
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEEcc--------CCcEEEEe
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF---IIHRDLKPSNLLLND--------KGCVKIVY 215 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---iiHrDlkp~Nill~~--------~~~~kl~D 215 (224)
.|+||||++++.+..+.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 899999998654444333 457999999999999999999999999 899999999999986 77899999
Q ss_pred ccccccc
Q psy13250 216 STYLELY 222 (224)
Q Consensus 216 fGla~~~ 222 (224)
||+|+.+
T Consensus 160 fg~~~~~ 166 (271)
T 3dtc_A 160 FGLAREW 166 (271)
T ss_dssp CCC----
T ss_pred CCccccc
Confidence 9999753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.7e-30 Score=209.98 Aligned_cols=149 Identities=26% Similarity=0.382 Sum_probs=125.4
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
..++|++.+.||+|+||.||+|.+. ++..||+|++..... .....+.+|+.+++.++||||+++++++. .....|+
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~l 104 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM--TPTERLL 104 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC--CSSCCEE
T ss_pred HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe--cCCceEE
Confidence 4568999999999999999999854 688999999865433 23346789999999999999999999994 4457899
Q ss_pred EEecccC-ChhHhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDNV---ESPFTESQVKCVILQVLKGLNYLHSN---FIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+.+ ++...+... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 184 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence 9999986 555555442 23489999999999999999999999 9999999999999999999999999999754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-30 Score=218.32 Aligned_cols=148 Identities=24% Similarity=0.316 Sum_probs=126.0
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
...++|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.+|++++||||+++++++.. ..+|+
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~~i 255 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYI 255 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC---CceEE
Confidence 345789999999999999999999874 4679999986543 234567899999999999999999999843 46899
Q ss_pred EEecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+.+ +|..++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 330 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 330 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence 9999986 566665532 345899999999999999999999999999999999999999999999999999754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-30 Score=222.43 Aligned_cols=147 Identities=24% Similarity=0.324 Sum_probs=126.8
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+|++++|+||+++++++.. ..+|||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---~~~~lv 339 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 339 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee---ccceEe
Confidence 45679999999999999999999874 4679999986543 234567899999999999999999999843 468999
Q ss_pred EecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ +|..++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 340 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 413 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 413 (535)
T ss_dssp ECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred eehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence 999986 566665532 345899999999999999999999999999999999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=202.12 Aligned_cols=148 Identities=23% Similarity=0.353 Sum_probs=125.6
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
...++|++.+.||+|+||.||+|.+. .+..+|+|.+.... .....+.+|+.+++.++||||+++++++.. +..|+
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~~~ 84 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYI 84 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC---CCcEE
Confidence 34578999999999999999999976 56789999886443 234567899999999999999999998842 35899
Q ss_pred EEecccC-ChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+.+ ++..++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 9999975 5555554322 26899999999999999999999999999999999999999999999999999754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-30 Score=204.66 Aligned_cols=149 Identities=20% Similarity=0.256 Sum_probs=126.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEcc---CCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSV---QDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~---~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++.+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.. +.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 86 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE---EP 86 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS---SS
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC---CC
Confidence 45789999999999999999998653 345699998865432 234567789999999999999999999842 25
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.|+||||+.+ ++..++......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.+
T Consensus 87 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 87 TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 6899999985 566666665667999999999999999999999999999999999999999999999999999754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-30 Score=205.01 Aligned_cols=146 Identities=29% Similarity=0.374 Sum_probs=118.4
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
..++|++.+.||+|+||.||+|.+.. .+|+|++..... ...+.+.+|+.+++.++||||+.++++.. ....+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---~~~~~ 95 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST---APQLA 95 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC---SSSCE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc---CCccE
Confidence 45679999999999999999998543 489998865433 23356778999999999999999999762 23689
Q ss_pred EEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+.+ ++...+......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccc
Confidence 99999985 565666555667999999999999999999999999999999999999999999999999998743
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-30 Score=207.15 Aligned_cols=148 Identities=29% Similarity=0.384 Sum_probs=125.2
Q ss_pred cceeEe-eeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEE
Q psy13250 73 AEFEKL-NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 73 ~~~~~~-~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 148 (224)
+.|.+. +.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++..+. ||||+++++++. ....+|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~--~~~~~~ 105 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE--NTSEII 105 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE--CSSEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE--eCCeEE
Confidence 457777 889999999999999999999999999875332 23456778999999884 699999999994 455899
Q ss_pred EEEecccC-ChhHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc---CCcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDN-VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND---KGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~---~~~~kl~DfGla~~~ 222 (224)
+||||+.+ ++..++.. ....+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+.+
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~ 184 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence 99999987 45554433 2456999999999999999999999999999999999999998 789999999999754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-30 Score=217.40 Aligned_cols=148 Identities=20% Similarity=0.220 Sum_probs=125.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.++..+.|.+.+..+..+. ......||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~-~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFG-VEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEE-EETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEE-eeCCEEEEEE
Confidence 467999999999999999999999999999999876443 2345778999999998755444433332 2345789999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE---ccCCcEEEEeccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL---NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfGla~~~ 222 (224)
||+.++|..++......+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+|+.+
T Consensus 83 e~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 999878888887667789999999999999999999999999999999999999 68899999999999865
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-29 Score=202.16 Aligned_cols=149 Identities=23% Similarity=0.266 Sum_probs=126.5
Q ss_pred cccceeEee-eeeccCceEEEEEEEc--cCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLN-RIGEGSYGVVYRVRDS--VQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~-~lG~G~fg~V~~~~~~--~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..++|.+.+ .||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.+++.++||||+++++++.. +.
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~ 83 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EA 83 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SS
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC---CC
Confidence 345788887 9999999999999854 4678899999875432 234567789999999999999999999832 35
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.|+||||+.+ ++..++......+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.+
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 8999999986 566666555567999999999999999999999999999999999999999999999999999754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-29 Score=202.41 Aligned_cols=148 Identities=31% Similarity=0.461 Sum_probs=127.2
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++++++||||+++++++.. ....|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~l 98 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED--SSSFYI 98 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC--CCeEEE
Confidence 4679999999999999999999998999999999865432 334567899999999999999999999854 458999
Q ss_pred EEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC---CcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK---GCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~---~~~kl~DfGla~~~ 222 (224)
||||+.+ ++...+.. ...+++..+..++.|++.||.|||++||+||||||+||+++.+ +.+||+|||+++.+
T Consensus 99 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 99 VGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 9999976 45555443 3569999999999999999999999999999999999999764 46999999998754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=207.05 Aligned_cols=146 Identities=24% Similarity=0.332 Sum_probs=118.6
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHH--HHHHHhhcCCCCCeeeeeEEEE---cCCc
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL--REVTGLTKCRHENIVQLKEVVV---GKSL 144 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~--~e~~~l~~l~h~niv~~~~~~~---~~~~ 144 (224)
...++|++.+.||+|+||.||+|.. +++.||+|++.... ..... .|+..+..+.|+||+++++.+. ....
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 3567899999999999999999976 68999999986432 22233 3444455689999999987553 2334
Q ss_pred ceEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCcEEEccCCcEEEE
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN---------FIIHRDLKPSNLLLNDKGCVKIV 214 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---------~iiHrDlkp~Nill~~~~~~kl~ 214 (224)
..+|+||||+++ +|..++.. ...++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred ceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 467999999976 56666543 3458899999999999999999999 99999999999999999999999
Q ss_pred eccccccc
Q psy13250 215 YSTYLELY 222 (224)
Q Consensus 215 DfGla~~~ 222 (224)
|||+|+.+
T Consensus 163 DFG~a~~~ 170 (336)
T 3g2f_A 163 DFGLSMRL 170 (336)
T ss_dssp CCTTCEEC
T ss_pred eccceeec
Confidence 99999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=210.11 Aligned_cols=148 Identities=24% Similarity=0.356 Sum_probs=119.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC------ccchhHHHHHHHhhcC----CCCCeeeeeEEEEc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN------TLTRGELREVTGLTKC----RHENIVQLKEVVVG 141 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~~~~~~~~ 141 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+..+.++ +|+||+++++++.
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~- 108 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE- 108 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe-
Confidence 3579999999999999999999999999999999864432 1223445788888887 8999999999984
Q ss_pred CCcceEEEEEec-ccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-cCCcEEEEeccc
Q psy13250 142 KSLSSIFLVMEY-CEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLN-DKGCVKIVYSTY 218 (224)
Q Consensus 142 ~~~~~~~lv~e~-~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~-~~~~~kl~DfGl 218 (224)
..+..++|||+ +.+ ++..++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++ .++.+||+|||+
T Consensus 109 -~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 109 -TQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred -cCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 34578999999 554 56555544 45699999999999999999999999999999999999999 789999999999
Q ss_pred cccc
Q psy13250 219 LELY 222 (224)
Q Consensus 219 a~~~ 222 (224)
++.+
T Consensus 187 ~~~~ 190 (312)
T 2iwi_A 187 GALL 190 (312)
T ss_dssp CEEC
T ss_pred hhhc
Confidence 8754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-30 Score=206.10 Aligned_cols=150 Identities=25% Similarity=0.398 Sum_probs=118.4
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc-cchhHH-HHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGEL-REVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~-~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... ...... .+...++.++||||+++++++.. .+.+|
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~--~~~~~ 100 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT--NTDVF 100 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEE
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec--CCcEE
Confidence 457899999999999999999999999999999998754332 222333 34456778899999999999954 45899
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN-FIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+++.+..+.......+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|||+++.+
T Consensus 101 lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 101 IAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp EEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 9999996555555555567899999999999999999999995 9999999999999999999999999999654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-29 Score=200.11 Aligned_cols=149 Identities=15% Similarity=0.200 Sum_probs=128.2
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
..++|++.+.||+|+||.||+|.+. +..+|+|++..... ...+.+.+|+.+++.++||||+++++++........|
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 5678999999999999999999975 88899999875432 2345678899999999999999999999665456889
Q ss_pred EEEecccC-ChhHhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVES-PFTESQVKCVILQVLKGLNYLHSNF--IIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+||||+++ ++..++..... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++..
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999986 66666655333 5899999999999999999999999 99999999999999999999999988743
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-30 Score=211.28 Aligned_cols=145 Identities=17% Similarity=0.184 Sum_probs=123.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEccC--------CeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeee---------
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQ--------DKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ--------- 134 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~--------~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 134 (224)
.++|++.+.||+|+||.||+|.+..+ +..||+|++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 46899999999999999999999874 789999988633 45778999999999999987
Q ss_pred ------eeEEEEcCCcceEEEEEecccCChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc
Q psy13250 135 ------LKEVVVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND 207 (224)
Q Consensus 135 ------~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~ 207 (224)
+++++.. .....|+||||+.++|..++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 116 ~~~i~~~~~~~~~-~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 116 LLAIPTCMGFGVH-QDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDP 194 (352)
T ss_dssp TCSCCCCCEEEEE-TTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEET
T ss_pred ccCccchhhcccc-CCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcC
Confidence 5566543 24589999999966777776653 367999999999999999999999999999999999999999
Q ss_pred CC--cEEEEeccccccc
Q psy13250 208 KG--CVKIVYSTYLELY 222 (224)
Q Consensus 208 ~~--~~kl~DfGla~~~ 222 (224)
++ .+||+|||+|+.+
T Consensus 195 ~~~~~~kl~Dfg~a~~~ 211 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRY 211 (352)
T ss_dssp TEEEEEEECCGGGCBCS
T ss_pred CCCceEEEecCcceeec
Confidence 98 8999999999754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-30 Score=203.13 Aligned_cols=148 Identities=26% Similarity=0.354 Sum_probs=122.0
Q ss_pred ccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
...++|++.+.||+|+||.||++.+. +..+|+|++... ...+.+.+|+..++.++||||+++++++... .+..|+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~~l 92 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGLYI 92 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CCEE
T ss_pred CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CCceEE
Confidence 35678999999999999999999874 889999988643 3456678999999999999999999987533 347899
Q ss_pred EEecccC-ChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEH-DLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+++ ++..++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++..
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 9999986 5666554432 23889999999999999999999999999999999999999999999999998753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=224.50 Aligned_cols=141 Identities=16% Similarity=0.052 Sum_probs=109.1
Q ss_pred EeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC----------ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcc
Q psy13250 77 KLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN----------TLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 77 ~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~----------~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~ 145 (224)
.....+.|++|.+..++....|+.+|+|++..... ...+.+.+|+.+|+++ .|+||+++++++. +.+
T Consensus 238 w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e--d~~ 315 (569)
T 4azs_A 238 WQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE--NAQ 315 (569)
T ss_dssp EECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE--CSS
T ss_pred hhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE--ECC
Confidence 34457888888888888888899999999865321 1234577899999999 6999999999994 456
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+||||||++|+.+..+....+++++. .|+.||+.||+|+|++|||||||||+|||++.+|.+||+|||+|+.+
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 899999999986555444556778765 47899999999999999999999999999999999999999999864
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-29 Score=204.73 Aligned_cols=144 Identities=24% Similarity=0.383 Sum_probs=120.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhc--CCCCCeeeeeEEEEcCCc--ceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTK--CRHENIVQLKEVVVGKSL--SSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~--~~~ 147 (224)
.++|++.+.||+|+||.||+|.+. +..||+|++.... .....+|..++.. ++||||+++++++..... ..+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 467999999999999999999875 8999999885432 2333445554444 589999999999875432 579
Q ss_pred EEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEccCCcEEEEeccc
Q psy13250 148 FLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN--------FIIHRDLKPSNLLLNDKGCVKIVYSTY 218 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~--------~iiHrDlkp~Nill~~~~~~kl~DfGl 218 (224)
|+||||+.+ ++..++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 111 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 999999986 56666543 3699999999999999999999998 999999999999999999999999999
Q ss_pred cccc
Q psy13250 219 LELY 222 (224)
Q Consensus 219 a~~~ 222 (224)
|+.+
T Consensus 189 a~~~ 192 (337)
T 3mdy_A 189 AVKF 192 (337)
T ss_dssp CEEC
T ss_pred ceee
Confidence 9654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-29 Score=206.71 Aligned_cols=149 Identities=25% Similarity=0.271 Sum_probs=120.5
Q ss_pred cccceeEeeeeeccCceEEEEEE-----EccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVR-----DSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~-----~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
..++|++.+.||+|+||.||+|. +..++..||+|.+..... .....+.+|+.+++.++||||+++++++. ..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~ 105 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL--QS 105 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc--CC
Confidence 34679999999999999999998 556788999999864322 23456778999999999999999999994 44
Q ss_pred ceEEEEEecccC-ChhHhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC---CcEEEE
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNVE------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK---GCVKIV 214 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~~------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~---~~~kl~ 214 (224)
...|+||||+++ ++..++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.+ ..+||+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 578999999965 5666665432 348999999999999999999999999999999999999954 469999
Q ss_pred ecccccc
Q psy13250 215 YSTYLEL 221 (224)
Q Consensus 215 DfGla~~ 221 (224)
|||+++.
T Consensus 186 Dfg~~~~ 192 (327)
T 2yfx_A 186 DFGMARD 192 (327)
T ss_dssp CCHHHHH
T ss_pred ccccccc
Confidence 9999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=205.29 Aligned_cols=148 Identities=22% Similarity=0.303 Sum_probs=126.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc------cchhHHHHHHHhhcCC--CCCeeeeeEEEEcCC
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT------LTRGELREVTGLTKCR--HENIVQLKEVVVGKS 143 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~ 143 (224)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.+. |+||+++++++..
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~-- 119 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-- 119 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC--
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec--
Confidence 45799999999999999999999999999999998754321 2345567899999886 5999999999954
Q ss_pred cceEEEEEeccc--CChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-cCCcEEEEeccccc
Q psy13250 144 LSSIFLVMEYCE--HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLN-DKGCVKIVYSTYLE 220 (224)
Q Consensus 144 ~~~~~lv~e~~~--~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~-~~~~~kl~DfGla~ 220 (224)
.+..++|||++. +++..++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++ .++.+||+|||+++
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 458999999997 456665544 46799999999999999999999999999999999999999 78999999999997
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
.+
T Consensus 199 ~~ 200 (320)
T 3a99_A 199 LL 200 (320)
T ss_dssp EC
T ss_pred cc
Confidence 54
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=220.26 Aligned_cols=149 Identities=23% Similarity=0.319 Sum_probs=127.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccC---CeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQ---DKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
..++|++.+.||+|+||.||+|.+..+ +..+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+ +.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 464 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 464 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---SS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec---Cc
Confidence 456899999999999999999998643 56799998764332 234567889999999999999999999832 36
Q ss_pred EEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.|+||||+.+ ++..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 8999999985 566666655557999999999999999999999999999999999999999999999999999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=224.34 Aligned_cols=148 Identities=23% Similarity=0.328 Sum_probs=122.9
Q ss_pred ccceeEeeeeeccCceEEEEEEEcc-CCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc---ce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSV-QDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL---SS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~ 146 (224)
.++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.++..++||||+++++++..... ..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 3689999999999999999999976 789999998864332 233456789999999999999999999864332 12
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.||||||++++.+.... ...+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.+
T Consensus 159 ~~lv~E~~~g~~L~~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEECCCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eEEEEEeCCCCcHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 79999999875433322 2379999999999999999999999999999999999999875 8999999999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=204.19 Aligned_cols=147 Identities=24% Similarity=0.337 Sum_probs=123.9
Q ss_pred ccceeEeeeeeccCceEEEEEEE-ccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCC------CeeeeeEEEEcCCc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRD-SVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHE------NIVQLKEVVVGKSL 144 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~ 144 (224)
.++|++.+.||+|+||.||+|.+ ..++..||+|++.... .......+|+.+++.+.|+ +++++++++.. .
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~--~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH--H 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE--T
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc--C
Confidence 45799999999999999999998 5678999999885322 2345566788888777655 59999999854 4
Q ss_pred ceEEEEEecccCChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc----------------
Q psy13250 145 SSIFLVMEYCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND---------------- 207 (224)
Q Consensus 145 ~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~---------------- 207 (224)
+.+|+||||+++++...+.... ..+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 90 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 90 GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 5899999999888887776543 36899999999999999999999999999999999999987
Q ss_pred ---CCcEEEEecccccc
Q psy13250 208 ---KGCVKIVYSTYLEL 221 (224)
Q Consensus 208 ---~~~~kl~DfGla~~ 221 (224)
++.+||+|||+|+.
T Consensus 170 ~~~~~~~kl~Dfg~~~~ 186 (339)
T 1z57_A 170 TLINPDIKVVDFGSATY 186 (339)
T ss_dssp EESCCCEEECCCSSCEE
T ss_pred cccCCCceEeeCccccc
Confidence 66899999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=202.51 Aligned_cols=149 Identities=28% Similarity=0.358 Sum_probs=119.4
Q ss_pred cccceeEeeeeeccCceEEEEEEEcc-CC--eEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSV-QD--KILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~--~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
..++|++.+.||+|+||+||+|.+.. ++ ..||+|++.... ....+.+.+|+..++.++||||+++++++...
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 93 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-- 93 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC--
Confidence 34679999999999999999998643 22 368999886432 23345677899999999999999999998533
Q ss_pred ceEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..++||||+.+ ++...+......+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.+
T Consensus 94 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 94 -PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred -CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 47899999985 666666655567999999999999999999999999999999999999999999999999998754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=205.45 Aligned_cols=147 Identities=20% Similarity=0.332 Sum_probs=124.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCC-eEEEEEEeeccCCccchhHHHHHHHhhcCCCCC------eeeeeEEEEcCCc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQD-KILALKKLFLQNNTLTRGELREVTGLTKCRHEN------IVQLKEVVVGKSL 144 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~-~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~ 144 (224)
.++|++.+.||+|+||+||+|.+..++ ..||+|++.... .....+.+|+.+++.+.|++ ++.+++++.. .
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~--~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF--H 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE--T
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee--C
Confidence 467999999999999999999998776 789999985322 23445667888888876655 8888888844 4
Q ss_pred ceEEEEEecccCChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE------------------
Q psy13250 145 SSIFLVMEYCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL------------------ 205 (224)
Q Consensus 145 ~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill------------------ 205 (224)
+..|+||||+++++...+.... ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 95 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~ 174 (355)
T 2eu9_A 95 GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEK 174 (355)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEE
T ss_pred CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccccc
Confidence 5899999999888887766543 469999999999999999999999999999999999999
Q ss_pred -ccCCcEEEEecccccc
Q psy13250 206 -NDKGCVKIVYSTYLEL 221 (224)
Q Consensus 206 -~~~~~~kl~DfGla~~ 221 (224)
+.++.+||+|||+|+.
T Consensus 175 ~~~~~~~kl~Dfg~~~~ 191 (355)
T 2eu9_A 175 SVKNTSIRVADFGSATF 191 (355)
T ss_dssp EESCCCEEECCCTTCEE
T ss_pred ccCCCcEEEeecCcccc
Confidence 6688999999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-29 Score=200.80 Aligned_cols=144 Identities=28% Similarity=0.390 Sum_probs=121.1
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC----CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN----NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
|...+.||+|+||.||+|.. ++..+|+|++.... ....+.+.+|+.+++.++||||+++++++. ..+..|+|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv 108 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS--DGDDLCLV 108 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEe--cCCceEEE
Confidence 44558999999999999985 57889999886432 223456778999999999999999999994 44578999
Q ss_pred EecccC-ChhHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNV--ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+ ++...+... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+|+..
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 183 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccc
Confidence 999975 565555432 346999999999999999999999999999999999999999999999999998753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=201.10 Aligned_cols=144 Identities=33% Similarity=0.465 Sum_probs=118.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||.||++.+. +..+|+|++... ...+.+.+|+..+++++||||+++++++. + ..|+|
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~--~~~lv 77 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--N--PVCLV 77 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--T--TTEEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--C--CcEEE
Confidence 4568999999999999999999874 788999987532 33456789999999999999999999873 2 47899
Q ss_pred EecccC-ChhHhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCcEEEccCCc-EEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVES--PFTESQVKCVILQVLKGLNYLHS---NFIIHRDLKPSNLLLNDKGC-VKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~---~~iiHrDlkp~Nill~~~~~-~kl~DfGla~~~ 222 (224)
|||+++ ++..++..... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++. +||+|||+|+.+
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 999986 56555544322 37899999999999999999999 89999999999999999887 799999998643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-29 Score=206.91 Aligned_cols=149 Identities=28% Similarity=0.319 Sum_probs=124.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-CC-----CeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-HE-----NIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~ 144 (224)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... .......+|+.++..+. |+ +|+.+++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-- 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-- 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET--
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC--
Confidence 3578999999999999999999999999999999986322 22344556777776664 44 599999998543
Q ss_pred ceEEEEEecccCChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEc--cCCcEEEEecccc
Q psy13250 145 SSIFLVMEYCEHDLASLQDNVE-SPFTESQVKCVILQVLKGLNYLH--SNFIIHRDLKPSNLLLN--DKGCVKIVYSTYL 219 (224)
Q Consensus 145 ~~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH--~~~iiHrDlkp~Nill~--~~~~~kl~DfGla 219 (224)
+.+|+||||+++++..++.... ..+++..+..++.|++.||.||| ..||+||||||+|||++ .++.+||+|||+|
T Consensus 129 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 129 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 5899999999998888776643 56999999999999999999999 57999999999999995 4778999999999
Q ss_pred ccc
Q psy13250 220 ELY 222 (224)
Q Consensus 220 ~~~ 222 (224)
+.+
T Consensus 209 ~~~ 211 (382)
T 2vx3_A 209 CQL 211 (382)
T ss_dssp EET
T ss_pred eec
Confidence 754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=201.44 Aligned_cols=144 Identities=26% Similarity=0.318 Sum_probs=122.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhc--CCCCCeeeeeEEEEcCCc--ceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTK--CRHENIVQLKEVVVGKSL--SSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~--~~~ 147 (224)
.++|++.+.||+|+||.||+|.+ +++.||+|++... ....+.+|..++.. ++||||+++++++..... ..+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 35799999999999999999987 4899999988533 23456678887776 789999999999865432 278
Q ss_pred EEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEEccCCcEEEEeccc
Q psy13250 148 FLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLH--------SNFIIHRDLKPSNLLLNDKGCVKIVYSTY 218 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH--------~~~iiHrDlkp~Nill~~~~~~kl~DfGl 218 (224)
|+||||+.+ ++..++.. ..+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+
T Consensus 116 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 999999987 56666644 46899999999999999999999 89999999999999999999999999999
Q ss_pred cccc
Q psy13250 219 LELY 222 (224)
Q Consensus 219 a~~~ 222 (224)
|+.+
T Consensus 194 ~~~~ 197 (342)
T 1b6c_B 194 AVRH 197 (342)
T ss_dssp CEEE
T ss_pred ceec
Confidence 9654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-28 Score=199.05 Aligned_cols=146 Identities=23% Similarity=0.319 Sum_probs=118.4
Q ss_pred ccceeEee-eeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHH-HHhhcCCCCCeeeeeEEEEc--CCcceE
Q psy13250 72 VAEFEKLN-RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREV-TGLTKCRHENIVQLKEVVVG--KSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~-~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~~~~~~~~--~~~~~~ 147 (224)
.++|.+.+ .||+|+||.||+|.+..+++.||+|++... ....+|+ ..++.+.||||+++++++.. .....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 45799965 599999999999999999999999998532 1222333 34566799999999998853 224468
Q ss_pred EEEEecccC-ChhHhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc---CCcEEEEeccccccc
Q psy13250 148 FLVMEYCEH-DLASLQDNVE-SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND---KGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~---~~~~kl~DfGla~~~ 222 (224)
|+||||+.+ ++..++.... ..+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+..
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 999999987 5666665432 36999999999999999999999999999999999999986 455999999999753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-29 Score=210.92 Aligned_cols=144 Identities=22% Similarity=0.277 Sum_probs=119.7
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.+|.+.+.||+|+||+|+. ....+++.||||++.... .....+|+.+++.+ +||||+++++++.+ ....|+||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEEEE
Confidence 4699999999999999764 444678899999885432 23456899999998 79999999999854 45899999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc---C--CcEEEEeccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND---K--GCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~---~--~~~kl~DfGla~~~ 222 (224)
|||++++...+......+.+..+..++.|++.||.|||+++|+||||||+|||++. + ..+||+|||+|+.+
T Consensus 98 E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 98 ELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp ECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred ECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 99999888887766656666677899999999999999999999999999999953 2 35789999999754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=198.84 Aligned_cols=146 Identities=24% Similarity=0.355 Sum_probs=124.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCC--CCCeeeeeEEEEcCCcceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCR--HENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~ 147 (224)
.++|++.+.||+|+||.||+|.+. ++..+|+|++..... .....+.+|+..+.++. |+||+++++++.. ....
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~--~~~~ 103 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT--DQYI 103 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--SSEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--CCEE
Confidence 457999999999999999999885 588899999865432 23456678999999987 5999999999854 4589
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+|||+..+++..++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++ ++.+||+|||+++.+
T Consensus 104 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 104 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp EEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred EEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 99999777777777665 45789999999999999999999999999999999999996 589999999999754
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=202.18 Aligned_cols=145 Identities=23% Similarity=0.407 Sum_probs=121.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
..++|++.+.||+|+||.||+|.+.. .+|+|++..... ...+.+.+|+..++.++|+||+++++++.. ...+|
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~ 105 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS--PPHLA 105 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC--SSCEE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec--CCceE
Confidence 45689999999999999999998764 389998865432 334556789999999999999999999954 34799
Q ss_pred EEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++|||+.+ ++..++......+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||+|+.
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 99999986 56666655455799999999999999999999999999999999999998 78999999999764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.3e-29 Score=204.82 Aligned_cols=151 Identities=25% Similarity=0.320 Sum_probs=125.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-----------CCCeeeeeEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-----------HENIVQLKEVV 139 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~ 139 (224)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... .......+|+.+++.+. |+||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 3467999999999999999999999999999999986322 23345567888877765 89999999998
Q ss_pred EcC--CcceEEEEEecccCChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEcc------CC
Q psy13250 140 VGK--SLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSN-FIIHRDLKPSNLLLND------KG 209 (224)
Q Consensus 140 ~~~--~~~~~~lv~e~~~~~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~-~iiHrDlkp~Nill~~------~~ 209 (224)
... ....++++|||+++++..++... ...+++..+..++.|++.||.|||++ ||+||||||+|||++. .+
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred hccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 643 23378999999977787776653 34599999999999999999999998 9999999999999954 34
Q ss_pred cEEEEeccccccc
Q psy13250 210 CVKIVYSTYLELY 222 (224)
Q Consensus 210 ~~kl~DfGla~~~ 222 (224)
.+||+|||+|+.+
T Consensus 176 ~~kl~Dfg~a~~~ 188 (373)
T 1q8y_A 176 QIKIADLGNACWY 188 (373)
T ss_dssp EEEECCCTTCEET
T ss_pred eEEEccccccccc
Confidence 7999999999754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-28 Score=203.99 Aligned_cols=152 Identities=16% Similarity=0.211 Sum_probs=116.8
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCC-CCe---------e----
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRH-ENI---------V---- 133 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h-~ni---------v---- 133 (224)
....|...+.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.++..+.| .|. +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 44568999999999999999999999999999998874332 235667789999998877 211 1
Q ss_pred --------eeeEEEEcCC---cceEEEEEecccCChhHhhh------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy13250 134 --------QLKEVVVGKS---LSSIFLVMEYCEHDLASLQD------NVESPFTESQVKCVILQVLKGLNYLHSNFIIHR 196 (224)
Q Consensus 134 --------~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHr 196 (224)
.+..++.... ....+++|+++.+++..++. .....+++..+..++.|++.||.|||+++|+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111111111 23578899998888877763 223457788899999999999999999999999
Q ss_pred CCCCCcEEEccCCcEEEEeccccccc
Q psy13250 197 DLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 197 Dlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+|||++.++.+||+|||+|+..
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~ 261 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRD 261 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEET
T ss_pred CcccceEEEecCCeEEEEeccceeec
Confidence 99999999999999999999998753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=204.24 Aligned_cols=143 Identities=25% Similarity=0.318 Sum_probs=113.5
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
.|...+.||+|+||+||.+ ...+++.||||++.... .....+|+.++..+ +||||+++++++. ....+|+|||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~--~~~~~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSET--TDRFLYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEE--CSSEEEEEEC
T ss_pred eeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEe--cCCeEEEEEe
Confidence 3566788999999999875 44578999999886432 34567899999875 8999999999984 4458999999
Q ss_pred cccCChhHhhhhcCCC------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC-------------CcEEE
Q psy13250 153 YCEHDLASLQDNVESP------FTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK-------------GCVKI 213 (224)
Q Consensus 153 ~~~~~l~~~~~~~~~~------l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~-------------~~~kl 213 (224)
||++++..++...... .++..+..++.|++.||.|||+++|+||||||+|||++.+ +.+||
T Consensus 90 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL 169 (434)
T 2rio_A 90 LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI 169 (434)
T ss_dssp CCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred cCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence 9998877776543211 1233457799999999999999999999999999999754 48999
Q ss_pred Eeccccccc
Q psy13250 214 VYSTYLELY 222 (224)
Q Consensus 214 ~DfGla~~~ 222 (224)
+|||+|+.+
T Consensus 170 ~DFG~a~~~ 178 (434)
T 2rio_A 170 SDFGLCKKL 178 (434)
T ss_dssp CCCTTCEEC
T ss_pred cccccceec
Confidence 999999754
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=215.52 Aligned_cols=151 Identities=30% Similarity=0.432 Sum_probs=124.2
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEc----CCcce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVG----KSLSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~ 146 (224)
.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.. ...+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 4679999999999999999999999999999998864322 234567789999999999999999998743 12457
Q ss_pred EEEEEecccC-ChhHhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc---EEEEeccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNVE--SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC---VKIVYSTYLE 220 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~---~kl~DfGla~ 220 (224)
.|+||||+.+ ++..++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+|+
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 8999999976 5665555432 25899999999999999999999999999999999999997765 9999999997
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
.+
T Consensus 173 ~~ 174 (676)
T 3qa8_A 173 EL 174 (676)
T ss_dssp BT
T ss_pred cc
Confidence 64
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=190.10 Aligned_cols=132 Identities=17% Similarity=0.126 Sum_probs=103.8
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc------------------cchhHHHHHHHhhcCCCCCeeeee
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT------------------LTRGELREVTGLTKCRHENIVQLK 136 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~~~ 136 (224)
|.+.+.||+|+||.||+|.+ .++..+|+|.+...... ....+.+|+.+++.++ | +.+.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 44559999999999999999 78999999998643211 1234678999999998 4 5555
Q ss_pred EEEEcCCcceEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEe
Q psy13250 137 EVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVY 215 (224)
Q Consensus 137 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~D 215 (224)
+++.. +..|+||||++| ++.. +. . .....++.|++.||.|||++||+||||||+|||++ +|.+||+|
T Consensus 168 ~~~~~---~~~~lvmE~~~g~~L~~-l~-----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 168 KVYAW---EGNAVLMELIDAKELYR-VR-----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CEEEE---ETTEEEEECCCCEEGGG-CC-----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred eEEec---cceEEEEEecCCCcHHH-cc-----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 54422 356999999987 4444 21 1 23457999999999999999999999999999999 99999999
Q ss_pred ccccccc
Q psy13250 216 STYLELY 222 (224)
Q Consensus 216 fGla~~~ 222 (224)
||+|+..
T Consensus 236 FG~a~~~ 242 (282)
T 1zar_A 236 FPQSVEV 242 (282)
T ss_dssp CTTCEET
T ss_pred CCCCeEC
Confidence 9999754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=181.07 Aligned_cols=137 Identities=18% Similarity=0.185 Sum_probs=103.8
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeE--EEEEEeeccCCcc------------------------chhHHHHHHHhhcC
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKI--LALKKLFLQNNTL------------------------TRGELREVTGLTKC 127 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~--~avK~~~~~~~~~------------------------~~~~~~e~~~l~~l 127 (224)
-|++.+.||+|+||.||+|.+..++.. ||||++....... .....+|+..|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378899999999999999998778888 9999875432111 01456899999988
Q ss_pred CCCCee--eeeEEEEcCCcceEEEEEecccC------ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCC
Q psy13250 128 RHENIV--QLKEVVVGKSLSSIFLVMEYCEH------DLASLQDNVESPFTESQVKCVILQVLKGLNYLH-SNFIIHRDL 198 (224)
Q Consensus 128 ~h~niv--~~~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH-~~~iiHrDl 198 (224)
.|+++. .++.. ...||||||+++ .+...... .++..+..++.|++.||.||| ++||+||||
T Consensus 128 ~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDl 197 (258)
T 1zth_A 128 KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADL 197 (258)
T ss_dssp HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSC
T ss_pred HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 877643 23322 245899999953 23222211 234567889999999999999 999999999
Q ss_pred CCCcEEEccCCcEEEEeccccccc
Q psy13250 199 KPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 199 kp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999754
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=198.06 Aligned_cols=132 Identities=17% Similarity=0.125 Sum_probs=97.4
Q ss_pred eEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc--------cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 76 EKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--------LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 76 ~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~--------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
...+.||+|+||.||+|. ..+..+++|+....... ..+.+.+|+.++++++||||+.+..++.... ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~ 414 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD--NK 414 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT--TT
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC--cc
Confidence 335689999999999994 45778899976432211 1234679999999999999995444443333 56
Q ss_pred EEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||||+++ +|.+++.. +..++.|++.||.|||+++|+||||||+|||++. .+||+|||+|+.+
T Consensus 415 ~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 415 RIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999985 45555433 5689999999999999999999999999999998 9999999999865
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=2.1e-21 Score=159.95 Aligned_cols=136 Identities=16% Similarity=0.134 Sum_probs=94.6
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc---------c-----chhH--------HHHHHHhhcCCCCC
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT---------L-----TRGE--------LREVTGLTKCRHEN 131 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~---------~-----~~~~--------~~e~~~l~~l~h~n 131 (224)
-|++...||+|+||.||+|.+. +|+.||||+++..... . .... .+|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3899999999999999999875 6889999987532110 0 0011 23555565554443
Q ss_pred eeeeeEEEEcCCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC--
Q psy13250 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG-- 209 (224)
Q Consensus 132 iv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~-- 209 (224)
+....-+.. . ..+|||||++|..+..+.. .+.+..++.|++.+|.|||++|||||||||.|||++.+|
T Consensus 175 v~vp~p~~~-~---~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQ-S---RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEE-E---TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeec-c---CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 322111111 1 2379999998754332211 123467889999999999999999999999999999877
Q ss_pred --------cEEEEeccccc
Q psy13250 210 --------CVKIVYSTYLE 220 (224)
Q Consensus 210 --------~~kl~DfGla~ 220 (224)
.+.||||+-|.
T Consensus 245 ~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp SCTTSEEEEEEECCCTTCE
T ss_pred ccccccccceEEEEeCCcc
Confidence 38999999764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.2e-14 Score=114.13 Aligned_cols=140 Identities=16% Similarity=0.068 Sum_probs=103.5
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv 150 (224)
+..|++...++.|+.+.||++... +..+++|............+.+|+..++.+. +..+.+++++... .+..|+|
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv 88 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLL 88 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEE
Confidence 456888899999999999998743 6789999876432223345778888888774 5667778877743 4578999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS---------------------------------------- 190 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---------------------------------------- 190 (224)
||+++|....... .+......++.+++.+|..||+
T Consensus 89 ~e~i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 9999985433221 0112234677889999999998
Q ss_pred -------------------CCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 191 -------------------NFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 191 -------------------~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
..++|+|++|.|||++..+.+.|+||+.|.
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999875556799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.45 E-value=3.1e-13 Score=105.60 Aligned_cols=135 Identities=12% Similarity=0.076 Sum_probs=92.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCC--eeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHEN--IVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~lv 150 (224)
..+.+....+.|..+.||++.. .++..+++|..... ......+|+..++.+.+.+ +.+++.+.. ..+..|+|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~--~~~~~~~v 93 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWLL 93 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc--CCCCCEEE
Confidence 3455544445666799999864 45667899986432 2345667888887775444 445777663 33568999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF-------------------------------------- 192 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~-------------------------------------- 192 (224)
|||++|.... .. ... ...++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~-~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 94 LGEVPGQDLL-SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp EECCSSEETT-TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEecCCcccC-cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9999985433 11 112 1245667777777777643
Q ss_pred --------------------ceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 193 --------------------IIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 193 --------------------iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
++|+|++|.|||++.++.+.|+|||.|..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999999863
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.3e-12 Score=105.71 Aligned_cols=141 Identities=9% Similarity=0.144 Sum_probs=99.1
Q ss_pred eEeeeeeccCceEEEEEEEccCCeEEEEEEee--ccCC-ccchhHHHHHHHhhcCC--CCCeeeeeEEEEcCCc-ceEEE
Q psy13250 76 EKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNN-TLTRGELREVTGLTKCR--HENIVQLKEVVVGKSL-SSIFL 149 (224)
Q Consensus 76 ~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~--~~~~-~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~-~~~~l 149 (224)
..++.|+.|.++.||++... +..+++|+.. .... .......+|..+++.+. +..+.+++..+.+... +..|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34678899999999998754 4567888664 2221 12345667888888776 3456777777643221 45789
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS--------------------------------------- 190 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--------------------------------------- 190 (224)
||||++|..... .....++......++.+++..|..||+
T Consensus 119 vme~v~G~~l~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999999843321 112246788888899999999999997
Q ss_pred -------------------CCceecCCCCCcEEEccCCc--EEEEeccccc
Q psy13250 191 -------------------NFIIHRDLKPSNLLLNDKGC--VKIVYSTYLE 220 (224)
Q Consensus 191 -------------------~~iiHrDlkp~Nill~~~~~--~kl~DfGla~ 220 (224)
..++|+|+++.|||++.++. +.|+||+.|.
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 35899999999999998753 6899999886
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=2.1e-09 Score=86.05 Aligned_cols=134 Identities=13% Similarity=0.099 Sum_probs=87.5
Q ss_pred eeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-CCCe--eeeeEEEEcCC-cceEEEEEec
Q psy13250 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-HENI--VQLKEVVVGKS-LSSIFLVMEY 153 (224)
Q Consensus 78 ~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~~-~~~~~lv~e~ 153 (224)
++.++.|....||++. ..+++|..... .......+|...|+.+. +..+ ...+....... ....|+|||+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 3568999999999753 34778865321 22345678888887763 3332 23333321111 1234889999
Q ss_pred ccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q psy13250 154 CEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS------------------------------------------- 190 (224)
Q Consensus 154 ~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~------------------------------------------- 190 (224)
++|........ ..++......++.+++..|..||+
T Consensus 98 i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 98 IKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred cCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99843221111 235666677777778777777775
Q ss_pred ---------------CCceecCCCCCcEEEcc--CCcEEEEeccccc
Q psy13250 191 ---------------NFIIHRDLKPSNLLLND--KGCVKIVYSTYLE 220 (224)
Q Consensus 191 ---------------~~iiHrDlkp~Nill~~--~~~~kl~DfGla~ 220 (224)
..++|+|++|.||+++. .+.+.|+||+.|.
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~ 222 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAA 222 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCE
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCc
Confidence 23799999999999998 4567899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=5.6e-08 Score=77.93 Aligned_cols=133 Identities=17% Similarity=0.111 Sum_probs=81.5
Q ss_pred eeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCC---CeeeeeEEEEcCCcceEEEEEecc
Q psy13250 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHE---NIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 78 ~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
++.++.|....||+. +..+++|... .........+|..+|..+.+. .+...+.+.. ...+..|++||++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~-~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK-RSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE-CTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc-cCCCceEEEEecc
Confidence 456788999999987 3457788642 112334567899888887642 2344444443 2334678999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS-------------------------------------------- 190 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-------------------------------------------- 190 (224)
+|........ ..++......++.++...|..||+
T Consensus 96 ~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 96 QGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp CSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 9843221100 112333333333334433333332
Q ss_pred ----------------CCceecCCCCCcEEEcc---CCcE-EEEeccccc
Q psy13250 191 ----------------NFIIHRDLKPSNLLLND---KGCV-KIVYSTYLE 220 (224)
Q Consensus 191 ----------------~~iiHrDlkp~Nill~~---~~~~-kl~DfGla~ 220 (224)
..++|+|++|.|||++. ++.+ .|+||+.|.
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 24699999999999997 4554 899999875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=8.9e-08 Score=75.03 Aligned_cols=132 Identities=16% Similarity=0.117 Sum_probs=81.5
Q ss_pred eeeccCce-EEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEEEEEecccCC
Q psy13250 80 RIGEGSYG-VVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIFLVMEYCEHD 157 (224)
Q Consensus 80 ~lG~G~fg-~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 157 (224)
.+..|..| .||+......+..+.+|+-... ....+.+|...|+.+. +--+.+++.++.+ .+..|+|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~--~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRT--PDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEE--CCeEEEEEEeeCCc
Confidence 44555554 6898877666777888976432 2334567777776653 2234456666633 35789999999874
Q ss_pred hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q psy13250 158 LASLQDNVESPFTESQVKCVILQVLKGLNYLHS----------------------------------------------- 190 (224)
Q Consensus 158 l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~----------------------------------------------- 190 (224)
........ .......+..++...|.-||.
T Consensus 106 ~~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 32221110 011122334444444444442
Q ss_pred ----C-------CceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 191 ----N-------FIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 191 ----~-------~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
. .++|+|+.+.|||++..+.+-|+||+.|.
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1 27999999999999987767799999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=1.4e-07 Score=78.19 Aligned_cols=76 Identities=18% Similarity=0.208 Sum_probs=46.2
Q ss_pred EeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-------ccchhHHHHHHHhhcCCC--C-CeeeeeEEEEcCCcce
Q psy13250 77 KLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-------TLTRGELREVTGLTKCRH--E-NIVQLKEVVVGKSLSS 146 (224)
Q Consensus 77 ~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~~~~~~~~~~~~~ 146 (224)
..+.||.|.++.||++.....+..+++|....... ........|..+++.+.. + .+..++.+. .. .
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~--~ 109 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE--M 109 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT--T
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CC--c
Confidence 35679999999999997655567899997642211 123345678877776532 3 334555432 32 3
Q ss_pred EEEEEecccC
Q psy13250 147 IFLVMEYCEH 156 (224)
Q Consensus 147 ~~lv~e~~~~ 156 (224)
.++|||++++
T Consensus 110 ~~lvmE~l~g 119 (397)
T 2olc_A 110 AVTVMEDLSH 119 (397)
T ss_dssp TEEEECCCTT
T ss_pred cEEEEEeCCC
Confidence 4799999975
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=5.4e-07 Score=73.45 Aligned_cols=82 Identities=10% Similarity=0.042 Sum_probs=49.4
Q ss_pred eeEeeee-eccCceEEEEEEEc--c----CCeEEEEEEeeccC---CccchhHHHHHHHhhcCCC---CCeeeeeEEEEc
Q psy13250 75 FEKLNRI-GEGSYGVVYRVRDS--V----QDKILALKKLFLQN---NTLTRGELREVTGLTKCRH---ENIVQLKEVVVG 141 (224)
Q Consensus 75 ~~~~~~l-G~G~fg~V~~~~~~--~----~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~ 141 (224)
....+.| +.|....+|+.... . .+..+++|...... ........+|..+++.+.. -.+.+++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3445678 88999999987643 0 15678888654322 0012445677777766532 235556665532
Q ss_pred CC-cceEEEEEecccC
Q psy13250 142 KS-LSSIFLVMEYCEH 156 (224)
Q Consensus 142 ~~-~~~~~lv~e~~~~ 156 (224)
.. .+..|+|||+++|
T Consensus 102 ~~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEG 117 (357)
T ss_dssp STTTSSCEEEEECCCC
T ss_pred CCccCCceEEEEecCC
Confidence 21 1356899999987
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.33 E-value=4.6e-06 Score=67.24 Aligned_cols=30 Identities=17% Similarity=0.241 Sum_probs=27.5
Q ss_pred CCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 191 NFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 191 ~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.05 E-value=2.3e-05 Score=65.40 Aligned_cols=31 Identities=13% Similarity=0.384 Sum_probs=27.3
Q ss_pred HhCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 189 HSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 189 H~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
+...++|+|++|.|||++.++ +.|+||+.+.
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~ 260 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSF 260 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccc
Confidence 356799999999999999877 9999998875
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.90 E-value=4.6e-05 Score=60.55 Aligned_cols=28 Identities=25% Similarity=0.110 Sum_probs=24.4
Q ss_pred CceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 192 FIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 192 ~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.++|+|+.+.||+ ..++.+.|+||..|.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 3899999999999 667788999998775
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.87 E-value=0.00017 Score=56.78 Aligned_cols=76 Identities=21% Similarity=0.141 Sum_probs=49.8
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCC---CeeeeeEEEEcCCcceEEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHE---NIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~~lv 150 (224)
...-++.+|.|..+.||+.+.. +|+.+.+|+...........+..|...|+.+.-. -+.+.+... . -++|
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~----~~lv 88 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D----RTLA 88 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----TEEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----ceEE
Confidence 4566788999999999998864 5778889976433333333456788877766321 233444332 2 3689
Q ss_pred EecccC
Q psy13250 151 MEYCEH 156 (224)
Q Consensus 151 ~e~~~~ 156 (224)
||++.+
T Consensus 89 ~e~l~~ 94 (288)
T 3f7w_A 89 MEWVDE 94 (288)
T ss_dssp EECCCC
T ss_pred EEeecc
Confidence 999874
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.87 E-value=0.00016 Score=57.97 Aligned_cols=75 Identities=13% Similarity=0.090 Sum_probs=51.3
Q ss_pred eEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC---CCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 76 EKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR---HENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 76 ~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
.-.+.|+.|.+..+|+... .+..+++|+.... ....+.+|...|+.+. ...+.+.+.+.. ..+..|+|||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~--~~g~~~lvme 111 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGN--SQGHSFLLLE 111 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE--CSSEEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEee--cCCceEEEEE
Confidence 3457789999999999874 4567888876532 2334567777776653 245666666653 3357899999
Q ss_pred cccCC
Q psy13250 153 YCEHD 157 (224)
Q Consensus 153 ~~~~~ 157 (224)
++++.
T Consensus 112 ~l~G~ 116 (312)
T 3jr1_A 112 ALNKS 116 (312)
T ss_dssp CCCCC
T ss_pred eccCC
Confidence 99863
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00013 Score=58.22 Aligned_cols=142 Identities=12% Similarity=0.076 Sum_probs=72.6
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-----CCCeeeee-EEEEcCCcceEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-----HENIVQLK-EVVVGKSLSSIF 148 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~-~~~~~~~~~~~~ 148 (224)
...++.|+.|....+|++... .+ .+++|..... ........|..++..+. -|.++... +.......+..+
T Consensus 24 ~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~ 99 (322)
T 2ppq_A 24 LTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPA 99 (322)
T ss_dssp EEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEE
T ss_pred ceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEE
Confidence 345667888988999998754 23 5778876532 12233445665554442 23332210 000000123578
Q ss_pred EEEecccCChh----------------Hhhhhc-C--CC----CCHHHHHH---------------HHHHHHHHHHHHHh
Q psy13250 149 LVMEYCEHDLA----------------SLQDNV-E--SP----FTESQVKC---------------VILQVLKGLNYLHS 190 (224)
Q Consensus 149 lv~e~~~~~l~----------------~~~~~~-~--~~----l~~~~~~~---------------~~~~i~~~l~~lH~ 190 (224)
++|++++|... .+.... . .+ ........ +...+...++++..
T Consensus 100 ~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~ 179 (322)
T 2ppq_A 100 ALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAA 179 (322)
T ss_dssp EEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHH
T ss_pred EEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHh
Confidence 99999986311 010000 0 00 11110000 00113344555552
Q ss_pred -------CCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 191 -------NFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 191 -------~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.+++|+|+.+.|||++.++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 180 HWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 369999999999999877666899998875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00036 Score=58.36 Aligned_cols=72 Identities=17% Similarity=0.181 Sum_probs=45.0
Q ss_pred EeeeeeccCceEEEEEEEcc-------CCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCe-eeeeEEEEcCCcceEE
Q psy13250 77 KLNRIGEGSYGVVYRVRDSV-------QDKILALKKLFLQNNTLTRGELREVTGLTKCRHENI-VQLKEVVVGKSLSSIF 148 (224)
Q Consensus 77 ~~~~lG~G~fg~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~ 148 (224)
.++.|+.|....+|++.... .+..+.+|+.... .......+|..++..+...++ .++++.+ .+ .
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~--~~----g 148 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIF--SG----G 148 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT----E
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEe--CC----C
Confidence 45678889999999998642 2467778866321 111445578777766543233 4566655 33 2
Q ss_pred EEEecccC
Q psy13250 149 LVMEYCEH 156 (224)
Q Consensus 149 lv~e~~~~ 156 (224)
+|+||++|
T Consensus 149 ~v~e~l~G 156 (429)
T 1nw1_A 149 RLEEYIPS 156 (429)
T ss_dssp EEECCCCE
T ss_pred EEEEEeCC
Confidence 78999976
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00055 Score=55.88 Aligned_cols=28 Identities=21% Similarity=0.439 Sum_probs=23.7
Q ss_pred CceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 192 FIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 192 ~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.++|+|+.+.|||++.++ +.|+||..|.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 589999999999998654 8999998774
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0023 Score=53.97 Aligned_cols=73 Identities=12% Similarity=0.091 Sum_probs=44.2
Q ss_pred EeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCe-eeeeEEEEcCCcceEEEEEeccc
Q psy13250 77 KLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENI-VQLKEVVVGKSLSSIFLVMEYCE 155 (224)
Q Consensus 77 ~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~lv~e~~~ 155 (224)
.++.|+.|-...+|++.....+..+.+|+..... ...-...+|..++..+...++ .++++.+ .+ .+||||++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~----G~v~e~I~ 184 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFF--TN----GRIEEFMD 184 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT----EEEEECCC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC----eEEEEeeC
Confidence 4567888999999998865434778888653221 111122467777777654444 4566665 32 25999998
Q ss_pred C
Q psy13250 156 H 156 (224)
Q Consensus 156 ~ 156 (224)
|
T Consensus 185 G 185 (458)
T 2qg7_A 185 G 185 (458)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00061 Score=56.06 Aligned_cols=136 Identities=14% Similarity=0.086 Sum_probs=74.5
Q ss_pred eeeeeccCceEEEEEEEcc-------CCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCC-eeeeeEEEEcCCcceEEE
Q psy13250 78 LNRIGEGSYGVVYRVRDSV-------QDKILALKKLFLQNNTLTRGELREVTGLTKCRHEN-IVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 78 ~~~lG~G~fg~V~~~~~~~-------~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~l 149 (224)
++.|..|....+|++.... .+..+.+|+... .........+|..+++.+.-.+ ..++++.+ ++ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~--~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVF--PE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEE--TT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEc--CC----cc
Confidence 3567778888899987532 246777886421 1112334457877776653222 24555555 33 28
Q ss_pred EEecccCChhH---------------hhhh---cC----CCC--CHHHHHHHHHHHHH-------------------HHH
Q psy13250 150 VMEYCEHDLAS---------------LQDN---VE----SPF--TESQVKCVILQVLK-------------------GLN 186 (224)
Q Consensus 150 v~e~~~~~l~~---------------~~~~---~~----~~l--~~~~~~~~~~~i~~-------------------~l~ 186 (224)
||||++|.... .+.. .. ... .+..+..+..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999862110 0111 01 111 23455555544322 233
Q ss_pred HHH----h----CCceecCCCCCcEEEccC----CcEEEEeccccc
Q psy13250 187 YLH----S----NFIIHRDLKPSNLLLNDK----GCVKIVYSTYLE 220 (224)
Q Consensus 187 ~lH----~----~~iiHrDlkp~Nill~~~----~~~kl~DfGla~ 220 (224)
+|. . ..++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 333 2 248999999999999887 789999998875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0013 Score=52.85 Aligned_cols=30 Identities=23% Similarity=0.307 Sum_probs=26.5
Q ss_pred CCceecCCCCCcEEEccC----CcEEEEeccccc
Q psy13250 191 NFIIHRDLKPSNLLLNDK----GCVKIVYSTYLE 220 (224)
Q Consensus 191 ~~iiHrDlkp~Nill~~~----~~~kl~DfGla~ 220 (224)
..++|+|+.+.|||++.+ +.+.|+||+.|.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 469999999999999875 679999999875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.48 E-value=0.023 Score=47.35 Aligned_cols=28 Identities=25% Similarity=0.502 Sum_probs=25.2
Q ss_pred CceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 192 FIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 192 ~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.++|+|+.+.||+ +.++.+.|+||..|.
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCC
Confidence 4899999999999 778899999998875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.51 E-value=0.0092 Score=47.54 Aligned_cols=28 Identities=18% Similarity=0.134 Sum_probs=24.5
Q ss_pred CCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 191 NFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 191 ~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
..++|+|+++.|||++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 4589999999999999 4 89999998775
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.83 E-value=0.015 Score=46.89 Aligned_cols=30 Identities=17% Similarity=0.274 Sum_probs=26.9
Q ss_pred CCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 191 NFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 191 ~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 469999999999999988889999998765
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.76 E-value=0.07 Score=43.98 Aligned_cols=28 Identities=25% Similarity=0.417 Sum_probs=24.1
Q ss_pred ceecCCCCCcEEE------ccCCcEEEEeccccc
Q psy13250 193 IIHRDLKPSNLLL------NDKGCVKIVYSTYLE 220 (224)
Q Consensus 193 iiHrDlkp~Nill------~~~~~~kl~DfGla~ 220 (224)
++|+|+.+.|||+ +.++.+.++||-.|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 346779999998875
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=90.40 E-value=4.5 Score=32.35 Aligned_cols=74 Identities=19% Similarity=0.209 Sum_probs=40.2
Q ss_pred eEEEEEecccCChhHhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEccCCc-EEEEecc
Q psy13250 146 SIFLVMEYCEHDLASLQDNV--ESPFTESQVKCVILQVLKGLNYLHSNF-----IIHRDLKPSNLLLNDKGC-VKIVYST 217 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~-----iiHrDlkp~Nill~~~~~-~kl~DfG 217 (224)
...++|||..|..+...... ...+.++....+. -+-+++++..+. +-+.--.++|||++.++. +.+||-+
T Consensus 156 ~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG--~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~n~~~~~IDhn 233 (342)
T 1cja_A 156 ANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLG--SLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVVPIDSK 233 (342)
T ss_dssp SEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHH--HHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEEECSCC
T ss_pred cceehhhhcCCCccccchhhhhhhhcCHHHHHhhc--hhheehhhhcCCccCcccccCCCChhheEEeCCCCeEEEEcCC
Confidence 46699999986321111100 0113333332211 134566666442 122235789999988555 8899999
Q ss_pred cccc
Q psy13250 218 YLEL 221 (224)
Q Consensus 218 la~~ 221 (224)
.|..
T Consensus 234 ~af~ 237 (342)
T 1cja_A 234 IIPL 237 (342)
T ss_dssp CCCC
T ss_pred cccc
Confidence 8853
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.98 E-value=0.019 Score=48.42 Aligned_cols=61 Identities=10% Similarity=0.028 Sum_probs=17.2
Q ss_pred EeeeeeccCceEEEEEEEccCCeEEEE------EEeeccC--CccchhHHHHHHHhhcCCCCCeeeeeEEEE
Q psy13250 77 KLNRIGEGSYGVVYRVRDSVQDKILAL------KKLFLQN--NTLTRGELREVTGLTKCRHENIVQLKEVVV 140 (224)
Q Consensus 77 ~~~~lG~G~fg~V~~~~~~~~~~~~av------K~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~ 140 (224)
+.+.|| ||.||++........||+ |...... ......+.+|..++..+.|+|+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 345666 999999988655557788 6543211 122345677888888899999999887764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=82.16 E-value=3.8 Score=30.54 Aligned_cols=85 Identities=11% Similarity=0.042 Sum_probs=56.0
Q ss_pred CCCCCeeeeeEEEEcCCcceEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy13250 127 CRHENIVQLKEVVVGKSLSSIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL 205 (224)
Q Consensus 127 l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill 205 (224)
..||+.+.. .+- ...+.+.+.++.-+.. .+..+. .++....++++.+|+....++ ..-+|--|.|+||++
T Consensus 42 ~~~~~Fl~~-~I~--e~eD~v~~~y~~~~~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f 112 (215)
T 4ann_A 42 QHSPYFIDA-ELT--ELRDSFQIHYDINDNHTPFDNIK----SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFF 112 (215)
T ss_dssp SCCTTBCCE-EEE--ECSSEEEEEECCCTTSEEGGGGG----GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEE
T ss_pred ccCCcccce-EEE--EcccEEEEEEEcCcccCCHHHHH----hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEE
Confidence 367887765 233 2334666666554421 122222 367788888888887766433 445677889999999
Q ss_pred ccCCcEEEEeccccc
Q psy13250 206 NDKGCVKIVYSTYLE 220 (224)
Q Consensus 206 ~~~~~~kl~DfGla~ 220 (224)
+.++.++++--|+-.
T Consensus 113 ~~~~~p~i~~RGik~ 127 (215)
T 4ann_A 113 TRDGLPIAKTRGLQN 127 (215)
T ss_dssp CTTSCEEESCCEETT
T ss_pred cCCCCEEEEEccCcc
Confidence 999999999888743
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.73 E-value=1.5 Score=32.89 Aligned_cols=84 Identities=13% Similarity=-0.037 Sum_probs=53.6
Q ss_pred CCCCeeeeeEEEEcCCcceEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc
Q psy13250 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLN 206 (224)
Q Consensus 128 ~h~niv~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~ 206 (224)
.||.+ .. .+- ...+.+.+.++.-.+. .+..+ ..++....++++.+|+.... -|...-+|--|.|+||+++
T Consensus 48 ~~~~f-~~-~I~--~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI-VR-DID--VSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS-EE-EEE--ECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEEC
T ss_pred cCCCC-Ce-EEE--EeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEe
Confidence 57776 32 222 3334666666554332 22222 23677888888887765544 1234567778899999999
Q ss_pred cCCcEEEEeccccc
Q psy13250 207 DKGCVKIVYSTYLE 220 (224)
Q Consensus 207 ~~~~~kl~DfGla~ 220 (224)
.++.++|+-.|+-.
T Consensus 119 ~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 119 RALEPFFLHVGVKE 132 (219)
T ss_dssp TTCCEEESCCEETT
T ss_pred CCCcEEEEEcCCcc
Confidence 99999999998743
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 224 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-40 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-37 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-37 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-36 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-34 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-33 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-33 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-33 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-31 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-31 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-31 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-30 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-30 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-30 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-30 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-29 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-29 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-29 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-29 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-28 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-28 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-28 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-28 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-27 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-27 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-27 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-26 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-25 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-25 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-25 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-25 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-25 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-24 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-23 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-21 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-19 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 4e-41
Identities = 44/140 (31%), Positives = 79/140 (56%), Gaps = 3/140 (2%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
+E + +G+G++G VY+ ++ + A K + ++ + E+ L C H NIV+
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 135 LKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFI 193
L + ++ ++++++E+C + ++ +E P TESQ++ V Q L LNYLH N I
Sbjct: 74 LLDAFYYEN--NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKI 131
Query: 194 IHRDLKPSNLLLNDKGCVKI 213
IHRDLK N+L G +K+
Sbjct: 132 IHRDLKAGNILFTLDGDIKL 151
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (347), Expect = 3e-40
Identities = 52/142 (36%), Positives = 81/142 (57%), Gaps = 5/142 (3%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL---FLQNNTLTRGELREVTGLTKCRHEN 131
F L IG GS+G VY RD +++A+KK+ Q+N + ++EV L K RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
+Q + + + + +LVMEYC + L + + P E ++ V L+GL YLHS+
Sbjct: 77 TIQYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
+IHRD+K N+LL++ G VK+
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKL 156
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 9e-40
Identities = 42/142 (29%), Positives = 71/142 (50%), Gaps = 4/142 (2%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCRHENI 132
+FEK++ +G G+ GVV++V ++A K + L+ R + +RE+ L +C I
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS-N 191
V I + ME+ + E + V + V+KGL YL +
Sbjct: 67 VGFYGAFYSDG--EISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
I+HRD+KPSN+L+N +G +K+
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKL 146
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 4e-38
Identities = 36/142 (25%), Positives = 70/142 (49%), Gaps = 3/142 (2%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRHENI 132
+++ + +GEG+YG V + V ++ +A+K + ++ + +E+ HEN+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
V+ ++ +L +EYC + + E + Q++ G+ YLH
Sbjct: 66 VKFYGHRREGNI--QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 193 IIHRDLKPSNLLLNDKGCVKIV 214
I HRD+KP NLLL+++ +KI
Sbjct: 124 ITHRDIKPENLLLDERDNLKIS 145
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 1e-37
Identities = 43/140 (30%), Positives = 74/140 (52%), Gaps = 5/140 (3%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
+ + +IG+G+ G VY D + +A++++ LQ + E+ + + ++ NIV
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 135 LKEVVVGKSLSSIFLVMEYCEHDLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFI 193
+ + +++VMEY SL D V E+ E Q+ V + L+ L +LHSN +
Sbjct: 82 YLDSYLVG--DELWVVMEYLAGG--SLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 194 IHRDLKPSNLLLNDKGCVKI 213
IHRD+K N+LL G VK+
Sbjct: 138 IHRDIKSDNILLGMDGSVKL 157
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 4e-37
Identities = 47/143 (32%), Positives = 70/143 (48%), Gaps = 5/143 (3%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL---FLQNNTLTRGELREVTGLTKCRHE 130
+FE +G+G +G VY R+ ILALK L L+ + REV + RH
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
NI++L + ++L++EY + S F E + I ++ L+Y HS
Sbjct: 67 NILRLYGYFHDAT--RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
+IHRD+KP NLLL G +KI
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKI 147
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 5e-36
Identities = 49/151 (32%), Positives = 80/151 (52%), Gaps = 11/151 (7%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE--LREVTGLTKCRHEN 131
++E L IG GSYG ++R KIL K+L + T + + EV L + +H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEH-DLASL---QDNVESPFTESQVKCVILQVLKGLNY 187
IV+ + ++ ++ +++++VMEYCE DLAS+ E V V+ Q+ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 188 LH-----SNFIIHRDLKPSNLLLNDKGCVKI 213
H + ++HRDLKP+N+ L+ K VK+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 155
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 126 bits (318), Expect = 1e-35
Identities = 32/143 (22%), Positives = 67/143 (46%), Gaps = 5/143 (3%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
++ +G G++GVV+RV + A K + + + +E+ ++ RH +V
Sbjct: 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 135 LKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFI 193
L + + + ++ E+ +L + + +E + + QV KGL ++H N
Sbjct: 88 LHDAFEDD--NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 145
Query: 194 IHRDLKPSNLLLNDK--GCVKIV 214
+H DLKP N++ K +K++
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLI 168
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-35
Identities = 59/153 (38%), Positives = 93/153 (60%), Gaps = 8/153 (5%)
Query: 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTK 126
C V+++EKL +IG+G++G V++ R + +ALKK+ ++N LRE+ L
Sbjct: 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL 65
Query: 127 CRHENIVQLKEVVV------GKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQ 180
+HEN+V L E+ + SI+LV ++CEHDLA L NV FT S++K V+
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125
Query: 181 VLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+L GL Y+H N I+HRD+K +N+L+ G +K+
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKL 158
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-35
Identities = 35/143 (24%), Positives = 61/143 (42%), Gaps = 5/143 (3%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL---FLQNNTLTRGELREVTGLTKCRHE 130
+F+ +GEGS+ V R+ + A+K L + RE +++ H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
V+L ++ + Y ++ F E+ + +++ L YLH
Sbjct: 69 FFVKLYFTFQDDE--KLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
IIHRDLKP N+LLN+ ++I
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQI 149
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 4e-35
Identities = 54/144 (37%), Positives = 86/144 (59%), Gaps = 7/144 (4%)
Query: 76 EKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE-----LREVTGLTKCRHE 130
EKL+ +GEG + VY+ RD ++I+A+KK+ L + + + LRE+ L + H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
NI+ L + KS +I LV ++ E DL + + T S +K +L L+GL YLH
Sbjct: 61 NIIGLLDAFGHKS--NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 191 NFIIHRDLKPSNLLLNDKGCVKIV 214
++I+HRDLKP+NLLL++ G +K+
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLA 142
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 124 bits (311), Expect = 1e-34
Identities = 32/162 (19%), Positives = 73/162 (45%), Gaps = 11/162 (6%)
Query: 56 EPIEILEQDCFGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTR 115
+P+E+ + + ++ L +G G++GVV+R + ++ K +
Sbjct: 18 QPVEVKQGSVYDY------YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 71
Query: 116 GELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQV 174
E++ + + H ++ L + K + L++E+ +L + +E++V
Sbjct: 72 TVKNEISIMNQLHHPKLINLHDAFEDK--YEMVLILEFLSGGELFDRIAAEDYKMSEAEV 129
Query: 175 KCVILQVLKGLNYLHSNFIIHRDLKPSNLLL--NDKGCVKIV 214
+ Q +GL ++H + I+H D+KP N++ VKI+
Sbjct: 130 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKII 171
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-33
Identities = 34/142 (23%), Positives = 70/142 (49%), Gaps = 7/142 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
+ + R+G G +G V+ + K+ A+K L Q + L E + + +H+ +V
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 134 QLKEVVVGKSLSSIFLVMEYCEHDLAS--LQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
+L VV + + +++ EY E+ L+ T +++ + Q+ +G+ ++
Sbjct: 72 RLYAVVTQEPI---YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
IHRDL+ +N+L++D KI
Sbjct: 129 NYIHRDLRAANILVSDTLSCKI 150
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-33
Identities = 44/143 (30%), Positives = 70/143 (48%), Gaps = 9/143 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE--LREVTGLTKCRHEN 131
+ RIG GS+G VY+ + +A+K L + T + + EV L K RH N
Sbjct: 9 QITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 132 IVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
I+ L +V ++CE L +E+ F ++ + Q +G++YLH+
Sbjct: 66 ILLFMGYSTAPQL---AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
IIHRDLK +N+ L++ VKI
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKI 145
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 120 bits (303), Expect = 2e-33
Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFL------QNNTLTRGELREVTGLTKC 127
+F IG G +G VY R + K+ A+K L Q TL E ++ ++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNY 187
IV + + +++ + F+E+ ++ +++ GL +
Sbjct: 65 DCPFIVCMSYAFHTPD--KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKIV 214
+H+ F+++RDLKP+N+LL++ G V+I
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRIS 149
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 4e-33
Identities = 39/141 (27%), Positives = 67/141 (47%), Gaps = 7/141 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
E + L IG+G +G V + +A+K + +N+ + L E + +T+ RH N+V
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 63
Query: 134 QLKEVVVGKSLSSIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
QL V+V + +++V EY L L+ S + L V + + YL N
Sbjct: 64 QLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 192 FIIHRDLKPSNLLLNDKGCVK 212
+HRDL N+L+++ K
Sbjct: 123 NFVHRDLAARNVLVSEDNVAK 143
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 5e-33
Identities = 49/145 (33%), Positives = 80/145 (55%), Gaps = 6/145 (4%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL-FLQNNTLTRGELREVTGLTKCRHENIV 133
+ L+ IGEG+YG+V D+V +A+KK+ ++ T + LRE+ L + RHENI+
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 134 QLKEVVVGKS---LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
+ +++ + + ++LV DL L + + + Q+L+GL Y+HS
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHS 127
Query: 191 NFIIHRDLKPSNLLLNDKGCVKIVY 215
++HRDLKPSNLLLN +KI
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICD 152
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-32
Identities = 51/156 (32%), Positives = 85/156 (54%), Gaps = 10/156 (6%)
Query: 67 GKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQD-KILALKKLFLQNNT-----LTRGELRE 120
G CR ++E + IGEG+YG V++ RD + +ALK++ +Q T E+
Sbjct: 1 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV 60
Query: 121 VTGLTKCRHENIVQLKEVVV---GKSLSSIFLVMEYCEHDLASLQDNVESP-FTESQVKC 176
+ L H N+V+L +V + + LV E+ + DL + D V P +K
Sbjct: 61 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 120
Query: 177 VILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVK 212
++ Q+L+GL++LHS+ ++HRDLKP N+L+ G +K
Sbjct: 121 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIK 156
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-32
Identities = 52/143 (36%), Positives = 90/143 (62%), Gaps = 5/143 (3%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENI 132
F+K+ +IGEG+YGVVY+ R+ + +++ALKK+ L T + +RE++ L + H NI
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQD-NVESPFTESQVKCVILQVLKGLNYLHSN 191
V+L +V+ ++ ++LV E+ DL D + + +K + Q+L+GL + HS+
Sbjct: 64 VKLLDVIHTEN--KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 192 FIIHRDLKPSNLLLNDKGCVKIV 214
++HRDLKP NLL+N +G +K+
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLA 144
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 116 bits (291), Expect = 3e-32
Identities = 37/144 (25%), Positives = 65/144 (45%), Gaps = 5/144 (3%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKL---FLQNNTLTRGELREVTGLTKCRHEN 131
+E +G G V+ RD + +A+K L ++ + RE H
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 132 IVQLKEVVVGKSLSS--IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
IV + + ++ + ++VMEY + + E P T + VI + LN+ H
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 128
Query: 190 SNFIIHRDLKPSNLLLNDKGCVKI 213
N IIHRD+KP+N++++ VK+
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKV 152
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-31
Identities = 30/140 (21%), Positives = 61/140 (43%), Gaps = 4/140 (2%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
+ +G G +G+V+R ++ K K + ++ +E++ L RH NI+
Sbjct: 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILH 65
Query: 135 LKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFI 193
L E + ++ E+ D+ + E ++ + QV + L +LHS+ I
Sbjct: 66 LHESFESME--ELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 194 IHRDLKPSNLLLNDKGCVKI 213
H D++P N++ + I
Sbjct: 124 GHFDIRPENIIYQTRRSSTI 143
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 2e-31
Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 11/143 (7%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
+ IG GS+GVVY+ + +++A+KK+ R + RE+ + K H NIV+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77
Query: 135 LKEVVVG----KSLSSIFLVMEYCEHDLASLQDNV---ESPFTESQVKCVILQVLKGLNY 187
L+ K + LV++Y + + + + VK + Q+ + L Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 188 LHSNFIIHRDLKPSNLLLNDKGC 210
+HS I HRD+KP NLLL+
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTA 160
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 114 bits (285), Expect = 2e-31
Identities = 41/151 (27%), Positives = 67/151 (44%), Gaps = 14/151 (9%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE---------LREVTGLT 125
+E +G G VV R K A+K + + E L+EV L
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 126 KCR-HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLK 183
K H NI+QLK+ + FLV + + +L + +E + + ++ +L+
Sbjct: 65 KVSGHPNIIQLKDTYETNT--FFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLE 121
Query: 184 GLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
+ LH I+HRDLKP N+LL+D +K+
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLT 152
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 5e-31
Identities = 41/143 (28%), Positives = 62/143 (43%), Gaps = 5/143 (3%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL---FLQNNTLTRGELREVTGLTKCRHE 130
+F+ L +G GS+G V+ +R + A+K L + E L+ H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
I+++ IF++M+Y E F K +V L YLHS
Sbjct: 65 FIIRMWGTFQDAQ--QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 191 NFIIHRDLKPSNLLLNDKGCVKI 213
II+RDLKP N+LL+ G +KI
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKI 145
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 5e-31
Identities = 42/147 (28%), Positives = 61/147 (41%), Gaps = 8/147 (5%)
Query: 75 FEKLNR-IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE--LREVTGLTKCRHEN 131
F K + IG GS+ VY+ D+ +A +L + T + + E L +H N
Sbjct: 10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69
Query: 132 IVQLKEVV--VGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLH 189
IV+ + K I LV E ++ Q+LKGL +LH
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 190 SN--FIIHRDLKPSNLLLNDK-GCVKI 213
+ IIHRDLK N+ + G VKI
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKI 156
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 7e-31
Identities = 48/147 (32%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCRHENI 132
+ L +G G+YG V D +A+KKL+ Q+ + RE+ L RHEN+
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 133 VQLKEVVVGKS----LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
+ L +V + +LVM + DL L + E +++ ++ Q+LKGL Y+
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYI 137
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKIVY 215
H+ IIHRDLKP NL +N+ +KI+
Sbjct: 138 HAAGIIHRDLKPGNLAVNEDCELKILD 164
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (282), Expect = 7e-31
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 7/155 (4%)
Query: 66 FGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDK---ILALKKLFLQNNTLTRGE-LREV 121
F K +++ + IG G +G V + K +A+K L R + L E
Sbjct: 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEA 78
Query: 122 TGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQ 180
+ + + H N++ L+ VV + + ++ E+ E+ L S + FT Q+ ++
Sbjct: 79 SIMGQFDHPNVIHLEGVVTKST--PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136
Query: 181 VLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVY 215
+ G+ YL +HRDL N+L+N K+
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSD 171
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (281), Expect = 9e-31
Identities = 32/142 (22%), Positives = 61/142 (42%), Gaps = 5/142 (3%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
+ +++G G YG VY +A+K L ++ L+E + + +H N+V
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLV 76
Query: 134 QLKEVVVGKSLSSIFLVMEYCEH--DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSN 191
QL V + +++ E+ + L L++ + + + Q+ + YL
Sbjct: 77 QLLGVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134
Query: 192 FIIHRDLKPSNLLLNDKGCVKI 213
IHRDL N L+ + VK+
Sbjct: 135 NFIHRDLAARNCLVGENHLVKV 156
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 112 bits (280), Expect = 1e-30
Identities = 53/142 (37%), Positives = 83/142 (58%), Gaps = 5/142 (3%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENI 132
+ L +IGEG+YGVVY+ +++ + ALKK+ L+ + +RE++ L + +H NI
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
V+L +V+ K + LV E+ + DL L D E K +LQ+L G+ Y H
Sbjct: 63 VKLYDVIHTKK--RLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 193 IIHRDLKPSNLLLNDKGCVKIV 214
++HRDLKP NLL+N +G +KI
Sbjct: 121 VLHRDLKPQNLLINREGELKIA 142
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (277), Expect = 6e-30
Identities = 40/145 (27%), Positives = 68/145 (46%), Gaps = 10/145 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL-REVTGLTKCRHENIV 133
++ + +G G++ V D K++A+K + + G + E+ L K +H NIV
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 134 QLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNYLHSN 191
L ++ ++L+M+ L D + +TE +I QVL + YLH
Sbjct: 71 ALDDIYESG--GHLYLIMQLVSGG--ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 192 FIIHRDLKPSNLLL---NDKGCVKI 213
I+HRDLKP NLL ++ + I
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMI 151
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 7e-30
Identities = 43/148 (29%), Positives = 65/148 (43%), Gaps = 10/148 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVR---DSVQDKILALKKL---FLQNNTLTRGELREVTGLTKC 127
+ L ++G+GS+GVV R S + +A+K L L +REV +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLN 186
H N+++L VV+ + +V E L + F + +QV +G+
Sbjct: 69 DHRNLIRLYGVVLTPPM---KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
YL S IHRDL NLLL + VKI
Sbjct: 126 YLESKRFIHRDLAARNLLLATRDLVKIG 153
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 8e-30
Identities = 37/137 (27%), Positives = 59/137 (43%), Gaps = 7/137 (5%)
Query: 81 IGEGSYGVVYRVRDSVQDK--ILALKKLFLQNNTLTRGE-LREVTGLTKCRHENIVQLKE 137
+G G++G V + ++ K +A+K L E +RE + + + IV+L
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 138 VVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHR 196
V ++L LVME L S V ++ QV G+ YL +HR
Sbjct: 77 VCQAEAL---MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 197 DLKPSNLLLNDKGCVKI 213
DL N+LL ++ KI
Sbjct: 134 DLAARNVLLVNRHYAKI 150
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 1e-29
Identities = 38/141 (26%), Positives = 64/141 (45%), Gaps = 5/141 (3%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
E + IG G +G+V+ +DK+ A+K + + + E + K H +V
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 134 QLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
QL V + ++ I LV E+ EH L+ F + + L V +G+ YL
Sbjct: 64 QLYGVCLEQA--PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 193 IIHRDLKPSNLLLNDKGCVKI 213
+IHRDL N L+ + +K+
Sbjct: 122 VIHRDLAARNCLVGENQVIKV 142
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-29
Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 11/147 (7%)
Query: 74 EFEKLNR-IGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTK-CRHEN 131
+++ ++ +G G G V ++ + + ALK L REV + + +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-----REVELHWRASQCPH 66
Query: 132 IVQLKEVVVGKSLS--SIFLVMEYCEH-DLAS-LQDNVESPFTESQVKCVILQVLKGLNY 187
IV++ +V + +VME + +L S +QD + FTE + ++ + + + Y
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 126
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKIV 214
LHS I HRD+KP NLL K I+
Sbjct: 127 LHSINIAHRDVKPENLLYTSKRPNAIL 153
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 3e-29
Identities = 34/144 (23%), Positives = 62/144 (43%), Gaps = 7/144 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
++G+G +G V+ + ++ A+K L + L+E + K RHE +V
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 75
Query: 134 QLKEVVVGKSLSSIFLVMEYCEHDLASL--QDNVESPFTESQVKCVILQVLKGLNYLHSN 191
QL VV S I++V EY + Q+ + Q+ G+ Y+
Sbjct: 76 QLYAVV---SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 192 FIIHRDLKPSNLLLNDKGCVKIVY 215
+HRDL+ +N+L+ + K+
Sbjct: 133 NYVHRDLRAANILVGENLVCKVAD 156
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 3e-29
Identities = 38/141 (26%), Positives = 64/141 (45%), Gaps = 5/141 (3%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIV 133
+ L +G G +GVV + Q + A+K + + + + E + HE +V
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 134 QLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
QL V + IF++ EY + L + + F Q+ + V + + YL S
Sbjct: 63 QLYGVCTKQR--PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 193 IIHRDLKPSNLLLNDKGCVKI 213
+HRDL N L+ND+G VK+
Sbjct: 121 FLHRDLAARNCLVNDQGVVKV 141
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (269), Expect = 5e-29
Identities = 53/142 (37%), Positives = 86/142 (60%), Gaps = 4/142 (2%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT--LTRGELREVTGLTKCRHENI 132
+EKL +IGEG+YG V++ ++ +I+ALK++ L ++ + LRE+ L + +H+NI
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 133 VQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF 192
V+L +V+ + LV E+C+ DL D+ VK + Q+LKGL + HS
Sbjct: 64 VRLHDVLHSDK--KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 193 IIHRDLKPSNLLLNDKGCVKIV 214
++HRDLKP NLL+N G +K+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLA 143
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (269), Expect = 6e-29
Identities = 32/143 (22%), Positives = 54/143 (37%), Gaps = 3/143 (2%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQ 134
+ +IG GS+G +Y D + +A+K ++ E + +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66
Query: 135 LKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
G +VME L L + F+ V + Q++ + Y+HS I
Sbjct: 67 TIRWC-GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125
Query: 195 HRDLKPSNLLLNDKGCVKIVYST 217
HRD+KP N L+ +VY
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYII 148
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 108 bits (271), Expect = 8e-29
Identities = 34/145 (23%), Positives = 62/145 (42%), Gaps = 5/145 (3%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL---FLQNNTLTRGELREVTGLTKCRHE 130
+F+++ +G GS+G V V+ A+K L + L E L
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
+V+L+ S + + + L+ F+E + Q++ YLHS
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS 159
Query: 191 NFIIHRDLKPSNLLLNDKGCVKIVY 215
+I+RDLKP NLL++ +G +++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTD 184
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-28
Identities = 31/145 (21%), Positives = 62/145 (42%), Gaps = 7/145 (4%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKIL----ALKKLFLQNNTLTRGE-LREVTGLTKCR 128
EF+K+ +G G++G VY+ + + + A+K+L + E L E +
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
+ ++ +L + + ++ + L + + +Q+ KG+NYL
Sbjct: 70 NPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
++HRDL N+L+ VKI
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKI 152
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 1e-28
Identities = 33/140 (23%), Positives = 59/140 (42%), Gaps = 7/140 (5%)
Query: 79 NRIGEGSYGVVYRV--RDSVQDKILALKKLFLQNNTLTRGE--LREVTGLTKCRHENIVQ 134
+G G++G V + + K +A+K L + N + L E + + + IV+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 135 LKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFII 194
+ + +S LVME E + + + ++ QV G+ YL + +
Sbjct: 73 MIGICEAESW---MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFV 129
Query: 195 HRDLKPSNLLLNDKGCVKIV 214
HRDL N+LL + KI
Sbjct: 130 HRDLAARNVLLVTQHYAKIS 149
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 2e-28
Identities = 39/144 (27%), Positives = 65/144 (45%), Gaps = 5/144 (3%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL---FLQNNTLTRGELREVTGLTKCRHE 130
+F+ L +G+G++G V VR+ + A+K L + + E L RH
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 131 NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS 190
+ LK + VMEY + E FTE + + +++ L YLHS
Sbjct: 66 FLTALKYAFQTHD--RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 191 NFIIHRDLKPSNLLLNDKGCVKIV 214
+++RD+K NL+L+ G +KI
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKIT 147
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 2e-28
Identities = 40/171 (23%), Positives = 66/171 (38%), Gaps = 32/171 (18%)
Query: 74 EFEKLNRIGEGSYGVVYRVRD-----SVQDKILALKKLFLQNNTLTRGE-LREVTGLTKC 127
E +G G++G V + +A+K L + ++ R + E+ +T+
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 128 -RHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASL----------------------QD 163
HENIV L I+L+ EYC + DL + ++
Sbjct: 98 GSHENIVNLLGACTLSG--PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 164 NVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
+ T + C QV KG+ +L +HRDL N+L+ VKI
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKIC 206
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 3e-28
Identities = 39/144 (27%), Positives = 65/144 (45%), Gaps = 8/144 (5%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE------LREVTGLTKCR 128
++ +G G + VV + R+ A K + + +R REV+ L + +
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
H N++ L EV K+ + L++E + TE + + Q+L G+ YL
Sbjct: 72 HPNVITLHEVYENKT--DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVK 212
HS I H DLKP N++L D+ K
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPK 153
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 3e-28
Identities = 35/145 (24%), Positives = 64/145 (44%), Gaps = 8/145 (5%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDK---ILALKKLFLQNNTLTRGE-LREVTGLTKCRH 129
E IGEG +G V++ + +A+K + R + L+E + + H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
+IV+L V+ + +++ME C +L S + + + Q+ L YL
Sbjct: 68 PHIVKLIGVITENPV---WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKI 213
S +HRD+ N+L++ CVK+
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKL 149
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 106 bits (264), Expect = 5e-28
Identities = 34/146 (23%), Positives = 69/146 (47%), Gaps = 9/146 (6%)
Query: 68 KCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKC 127
+ N +++ + ++G G Y V+ + ++ + +K L + RE+ L
Sbjct: 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENL 86
Query: 128 R-HENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGL 185
R NI+ L ++V + LV E+ + D L T+ ++ + ++LK L
Sbjct: 87 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKAL 142
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCV 211
+Y HS I+HRD+KP N++++ +
Sbjct: 143 DYCHSMGIMHRDVKPHNVMIDHEHRK 168
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 1e-27
Identities = 36/166 (21%), Positives = 56/166 (33%), Gaps = 27/166 (16%)
Query: 74 EFEKLNRIGEGSYGVVYRVRD-----SVQDKILALKKLFLQNNTLTRGE-LREVTGLTKC 127
+G G++G V S +A+K L + R + E+ L+
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 128 -RHENIVQLKEVVVGKSLSSIFLVMEYCEH------------------DLASLQDNVESP 168
H NIV L ++ EYC + ++ ++ E
Sbjct: 84 GNHMNIVNLLGACTIGG--PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 169 FTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIV 214
+ QV KG+ +L S IHRDL N+LL KI
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKIC 187
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 2e-27
Identities = 37/147 (25%), Positives = 67/147 (45%), Gaps = 10/147 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKL----FLQNNTLTRGELREVTGLTKCRH 129
+F +G+GS+G V+ ++ A+K L L ++ + + + H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVES--PFTESQVKCVILQVLKGLNY 187
+ + K ++F VMEY L +++S F S+ +++ GL +
Sbjct: 63 PFLTHMFCTFQTKE--NLFFVMEYLNGG--DLMYHIQSCHKFDLSRATFYAAEIILGLQF 118
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKIV 214
LHS I++RDLK N+LL+ G +KI
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIA 145
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 4e-27
Identities = 37/162 (22%), Positives = 63/162 (38%), Gaps = 22/162 (13%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQD-----KILALKKLFL-QNNTLTRGELREVTGLTKC 127
+ +G G++G V D + +A+K L ++ R + E+ L
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEHDL----------------ASLQDNVESPFTE 171
H V K + +++E+C+ + +D + T
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 172 SQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ C QV KG+ +L S IHRDL N+LL++K VKI
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKI 175
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 8e-27
Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE--LREVTGLTKCRHENI 132
++ L+ +G G+YG V D+ +A+KKL ++ + RE+ L +HEN+
Sbjct: 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 133 VQLKEVVVGKS----LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
+ L +V + ++LV DL ++ T+ V+ +I Q+L+GL Y+
Sbjct: 80 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYI 137
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKIVY 215
HS IIHRDLKPSNL +N+ +KI+
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILD 164
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 3e-26
Identities = 46/146 (31%), Positives = 78/146 (53%), Gaps = 9/146 (6%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLF--LQNNTLTRGELREVTGLTKCRHENI 132
++ L IG G+ G+V D+V D+ +A+KKL QN T + RE+ + H+NI
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 133 VQLKEVVVGKS----LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYL 188
+ L V + ++LVME + +L ++ ++ ++ Q+L G+ +L
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLC---QVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 189 HSNFIIHRDLKPSNLLLNDKGCVKIV 214
HS IIHRDLKPSN+++ +KI+
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKIL 161
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 6e-26
Identities = 39/147 (26%), Positives = 60/147 (40%), Gaps = 16/147 (10%)
Query: 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKE 137
IG+G +G V+R + + +A+K + E E+ RHENI+
Sbjct: 8 QESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFRE-AEIYQTVMLRHENILGFIA 64
Query: 138 VVV--GKSLSSIFLVMEYCEHDLASLQDNVES-PFTESQVKCVILQVLKGLNYLHSNF-- 192
+ + ++LV +Y EH SL D + T + + L GL +LH
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHG--SLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 193 ------IIHRDLKPSNLLLNDKGCVKI 213
I HRDLK N+L+ G I
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCI 149
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 99.1 bits (246), Expect = 1e-25
Identities = 33/137 (24%), Positives = 59/137 (43%), Gaps = 5/137 (3%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIV 133
++ RIGEGS+GV++ + + ++ +A+K +++ R E R L C V
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 134 QLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFI 193
G+ LV++ L L D F+ V Q+L + +H +
Sbjct: 67 ----YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122
Query: 194 IHRDLKPSNLLLNDKGC 210
++RD+KP N L+
Sbjct: 123 VYRDIKPDNFLIGRPNS 139
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 1e-25
Identities = 34/158 (21%), Positives = 67/158 (42%), Gaps = 18/158 (11%)
Query: 74 EFEKLNRIGEGSYGVVYRVRD-----SVQDKILALKKLFLQNNTLTRGE-LREVTGLTKC 127
+ +G+GS+G+VY + +A+K + + R E L E + + +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCE----------HDLASLQDNVESPFTESQVKCV 177
++V+L VV ++ME A + V +P + S++ +
Sbjct: 81 NCHHVVRLLGVVSQGQ--PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 178 ILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVY 215
++ G+ YL++N +HRDL N ++ + VKI
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 2e-25
Identities = 33/146 (22%), Positives = 63/146 (43%), Gaps = 8/146 (5%)
Query: 74 EFEKLNRIGEGSYGVVYRVR----DSVQDKILALKKLFLQNNTLTRGE-LREVTGLTKCR 128
+ IG G +G VY+ ++ +A+K L R + L E + +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 129 HENIVQLKEVVVGKSLSSIFLVMEYCEHDLA-SLQDNVESPFTESQVKCVILQVLKGLNY 187
H NI++L+ V+ + ++ EY E+ + F+ Q+ ++ + G+ Y
Sbjct: 68 HHNIIRLEGVISKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 188 LHSNFIIHRDLKPSNLLLNDKGCVKI 213
L + +HRDL N+L+N K+
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKV 151
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 2e-25
Identities = 36/162 (22%), Positives = 64/162 (39%), Gaps = 22/162 (13%)
Query: 74 EFEKLNRIGEGSYGVVYRVRD--SVQDKILALKKLFLQNNTLTRGE-LREVTGLTKC-RH 129
+ + + IGEG++G V + R A+K++ + + E+ L K H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 130 ENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASL---------------QDNVESPFTESQ 173
NI+ L + ++L +EY H +L ++ S + Q
Sbjct: 71 PNIINLLGACEHRG--YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 174 VKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVY 215
+ V +G++YL IHRDL N+L+ + KI
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 170
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.4 bits (244), Expect = 2e-25
Identities = 39/170 (22%), Positives = 66/170 (38%), Gaps = 32/170 (18%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQD-----KILALKKLFLQNNTLTRGE-LREVTGLTKC 127
E + IGEG++G V++ R ++A+K L + + + + RE + +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 128 RHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASL-----------------------QD 163
+ NIV+L V + L+ EY + DL
Sbjct: 74 DNPNIVKLLGVCAVGK--PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 164 NVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
P + ++ C+ QV G+ YL +HRDL N L+ + VKI
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKI 181
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 1e-24
Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 8/163 (4%)
Query: 56 EPIEILEQDCFGKCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDK---ILALKKLFLQNNT 112
E ++ ++ G + F ++ IG G +G VY D A+K L +
Sbjct: 12 ELVQAVQHVVIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 69
Query: 113 LTRGE-LREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASLQDNVESPFT 170
+ L E + H N++ L + + S +V+ Y +H DL + N T
Sbjct: 70 GEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE-GSPLVVLPYMKHGDLRNFIRNETHNPT 128
Query: 171 ESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ LQV KG+ +L S +HRDL N +L++K VK+
Sbjct: 129 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKV 171
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.2 bits (236), Expect = 3e-24
Identities = 31/152 (20%), Positives = 63/152 (41%), Gaps = 14/152 (9%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE------LREVTGLTKC 127
+++ +G G +G VY + +A+K + + EV L K
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 128 R--HENIVQLKEVVVGKSLSSIFLVMEYCE--HDLASLQDNVESPFTESQVKCVILQVLK 183
+++L + S L++E E DL E + QVL+
Sbjct: 65 SSGFSGVIRLLDWFERPD--SFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLE 121
Query: 184 GLNYLHSNFIIHRDLKPSNLLLN-DKGCVKIV 214
+ + H+ ++HRD+K N+L++ ++G +K++
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLI 153
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 1e-23
Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 10/150 (6%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQ---DKILALKKL----FLQNNTLTRGELREVTGLTK 126
FE L +G G+YG V+ VR K+ A+K L +Q T E L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 127 CRHE-NIVQLKEVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGL 185
R +V L ++ + L+++Y + FTE +V+ + +++ L
Sbjct: 85 IRQSPFLVTLHYAFQTET--KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 186 NYLHSNFIIHRDLKPSNLLLNDKGCVKIVY 215
+LH II+RD+K N+LL+ G V +
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTD 172
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 3e-23
Identities = 35/167 (20%), Positives = 61/167 (36%), Gaps = 27/167 (16%)
Query: 74 EFEKLNRIGEGSYGVVYRVRDSVQDK-------ILALKKLFLQNNTLTRGE-LREVTGLT 125
+GEG++G V DK +A+K L + + E+ +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 126 KC-RHENIVQLKEVVVGKSLSSIFLVMEYCEH-DLASL---------------QDNVESP 168
+H+NI+ L +++++EY +L N E
Sbjct: 74 MIGKHKNIINLLGACTQDG--PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 169 FTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVY 215
+ + QV +G+ YL S IHRDL N+L+ + +KI
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.1 bits (207), Expect = 8e-21
Identities = 20/147 (13%), Positives = 48/147 (32%), Gaps = 20/147 (13%)
Query: 79 NRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGE----------LREVTGLTKCR 128
+GEG V+ + +K + + + + + +
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 129 HENIVQLKEVVVGKSL--SSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLN 186
+ +L+ + V K ++ME + V+ +L+ +
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAK-------ELYRVRVENPDEVLDMILEEVA 117
Query: 187 YLHSNFIIHRDLKPSNLLLNDKGCVKI 213
+ I+H DL N+L++++G I
Sbjct: 118 KFYHRGIVHGDLSQYNVLVSEEGIWII 144
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.5 bits (205), Expect = 1e-19
Identities = 33/155 (21%), Positives = 66/155 (42%), Gaps = 16/155 (10%)
Query: 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHEN--- 131
+ + ++G G + V+ +D V + +A+K + + T E+ L + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 132 --------IVQLKEVVVGKSLSSIFLVMEYCEHD---LASLQDNVESPFTESQVKCVILQ 180
I++L + K + + +VM + LA ++ VK + Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 181 VLKGLNYLHSNF-IIHRDLKPSNLLLNDKGCVKIV 214
+L GL+Y+H IIH D+KP N+L+ + +
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 224 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.95 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.74 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.38 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.22 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.23 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.02 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.42 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 85.93 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-41 Score=266.50 Aligned_cols=148 Identities=26% Similarity=0.414 Sum_probs=128.8
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|++++.||+|+||+||+|.++.+++.||+|++..... ...+.+.+|+.+|++++||||+++++++.+ .+.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~--~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE--GNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CceeEEE
Confidence 4679999999999999999999999999999999875432 234567899999999999999999999964 4589999
Q ss_pred EecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||++ +|...+ .....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 mEy~~gg~L~~~l-~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 82 LEYCSGGELFDRI-EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF 153 (271)
T ss_dssp EECCTTEEGGGGS-BTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeccCCCcHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheee
Confidence 999986 455554 34567999999999999999999999999999999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-41 Score=265.79 Aligned_cols=148 Identities=30% Similarity=0.498 Sum_probs=133.4
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
+.|++++.||+|+||+||+|++..++..||+|++........+.+.+|+.+|++++|||||++++++.. .+.+|+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY--ENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee--CCeEEEEEe
Confidence 469999999999999999999999999999999987666666788999999999999999999999954 458999999
Q ss_pred cccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||.++ +..++......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhcc
Confidence 99875 55555555677999999999999999999999999999999999999999999999999999754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=261.58 Aligned_cols=149 Identities=32% Similarity=0.453 Sum_probs=131.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc---CCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ---NNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
.+++|++.+.||+|+||+||+|++..+++.||+|++... .......+.+|+.+++.++||||+++++++.+ .+.+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~ 81 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD--ATRV 81 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--SSEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE--CCEE
Confidence 467899999999999999999999999999999998643 22344567889999999999999999999954 4589
Q ss_pred EEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+|||||+++ +...+. ....+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 82 ~ivmEy~~~g~L~~~l~-~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~ 156 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQ-KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 156 (263)
T ss_dssp EEEEECCTTCBHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCC
T ss_pred EEEEeecCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeec
Confidence 9999999865 544444 4567999999999999999999999999999999999999999999999999999754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-41 Score=266.81 Aligned_cols=148 Identities=26% Similarity=0.431 Sum_probs=131.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++++.||+|+||+||+|.+..+++.||+|++........+.+.+|+.+|+.++|||||++++++... +.+|+||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~ivm 96 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG--DELWVVM 96 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET--TEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC--CEEEEEE
Confidence 45799999999999999999999999999999999876655566788999999999999999999999644 4899999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+++.+..+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 97 Ey~~gg~L~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~ 166 (293)
T d1yhwa1 97 EYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (293)
T ss_dssp ECCTTCBHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCcHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheee
Confidence 9998754443333 356999999999999999999999999999999999999999999999999999865
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-40 Score=265.52 Aligned_cols=148 Identities=34% Similarity=0.545 Sum_probs=132.5
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
..|+.++.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.+|++++|||||++++++... +.+|+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--~~~~i 92 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWL 92 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET--TEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC--CEEEE
Confidence 459999999999999999999999999999999875432 2234578999999999999999999999654 58999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||||.++++..+.....++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeeccccccc
Confidence 9999998877666666778999999999999999999999999999999999999999999999999999854
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=268.44 Aligned_cols=148 Identities=28% Similarity=0.442 Sum_probs=130.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.++|++++.||+|+||+||+|++..+++.||+|++..... .....+.+|+.+|+.++|||||++++++.. .+.+|+|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS--DGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 4679999999999999999999999999999999875433 334567899999999999999999999954 4589999
Q ss_pred EecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||.++ |..++. ..+.+++..++.++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 83 mEy~~gg~L~~~l~-~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~ 155 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155 (322)
T ss_dssp EECCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred EEcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence 9999975 544444 35679999999999999999999997 59999999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-40 Score=265.44 Aligned_cols=150 Identities=26% Similarity=0.375 Sum_probs=132.7
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc---CCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ---NNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
.+++|++++.||+|+||+||+|++..+++.||||++... .......+.+|+.+|+.++||||+++++++. +.+.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~~ 80 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ--THDRL 80 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE--CSSEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec--ccccc
Confidence 467899999999999999999999999999999999743 2234466789999999999999999999995 44589
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+|||||.++.+..+....+.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccc
Confidence 999999997655444455678999999999999999999999999999999999999999999999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-40 Score=259.87 Aligned_cols=148 Identities=24% Similarity=0.339 Sum_probs=130.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.+|++++||||+++++++.+ .+.+|
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~--~~~~~ 84 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD--DEKLY 84 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC--SSEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE--CCEEE
Confidence 357999999999999999999999999999999986432 2334567899999999999999999999954 45899
Q ss_pred EEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||||+++ +..++. ..+.+++..++.++.|++.||+|||+++|+||||||+|||++.+|.+||+|||+|+.+
T Consensus 85 ivmEy~~gg~L~~~~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp EEECCCTTEEHHHHHH-HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEccCCCCHHHhhh-ccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceec
Confidence 999999875 545444 4567999999999999999999999999999999999999999999999999999865
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.5e-39 Score=265.38 Aligned_cols=149 Identities=19% Similarity=0.323 Sum_probs=131.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++++.||+|+||+||+|.+..+++.||||++..........+.+|+.+|++++|||||++++++. ..+.+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~--~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE--DKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE--CSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEEEE
Confidence 356999999999999999999999999999999987654444556778999999999999999999995 445899999
Q ss_pred ecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc--cCCcEEEEeccccccc
Q psy13250 152 EYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLN--DKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~--~~~~~kl~DfGla~~~ 222 (224)
|||+|+ |...+.....++++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.+
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence 999864 5555555556799999999999999999999999999999999999998 5789999999999864
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-39 Score=261.74 Aligned_cols=149 Identities=28% Similarity=0.368 Sum_probs=133.3
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeecc---CCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ---NNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
+++|++++.||+|+||+||+|+++.+++.||||++... .....+.+.+|+.+|+.++||||+++++++. ..+.+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~ 80 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ--DAQQIF 80 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE--CSSEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe--eCCeee
Confidence 57899999999999999999999999999999998643 2234456789999999999999999999995 445899
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||||.|+.+..+......+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 81 ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~ 154 (316)
T d1fota_ 81 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV 154 (316)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred eEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEe
Confidence 99999998766666666778999999999999999999999999999999999999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-39 Score=259.70 Aligned_cols=149 Identities=21% Similarity=0.299 Sum_probs=130.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||+||+|.+..+++.||||++.... ...+.+.+|+.+|++++|||||++++++. ..+.+|+|
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~iv 91 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT--REPPFYII 91 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC--SSSSCEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEe--eCCeeEEE
Confidence 4568999999999999999999999999999999986543 33456789999999999999999999994 44588999
Q ss_pred EecccCC-hhHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHD-LASLQDN-VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~-l~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+++ +...+.. ....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 9999864 5555543 3457899999999999999999999999999999999999999999999999999865
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=257.29 Aligned_cols=151 Identities=32% Similarity=0.474 Sum_probs=124.1
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~l 149 (224)
.++|++++.||+|+||+||+|+++.+++.||+|++..... ...+.+.+|+.+|++++|||||++++++.+...+.+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 3679999999999999999999999999999999875432 22345678999999999999999999998766668999
Q ss_pred EEecccC-ChhHhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 150 VMEYCEH-DLASLQDN---VESPFTESQVKCVILQVLKGLNYLHSNF-----IIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 150 v~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH~~~-----iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
|||||++ +|..++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999986 45555432 3567999999999999999999999876 9999999999999999999999999998
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
.+
T Consensus 163 ~~ 164 (269)
T d2java1 163 IL 164 (269)
T ss_dssp HC
T ss_pred ec
Confidence 64
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.7e-39 Score=263.73 Aligned_cols=150 Identities=21% Similarity=0.350 Sum_probs=132.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
.+++|++++.||+|+||+||+|++..+++.||||++........+.+.+|+.+|++++|||||++++++.+ .+.+|||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~iv 101 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED--DNEMVMI 101 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE--CCEEEEE
Confidence 35689999999999999999999999999999999876554445667899999999999999999999954 4589999
Q ss_pred EecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc--CCcEEEEeccccccc
Q psy13250 151 MEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND--KGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~--~~~~kl~DfGla~~~ 222 (224)
||||++ +|...+....+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+|+.+
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 999986 566666555677999999999999999999999999999999999999964 578999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-39 Score=257.16 Aligned_cols=148 Identities=34% Similarity=0.649 Sum_probs=130.2
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
++|++++.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.+|++++|||||++++++.. .+.+|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~--~~~~~iv 79 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT--ENKLYLV 79 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE--TTEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc--ccceeEE
Confidence 589999999999999999999999999999999865432 345677899999999999999999999954 4589999
Q ss_pred EecccCChhHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDN-VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+.+++...... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~ 152 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 152 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceec
Confidence 99999876665544 3567999999999999999999999999999999999999999999999999999754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.4e-39 Score=255.83 Aligned_cols=152 Identities=23% Similarity=0.335 Sum_probs=123.8
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCe---EEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDK---ILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~---~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
....++|++.+.||+|+||+||+|.+..++. .||||.+..... ...+.+.+|+.+|++++|||||++++++. ..
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~--~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT--KS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe--eC
Confidence 3456789999999999999999999876553 688888764333 23456789999999999999999999994 44
Q ss_pred ceEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 145 SSIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 145 ~~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+.+|+|||||+++ +..++....+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 5799999999875 55555555667999999999999999999999999999999999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-38 Score=250.97 Aligned_cols=147 Identities=27% Similarity=0.373 Sum_probs=129.6
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCcc---------chhHHHHHHHhhcCC-CCCeeeeeEEEEcC
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTL---------TRGELREVTGLTKCR-HENIVQLKEVVVGK 142 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~---------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~ 142 (224)
++|++.+.||+|+||+||+|++..+++.+|||++....... ...+.+|+.+++++. ||||+++++++.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~-- 80 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE-- 80 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc--
Confidence 57999999999999999999999999999999987543221 234678999999997 999999999995
Q ss_pred CcceEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecccccc
Q psy13250 143 SLSSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLEL 221 (224)
Q Consensus 143 ~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~ 221 (224)
+.+.+|||||||++ +|.+++.. ++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 159 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 159 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred cCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeE
Confidence 45689999999986 56655544 56799999999999999999999999999999999999999999999999999986
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
+
T Consensus 160 ~ 160 (277)
T d1phka_ 160 L 160 (277)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-38 Score=259.59 Aligned_cols=149 Identities=26% Similarity=0.366 Sum_probs=130.9
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
+++|++++.||+|+||+||+|+++.+++.||||++.... ....+.+.+|+.+|+.++|||||++++++. ....+|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~--~~~~~~ 117 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK--DNSNLY 117 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE--CSSEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc--cccccc
Confidence 578999999999999999999999999999999986432 233456789999999999999999999995 445899
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+||||+.++.+.......+.+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+|+.+
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 99999987644444444567999999999999999999999999999999999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-38 Score=249.63 Aligned_cols=148 Identities=27% Similarity=0.269 Sum_probs=125.7
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEc--CCcceEEEE
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVG--KSLSSIFLV 150 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--~~~~~~~lv 150 (224)
|++.++||+|+||+||+|.+..++..||+|++..... ...+.+.+|+.+|++++|||||++++++.. .....+|+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 5777889999999999999999999999999875432 233456799999999999999999999864 234578999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEc-cCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNF--IIHRDLKPSNLLLN-DKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--iiHrDlkp~Nill~-~~~~~kl~DfGla~~~ 222 (224)
||||+++.+..+......+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+..
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999987544443344567999999999999999999999998 99999999999997 4789999999999853
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-38 Score=255.47 Aligned_cols=147 Identities=27% Similarity=0.368 Sum_probs=119.7
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
+.|++.+.||+|+||+||+|++..+++.||||++..... .....+.+|+.+|+.++|||||++++++. ..+.+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE--SGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE--CSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCEEEEEE
Confidence 459999999999999999999999999999999875432 23345668999999999999999999995 445899999
Q ss_pred ecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc---cCCcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLN---DKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~---~~~~~kl~DfGla~~~ 222 (224)
|||+| +|..++. ..+.+++..+..++.||+.||.|||+++|+||||||+|||+. .++.+||+|||+|+..
T Consensus 87 E~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIV-EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHH-TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhh-cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99986 5555554 467799999999999999999999999999999999999995 4789999999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-38 Score=249.93 Aligned_cols=147 Identities=27% Similarity=0.393 Sum_probs=127.8
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC------ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN------TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.+|++++|||||++++++. +.+.
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~ 87 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE--NKTD 87 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE--CSSE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE--ECCE
Confidence 459999999999999999999999999999999865322 12355789999999999999999999995 4458
Q ss_pred EEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC----cEEEEecccccc
Q psy13250 147 IFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG----CVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~----~~kl~DfGla~~ 221 (224)
+|||||||+++ |..++.. .+.+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+|+.
T Consensus 88 ~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 99999999865 5555443 56799999999999999999999999999999999999999877 499999999975
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
.
T Consensus 167 ~ 167 (293)
T d1jksa_ 167 I 167 (293)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-38 Score=248.33 Aligned_cols=147 Identities=24% Similarity=0.349 Sum_probs=125.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++.+.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+.++++++||||+++++++.. .+.+|+||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~~lv~ 79 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE--QAPICLVF 79 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSSCEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceecc--CCceEEEE
Confidence 457999999999999999999986 56789999986433 344678899999999999999999999954 45789999
Q ss_pred ecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||+++ +..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 151 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFV 151 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheec
Confidence 999864 55555555677999999999999999999999999999999999999999999999999999864
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-38 Score=253.97 Aligned_cols=148 Identities=21% Similarity=0.354 Sum_probs=129.2
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++++.||+|+||+||+|.+..+++.||+|++..... ....+.+|+.+|+.++||||+++++++.+ .+.+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~--~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFES--MEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEE--TTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEE--CCEEEEEE
Confidence 4579999999999999999999999999999999865432 23456799999999999999999999954 45899999
Q ss_pred ecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC--CcEEEEeccccccc
Q psy13250 152 EYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK--GCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~--~~~kl~DfGla~~~ 222 (224)
|||+| +|...+......+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+..
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence 99986 5666665555579999999999999999999999999999999999999854 47999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-38 Score=254.77 Aligned_cols=144 Identities=37% Similarity=0.627 Sum_probs=126.2
Q ss_pred EeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-----ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 77 KLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-----TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 77 ~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.+|+.++|||||++++++. ..+.+|+||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~--~~~~~~ivm 79 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG--HKSNISLVF 79 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC--CTTCCEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec--cCCceeehh
Confidence 46889999999999999999999999999864332 22456789999999999999999999994 455899999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||.+++...+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~ 150 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 150 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCcccccc
Confidence 99998877777776778999999999999999999999999999999999999999999999999999764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.2e-38 Score=257.43 Aligned_cols=148 Identities=22% Similarity=0.345 Sum_probs=125.7
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---Cccch---hHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTR---GELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
+++|++.+.||+|+||.||+|++..+++.||||++.... ..... ...+++.+++.+.|||||++++++.. .+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~--~~ 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT--PD 80 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC--SS
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE--CC
Confidence 578999999999999999999999999999999986422 11122 22345677888899999999999954 45
Q ss_pred eEEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+|+|||||.++ |..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus 81 ~~~ivmE~~~gg~L~~~l~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLS-QHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEEEEECCCCSCBHHHHHH-HHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEEEEecCCCcHHHHHH-hcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 899999999865 554444 4567999999999999999999999999999999999999999999999999999865
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.2e-38 Score=248.35 Aligned_cols=147 Identities=35% Similarity=0.616 Sum_probs=132.9
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
++|+++++||+|+||+||+|++. +++.||||++..... ...+.+.+|+.+|++++||||+++++++.. .+..|++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~--~~~~~i~ 78 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT--KKRLVLV 78 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC--SSCEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc--CCceeEE
Confidence 57999999999999999999986 778999999865432 335678899999999999999999999954 4589999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||++.+++...+....+.+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|..+
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~ 150 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF 150 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceec
Confidence 999999888888777888999999999999999999999999999999999999999999999999999754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-38 Score=249.02 Aligned_cols=146 Identities=29% Similarity=0.379 Sum_probs=125.4
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIF 148 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 148 (224)
..++|++.+.||+|+||+||+|+.. ..||||++..... ...+.+.+|+.+|++++|||||++++++.. ..+|
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---~~~~ 79 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---PQLA 79 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS---SSCE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec---cEEE
Confidence 4568999999999999999999753 3599999865432 334567899999999999999999998732 3589
Q ss_pred EEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||||++ +|..++......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 99999985 566666666677999999999999999999999999999999999999999999999999999764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=246.29 Aligned_cols=147 Identities=23% Similarity=0.357 Sum_probs=125.8
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
+.++|++.+.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+.+|++++|||||++++++.+ +.+|+|
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~---~~~~iv 85 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ---EPIYII 85 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc---CCeEEE
Confidence 4578999999999999999999976 57889999986433 334668899999999999999999998743 357999
Q ss_pred EecccCC-hhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHD-LASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~-l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||+++ +...+... ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEc
Confidence 9999875 44433222 235999999999999999999999999999999999999999999999999999865
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=250.65 Aligned_cols=149 Identities=23% Similarity=0.311 Sum_probs=127.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccC---CccchhHHHHHHHhh-cCCCCCeeeeeEEEEcCCcceE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQN---NTLTRGELREVTGLT-KCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~ 147 (224)
+++|++.+.||+|+||+||+|.+..+++.||||++.... ....+...+|+.++. .++||||+++++++.+ .+.+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--~~~~ 78 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--KENL 78 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc--CCce
Confidence 367999999999999999999999999999999997432 233345567777665 6899999999999954 4589
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||||||+++.+..+......+++..++.++.||+.||+|||+++|+||||||+|||++.+|.+||+|||+|+..
T Consensus 79 yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 79 FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred eEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhc
Confidence 999999987544444444667999999999999999999999999999999999999999999999999999854
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-37 Score=244.93 Aligned_cols=149 Identities=21% Similarity=0.317 Sum_probs=124.0
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCC----eEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQD----KILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~----~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
.+.|++.+.||+|+||.||+|.+..++ ..||||++...... ....+.+|+.++++++|||||++++++. ....
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~--~~~~ 83 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS--KYKP 83 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe--cCCc
Confidence 456999999999999999999877554 57999998654332 3345789999999999999999999994 4457
Q ss_pred EEEEEecccCCh-hHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHDL-ASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~l-~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+|||||.+++ ..........+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 999999998754 4445555677999999999999999999999999999999999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-37 Score=240.89 Aligned_cols=147 Identities=25% Similarity=0.343 Sum_probs=129.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEE
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
.++|++.++||+|+||+||+|+++ ++..||||+++.... ..+.+.+|+..+++++||||+++++++. ..+.+|+||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~--~~~~~~iv~ 78 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT--KQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEEC--CSSSEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEe--eCCceEEEE
Confidence 468999999999999999999985 778899999875433 3467889999999999999999999994 445899999
Q ss_pred ecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 152 EYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 152 e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+.++ +..........+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.+
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~ 150 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 150 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheec
Confidence 999864 55555555677999999999999999999999999999999999999999999999999999754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-37 Score=243.56 Aligned_cols=148 Identities=24% Similarity=0.269 Sum_probs=125.9
Q ss_pred ccceeEeee-eeccCceEEEEEEEcc--CCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 72 VAEFEKLNR-IGEGSYGVVYRVRDSV--QDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 72 ~~~~~~~~~-lG~G~fg~V~~~~~~~--~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
.++|.+.+. ||+|+||+||+|.+.. ++..||||++..... ...+.+.+|+.+|++++|||||++++++.. +.+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~ 83 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA---EAL 83 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES---SSE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc---CeE
Confidence 356888884 9999999999997653 456899999865433 334667899999999999999999999853 258
Q ss_pred EEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+|||||+++ |..++...+..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcc
Confidence 9999999964 55555555677999999999999999999999999999999999999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-37 Score=247.64 Aligned_cols=150 Identities=26% Similarity=0.342 Sum_probs=124.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCC-----eEEEEEEeeccC-CccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQD-----KILALKKLFLQN-NTLTRGELREVTGLTKC-RHENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~-----~~~avK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (224)
+.++|++.+.||+|+||+||+|++..++ ..||+|.+.... ......+.+|+.+|.++ +|||||++++++. .
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~--~ 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT--L 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC--S
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe--e
Confidence 4578999999999999999999986544 368999886433 23455678999999987 8999999999994 4
Q ss_pred cceEEEEEecccC-ChhHhhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy13250 144 LSSIFLVMEYCEH-DLASLQDNVE----------------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKP 200 (224)
Q Consensus 144 ~~~~~lv~e~~~~-~l~~~~~~~~----------------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp 200 (224)
.+.+|+|||||++ +|..++.... ..+++..++.++.|++.||.|||+++|+||||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCch
Confidence 4589999999986 5665554332 3488999999999999999999999999999999
Q ss_pred CcEEEccCCcEEEEeccccccc
Q psy13250 201 SNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 201 ~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||++.++.+||+|||+|+..
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~ 214 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDI 214 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCG
T ss_pred hccccccCCeEEEeeccccccc
Confidence 9999999999999999999754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7e-37 Score=242.23 Aligned_cols=150 Identities=25% Similarity=0.281 Sum_probs=129.8
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC---ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc--ceE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN---TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL--SSI 147 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~~ 147 (224)
++|++.+.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++..... ..+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 469999999999999999999999999999999875432 233457899999999999999999999865432 358
Q ss_pred EEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|||||||+|+.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++..
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence 999999997654444444567999999999999999999999999999999999999999999999999998653
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=244.71 Aligned_cols=154 Identities=39% Similarity=0.690 Sum_probs=133.0
Q ss_pred cccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC---
Q psy13250 69 CRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKS--- 143 (224)
Q Consensus 69 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--- 143 (224)
+..+++|++++.||+|+||+||+|++..+++.||||++..... .....+.+|+.+|+.++||||+++++++....
T Consensus 6 ~~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~ 85 (318)
T d3blha1 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPY 85 (318)
T ss_dssp SCBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred CCccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccc
Confidence 4567899999999999999999999999999999999865432 34566789999999999999999999885422
Q ss_pred ---cceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 144 ---LSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 144 ---~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.+.+|++||||.+++..........+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 86 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 34689999999988877777767789999999999999999999999999999999999999999999999999997
Q ss_pred cc
Q psy13250 221 LY 222 (224)
Q Consensus 221 ~~ 222 (224)
.+
T Consensus 166 ~~ 167 (318)
T d3blha1 166 AF 167 (318)
T ss_dssp EC
T ss_pred ec
Confidence 54
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-36 Score=241.69 Aligned_cols=148 Identities=36% Similarity=0.670 Sum_probs=133.5
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
++|++++.||+|+||+||+|++..+++.||||+++.... .....+.+|+.+|+.++||||+++++++.. ....+++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~iv 79 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS--DKKLTLV 79 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC--SSEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc--ccceeEE
Confidence 579999999999999999999999999999999875443 234567899999999999999999999954 4588999
Q ss_pred EecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|++.++.+..+....+.+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||.|+.+
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~ 151 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF 151 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcc
Confidence 999998777777677788999999999999999999999999999999999999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-36 Score=248.01 Aligned_cols=145 Identities=28% Similarity=0.420 Sum_probs=125.3
Q ss_pred ceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcC----CcceEEE
Q psy13250 74 EFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGK----SLSSIFL 149 (224)
Q Consensus 74 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~~~~l 149 (224)
+|+.++.||+|+||+||+|++..+++.||||++..... ...+|+.+|++++||||+++++++... +..++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 69999999999999999999999999999999865432 234799999999999999999998532 3346899
Q ss_pred EEecccCChhHhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC-cEEEEeccccccc
Q psy13250 150 VMEYCEHDLASLQD---NVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG-CVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~l~~~~~---~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfGla~~~ 222 (224)
|||||++++...+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999987655443 3456799999999999999999999999999999999999999876 8999999999764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-36 Score=244.35 Aligned_cols=146 Identities=23% Similarity=0.389 Sum_probs=127.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~l 149 (224)
..++|+++++||+|+||+||+|++..+++.||||++... ..+.+.+|+.+|+.+. ||||+++++++.......+|+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 456899999999999999999999999999999998532 3456788999999985 999999999997666678999
Q ss_pred EEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC-cEEEEeccccccc
Q psy13250 150 VMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKG-CVKIVYSTYLELY 222 (224)
Q Consensus 150 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfGla~~~ 222 (224)
|||||.++.+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.+
T Consensus 110 v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~ 180 (328)
T d3bqca1 110 VFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180 (328)
T ss_dssp EEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred EEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceec
Confidence 9999997654333 34699999999999999999999999999999999999999765 6899999999754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-36 Score=239.79 Aligned_cols=141 Identities=24% Similarity=0.280 Sum_probs=118.7
Q ss_pred eeeeccCceEEEEEEEc--cCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEecc
Q psy13250 79 NRIGEGSYGVVYRVRDS--VQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVMEYC 154 (224)
Q Consensus 79 ~~lG~G~fg~V~~~~~~--~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 154 (224)
++||+|+||+||+|.+. .+++.||||++..... ...+.+.+|+.+|++++|||||++++++.. +..|||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~---~~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---ESWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES---SSEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc---CCEEEEEEcC
Confidence 46999999999999864 3567899999864322 234567899999999999999999999843 2578999999
Q ss_pred cCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 155 EHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+++.+..+......+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 90 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 90 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhc
Confidence 87544444444677999999999999999999999999999999999999999999999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-37 Score=240.85 Aligned_cols=148 Identities=20% Similarity=0.223 Sum_probs=125.2
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC------ccchhHHHHHHHhhcCC--CCCeeeeeEEEEcCCc
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN------TLTRGELREVTGLTKCR--HENIVQLKEVVVGKSL 144 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~ 144 (224)
++|++.+.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+|++++ ||||+++++++. ..
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~--~~ 81 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--RP 81 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--CS
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe--eC
Confidence 479999999999999999999999999999999875321 12234568999999886 899999999995 44
Q ss_pred ceEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC-CcEEEEeccccccc
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDK-GCVKIVYSTYLELY 222 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~-~~~kl~DfGla~~~ 222 (224)
+.+|+||||+.+ +....+......+++..++.++.|++.||+|||+++|+||||||+|||++.+ +.+||+|||+|+..
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 589999999975 3333333345679999999999999999999999999999999999999854 79999999999754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-36 Score=240.51 Aligned_cols=147 Identities=24% Similarity=0.327 Sum_probs=124.9
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEE
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLV 150 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv 150 (224)
..++|++.+.||+|+||+||+|.+..+ ..||||++.... ...+.+.+|+.+|++++|||||++++++.+ +.+|+|
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~---~~~~lv 89 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---EPIYIV 89 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS---SSCEEE
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec---CCeEEE
Confidence 346899999999999999999998755 569999986443 334678899999999999999999999843 357999
Q ss_pred EecccCC-hhHhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 151 MEYCEHD-LASLQDN-VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 151 ~e~~~~~-l~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||||.++ +..++.. ....+++..++.++.||+.||.|||+++|+||||||+|||++.++++||+|||+|+.+
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 9999875 4444333 2356999999999999999999999999999999999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-36 Score=238.20 Aligned_cols=149 Identities=23% Similarity=0.314 Sum_probs=121.7
Q ss_pred cccceeEeeeeeccCceEEEEEEEccC---CeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQ---DKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 146 (224)
+.++|++.+.||+|+||+||+|.+..+ +..||||.+..... ...+.+.+|+.+|++++||||+++++++.+ +.
T Consensus 5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~---~~ 81 (273)
T d1mp8a_ 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE---NP 81 (273)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---SS
T ss_pred CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---Ce
Confidence 446899999999999999999998654 45788998754333 234567899999999999999999999842 46
Q ss_pred EEEEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+|||||+++ +..+.......+++..++.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+|+.+
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 89999999865 55555555677999999999999999999999999999999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-36 Score=242.58 Aligned_cols=147 Identities=22% Similarity=0.327 Sum_probs=124.4
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCe----EEEEEEeeccC-CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDK----ILALKKLFLQN-NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~----~~avK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
.+|++++.||+|+||+||+|.+..+++ .||+|.+.... ....+.+.+|+.++++++|||||++++++... ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS---SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---Ce
Confidence 579999999999999999999887765 57888775432 23456788999999999999999999999643 46
Q ss_pred EEEEeccc-CChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCE-HDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+++||++. +++...+......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 77788876 5677777776778999999999999999999999999999999999999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-36 Score=243.42 Aligned_cols=147 Identities=24% Similarity=0.340 Sum_probs=124.7
Q ss_pred cccceeEee-eeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhc-CCCCCeeeeeEEEEc--CCcce
Q psy13250 71 NVAEFEKLN-RIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTK-CRHENIVQLKEVVVG--KSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~-~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~--~~~~~ 146 (224)
-.++|+++. .||+|+||+||+|++..+++.||||++.. .....+|+.++.+ .+|||||+++++|.+ .....
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 356899886 59999999999999999999999999852 3456789988655 589999999999853 33457
Q ss_pred EEEEEecccC-ChhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc---CCcEEEEecccccc
Q psy13250 147 IFLVMEYCEH-DLASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND---KGCVKIVYSTYLEL 221 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~---~~~~kl~DfGla~~ 221 (224)
+|||||||+| +|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+.
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence 9999999986 566666543 346999999999999999999999999999999999999986 56799999999986
Q ss_pred c
Q psy13250 222 Y 222 (224)
Q Consensus 222 ~ 222 (224)
.
T Consensus 164 ~ 164 (335)
T d2ozaa1 164 T 164 (335)
T ss_dssp C
T ss_pred c
Confidence 5
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-36 Score=243.83 Aligned_cols=148 Identities=33% Similarity=0.556 Sum_probs=125.4
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc---ceEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSL---SSIF 148 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~~~ 148 (224)
++|++++.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.+|+.++||||+++++++..... ...|
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 469999999999999999999999999999999865432 334567899999999999999999999864322 3467
Q ss_pred EEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 149 LVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 149 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
++|++++++|..++.. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 88 l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 7777777778777654 46999999999999999999999999999999999999999999999999999754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-35 Score=235.50 Aligned_cols=155 Identities=33% Similarity=0.587 Sum_probs=128.3
Q ss_pred ccccccceeEeeeeeccCceEEEEEEEccC-CeEEEEEEeeccCC--ccchhHHHHHHHhhc---CCCCCeeeeeEEEEc
Q psy13250 68 KCRNVAEFEKLNRIGEGSYGVVYRVRDSVQ-DKILALKKLFLQNN--TLTRGELREVTGLTK---CRHENIVQLKEVVVG 141 (224)
Q Consensus 68 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~-~~~~avK~~~~~~~--~~~~~~~~e~~~l~~---l~h~niv~~~~~~~~ 141 (224)
.++..++|++++.||+|+||+||+|++..+ ++.||||++..... .......+|+.+|+. ++||||+++++++..
T Consensus 2 ~c~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~ 81 (305)
T d1blxa_ 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81 (305)
T ss_dssp CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred CCCCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence 345567899999999999999999999755 67899999865432 234456677776655 489999999998853
Q ss_pred ---CCcceEEEEEecccCChhHhhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEecc
Q psy13250 142 ---KSLSSIFLVMEYCEHDLASLQD-NVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYST 217 (224)
Q Consensus 142 ---~~~~~~~lv~e~~~~~l~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG 217 (224)
.....+|++|||+.+++..+.. .....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 82 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchh
Confidence 2345789999999987665443 345569999999999999999999999999999999999999999999999999
Q ss_pred ccccc
Q psy13250 218 YLELY 222 (224)
Q Consensus 218 la~~~ 222 (224)
+++..
T Consensus 162 ~~~~~ 166 (305)
T d1blxa_ 162 LARIY 166 (305)
T ss_dssp SCCCC
T ss_pred hhhhh
Confidence 99754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-36 Score=243.93 Aligned_cols=149 Identities=32% Similarity=0.535 Sum_probs=123.4
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCC----cc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGKS----LS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~ 145 (224)
.++|++++.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.+|+.++|||||++++++.... ..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 3579999999999999999999999999999999864322 23456789999999999999999999996432 23
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+|+|||||+.++..+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+|++|||+|+..
T Consensus 97 ~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 97 DFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 5799999997666655543 56999999999999999999999999999999999999999999999999999754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-36 Score=238.53 Aligned_cols=151 Identities=25% Similarity=0.344 Sum_probs=115.3
Q ss_pred cccceeEeeeeeccCceEEEEEEEcc-----CCeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSV-----QDKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (224)
+.++|++.+.||+|+||+||+|.+.. +++.||||++..... ...+.+.+|+..+.++ +|+||+.+++++..+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~- 89 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 89 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC-
Confidence 45789999999999999999999754 347899999864433 2344566777777665 689999999887533
Q ss_pred cceEEEEEecccCC-hhHhhhhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc
Q psy13250 144 LSSIFLVMEYCEHD-LASLQDNV---------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND 207 (224)
Q Consensus 144 ~~~~~lv~e~~~~~-l~~~~~~~---------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~ 207 (224)
...+|+|||||+++ +..++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 34789999999864 55554322 235889999999999999999999999999999999999999
Q ss_pred CCcEEEEeccccccc
Q psy13250 208 KGCVKIVYSTYLELY 222 (224)
Q Consensus 208 ~~~~kl~DfGla~~~ 222 (224)
++.+||+|||+|+..
T Consensus 170 ~~~~Kl~DFGla~~~ 184 (299)
T d1ywna1 170 KNVVKICDFGLARDI 184 (299)
T ss_dssp GGCEEECC------C
T ss_pred CCcEEEccCcchhhc
Confidence 999999999999754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-36 Score=235.98 Aligned_cols=148 Identities=28% Similarity=0.361 Sum_probs=119.6
Q ss_pred ccceeEeeeeeccCceEEEEEEEccC---CeEEEEEEeeccC---CccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQ---DKILALKKLFLQN---NTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~---~~~~avK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 145 (224)
.++|++.+.||+|+||+||+|+.... ...||||++.... ....+.+.+|+.+|++++||||+++++++.+ .
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~---~ 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT---P 83 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---S
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee---c
Confidence 46799999999999999999986533 3478999886432 2334567899999999999999999999943 2
Q ss_pred eEEEEEecccC-ChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEH-DLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
.+++|||||++ ++..........+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence 57899999985 555555555667999999999999999999999999999999999999999999999999999865
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-35 Score=236.58 Aligned_cols=150 Identities=26% Similarity=0.378 Sum_probs=127.1
Q ss_pred cccceeEeeeeeccCceEEEEEEEcc-----CCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCCc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSV-----QDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKSL 144 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 144 (224)
+.++|++.+.||+|+||+||+|++.. ++..||||++...... ..+.+.+|+.+|+.++||||+++++++. ..
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~--~~ 88 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA--VG 88 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec--cC
Confidence 45689999999999999999999753 4678999998754433 3456789999999999999999999994 44
Q ss_pred ceEEEEEecccC-ChhHhhhhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy13250 145 SSIFLVMEYCEH-DLASLQDNV-----------------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKP 200 (224)
Q Consensus 145 ~~~~lv~e~~~~-~l~~~~~~~-----------------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp 200 (224)
...+++|||+.+ ++..++... ...+++..+..++.|++.||+|||+++|+||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence 578999999985 455554322 12488999999999999999999999999999999
Q ss_pred CcEEEccCCcEEEEeccccccc
Q psy13250 201 SNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 201 ~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|||++.++.+||+|||+|+.+
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~ 190 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNI 190 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHH
T ss_pred cceEECCCCcEEEccchhheec
Confidence 9999999999999999999754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-35 Score=235.97 Aligned_cols=150 Identities=25% Similarity=0.354 Sum_probs=125.5
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeE--EEEEEeecc-CCccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCCcce
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKI--LALKKLFLQ-NNTLTRGELREVTGLTKC-RHENIVQLKEVVVGKSLSS 146 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~--~avK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~ 146 (224)
+.++|++.+.||+|+||+||+|.+..++.. ||||++... .....+.+.+|+.+|+++ +|||||++++++... +.
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~ 85 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GY 85 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--Ce
Confidence 457899999999999999999999888764 677776533 223456788999999998 799999999999644 58
Q ss_pred EEEEEecccC-ChhHhhhh---------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCc
Q psy13250 147 IFLVMEYCEH-DLASLQDN---------------VESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGC 210 (224)
Q Consensus 147 ~~lv~e~~~~-~l~~~~~~---------------~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 210 (224)
+|+||||+++ ++..++.. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc
Confidence 9999999986 45555432 1356999999999999999999999999999999999999999999
Q ss_pred EEEEeccccccc
Q psy13250 211 VKIVYSTYLELY 222 (224)
Q Consensus 211 ~kl~DfGla~~~ 222 (224)
+||+|||+|+..
T Consensus 166 ~kl~DfG~a~~~ 177 (309)
T d1fvra_ 166 AKIADFGLSRGQ 177 (309)
T ss_dssp EEECCTTCEESS
T ss_pred eEEccccccccc
Confidence 999999999753
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-35 Score=231.32 Aligned_cols=150 Identities=25% Similarity=0.344 Sum_probs=123.9
Q ss_pred ccccccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceE
Q psy13250 68 KCRNVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 68 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 147 (224)
+....++|++.+.||+|+||.||+|.++ +..||||+++.+ ...+.+.+|+.++++++||||+++++++.+. .+.+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~ 76 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-KGGL 76 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---CC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec-CCcE
Confidence 3446778999999999999999999974 778999998543 3456788999999999999999999998643 3468
Q ss_pred EEEEecccCC-hhHhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 148 FLVMEYCEHD-LASLQDNV-ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 148 ~lv~e~~~~~-l~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
|+||||++++ +.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||++.+|.+||+|||+++..
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~ 153 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 153 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceec
Confidence 9999999864 55554432 235899999999999999999999999999999999999999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-34 Score=230.27 Aligned_cols=147 Identities=20% Similarity=0.257 Sum_probs=128.2
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCC-CCeeeeeEEEEcCCcceEEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRH-ENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~lv~ 151 (224)
++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|+..++.+.| +|++.+++++. .....|+||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~--~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ--EGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE--ETTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEee--cCCccEEEE
Confidence 57999999999999999999999999999999875433 23456678888888865 89999998884 345889999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc-----CCcEEEEecccccccc
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND-----KGCVKIVYSTYLELYL 223 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~-----~~~~kl~DfGla~~~~ 223 (224)
||+++++...+......+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+.+.
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 81 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99998888887776778999999999999999999999999999999999999974 5789999999998753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-35 Score=237.81 Aligned_cols=147 Identities=30% Similarity=0.472 Sum_probs=125.5
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcC----Ccce
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGK----SLSS 146 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~~ 146 (224)
++|++++.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+++.++||||++++++|... ....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 579999999999999999999999999999999975432 2334577999999999999999999999643 3368
Q ss_pred EEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 147 IFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 147 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
+|+|||||.++++... ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~iv~Ey~~~~l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEEHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchHHHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcc
Confidence 9999999998877655 346899999999999999999999999999999999999999999999999998754
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-34 Score=232.74 Aligned_cols=151 Identities=21% Similarity=0.260 Sum_probs=125.9
Q ss_pred ccccceeEeeeeeccCceEEEEEEEcc-----CCeEEEEEEeeccCCc-cchhHHHHHHHhhcCCCCCeeeeeEEEEcCC
Q psy13250 70 RNVAEFEKLNRIGEGSYGVVYRVRDSV-----QDKILALKKLFLQNNT-LTRGELREVTGLTKCRHENIVQLKEVVVGKS 143 (224)
Q Consensus 70 ~~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~~~avK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 143 (224)
...++|++.+.||+|+||.||+|.+.. ++..||||++...... ....+.+|+.++++++||||+++++++. .
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~--~ 94 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS--Q 94 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC--S
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe--c
Confidence 345789999999999999999998753 3578999998644332 2345689999999999999999999994 4
Q ss_pred cceEEEEEecccCC-hhHhhhhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEE
Q psy13250 144 LSSIFLVMEYCEHD-LASLQDNV---------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKI 213 (224)
Q Consensus 144 ~~~~~lv~e~~~~~-l~~~~~~~---------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl 213 (224)
....++|||||.++ +..++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++++||
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence 45789999999864 44443321 134789999999999999999999999999999999999999999999
Q ss_pred Eeccccccc
Q psy13250 214 VYSTYLELY 222 (224)
Q Consensus 214 ~DfGla~~~ 222 (224)
+|||+|+.+
T Consensus 175 ~DFGla~~~ 183 (308)
T d1p4oa_ 175 GDFGMTRDI 183 (308)
T ss_dssp CCTTCCCGG
T ss_pred eecccceec
Confidence 999999865
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-34 Score=230.26 Aligned_cols=147 Identities=22% Similarity=0.229 Sum_probs=126.0
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.++|+|++..+..+. ......++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~-~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCG-AEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEE-EETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEE-ecCCEEEEEEE
Confidence 46999999999999999999999999999999876543 2345778999999998887666554443 23457899999
Q ss_pred cccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc---CCcEEEEeccccccc
Q psy13250 153 YCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLND---KGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~---~~~~kl~DfGla~~~ 222 (224)
|+++++..........+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+.+
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 9998888877777778999999999999999999999999999999999999864 457999999999865
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-35 Score=237.18 Aligned_cols=150 Identities=26% Similarity=0.336 Sum_probs=127.4
Q ss_pred cccceeEeeeeeccCceEEEEEEEc---cCCeEEEEEEeeccC----CccchhHHHHHHHhhcCCC-CCeeeeeEEEEcC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS---VQDKILALKKLFLQN----NTLTRGELREVTGLTKCRH-ENIVQLKEVVVGK 142 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~---~~~~~~avK~~~~~~----~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~ 142 (224)
.+++|++++.||+|+||+||+|.+. .+++.||||++.... ....+.+.+|+.+|++++| |||+++++++.+
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~- 100 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT- 100 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc-
Confidence 4578999999999999999999874 468999999885432 2234567789999999976 899999999954
Q ss_pred CcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 143 SLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 143 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
...+|++|||+.++.+.......+.+++..+..++.|++.||+|||+++|+||||||+|||++.+|.+||+|||+|+.+
T Consensus 101 -~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 101 -ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp -TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred -CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 4589999999987544444444567889999999999999999999999999999999999999999999999999865
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-34 Score=231.31 Aligned_cols=145 Identities=26% Similarity=0.266 Sum_probs=122.1
Q ss_pred EeeeeeccCceEEEEEEEccC---CeEEEEEEeeccCC-ccchhHHHHHHHhhcCCCCCeeeeeEEEEcCCcceEEEEEe
Q psy13250 77 KLNRIGEGSYGVVYRVRDSVQ---DKILALKKLFLQNN-TLTRGELREVTGLTKCRHENIVQLKEVVVGKSLSSIFLVME 152 (224)
Q Consensus 77 ~~~~lG~G~fg~V~~~~~~~~---~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 152 (224)
..+.||+|+||+||+|.+..+ ...||||++..... ...+.+.+|+.+|++++||||+++++++... .+..|+|||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~~lv~E 109 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS-EGSPLVVLP 109 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET-TTEEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec-CCceEEEEE
Confidence 357899999999999998654 34689999864332 3446788999999999999999999998643 347899999
Q ss_pred cccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 153 YCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 153 ~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
||+++ +..++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+..
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 180 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCT
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhc
Confidence 99875 44455555566888999999999999999999999999999999999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-34 Score=231.15 Aligned_cols=150 Identities=24% Similarity=0.266 Sum_probs=126.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEc-----cCCeEEEEEEeeccCC-ccchhHHHHHHHhhcC-CCCCeeeeeEEEEcCC
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDS-----VQDKILALKKLFLQNN-TLTRGELREVTGLTKC-RHENIVQLKEVVVGKS 143 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~-----~~~~~~avK~~~~~~~-~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~ 143 (224)
+.++|++.+.||+|+||.||+|.+. .+++.||||++..... .....+.+|+.+++++ +|||||++++++. .
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~--~ 98 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT--I 98 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--S
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe--e
Confidence 4468999999999999999999863 4567999999875443 2344677899999998 6999999999994 4
Q ss_pred cceEEEEEecccCC-hhHhhhhc-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy13250 144 LSSIFLVMEYCEHD-LASLQDNV-----------------ESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL 205 (224)
Q Consensus 144 ~~~~~lv~e~~~~~-l~~~~~~~-----------------~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill 205 (224)
...+|++||||+++ +..++... ...+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc
Confidence 45789999999865 44443322 2358999999999999999999999999999999999999
Q ss_pred ccCCcEEEEeccccccc
Q psy13250 206 NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 206 ~~~~~~kl~DfGla~~~ 222 (224)
+.++.+|++|||+|+..
T Consensus 179 ~~~~~~ki~DfG~~~~~ 195 (311)
T d1t46a_ 179 THGRITKICDFGLARDI 195 (311)
T ss_dssp ETTTEEEECCCGGGSCT
T ss_pred cccCcccccccchheec
Confidence 99999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-34 Score=231.34 Aligned_cols=150 Identities=21% Similarity=0.302 Sum_probs=120.6
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCC-------eEEEEEEeeccCCc-cchhHHHHHHHhhcC-CCCCeeeeeEEEEc
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQD-------KILALKKLFLQNNT-LTRGELREVTGLTKC-RHENIVQLKEVVVG 141 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~-------~~~avK~~~~~~~~-~~~~~~~e~~~l~~l-~h~niv~~~~~~~~ 141 (224)
+.++|++.+.||+|+||.||+|+...++ ..||||++...... ....+.+|...+.++ +|||||++++++.+
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 4578999999999999999999876544 47999998654432 335667888888877 79999999999954
Q ss_pred CCcceEEEEEecccCC-hhHhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy13250 142 KSLSSIFLVMEYCEHD-LASLQDNVE---------------SPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLL 205 (224)
Q Consensus 142 ~~~~~~~lv~e~~~~~-l~~~~~~~~---------------~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill 205 (224)
.+.+|+|||||.++ +..++.... ..+++..++.++.|++.||.|||+++|+||||||+|||+
T Consensus 91 --~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 91 --DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp --SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred --CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 45899999999865 555543322 358999999999999999999999999999999999999
Q ss_pred ccCCcEEEEeccccccc
Q psy13250 206 NDKGCVKIVYSTYLELY 222 (224)
Q Consensus 206 ~~~~~~kl~DfGla~~~ 222 (224)
+.++.+||+|||+++..
T Consensus 169 ~~~~~~kl~dfg~~~~~ 185 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDI 185 (299)
T ss_dssp CTTCCEEECSTTCCCCG
T ss_pred cCCCCeEeccchhhccc
Confidence 99999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-34 Score=234.01 Aligned_cols=149 Identities=32% Similarity=0.486 Sum_probs=121.2
Q ss_pred ccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCC--ccchhHHHHHHHhhcCCCCCeeeeeEEEEcC----Ccc
Q psy13250 72 VAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNN--TLTRGELREVTGLTKCRHENIVQLKEVVVGK----SLS 145 (224)
Q Consensus 72 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~ 145 (224)
.++|++++.||+|+||+||+|++..+++.||||++..... ...+.+.+|+.+|+.++|||||++++++... ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 3579999999999999999999999999999999865432 2334677999999999999999999998532 222
Q ss_pred eEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEeccccccc
Q psy13250 146 SIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYSTYLELY 222 (224)
Q Consensus 146 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfGla~~~ 222 (224)
..|+++++++++|..++. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|...
T Consensus 97 ~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence 345555554556666553 356999999999999999999999999999999999999999999999999998653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-34 Score=228.63 Aligned_cols=143 Identities=26% Similarity=0.316 Sum_probs=118.9
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHH--HHHHHhhcCCCCCeeeeeEEEEcCCc--ceEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGEL--REVTGLTKCRHENIVQLKEVVVGKSL--SSIF 148 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~--~e~~~l~~l~h~niv~~~~~~~~~~~--~~~~ 148 (224)
.+|.+.+.||+|+||.||+|+. ++..||||++.... ..... .|+..+..++||||+++++++..+.. ..+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 3689999999999999999986 58899999886432 22333 35556667899999999999975443 3689
Q ss_pred EEEecccCC-hhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCcEEEccCCcEEEEecccc
Q psy13250 149 LVMEYCEHD-LASLQDNVESPFTESQVKCVILQVLKGLNYLHS--------NFIIHRDLKPSNLLLNDKGCVKIVYSTYL 219 (224)
Q Consensus 149 lv~e~~~~~-l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~--------~~iiHrDlkp~Nill~~~~~~kl~DfGla 219 (224)
+|||||.++ +..++.. ..+++.....++.|++.||.|+|+ ++|+||||||+|||++.++.+||+|||+|
T Consensus 78 lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999864 5555543 368999999999999999999996 59999999999999999999999999999
Q ss_pred ccc
Q psy13250 220 ELY 222 (224)
Q Consensus 220 ~~~ 222 (224)
+.+
T Consensus 156 ~~~ 158 (303)
T d1vjya_ 156 VRH 158 (303)
T ss_dssp EEE
T ss_pred ccc
Confidence 865
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=6e-29 Score=203.11 Aligned_cols=149 Identities=24% Similarity=0.343 Sum_probs=119.3
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-----------CCCeeeeeEEEEc
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-----------HENIVQLKEVVVG 141 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~ 141 (224)
++|+++++||+|+||+||+|++..+++.||||++.... ...+...+|+.+++.+. |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999999999999999986432 22345567777776654 6889999998865
Q ss_pred CCcceEEEEEecccC--ChhH-hhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCc------E
Q psy13250 142 KSLSSIFLVMEYCEH--DLAS-LQDNVESPFTESQVKCVILQVLKGLNYLHS-NFIIHRDLKPSNLLLNDKGC------V 211 (224)
Q Consensus 142 ~~~~~~~lv~e~~~~--~l~~-~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~iiHrDlkp~Nill~~~~~------~ 211 (224)
......+++|+++.. +... ........+++..+..++.|++.||+|||+ +||+||||||+|||++.++. +
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 555567777777653 2222 233335678999999999999999999997 89999999999999987664 9
Q ss_pred EEEeccccccc
Q psy13250 212 KIVYSTYLELY 222 (224)
Q Consensus 212 kl~DfGla~~~ 222 (224)
+++|||.|+..
T Consensus 172 kl~dfg~s~~~ 182 (362)
T d1q8ya_ 172 KIADLGNACWY 182 (362)
T ss_dssp EECCCTTCEET
T ss_pred eEeeccccccc
Confidence 99999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.95 E-value=2.3e-28 Score=182.72 Aligned_cols=133 Identities=15% Similarity=0.081 Sum_probs=103.1
Q ss_pred eeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCc------------------cchhHHHHHHHhhcCCCCCeeeee
Q psy13250 75 FEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNT------------------LTRGELREVTGLTKCRHENIVQLK 136 (224)
Q Consensus 75 ~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~niv~~~ 136 (224)
+.+.++||+|+||+||+|.+. +++.||||+++..... ......+|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 457789999999999999885 6899999987532110 011223577788899999999887
Q ss_pred EEEEcCCcceEEEEEecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCcEEEEec
Q psy13250 137 EVVVGKSLSSIFLVMEYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHSNFIIHRDLKPSNLLLNDKGCVKIVYS 216 (224)
Q Consensus 137 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~iiHrDlkp~Nill~~~~~~kl~Df 216 (224)
++. . .+++|||+++..... ++...+..++.|++.+|.|||++||+||||||+|||++++ .++|+||
T Consensus 81 ~~~--~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWE--G----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEE--T----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred Eec--C----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 664 2 269999998753321 3445567889999999999999999999999999999865 5899999
Q ss_pred cccccc
Q psy13250 217 TYLELY 222 (224)
Q Consensus 217 Gla~~~ 222 (224)
|+|+..
T Consensus 147 G~a~~~ 152 (191)
T d1zara2 147 PQSVEV 152 (191)
T ss_dssp TTCEET
T ss_pred CCcccC
Confidence 999754
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.74 E-value=3.8e-08 Score=74.87 Aligned_cols=139 Identities=16% Similarity=0.062 Sum_probs=82.7
Q ss_pred cceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCC-CCCeeeeeEEEEcCCcceEEEEE
Q psy13250 73 AEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCR-HENIVQLKEVVVGKSLSSIFLVM 151 (224)
Q Consensus 73 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~ 151 (224)
..|+..+..+-++.+.||+.. ..+..+.+|+.............+|...+..+. +--+.+++.+.. ..+..|+||
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~--~~~~~~lv~ 89 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER--HDGWSNLLM 89 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE--ETTEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe--cCCceEEEE
Confidence 456766665555567899875 345667788775444334445567777665543 222344555543 335789999
Q ss_pred ecccCChhHhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q psy13250 152 EYCEHDLASLQDNVESPFTESQVKCVILQVLKGLNYLHS----------------------------------------- 190 (224)
Q Consensus 152 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~----------------------------------------- 190 (224)
++++|........ ..... ..++.++...+..||+
T Consensus 90 ~~l~G~~~~~~~~--~~~~~---~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 90 SEADGVLCSEEYE--DEQSP---EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp ECCSSEEHHHHTT--TCSCH---HHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred Eeccccccccccc--ccccH---HHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 9998743321111 00111 1122333333333332
Q ss_pred ------------------CCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 191 ------------------NFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 191 ------------------~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
..++|+|+.|.|||++.++.+-|+||+.|.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 127899999999999976666799998875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.38 E-value=5.3e-07 Score=72.77 Aligned_cols=75 Identities=19% Similarity=0.211 Sum_probs=44.9
Q ss_pred eeeeeccCceEEEEEEEccCCeEEEEEEeecc----CC---ccchhHHHHHHHhhcCC---CCCeeeeeEEEEcCCcceE
Q psy13250 78 LNRIGEGSYGVVYRVRDSVQDKILALKKLFLQ----NN---TLTRGELREVTGLTKCR---HENIVQLKEVVVGKSLSSI 147 (224)
Q Consensus 78 ~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~----~~---~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~ 147 (224)
.+.||.|....||++....+++.+++|..... .. ....+...|...|..+. ...+.+++.+. +. ..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~--~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE--MA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT--TT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CC--CC
Confidence 45789999999999987777778899965321 11 12234456777665442 23455565543 33 34
Q ss_pred EEEEecccC
Q psy13250 148 FLVMEYCEH 156 (224)
Q Consensus 148 ~lv~e~~~~ 156 (224)
++|||++++
T Consensus 107 ~lvmE~L~~ 115 (392)
T d2pula1 107 VTVMEDLSH 115 (392)
T ss_dssp EEEECCCTT
T ss_pred EEEEeccCC
Confidence 689999975
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.22 E-value=6.4e-06 Score=61.82 Aligned_cols=71 Identities=14% Similarity=0.107 Sum_probs=42.5
Q ss_pred eeeccCc-eEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCC--CCeeeeeEEEEcCCcceEEEEEecccC
Q psy13250 80 RIGEGSY-GVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRH--ENIVQLKEVVVGKSLSSIFLVMEYCEH 156 (224)
Q Consensus 80 ~lG~G~f-g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~lv~e~~~~ 156 (224)
.+..|.. +.||+.... .+..+.+|...... ...+..|...++.+.. -.+.+++.+.. +.+..|+||++++|
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~--~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVT--EAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEE--CSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecc--cccceEEEEEeeec
Confidence 4445553 678987753 45567788654332 2334566666655432 22445565553 34578999999986
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.23 E-value=0.00082 Score=53.49 Aligned_cols=71 Identities=15% Similarity=0.147 Sum_probs=43.0
Q ss_pred eeeeeccCceEEEEEEEccC-------CeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCe-eeeeEEEEcCCcceEEE
Q psy13250 78 LNRIGEGSYGVVYRVRDSVQ-------DKILALKKLFLQNNTLTRGELREVTGLTKCRHENI-VQLKEVVVGKSLSSIFL 149 (224)
Q Consensus 78 ~~~lG~G~fg~V~~~~~~~~-------~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~l 149 (224)
++.|+.|-.-.+|++..... ...+.+++. .. ........+|..+++.+.-.++ .++++++ ++ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~-g~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~--~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVY-FN-PETESHLVAESVIFTLLSERHLGPKLYGIF--SG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEE-CS-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEec-CC-cchhhHHHHHHHHHHHHHhCCCCCeEEEEc--CC----ce
Confidence 35788899999999886432 244555543 22 2222334567777766542233 3667666 33 57
Q ss_pred EEecccC
Q psy13250 150 VMEYCEH 156 (224)
Q Consensus 150 v~e~~~~ 156 (224)
|+||++|
T Consensus 119 I~efi~g 125 (395)
T d1nw1a_ 119 LEEYIPS 125 (395)
T ss_dssp EECCCCE
T ss_pred EEEEecc
Confidence 8999986
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.02 E-value=0.00048 Score=53.41 Aligned_cols=28 Identities=25% Similarity=0.286 Sum_probs=23.1
Q ss_pred CCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 191 NFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 191 ~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.++||+|+.+.|||++. + ..++||+-++
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence 36899999999999963 3 4589999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.42 E-value=0.00035 Score=53.76 Aligned_cols=30 Identities=17% Similarity=0.166 Sum_probs=27.2
Q ss_pred CCceecCCCCCcEEEccCCcEEEEeccccc
Q psy13250 191 NFIIHRDLKPSNLLLNDKGCVKIVYSTYLE 220 (224)
Q Consensus 191 ~~iiHrDlkp~Nill~~~~~~kl~DfGla~ 220 (224)
.|+||+|+.++||+++.+...-|+||+.|.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988777899999885
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=85.93 E-value=3.5 Score=30.84 Aligned_cols=141 Identities=14% Similarity=0.179 Sum_probs=69.0
Q ss_pred cccceeEeeeeeccCceEEEEEEEccCCeEEEEEEeeccCCccchhHHHHHHHhhcCCCCCeeeeeEEE-----------
Q psy13250 71 NVAEFEKLNRIGEGSYGVVYRVRDSVQDKILALKKLFLQNNTLTRGELREVTGLTKCRHENIVQLKEVV----------- 139 (224)
Q Consensus 71 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~----------- 139 (224)
+.+.++.++.=-.|+-|..|. . . .+..+++|-- .....+.+..++...-.+.-|....+...-
T Consensus 67 ~l~~~K~i~~s~~Gs~Gv~FV-~-~-e~gaiVlK~s---~tta~E~y~~eLAr~LGvpvPqmRvI~~~~~E~~~~~~~~l 140 (342)
T d1cjaa_ 67 NLQQFKGIERSEKGTEGLFFV-E-T-ESGVFIVKRS---TNIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLA 140 (342)
T ss_dssp CGGGEEEEEECCSTTSCEEEE-E-E-SSCEEEEECC---TTHHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHH
T ss_pred hHHhhhceEEeecCCceEEEE-E-c-CCceEEEecC---CchHHHHHHHHHHHHhCCCCCceEEecCCCHHHHHHHHHHh
Confidence 345566666655677776664 2 2 3445567742 222223333444444445555554432000
Q ss_pred ---------EcCCcceEEEEEecccCChhHhhhhc--CCCCCHHHHHHHHHHHHHHHH-HHHhC---CceecCC-CCCcE
Q psy13250 140 ---------VGKSLSSIFLVMEYCEHDLASLQDNV--ESPFTESQVKCVILQVLKGLN-YLHSN---FIIHRDL-KPSNL 203 (224)
Q Consensus 140 ---------~~~~~~~~~lv~e~~~~~l~~~~~~~--~~~l~~~~~~~~~~~i~~~l~-~lH~~---~iiHrDl-kp~Ni 203 (224)
...-.....++|||..|..+...... ...+....+..+.+ +-+++ +++.. .+++|+- .+.||
T Consensus 141 ~~~e~d~~I~sel~~A~~liMeYvpG~~l~e~~~~~a~~~fs~~~l~~LGk--IiaFDifInN~DR~PL~Wrn~GN~~Ni 218 (342)
T d1cjaa_ 141 AIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLGS--LMALDVIVNNSDRLPIAWTNEGNLDNI 218 (342)
T ss_dssp HHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHHH--HHHHHHHHTCCSSSCSSSCSCCCGGGE
T ss_pred cCCChhHHHHHHHhcccceeeeccCCccccccccccchhhhcHHHHHHhhh--HHHHHHHHcCCccccccccCCCCccce
Confidence 00011235789999987432211110 00123333322211 22333 45532 3566632 79999
Q ss_pred EEccCC-cEEEEecccc
Q psy13250 204 LLNDKG-CVKIVYSTYL 219 (224)
Q Consensus 204 ll~~~~-~~kl~DfGla 219 (224)
++..++ .+..+|-|..
T Consensus 219 ml~~n~~~~~~IDs~i~ 235 (342)
T d1cjaa_ 219 MLSERGATVVPIDSKII 235 (342)
T ss_dssp EEESBTTCEEECSCCCC
T ss_pred EEecCCcEEEEecCCcc
Confidence 999877 6788887665
|